

ACCESSION NUMBER:		0001140361-15-013726
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		17
CONFORMED PERIOD OF REPORT:	20141231
FILED AS OF DATE:		20150331
DATE AS OF CHANGE:		20150331
FILER:
	COMPANY DATA:	
		COMPANY CONFORMED NAME:			RiceBran Technologies
		CENTRAL INDEX KEY:			0001063537
		STANDARD INDUSTRIAL CLASSIFICATION:	GRAIN MILL PRODUCTS [2040]
		IRS NUMBER:				870673375
		STATE OF INCORPORATION:			CA
		FISCAL YEAR END:			1231
	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36245
		FILM NUMBER:		15740346
	BUSINESS ADDRESS:	
		STREET 1:		6720 N SCOTTSDALE RD
		STREET 2:		SUITE 390
		CITY:			SCOTTSDALE
		STATE:			AZ
		ZIP:			85253
		BUSINESS PHONE:		6025223000
	MAIL ADDRESS:	
		STREET 1:		6720 N SCOTTSDALE RD
		STREET 2:		SUITE 390
		CITY:			SCOTTSDALE
		STATE:			AZ
		ZIP:			85253
	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NUTRACEA
		DATE OF NAME CHANGE:	20030930
	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NUTRASTAR INC
		DATE OF NAME CHANGE:	20011221
	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ALLIANCE CONSUMER INTERNATIONAL INC
		DATE OF NAME CHANGE:	20010418











    Document created using Disclosure Solutions PROFILE 3.2.1.0





























































 Suite # 390 Scottsdale



















 Including Area Code:







Common Stock
 no par value









 and (2) has been subject to such filing requirements for the past 90 days.&#160; Yes &#9746; No &#9744;


 if any
 every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).&#160; Yes &#9746; No &#9744;


 and will not be contained
 to the best of the registrant&#8217;s knowledge
 in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.&#160; &#9744;


 an accelerated filer
 a non-accelerated filer


















&#160;

 as amended).&#160; YES &#9744; NO &#9746;


 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court.&#160; &#160; Yes&#160; &#9746;&#160;&#160;&#160; No&#160; &#9744;


 2014
 the aggregate market value of our common stock held by non-affiliates was $35
220



 2015
 there were 9
386
822 shares of common stock outstanding. 





 which Definitive Proxy Statement will be filed with the Commission not later than 120 days after the registrant&#8217;s fiscal year ended December 31
 2014











































































































Market for Registrant&#8217;s Common Equity
 Related Stockholder Matters and Issuer Purchases of Equity Securities





































































































Directors
 Executive Officers and Corporate Governance



































Certain Relationships and Related Transactions
 and Director Independence

















































 but are based on current expectations
 estimates and projections about our industry
 our beliefs and our assumptions.&#160; Words such as &#8220;believes
&#8221; &#8220;anticipates
&#8221; &#8220;expects
&#8221; &#8220;intends&#8221; and similar expressions are intended to identify forward-looking statements
 but are not the exclusive means of identifying such statements.&#160; These forward-looking statements are not guarantees of future performance and concern matters that could subsequently differ materially from those described in the forward-looking statements.&#160; Actual events or results may also differ materially from those discussed in this Annual Report.&#160; These risks and uncertainties include those described in &#8220;Risk Factors&#8221; and elsewhere in this Annual Report.&#160; Except as required by law






















 functional food ingredient
&#160; packaged functional food and animal nutrition company focused on value-added processing and marketing of healthy
 natural and nutrient dense products derived from raw rice




 we apply our proprietary and patented technologies and intellectual properties to convert raw rice bran into numerous high value products including stabilized rice bran (SRB)
 rice bran oil (RBO)
 defatted rice bran (DRB) and derivative products including: RiBalance
 a complete rice bran nutritional package derived from further processing of SRB; RiSolubles
 a highly nutritious
 carbohydrate and lipid rich fraction of RiBalance; RiFiber
 a fiber rich insoluable derivative of RiBalance
 and ProRyza
 rice bran protein-based products




 functional food
 cosmetic and animal nutrition manufacturers
 wholesalers and retailers




 which manufactures and distributes SRB (for human food ingredient and animal nutrition customers) and derivative&#160; products (ii) Brazil segment
 which extracts crude RBO and DRB from rice bran
 which are then further processed into fully refined rice bran oil for sale internationally and in Brazil
 compounded animal nutrition products for horses
 cows
 swine
 sheep and poultry and a number of human food and animal nutrition products
 derivatives and co-products. We incur corporate and other expenses not directly attributable to operating segments
 which include costs related to our corporate staff
 general and administrative expenses including public company expenses
 intellectual property
 professional fees
 and other expenses.&#160; No Corporate allocations
 including interest




 value-added constituents and finished products.&#160; Over the past decade
 we have developed and optimized our proprietary bio-refining processes to support the production of healthy
 natural
 hypoallergenic
 gluten free
 and non-genetically modified ingredients for use in meats
 baked goods
 cereals
 coatings
 health foods
 nutritional supplements





 2014
 we acquired H&amp;N Distribution Inc.
 an Irving
 Texas based company now operating as Healthy Natural
 Inc. (HN) which has a formulating
 blending and co-packaging facility in Irving
 Texas





 through our Delaware subsidiary Nutra S.A.
Irgovel)
 our rice bran oil processing plant in Pelotas
 Brazil.&#160; During 2011
 we sold a minority interest in Nutra SA




 1998.&#160; From July 2003 until October 2012













 located within supplier rice mills in Arbuckle and West Sacramento
 California
 and one owned facility in Mermentau
 Louisiana.&#160; At Dillon
 Montana
 the USA segment also produces our Stage II products including: RiSolubles
 a highly nutritious
 carbohydrate and lipid rich fraction of SRB; RiFiber
 a fiber rich derivative of SRB; RiBalance
 a complete rice bran nutritional package derived from further processing RiBalance
 and ProRyza
 protein-based products.&#160; &#8220;Stage II&#8221; refers to the proprietary processes run at our Dillon
 Montana facility and describes products produced at that facility using our patented processes.&#160; The manufacturing facilities included in our USA segment have proprietary processing equipment and process patented technology for the stabilization and further processing of rice bran into finished products.&#160; Beginning January 2
 2014
 with the acquisition of HN
 we also formulate and copack products at a leased facility in Irving Texas.&#160; We lease a facility in West Sacramento
 California that houses a laboratory
 warehouse and production facilities.&#160; We use an owned facility in Lake Charles
 Louisiana as a temporary warehouse.&#160; In 2014







 whose only operating subsidiary is Irgovel
 located in Pelotas
 Brazil.&#160; Irgovel manufactures RBO and DRB products for both the human ingredient and animal nutrition markets in Brazil and internationally.&#160; In refining RBO to an edible grade
 several co-products are obtained.&#160; One such product is distilled fatty acids
 a valuable raw material for the detergent industry.&#160; Irgovel also produces rice lecithin
 which has application in human nutrition
 animal nutrition and industrial applications.&#160; DRB is compounded with a number of other ingredients to produce complex animal nutrition products which are packaged and sold under Irgovel brands in the Brazilian market
 sold as a raw material for further processing into human food ingredients or sold in bulk into the animal nutrition markets in Brazil and neighboring countries.&#160; In 2014
 approximately 39% of Brazil segment product revenue was from sales of RBO products and the remainder was from sales of DRB products.&#160; Irgovel
 however
 was shut down for a portion of 2014 to complete the final stages of a capital expansion project
 which caused a temporary change in sales mix.&#160; We expect RBO sales to return to historical levels
 approximately 45% of product revenues




 Brazil.&#160; These facilities include a plant for extraction of RBO from raw rice bran
 RBO refining processes
 compounded animal nutrition manufacturing
 consumer RBO bottling
 distilled fatty acid manufacture
 lecithin manufacture
 and support systems for the plant
 including steam generation
 maintenance








 we entered into a membership interest purchase agreement with AF Bran Holdings-NL LLC and AF Bran Holdings LLC (collectively
 the Investors) and sold a minority interest in Nutra SA to the Investors in January 2011.&#160; The Investors initially purchased a 35.6% interest in Nutra SA.&#160; The Investors ownership percentage in Nutra SA averaged 40.0% in 2014 and 49.0% in 2013 and was 34.7% at December 31
 2014.&#160; Under agreements with the Investors






 2016.&#160; The right terminates upon the occurrence of certain events (a $50.0 million Nutra SA initial public offering or a change of control





 as amended (LLC agreement)
 any units of membership interest held by the Investors beginning January 1
 2014
 accrue a yield at 4% (the Yield).&#160; Commencing with the first quarter of 2014
 Nutra SA must make distributions to the Investors quarterly in the amount equal to the previously accrued and unpaid Yield plus any additional distributions owed to the Investors
 to the extent there is distributable cash




 Nutra SA must distribute all distributable cash (as defined in the LLC Agreement) to the members on March 31 of each year as follows: (i) first
 to the Investors in an amount equal to 2.3 times the Investors&#8217; capital contributions
 less the aggregate amount of distributions paid to the Investors
 (ii) second
 to us in an amount equal to two times the capital contributions made by us
 less the aggregate amount of distributions paid to us; and (iii) third










 the business of Nutra SA is to be conducted by the manager
 currently our CEO
 subject to the oversight of the management committee.&#160; The management committee is comprised of three of our representatives and two Investor representatives.&#160; Upon an event of default or a qualifying event
 we will no longer control the management committee and the management committee will include three Investor representatives and two of our representatives.&#160; In addition
 following an event of default or a qualifying event







 our greatest opportunities are in the functional food











 nutritional supplement retailers and direct sales companies.&#160; In August 2013
 we entered into a multi-year agreement to sell certain of our Stage II products to a rapidly growing direct marketing company.&#160; Pursuant to that agreement
 that company is obligated to purchase a minimum of $7.7 million in products during the term of the agreement which expires in December 2016.&#160; We will seek additional long-term supply agreements with similar companies in the future.&#160; As part of this strategy







 DRB
 RBO and derivatives are nutritional
 economical and beneficial food products that contain a unique combination of oil
 protein
 carbohydrates
 vitamins
 minerals
 fibers
 and antioxidants that enhance the nutritional value of popular consumer products.&#160; Foods that are ideally suited for the addition of our SRB and DRB to their products include processed meats
 cereals
 baked goods
 breading and batters.&#160; The inclusion of DRB in breading and batters can result in a reduction in oil uptake
 higher moisture retention
 improved nutritional profiles




 we received USDA/FSIS approval to market rice bran as an ingredient to be used as a filler in comminuted meat products
 such as meat and poultry sausages that contain binders
 nugget-shaped patties
 meatballs
 meatloaf
 and meat and poultry patties.&#160; Our products replace functional ingredients like soy protein isolate
 soy protein concentrate
 modified food starch
 pea protein and mustard flour at a significantly reduced cost.&#160; With strong application benefits such as reduced cost per unit
 increased product yield and reduced purge







 we also blend DRB with other ingredients to produce a variety of feed formulations targeted to animal species such as horses
 beef cattle
 dairy cows
 pigs







 Brazil and the United States rank 9th and 10th
 respectively
 in production of rice




 individual rice kernels are stored in common receiving locations such as farm silos for future delivery to grain dryers or area rice mills.&#160; At this stage
 large quantities of individual rice kernels are collectively called &#8220;paddy rice
&#8221; or &#8220;rough&#8221; rice.&#160; In this form
 the rice kernel is fully enveloped by the rice hull
 which serves as a protective cover










 if necessary
 paddy rice is cleaned of foreign material (scalping
 de-stoning and aspiration) just before it enters the first stage of milling
 or paddy husking.&#160; In the paddy husker
 the hull is removed from rough rice by differential speed rubber rollers.&#160; Loosened hulls are carried off by aspiration.&#160; After husking




 the outer brown layers of bran are removed from the inner white starch endosperm by an abrasive or frictional milling process which produces a milled
 white rice kernel.&#160; After milling
 white rice is typically sorted by size to remove broken pieces of rice kernels from whole kernels




 testa
 nucellus and aleurone) surrounding the white starchy endosperm.&#160; Commercial rice bran makes up approximately 10% of rough rice by weight.&#160; Rice germ
 an especially nutrient rich material




 the oils present in raw rice bran come into contact with native lipase enzymes that are naturally present in the rice kernel.&#160; These lipase enzymes initiate a rapid enzymatic hydrolysis of the oil
 converting oils (triglycerides) into monoglycerides
 diglycerides and free fatty acids (FFA).&#160; As the FFA content builds in raw rice bran
 the bran becomes unpalatable and off flavors (rancidity) develop.&#160; If left unchecked
 enzymatic degradation at normal room temperatures can increase the FFA levels to 5-8% within 24 hours and can continue at a rate of approximately 4-5% per day thereafter.&#160; Enzymatic degradation is the most serious form of degradation of raw rice bran. Rice bran stabilization is the process of carefully deactivating native enzymes to prevent the increase of FFA otherwise caused by lipase enzyme activity. Proper stabilization is critical in the preservation of the nutritional value of the bran




 including the use of chemicals
 microwave heating










 pressure and other conditions necessary to thoroughly deactivate enzymes without significantly damaging the structure or nutrient content of raw rice bran.&#160; This means that higher value compounds in bran
 such as oils




 on the premises of or in near proximity to any conventional rice mill so that freshly milled raw rice bran can be quickly delivered to our proprietary stabilizers.&#160; Process logic controllers maintain exact process conditions within the prescribed pressure/temperature regime.&#160; In case of power failure or interruption of the flow of fresh bran into the system








000 pounds of bran per hour and has a capacity of over 7
200 tons per year.&#160; Stabilization production capacity can be doubled
 tripled or further multiplied by installing additional units sharing a common conveyor and stage system
 which we believe can handle the output of the world&#8217;s largest rice mills.&#160; We have also developed and tested a smaller production unit
 with a maximum production capacity of 840 tons per year




 including proteins
 fibers
 lipids and micronutrients such as vitamins
 minerals and phytosterols
 among others.&#160; In these processes SRB or DRB
 in an aqueous slurry
 is treated with one or more enzymes













 vitamins
 antioxidants






















































































 raw rice bran is obtained from a number of rice mills and transported to a facility within which it is first stabilized via extrusion and then solvent extracted to produce crude RBO and DRB.&#160; Crude RBO is subsequently processed in a number of steps designed to sequentially capture constituents of value and to remove and discard impurities.&#160; The final outcome of these steps is a highly refined
 edible RBO that has superior flavor and functional properties.&#160; In addition
 the various co-products of crude RBO processing
 distilled fatty acids for example
 are refined and sold as products in their own right.&#160; DRB is finely ground and packaged for use as a versatile food ingredient in many applications.&#160; DRB may also be compounded with other ingredients such as a vegetable proteins
 carbohydrates




 except that the oil has been removed.&#160; This is important for several ingredient applications where SRB&#8217;s oil content could present food formulation challenges.&#160; By removing oil from SRB
 nutritionists have greater options to formulate DRB into breakfast bars
 low-calorie foods
 low-fat baking applications and batter and breading for frying applications.&#160; Additionally
 DRB is ideally suited for downstream enzymatic processing




 RBO becomes high quality cooking oil possessing beneficial high temperature frying characteristics.&#160; RBO has a unique fatty acid content that imparts improved oxidative stability as compared to other vegetable oils such as soy or cottonseed giving it advantages when used in food applications.&#160; The RBO extraction process utilized at our Brazilian facility uses a conventional solvent extraction process to separate oil from raw bran
 resulting in crude RBO available for sale to industrial markets or other processors.&#160; Additional refining processes done in Brazil can involve degumming
 neutralization
 bleaching















 &#8211; Our Brazil segment currently sells all of the rice bran oil it can produce in our oil extraction and refining plant in Pelotas
 Brazil.&#160; Following the capital expansion project at this plant











 &#8211; We have co-developed proprietary technologies with DSM Innovation Center
 a subsidiary of Royal DSM N.V.
 that enables the extraction of protein from DRB and SRB feed-stocks that we produce in both of our Brazil and USA segments.&#160; We recently launched new protein products from our U.S. operations based on these technologies and plan to produce protein from DRB in our Brazil segment in the future.&#160; In addition
 we have entered into a series of agreements with various affiliates of Wilmar International Limited (collectively
 Wilmar) to develop and commercialize rice bran products
 including protein

















 &#8211; The market for healthy and nutritious foods is rapidly expanding in the US
 Europe and other global markets with increasing demand for healthy
 natural and minimally processed ingredients that are hypoallergenic
 non-genetically modified
 and produced in a sustainable fashion.&#160; The regulatory need to add front-of-label warnings on food items is driving food companies to replace standard food ingredients like soy and wheat with &#8220;cleaner&#8221; ingredients such as rice bran which is non-allergenic
 non-genetically modified
 natural and minimally processed.&#160; Incorporation of our food ingredients by major global food companies into meats











The value of proprietary

 consumers are becoming more proactive in adopting and maintaining healthier lifestyles through exercise
 balanced nutrition and increased consumption of functional foods and nutraceuticals.&#160; Associated with this trend is higher demand by marketers of nutraceuticals and functional foods for novel functional ingredients and particularly for proprietary and patented ingredients that provide barriers to competition in the marketplace










 the U.S. nutraceutical and functional foods market is projected to reach $75.3 billion in 2017 and grow at compound annual growth rate of nearly 6% between 2013 and 2017.&#160; We have invested significant resources on research and development of rice bran derivatives with health-related applications.&#160; Functionalities for a subset of these products were validated through scientific studies and human clinical studies.&#160; Our portfolio of functional ingredients includes rice bran extracts that demonstrate beneficial properties in areas of cardiovascular health
 weight management
 glucose balance
 inflammatory response and gastrointestinal health.&#160; Premium ingredient manufacturers are in high demand and we are strategically positioned to take advantage of this growing and sustainable market opportunity.&#160; We believe our proprietary technology and patents represent valuable assets for achieving strategic leverage in this industry segment particularly in the nutraceuticals



We believe that marketing our active ingredients directly to formulators and co-packers who manufacture turnkey finished products for direct to consumer marketing companies (i.e. multi-level marketing (MLM)
 web
 radio
 retail) and to active ingredient distributors will reduce new product development cycles and drive sales of our functional ingredients.&#160; Co-packers and distributors of healthy and natural products have established credibility with multiple marketing companies who rely on these businesses to develop and manufacture new turnkey products.&#160; In our experience







In January 2014
 we acquired HN.&#160; By incorporating HN&#8217;s formulating and packaging capabilities into our business model



.&#160; During 2014
 we approximately doubled our capacity to produce certain Stage II products at our Dillon
 Montana facility



As part of our long-term strategy to grow the NFF business
 we will continue to develop functional ingredients and packaged



















000 metric tons per month to approximately 9
000 metric tons per month







 we obtained the right to purchase 45% of the capital stock of any entity Wilmar establishes to develop new products relating to rice bran or its derivative
 as defined in the agreement
 using the intellectual property licensed to Wilmar.&#160; If we decline the right to purchase 45% of the capital stock of any such new entity
 we have the option to purchase 25% of the entity within two years of the entity&#8217;s formation.&#160; The exercise price for this option will equal 25% of the capital investment made in the entity
 plus interest







 with our funding
 suggested that consumption of our RiSolubles nutritional supplements may lower blood glucose levels of type 1 and type 2 diabetes mellitus patients and may be beneficial in reducing high blood cholesterol and high blood lipid levels.&#160; If warranted
 we may develop products which address the use of SRB products as medical foods for
 and to potentially make health benefit claims relating to




 its Soluble and Fiber Fractions on Blood Glucose Levels and Serum Lipid Parameters in Humans with Diabetes Mellitus Types I and II&#8221; published in the Journal of Nutritional Biochemistry (March 2002
 175-187).&#160; The trial produced positive results by showing that the levels of blood lipids and glycosylated hemoglobin were reduced.&#160; Subsequently




 we formed Rice Science
 LLC (Rice Science)
 a Delaware limited liability company
 with Herbal Science Singapore Pte. Ltd. (Herbal Science) to develop nutraceutical extracts and pharmaceutical chemistries from our SRB.&#160; Herbal Science utilized sophisticated methodologies in the identification and isolation of specific biologically active compounds that have been tested for effectiveness against specific disease conditions.&#160; In March 2011
 our partnership with Herbal Science ended with us acquiring the membership interest formerly owned by Herbal Science




 Rice Science conducted research regarding the development of extracts from SRB that would be effective in addressing inflammation and pain. A number of SRB extracts have been tested with two identified as having significant in vitro activities. A blend of these two extracts was created to produce a third extract that exhibits a high level of in vitro inhibition of Cox 1
 Cox 2 and Lox 5 enzymes (Journal of Medicinal Food (2009) 12




 the Cancer Biomarkers Group in the Department of Cancer Studies and Molecular Medicine
 University of Leicester in Leicester
 UK published a research paper evaluating the effect of our SRB in ApcMin mice (British Journal of Cancer (2007) 96
 248-254).&#160; The mice were genetically modified to serve as models for mammary













 we engaged in a joint research project with DSM Innovation Center
 a subsidiary of Royal DSM N.V.
 to develop methods for extracting and concentrating high quality vegetable protein from rice bran.&#160; Combined spending on research and development related to that project totaled $3.0 million.&#160; In March 2013




 we have been issued fourteen additional foreign patents covering the subject areas.&#160; We intend to apply for additional patents in the future as new products




 as we develop improvements we intend to periodically review whether we should seek patent protection for them.&#160; We believe that certain unique products
 and their biological effects







 foreign
 state
 and local government laws and regulations
 including those relating to zoning
 workplace safety
 and accommodations for the disabled
 and our relationship with our employees are subject to regulations
 including minimum wage requirements
 anti-discrimination laws
 overtime and working conditions




 we are affected by extensive laws
 governmental regulations
 administrative determinations
 court decisions and similar constraints.&#160; Such laws
 regulations and other constraints exist at the federal
 state or local levels in the United States
 and at all levels of government in foreign jurisdictions
 including regulations pertaining to the formulation
 manufacturing
 packaging
 labeling
 distribution
 sale and storage of our products.&#160; In addition







 manufacturing
 packaging
 labeling
 advertising
 distribution and sale of our products are subject to regulation by one or more federal agencies
 primarily the FDA
 the FTC
 and the USDA.&#160; Our activities are also regulated by various governmental agencies for the states and localities in which our products are manufactured and sold
 as well as by governmental agencies in certain countries outside the United States
 such as Brazil (discussed below)
 in which our products are manufactured and sold.&#160; Among other matters
 regulation by the FDA and FTC is concerned with product safety and claims made with respect to a product's ability to provide health-related benefits.&#160; Specifically
 the FDA
 under the Federal Food
 Drug
 and Cosmetic Act (FDCA)
 regulates the formulation
 manufacturing
 packaging
 labeling




 primarily the FDA and the FTC
 have a variety of procedures and enforcement remedies available to them
 including initiating investigations
 issuing warning letters and cease-and-desist orders
 requiring corrective labeling or advertising
 requiring consumer redress such as requiring that a company offer to repurchase products previously sold
 seeking injunctive relief or product seizures
 imposing civil penalties or commencing criminal prosecution.&#160; In addition
 certain state agencies have similar authority.&#160; These federal and state agencies have in the past used these remedies in regulating participants in the food and dietary supplement industries




 enacted January 4
 2011
 amended the FDCA to significantly enhance FDA's authority over various aspects of food regulation including dietary supplements.&#160; The FSMA granted FDA mandatory recall authority when the FDA determines there is a reasonable probability that a food is adulterated or misbranded and that the use of
 or exposure to
 the food will cause serious adverse health consequences or death to humans or animals.&#160; One of the FSMA's more significant changes is the requirement of hazard analysis and risk-based preventive controls (HARPC) for all food facilities required to register with the FDA










 unless the substance is generally recognized
 among qualified experts
 as having been adequately shown to be safe under the conditions of its intended use
 or unless the use of the substance is otherwise excluded from the definition of a food additive.&#160; When an additive is proposed for use in a meat
 its safety
 technical function
 and conditions of use must also be evaluated by the USDA.&#160; Because the USDA retains jurisdiction over meat products and food ingredients intended for use in meats










 Livestock and Food Supply (MAPA)
 one of the Federal administrative bodies
 is the primary regulator of agricultural products in Brazil
 and its main activity is the management of public policies to encourage agriculture
 the promotion of agribusiness and the regulation and standardization of services related to the sector.&#160; Amongst other activities
 MAPA is responsible for the regulation and control of pharmaceuticals
 biological products and medicated feed additives for animal use.&#160; MAPA is organized into departments
 each one responsible for different sectors of the nation&#8217;s agribusiness.&#160; Amongst these departments
 the Secretary of Agricultural Defense (SDA) is responsible for implementing the actions of the State which aims at the prevention
 control and eradication of animal diseases and plant pests.&#160; The SDA also contributes to the formulation of the national agricultural policy by planning
 regulating
 coordinating and supervising the activities of agricultural defense throughout the country
 being responsible for the coordination of the Department of Inspection of Livestock Products.&#160; In order to fulfill its mission
 the SDA provides central management and regulatory bodies as well as projections within the states for the implementation and coordination of those activities for which it is responsible.&#160; Furthermore
 ANVISA
 a regulatory agency which operates in all those sectors related to products and services that affect the health of the population
 and with expertise that covers both sanitary regulation and the economic regulation of the market
 contributes to the enforcement of most of the regulations regarding processed food products
 including vegetable oils







 outside independent sales representatives and third party distributors to market our portfolio of products domestically and internationally. In 2014
 three customers accounted for 60% of USA segment revenues. In our Brazil segment
 three customers accounted for 23% of segment revenues. In 2013
 three customers accounted for approximately 38% of USA segment revenues and in our Brazil segment
e continue to diversify our customer base in an attempt to mitigate the concentration of customers. We have recently signed multi-year contracts with two customers who we expect to grow significantly. In addition







 we entered into an agreement with DSM Innovation Center
 a subsidiary of Royal DSM N.V.
 with the goal of developing technology to extract and concentrate protein from rice bran. In March 2013
 the agreement was mutually terminated under terms whereby we each received (i) the right to separately develop
 modify and improve the jointly developed technology owned by the partner and (ii) a nonexclusive
 royalty free




 LLC (RBT PRO) was a wholly owned subsidiary whose only asset was the license acquired in March 2013. In April 2013
 we entered into a series of agreements with Wilmar.&#160; In connection therewith
 we sold a 50% membership interest in RBT PRO to Wilmar for $1.2 million. RBT PRO granted an exclusive
 royalty free
 perpetual sublicense of the license to Wilmar for use throughout China and to us for use worldwide




 and under the agreements
 we obtained the right to purchase 45% of the capital stock of any entity Wilmar establishes to develop new products relating to rice bran or its derivatives
 as defined in the agreement
 using the intellectual property licensed to Wilmar.&#160; If we decline the right to purchase 45% of the capital stock of any such new entity
 we have the option to purchase 25% of the entity within two years of the entity&#8217;s formation.&#160; The exercise price for this option will equal 25% of the capital investment made in the entity
 plus interest













 as such
 have developed significant brand recognition in the animal feed and human food ingredient sectors both domestically and internationally.&#160; Together with our decades of application technology know-how and patented processing methods




 Europe and Asia.&#160; We believe that our major nutritional supplement competitors include producers of isolated soy protein
 wheat bran and oat bran







 we also began to compete in the world's edible oil market.&#160; Our competition for exports of rice bran oil resides primarily in Southeast Asia.&#160; Our branded rice bran oil &#8220;Carreteiro&#8221; competes with other bottled oils such as soy
 palm
 canola
 peanut and others in the Brazilian market.&#160; In addition
 our exported rice bran oil competes with those same oils from other grains







 2014







 our quarterly reports on Form 10-Q and our current reports on Form 8-K.&#160; We make this information available on our website free of charge as soon as reasonably practicable after we electronically file the information with
 or furnish it to
 the SEC.&#160; The contents of our website are not incorporated by reference in this report on Form 10-K and shall not be deemed &#8220;filed&#8221; under the Securities Exchange Act of 1934.&#160; The public may also read and copy any materials that we file with the SEC at the SEC&#8217;s Public Reference Room at 100 F Street
 N.E.
 Washington
 D.C. 20549.&#160; You may obtain information about the Public Reference Room by contacting the SEC at 1-800-SEC-0330.&#160; Reports filed with the SEC are also made available on the SEC website (






 including those described below
 which could adversely affect our business
 financial condition
 results of operations
 cash flows




















 profitability or positive cash flow
 on either a quarterly or annual basis
 and that profitability
 if achieved
 may not be sustained.&#160; If we are unable to achieve or sustain profitability
 we may not be financially viable in the future and may have to curtail
 suspend
 or cease operations
 restructure existing operations to attempt to ensure future viability
 or pursue other alternatives such as re-filing for bankruptcy
 pursuing dissolution and liquidation
 seeking to merge with another company
 selling all or substantially all of our assets or raising additional capital through equity or debt financings.&#160; Because of our recurring losses and negative cash flows from operations




 and losses in the future could cause the trading price of our stock to decline or have a material adverse effect on our financial condition




 we have incurred an accumulated deficit in excess of $240 million.&#160; We may not be able to achieve or maintain profitable operations if achieved.&#160; If our losses continue
 our liquidity may continue to be severely impaired
 our stock price may fall and our shareholders may lose all or a significant portion of their investment.&#160; If we are not able to attain profitability in the near future our financial condition could deteriorate further which could have a material adverse impact on our business and prospects and result in a significant or complete loss of your investment.&#160; Further
 we may be unable to pay our debt obligations as they become due








 strengthen our financial position or to make acquisitions.&#160; Our board of directors has the ability
 without seeking shareholder approval
 to issue convertible debt and additional shares of common stock or preferred stock that is convertible into common stock for such consideration as the board of directors may consider sufficient
 which may be at a discount to the market price.&#160; Any sales of additional equity or convertible debt securities would result in dilution of the equity interests of our existing shareholders
 which could be substantial.&#160; Additionally
 if we issue shares of preferred stock or convertible debt to raise funds
 the holders of those securities might be entitled to various preferential rights over the holders of our common stock
 including repayment of their investment
 and possibly additional amounts
 before any payments could be made to holders of our common stock in connection with an acquisition of us.&#160; Such preferred shares
 if authorized
 might be granted rights and preferences that would be senior to
 or otherwise adversely affect
 the rights and the value of our common stock.&#160; Also








 or difficulties encountered in the implementation of such controls
 could harm our operating results
 cause us to fail to meet our reporting obligations or result in material misstatements in our financial statements.&#160; Any such failure could
 in turn
 affect the future ability of our management to certify that internal control over our financial reporting is effective.&#160; Inferior internal control over financial reporting could also subject us to the scrutiny of the SEC and other regulatory bodies which could cause investors to lose confidence in our reported financial information and could subject us to civil or criminal penalties or shareholder litigation




 if we or our independent registered public accounting firm identify deficiencies in our internal control over financial reporting
 the disclosure of that fact
 even if quickly remedied
 could reduce the market&#8217;s confidence in our financial statements and harm our share price.&#160; Furthermore
 deficiencies could result in future non-compliance with Section 404 of the Sarbanes-Oxley Act of 2002.&#160; Such non-compliance could subject us to a variety of administrative sanctions

















 our anticipated share of this market
 the estimated price and acceptance of our products and other factors.&#160; These assumptions are based on our best estimates
 however our assessments may not prove to be correct.&#160; Any future success may depend upon factors including changes in the dietary supplement industry
 governmental regulation
 increased levels of competition
 including the entry of additional competitors and increased success by existing competitors
 changes in general economic conditions
 increases in operating costs including costs of rice bran
 production
 supplies
 personnel
 equipment










 we expect to review opportunities to buy other businesses or technologies
 such as the acquisition of HN that was completed on January 2
 2014
 that would complement our current products
 expand the breadth of our markets or enhance technical capabilities
 or that may otherwise offer growth opportunities.&#160; Such acquisitions involve numerous risks
























































































































 we have an operation in Brazil which manufactures rice bran oil.&#160; In 2015 we intend to install our proprietary SRB stabilization equipment in South America to allow Irgovel more operating flexibility. There are risks in operating facilities in foreign countries because
 among other reasons
 we may be unable to attract sufficient qualified personnel
 intellectual property rights may not be enforced as we expect
 and legal rights may not be available as contemplated.&#160; Should any of these risks occur
 our ability to expand our foreign operations may be materially limited and we may be unable to maximize the output from these facilities and our financial results may decrease from our anticipated levels.&#160; The inherent risks of international operations could materially adversely affect our business
 financial condition and results of operations.&#160; The types of risks faced in connection with international operations and sales include


























































































































 political and other conditions
 and Brazilian government policies or actions in response to these conditions






 taxation
 credit
 tariff and other policies to influence the course of Brazil&#8217;s economy.&#160; For example
 the government&#8217;s actions to control inflation have at times involved setting wage and price controls
 blocking access to bank accounts
 imposing exchange controls and limiting imports into Brazil.&#160; In addition
 periodically there are disruptions related to national transportation strikes
 like those occurring in February 2015
 which may limit Irgovel&#8217;s ability to receive raw rice bran and ship products to customers.&#160; We have no control over
 and cannot predict




 results of operations
 financial condition and prospects may be adversely affected by
 among others


























 or contraction of the Brazilian economy



























 political


























































 2016.&#160; Should the Investors desire to sell 100% of Nutra SA to a third party
 we are obligated to cooperate in the negotiation and sale of Nutra SA in accordance with the terms of such sale as agreed to thereby.&#160; In the event of a sale
 the Investors are entitled to a preferential return of any proceeds received from the sale of Nutra SA in an amount equal to the amount of their unreturned 4% yield
 plus 2.3 times such investors&#8217; unreturned capital balance
 which amounts must be distributed to such investors before any amounts my be distributed to us.&#160; The unreturned capital balance for the Investors as of March 31
 2015
 is $14.4 million.&#160; Because of these drag along rights
 we will only receive a certain portion of the proceeds if the sales proceeds are greater than the amount of such preferential return










 our new equipment may not perform as expected or may differ from design and/or specifications.&#160; For example
 in August 2014 we experienced a structural breakdown inside the ash house attached to the boiler system at our Irgovel facility.&#160; As a result
 the steam necessary to operate the plant was unavailable and the plant was temporarily shut down.&#160; If we are required to redesign or modify the equipment to ensure that it performs as expected








 Irgovel must meet certain minimum annual processing targets and must achieve EBITDA of at least $4.0 million
 beginning in 2015.&#160; If Irgovel fails to meet these financial requirements
 we could lose management control over Irgovel&#8217;s operations
 and management control would transfer to the other investors in Nutra SA.&#160; Any such change in management control would cause us to no longer consolidate Irgovel&#8217;s financial results with our financial results.&#160; Instead


















 we are subject to the risk of labor disputes
 strikes
 work stoppages and other labor-relations matters.&#160; Our collective bargaining agreement in Brazil has a one-year term and requires that we provide wage adjustments each year.&#160; We may be unable to negotiate new collective bargaining agreements on similar or more favorable terms and may experience work stoppages or other labor problems in the future.&#160; We could experience a disruption of our operations or higher ongoing labor costs
 which could have a material adverse effect on our operating results and financial condition
 potentially resulting in cancelled orders by customers







 pay expenses
 own assets and incur liabilities in countries using currencies other than the U.S. Dollar
 including primarily the Brazilian Real.&#160; Currently
 a significant portion of our revenues and expenses occur in our Brazilian subsidiary
 Irgovel.&#160; Because our consolidated financial statements are presented in U.S. Dollars
 we must translate revenues
 income and expenses
 as well as assets and liabilities
 into U.S. Dollars at exchange rates in effect historically
 during or at the end of each reporting period.&#160; Therefore
 increases or decreases in the value of the U.S. Dollar against the Brazilian Real and any other currency which affects a material amount of our operations
 will affect our revenues
 cost of sales
 gross profit (loss)
 operating expenses
 or other income and expenses and the value of balance sheet items denominated in foreign currencies.&#160; These fluctuations may have a material adverse effect on our financial results.&#160; Disruptions in financial markets may result in significant changes in foreign exchange rates in relatively short periods of time which further increases the risk of an adverse currency effect.&#160; Since we plan to expand our international operations
 we will likely increase our exposure to foreign currency risks.&#160; We do not hedge our currency risk
 and do not expect to











 in 2014
 three customers accounted for 60% of segment revenues and the top ten customers accounted for 75% of segment revenues.&#160; As of December 31
 2014




 three customers accounted for 23% of 2014 segment revenues and our top ten customers accounted for 47% of 2014 segment revenues.&#160; As of December 31
 2014











 the remoteness of the possible risk that a default event will occur
 the potential benefits to our future growth and development
 possible actions to reduce the likelihood of a default event and the benefits from the transaction before entering into a large credit limit for a customer.&#160; Although we analyze these factors
 the ultimate collection of the obligation from the customer may not occur.&#160; Although we continue to expand our customer base in an attempt to mitigate the concentration of credit risk
 the writing off of an accounts receivable balance could have an adverse effect on our results of operations.&#160; Financial instruments that potentially subject us to concentration of credit risk consist primarily of cash and cash equivalents and trade receivables.&#160; Historically
 we have not experienced any loss of our cash and cash equivalents

















 our objective is to protect our profitability
 but also to protect
 to the extent we can
 our ongoing relationships with our distributors and customers.&#160; However
 as part of our credit risk policies
 we occasionally must
 among other things
 cancel
 reduce credit limits and place cash only requirements for certain questionable accounts.&#160; These credit risk policies may negatively impact our relationships with our distributors and customers









 2014
 have been based on SRB produced at our U.S. facilities and RBO extracted at Irgovel.&#160; A decline in the market demand for our SRB and RBO products or the products of other companies utilizing our SRB and RBO products









 food manufacturers
 mass merchandisers and health food retailers









 which is a by-product from milling paddy rice to white rice.&#160; Our ability to manufacture SRB is currently limited to the production capability of our equipment located at our two suppliers&#8217; rice mills in California and our own plant located adjacent to our supplier in Mermentau
 Louisiana.&#160; At the facilities and our value-added product plants in Dillon
 Montana and our facility in Pelotas
 Brazil
 we currently are capable of producing enough finished products to meet current demand.&#160; If demand for our products were to increase dramatically in the future











 for example the current drought in California
 adversely affect the amount of rice planted or harvested








 including nutraceuticals
 functional food ingredients
 rice bran oils
 animal feed supplements and companion pet food ingredients is vigorous
 with a large number of businesses engaged in the various industries.&#160; Many of our competitors have established reputations for successfully developing and marketing their products
 including products that incorporate bran from other cereal grains and other alternative ingredients that are widely recognized as providing similar benefits as rice bran.&#160; In addition
 many of our competitors have greater financial
 managerial
 and technical resources than we do.&#160; If we are not successful in competing in these markets















 sale
 supply
 production and other agreements which govern our business operations.&#160; We also have contractual obligations which require ongoing payments such as various debt agreements and lease obligations and the agreement of Irgovel to pay tax obligations to the Brazilian government.&#160; While we seek to comply at all times with these obligations
 we may not be able to comply with the terms of all contracts during all periods of time
 especially if there are significant changes in market conditions or our financial condition.&#160; If we are unable to comply with our material contractual obligations






 governmental regulations
 administrative determinations
 court decisions and similar constraints both domestically and abroad and our failure to comply with these laws
 regulations and constraints could lead to the imposition of significant penalties or claims




 the formulation
 manufacturing
 packaging
 labeling
 distribution
 sale and storage of our products are affected by extensive laws
 governmental regulations
 administrative determinations
 court decisions and similar constraints.&#160; Such laws
 regulations and other constraints may exist at the federal
 state or local levels in the United States and at all levels of government in foreign jurisdictions.&#160; The dietary supplement and cosmetic industries are subject to considerable government regulation
 both as to efficacy as well as labeling and advertising.&#160; We are subject to regulation by one or more federal agencies including the U.S. Food and Drug Administration (FDA)
 the U.S. Federal Trade Commission (FTC)
 and the U.S. Department of Agriculture (USDA)
 state and local authorities and foreign governmental agencies including the Brazilian National Health Surveillance Agency.&#160; In addition
 the adoption of new regulations or changes in the interpretations of existing regulations may result in significant compliance costs or discontinuation of product sales and may negatively impact the marketing of our products
 resulting in significant loss of sales revenues.&#160; Our failure to comply with these current and new regulations could lead to the imposition of significant penalties or claims









 which involves risks such as product contamination or spoilage
 product tampering and other adulteration of food products.&#160; We may be subject to liability if the consumption of any of our products causes injury
 illness or death.&#160; We maintain a product liability policy for $5.0 million per year in the aggregate.&#160; In addition
 we may voluntarily recall products in the event of contamination or damage.&#160; A significant product liability judgment or a widespread product recall may cause a material adverse effect on our financial condition.&#160; Even if a product liability claim is unsuccessful







 environmental
 fire
 employee
 manufacturing
 shipping and other risks.&#160; Although we have insurance to cover some of these risks
 the amount of this insurance is limited and includes numerous exceptions and limitations to coverage.&#160; In the event we were to suffer a significant uninsured claim




 enforce and protect our patents




 trade secrets and trademarks that we have and to develop and obtain new patents and trademarks for future processes
 machinery
 compounds and products that we develop.&#160; The process of seeking patent protection may be long and expensive
 and patents might not be issued or not be broad enough in scope.&#160; We may not be able to protect our technology adequately










 but infringement claims by third parties
 or claims for indemnification resulting from infringement claims
 could be asserted in the future or that such assertions
 if proven to be accurate
 could have a material adverse effect on our business
 financial condition and results of operations.&#160; In the future
 litigation may be necessary to enforce our patents
 to protect our trade secrets or know-how or to defend against claimed infringement of the rights of others and to determine the scope and validity of the proprietary rights of others.&#160; Any litigation could result in substantial cost and diversion of our efforts and other resources
 which could have a material adverse effect on our financial condition and results of operations.&#160; Adverse determinations in any litigation could result in the loss of our proprietary rights
 subjecting us to significant liabilities to third parties
 require us to seek licenses from third parties or prevent us from manufacturing or selling our systems
 any of which could have a material adverse effect on our financial condition and results of operations.&#160; A license under a third party&#8217;s intellectual property rights might not be available to us on reasonable terms











 including the efforts of John Short (chief executive officer)
 Dale Belt (chief financial officer)
 Mark McKnight (senior vice president sales) and Robert Smith
 PhD (senior vice president of operations and R&amp;D).&#160; Although we have written employment agreements with our CEO and CFO and senior vice president of sales
 such individuals could die
 become disabled
 or resign.&#160; In addition
 our success is dependent upon our ability to attract and retain key management persons for positions relating to the marketing and distribution of our products.&#160; We may not be able to recruit and employ such executives at times and on terms acceptable to us.&#160; Also
 volatility
 lack of positive performance in our stock price and changes in our overall compensation program
 including our equity incentive program











 regulations and standards relating to corporate governance and public disclosure
 including the Sarbanes-Oxley Act of 2002
 and new regulations issued by the SEC
 such as Dodd-Frank
 are creating uncertainty for companies.&#160; In order to comply with these laws
 we may need to invest substantial resources to comply with evolving standards







 unless that officer or director violates a duty of loyalty
 did not act in good faith
 engaged in intentional misconduct or knowingly violated the law
 approved an improper dividend
















































































































 to expand our operations
 domestically and internationally;

















 involving us
 our industry or both;
































 following periods of volatility in the market price of a company&#8217;s securities







 2015
 we had 9
386
822 shares of common stock outstanding and 6
773
601 shares of our common stock were issuable upon exercise of our outstanding options and warrants.&#160; The possibility that substantial amounts of our common stock may be sold by investors or the perception that such sales could occur
 often called &#8220;equity overhang






As of March 31
 2015

489 shares of common stock issuable upon exercise of outstanding warrants that contain antidilution provisions
 with a current exercise price of $5.24






 without further action or vote by holders of our common stock
 has the right to establish the terms
 preference
 rights and restrictions and issue shares of preferred stock.&#160; The terms of any series of preferred stock could be issued with terms
 rights
 preferences and restrictions that could adversely affect the rights of holders of our common stock and thereby reduce the value of our common stock.&#160; The designation and issuance of preferred stock favorable to current management or shareholders could make it more difficult to gain control of our board of directors or remove our current management and may be used to defeat hostile bids for control which might provide shareholders with premiums for their shares.&#160; We have designated and issued five series of preferred stock












 and we also have outstanding warrants listed on the NASDAQ Capital Market under the symbol &#8220;RIBTW&#8221;.&#160; For our common stock and warrants to continue to be listed on the NASDAQ Capital Market
 we must meet the current NASDAQ Capital Market continued listing requirements.&#160; If we were unable to meet these requirements
 including
 but not limited to
 requirements to obtain shareholder approval of a transaction other than a public offering involving the sale or issuance equal to 20% or more of our common stock at a price that is less than the market value of our common stock
 our common stock and warrants could be delisted from the NASDAQ Capital Market.&#160; If our securities were to be delisted from the NASDAQ Capital Market
 our securities could continue to trade on the over-the-counter bulletin board following any delisting from the NASDAQ Capital Market
 or on the Pink Sheets
 as the case may be.&#160; Any such delisting of our securities could have an adverse effect on the market price of
 and the efficiency of the trading market for our securities
 not only in terms of the number of shares that can be bought and sold at a given price
 but also through delays in the timing of transactions and less coverage of us by securities analysts
 if any.&#160; Also
 if in the future we were to determine that we need to seek additional equity capital




















 warehousing
 research and development
 distribution
 and administrative functions.&#160; These facilities consist of both owned and leased properties.&#160; The following table summarizes the properties used to conduct our operations as of March 31




































































































































































































































 Suite 390
 Scottsdale
 AZ&#160; 85253.&#160; We lease approximately 9




 the machinery and equipment are well-maintained











 claims
 proceedings and investigations are pending involving us as described below in this section.&#160; When applicable
 we record accruals for contingencies when it is probable that a liability will be incurred and the amount of loss can be reasonably estimated.&#160; In addition to the matters described herein
 we are involved in or subject to
 or may become involved in or subject to
 routine litigation
 claims
 disputes
 proceedings and investigations in the ordinary course of business
 which in our opinion will not have a material adverse effect on our financial condition







 2008
 former Irgovel stockholder David Resyng filed an indemnification suit against Irgovel
 Osmar Brito and the remaining former Irgovel stockholders (Sellers)
 requesting:&#160; (i) the freezing of the escrow account maintained in connection with the transfer of Irgovel&#8217;s corporate control to us and the presentation of all documentation related to the transaction
 and (ii) damages in the amount of the difference between (a) the sum received by David Resyng in connection with the judicial settlement agreement executed in the action for the partial dissolution of the limited liability company filed by David Resyng against Irgovel and the Sellers and (b) the amount received by the Sellers in connection with the sale of Irgovel&#8217;s corporate control to us




 executed by and among the Sellers and us on January 31
 2008 (Purchase Agreement).&#160; Consequently
 we believe that the responsibility for any indemnity









On February 6
 2009
 the Sellers filed a collection lawsuit against us seeking payment of the second installment of the purchase price under the Purchase Agreement
 which the Sellers allege is approximately $1.0 million.&#160; We have withheld payment of the second installment pending resolution of the Resyng lawsuit noted above.&#160; Our parent company has not been served with any formal notices in regard to this matter.&#160; To date
 only Irgovel has received formal legal notice.&#160; In addition

 2010
 we initiated an arbitration proceeding against the Sellers for breaches of the Purchase Agreement
 including claims related to Sellers&#8217; handling of the Resyng claim and whether any future payments are required under the Purchase Agreement.&#160; On February 25
 2015
 the arbitration panel issued its opinion and ordered the Sellers to pay Irgovel and us R$3.6 million plus arbitration fees
 legal fees



As part of the Purchase Agreement
 $2.0 million was deposited into an escrow account to cover contingencies with the net remaining funds payable to the Sellers upon resolution of all contingencies.&#160; As of December 31 2014 and 2013
 the balance in the escrow account was $1.9 million and is included in restricted cash in our balance sheets.&#160; There is an escrow liability related to the lawsuit in accrued expenses on our balance sheets as of December 2014 and 2013
 totaling $1.6 million.&#160; When the escrow account was funded
 we established an accrued liability equal to the amount of the escrow for contingencies and the net balance due to the Sellers under the terms of the Purchase Agreement.&#160; As of December 31
 2014
 $0.5 million of pre-acquisition contingencies have either been paid or specifically identified and accrued

 w


Diabco Life Sciences
 LLC



 we filed a complaint in the Superior Court of California
 Sacramento County
 seeking damages arising out of Diabco Life Sciences
 LLC&#8217;s (Diabco) breach of a 2008 promissory note in the principal amount of $0.5 million.&#160; At trial in August 2013
 Diabco stipulated that total damages through July 2013
 including interest and late fees
 amounted to $0.9 million.&#160; In September 2013
 the court issued its tentative statement of decision indicating that judgment will be entered in our favor in the amount of $0.9 million as of July 2013
 plus interest.&#160; In January 2014
 the court issued its final judgment in the amount of $1.0 million.&#160; Diabco filed a notice of appeal which was dismissed in October 2014.&#160; We have no receivable from Diabco recorded in the accompanying financial statements












ITEM 5. MARKET FOR REGISTRANT&#8217;S COMMON EQUITY
 RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES





Our common stock is traded on the NASDAQ Capital Market under the symbol &#8220;RIBT.&#8221;&#160; Our CUSIP No. is 762831-10-5.&#160; The following table sets forth the range of high and low sales prices for our common stock for the periods indicated below.&#160; The quotations below reflect inter-dealer prices
 without retail mark-up
 markdown or commission
Through December 12
 2013
 our common stock was quoted on the OTCQB under the symbol &#8220;RIBT.&#8221; All share and per share information in the table below reflects the one-for-200 reverse stock split which was effected on November 13
 2013.&#160; Our shares of common stock did not trade on a post-adjusted basis until the opening of the market on November 18
 2013.

































































































































































































































 2015
 there were approximately 280 holders of record and 9






 limited liability company agreement for Nutra SA
 LLC






 2014
 we issued the securities described below without registration under the Securities Act.&#160; Unless otherwise indicated below
 the securities were issued pursuant to the private placement exemption provided by Section 4(2) of the Securities Act of 1933.&#160; All issuances below were made without any public solicitation

















































































 without limitation
 statements about our market opportunities
 strategies
 competition
 and expected activities and expenditures and at times may be identified by the use of words such as &#8220;may
&#8221; &#8220;could
&#8221; &#8220;should
&#8221; &#8220;would
&#8221; &#8220;project
&#8221; &#8220;believe
&#8221; &#8220;anticipate
&#8221; &#8220;expect
&#8221; &#8220;plan
&#8221; &#8220;estimate
&#8221; &#8220;forecast
&#8221; &#8220;potential
&#8221; &#8220;intend
&#8221; &#8220;continue&#8221; and variations of these words or comparable words.&#160; Forward-looking statements inherently involve risks and uncertainties.&#160; Accordingly
 actual results may differ materially from those expressed or implied by these forward-looking statements.&#160; Factors that could cause or contribute to such differences include
 but are not limited to






In 2014
e believe that we will be able to obtain additional funds to operate our business
 should it be necessary
 however
 there can be no assurances that our efforts will prove successful.&#160; The accompanying consolidated financial statements do not include any adjustments that might be necessary if we are unable to continue as a going concern.



 in January 2014
 we completed the acquisition of H&amp;N Distribution
 Inc.
 the operations of which are accretive to cash flows.&#160; Our Brazilian subsidiary
 Irgovel
 recently complete the final stages of a major capital expansion.&#160; Significant cash was used during the shutdown period.&#160; Operations at Irgovel are expected to normalize during the second quarter of 2015







 which manufactures and distributes SRB (for human food ingredient and animal nutrition customers) and derivative products and (ii) Brazil segment
 which extracts crude RBO and DRB from rice bran
 which are then further processed into fully refined rice bran oil for sale internationally and in Brazil
 compounded animal nutrition products and a number of valuable human food and animal nutrition products. derivatives and co-products.&#160; We incur corporate expenses not directly attributable to operating segments
 which include costs related to our corporate staff
 general and administrative expenses including public company expenses
 intellectual property
 professional fees
 and other expenses.&#160; No corporate allocations
 including interest





 value-added constituents and finished products.&#160; Over the past decade
 we have developed and optimized our proprietary bio-refining processes to support the production of healthy
 natural
 hypoallergenic
 gluten free
 and non-genetically modified ingredients and supplements for use in human meats
 baked goods
 cereals
 coatings
 health foods
 nutritional supplements





 located within supplier rice mills in Arbuckle and West Sacramento
 California
 and one owned facility in Mermentau
 Louisiana.&#160; At Dillon
 Montana
 the USA segment also produces our Stage II products including: RiSolubles
 a highly nutritious
 carbohydrate and lipid rich fraction of SRB; RiFiber
 a fiber rich derivative of SRB
 RiBalance
 a complete rice bran nutritional package derived from further processing RiBalance
 and ProRyza
 protein-based products.&#160; &#8220;Stage II&#8221; refers to the proprietary processes run at our Dillon
 Montana facility and describes products produced at that facility using our patented processes.&#160; The manufacturing facilities included in our USA segment have proprietary processing equipment and process patented technology for the stabilization and further processing of rice bran into finished products.&#160; Beginning January 2
 2014
 with the acquisition of HN
 we also formulate and copack products at a leased facility in Irving Texas.&#160; We lease a facility in West Sacramento
 California that houses a laboratory
 warehouse and production facilities.&#160; We use an owned facility in Lake Charles
 Louisiana
 as a temporary warehouse.&#160; In 2014










 whose only operating subsidiary is Irgovel
 located in Pelotas
 Brazil.&#160; Irgovel manufactures RBO and DRB products for both the human ingredient and animal nutrition markets in Brazil and internationally.&#160; In refining RBO to an edible grade
 several co-products are obtained.&#160; One such product is distilled fatty acids
 a valuable raw material for the detergent industry.&#160; Irgovel also produces rice lecithin
 which has application in human nutrition
 animal nutrition and industrial applications.&#160; DRB is compounded with a number of other ingredients to produce complex animal nutrition products which are packaged and sold under Irgovel brands in the Brazilian market
 sold as a raw material for further processing into human food ingredients or sold in bulk into the animal nutrition markets in Brazil and neighboring countries.&#160; In 2014
 approximately 39% of Brazil segment product revenue was from sales of RBO products and the remainder was from sales of DRB products.&#160; Irgovel
 however
 was shut down for a portion of 2014 to complete the final stages of a capital expansion project
 which caused a temporary change in sales mix.&#160; We expect RBO sales to return to historical levels
 approximately 45% of product revenues







 or $3.96 per share
 compared to $15.0 million








































































































































































































 were $40.1 million compared to $35.1 million in 2013
 an increase of $5.1 million




 or 92.1%
 in 2014 compared to 2013.&#160; Animal feed product revenues decreased $1.7 million on lower volume while human nutrition product revenues increased $12.7 million
 in large part due to increased sales in the human functional food market as a result of the acquisition of HN.&#160; The decline in animal feed revenue was primarily attributable to reduced sales to two large



Brazil segment revenues decreased $6.0 million
 or 26.1%
 in 2014 compared to 2013.&#160; Revenues decreased $1.7 million as a result of the 8.9% decrease in the average foreign currency translation rate between these periods.&#160; On a local currency basis
 prior to translation into U.S. Dollars
 for expansion of the rice bran oil extractor
 the key functional part of the plant
2014 on a limited basis.&#160; During the 2014 first quarter
 inventory available for sale was limited to certain animal feed products that utilized DRB that had been stockpiled prior to the shutdown.&#160; During the 2014 third quarter
 Irgovel experienced production downtimes due to an equipment failure and experienced difficulty procuring raw bran as a result of disengaging with bran suppliers during the prolonged shut down period and working capital issues
 which reduced production and product available for sale.&#160; Additionally
 Irgovel shut down for two weeks in December 2014 for annual maintenance and resumed operations in January 2015
 however
 it has not yet consistently operated at its new increased capacity for a 30 day period due to an equipment failure in January 2015 and disruptions related to national transportation strikes in February 2015 which limited Irgovel&#8217;s ability to receive raw rice bran and ship product to customers.

















































































































































































































million



Brazil segment gross profit declined $3.5 million between years.&#160; As noted previously
 the Irgovel plant was shut down in January 2014.&#160; Production began again at the beginning of the second quarter on a limited basis.&#160; Processing levels are expected to consistently reach approximately 150% of 























































































































































































































































































































































































































































































































































 compared to $13.9 million for 2013



 general and administrative expenses (SG&amp;A) were relatively the same in 2014 and 2013.&#160; SG&amp;A in 2014 included $0.3 of acquisition costs related to the closing of the HN acquisition in January 2014.&#160; This expense was offset by reductions in other expenses between years




 acquired in January 2014
 were approximately $0.9 million.&#160; The prior year period included a $0.3 million gain on sale of property. The remainder of the increase related primarily to increased travel
 salary





































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































The convertible notes issued in the March 2014 and May 2014 private placement offering closings
 automatically converted into common stock in May 2014 upon shareholders approving an increase in our authorized shares of common stock.&#160; When the notes converted
 we recognized a noncash charge for interest expense of $6.1 million
 to accrete the notes to their face value






Corporate segment financing expense increased $1.5 million.&#160; In 2014
was associated with the March 2014 and May 2014 private placement issuance of convertible notes and related warrants and represented the excess of the values assigned to the equity warrants and derivative liability warrants
 at issuance
 over the net proceeds from issuance
 as described further in Note 10 to the consolidated financial statements.








Corporate segment loss on extinguishment decreased $2.0 million between periods.&#160; In 2014
he fair value of the shares issued ($3.9 million) and the carrying amount of the notes ($2.4 million) and related conversion feature ($0.6 million)
 




With respect to liquidity and capital resources
 we manage the Brazil segment
 consisting currently of our plant in Brazil
.&#160; Cash used in operating activities for 2014 and 2013
 is presented below (in thousands).























































































































































































































































































































































































































































































































































































































































 the Corporate and USA segments used $2.9 million of cash in operating activities in 2014.&#160; We expect USA cash flows will improve in 2015 as a result of the acquisition of HN in January 2014.&#160; During 2014




 compared to $1.6 million of operating cash used in 2013.&#160; Facility shut down and subsequent restart expenses
 as well as lack of adequate working capital in some periods
 adversely affected our operating results in 2014.&#160; Irgovel completed the final stages of a capital expansion project involving installation of new equipment and improvements to existing infrastructure.&#160; As a result of the project
 the Irgovel facility was shutdown approximately ten weeks in the first quarter of 2014
 while certain new equipment was brought on line.&#160; Upon restarting the plant in April
 the plant experienced excessive downtime and inefficiencies during the &#8220;debugging&#8221; of plant production processes.&#160; Where possible
 we stockpiled certain inventory for sale during the period the plant was shut down.&#160; However
 this inventory was not adequate to timely fulfill all outstanding orders during this period.&#160; In addition
 Irgovel shut down for two weeks in December 2014 for annual maintenance and resumed operations in January 2015
 however













 the Corporate segment made additional investments in Nutra SA (Brazil segment) of $10.2 million
 and in the period from January 1
 2015 to March 31
 2015






In 2014
 proceeds from public and private offerings
 net of cash costs


 we paid our secured debt in full.&#160; On May 31
 2014
 all of our convertible debt outstanding
 with a face amount of $9.4 million
 converted into shares of our common stock and as of December 31
 2014
 no convertible debt remains outstanding.&#160; We believe that more traditional commercial bank debt financing at significantly lower interest rates may be available as our performance improves in 2015.






 subordinated retained interests
 derivative instruments or other contingent arrangements that expose us to material continuing risks
 contingent liabilities









 &#8211; Accounts receivable represent amounts receivable on trade accounts.&#160; The allowance for doubtful accounts is based on our assessment of the collectability of customer accounts and the aging of accounts receivable.&#160; We analyze the aging of customer accounts
 customer concentrations
 customer credit-worthiness
 current economic trends and changes in our customer payment patterns when evaluating the adequacy of the allowance for doubtful accounts.&#160; From period to period



Inventories are stated at the lower of cost or market
 with cost determined by the first-in
 first-out method.&#160; In the USA segment
 we employ a full absorption procedure using standard cost techniques.&#160; The standards are customarily reviewed and adjusted annually so that they are materially consistent with actual purchase and production costs.&#160; In the Brazil segment we use actual average purchase and production costs.&#160; Provisions for potentially obsolete or slow moving inventory are made based upon our analysis of inventory levels



Long-Lived Assets

 consisting primarily of property
 intangible assets
 and goodwill










 used to identify potential impairment
 compares the fair value of a reporting unit with its carrying amount
 including goodwill.&#160; If the fair value of a reporting unit exceeds its carrying amount
 goodwill of the reporting unit is not considered impaired
 and
 thus
 the second step of the quantitative impairment test is unnecessary.&#160; If the carrying amount of a reporting unit exceeds its fair value
 the second step of the quantitative goodwill impairment test is performed to measure the amount of impairment loss




 we make estimates and assumptions about sales
 operating margin
 terminal growth rates and discount rates based on our budgets
 business plans
 economic projections
 anticipated future cash flows and marketplace data.&#160; While our annual impairment testing as of December 31
 2014
 supported the carrying amount of goodwill
 we may be required to reevaluate the carrying amount in future periods
 thus utilizing different assumptions that reflect the then current market conditions and expectations
 and
 therefore




 which include intangible assets subject to amortization
 for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.&#160; An impairment loss is recognized when the undiscounted future cash flows estimated to be generated by the asset to be held and used are not sufficient to recover the unamortized balance of the asset.&#160; An impairment loss is recognized based on the difference between the carrying values and estimated fair value.&#160; The estimated fair value is determined based on either the discounted future cash flows or other appropriate fair value methods with the amount of any such deficiency charged to operations in the current year.&#160; Estimates of future cash flows are based on many factors
 including current operating results
 expected market trends and competitive influences.&#160; We also evaluate the amortization periods assigned to its intangible assets to determine whether events or changes in circumstances warrant revised estimates of useful lives. Assets to be disposed of by sale are reported at the lower of the carrying amount or fair value



 &#8211; We recognize revenue for product sales when title and risk of loss pass to our customers
 generally upon shipment for USA segment customers and Brazil segment international customers and upon customer receipt for Brazil segment domestic customers.&#160; Each transaction is evaluated to determine if all of the following four criteria are met: (i) persuasive evidence of an arrangement exists; (ii) delivery has occurred; (iii) the selling price is fixed and determinable; and (iv) collectability is reasonably assured.&#160; If any of the above criteria cannot be satisfied then such a transaction is not recorded as revenue




 discounts and price adjustments when they are reasonably estimable.&#160; Revenues on the statements of operations are net of provisions for estimated returns
 routine sales discounts






We have certain warrant agreements in effect that contain antidilution clauses.&#160; Under these clauses
 we may be required to lower the exercise price on these warrants and issue additional warrants based on future issuances of our common stock and awards of options to employees
 additional issuance of warrants and/or other convertible instruments below certain exercise prices.&#160; 


Share-based compensation expense for employees is calculated at the grant date using the Black-Scholes-Merton valuation model based on awards ultimately expected to vest
 reduced for estimated forfeitures
 and expensed on a straight-line basis over the service period of the grant.&#160; Forfeitures are estimated at the time of grant based on our historical forfeiture experience and are revised in subsequent periods if actual forfeitures differ from those estimates.&#160; The Black-Scholes-Merton option pricing model requires us to estimate key assumptions such as expected life
 volatility
 risk-free interest rates and dividend yield to determine the fair value of share-based awards









We account for share-based compensation awards granted to non-employees and consultants by determining the fair value of the awards granted at either the fair value of the consideration received or the fair value of the equity instruments issued

 it is measured using the stock price and other measurement assumptions as of the earlier of (i) the date at which a commitment for performance by the counterparty to earn the equity instruments is reached or (ii) the date at which the counterparty's performance is complete.&#160; The expense associated with stock awards issued to consultants or other third parties are recognized over the term of service.&#160; In the event services are terminated early or we require no specific future performance
 the entire amount is expensed.&#160; 






 when necessary



 &#8211; The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period.&#160; Because of the uncertainty inherent in such estimates




























 2014
 and the related consolidated statements of operations
 comprehensive loss
 changes in equity




 nor were we engaged to perform
 an audit of its internal control over financial reporting.&#160; Our audit included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances
 but not for the purpose of expressing an opinion on the effectiveness of the Company&#8217;s internal control over financial reporting.&#160; Accordingly
 we express no such opinion.&#160; An audit also includes examining
 on a test basis
 evidence supporting the amounts and disclosures in the financial statements
 assessing the accounting principles used and significant estimates made by management




 the consolidated financial statements referred to above present fairly
 in all material respects
 the consolidated financial position of&#160;RiceBran Technologies&#160;as of&#160;December 31
 2014




 the Company has suffered recurring losses from operations resulting in an accumulated deficit of $242.5 million at December 31
 2014. This factor among other things






























 2013
 and the related consolidated statements of operations
 comprehensive loss
 changes in equity




 nor were we engaged to perform
 an audit of its internal control over financial reporting.&#160; Our audit included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances
 but not for the purpose of expressing an opinion on the effectiveness of the Company&#8217;s internal control over financial reporting.&#160; Accordingly
 we express no such opinion.&#160; An audit also includes examining
 on a test basis
 evidence supporting the amounts and disclosures in the financial statements
 assessing the accounting principles used and significant estimates made by management




 the consolidated financial statements referred to above present fairly
 in all material respects
 the financial position of the Company at December 31
 2013




 the Company has suffered recurring losses from operations.&#160; This factor among other things
















































































































 net of allowance for doubtful accounts of $574 and $501 (variable interest entity restricted $1
980 and $1














































































































 net (variable interest entity restricted $3
727 and $4
























































































































































































































758 and&#160; $6







































 less current portion (variable interest entity nonrecourse $6
203 and $6





































































































































































 20
000


















 no par value
 25
000
000 shares authorized
 9
383
571 and 2
832





































































































































































































































































































































































































































































































































































































































































































































































































































809







160












809







160


















































































































































































































































































































 January 1






038
















































































































714






































































































































































































































































































 December 31






832









































































































786









































































688




































724


























































































































































































 December 31






383





















































































































































































































































































































































































































































































































































































































































































































































































































































































































































NOTE 1. LIQUIDITY
 MANAGEMENT PLANS AND GENERAL BUSINESS





In 2014
e believe that we will be able to obtain additional funds to operate our business
 should it be necessary
 however
 there can be no assurances that our efforts will prove successful.&#160; The accompanying consolidated financial statements do not include any adjustments that might be necessary if we are unable to continue as a going concern.



 in January 2014
 we completed the acquisition of H&amp;N Distribution
 Inc. (HN)
 the operations of which are accretive to cash flows.&#160; Our Brazilian subsidiary
 Industria Riograndens De Oleos Vegetais Ltda. (Irgovel)
 recently completed the final stages of a major capital expansion.&#160; Significant cash was used during the shutdown period.&#160; Operations at Irgovel are expected to normalize during the second quarter of 2015
 such that Irgovel will then be operating at its newly increased capacity and begin generating cash from operations. However






We are a human food ingredient
 nutritional supplement and animal nutrition company focused on value-added processing and marketing of healthy
 natural and nutrient dense products derived from raw rice bran an underutilized by-product of the rice milling industry.&#160; Using our bio-refining business model
 we apply our proprietary and patented technologies and intellectual properties to convert raw rice bran into numerous high value products including stabilized rice bran (SRB)
 rice bran oil (RBO)
 defatted rice bran (DRB)

 a complete rice bran nutritional package derived from further processing of SRB; RiSolubles
 a highly nutritious
 carbohydrate and lipid rich fraction of RiBalance; RiFiber
 a fiber rich insoluable derivative of RiBalance
 and ProRyza
 rice bran protein-based products

 functional food
 nutraceutical supplement and animal nutrition manufacturers
 wholesalers and retailers
 both domestically and internationally.



 which manufactures and distributes SRB (for human food ingredient and animal nutrition customers) in various granulations along with Stage II products and derivatives and (ii) Brazil segment
 which extracts crude RBO and DRB from rice bran
 which are then further processed into fully refined rice bran oil for sale internationally and in Brazil
 compounded animal nutrition products for horses
 cows
 swine


 which include costs related to our corporate staff
 general and administrative expenses including public company expenses
 intellectual property
 professional fees
 and other expenses.&#160; No corporate allocations
 including interest





 value-added constituents and finished products.&#160; Over the past decade
 we have developed and optimized our proprietary bio-refining processes to support the production of healthy
 natural
 hypoallergenic
 gluten free
 and non-genetically modified ingredients and supplements for use in human meats
 baked goods
 cereals
 coatings
 health foods
 nutritional supplements





 the USA segment produced SRB inside two supplier rice mills in California and our facility in Mermentau

 Louisiana has been idle since May 2009.&#160; The USA segment also includes our Dillon

 a complete rice bran nutritional package derived from further processing of SRB; RiSolubles
 a highly nutritious
 carbohydrate and lipid rich fraction of RiBalance; RiFiber
 a fiber rich insoluable derivative of RiBalance
 and ProRyza
 rice bran protein-based products

 approximately 82% of USA segment revenue was from sales of human food products and the remainder was from sales of animal nutrition products.















 whose only operating subsidiary is Irgovel
 located in Pelotas
 Brazil.&#160; Irgovel manufactures RBO and DRB products for both the human ingredient and animal nutrition markets in Brazil and internationally.&#160; In refining RBO to an edible grade
 several co-products are obtained.&#160; One such product is distilled fatty acids
 a valuable raw material for the detergent industry.&#160; Irgovel also produces rice lecithin
 which has application in human nutrition
 animal nutrition and industrial applications.&#160; DRB is compounded with a number of other ingredients to produce complex animal nutrition products which are packaged and sold under Irgovel brands in the Brazilian market
 sold as a raw material for further processing into human food ingredients or sold in bulk into the animal nutrition markets in Brazil and neighboring countries.&#160; In 2014
 approximately 39% of Brazil segment product revenue was from sales of RBO products and the remainder was from sales of DRB products.&#160; Irgovel
 however
 was shut down for a portion of 2014 to complete the final stages of a capital expansion project
 which caused a temporary change in sales mix.&#160; We expect RBO sales to return to historical levels
 approximately 45% of product revenues









 - The consolidated financial statements are presented in our reporting currency
 U.S. Dollars.&#160; The functional currency for Irgovel is the Brazilian Real.&#160; Assets and liabilities of Irgovel are translated into U.S. Dollars using the exchange rate in effect at the consolidated balance sheet date.&#160; Equity accounts are translated at historical rates
 except for the change in accumulated deficit during the year
 which is the result of the income statement translation process. Irgovel&#8217;s revenues and expenses are translated using the average exchange rates in effect during the period.&#160; Translation differences are recorded in accumulated other comprehensive income (loss) as foreign currency translation.&#160; Gains or losses on transactions denominated in a currency other than Irgovel&#8217;s functional currency which arise as a result of changes in foreign exchange rates are recorded as foreign exchange gain or loss in the statements of operations. As of March 31
 2015
 the Brazilian Real has fallen against the U.S. Dollar since December 31
 2014



 &#8211; We consider all highly liquid investments purchased with an original maturity of three months or less at the time of purchase to be cash equivalents.&#160; As of December 31
 2014
 we maintained our cash
 including restricted cash
 and cash equivalents



 &#8211; Accounts receivable represent amounts receivable on trade accounts.&#160; The allowance for doubtful accounts is based on our assessment of the collectability of customer accounts and the aging of accounts receivable.&#160; We analyze the aging of customer accounts
 customer concentrations
 customer credit-worthiness
 current economic trends and changes in our customer payment patterns when evaluating the adequacy of the allowance for doubtful accounts.&#160; From period to period



Inventories are stated at the lower of cost or market
 with cost determined by the first-in
 first-out method.&#160; In the USA segment
 we employ a full absorption procedure using standard cost techniques.&#160; The standards are customarily reviewed and adjusted annually so that they are materially consistent with actual purchase and production costs.&#160; In the Brazil segment we use actual average purchase and production costs.&#160; Provisions for potentially obsolete or slow moving inventory are made based upon our analysis of inventory levels



Long-Lived Assets

 consisting primarily of property
 intangible assets
 and goodwill
















 used to identify potential impairment
 compares the fair value of a reporting unit with its carrying amount
 including goodwill.&#160; If the fair value of a reporting unit exceeds its carrying amount
 goodwill of the reporting unit is not considered impaired
 and
 thus
 the second step of the quantitative impairment test is unnecessary.&#160; If the carrying amount of a reporting unit exceeds its fair value
 the second step of the quantitative goodwill impairment test is performed to measure the amount of impairment loss




 we make estimates and assumptions about sales
 operating margin
 terminal growth rates and discount rates based on our budgets
 business plans
 economic projections
 anticipated future cash flows and marketplace data.&#160; No impairment was deemed to exist as of December 31




 which include intangible assets subject to amortization
 for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.&#160; An impairment loss is recognized when the undiscounted future cash flows estimated to be generated by the asset to be held and used are not sufficient to recover the unamortized balance of the asset.&#160; An impairment loss is recognized based on the difference between the carrying values and estimated fair value.&#160; The estimated fair value is determined based on either the discounted future cash flows or other appropriate fair value methods with the amount of any such deficiency charged to operations in the current year.&#160; Estimates of future cash flows are based on many factors
 including current operating results
 expected market trends and competitive influences.&#160; We also evaluate the amortization periods assigned to its intangible assets to determine whether events or changes in circumstances warrant revised estimates of useful lives. Assets to be disposed of by sale are reported at the lower of the carrying amount or fair value



 &#8211; We recognize revenue for product sales when title and risk of loss pass to our customers
 generally upon shipment for USA segment customers and Brazil segment international customers and upon customer receipt for Brazil segment domestic customers.&#160; Each transaction is evaluated to determine if all of the following four criteria are met: (i) persuasive evidence of an arrangement exists; (ii) delivery has occurred; (iii) the selling price is fixed and determinable; and (iv) collectability is reasonably assured.&#160; If any of the above criteria cannot be satisfied then such a transaction is not recorded as revenue




 discounts and price adjustments when they are reasonably estimable.&#160; Revenues on the statements of operations are net of provisions for estimated returns
 routine sales discounts









We had certain convertible debt outstanding that contained antidilution clauses.&#160; Under these clauses
 we were required to lower the conversion price on the convertible debt based on certain issuances of our common stock
 awards of options to employees

 separate from the host debt.&#160; The conversion liabilities were classified as debt on our consolidated balance sheets.&#160; These conversion liabilities were valued using the lattice model in each reporting period and the resultant change in fair value was recorded in the consolidated statements of operations in other income (expense).&#160; There were no derivative conversion liabilities at December 31
 2014.














We have certain warrant agreements in effect that contain antidilution clauses.&#160; Under these clauses
 we may be required to lower the exercise price on these warrants and issue additional warrants based on future issuances of our common stock and awards of options to employees
 additional issuance of warrants and/or other convertible instruments below certain exercise prices.&#160; 


Share-based compensation expense for employees is calculated at the grant date using the Black-Scholes-Merton valuation model based on awards ultimately expected to vest
 reduced for estimated forfeitures
 and expensed on a straight-line basis over the service period of the grant.&#160; Forfeitures are estimated at the time of grant based on our historical forfeiture experience and are revised in subsequent periods if actual forfeitures differ from those estimates.&#160; The Black-Scholes-Merton option pricing model requires us to estimate key assumptions such as expected life
 volatility
 risk-free interest rates and dividend yield to determine the fair value of share-based awards



We account for share-based compensation awards granted to non-employees and consultants by determining the fair value of the awards granted at either the fair value of the consideration received or the fair value of the equity instruments issued

 it is measured using the stock price and other measurement assumptions as of the earlier of (i) the date at which a commitment for performance by the counterparty to earn the equity instruments is reached or (ii) the date at which the counterparty's performance is complete.&#160; The expense associated with stock awards issued to consultants or other third parties are recognized over the term of service.&#160; In the event services are terminated early or we require no specific future performance
 the entire amount is expensed.&#160; 






 when necessary



 &#8211; The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period.&#160; Because of the uncertainty inherent in such estimates










 the Financial Accounting Standards Board (FASB) issued guidance on revenue from contracts with customers
















 the FASB issued guidance which makes targeted amendments to current consolidation guidance.&#160; Among other things




































































































809







160





























809







160













































































651


















































 2014 and 2013
 were not included in the calculation of diluted EPS in 2014 and 2013 because to do so would be antidilutive.&#160; Those securities listed in the table above which were antidilutive in 2014 and 2013
 which remain outstanding







 we purchased all of the outstanding shares of HN for $2.0 million in cash ($1.8 million paid in January 2014 and $0.2 million payable upon the resolution of certain contingencies) and promissory notes in the face amount of $3.3 million

 Texas-based formulator and co-packer of products targeted at customers in the direct marketing
 internet sales and retail distribution markets. HN serves the natural products
 nutritional supplement
The acquisition has been accounted for as a business combination.&#160; The results of HN&#8217;s operations are included in our consolidated financial statements beginning January 2
 2014















 we incurred $0.3 million of acquisition-related costs which are included in selling
 general and administrative expenses in the consolidated statements of operations.&#160; The following table summarizes the aggregate purchase price allocation
 the consideration transferred to acquire HN
 as well as the amounts of identified assets acquired and liabilities assumed based on the estimated fair value as of the January 2
 2014






























































 including acquired cash of $1






































































































 2014
 was $0.1 million which equaled the gross amount receivable.&#160; We assigned a $3.8 million value to a customer relationship intangible and we are amortizing that intangible over a three-year period.&#160; In 2014




 we have been unable to determine the underlying information required to prepare pro forma information for 2013
 as if the HN acquisition had occurred January 1
 2013.&#160; After making a reasonable effort







 LLC (Nutra SA).&#160; We are the primary beneficiary of Nutra SA
 and as such
 Nutra SA&#8217;s assets
 liabilities and results of operations are included in our consolidated financial statements.&#160; The other equity holders&#8217; interests are reflected in net loss attributable to noncontrolling interest in Nutra SA
 in the consolidated statements of operations
 and redeemable noncontrolling interest in Nutra SA



















































980 and $1




















 net (restricted $3
727 and $4










































































































































































































































































































































































































 we entered into a membership interest purchase agreement (MIPA) with AF Bran Holdings-NL LLC and AF Bran Holdings LLC (Investors).&#160; The Investors&#8217; share of Nutra SA&#8217;s net income (loss) increases (decreases) redeemable noncontrolling interest.&#160; We are restricted from competing with Nutra SA and Irgovel in Brazil as further described in the MIPA.&#160; In 2014 and 2013




 above the equity section and after liabilities on our consolidated balance sheets
 because the Investors have drag along rights which provide the Investors the ability to force a sale of Nutra SA assets in the future.&#160; We have assessed the likelihood of the Investors exercising these rights as less than probable at December 31
 2014.&#160; We will continue to evaluate the probability of the Investors exercising their 



 as amended
 any units held by the Investors beginning January 1
 2014
 accrue a yield at 4% (the Yield).&#160; Commencing with the first quarter of 2014
 Nutra SA must make distributions to the Investors quarterly in the amount equal to the previously accrued and unpaid Yield plus any additional distributions owed to the Investors
 to the extent there is distributable cash
 as defined in the LLC agreement.&#160; As of December 31
 2014




 Nutra SA must distribute all distributable cash (as defined in the LLC Agreement) to the members on March 31 of each year as follows: (i) first
 to the Investors in an amount equal to 2.3 times the Investors&#8217; capital contributions
 less the aggregate amount of non-Yield distributions paid to the Investors
 (ii) second
 to us in an amount equal to twice the capital contributions made by us
 less the aggregate amount of distributions paid to us; and (iii) third




 the business of Nutra SA is to be conducted by the manager
 currently our CEO
 subject to the oversight of the management committee.&#160; The management committee is comprised of three of our representatives and two Investor representatives.&#160; Upon an event of default or a qualifying event
 we will no longer control the management committee and the management committee will include three Investor representatives and two of our representatives.&#160; In addition
 following an event of default or a qualifying event




 2014
 there have been no unwaived events of default.&#160; Events of default
 as defined in the MIPA and the October 2013 amendment of investment agreements




 2014
 there have been no qualifying events.&#160; The LLC agreement defines a qualifying event as any event prior to September 16
 2014
 which results
 or will result
 in (i) a person or group of persons exercising the right to appoint members to our board of directors holding one third or more of the votes of all board members
 (ii) the sale
 exchange




 the right to begin a process to force the sale of all Nutra SA assets after January 1
 2016.&#160; The right terminates upon the occurrence of certain events (a $50 million Nutra SA initial public offering or a change of control
















 we considered the matters which could be put to a vote of the members.&#160; Until there is an event of default or a qualifying event
 the Investors&#8217; rights and abilities
 individually or in the aggregate













 none of our revenues in 2013
 and 2.9% of our receivables as of December 31
 2014.&#160; A second USA segment customer accounted for none of our sales in 2014 and 6% of our sales in 2013
 none of our outstanding accounts receivable at December 31
 2014 and 2013.&#160; A third Brazil segment customer accounted for approximately 3% and 5% of our sales in 2014 and 2013 and approximately 7% and 16% of our accounts receivable balances at December 31
 2014 and 2013.&#160; A fourth Brazil segment customer accounted for approximately 3% and 9% of our sales in 2014 and 2013 and approximately 22% and 4% of our accounts receivable balances at December 31
 2014 and 2013.&#160; A fifth Brazil segment customer accounted for approximately 4% and 9% of our sales in 2014 and 2013 and approximately 3% and 10% of our accounts receivable balances at December 31




 2014




 2014
 Brazil made up $2.0 million of the $3.1 million consolidated accounts receivable balance







































































































































































































































































































































































































































































December 31
 2014
























































































































































































































December 31
 2013



































































































































































































































































Amortization expense is expected to be $1.5 million in 2015
 $1.0 million in 2016
 $0.1 million in 2017 and $0.1 million in 2018.&#160; 












































































































In May 2014
 our shareholders approved an increase in our authorized shares of common stock from 6
000
000 shares to 25
000

 our shareholders approved an increase in the number of our authorized shares of common stock from 2
500
000 to 6
000




 2013
 our board of directors approved a 1 for 200 reverse split of our common stock.&#160; We began trading on a post-split basis on November 18
 2013.&#160; All share and per share information has been retrospectively adjusted for all prior periods presented giving retroactive effect to the reverse stock split.&#160; Such adjustments include calculations of our weighted averages number of shares outstanding and loss per share



Pursuant to the terms of the senior convertible debentures
 we may not pay any dividends while a debenture is outstanding.&#160; Cash provided by operations in our Brazil segment is generally unavailable for distribution to our Corporate and USA segments pursuant to the terms of the


Stock
 Convertible Note and Warrant Offerings



 we completed a secondary public offering in which we issued and sold 1
714
286 shares of common stock for $5.24 per share and publicly traded warrants to purchase 1
714
286 shares of common stock for $0.01 per underlying share.&#160; The net proceeds from the offering were $7.6 million after deducting underwriting discounts and commissions of $0.7 million and other offering expenses of approximately $1.4 million.&#160; The publicly traded warrants have an exercise price of $6.55 per share and expire in December 2018.&#160; The underwriters on the offering also received a warrant for the purchase of 85
715 shares
 at an exercise price of $6.55 per share















 an underwriter exercised its overallotment rights related to our December 2013 secondary public offering.&#160; We issued and sold 162
586 shares of common stock for $5.24 per share and publicly traded warrants to purchase 162
586 shares of common stock ($6.55 per share exercise price and December 2018 expiration) for $0.01 per underlying share.&#160; In connection with the overallotment exercise
 the underwriters for the offering also received a warrant for the purchase of 8
130 shares of common stock (exercise price of $6.55 per share and December 2018 expiration).&#160; The net proceeds from the overallotment exercise were $0.8 million
 after deducting underwriting discounts and commissions and other cash offering expenses of $0.1 million




399
614 shares of common stock ($5.25 per share exercise price and March 2019 expiration).&#160;&#160; We contributed $1.0 million of the $4.3 million proceeds
 net of $0.6 million of costs
 to Nutra SA
 and used the remainder of the proceeds for capital projects in the United States and for general corporate purposes.&#160; On a fully diluted basis
 at issuance we had available shares of common stock for 15.8% of the shares underlying the Warrants.&#160; To the extent there were available shares
 we allocated proceeds to equity for the warrants ($0.4 million).&#160; We recorded a derivative liability for the warrants to the extent there were not available shares ($5.0 million).&#160; We recorded $1.1 million in financing expense at closing representing the excess of the amounts recorded for the warrants over the net proceeds from the offering.&#160; The convertible notes issued in the offering were initially recorded with a discount equal to the face amount of the notes.&#160; As discussed below
 in Debt Conversions section




075 shares of common stock
 with an exercise price of $5.25 per share and a May 2019 expiration.&#160; We contributed $0.5 million of the $1.1 million proceeds
 net of $0.2 million of costs
 to Nutra SA
 and used the remainder of the proceeds for capital projects in the United States and for general corporate purposes.&#160; On a fully diluted basis
 at issuance we had no available shares of common stock for the shares underlying these warrants and
 as a result
 recorded a derivative liability for the fair value of these warrants at issuance ($2.0 million).&#160; We recorded $1.0 million in financing expense at closing
 representing the excess of the amounts recorded for the warrants over the net proceeds from the offering.&#160; The convertible notes issued in the offering were initially recorded with a discount equal to the face amount of the notes.&#160; As discussed below
 in Debt Conversions section




 we issued and sold 1
417
500 shares of common stock for $5.29 per share and warrants to purchase 708
750 shares of common stock (exercise price of $5.87 per share and June 2019 expiration) for $0.01 per underlying share.&#160; The underwriters for the offering also received a warrant for the purchase of 85
050 shares of common stock (exercise price of $6.625 per share and June 2019 expiration).&#160; The net proceeds from the offering of $6.8 million
 after deducting underwriting discounts and commissions and other cash offering expenses of $0.7 million




 we issued warrants to purchase 265




 we issued and sold 1
181
695 shares of common stock and warrants to purchase 1
181
695 shares of common stock (exercise price of $5.27 per share
 exercisable beginning April 2015
 April 2020 expiration) for $5.40 per unit
 where a unit is one share of common stock and a warrant to purchase one share of common stock.&#160; The underwriters of the offering also received a warrant for the purchase of 94
536 shares of common stock (exercise price of $5.27 per share and October 2019 expiration).&#160; The net proceeds from the offering of $5.8 million
 after deducting underwriting discounts and commissions and other estimated cash offering expenses of $0.6 million






In the fourth quarter of 2013

 change the maturity of the notes to July 2016 (if there was a different maturity date) and to remove the conversion feature and antidilution protections upon the closing of an equity raise in excess of $7.0 million (Modification).&#160; Concurrently
 certain warrant holders agreed to exchange warrants to purchase 496
060 shares of common stock for the future issuance of 1
554
734 shares of our common stock (Exchange).&#160; Most of the warrants impacted (warrants to purchase 441
395 shares) were warrants issued to the note holders when their notes were originally issued and had contained antidilution protections which caused them to be carried at fair value on our balances sheets.&#160; The former warrant holders committed to exchange their warrants
.&#160; The fair market value of the shares was recorded in common stock in the fourth quarter of 2013.&#160; We issued the shares
 as required
 after shareholders approved an increase in our authorized shares of common stock
















 we also issued $500
000 of notes to a holder and agreed to issue the holder 134
250 shares of common stock.&#160; The fair market value of the shares was recorded in common stock in the fourth quarter of 2013.&#160; We issued these shares
 as required
 after shareholders approved an increase in our authorized shares of common stock





In connection with the January 2014 acquisition of HN

 2015
 and ending on December 31
 2018 and bore interest at 1% per year until January 2015
 5% per year from February 2015 until January 2016 and 10% per year after January 2016.&#160; We recorded the notes at their $2.2 million fair value and the conversion features at their $0.6 million fair value on the date of issuance.&#160; We accreted the notes at an effective interest rate of 18.9%
 until the notes
 and accumulated interest thereon
 converted into 543
894 shares of common stock upon our issuance of shares to the former warrant holders in the Exchange.&#160; The notes converted in May 2014.&#160; Upon conversion




 due in July 2016
 bore interest at 5% interest until the $6.2 million outstanding on the notes
 including accumulated interest thereon (less than $0.1 million)
 automatically converted in May 2014
 at a conversion price of $5.25
 into 1
180
567 shares of common stock upon shareholders voting to approve an increase in our authorized shares of common stock.&#160; When the notes converted
 we recognized interest expense of $6.2 million
 to accrete the notes to their face value







000
000 share increase in our authorized shares of common stock.&#160; As a result
 during the second quarter of 2014
 we transferred to equity the $8.9 million fair value of warrants previously classified as derivative liabilities solely due to a lack
 on a fully-diluted basis



Equity Incentive Plans
 Options and Warrants







































































 January 1






































































859











































































































































































 December 31

























406









































262

































































































 December 31



























503





















 December 31



























322

































 after the plan was approved by shareholders.&#160; A total of 1
600
000 shares of common stock were initially reserved for issuance under the plan.&#160; Under the terms of the plan
 we may grant options to purchase common stock and shares of common stock to officers
 directors
 employees or consultants providing services on such terms as are determined by the board of directors.&#160; Our board of directors administers the plan
 determines vesting schedules on plan awards and may accelerate the vesting schedules for award recipients.&#160; The options granted under the plan have terms of up to 10 years.&#160; As of December 31
 2014
 options to purchase 141
134 shares have been issued and remain outstanding
 281
620 common shares have been issued and remain outstanding and 1
177




000 shares of common stock were initially reserved for issuance under the 2010 Plan.&#160; The amount reserved increased annually each January 1st by 5% of the outstanding shares as of the prior December 31st.&#160; Additionally
 in 2011 the board approved a 40




 we could grant options to purchase common stock and shares of common stock to officers
 directors
 employees or consultants providing services on such terms as are determined by the board of directors.&#160; Our board of directors administered the 2010 Plan
 determined vesting schedules on plan awards and could accelerate the vesting schedules for award recipients.&#160; The options granted under the 2010 Plan have terms of up to 10 years.&#160; In 2013




 we could grant options to purchase common stock and shares of common stock to officers
 directors




384 options awarded to current and former directors
 employees and consultants at various times beginning in 2004 through 2009 that do not fall under the plans described above.&#160; Expiration periods
 typically ten years




 general and administrative expenses in the statements of operations











































































































































































 we issued shares of common stock to directors and executive officers at a grant date fair value of $4.91 per share.&#160; We issued 44
026 shares which vested in August 2014
 52
412 shares which vest in August 2015 (or at the next annual shareholder meeting date if earlier) and 185
182 shares which vest in August 2017.&#160; In 2014
 we recognized $0.5 million in compensation for these share of common stock.&#160; These shares are the only shares vesting in the future.&#160; As of December 31
 2014




 our board granted each of our five non-employee directors a stock option to purchase up to 3
750 shares of common stock.&#160; Each option has an exercise price of $16.00 per share
 vests in nine equal monthly installments ending December 31
 2013
 and expires in April 2023.&#160; In January 2013
 we issued each of those five non-employee directors an option for the purchase of up to 1
250 shares of common stock under the non-employee director automatic grant provision.&#160; Each option has an exercise price of $16.00 per share
 vested in twelve equal monthly installments ending December 2013















 the Board granted each of the two directors serving on the strategic committee and consulting special counsel each a stock option to purchase up to 1
250 shares of common stock.&#160; Each option has an exercise price of $16.00 per share




































































&#160; January 1































































































































































 December 31

























































































































































 December 31


































































 December 31












































 2014























































































































































































































































































































































































































































































































































































































































































































 January 1





















































820






























































































































































































 December 31






815











































262











































































































 December 31






077










































 December 31






895








































































































































































































006



















824































055



















055





























































































































503





















322

































 2014
 we have two warrant agreements outstanding (with one holder) that contain antidilution clauses.&#160; The related warrants are classified as derivative warrant liabilities in our balance sheets.&#160; Under the antidilution clauses contained in these warrants
 in the event of equity issuances at prices below the exercise prices of these warrants
 we may be required to lower the exercise price on these warrants and increase the number of shares underlying these warrants.&#160; Equity issuances may include issuances of our common stock
 certain awards of options to employees




 as a result
 we were required to lower the exercise price and increase the number of shares underlying certain liability warrants.&#160; In addition























































































































































































































































































































 follow (in thousands).


































































































































































































































































 2014







 in May 2014







 2014
 subordinated notes in the principal amount of $6.5 million remain outstanding.&#160; The notes bear interest of 5% per year
 payable quarterly
 and mature in July 2016.&#160; The notes are secured by interest in substantially all of our assets
 excluding our interest in Nutra SA and RBT PRO

 during the fourth quarter of 2013















 Irgovel entered into loan agreements with the Bank of Brazil.&#160; As of December 31
 2014
 the notes held a principal balance of R$8.1 million. The annual interest rate on the loans is 6.5%
 payable quarterly and the loans mature December 2021.&#160; Irgovel must make monthly principal payments under each of the loans.&#160; Irgovel used R$1.5 million of the proceeds for working capital purposes and the remainder for the purchase of equipment and machinery.&#160; In July 2012







 depending on the agreement.&#160; The annual interest rates on this debt range from 12.5% to 125.4%

























 Irgovel&#8217;s debt under several notes was consolidated into one note and Irgovel financed an additional $0.9 million of taxes payable under the programs.&#160; Principal and interest payments are due monthly through January 2029.&#160; Interest on the notes is payable monthly at the Brazilian SELIC target rate
 which was 11.8% at December 31







 we entered into an agreement with a partner with the goal of developing technology to extract and concentrate protein from rice bran.&#160; In March 2013
 the agreement was mutually terminated under terms whereby we each received (i) the right to separately develop
 modify and improve the jointly developed technology owned by the partner and (ii) a nonexclusive
 royalty free



RBT PRO
n April 2013

 for $1.2 million.&#160; RBT PRO granted a royalty free




 and under the agreements
 we obtained rights to purchase a percentage of the capital stock of any entity Wilmar establishes to develop new products relating to rice bran or its derivative
 as defined in the agreement




 2014 and 2013

















































































































































































































































































































































































































































































































 net of $0.6 million impact from foreign currency translation
 offset by (i) the $41.8 million impact of net operating losses expiring and those being limited due to ownership changes (ii) $0.9 million from the impact of state rate changes (iii) $1.3 million from the establishment of deferred tax liabilities in the acquisition of HN (iv) $1.1 million of adjustments to intangibles and stock compensation deferreds
 and (v) $7.5 million of adjustment to fixed asset deferred balance as a result of an accounting method change.&#160; The change in valuation allowance of $4.9 million in 2013 was due to (i) $3.9 million in net operating loss and (ii) $0.7 million from the impact of state rate changes and (iii) $0.9 million for the establishment of a valuation allowance against Brazil deferred tax assets




 2014
 net operating loss carryforwards for U.S. federal tax purposes totaled $6.5 million and expire at various dates from 2018 through 2034.&#160; Net operating loss carryforwards for state tax purposes totaled $6.0 million as of December 31
 2014
 and expire at various dates from 2015 through 2034.&#160; As of December 31
 2014




 we believe our ability to utilize previously accumulated net operating loss carryforwards are subject to substantial annual limitations due to &#8220;change in ownership&#8221; provisions of the Internal Revenue Code of 1986
 as amended
 and similar state regulations.&#160; Therefore in 2014
 we recorded the impact of the expiration of substantial net operating loss carryforwards prior to utilization.&#160; We have not yet finalized the exact amount of such limitation
 as the rules in this area are complex















 generally































































































































































































































































































































































































































 general and administrative expenses. We have not identified any uncertain tax positions requiring a reserve as of December 31













 we periodically enter into employment agreements which incorporate indemnification provisions.&#160; While the maximum amount to which we may be exposed under such agreements cannot be reasonably estimated
 we maintain insurance coverage




















 2014







 from time to time we are involved in litigation incidental to the conduct of our business.&#160; When applicable
 we record accruals for contingencies when it is probable that a liability will be incurred and the amount of loss can be reasonably estimated.&#160; While the outcome of lawsuits and other proceedings against us cannot be predicted with certainty
 in the opinion of management
 individually or in the aggregate










 2008
 former Irgovel stockholder David Resyng filed an indemnification suit against Irgovel
 Osmar Brito and the remaining former Irgovel stockholders (Sellers)
 requesting:&#160; (i) the freezing of the escrow account maintained in connection with the transfer of Irgovel&#8217;s corporate control to us and the presentation of all documentation related to the transaction
 and (ii) damages in the amount of the difference between (a) the sum received by David Resyng in connection with the judicial settlement agreement executed in the action for the partial dissolution of the limited liability company filed by David Resyng against Irgovel and the Sellers and (b) the amount received by the Sellers in connection with the sale of Irgovel&#8217;s corporate control to us




 executed by and among the Sellers and us on January 31
 2008 (Purchase Agreement).&#160; Consequently
 we believe that the responsibility for any indemnity



On February 6
 2009
 the Sellers filed a collection lawsuit against us seeking payment of the second installment of the purchase price under the Purchase Agreement
 which the Sellers allege is approximately $1.0 million.&#160; We have withheld payment of the second installment pending resolution of the Resyng lawsuit noted above.&#160; Our parent company has not been served with any formal notices in regard to this matter.&#160; To date
 only Irgovel has received formal legal notice.&#160; In addition

 2010
 we initiated an arbitration proceeding against the Sellers for breaches of the Purchase Agreement
 including claims related to Sellers&#8217; handling of the Resyng claim and whether any future payments are required under the Purchase Agreement.&#160; On February 25
 2015
 the arbitration panel issued its opinion and ordered the Sellers to pay Irgovel and us R$3.6 million plus arbitration fees
 legal fees



As part of the Purchase Agreement
 $2.0 million was deposited into an escrow account to cover contingencies with the net remaining funds payable to the Sellers upon resolution of all contingencies.&#160; As of December 31 2014 and 2013
 the balance in the escrow account was $1.9 million and is included in restricted cash in our balance sheets.&#160; There is an escrow liability related to the lawsuit in accrued expenses on our balance sheets as of December 2014 and 2013
 totaling $1.6 million.&#160; When the escrow account was funded
 we established an accrued liability equal to the amount of the escrow for contingencies and the net balance due to the Sellers under the terms of the Purchase Agreement.&#160; As of December 31
 2014
 $0.5 million of pre-acquisition contingencies have either been paid or specifically identified and accrued

 w














Diabco Life Sciences
 LLC



 we filed a complaint in the Superior Court of California
 Sacramento County
 seeking damages arising out of Diabco Life Sciences
 LLC&#8217;s (Diabco) breach of a 2008 promissory note in the principal amount of $0.5 million.&#160; At trial in August 2013
 Diabco stipulated that total damages through July 2013
 including interest and late fees
 amounted to $0.9 million.&#160; In September 2013
 the court issued its tentative statement of decision indicating that judgment will be entered in our favor in the amount of $0.9 million as of July 2013
 plus interest.&#160; In January 2014
 the court issued its final judgment in the amount of $1.0 million.&#160; Diabco filed a notice of appeal which was dismissed in October 2014.&#160; We have no receivable from Diabco recorded in the accompanying financial statements










 a director
 invested $2.6 million in our subordinated convertible notes and related warrants prior to 2013.&#160; In 2014 and 2013
 we paid and expensed $0.1 million and $0.2 million
 respectively



connection with the Exchange
 warrants beneficially owned by Mr. Halpern for the purchase of up to 185
714 shares of common stock ($14.00 per share exercise price with a July 31
 2017 expiration)
 related to the subordinated convertible notes were cancelled in exchange for 634
679 shares of our common stock (with a fair value of $2.9 million at time of the Exchange).&#160; The shares were not required to be issued until after our shareholders approved an increase in our authorized shares of common stock
 which occurred on May 30



connection with the Exchange
 other warrants beneficially owned by Mr. Halpern for the purchase of up to 45
683 shares of common stock ($14.00 per share exercise prices and expirations between January 2017 and August 2017) were cancelled in exchange for 75
377 shares of our common stock (with a fair value of $0.3 million at time of the Exchange).&#160; The shares were not required to be issued until after our shareholders approved an increase in our authorized shares of common stock
 which occurred on May 30






. John Short
 our chief executive officer and director
 invested $25 thousand in our subordinated convertible notes and related warrants in January 2012 and an additional $25 thousand in April 2013.&#160; In 2014 and 2013
 of interest on subordinated notes beneficially owned by Mr. Short.&#160; In June 2013
 Mr. Short made an election to be paid in stock
 rather than cash
 for interest accruing under the notes from February 2013 through June 2014.&#160; In connection with the election
 in 2013 we issued to Mr. Short a PIK warrant with 234 underlying shares of common stock
 and increased the shares underlying Mr. Short&#8217;s convertible notes by 234 shares as payment for interest accruing under the convertible notes from February 2013 through October 2013.&#160; The terms of the notes beneficially owned by Mr.


connection with the Exchange
 Mr. Short for the purchase of up to 3
806 shares of common stock ($14.00 per share exercise prices and expirations of July 2017 and May 2018)
 including the PIK warrant
 were cancelled in exchange for 12
777 shares of our common stock.&#160; The shares were not required to be issued until after our shareholders approved an increase in our authorized shares of common stock
 which occurred on May 30







 we purchased all of the outstanding shares of HN for $2.0 million in cash
 plus convertible promissory notes for $3.3 million.&#160; Mark McKnight
 our current senior vice president of sales
 and his wife collectively owned a majority interest in HN prior to the acquisition.&#160; In connection with our acquisition of HN
 Mark McKnight received $0.7 million in cash and a convertible promissory note for $1.4 million and Nicole McKnight
 his wife
 received $0.7 million in cash and a convertible promissory note for $1.4 million.&#160; We had the option to pay principal and accrued interest under the notes in either cash or in our common stock
 however
 if we issued shares to our former warrants holders upon an increase in authorized shares
 under the terms of the Exchange
 then we were required to settle any outstanding balance on the notes through the issuance of shares of our common stock.&#160; On May 30
 2014
 we issued 225
925 shares of common stock to settle Mark McKnight&#8217;s note and 225
















 we entered into a $0.1 million
 5% unsecured




 prior to the acquisition







 which manufactures and distributes SRB in various granulations along with Stage II products and derivatives and (ii) Brazil segment
 which extracts crude RBO and DRB from rice bran
 which are then further processed into fully refined rice bran oil for sale internationally and in Brazil
 compounded animal nutrition products for horses
 cows
 swine
 sheep and poultry and a number of valuable human food and animal nutrition products derivatives and co-products. In addition we incur corporate and other expenses not directly attributable to operating segments
 which include costs related to our corporate staff
 general and administrative expenses including public company expenses
 intellectual property
 professional fees
 and other expenses.&#160; No Corporate allocations
 including interests































































































































































































































































































































































































































































 net

































































 net



































































































































































































































































































































































































































































































































































 net

































































 net













































































































































































 accounts and other receivables and accounts payable approximates their carrying value due to their shorter maturities.&#160; As of December 31 2014
 the fair value of our Corporate segment debt (Level 3 measurement) is approximately $0.2 million higher than the $5.1 million carrying value of that debt


























































































December 31
 2014



























































































































December 31
 2013



























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































machinery and equipment not currently in use was evaluated for impairment and as a result was written down to estimated fair value in the first quarter of 2013.&#160; Fair value was an estimate of net realizable value comprised of an estimate of proceeds from sale
 based on an internal evaluation of market conditions






























 2014
 under the supervision and with the participation of our current management
 including our current Chief Executive Officer and Chief Financial Officer.&#160; Our disclosure controls and procedures have been designed to ensure that information we are required to disclose in reports we file or submit under the Exchange Act is recorded
 processed
 summarized and reported within the time periods specified by the SEC&#8217;s rules and forms and that such information is accumulated and communicated to our management
 including our Chief Executive Officer and Chief Financial Officer




 our Chief Executive Officer and our Chief Financial Officer concluded that our disclosure controls and procedures were effective as of December 31







 2014
 that have materially affected
 or are reasonably likely to materially affect















 in reasonable detail




















 or timely detection
 of unauthorized acquisition







 internal control over financial reporting may not prevent or detect misstatements. Also
 projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions




 including our current Chief Executive Officer and Chief Financial Officer
 we conducted an assessment of the effectiveness of the Company&#8217;s internal control over financial reporting as of December 31
 2014.&#160; In making this assessment




 2014
 we maintained effective internal control over financial reporting based on the criteria established in the Internal Control &#8211; Integrated Framework (1992)



















ITEM 10. DIRECTORS
 EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE



 to be filed within 120 days of our fiscal year end







 to be filed within 120 days of our fiscal year end







 to be filed within 120 days of our fiscal year end



ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS
 AND DIRECTOR INDEPENDENCE



 to be filed within 120 days of our fiscal year end







 to be filed within 120 days of our fiscal year end






































Warrant Agreement dated December 18
 2013

 filed December 18










 dated January 31
 2008
 with Quota Holders of Irgovel - Industria Riograndens De Oleos Begetais Ltda (incorporated herein by reference to exhibits previously filed on registrant&#8217;s quarterly report on Form 10-Q
 filed on August 11
 2008 and on registrant&#8217;s annual report on Form 10-K
 filed on March 17










 2001 (incorporated herein by reference to exhibits previously filed on registrant&#8217;s annual report on Form 10-KSB
 filed on April 16










 2003 (incorporated herein by reference to exhibits previously filed on registrant&#8217;s Registration Statement on Form SB-2
 filed on November 18










 2003 (incorporated herein by reference to exhibits previously filed on registrant&#8217;s quarterly report on Form 10-QSB
 filed on November 19










 2005 (incorporated herein by reference to exhibits previously filed on registrant&#8217;s Registration Statement on Form SB-2
 filed on November 18










 2007 (incorporated herein by reference to exhibits previously filed on registrant&#8217;s quarterly report on Form 10-Q
 filed on August 14










 2011 (incorporated herein by reference to exhibits previously filed on registrant&#8217;s current report on Form 8-K
 filed on July 5










 2013 (incorporated herein by reference to exhibits previously filed on registrant&#8217;s quarterly report on Form 10-Q
 filed August 14










 2014 (incorporated herein by reference to exhibits previously filed on registrant&#8217;s registration statement on Form S-3 filed June 5










 Preferences
 and Privileges of the Series A Preferred Stock as filed with the Secretary of State of California on December 13
 2001 (incorporated herein by reference to exhibits previously filed on registrant&#8217;s Registration Statement on Form SB-2
 filed on June 4










 Preferences and Rights of Series B Convertible Preferred Stock as filed with the Secretary of State of California on October 4
 2005 (incorporated herein by reference to exhibits previously filed on registrant&#8217;s current report on Form 8-K
 filed on October 4










 Preferences and Rights of Series C Convertible Preferred Stock as filed with the Secretary of State of California on May 10
 2006 (incorporated herein by reference to exhibits previously filed on registrant&#8217;s current report on Form 8-K
 filed on May 15










 Preferences and Rights of the Series D Convertible Preferred Stock
 as filed with the Secretary of State of California on October 17
 2008 (incorporated herein by reference to exhibits previously filed on registrant&#8217;s current report on Form 8-K
 filed on October 20










 Preferences and Rights of the Series E Convertible Preferred Stock
 as filed with the Secretary of State of California on May 7
 2009 (incorporated herein by reference to exhibits previously filed on registrant&#8217;s current report on Form 8-K
 filed on May 8










 filed on June 12










 2007 (incorporated herein by reference to exhibits previously filed on registrant&#8217;s current report on Form 8-K
 filed on June 25










 2009 (incorporated herein by reference to exhibits previously filed on registrant&#8217;s current report on Form 8-K
 filed on December 10










 2012 (incorporated herein by reference to exhibits previously filed on registrant&#8217;s current report on Form 8-K
 filed on October 10




















 filed on January 23










 filed on January 23










 filed on August 6










 filed on December 18










 2014 (incorporated herein by reference to exhibits previously filed on registrant&#8217;s current report on Form 8-K
 filed on March 21










 2014 (incorporated herein by reference to exhibits previously filed on registrant&#8217;s current report on Form 8-K
 filed on March 21










 filed on June 20










 filed on September 30












 filed on July 10












 filed on July 10












 filed on May 11












 2010 (incorporated herein by reference to exhibit 10.1 previously filed on registrant&#8217;s current report on Form 8-K
 filed on July 8












 2011 (incorporated herein by reference to exhibits previously filed on registrant&#8217;s current report on Form 8-K
 filed on July 20












 2010 (incorporated herein by reference to exhibit 10.1 previously filed on registrant&#8217;s current report on Form 8-K
 filed on June 8












 2011 (incorporated herein by reference to exhibits previously filed on registrant&#8217;s current report on Form 8-K
 filed on July 20












 2012 (incorporated herein by reference to exhibits previously filed on registrant&#8217;s annual report on Form 10-K
 filed on March 30












 2014 (incorporated herein by reference to exhibits previously filed on registrant&#8217;s current report on Form 8-K
 filed on June 3












 2010 (incorporated herein by reference to exhibits previously filed on registrant&#8217;s current report on Form 8-K
 filed on January 5












 2011 (incorporated herein by reference to exhibits previously filed on registrant&#8217;s current report on Form 8-K
 filed on July 20












 filed on November 18












 filed on March 17












 filed on May 12












 filed on August 11










 2010 (incorporated herein by reference to exhibit 10.77 previously filed on registrant&#8217;s annual report on Form 10-K
 filed on February 24










 2010 (incorporated herein by reference to exhibit 10.1 previously filed on registrant&#8217;s current report on Form 8-K
 filed on May 18












 LLC Membership Interest Purchase Agreement dated December 29
 2010 (incorporated herein by reference to exhibits previously filed on registrant&#8217;s current report on Form 8-K/A
 filed on August 10










 filed on January 5










 LLC (incorporated herein by reference to exhibits previously filed on registrant&#8217;s annual report on Form 10-K
 filed on February 24






















 filed on May 11












 filed on March 30










 filed on March 30












 filed on March 30










 filed on May 11










784
838
 respectively
 with a Brazilian bank dated December 15
 2011
 English translation from the original Portuguese (incorporated herein by reference to exhibits previously filed on registrant&#8217;s annual report on Form 10-K
 filed on March 30










676
012 dated December 15
 2011
 English translation from the original Portuguese (incorporated herein by reference to exhibits previously filed on registrant&#8217;s Annual Report on Form 10-K
 filed on March 30










 2012 (incorporated herein by reference to exhibits previously filed on registrant&#8217;s current report on Form 8-K
 filed on January 23










 2012 (incorporated herein by reference to exhibits previously filed on registrant&#8217;s current report on Form 8-K
 filed on January 23










 2012 (incorporated herein by reference to exhibits previously filed on registrant&#8217;s current report on Form 8-K
 filed on January 23










 2013 (incorporated herein by reference to exhibits previously filed on registrant&#8217;s current report on Form 8-K
 filed on January 23










 2012 (incorporated herein by reference to exhibits previously filed on registrant&#8217;s current report on Form 8-K
 filed on January 23










 filed on January 23










 2012 (incorporated herein by reference to exhibits previously filed on registrant&#8217;s current report on Form 8-K
 filed on January 23










 filed on January 23










 2012 (incorporated herein by reference to exhibits previously filed on registrant&#8217;s current report on Form 8-K
 filed on August 6










 2012 (incorporated herein by reference to exhibits previously filed on registrant&#8217;s current report on Form 8-K
 filed on August 6










 2012 (incorporated herein by reference to exhibits previously filed on registrant&#8217;s current report on Form 8-K
 filed on August 6










009
200 Original Issue Discount Senior Secured Convertible Debenture Due January 1
 2014 (incorporated herein by reference to exhibits previously filed on registrant&#8217;s current report on Form 8-K
 filed on August 6










000 Original Issue Discount Senior Secured Convertible Debenture Due January 1
 2014 (incorporated herein by reference to exhibits previously filed on registrant&#8217;s current report on Form 8-K
 filed on August 6










 2012 with Hillair Capital Investments L.P. (incorporated herein by reference to exhibits previously filed on registrant&#8217;s current report on Form 8-K
 filed on August 6










 2012 (incorporated herein by reference to exhibits previously filed on registrant&#8217;s current report on Form 8-K
 filed on August 6










 2012 (incorporated herein by reference to exhibits previously filed on registrant&#8217;s current report on Form 8-K
 filed on August 6










 2012 regarding Nutra SA
 LLC (incorporated herein by reference to exhibits previously filed on registrant&#8217;s current report on Form 8-K
 filed on December 31










 LLC dated December 24
 2012 (incorporated herein by reference to exhibits previously filed on registrant&#8217;s current report on Form 8-K
 filed on December 31










 2013 (incorporated herein by reference to exhibits previously filed on registrant&#8217;s current report on Form 8-K
 filed on March 20










 2013 (incorporated herein by reference to exhibits previously filed on registrant&#8217;s current report on Form 8-K
 filed on April 5




















 Ltd. dated April 2
 2013 (incorporated herein by reference to exhibits previously filed on registrant&#8217;s current report on Form 8-K
 filed on April 5










 2013 (incorporated herein by reference to exhibits previously filed on registrant&#8217;s current report on Form 8-K
 filed on April 5










 Ltd. dated April 2
 2013 (incorporated herein by reference to exhibits previously filed on registrant&#8217;s current report on Form 8-K
 filed on April 5










 dated April 2
 2013 (incorporated herein by reference to exhibits previously filed on registrant&#8217;s current report on Form 8-K
 filed on April 5










 LP
 dated as of April 30
 2013(incorporated herein by reference to exhibits previously filed on registrant&#8217;s current report on Form 8-K
 filed on May 30










 LP
 dated as of April 30
 2013(incorporated herein by reference to exhibits previously filed on registrant&#8217;s current report on Form 8-K
 filed on May 30










 LP
 dated as of April 30
 2013(incorporated herein by reference to exhibits previously filed on registrant&#8217;s current report on Form 8-K
 filed on May 30










 LP
 dated as of April 30
 2013(incorporated herein by reference to exhibits previously filed on registrant&#8217;s current report on Form 8-K
 filed on May 30










 dated as of April 30
 2013
 by Subsidiary Guarantors and TCA Global Credit Master Fund
 LP(incorporated herein by reference to exhibits previously filed on registrant&#8217;s current report on Form 8-K
 filed on May 30










 LP
 dated as of April 30
 2013(incorporated herein by reference to exhibits previously filed on registrant&#8217;s current report on Form 8-K
 filed on May 30










 dated as of May 24
 2013(incorporated herein by reference to exhibits previously filed on registrant&#8217;s current report on Form 8-K
 filed on May 30










 2013(incorporated herein by reference to exhibits previously filed on registrant&#8217;s quarterly report on Form 10-Q
 filed August 14










 2013(incorporated herein by reference to exhibits previously filed on registrant&#8217;s quarterly report on Form 10-Q
 filed August 14










 2013(incorporated herein by reference to exhibits previously filed on registrant&#8217;s quarterly report on Form 10-Q
 filed August 14










 LP dated July 18
 2013(incorporated herein by reference to exhibits previously filed on registrant&#8217;s quarterly report on Form 10-Q
 filed August 14










 LP dated July 18
 2013(incorporated herein by reference to exhibits previously filed on registrant&#8217;s quarterly report on Form 10-Q
 filed August 14










 Inc. dated September 24
 2013 (incorporated herein by reference to exhibits previously filed on registrant&#8217;s current report on Form 8-K
 filed on September 26









Amendment of Investment Agreements effective as of October 31

 filed on November 8










 LP dated October 11
 2013 (incorporated herein by reference to exhibits previously filed on registrant&#8217;s quarterly report on Form 10-Q
 filed November 12










 LP dated October 11
 2013 (incorporated herein by reference to exhibits previously filed on registrant&#8217;s quarterly report on Form 10-Q
 filed November 12









Underwriting Agreement dated December 12
 2013
 with Maxim Group
 LLC

 filed on December 18










 2014 (incorporated herein by reference to exhibits previously filed on registrant&#8217;s current report on Form 8-K
 filed on March 21










 2014 (incorporated herein by reference to exhibits previously filed on registrant&#8217;s current report on Form 8-K
 filed on March 21












 filed on August 25

































2014 Equity Incentive Plan










 filed on October 1










 filed on October 1










 2013 (incorporated herein by reference to exhibits previously filed on Amendment No. 1 to registrant&#8217;s annual report on Form 10-K
 filed on April 30










 2013 (incorporated herein by reference to exhibits previously filed on Amendment No. 1 to registrant&#8217;s annual report on Form 10-K
 filed on April 30










 LLC dated December 9
 2014







































































































































































 as amended
 is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934
 as amended




























    Document created using Disclosure Solutions PROFILE 3.2.1.0













































are granted an option to purchase Common Stock of the Company as provided below
)
the 2014 Equity Incentive Plan
)
attached hereto. Unless otherwise defined in this Notice of Grant or the Option Agreement
 the defined terms used in this Notice of Grant and in the Option Agreement shall have the meanings given those terms in the Plan.












































































































































































































By Participant&#8217;s signature and the signature of the Company&#8217;s representative below
 Participant and the Company agree that this Option is granted under and governed by the terms and conditions of the Plan
 this Notice of Grant and the Option Agreement. Participant has reviewed the Plan
 Option Agreement and this Notice of Grant in their entirety
 is familiar with and fully understands the terms and provisions thereof
 has had an opportunity to obtain the advice of counsel prior to executing this Notice of Grant and hereby accepts the Option subject to all of the terms and provisions hereof. Participant understands that Participant&#8217;s employment or consulting relationship
 or service with the Company is for an unspecified duration and can be terminated at any time (i.e.
 is &#8220;at-will&#8221;)
 and that nothing in this Notice of Grant
 the Stock Option Award Agreement or the Plan changes the at-will nature of that relationship. Participant acknowledges that the vesting of shares pursuant to this Notice of Grant is earned only by Participant&#8217;s continuing service as an Employee or Consultant of the Company.












































































































Unless otherwise defined herein
 or in the Notice of Grant
 the terms used in this Award Agreement (the 


). The Option is subject to the terms and conditions of the Plan
 the Notice of Stock Option Grant 


. Subject to the applicable provisions of the Plan and this Agreement
 this Option may be exercised
 in whole or in part
 in accordance with the Vesting Schedule set forth in the Notice of Grant. In the event of a Change of Control transaction
 as defined in the Plan
 the vesting of all Options granted to Participant shall accelerate and such Options will become exercisable in full immediately prior to the consummation of the consummation of the Change of Control transaction. If such Options are not exercised on or prior to the consummation of the transaction
 they shall terminate immediately following the consummation of the Change of Control transaction.





. Except as provided below
 and subject to the Plan
 this Option may be exercised for 3 months after an involuntary Termination without Cause of Participant. In no event shall this Option be exercised later than the Term/Expiration Date set forth in the Notice of Grant.


. Upon the Termination of Participant by reason of his or her death
 this Option may be exercised for twelve months after the date of Termination
 provided that in no event shall this Option be exercised later than the Term/Expiration Date set forth in the Notice of Grant.


. Upon the Termination of Participant by reason of his or her Disability
 this Option may be exercised for twelve months after the date of Termination
 provided that in no event shall this Option be exercised later than the Term/Expiration Date set forth in the Notice of Grant.


. Upon the Termination of Participant for Cause
 the Option shall expire on such date of Participant&#8217;s Termination Date.


). In the event of a conflict between the terms and conditions of the Plan and the terms and conditions of this Agreement
 the terms and conditions of the Plan shall prevail.


)
 this Option is intended to qualify as an Incentive Stock Option under Section 422 of the Code. However
 if this Option is intended to be an Incentive Stock Option
 to the extent that it exceeds the $100
000 rule of Code Section 422(d) it shall be treated as a Nonqualified Stock Option (





. This Option is exercisable during its term in accordance with the Vesting Schedule set forth in the Notice of Grant and the applicable provisions of the Plan and this Agreement. In the event of Participant&#8217;s death
 Disability
 Termination for Cause or involuntary Termination without Cause
 the exercisability of the Option is governed by the applicable provisions of the Plan
 the Notice of Stock Option Grant and this Agreement.



&#8221;)

)
 and such other representations and agreements as may be required by the Company pursuant to the provisions of the Plan. The Exercise Notice shall be delivered in person
 by mail
 via electronic mail or facsimile or by other authorized method to the Secretary of the Company or other person designated by the Company. The Exercise Notice shall be accompanied by payment of the aggregate Exercise Price as to all Exercised Shares. This Option shall be deemed to be exercised upon receipt by the Company of such fully executed Exercise Notice accompanied by such aggregate Exercise Price.


. No Shares shall be issued pursuant to the exercise of this Option unless such issuance and exercise complies with all relevant provisions of law and the requirements of any stock exchange or quotation service upon which the Shares are then listed. Assuming such compliance
 for income tax purposes the Exercised Shares shall be considered transferred to the Participant on the date the Option is exercised with respect to such Exercised Shares.


. Payment of the aggregate Exercise Price shall be by any of the following
 or a combination thereof
 at the election of the Participant:











. This Option may not be transferred in any manner other than by will or by the laws of descent or distribution or court order and may be exercised during the lifetime of Participant only by the Participant. The terms of the Plan and this Agreement shall be binding upon the executors
 administrators
 heirs
 successors and assigns of the Participant.


. This Option may be exercised only within the term set out in the Notice of Grant
 and may be exercised during such term only in accordance with the Notice of Grant
 the Plan and the terms of this Agreement.


. In the event that any dividend or other distribution (whether in the form of cash
 Shares
 other securities
 or other property)
 recapitalization
 stock split
 reverse stock split
 reorganization
 merger
 consolidation
 split-up
 spin-off
 combination
 or exchange of Shares or other securities of the Company
 or other change in the corporate structure of the Company affecting the Shares occurs
 the Committee
 in order to prevent diminution or enlargement of the benefits or potential benefits intended to be made available under the Plan
 shall equitably adjust the number
 class
 and price of Shares covered by this Agreement.


. For Participants subject to U.S. income tax
 some of the federal tax consequences relating to this Option
 as of the date of this Option
 are set forth below. All other Participants should consult a tax advisor for tax consequences relating to this Option in their respective jurisdiction. THIS SUMMARY IS NECESSARILY INCOMPLETE
 AND THE TAX LAWS AND REGULATIONS ARE SUBJECT TO CHANGE. THE PARTICIPANT SHOULD CONSULT A TAX ADVISER BEFORE EXERCISING THIS OPTION OR DISPOSING OF THE SHARES.





. The Participant may incur regular federal income tax liability upon exercise of a NQSO. The Participant will be treated as having received compensation income (taxable at ordinary income tax rates) equal to the excess
 if any
 of the Fair Market Value of the Exercised Shares on the date of exercise over their aggregate Exercise Price. If the Participant is an Employee or a former Employee
 the Company will be required to withhold from his or her compensation or collect from Participant and pay to the applicable taxing authorities an amount in cash equal to a percentage of this compensation income at the time of exercise
 and may refuse to honor the exercise and refuse to deliver Shares if such withholding amounts are not delivered at the time of exercise.



. If this Option qualifies as an ISO
 the Participant will have no regular federal income tax liability upon its exercise
 although the excess
 if any
 of the aggregate Fair Market Value of the Exercised Shares on the date of exercise over their aggregate Exercise Price will be treated as an adjustment to alternative minimum taxable income for federal tax purposes and may subject the Participant to alternative minimum tax in the year of exercise.





. If the Participant holds NQSO Shares for at least one year
 any gain realized on disposition of the Shares will be treated as long-term capital gain for federal income tax purposes.


. If the Participant holds ISO Shares for at least one year after exercise and two years after the grant date
 any gain realized on disposition of the Shares will be treated as long-term capital gain for federal income tax purposes. If the Participant disposes of ISO Shares within one year after exercise or two years after the grant date
 any gain realized on such disposition will be treated as compensation income (taxable at ordinary income rates) to the extent of the excess
 if any
 of the lesser of (A) the difference between the Fair Market Value of the Shares acquired on the date of exercise and the aggregate Exercise Price
 or (B) the difference between the sale price of such Shares and the aggregate Exercise Price.


. If the Participant sells or otherwise disposes of any of the Shares acquired pursuant to an ISO on or before the later of (i) two years after the grant date
 or (ii) one year after the exercise date
 the Participant shall immediately notify the Company in writing of such disposition. The Participant agrees that he or she may be subject to income tax withholding by the Company on the compensation income recognized from such early disposition of ISO Shares by payment in cash or out of the current earnings paid to the Participant.


. Section 409A of the Code applies to arrangements that provide for the deferral of compensation. Generally
 a stock option granted with an exercise price per share of not less than the &#8220;fair market value&#8221; (determined in a manner consistent with Section 409A of the Code and the regulations and other guidance promulgated thereunder) per share on the date of grant of the stock option and with no other feature providing for the deferral of compensation will not be subject to Section 409A of the Code. However
 if the exercise price of the stock option is less than such &#8220;fair market value&#8221; or the stock option has another feature for the deferral of compensation
 then if the stock option is not administered within the parameters established under Section 409A the optionholder will be subject to additional taxes. Also
 the amount deemed to be deferred compensation under Section 409A of the Code will be subject to ordinary income and employment taxes (in this respect the IRS has not yet indicated how it will calculate the amount of deferred compensation subject to tax and the timing and frequency of taxation
 but it seems likely that the income will be measured and taxes imposed at least on the vesting dates of the stock option). If Section 409A of the Code does apply to this Option
 then special rules apply to the timing of making and effecting certain amendments of this Option with respect to distribution of any deferred compensation.


. The Plan is incorporated herein by reference. The Plan
 the Notice of Grant
 the employment agreement by and between the Company and the Participant (to the extent it applies to the Option) and this Agreement constitute the entire agreement of the parties with respect to the subject matter hereof and supersede in their entirety all prior undertakings and agreements of the Company and Participant with respect to the subject matter hereof
 and may not be modified adversely to the Participant&#8217;s interest except by means of a writing signed by the Company and Participant. This agreement is governed by California law except for that body of law pertaining to conflict of laws.


No Rights as Employee
. Nothing in this Agreement shall affect in any manner whatsoever the right or power of the Company
 or a Parent or Subsidiary of the Company
s employment
 for any reason
 with or without cause.



. In connection with the issuance of the Option
 the Participant specifically represents to the Company as follows:


The Participant is aware of the Company's business affairs and financial condition
 and has acquired information about the Company sufficient to reach an informed and knowledgeable decision to acquire this Option. The holder is acquiring this Option for its own account for investment purposes only and not with a view to
 or for the resale in connection with
 any distribution thereof.


The Participant understands that this Option has not been registered under the Securities Act in reliance upon a specific exemption therefrom
 which exemption depends upon
 among other things
 the bona fide nature of the Participant&#8217;s investment intent as expressed herein.


The Participant further understands that the Company shall not be obligated to issue any Shares and the Participant may not be able to exercise the Option at any time when the offering of the Shares covered by this Option have not been registered under the Securities Act of 1933
 pursuant to Form S-8 or otherwise
 and such other state
 federal or foreign laws
 rules or regulations as the Company or the Board deems applicable and
 in the opinion of legal counsel for the Company
 there is no exemption from the registration requirements of such laws
 rules or regulations available for the offering and sale of such Shares. In the absence of such effective registration or an available exemption from registration under the Securities Act
 issuance of Shares upon exercise of the Option may be delayed until registration of such Shares is effective or an exemption from registration under the Securities Act is available.


By your signature and the signature of the Company&#8217;s representative on the Notice of Grant
 you and the Company agree that this Option is granted under and governed by the terms and conditions of the Plan
 the Notice of Grant
 and this Agreement. Participant has reviewed the Plan
 the Notice of Grant
 and this Agreement in their entirety
 has had an opportunity to obtain the advice of counsel prior to executing the Notice of Grant
 and fully understands all provisions of the Plan
 the Notice of Grant
 and this Agreement. Participant hereby agrees to accept as binding
 conclusive and final all decisions or interpretations of the Committee upon any questions relating to the Plan
 the Notice of Grant and the Agreement. Participant further agrees to notify the Company upon any change in the residence address indicated on the Notice of Grant.















) is made and entered into as of 
) by and between RiceBran Technologies
)
 and the purchaser named below (the 
































































































) granted to Purchaser under the Plan and subject to the terms and conditions of this Exercise Agreement
 Purchaser hereby purchases from the Company
 and the Company hereby sells to Purchaser
) of the Company&#8217;s Common Stock
). As used in this Exercise Agreement
 refers to the Shares purchased under this Exercise Agreement and includes all securities received (i) in replacement of the Shares
 (ii) as a result of stock dividends or stock splits with respect to the Shares
 and (iii) all securities received in replacement of the Shares in a merger
 recapitalization
 reorganization or similar corporate transaction.

































&#160;&#9744; Individual
 as separate property


&#160;&#9744; Husband and wife
 as community property





















































Upon its receipt of the Exercise Price
 payment or other provision for any applicable tax obligations and all the documents to be executed and delivered by Purchaser to the Company under Section 2.1
 the Company will issue a duly executed stock certificate evidencing the Shares in the name of Purchaser.





Purchaser has received a copy of the Plan and the Stock Option Agreement
 has read and understands the terms of the Plan
 the Stock Option Agreement and this Exercise Agreement
 and agrees to be bound by their terms and conditions. Purchaser acknowledges that there may be adverse tax consequences upon exercise of the Option or disposition of the Shares
 and that Purchaser should consult a tax adviser prior to such exercise or disposition.


Purchaser has had access to all information regarding the Company and its present and prospective business
 assets
 liabilities and financial condition that Purchaser reasonably considers important in making the decision to purchase the Shares
 and Purchaser has had ample opportunity to ask questions of the Company&#8217;s representatives concerning such matters and this investment.


Purchaser is fully aware of: (i) the highly speculative nature of the investment in the Shares; (ii) the financial hazards involved; (iii) the qualifications and backgrounds of the management of the Company; and (iv) the tax consequences of investment in the Shares. Purchaser is capable of evaluating the merits and risks of this investment
 has the ability to protect Purchaser&#8217;s own interests in this transaction and is financially capable of bearing a total loss of this investment.








Purchaser understands that Purchaser may not transfer any Shares except when such Shares are registered under the Securities Act or qualified under applicable state securities laws or unless
 in the opinion of counsel to the Company
 exemptions from such registration and qualification requirements are available. Purchaser understands that only the Company may file a registration statement with the SEC and that the Company is under no obligation to do so with respect to the Shares
 and may withdraw any such registration statement at any time after filing. Purchaser has also been advised that exemptions from registration and qualification may not be available or may not permit Purchaser to transfer all or any of the Shares in the amounts or at the times proposed by Purchaser.


If Purchaser is an &#8220;affiliate&#8221; for purposes of Rule 144 promulgated under the Securities Act
 then in addition
 Purchaser has been advised that Rule 144 requires that the Shares be held for a minimum of six (6) months
 and in certain cases one year
 after they have been purchased 



Subject to the terms and conditions of this Exercise Agreement
 Purchaser will have all of the rights of a stockholder of the Company with respect to the Shares from and after the date that Shares are issued to Purchaser until such time as Purchaser disposes of the Shares.





Purchaser understands and agrees that the Company will place any legends that may be required by state or U.S. Federal securities laws
 the Company&#8217;s Articles of Incorporation or Bylaws
 any other agreement between Purchaser and the Company or
 subject to the assent of the Company
 any agreement between Purchaser and any third party.


Purchaser agrees that
 to ensure compliance with any restrictions imposed by this Exercise Agreement
 the Company may issue appropriate &#8220;stop-transfer&#8221; instructions to its transfer agent
 if any
 and if the Company transfers its own securities
 it may make appropriate notations to the same effect in its own records.


The Company will not be required (i) to transfer on its books any Shares that have been sold or otherwise transferred in violation of any of the provisions of this Exercise Agreement or (ii) to treat as owner of such Shares
 or to accord the right to vote or pay dividends to any purchaser or other transferee to whom such Shares have been so transferred.


PURCHASER UNDERSTANDS AND REPRESENTS: (i) THAT PURCHASER HAS REVIEWED THE PROSPECTUS PREPARED FOR THE PLAN AND CONSULTED PURCHASER&#8217;S PERSONAL TAX ADVISER IN CONNECTION WITH THE PURCHASE OR DISPOSITION OF THE SHARES AND (ii) THAT PURCHASER IS NOT RELYING ON THE COMPANY FOR ANY TAX ADVICE. SET FORTH BELOW IS A BRIEF SUMMARY AS OF THE DATE THE PLAN WAS ADOPTED BY THE BOARD OF SOME OF THE U.S. FEDERAL TAX CONSEQUENCES OF EXERCISE OF THE OPTION AND DISPOSITION OF THE SHARES. THIS SUMMARY IS NECESSARILY INCOMPLETE
 AND THE TAX LAWS AND REGULATIONS ARE SUBJECT TO CHANGE. PURCHASER SHOULD CONSULT THE PROSPECTUS AND PURCHASER&#8217;S PERSONAL TAX ADVISER BEFORE EXERCISING THIS OPTION OR DISPOSING OF THE SHARES.


If the Option qualifies as an ISO
 there will be no regular U.S. Federal income tax liability upon the exercise of the Option
 although the excess
 if any
 of the Fair Market Value of the Shares on the date of exercise over the Exercise Price will be treated as a tax preference item for U.S. Federal alternative minimum tax purposes and may subject Purchaser to the alternative minimum tax in the year of exercise.


If the Option does not qualify as an ISO
 there may be a regular U.S. Federal income tax liability upon the exercise of the Option. Purchaser will be treated as having received compensation income (taxable at ordinary income tax rates) equal to the excess
 if any
 of the Fair Market Value of the Shares on the date of exercise over the Exercise Price. If Purchaser is or was an employee of the Company
 the Company may be required to withhold from Purchaser&#8217;s compensation or collect from Purchaser and pay to the applicable taxing authorities an amount equal to a percentage of this compensation income at the time of exercise.





. If the Shares are held for more than twelve (12) months after the date of the transfer of the Shares pursuant to the exercise of an ISO and are disposed of more than two (2) years after the Date of Grant
 any gain realized on disposition of the Shares will be treated as long term capital gain for federal income tax purposes. If Shares purchased under an ISO are disposed of within the applicable one (1) year or two (2) year period
 any gain realized on such disposition will be treated as compensation income (taxable at ordinary income rates) to the extent of the excess
 if any
 of the Fair Market Value of the Shares on the date of exercise over the Exercise Price.



. If the Shares are held for more than twelve (12) months after the date of the transfer of the Shares pursuant to the exercise of an NQSO
 any gain realized on disposition of the Shares will be treated as long-term capital gain.








The Company may assign any of its rights under this Exercise Agreement. No other party to this Exercise Agreement may assign
 whether voluntarily or by operation of law
 any of its rights and obligations under this Exercise Agreement
 except with the prior written consent of the Company. This Exercise Agreement shall be binding upon and inure to the benefit of the successors and assigns of the Company. Subject to the restrictions on transfer herein set forth
 this Exercise Agreement will be binding upon Purchaser and Purchaser&#8217;s heirs
 executors
 administrators
 legal representatives
 successors and assigns.


This Exercise Agreement shall be governed by and construed in accordance with the laws of the State of California
 without giving effect to that body of laws pertaining to conflict of laws.


Any and all notices required or permitted to be given to a party pursuant to the provisions of this Exercise Agreement will be in writing and will be effective and deemed to provide such party sufficient notice under this Exercise Agreement on the earliest of the following: (i) at the time of personal delivery
 if delivery is in person; (ii) one (1) business day after deposit with an express overnight courier for United States deliveries
 or two (2) business days after such deposit for deliveries outside of the United States
 with proof of delivery from the courier requested; or (iii) three (3) business days after deposit in the United States mail by certified mail (return receipt requested) for United States deliveries. All notices for delivery outside the United States will be sent by express courier. All notices not delivered personally will be sent with postage and/or other charges prepaid and properly addressed to the party to be notified at the address set forth below the signature lines of this Exercise Agreement
 or at such other address as such other party may designate by one of the indicated means of notice herein to the other parties hereto. Notices to the Company will be marked &#8220;Attention: Stock Plan Administration&#8221;.





The titles
 captions and headings of this Exercise Agreement are included for ease of reference only and will be disregarded in interpreting or construing this Exercise Agreement. Unless otherwise specifically stated
 all references herein to &#8220;sections&#8221; will mean &#8220;sections&#8221; to this Exercise Agreement.


The Plan
 the Notice
 the Stock Option Agreement
 the employment agreement by and between the Company and the Purchaser (to the extent it applies to the Option) and this Exercise Agreement constitute the entire agreement and understanding of the parties with respect to the subject matter of this Exercise Agreement
 and supersede all prior understandings and agreements
 whether oral or written
 between or among the parties hereto with respect to the specific subject matter hereof.



This Exercise Agreement may be executed in any number of counterparts
 each of which when so executed and delivered will be deemed an original
 and all of which together shall constitute one and the same agreement.


If any provision of this Exercise Agreement is determined by any court or arbitrator of competent jurisdiction to be invalid
 illegal or unenforceable in any respect
 such provision will be enforced to the maximum extent possible given the intent of the parties hereto. If such clause or provision cannot be so enforced
 such provision shall be stricken from this Exercise Agreement and the remainder of this Exercise Agreement shall be enforced as if such invalid
 illegal or unenforceable clause or provision had (to the extent not enforceable) never been contained in this Exercise Agreement. Notwithstanding the forgoing
 if the value of this Exercise Agreement based upon the substantial benefit of the bargain for any party is materially impaired
 which determination as made by the presiding court or arbitrator of competent jurisdiction shall be binding
 then both parties agree to substitute such provision(s) through good faith negotiations.







 the Company has caused this Exercise Agreement to be executed by its duly authorized representative and Purchaser has executed this Exercise Agreement as of the Effective Date
 indicated above.






























































































































































    Document created using Disclosure Solutions PROFILE 3.2.1.0






















































&#8221;) as provided below
Terms and Conditions

&#8221;) and the RiceBran Technologies 2014 Equity Incentive Plan
&#8221;).&#160; Unless otherwise defined in this Agreement
 the defined terms used in this Agreement have the meanings given those terms in the Plan.











































































 Participant and the Company agree that this Award of Restricted Stock is granted under and governed by the terms and conditions of the Plan and this Agreement. Participant has reviewed the Plan and this Agreement in their entirety
 has had an opportunity to obtain the advice of counsel prior to executing this Agreement and fully understands all provisions of the Plan and this Agreement. Participant hereby agrees to accept as binding
























































































































&#8221;) under the Plan for past services and as a separate incentive in connection with his or her services and not in lieu of any salary or other compensation for his or her services
&#8221;)
 subject to all of the terms and conditions in this Agreement and the Plan
 which is incorporated herein by reference.





&#8221;) will
 upon execution of this Agreement
&#8221;). The Shares will be held by the Escrow Holder until such time as the Shares vest or the date Participant ceases to be an employee
 director or consultant to the Company (a &#8220;





Upon Participant&#8217;s termination as a Service Provider for any reason
 the Escrow Holder
 upon receipt of written notice of such termination
 will take all steps necessary to accomplish the transfer of the unvested Shares to the Company. Participant hereby appoints the Escrow Holder with full power of substitution
 as Participant&#8217;s true and lawful attorney-in-fact with irrevocable power and authority in the name and on behalf of Participant to take any action and execute all documents and instruments
 including
 without limitation
 stock powers which may be necessary to transfer the certificate or certificates evidencing such unvested Shares to the Company upon such termination.





Subject to the terms hereof
 Participant will have all the rights of a stockholder with respect to the Shares while they are held in escrow
 including without limitation
 the right to vote the Shares and to receive any cash dividends declared thereon.


In the event of any dividend or other distribution (whether in the form of cash
 Common Stock
 other securities
 or other property)
 recapitalization
 stock split
 reverse stock split
 reorganization
 merger
 consolidation
 split-up
 spin-off
 combination
 repurchase
 or exchange of Common Stock or other securities of the Company
 or other change in the corporate structure of the Company affecting the Common Stock
 the Shares will be increased
 reduced or otherwise changed
 and by virtue of any such change Participant will in his or her capacity as owner of unvested shares of Restricted Stock be entitled to new or additional or different shares of stock
 cash or securities (other than rights or warrants to purchase securities); such new or additional or different shares
 cash or securities will thereupon be considered to be unvested Shares and will be subject to all of the conditions and restrictions which were applicable to the unvested Shares pursuant to this Agreement. If Participant receives rights or warrants with respect to any unvested Shares
 such rights or warrants may be held or exercised by Participant
 provided that until such exercise any such rights or warrants and after such exercise any shares or other securities acquired by the exercise of such rights or warrants will be considered to be unvested Shares and will be subject to all of the conditions and restrictions which were applicable to the unvested Shares pursuant to this Agreement.






.&#160; Except as provided in Section&#160;4
 and subject to Section&#160;5
 the Shares awarded by this Agreement will vest in accordance with the Vesting Schedule set forth in the Notice of Grant.

The Shares scheduled to vest on a certain date or upon the occurrence of a certain condition will not vest in Participant in accordance with any of the provisions of this Agreement
 unless Participant will have been continuously a Service Provider from the Date of Grant until the date such vesting occurs.


In the event of a Change of Control transaction
 as defined in the Plan
 the vesting of all Shares granted to Service Provider shall accelerate and become fully vested prior to the consummation of the transaction.


.&#160; The Committee
 in its discretion
 may accelerate the vesting of the balance
 or some lesser portion of the balance
 of the unvested Restricted Stock at any time
 subject to the terms of the Plan. If so accelerated
 such Restricted Stock will be considered as having vested as of the date specified by the Committee.


.&#160; Notwithstanding any contrary provision of this Agreement
 the balance of the Shares that have not vested at the time of Participant&#8217;s termination as a Service Provider for any reason will be forfeited and automatically transferred to and reacquired by the Company at no cost to the Company upon the date of such termination and Participant will have no further rights thereunder. Participant will not be entitled to a refund of the price paid for the Shares
 if any
 returned to the Company pursuant to this Section&#160;5. Participant hereby appoints the Escrow Holder with full power of substitution
 as Participant&#8217;s true and lawful attorney-in-fact with irrevocable power and authority in the name and on behalf of Participant to take any action and execute all documents and instruments
 including
 without limitation
 stock powers which may be necessary to transfer the certificate or certificates evidencing such unvested Shares to the Company upon such termination of service.


.&#160; Any distribution or delivery to be made to Participant under this Agreement will
 if Participant is then deceased
 be made to Participant&#8217;s designated beneficiary
 or if no beneficiary survives Participant
 the administrator or executor of Participant&#8217;s estate. Any such transferee must furnish the Company with (a)&#160;written notice of his or her status as transferee
 and (b)&#160;evidence satisfactory to the Company to establish the validity of the transfer and compliance with any laws or regulations pertaining to said transfer.&#160; This Section 6 is subject in its entirety to Section 5 above.

.&#160; Notwithstanding any contrary provision of this Agreement
 no certificate representing the Shares may be released from the escrow established pursuant to Section&#160;2
 unless and until satisfactory arrangements (as determined by the Committee) will have been made by Participant with respect to the payment of income
 employment and other taxes which the Company determines must be withheld with respect to such Shares. The Committee
 in its sole discretion and pursuant to such procedures as it may specify from time to time
 may permit Participant to satisfy such tax withholding obligation
 in whole or in part by one or more of the following (without limitation): (a)&#160;paying cash
 (b)&#160;electing to have the Company withhold otherwise deliverable Common Stock having a Fair Market Value equal to the minimum amount required to be withheld
 (c)&#160;delivering to the Company already vested and owned Common Stock having a Fair Market Value equal to the amount required to be withheld
 or (d)&#160;selling a sufficient number of such Common Stock otherwise deliverable to Participant through such means as the Company may determine in its sole discretion (whether through a broker or otherwise) equal to the amount required to be withheld. To the extent determined appropriate by the Company in its discretion
 it will have the right (but not the obligation) to satisfy any tax withholding obligations by reducing the number of Common Stock otherwise deliverable to Participant. If Participant fails to make satisfactory arrangements for the payment of any required tax withholding obligations hereunder at the time any applicable Shares are scheduled to vest pursuant to Sections 3 or 4
 Participant will permanently forfeit such Common Stock and the Common Stock will be returned to the Company at no cost to the Company.


.&#160; Neither Participant nor any person claiming under or through Participant will have any of the rights or privileges of a stockholder of the Company in respect of any Shares deliverable hereunder unless and until certificates representing such Shares will have been issued
 recorded on the records of the Company or its transfer agents or registrars
 and delivered to Participant or the Escrow Holder. Except as provided in Section&#160;2
 after such issuance
 recordation and delivery
 Participant will have all the rights of a stockholder of the Company with respect to voting such Shares and receipt of dividends and distributions on such Shares.



.&#160; PARTICIPANT ACKNOWLEDGES AND AGREES THAT THE VESTING OF THE SHARES OF RESTRICTED STOCK PURSUANT TO THE VESTING SCHEDULE HEREOF IS EARNED ONLY BY CONTINUING AS A SERVICE PROVIDER AT THE WILL OF THE COMPANY (OR THE PARENT OR SUBSIDIARY EMPLOYING OR RETAINING PARTICIPANT) AND NOT THROUGH THE ACT OF BEING HIRED
 BEING GRANTED THIS RESTRICTED STOCK OR ACQUIRING COMMON STOCK HEREUNDER. PARTICIPANT FURTHER ACKNOWLEDGES AND AGREES THAT THIS AGREEMENT
 THE TRANSACTIONS CONTEMPLATED HEREUNDER AND THE VESTING SCHEDULE SET FORTH HEREIN DO NOT CONSTITUTE AN EXPRESS OR IMPLIED PROMISE OF CONTINUED ENGAGEMENT AS A SERVICE PROVIDER FOR THE VESTING PERIOD
 FOR ANY PERIOD
 OR AT ALL
 AND WILL NOT INTERFERE IN ANY WAY WITH PARTICIPANT&#8217;S RIGHT OR THE RIGHT OF THE COMPANY (OR THE PARENT OR SUBSIDIARY EMPLOYING OR RETAINING PARTICIPANT) TO TERMINATE PARTICIPANT&#8217;S RELATIONSHIP AS A SERVICE PROVIDER AT ANY TIME
 WITH OR WITHOUT CAUSE.


.&#160; Any notice to be given to the Company under the terms of this Agreement will be addressed to the Company at RiceBran Technologies
 6720 N. Scottsdale Road
 Suite 390
 Scottsdale
 Arizona 85253
 or at such other address as the Company may hereafter designate in writing.


.&#160; The unvested Shares subject to this grant and the rights and privileges conferred hereby will not be transferred
 assigned
 pledged or hypothecated in any way (whether by operation of law or otherwise) and will not be subject to sale under execution
 attachment or similar process. Upon any attempt to transfer
 assign
 pledge
 hypothecate or otherwise dispose of any unvested Shares subject to this grant
 or any right or privilege conferred hereby
 or upon any attempted sale under any execution
 attachment or similar process
 this grant and the rights and privileges conferred hereby immediately will become null and void.


.&#160; Subject to the limitation on the transferability of this grant contained herein
 this Agreement will be binding upon and inure to the benefit of the heirs
 legatees
 legal representatives
 successors and assigns of the parties hereto.


.&#160; The Company will not be required to issue any certificate or certificates for Shares hereunder or release such Shares from the escrow established pursuant to Section&#160;2 prior to fulfillment of all the following conditions: (a)&#160;the admission of Common Stock to listing on all stock exchanges on which such class of stock is then listed; (b)&#160;the completion of any registration or other qualification of such shares under any state or federal law or under the rulings or regulations of the Securities and Exchange Commission or any other governmental regulatory body
 which the Committee will
 in its absolute discretion
 deem necessary or advisable; (c)&#160;the obtaining of any approval or other clearance from any state or federal governmental agency
 which the Committee will
 in its absolute discretion
 determine to be necessary or advisable; and (d)&#160;the lapse of such reasonable period of time following the date of grant of the Restricted Stock as the Committee may establish from time to time for reasons of administrative convenience.


.&#160; This Agreement is subject to all terms and provisions of the Plan. In the event of a conflict between one or more provisions of this Agreement and one or more provisions of the Plan
 the provisions of the Plan will govern. Capitalized terms used and not defined in this Agreement will have the meaning set forth in the Plan.


. The Committee will have the power to interpret the Plan and this Agreement and to adopt such rules for the administration
 interpretation and application of the Plan as are consistent therewith and to interpret or revoke any such rules (including
 but not limited to
 the determination of whether or not any shares of Restricted Stock have vested). All actions taken and all interpretations and determinations made by the Committee in good faith will be final and binding upon Participant
 the Company and all other interested persons. No member of the Committee will be personally liable for any action
 determination or interpretation made in good faith with respect to the Plan or this Agreement.


.&#160; The Company may
 in its sole discretion
 decide to deliver any documents related to the Shares awarded under the Plan or future Restricted Stock that may be awarded under the Plan by electronic means or request Participant&#8217;s consent to participate in the Plan by electronic means. Participant hereby consents to receive such documents by electronic delivery and agrees to participate in the Plan through any on-line or electronic system established and maintained by the Company or another third party designated by the Company.






.&#160; In the event that any provision in this Agreement will be held invalid or unenforceable
 such provision will be severable from
 and such invalidity or unenforceability will not be construed to have any effect on
 the remaining provisions of this Agreement.


. This Agreement constitutes the entire understanding of the parties on the subjects covered. Participant expressly warrants that he or she is not accepting this Agreement in reliance on any promises
 representations
 or inducements other than those contained herein. Modifications to this Agreement or the Plan can be made only in an express written contract executed by a duly authorized officer of the Company. Notwithstanding anything to the contrary in the Plan or this Agreement
 the Company reserves the right to revise this Agreement as it deems necessary or advisable
 in its sole discretion and without the consent of Participant
 to comply with Section&#160;409A of the Internal Revenue Code of 1986
 as amended (the &#8220;


Amendment
.&#160; By accepting this Award
 Participant expressly warrants that he or she has received an Award of Restricted Stock under the Plan
 and has received
 read and understood a description of the Plan. Participant understands that the Plan is discretionary in nature and may be amended
 suspended or terminated by the Company at any time.


.&#160; This Agreement will be governed by the laws of the State of California
 without giving effect to the conflict of law principles thereof. For purposes of litigating any dispute that arises under this Award of Restricted Stock or this Agreement


 California or the federal courts for the United States for the Eastern District of California
 and no other courts
 where this Award of Restricted Stock is made and/or to be performed.

. Participant hereby acknowledges that he or she has been informed that
 with respect to the purchase of the Shares
 an election may be filed by the Participant with the Internal Revenue Service
 within 30 days of the purchase of the Shares
 electing pursuant to Section 83(b) of the Code to be taxed currently on any difference between the purchase price of the Shares
 if any
&#8221;). Making the Election will result in recognition of taxable income to the Participant on the date of purchase
 measured by the excess
 if any
 of the Fair Market Value of the Shares over the purchase price for the Shares. Absent such an Election
 taxable income will be measured and recognized by Participant at the time or times on which the Company&#8217;s right to reacquire the Shares lapses. Participant is strongly encouraged to seek the advice of his or her own tax consultants in connection with the purchase of the Shares and the advisability of filing of the Election. PARTICIPANT ACKNOWLEDGES THAT IT IS SOLELY PARTICIPANT&#8217;S RESPONSIBILITY
 AND NOT THE COMPANY&#8217;S RESPONSIBILITY
 TO TIMELY FILE THE ELECTION UNDER SECTION 83(b) OF THE CODE
 EVEN IF PARTICIPANT REQUESTS THE COMPANY
 OR ITS REPRESENTATIVE
 TO MAKE THIS FILING ON PARTICIPANT&#8217;S BEHALF.




















    Document created using Disclosure Solutions PROFILE 3.2.1.0












 day of December
&#8221;)
 by and among RiceBran Technologies (f/k/a NutraCea)
&#8221;)
&#8221;)
 in each case
&#8221;)
 Industria Riograndese de Oleos Vegetais Ltda
&#8221;) and Nutra SA
 LLC
&#8221;).&#160; The Company
 RBT
 Irgovel and Investor are sometimes referred herein collectively as the &#8220;



&#8221;)
&#8221;) dated as of December 24
 2012
 as amended on January 29
 2013

 2010
 as modified pursuant to a Waiver of Investor Rights Agreement effective as of December 6
 2013
 (iii) a Membership Interest Purchase Agreement dated as of December 29
 2010
 as amended on January 18
&#8221;) dated October 31
 2013
 and (iv) a Second Amended and Restated Limited Liability Company Agreement for Nutra SA
&#8221;) dated as of December 24
 2012




 pursuant to the First Amendment
 RBT agreed to purchase at least $3
000
000 of Units from the Company between the date of the First Amendment and December 31
 2013 and did purchase such $3
000
000 of Units by December 31





 as amended
 RBT further agreed that upon the release to RBT or any of its affiliates
&#8221;) established by U.S. Bank National Association in San Francisco
 California under that certain Escrow Agreement dated as of February 18
 2008 in connection with RBT's purchase of 100% of the total capital stock of Irgovel
 RBT would cause 90% of such released funds to be promptly paid over to the Company
 which funds were not to constitute a Capital Contribution (as defined in the LLC Agreement) by RBT to the Company and would not entitle RBT to receive any additional Units or be counted towards the Unreturned RBT Capital Contributions (as defined in the LLC Agreement);



 the funds in the Escrow Account have not yet been released
 but RBT has made additional contributions to the Company in 2014 in amounts that exceeded 90% of the anticipated Escrow Funds; 









 THEREFORE
 in consideration of the foregoing premises and other good and valuable consideration
 the receipt and sufficiency of which are hereby acknowledged



. The Parties agree and acknowledge that since the date of the First Amendment
 RBT has made an additional cash Capital Contributions to the Company as follows: (i) $3
000
000 in December of 2013
 and (ii) $10
245
000 cumulatively in 2014. Such contributions comprised Capital Contributions by RBT to the Company and RBT has received an additional 5
122
500 Units in the Company and a corresponding increase in its Percentage Interest (as defined in the LLC Agreement) for such contributions. For clarity purposes
 Exhibit A sets forth the Company&#8217;s equity table as of the date of this Agreement.




.&#160; Upon release to RBT or any of its affiliates
 subsidiaries or other related parties of any funds held in the Escrow Fund
 RBT shall retain such funds and shall not be obligated to pay the funds to the Company.&#160; 90% of such released funds shall be treated as a distribution from the Company to RBT
 and shall reduce the Unreturned RBT Capital Contributions in the Company as defined in the LLC Agreement.&#160; Accordingly
 upon the release of all of the Escrow Funds to RBT
 RBT&#8217;s Capital Account shall be decreased by $2.00 per Unit calculated on 90% of net proceeds received by RBT.&#160; Should RBT subsequently contribute to the Company any of the released funds
 the contributions will comprise an additional RBT Capital Contribution and will increase RBT&#8217;s Units and Percentage Interest accordingly.&#8221;


. AF hereby agrees that it will not exercise its right to cause the sale of RBT or Irgovel until January 1
 2016 at the earliest and that the &#8220;Drag Along Trigger Date&#8221; (as defined in the LLC Agreement) shall not occur until January 1
 2016.


.&#160; The Parties acknowledge and agree that there are no other amendments
 changes
 waivers or modifications to the Investment Agreements other than as set forth in this Amendment
 and all other terms of the Investment Agreements remain in full force and effect except as expressly modified or waived herein or therein.&#160; The Parties agree that except as expressly set forth herein
 this Amendment shall not be construed as a waiver by any Party of any of its other rights or obligations under the Investment Agreements.


This Amendment may be executed in any number of counterparts with the same effect as if the Parties had all signed the same document.&#160; All counterparts shall be construed together and shall constitute one agreement. This Amendment
 to the extent executed and delivered by means of a photographic
 photostatic
 facsimile or similar reproduction of such signed writing using a facsimile machine or electronic mail shall be treated in all manner and respects as an original agreement or instrument and shall be considered to have the same binding legal effect as if it were the original signed version thereof delivered in person.&#160; At the request of any Party or to any such agreement or instrument
 each other Party or party thereto shall re execute original forms thereof and deliver them to all other Parties.&#160; No Party shall raise the use of a facsimile machine or electronic mail to deliver a signature or the fact that any signature or agreement or instrument was transmitted or communicated through the use of a facsimile machine or electronic mail as a defense to the formation or enforceability of a contract and each such Party forever waives any such defense.





















































































































































































































































































































 RS











































    Document created using Disclosure Solutions PROFILE 3.2.1.0












































































































































































































































































    Document created using Disclosure Solutions PROFILE 3.2.1.0


















 333-196950 and 333-199646) and on Form S-8 (Nos. 333-110585
 333-135814 and 333-199648) of RiceBran Technologies (the Company) of our report dated March 31
 2015
&#160;with respect to our audit of&#160;the consolidated financial statements as of December 31
 2014 and for the year then ended which&#160;is included&#160;in this Form 10-K of RiceBran Technologies for the year ended December 31
































    Document created using Disclosure Solutions PROFILE 3.2.1.0




















 333-196950 and 333-199646) and on Form S-8 (Nos. 333-110585
 333-135814 and 333-199648) of RiceBran Technologies (the Company) of our report dated March 31
 2014































    Document created using Disclosure Solutions PROFILE 3.2.1.0













 the registrant duly caused this report to be signed on its behalf by the undersigned














































 true and lawful attorney-in-fact
 with the power of substitution
 for him/her in any and all capacities
 to sign amendments to this Report on Form 10-K
 and to file the same
 with all exhibits thereto and other documents in connection therewith
 with the Securities and Exchange Commission
 hereby ratifying and confirming all that said attorneys-in-fact
 or his substitute or substitutes




 as amended






































































































































































































































































































































    Document created using Disclosure Solutions PROFILE 3.2.1.0













 W. John Short
 Chief Executive Officer of RiceBran Technologies



















 this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made
 in light of the circumstances under which such statements were made











 the financial statements
 and other financial information included in this report
 fairly present in all material respects the financial condition
 results of operations and cash flows of the registrant as of
 and for






















 or caused such disclosure controls and procedures to be designed under our supervision
 to ensure that material information relating to the registrant
 including its consolidated subsidiaries
 is made known to us by others within those entities












 or caused such internal control over financial reporting to be designed under our supervision
























 or is reasonably likely to materially affect











 based on our most recent evaluation of internal control over financial reporting












 process












 whether or not material





&#160; March 31
















































    Document created using Disclosure Solutions PROFILE 3.2.1.0













 Jerry Dale Belt
 Chief Financial Officer of RiceBran Technologies



















 this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made
 in light of the circumstances under which such statements were made











 the financial statements
 and other financial information included in this report
 fairly present in all material respects the financial condition
 results of operations and cash flows of the registrant as of
 and for






















 or caused such disclosure controls and procedures to be designed under our supervision
 to ensure that material information relating to the registrant
 including its consolidated subsidiaries
 is made known to us by others within those entities












 or caused such internal control over financial reporting to be designed under our supervision
























 or is reasonably likely to materially affect











 based on our most recent evaluation of internal control over financial reporting












 process












 whether or not material





&#160; March 31

















































    Document created using Disclosure Solutions PROFILE 3.2.1.0


















 2014
 as filed with the Securities and Exchange Commission on the date hereof (the Report)
 we
 W. John Short.
 Chief Executive Officer of the Company
 and Jerry Dale Belt
 Chief Financial Officer of the Company
 certify
 pursuant to 18 U.S.C. &#167; 1350
 as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002


















 in all material respects


























































































      


      
      




      


      




      


      




      


      




      


      




      

        



      




      

        



      




      


      
      




      

        



      




      

        



      




      

        



      




      


      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      




      

        



      




      

        



      




      

        



      




      

        



      




      

        



      




      

        
        



      
      




      

        
        



      
      




      

        
        



      
      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      




      

        



      
      




      


      




      


      
      




      

        



      




      

        
        
        



      
      




      

        
        



      
      




      

        
        



      




      

        



      
      




      

        



      
      




      

        
        



      




      

        
        



      




      

        
        



      
      




      

        
        



      
      




      

        
        



      




      

        
        



      
      




      

        
        



      
      




      

        
        



      




      

        



      




      

        



      




      

        
        
        



      
      




      

        
        
        



      
      




      

        
        
        



      
      




      

        
        
        
        



      
      




      

        
        
        
        



      
      




      

        
        
        
        



      
      




      

        
        
        
        



      
      




      

        
        
        



      
      




      

        
        
        
        



      
      




      

        
        
        
        



      
      




      

        
        
        
        



      
      




      

        
        
        
        



      
      




      

        
        
        
        



      
      




      

        
        
        



      
      




      

        
        
        



      
      




      

        
        
        
        



      
      




      

        
        
        
        



      
      




      

        
        
        



      
      




      

        
        
        



      
      




      

        
        
        



      
      




      

        
        
        
        



      
      




      

        
        
        



      
      




      

        
        
        
        



      
      




      

        
        
        



      
      




      

        
        
        
        



      
      




      

        
        
        



      
      




      

        
        
        



      
      




      

        
        
        
        



      
      




      

        
        
        



      
      




      

        
        
        
        



      
      




      

        
        
        



      
      




      

        
        
        
        



      
      




      

        
        
        
        



      
      




      

        
        
        



      
      




      

        
        
        
        



      
      




      

        



      




      

        



      




      

        



      




      

        



      




      

        



      




      

        



      




      

        



      




      

        



      




      

        



      




      

        



      




      

        



      




      

        



      




      

        



      




      

        



      




      

        



      




      

        
        



      
      




      

        
        



      
      




      

        
        



      
      




      

        
        



      
      




      

        
        



      
      




      

        
        



      
      




      

        
        



      
      




      

        
        



      
      




      

        
        



      
      




      

        
        



      
      




      

        
        



      




      

        
        



      




      

        
        



      




      

        
        



      




      

        
        



      




      

        
        



      




      

        
        



      




      

        
        



      




      

        
        



      




      

        
        



      




      

        
        
        



      
      




      

        
        



      
      




      

        
        



      
      




      

        
        



      
      




      

        
        
        



      
      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      
      




      


      
      




      


      




      


      




      


      




      


      




      


      




      

        



      




      

        



      




      

        



      




      


      




      


      
      




      


      
      




      

        



      
      




      

        



      
      




      

        



      
      




      


      
      




      

        



      
      




      

        



      
      




      

        



      




      

        



      




      


      
      




      


      
      




      

        



      
      




      

        



      




      

        



      
      




      

        



      
      




      

        



      




      

        



      
      




      

        



      




      

        



      




      

        



      
      




      

        



      
      




      

        



      




      

        



      




      

        



      
      




      

        



      




      

        



      
      




      

        



      
      




      

        



      




      

        



      




      

        



      
      




      

        



      




      

        



      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      
      




      

        
        



      
      




      

        
        
        



      
      




      

        
        
        



      
      




      

        
        



      
      




      

        
        



      
      




      

        
        



      
      




      

        
        



      
      




      

        
        



      
      




      

        
        



      
      




      

        
        



      
      




      

        
        



      
      




      

        
        



      
      




      

        
        



      
      




      

        
        



      
      




      

        
        



      
      




      

        
        



      
      




      

        
        



      




      

        
        



      




      

        
        



      




      

        
        



      
      




      

        
        



      
      




      

        
        



      




      

        
        



      




      

        
        



      




      

        
        



      




      

        



      




      

        



      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      




      

        



      




      

        



      




      

        



      




      

        



      




      

        



      




      

        



      




      

        



      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      
      




      

        
        



      




      

        
        



      




      

        
        



      
      




      

        
        



      
      




      

        
        



      
      




      

        
        



      
      




      

        
        



      




      

        
        



      




      

        
        



      




      

        
        



      




      

        
        



      
      




      

        
        



      
      




      

        
        



      
      




      

        
        



      
      




      

        
        



      
      




      

        
        



      
      




      

        
        



      
      




      

        
        



      




      

        
        



      




      

        
        



      




      

        
        



      




      

        
        



      




      

        
        



      




      

        



      




      

        



      




      

        
        



      




      

        
        



      




      

        
        



      




      

        
        



      




      

        
        



      




      

        



      




      

        
        



      




      

        
        



      




      

        
        



      




      

        
        



      




      

        
        



      




      

        
        



      




      

        



      




      

        
        



      




      

        
        



      




      

        
        



      




      

        
        



      




      


      




      

        
        
        



      




      

        
        
        



      




      

        
        
        



      




      

        
        
        



      




      

        
        
        



      




      

        
        



      




      

        
        



      




      

        
        
        



      




      

        
        



      
      




      

        
        



      
      




      

        
        



      
      




      

        
        



      
      




      

        
        



      
      




      

        
        



      
      




      

        



      




      

        



      




      

        



      




      

        



      
      




      

        



      
      




      

        



      




      

        



      




      

        



      




      

        



      




      

        



      




      

        



      




      

        
        



      




      

        



      




      

        



      
      




      

        



      




      

        



      




      

        



      
      




      

        



      




      

        



      




      

        



      




      

        



      




      

        
        



      
      




      

        
        
        



      
      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      
      




      

        
        



      
      




      

        
        



      
      




      

        



      
      




      

        



      
      




      

        
        



      




      

        
        



      
      




      

        
        



      
      




      

        
        



      




      

        
        



      




      

        
        



      




      

        



      
      




      

        
        



      
      




      

        



      
      




      

        
        



      
      




      

        
        



      
      




      

        
        



      
      




      

        



      
      




      

        



      




      

        
        



      




      

        
        



      




      

        



      




      

        
        



      




      

        
        



      




      

        
        



      
      




      

        
        



      
      




      

        
        



      
      




      

        
        



      
      




      

        
        



      
      




      

        
        



      
      




      

        
        
        



      




      

        
        
        



      




      

        
        
        



      




      

        
        
        



      




      

        
        



      




      

        
        



      




      

        
        
        



      




      

        
        
        



      




      

        
        



      




      

        
        



      




      

        
        



      




      

        
        



      




      

        
        



      




      

        



      




      

        
        



      




      

        



      




      

        
        
        



      
      




      

        
        
        



      
      




      

        
        
        



      
      




      

        
        
        



      
      




      

        
        
        



      
      




      

        
        
        



      
      




      

        
        



      
      




      

        
        



      
      




      

        
        



      




      

        



      




      

        
        



      




      

        
        



      




      

        



      
      




      

        
        



      




      

        
        



      




      

        
        



      




      

        



      




      

        
        



      
      




      

        



      
      




      

        



      
      




      

        
        



      
      




      

        
        



      



    


    




        


        




    


    


    


    


    


    


    


    


  

  

  

  

  

  

  

  

  

  


  

  

  

  

  

  

 Net
 Current-Variable Interest Entity

  

 Net
 Current-Variable Interest Entity

  

 net of allowance for doubtful accounts of $574 and $501 (variable interest entity restricted $1
980 and $1

  

 net of allowance for doubtful accounts of $574 and $501 (variable interest entity restricted $1
980 and $1

  

 net of allowance for doubtful accounts of $574 and $501 (variable interest entity restricted $1
980 and $1

  

  

  

  

  

  

  

  

  

  

  

  


  

  

  

 Share-based Compensation
 Stock Options

  

 Share-based Compensation
 Stock Options

  

 Share-based Compensation
 Stock Options

  

 Share-based Compensation
 Stock Options

  

 Share-based Compensation
 Stock Options

  

 Share-based Compensation
 Stock Options

  

 Share-based Compensation
 Stock Options

  

 Share-based Compensation
 Stock Options

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  


  


  


  


  


  


  


  


  


  


  

  

  

  

  

  

  

  


  


  

  

  

  

  

  

  


  


  

 Recognized Identifiable Assets Acquired and Liabilities Assumed

  

 Recognized Identifiable Assets Acquired and Liabilities Assumed

  

 Recognized Identifiable Assets Acquired and Liabilities Assumed

  

  

  

 Recognized Identifiable Assets Acquired and Liabilities Assumed

  

  

 Recognized Identifiable Assets Acquired and Liabilities Assumed

  

 Recognized Identifiable Assets Acquired and Liabilities Assumed

  


 we purchased all of the outstanding shares of HN for $2.0 million in cash ($1.8 million paid in January 2014 and $0.2 million payable upon the resolution of certain contingencies) and promissory notes in the face amount of $3.3 million
 subject to working capital adjustments.&amp;#160; &lt;font style=font-size: 10pt; font-family: 'Times New Roman', Times, serif;&gt;HN is an Irving
 Texas-based formulator and co-packer of products targeted at customers in the direct marketing
 internet sales and retail distribution markets. HN serves the natural products
 nutritional supplement

 2014

 we incurred $0.3 million of acquisition-related costs which are included in selling
 general and administrative expenses in the consolidated statements of operations.&amp;#160; The following table summarizes the aggregate purchase price allocation
 the consideration transferred to acquire HN
 as well as the amounts of identified assets acquired and liabilities assumed based on the estimated fair value as of the January 2
 2014



785&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=bottom style=width: 68%; vertical-align: bottom; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=bottom style=width: 68%; vertical-align: bottom; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;&gt;Financial assets
 including acquired cash of $1
075&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif;&gt;1


847&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=bottom style=width: 68%; vertical-align: bottom; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;&gt;Deferred&amp;#160; income taxes
 net&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif;&gt;(1



 2014
 was $0.1 million which equaled the gross amount receivable.&amp;#160; We assigned a $3.8 million value to a customer relationship intangible and we are amortizing that intangible over a three-year period.&amp;#160; In 2014
 we recognized $1.7 million of amortization expense in the USA segment related to this intangible and expect to recognize $1.3 million in 2015 and $0.9 million in 2016.&amp;#160; &lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify;&gt;Our consolidated revenues include $12.1 million of HN revenues for 2014.&amp;#160; After making a reasonable effort
 we have been unable to determine the underlying information required to prepare pro forma information for 2013
 as if the HN acquisition had occurred January 1
 2013.&amp;#160; After making a reasonable effort


  

 Acquired Receivables

  

  


 2014
 we maintained our cash
 including restricted cash
 and cash equivalents



  


  


  


  


  

 at Carrying Value-Variable Interest Entity

  

 at Carrying Value-Variable Interest Entity

  

  


  


  


  


  


  


  


  


  


  


  


  






 we periodically enter into employment agreements which incorporate indemnification provisions.&amp;#160; While the maximum amount to which we may be exposed under such agreements cannot be reasonably estimated
 we maintain insurance coverage

 2014

 from time to time we are involved in litigation incidental to the conduct of our business.&amp;#160; When applicable
 we record accruals for contingencies when it is probable that a liability will be incurred and the amount of loss can be reasonably estimated.&amp;#160; While the outcome of lawsuits and other proceedings against us cannot be predicted with certainty
 in the opinion of management
 individually or in the aggregate

 2008
 former Irgovel stockholder David Resyng filed an indemnification suit against Irgovel
 Osmar Brito and the remaining former Irgovel stockholders (Sellers)
 requesting:&amp;#160; (i) the freezing of the escrow account maintained in connection with the transfer of Irgovel&amp;#8217;s corporate control to us and the presentation of all documentation related to the transaction
 and (ii) damages in the amount of the difference between (a) the sum received by David Resyng in connection with the judicial settlement agreement executed in the action for the partial dissolution of the limited liability company filed by David Resyng against Irgovel and the Sellers and (b) the amount received by the Sellers in connection with the sale of Irgovel&amp;#8217;s corporate control to us
 in addition to moral damages as determined in the court&amp;#8217;s discretion.&amp;#160; The amount of damage claimed by Mr. Resyng is approximately $3 million.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify;&gt;We believe that the filing of the above lawsuit is a fundamental default of the obligations undertaken by the Sellers under the Quotas Purchase Agreement for the transfer of Irgovel&amp;#8217;s corporate control
 executed by and among the Sellers and us on January 31
 2008 (Purchase Agreement).&amp;#160; Consequently
 we believe that the responsibility for any indemnity

 2009
 the Sellers filed a collection lawsuit against us seeking payment of the second installment of the purchase price under the Purchase Agreement
 which the Sellers allege is approximately $1.0 million.&amp;#160; We have withheld payment of the second installment pending resolution of the Resyng lawsuit noted above.&amp;#160; Our parent company has not been served with any formal notices in regard to this matter.&amp;#160; To date
 only Irgovel has received formal legal notice.&amp;#160; In addition
 the Purchase Agreement requires that all disputes between us and the Sellers be adjudicated through arbitration.&amp;#160; &lt;/font&gt;On October 29
 2010
 we initiated an arbitration proceeding against the Sellers for breaches of the Purchase Agreement
 including claims related to Sellers&amp;#8217; handling of the Resyng claim and whether any future payments are required under the Purchase Agreement.&amp;#160; On February 25
 2015
 the arbitration panel issued its opinion and ordered the Sellers to pay Irgovel and us R$3.6 million plus arbitration fees
 legal fees

 $2.0 million was deposited into an escrow account to cover contingencies with the net remaining funds payable to the Sellers upon resolution of all contingencies.&amp;#160; As of December 31 2014 and 2013
 the balance in the escrow account was $1.9 million and is included in restricted cash in our balance sheets.&amp;#160; There is an escrow liability related to the lawsuit in accrued expenses on our balance sheets as of December 2014 and 2013
 totaling $1.6 million.&amp;#160; When the escrow account was funded
 we established an accrued liability equal to the amount of the escrow for contingencies and the net balance due to the Sellers under the terms of the Purchase Agreement.&amp;#160; As of December 31
 2014
 $0.5 million of pre-acquisition contingencies have either been paid or specifically identified and accrued
 leaving a balance of $1.6 million to settle any remaining contingencies.&amp;#160; We believe &lt;/font&gt;that there is no additional material exposure as any amounts determined to be owed as a result of the above noted litigation and contingencies will be covered by the escrow account.&amp;#160; If and when received

 LLC&lt;/u&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify;&gt;In January 2012
 we filed a complaint in the Superior Court of California
 Sacramento County
 seeking damages arising out of Diabco Life Sciences
 LLC&amp;#8217;s (Diabco) breach of a 2008 promissory note in the principal amount of $0.5 million.&amp;#160; At trial in August 2013
 Diabco stipulated that total damages through July 2013
 including interest and late fees
 amounted to $0.9 million.&amp;#160; In September 2013
 the court issued its tentative statement of decision indicating that judgment will be entered in our favor in the amount of $0.9 million as of July 2013
 plus interest.&amp;#160; In January 2014
 the court issued its final judgment in the amount of $1.0 million.&amp;#160; Diabco filed a notice of appeal which was dismissed in October 2014.&amp;#160; We have no receivable from Diabco recorded in the accompanying financial statements



  


  


  

 no par value
 25
000
000 shares authorized
 9
383
571 and 2
832

  

 no par value
 25
000
000 shares authorized
 9
383
571 and 2
832

  


  


  


  


  


  


  


  


  


  


  

  


  


  


  


  


  


  

 Net of Tax

  

 Net of Tax

  

 Net of Tax

  

 Net of Tax

  

 Net of Tax

  

 Net of Tax

  


 none of our revenues in 2013
 and 2.9% of our receivables as of December 31
 2014.&amp;#160; A second USA segment customer accounted for none of our sales in 2014 and 6% of our sales in 2013
 none of our outstanding accounts receivable at December 31
 2014 and 2013.&amp;#160; A third Brazil segment customer accounted for approximately 3% and 5% of our sales in 2014 and 2013 and approximately 7% and 16% of our accounts receivable balances at December 31
 2014 and 2013.&amp;#160; A fourth Brazil segment customer accounted for approximately 3% and 9% of our sales in 2014 and 2013 and approximately 22% and 4% of our accounts receivable balances at December 31
 2014 and 2013.&amp;#160; A fifth Brazil segment customer accounted for approximately 4% and 9% of our sales in 2014 and 2013 and approximately 3% and 10% of our accounts receivable balances at December 31
 2014 and 2013.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify;&gt;As of December 31
 2014
 232 of our 295 employees were located in Brazil.&amp;#160; All of our employees in Brazil are represented by a labor union and are covered by a collective bargaining agreement.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify;&gt;At December 31
 2014
 Brazil made up $2.0 million of the $3.1 million consolidated accounts receivable balance



  


  


  


  


  


  


  


  


  


  


  


  


  


  


  


  


  


  


  


  


  


  


  


  


  


  


  


  


  


  


  


  


  


  


  


  


  


  

  


  


  


  


  


  


  


  


  


  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  


  


  


  




988&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=bottom style=width: 56%; vertical-align: top; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000; text-align: left; margin-left: 16.2pt; text-indent: -7.2pt;&gt;Subordinated notes
 net&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;4
978&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;4

135&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;6

629&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;4

408&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;3

810&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;2

016&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;2

961&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;12

096&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;19

808&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;8



 2014&lt;font style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;

758&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;4

591&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: right; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;1
045&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: right; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;7

873&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;2
873&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=bottom style=width: 44%; vertical-align: top; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;6
705&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;10
961&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;17





096&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000; text-align: justify;&gt;As of December 31
 2014

 in May 2014

 2014
 subordinated notes in the principal amount of $6.5 million remain outstanding.&amp;#160; The notes bear interest of 5% per year
 payable quarterly
 and mature in July 2016.&amp;#160; The notes are secured by interest in substantially all of our assets
 excluding our interest in Nutra SA and RBT PRO
 LLC.&amp;#160; See further discussion in Note 12.&amp;#160; We accrete the notes up to their face value at an average annual interest rate of 22.7%.&amp;#160; &lt;font style=font-size: 10pt; font-family: 'Times New Roman', Times, serif;&gt;In connection with the Modification discussed further in Note 10
 during the fourth quarter of 2013
 &lt;/font&gt;the holders of our subordinated convertible notes agreed to amend their notes to reduce the annual interest rate to 5% from 10%


 Irgovel entered into loan agreements with the Bank of Brazil.&amp;#160; As of December 31
 2014
 the notes held a principal balance of R$8.1 million. The annual interest rate on the loans is 6.5%
 payable quarterly and the loans mature December 2021.&amp;#160; Irgovel must make monthly principal payments under each of the loans.&amp;#160; Irgovel used R$1.5 million of the proceeds for working capital purposes and the remainder for the purchase of equipment and machinery.&amp;#160; In July 2012

 depending on the agreement.&amp;#160; The annual interest rates on this debt range from 12.5% to 125.4%


 Irgovel&amp;#8217;s debt under several notes was consolidated into one note and Irgovel financed an additional $0.9 million of taxes payable under the programs.&amp;#160; Principal and interest payments are due monthly through January 2029.&amp;#160; Interest on the notes is payable monthly at the Brazilian SELIC target rate
 which was 11.8% at December 31


 Convertible

  

 Convertible

  

  


  


  


  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

 Property

  

 Property

  

  

  

  

  

  

  

  

  

  


  


  

  

  

  

  


  


  

  

  

 Operating Loss Carryforwards

  

 Operating Loss Carryforwards

  

 Valuation Allowance

  

 Valuation Allowance

  


  


  

  

  

 Property

  

 Property

  


  


  

  

  

  

 Depletion and Amortization

  

 Depletion and Amortization

  

  

  

  

  

  

  

 Liabilities [Member]-Fair Value
 Measurements

  

 Measurements
 Recurring [Member]-Derivative Financial Instruments

  

 Liabilities [Member]-Level 3 [Member]-Fair Value
 Measurements

  

 Liabilities [Member]-Fair Value
 Measurements

  

 Measurements
 Recurring [Member]-Derivative Financial Instruments

  

 Measurements
 Recurring [Member]-Derivative Financial Instruments

  

 Liabilities [Member]-Level 2 [Member]-Fair Value
 Measurements

  

 Liabilities [Member]-Level 1 [Member]-Fair Value
 Measurements

  

  

  

  





809
364&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif;&gt;1
160

809
364&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif;&gt;1
160

584&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif;&gt;179

651
380&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif;&gt;809



 2014 and 2013
 were not included in the calculation of diluted EPS in 2014 and 2013 because to do so would be antidilutive.&amp;#160; Those securities listed in the table above which were antidilutive in 2014 and 2013
 which remain outstanding


  

  

  

  

  

  

  

  


  


  

  

  


 we entered into an agreement with a partner with the goal of developing technology to extract and concentrate protein from rice bran.&amp;#160; In March 2013
 the agreement was mutually terminated under terms whereby we each received (i) the right to separately develop
 modify and improve the jointly developed technology owned by the partner and (ii) a nonexclusive
 royalty free

 LLC (RBT PRO)&lt;/font&gt; was a wholly owned subsidiary whose only asset was the License acquired in March 2013.&amp;#160; I&lt;font style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;n April 2013
 &lt;/font&gt;we entered into a series of agreements with various affiliates of Wilmar International Limited (collectively Wilmar).&amp;#160; In connection therewith
 &lt;font style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;we sold a 50% membership interest in RBT PRO to Wilmar&lt;/font&gt; for $1.2 million.&amp;#160; RBT PRO granted a royalty free
 perpetual sublicense of the License to Wilmar for exclusive use throughout China.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify;&gt;We also entered into a cross license agreement with Wilmar
 and under the agreements
 we obtained rights to purchase a percentage of the capital stock of any entity Wilmar establishes to develop new products relating to rice bran or its derivative
 as defined in the agreement
 using the intellectual property licensed to Wilmar.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify;&gt;There was no gain or loss recognized on these transactions because we entered the agreement with the partner in contemplation of the agreements with Wilmar.&amp;#160; We account for our investment in RBT PRO under the equity method.&amp;#160; Our investment in RBT PRO was zero as of December 31
 2014 and 2013


  

 Liabilities [Member]-Fair Value
 Measurements

  

 Measurements
 Recurring [Member]-Derivative Financial Instruments

  






 based on an internal evaluation of market conditions


 Measurements
 Recurring [Member]-Derivative Financial Instruments

  

 Liabilities [Member]-Fair Value
 Measurements

  

 Liabilities [Member]-Fair Value
 Measurements

  

 Measurements
 Recurring [Member]-Minimum [Member]-Derivative Financial Instruments

  

 Liabilities [Member]-Fair Value
 Measurements

  

 Measurements
 Recurring [Member]-Weighted Average [Member]-Derivative Financial Instruments

  

 Measurement with Unobservable Inputs Reconciliation
 Recurring Basis
 Liability
 Issuances-Fair Value
 Measurements

  

 Measurement with Unobservable Inputs Reconciliation
 Recurring Basis
 Liability
 Issuances-Derivative conversion liability [Member]-Fair Value
 Measurements

  

 Measurement with Unobservable Inputs Reconciliation
 Recurring Basis
 Liability
 Issuances-Derivative Financial Instruments
 Liabilities [Member]-Fair Value
 Measurements

  

 Measurement with Unobservable Inputs Reconciliation
 Recurring Basis
 Liability
 Issuances-Fair Value
 Measurements
 Recurring [Member]-Derivative Financial Instruments

  

 Measurement with Unobservable Inputs Reconciliation
 Recurring Basis
 Liability
 Issuances-Derivative conversion liability [Member]-Fair Value
 Measurements

  

 Measurement with Unobservable Inputs Reconciliation
 Recurring Basis
 Liability
 Issuances-Fair Value
 Measurements

  

 Measurement with Unobservable Inputs Reconciliations
 Recurring Basis
 Liability Value-Derivative conversion liability [Member]-Fair Value
 Measurements

  

 Measurement with Unobservable Inputs Reconciliations
 Recurring Basis
 Liability Value-Derivative conversion liability [Member]-Fair Value
 Measurements

  

 Measurement with Unobservable Inputs Reconciliations
 Recurring Basis
 Liability Value-Fair Value
 Measurements
 Recurring [Member]-Derivative Financial Instruments

  

 Measurement with Unobservable Inputs Reconciliations
 Recurring Basis
 Liability Value-Fair Value
 Measurements
 Recurring [Member]-Derivative Financial Instruments

  

 Measurement with Unobservable Inputs Reconciliations
 Recurring Basis
 Liability Value-Fair Value
 Measurements

  

 Measurement with Unobservable Inputs Reconciliations
 Recurring Basis
 Liability Value-Fair Value
 Measurements

  

 Measurement with Unobservable Inputs Reconciliations
 Recurring Basis
 Liability Value-Fair Value
 Measurements
 Recurring [Member]-Derivative Financial Instruments

  

 Measurement with Unobservable Inputs Reconciliations
 Recurring Basis
 Liability Value-Derivative conversion liability [Member]-Fair Value
 Measurements

  

 Measurement with Unobservable Inputs Reconciliations
 Recurring Basis
 Liability Value-Fair Value
 Measurements

  


 accounts and other receivables and accounts payable approximates their carrying value due to their shorter maturities.&amp;#160; As of December 31 2014
 the fair value of our Corporate segment debt (Level 3 measurement) is approximately $0.2 million higher than the $5.1 million carrying value of that debt









 2014&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; padding-bottom: 2px;&gt;&amp;#160;&lt;/td&gt;&lt;td colspan=2 valign=bottom style=vertical-align: top; border-bottom: #000000 2px solid;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; color: #000000; text-align: center;&gt;December 31























 based on an internal evaluation of market conditions































 Measurement with Unobservable Inputs Reconciliation
 Recurring Basis
 Liability
 Transfers
 Net-Fair Value
 Measurements

  

 Measurement with Unobservable Inputs Reconciliation
 Recurring Basis
 Liability
 Transfers
 Net-Derivative Financial Instruments
 Liabilities [Member]-Fair Value
 Measurements

  

 Measurement with Unobservable Inputs Reconciliation
 Recurring Basis
 Liability
 Transfers
 Net-Fair Value
 Measurements
 Recurring [Member]-Derivative Financial Instruments

  

 Measurement with Unobservable Inputs Reconciliation
 Recurring Basis
 Liability
 Transfers
 Net-Derivative conversion liability [Member]-Fair Value
 Measurements

  

 Measurement with Unobservable Inputs Reconciliation
 Recurring Basis
 Liability
 Transfers
 Net-Fair Value
 Measurements

  

 Measurement with Unobservable Inputs Reconciliation
 Recurring Basis
 Liability
 Transfers
 Net-Derivative conversion liability [Member]-Fair Value
 Measurements

  

 Measurement with Unobservable Inputs Reconciliation
 Recurring Basis
 Liability
 Gain (Loss) Included in Earnings-Derivative conversion liability [Member]-Fair Value
 Measurements

  

 Measurement with Unobservable Inputs Reconciliation
 Recurring Basis
 Liability
 Gain (Loss) Included in Earnings-Fair Value
 Measurements

  

 Measurement with Unobservable Inputs Reconciliation
 Recurring Basis
 Liability
 Gain (Loss) Included in Earnings-Fair Value
 Measurements
 Recurring [Member]-Derivative Financial Instruments

  

 Measurement with Unobservable Inputs Reconciliation
 Recurring Basis
 Liability
 Gain (Loss) Included in Earnings-Fair Value
 Measurements

  

 Measurement with Unobservable Inputs Reconciliation
 Recurring Basis
 Liability
 Gain (Loss) Included in Earnings-Derivative Financial Instruments
 Liabilities [Member]-Fair Value
 Measurements

  

 Measurement with Unobservable Inputs Reconciliation
 Recurring Basis
 Liability
 Gain (Loss) Included in Earnings-Derivative conversion liability [Member]-Fair Value
 Measurements

  

  

 Amortization Expense

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  


  


  


  


  


  


  


  


  


  


  


  


  


  


  


  


  


  


  


  


  


  


  


  


  

 Amortization Expense

  

  

  

  

  


 U.S. Dollars.&amp;#160; The functional currency for Irgovel is the Brazilian Real.&amp;#160; Assets and liabilities of Irgovel are translated into U.S. Dollars using the exchange rate in effect at the consolidated balance sheet date.&amp;#160; Equity accounts are translated at historical rates
 except for the change in accumulated deficit during the year
 which is the result of the income statement translation process. Irgovel&amp;#8217;s revenues and expenses are translated using the average exchange rates in effect during the period.&amp;#160; Translation differences are recorded in accumulated other comprehensive income (loss) as foreign currency translation.&amp;#160; Gains or losses on transactions denominated in a currency other than Irgovel&amp;#8217;s functional currency which arise as a result of changes in foreign exchange rates are recorded as foreign exchange gain or loss in the statements of operations. As of March 31
 2015
 the Brazilian Real has fallen against the U.S. Dollar since December 31
 2014



  


  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

 Measurements

  

 Income Taxes
 Extraordinary Items

  

 Income Taxes
 Extraordinary Items

  

 Extraordinary Items

  

 Extraordinary Items

  

  

  

  

  

  

  

  

  

  

  








671&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;53





666&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;2



 net of $0.6 million impact from foreign currency translation
 offset by (i) the $41.8 million impact of net operating losses expiring and those being limited due to ownership changes (ii) $0.9 million from the impact of state rate changes (iii) $1.3 million from the establishment of deferred tax liabilities in the acquisition of HN (iv) $1.1 million of adjustments to intangibles and stock compensation deferreds
 and (v) $7.5 million of adjustment to fixed asset deferred balance as a result of an accounting method change.&amp;#160; The change in valuation allowance of $4.9 million in 2013 was due to (i) $3.9 million in net operating loss and (ii) $0.7 million from the impact of state rate changes and (iii) $0.9 million for the establishment of a valuation allowance against Brazil deferred tax assets
 offset by (i) the $0.4 million impact of expiring net operating losses and (ii) $0.2 million of other deferred items.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000; text-align: justify;&gt;As of December 31
 2014
 net operating loss carryforwards for U.S. federal tax purposes totaled $6.5 million and expire at various dates from 2018 through 2034.&amp;#160; Net operating loss carryforwards for state tax purposes totaled $6.0 million as of December 31
 2014
 and expire at various dates from 2015 through 2034.&amp;#160; As of December 31
 2014
 net operating loss carryforwards for Brazil tax purposes totaled $13.7 million and do not expire but may be subject to substantial annual limitations (generally 30% of taxable income in any year).&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000; text-align: justify;&gt;Due to offerings and conversions occurring between December 2013 and May 2014
 we believe our ability to utilize previously accumulated net operating loss carryforwards are subject to substantial annual limitations due to &amp;#8220;change in ownership&amp;#8221; provisions of the Internal Revenue Code of 1986
 as amended
 and similar state regulations.&amp;#160; Therefore in 2014
 we recorded the impact of the expiration of substantial net operating loss carryforwards prior to utilization.&amp;#160; We have not yet finalized the exact amount of such limitation
 as the rules in this area are complex

 generally



















 general and administrative expenses. We have not identified any uncertain tax positions requiring a reserve as of December 31


  

  

  

  

  

  

  

  


  


  


 when necessary


  

  

  

  

  

  

  

  

  

  


  


  


  


  


  


  


  


  












740&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=bottom style=width: 18%; vertical-align: bottom; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=bottom style=width: 18%; vertical-align: bottom; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-variant: normal; font-weight: normal; font-style: normal; text-align: left; margin-left: 7.2pt; background-color: #cceeff; text-indent: -7.2pt;&gt;&lt;u&gt;December 31











 $1.0 million in 2016








 Net (Including Goodwill)-Variable Interest Entity

  

 Net (Including Goodwill)-Variable Interest Entity

  

  

  

  

  

  

  

  

  

  


  


  

  

  

  

  

  

  


  


  



 with cost determined by the first-in
 first-out method.&amp;#160; In the USA segment
 we employ a full absorption procedure using standard cost techniques.&amp;#160; The standards are customarily reviewed and adjusted annually so that they are materially consistent with actual purchase and production costs.&amp;#160; In the Brazil segment we use actual average purchase and production costs.&amp;#160; Provisions for potentially obsolete or slow moving inventory are made based upon our analysis of inventory levels


  

  

  

  









 Work in Process

  

 Work in Process

  

  

  

  

  

  

  


  


  

  

  

 Fair Value Disclosure-Level 3 [Member]-Fair Value
 Measurements

  

 Fair Value Disclosure-Level 2 [Member]-Fair Value
 Measurements

  

 Fair Value Disclosure-Level 2 [Member]-Fair Value
 Measurements

  

 Fair Value Disclosure-Level 1 [Member]-Fair Value
 Measurements

  

 Fair Value Disclosure-Level 3 [Member]-Fair Value
 Measurements

  


  

 Fair Value Disclosure-Fair Value
 Measurements

  

 Fair Value Disclosure-Level 1 [Member]-Fair Value
 Measurements

  

 Fair Value Disclosure-Fair Value
 Measurements

  

  

  


  


  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

 Maturities

  

 Maturities

  

 Maturities

  

 Maturities

  

 Maturities

  

 Maturities

  

 Maturities

  

 Maturities

  

 Maturities

  

758 and $6

  

758 and $6

  

758 and $6
262)-Variable Interest Entity

  

758 and $6
262)-Variable Interest Entity

  

 less current portion (variable interest entity nonrecourse $6
203 and $6

  

 less current portion (variable interest entity nonrecourse $6
203 and $6

  

 less current portion (variable interest entity nonrecourse $6
203 and $6
658)-Variable Interest Entity

  

 less current portion (variable interest entity nonrecourse $6
203 and $6
658)-Variable Interest Entity

  

 Maturities

  

 Maturities

  

 Maturities

  

 Maturities

  

 Maturities

  

 Maturities

  

 Maturities

  

 Maturities

  

 Maturities

  

  

  

 Damages Sought

  


 LLC (Nutra SA).&amp;#160; We are the primary beneficiary of Nutra SA
 and as such
 Nutra SA&amp;#8217;s assets
 liabilities and results of operations are included in our consolidated financial statements.&amp;#160; The other equity holders&amp;#8217; interests are reflected in net loss attributable to noncontrolling interest in Nutra SA
 in the consolidated statements of operations
 and redeemable noncontrolling interest in Nutra SA


686&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=bottom style=width: 56%; vertical-align: bottom; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;&gt;Other current assets (restricted $1
980 and $1
967)&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif;&gt;4
735&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif;&gt;4
546&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=bottom style=width: 56%; vertical-align: bottom; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;&gt;Property
 net (restricted $3
727 and $4
969)&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif;&gt;15
258&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif;&gt;17
672&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=bottom style=width: 56%; vertical-align: bottom; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;&gt;Goodwill and intangibles
 net&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif;&gt;3
722&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif;&gt;4





758&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif;&gt;6
262&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=bottom style=width: 56%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;&gt;Long-term debt
 less current portion (nonrecourse)&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif;&gt;6
203&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif;&gt;6












 we entered into a membership interest purchase agreement (MIPA) with AF Bran Holdings-NL LLC and AF Bran Holdings LLC (Investors).&amp;#160; The Investors&amp;#8217; share of Nutra SA&amp;#8217;s net income (loss) increases (decreases) redeemable noncontrolling interest.&amp;#160; We are restricted from competing with Nutra SA and Irgovel in Brazil as further described in the MIPA.&amp;#160; In 2014 and 2013
 we invested an additional $10.3 million and $3.9 million in Nutra SA.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify;&gt;Redeemable noncontrolling interest in Nutra SA is recorded in temporary equity
 above the equity section and after liabilities on our consolidated balance sheets
 because the Investors have drag along rights which provide the Investors the ability to force a sale of Nutra SA assets in the future.&amp;#160; We have assessed the likelihood of the Investors exercising these rights as less than probable at December 31

 as amended
 any units held by the Investors beginning January 1
 2014
 accrue a yield at 4% (the Yield).&amp;#160; Commencing with the first quarter of 2014
 Nutra SA must make distributions to the Investors quarterly in the amount equal to the previously accrued and unpaid Yield plus any additional distributions owed to the Investors
 to the extent there is distributable cash
 as defined in the LLC agreement.&amp;#160; As of December 31
 2014
 our balance sheet includes an other liability of $0.6 million for Yield accumulated and unpaid.&amp;#160; Nutra SA has made no Yield payments.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify;&gt;Following the payment of the Yield
 Nutra SA must distribute all distributable cash (as defined in the LLC Agreement) to the members on March 31 of each year as follows: (i) first
 to the Investors in an amount equal to 2.3 times the Investors&amp;#8217; capital contributions
 less the aggregate amount of non-Yield distributions paid to the Investors
 (ii) second
 to us in an amount equal to twice the capital contributions made by us
 less the aggregate amount of distributions paid to us; and (iii) third
 to us and the Investors in proportion to our respective membership interests.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify;&gt;Under the LLC agreement
 the business of Nutra SA is to be conducted by the manager
 currently our CEO
 subject to the oversight of the management committee.&amp;#160; The management committee is comprised of three of our representatives and two Investor representatives.&amp;#160; Upon an event of default or a qualifying event
 we will no longer control the management committee and the management committee will include three Investor representatives and two of our representatives.&amp;#160; In addition
 following an event of default or a qualifying event
 a majority of the members of the management committee may replace the manager of Nutra SA.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify;&gt;As of December 31
 2014
 there have been no unwaived events of default.&amp;#160; Events of default
 as defined in the MIPA and the October 2013 amendment of investment agreements
 are failure of Irgovel to meet minimum annual processing targets or to achieve EBITDA of at least $4.0 million in any year beginning in 2015.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify;&gt;As of December 31
 2014
 there have been no qualifying events.&amp;#160; The LLC agreement defines a qualifying event as any event prior to September 16
 2014
 which results
 or will result
 in (i) a person or group of persons exercising the right to appoint members to our board of directors holding one third or more of the votes of all board members
 (ii) the sale
 exchange
 pledge or use as guarantee of one half or more of our ownership interest in Nutra SA to a third party or (iii) the bankruptcy of RiceBran Technologies or Nutra SA.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify;&gt;The Investors have drag along rights
 the right to begin a process to force the sale of all Nutra SA assets after January 1
 2016.&amp;#160; The right terminates upon the occurrence of certain events (a $50 million Nutra SA initial public offering or a change of control

 we considered the matters which could be put to a vote of the members.&amp;#160; Until there is an event of default or a qualifying event
 the Investors&amp;#8217; rights and abilities
 individually or in the aggregate


 Ownership Percentage by Noncontrolling Owners-Variable Interest Entity

  

 Ownership Percentage by Noncontrolling Owners-Variable Interest Entity

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  


  


  


  


  


  


  


  


  

  

  


 the Financial Accounting Standards Board (FASB) issued guidance on revenue from contracts with customers

 the FASB issued guidance which makes targeted amendments to current consolidation guidance.&amp;#160; Among other things


  

  

  

  

  

  

 Future Minimum Payments

  

  

  

 Future Minimum Payments

  

 Future Minimum Payments

  

  

  

 Future Minimum Payments

  

  

  

  

  

  

  

  

  

 Future Minimum Payments

  

  

  

  

  

  

  

  

  

 Future Minimum Payments Due

  

  

  

  

 Foreign Currency Transaction and Translation Adjustment

  

 Foreign Currency Transaction and Translation Adjustment

  

  

  


  


  

  

  

  

  


  


  

  

  

  

  

  

  

  

  

  

  

  

  


  


  

 Noncurrent-Variable Interest Entity

  

 Noncurrent-Variable Interest Entity

  

 Current-Variable Interest Entity

  

 Current-Variable Interest Entity

  

  

  

  

 Foreign Currency Transaction and Translation Adjustment
 Net of Tax

  

 Foreign Currency Transaction and Translation Adjustment
 Net of Tax

  

 Foreign Currency Transaction and Translation Adjustment
 Net of Tax

  

 Foreign Currency Transaction and Translation Adjustment
 Net of Tax

  

 Foreign Currency Transaction and Translation Adjustment
 Net of Tax

  

 Foreign Currency Transaction and Translation Adjustment
 Net of Tax

  

 Foreign Currency Transaction and Translation Adjustment
 Net of Tax

  

 Foreign Currency Transaction and Translation Adjustment
 Net of Tax

  

  


  


  


  


  

  

  

 Plant

  

 Plant

  

  

 20
000

  

 20
000

  


  


  


  


  

  

  

  

  

  


  


  


  


  


  


  


  

  

  


  


  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  


  


  


  


  


  


  


  


  


  


  


  


  


  


  


  


  

 Plant
 and Equipment
 Fair Value Disclosure-Level 3 [Member]-Fair Value
 Measurements

  

 Plant
 and Equipment
 Fair Value Disclosure-Fair Value
 Measurements

  

 Plant
 and Equipment
 Fair Value Disclosure-Level 2 [Member]-Fair Value
 Measurements

  

 Plant
 and Equipment
 Fair Value Disclosure-Level 1 [Member]-Fair Value
 Measurements

  

 net (variable interest entity restricted $3
727 and $4

  

 net (variable interest entity restricted $3
727 and $4

  

 net (variable interest entity restricted $3
727 and $4
969)-Variable Interest Entity

  

 net (variable interest entity restricted $3
727 and $4
969)-Variable Interest Entity

  

 net (variable interest entity restricted $3
727 and $4

  

 net (variable interest entity restricted $3
727 and $4

  

 net (variable interest entity restricted $3
727 and $4

  

 net (variable interest entity restricted $3
727 and $4

  

 net (variable interest entity restricted $3
727 and $4

  

 net (variable interest entity restricted $3
727 and $4

  

 Plant and Equipment

  

 Plant and Equipment

  

 Plant and Equipment

  

 Plant and Equipment

  

 Plant and Equipment

  

 Plant and Equipment

  

 Plant and Equipment

  

 Plant and Equipment

  




942&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif;&gt;14
582&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 38%; vertical-align: bottom; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;&gt;25-30&amp;#160;years

701&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif;&gt;1

519&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif;&gt;14


633&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif;&gt;39

880&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif;&gt;14
270&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 38%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=bottom style=width: 28%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;&gt;Property







942&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif;&gt;14
582&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 38%; vertical-align: bottom; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;&gt;25-30&amp;#160;years

701&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif;&gt;1

519&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif;&gt;14


633&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif;&gt;39

880&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif;&gt;14
270&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 38%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=bottom style=width: 28%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;&gt;Property




  

  












  

  


  


  


  


 a director
 invested $2.6 million in our subordinated convertible notes and related warrants prior to 2013.&amp;#160; In 2014 and 2013
 we paid and expensed $0.1 million and $0.2 million
 respectively

 warrants beneficially owned by Mr. Halpern for the purchase of up to 185
714 shares of common stock ($14.00 per share exercise price with a July 31
 2017 expiration)
 related to the subordinated convertible notes were cancelled in exchange for 634
679 shares of our common stock (with a fair value of $2.9 million at time of the Exchange).&amp;#160; The shares were not required to be issued until after our shareholders approved an increase in our authorized shares of common stock
 which occurred on May 30

 other warrants beneficially owned by Mr. Halpern for the purchase of up to 45
683 shares of common stock ($14.00 per share exercise prices and expirations between January 2017 and August 2017) were cancelled in exchange for 75
377 shares of our common stock (with a fair value of $0.3 million at time of the Exchange).&amp;#160; The shares were not required to be issued until after our shareholders approved an increase in our authorized shares of common stock
 which occurred on May 30

 our chief executive officer and director
 invested $25 thousand in our subordinated convertible notes and related warrants in January 2012 and an additional $25 thousand in April 2013.&amp;#160; In 2014 and 2013
 we paid&lt;font style=font-size: 10pt; font-family: 'Times New Roman', Times, serif;&gt; less than $10 thousand&lt;/font&gt; of interest on subordinated notes beneficially owned by Mr. Short.&amp;#160; In June 2013
 Mr. Short made an election to be paid in stock
 rather than cash
 for interest accruing under the notes from February 2013 through June 2014.&amp;#160; In connection with the election
 in 2013 we issued to Mr. Short a PIK warrant with 234 underlying shares of common stock

 warrants beneficially owned &lt;font style=font-size: 10pt; font-family: 'Times New Roman', Times, serif;&gt;by&lt;/font&gt; Mr. Short for the purchase of up to 3
806 shares of common stock ($14.00 per share exercise prices and expirations of July 2017 and May 2018)
 including the PIK warrant
 were cancelled in exchange for 12
777 shares of our common stock.&amp;#160; The shares were not required to be issued until after our shareholders approved an increase in our authorized shares of common stock
 which occurred on May 30

 we purchased all of the outstanding shares of HN for $2.0 million in cash
 plus convertible promissory notes for $3.3 million.&amp;#160; Mark McKnight
 our current senior vice president of sales
 and his wife collectively owned a majority interest in HN prior to the acquisition.&amp;#160; In connection with our acquisition of HN
 Mark McKnight received $0.7 million in cash and a convertible promissory note for $1.4 million and Nicole McKnight
 his wife
 received $0.7 million in cash and a convertible promissory note for $1.4 million.&amp;#160; We had the option to pay principal and accrued interest under the notes in either cash or in our common stock
 however
 if we issued shares to our former warrants holders upon an increase in authorized shares
 under the terms of the Exchange
 then we were required to settle any outstanding balance on the notes through the issuance of shares of our common stock.&amp;#160; On May 30
 2014
 we issued 225
925 shares of common stock to settle Mark McKnight&amp;#8217;s note and 225

 we entered into a $0.1 million
 5% unsecured
 promissory note with Nicole McKnight.&amp;#160; We paid all principal and interest due under the note in October 2014.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify;&gt;During 2013
 prior to the acquisition




 we continued to experience losses and negative cash flows from operations which raises substantial doubt about our ability to continue as a going concern.&amp;#160; &lt;/font&gt;W&lt;font style=font-size: 10pt; font-family: 'Times New Roman', Times, serif;&gt;e believe that we will be able to obtain additional funds to operate our business
 should it be necessary
 however

 in January 2014
 we completed the acquisition of H&amp;amp;N Distribution
 Inc. (HN)
 the operations of which are accretive to cash flows.&amp;#160; Our Brazilian subsidiary
 Industria Riograndens De Oleos Vegetais Ltda. (Irgovel)
 recently completed the final stages of a major capital expansion.&amp;#160; Significant cash was used during the shutdown period.&amp;#160; Operations at Irgovel are expected to normalize during the second quarter of 2015
 such that Irgovel will then be operating at its newly increased capacity and begin generating cash from operations. However

 nutritional supplement and animal nutrition company focused on value-added processing and marketing of healthy
 natural and nutrient dense products derived from raw rice bran an underutilized by-product of the rice milling industry.&amp;#160; Using our bio-refining business model
 we apply our proprietary and patented technologies and intellectual properties to convert raw rice bran into numerous high value products including stabilized rice bran (SRB)
 rice bran oil (RBO)
 defatted rice bran (DRB)
 &lt;/font&gt;RiBalance
 a complete rice bran nutritional package derived from further processing of SRB; RiSolubles
 a highly nutritious
 carbohydrate and lipid rich fraction of RiBalance; RiFiber
 a fiber rich insoluable derivative of RiBalance
 and ProRyza
 rice bran protein-based products
 and a variety of other valuable derivatives extracted from these core products.&amp;#160; &lt;font style=font-size: 10pt; font-family: 'Times New Roman', Times, serif;&gt;Our target markets are natural food
 functional food
 nutraceutical supplement and animal nutrition manufacturers
 wholesalers and retailers
 both domestically and internationally.&lt;/font&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify;&gt;We have two reportable operating segments: (i) USA segment
 which manufactures and distributes SRB (for human food ingredient and animal nutrition customers) in various granulations along with Stage II products and derivatives and (ii) Brazil segment
 which extracts crude RBO and DRB from rice bran
 which are then further processed into fully refined rice bran oil for sale internationally and in Brazil
 compounded animal nutrition products for horses
 cows
 swine
 sheep and poultry and a number of valuable human food and animal nutrition products derivatives and co-products. &lt;font style=font-size: 10pt; font-family: 'Times New Roman', Times, serif;&gt;Stage II refers to the proprietary processes run at our Dillon
 Montana facility and includes products produced at that facility using our patented processes. &lt;/font&gt;In addition we incur corporate and other expenses not directly attributable to reportable operating segments
 which include costs related to our corporate staff
 general and administrative expenses including public company expenses
 intellectual property
 professional fees
 and other expenses.&amp;#160; No corporate allocations
 including interest
 are made to the reportable operating segments.&lt;/div&gt;&lt;div style=background-color: #ffffff;&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify;&gt;The combined operations of our USA and Brazil segments encompass our bio-refining approach to processing raw rice bran into various high quality
 value-added constituents and finished products.&amp;#160; Over the past decade
 we have developed and optimized our proprietary bio-refining processes to support the production of healthy
 natural
 hypoallergenic
 gluten free
 and non-genetically modified ingredients and supplements for use in human meats
 baked goods
 cereals
 coatings
 health foods
 nutritional supplements
 nutraceuticals and high-end animal nutrition and health products.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify;&gt;In 2014
 the USA segment produced SRB inside two supplier rice mills in California and our facility in Mermentau
 Louisiana.&amp;#160; &lt;font style=font-size: 10pt; font-family: 'Times New Roman', Times, serif;&gt;A facility located in Lake Charles
 Louisiana has been idle since May 2009.&amp;#160; The USA segment also includes our Dillon
 Montana Stage II facility which produces our Stage II products: &lt;/font&gt;RiBalance
 a complete rice bran nutritional package derived from further processing of SRB; RiSolubles
 a highly nutritious
 carbohydrate and lipid rich fraction of RiBalance; RiFiber
 a fiber rich insoluable derivative of RiBalance
 and ProRyza
 rice bran protein-based products
 and a variety of other valuable derivatives extracted from these core products.&lt;font style=font-size: 10pt; font-family: 'Times New Roman', Times, serif;&gt;&amp;#160; &amp;#160; The manufacturing facilities included in our USA segment have proprietary processing equipment and process patented technology for the stabilization and further processing of rice bran into finished products.&amp;#160; In 2014

 whose only operating subsidiary is Irgovel
 located in Pelotas
 Brazil.&amp;#160; Irgovel manufactures RBO and DRB products for both the human ingredient and animal nutrition markets in Brazil and internationally.&amp;#160; In refining RBO to an edible grade
 several co-products are obtained.&amp;#160; One such product is distilled fatty acids
 a valuable raw material for the detergent industry.&amp;#160; Irgovel also produces rice lecithin
 which has application in human nutrition
 animal nutrition and industrial applications.&amp;#160; DRB is compounded with a number of other ingredients to produce complex animal nutrition products which are packaged and sold under Irgovel brands in the Brazilian market
 sold as a raw material for further processing into human food ingredients or sold in bulk into the animal nutrition markets in Brazil and neighboring countries.&amp;#160; In 2014
 approximately 39% of Brazil segment product revenue was from sales of RBO products and the remainder was from sales of DRB products.&amp;#160; Irgovel
 however
 was shut down for a portion of 2014 to complete the final stages of a capital expansion project
 which caused a temporary change in sales mix.&amp;#160; We expect RBO sales to return to historical levels
 approximately 45% of product revenues


  

  

  


  


  

  

  


 generally upon shipment for USA segment customers and Brazil segment international customers and upon customer receipt for Brazil segment domestic customers.&amp;#160; Each transaction is evaluated to determine if all of the following four criteria are met: (i) persuasive evidence of an arrangement exists; (ii) delivery has occurred; (iii) the selling price is fixed and determinable; and (iv) collectability is reasonably assured.&amp;#160; If any of the above criteria cannot be satisfied then such a transaction is not recorded as revenue
 or is recorded as deferred revenue and recognized only when the sales cycle is complete and payment is either received or becomes reasonably assured.&amp;#160; Changes in judgments and estimates regarding the application of the above mentioned four criteria might result in a change in the timing or amount of revenue recognized by such transactions.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify;&gt;We make provisions for estimated returns
 discounts and price adjustments when they are reasonably estimable.&amp;#160; Revenues on the statements of operations are net of provisions for estimated returns
 routine sales discounts


  

  

  

  

  

  

  

  

  


 our shareholders approved an increase in our authorized shares of common stock from 6
000
000 shares to 25
000
000 shares.&lt;/font&gt; In June 2013
 our shareholders approved an increase in the number of our authorized shares of common stock from 2
500
000 to 6
000
000.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000; text-align: justify;&gt;On October 28
 2013
 our board of directors approved a 1 for 200 reverse split of our common stock.&amp;#160; We began trading on a post-split basis on November 18
 2013.&amp;#160; All share and per share information has been retrospectively adjusted for all prior periods presented giving retroactive effect to the reverse stock split.&amp;#160; Such adjustments include calculations of our weighted averages number of shares outstanding and loss per share


 Convertible Note and Warrant Offerings&lt;/u&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify; background-color: #ffffff;&gt;In December 2013
 we completed a secondary public offering in which we issued and sold 1
714
286 shares of common stock for $5.24 per share and publicly traded warrants to purchase 1
714
286 shares of common stock for $0.01 per underlying share.&amp;#160; The net proceeds from the offering were $7.6 million after deducting underwriting discounts and commissions of $0.7 million and other offering expenses of approximately $1.4 million.&amp;#160; The publicly traded warrants have an exercise price of $6.55 per share and expire in December 2018.&amp;#160; The underwriters on the offering also received a warrant for the purchase of 85
715 shares
 at an exercise price of $6.55 per share

 an underwriter exercised its overallotment rights related to our December 2013 secondary public offering.&amp;#160; We issued and sold 162
586 shares of common stock for $5.24 per share and publicly traded warrants to purchase 162
586 shares of common stock ($6.55 per share exercise price and December 2018 expiration) for $0.01 per underlying share.&amp;#160; In connection with the overallotment exercise
 the underwriters for the offering also received a warrant for the purchase of 8
130 shares of common stock (exercise price of $6.55 per share and December 2018 expiration).&amp;#160; The net proceeds from the overallotment exercise were $0.8 million
 after deducting underwriting discounts and commissions and other cash offering expenses of $0.1 million
 and are included in equity.&amp;#160; &lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify;&gt;We completed the first closing of a private placement offering in March 2014.&amp;#160;&amp;#160; We issued convertible notes in the principal amount of $4.9 million and warrants for the purchase of up to 1
399
614 shares of common stock ($5.25 per share exercise price and March 2019 expiration).&amp;#160;&amp;#160; We contributed $1.0 million of the $4.3 million proceeds
 net of $0.6 million of costs
 to Nutra SA
 and used the remainder of the proceeds for capital projects in the United States and for general corporate purposes.&amp;#160; On a fully diluted basis
 at issuance we had available shares of common stock for 15.8% of the shares underlying the Warrants.&amp;#160; To the extent there were available shares
 we allocated proceeds to equity for the warrants ($0.4 million).&amp;#160; We recorded a derivative liability for the warrants to the extent there were not available shares ($5.0 million).&amp;#160; We recorded $1.1 million in financing expense at closing representing the excess of the amounts recorded for the warrants over the net proceeds from the offering.&amp;#160; The convertible notes issued in the offering were initially recorded with a discount equal to the face amount of the notes.&amp;#160; As discussed below
 in Debt Conversions section
 these notes converted in May 2014.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify;&gt;We completed the second closing of the private placement offering in May 2014.&amp;#160;&amp;#160; We issued convertible notes in the principal amount of $1.2 million and warrants for the purchase of up to 357
075 shares of common stock
 with an exercise price of $5.25 per share and a May 2019 expiration.&amp;#160; We contributed $0.5 million of the $1.1 million proceeds
 net of $0.2 million of costs
 to Nutra SA
 and used the remainder of the proceeds for capital projects in the United States and for general corporate purposes.&amp;#160; On a fully diluted basis
 at issuance we had no available shares of common stock for the shares underlying these warrants and
 as a result
 recorded a derivative liability for the fair value of these warrants at issuance ($2.0 million).&amp;#160; We recorded $1.0 million in financing expense at closing
 representing the excess of the amounts recorded for the warrants over the net proceeds from the offering.&amp;#160; The convertible notes issued in the offering were initially recorded with a discount equal to the face amount of the notes.&amp;#160; As discussed below
 in Debt Conversions section
 these notes converted in May 2014.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify;&gt;In late June 2014
 we issued and sold 1
417
500 shares of common stock for $5.29 per share and warrants to purchase 708
750 shares of common stock (exercise price of $5.87 per share and June 2019 expiration) for $0.01 per underlying share.&amp;#160; The underwriters for the offering also received a warrant for the purchase of 85
050 shares of common stock (exercise price of $6.625 per share and June 2019 expiration).&amp;#160; The net proceeds from the offering of $6.8 million
 after deducting underwriting discounts and commissions and other cash offering expenses of $0.7 million
 are included in common stock.&amp;#160;&amp;#160; We contributed $3.0 million of the proceeds to Nutra SA and used $0.8 million of the proceeds to pay all amounts due under the USA segment senior revolving note. &lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify;&gt;In a separate agreement occurring in mid June 2014
 we issued warrants to purchase 265
000 shares of common stock (exercise price of $5.25 per share and June 2019 expiration).&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify;&gt;In October 2014
 we issued and sold 1
181
695 shares of common stock and warrants to purchase 1
181
695 shares of common stock (exercise price of $5.27 per share
 exercisable beginning April 2015
 April 2020 expiration) for $5.40 per unit
 where a unit is one share of common stock and a warrant to purchase one share of common stock.&amp;#160; The underwriters of the offering also received a warrant for the purchase of 94
536 shares of common stock (exercise price of $5.27 per share and October 2019 expiration).&amp;#160; The net proceeds from the offering of $5.8 million
 after deducting underwriting discounts and commissions and other estimated cash offering expenses of $0.6 million

 &lt;/font&gt;the holders of our subordinated convertible notes agreed to amend their notes to reduce the interest rate to 5% from 10%
 change the maturity of the notes to July 2016 (if there was a different maturity date) and to remove the conversion feature and antidilution protections upon the closing of an equity raise in excess of $7.0 million (Modification).&amp;#160; Concurrently
 certain warrant holders agreed to exchange warrants to purchase 496
060 shares of common stock for the future issuance of 1
554
734 shares of our common stock (Exchange).&amp;#160; Most of the warrants impacted (warrants to purchase 441
395 shares) were warrants issued to the note holders when their notes were originally issued and had contained antidilution protections which caused them to be carried at fair value on our balances sheets.&amp;#160; The former warrant holders committed to exchange their warrants
 which were cancelled upon our&lt;font style=font-size: 10pt; font-family: 'Times New Roman', Times, serif;&gt; closing an equity raise in the fourth quarter of 2013&lt;/font&gt;.&amp;#160; The fair market value of the shares was recorded in common stock in the fourth quarter of 2013.&amp;#160; We issued the shares
 as required

 we also issued $500
000 of notes to a holder and agreed to issue the holder 134
250 shares of common stock.&amp;#160; The fair market value of the shares was recorded in common stock in the fourth quarter of 2013.&amp;#160; We issued these shares
 as required

 we issued convertible promissory notes in the face amount of $3.3 million.&amp;#160; &lt;/font&gt;The notes were due in equal quarterly payments commencing on March 31
 2015
 and ending on December 31
 2018 and bore interest at 1% per year until January 2015
 5% per year from February 2015 until January 2016 and 10% per year after January 2016.&amp;#160; We recorded the notes at their $2.2 million fair value and the conversion features at their $0.6 million fair value on the date of issuance.&amp;#160; We accreted the notes at an effective interest rate of 18.9%
 until the notes
 and accumulated interest thereon
 converted into 543
894 shares of common stock upon our issuance of shares to the former warrant holders in the Exchange.&amp;#160; The notes converted in May 2014.&amp;#160; Upon conversion
 we recognized a $0.9 million loss on extinguishment for the difference between the fair value of the shares issued ($3.9 million) and the carrying amount of the notes ($2.4 million) and related conversion feature ($0.6 million).&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify;&gt;The convertible notes issued in the March 2014 and May 2014 private placement closings
 due in July 2016
 bore interest at 5% interest until the $6.2 million outstanding on the notes
 including accumulated interest thereon (less than $0.1 million)
 automatically converted in May 2014
 at a conversion price of $5.25
 into 1
180
567 shares of common stock upon shareholders voting to approve an increase in our authorized shares of common stock.&amp;#160; When the notes converted
 we recognized interest expense of $6.2 million
 to accrete the notes to their face value

000
000 share increase in our authorized shares of common stock.&amp;#160; As a result
 during the second quarter of 2014
 we transferred to equity the $8.9 million fair value of warrants previously classified as derivative liabilities solely due to a lack
 on a fully-diluted basis
 of available shares of common stock.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000; text-align: left;&gt;&lt;u&gt;Equity Incentive Plans

 January 1
 2013&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif;&gt;169



859



 expired or cancelled&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif;&gt;(29


 December 31
 2013&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif;&gt;179

406


262

 expired or cancelled&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif;&gt;(50


 December 31
 2014&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif;&gt;269

503

 December 31
 2014&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif;&gt;138

322

 after the plan was approved by shareholders.&amp;#160; A total of 1
600
000 shares of common stock were initially reserved for issuance under the plan.&amp;#160; Under the terms of the plan
 we may grant options to purchase common stock and shares of common stock to officers
 directors
 employees or consultants providing services on such terms as are determined by the board of directors.&amp;#160; Our board of directors administers the plan
 determines vesting schedules on plan awards and may accelerate the vesting schedules for award recipients.&amp;#160; The options granted under the plan have terms of up to 10 years.&amp;#160; As of December 31
 2014
 options to purchase 141
134 shares have been issued and remain outstanding
 281
620 common shares have been issued and remain outstanding and 1
177
246 shares are reserved for future grants.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify;&gt;Our board of directors adopted our 2010 Equity Incentive Plan (2010 Plan) in February 2010.&amp;#160; A total of 125
000 shares of common stock were initially reserved for issuance under the 2010 Plan.&amp;#160; The amount reserved increased annually each January 1st by 5% of the outstanding shares as of the prior December 31st.&amp;#160; Additionally
 in 2011 the board approved a 40
000 increase in the number of shares of common stock reserved under the plan.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify;&gt;Under the terms of the 2010 Plan
 we could grant options to purchase common stock and shares of common stock to officers
 directors
 employees or consultants providing services on such terms as are determined by the board of directors.&amp;#160; Our board of directors administered the 2010 Plan
 determined vesting schedules on plan awards and could accelerate the vesting schedules for award recipients.&amp;#160; The options granted under the 2010 Plan have terms of up to 10 years.&amp;#160; In 2013
 the board of directors froze the 2010 Plan and there are no longer any shares reserved for future grants.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify;&gt;Our board of directors adopted the 2005 Equity Incentive Plan (2005 Plan) in May 2005 and our shareholders approved the 2005 Plan in September 2005.&amp;#160; Under the terms of the 2005 Plan
 we could grant options to purchase common stock and shares of common stock to officers
 directors
 employees or consultants providing services on such terms as are determined by the board of directors.&amp;#160; Options granted under the 2005 Plan have terms of up to 10 years.&amp;#160; There are no longer any shares reserved for future grants under the 2005 Plan.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify;&gt;We have outstanding a total of 17
384 options awarded to current and former directors
 employees and consultants at various times beginning in 2004 through 2009 that do not fall under the plans described above.&amp;#160; Expiration periods
 typically ten years
 and other terms of these non-plan specific options are not materially different from those issued under the 2010 Plan and 2005 Plan.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify;&gt;Share-based compensation expenses related to option and stock grants issued to employees and directors are included in selling
 general and administrative expenses in the statements of operations

 we issued shares of common stock to directors and executive officers at a grant date fair value of $4.91 per share.&amp;#160; We issued 44
026 shares which vested in August 2014
 52
412 shares which vest in August 2015 (or at the next annual shareholder meeting date if earlier) and 185
182 shares which vest in August 2017.&amp;#160; In 2014
 we recognized $0.5 million in compensation for these share of common stock.&amp;#160; These shares are the only shares vesting in the future.&amp;#160; As of December 31
 2014
 we expect to recognize the remaining $0.9 million of unrecognized compensation over a weighted average period of 2.3 years.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify;&gt;In April 2013
 our board granted each of our five non-employee directors a stock option to purchase up to 3
750 shares of common stock.&amp;#160; Each option has an exercise price of $16.00 per share
 vests in nine equal monthly installments ending December 31
 2013
 and expires in April 2023.&amp;#160; In January 2013
 we issued each of those five non-employee directors an option for the purchase of up to 1
250 shares of common stock under the non-employee director automatic grant provision.&amp;#160; Each option has an exercise price of $16.00 per share
 vested in twelve equal monthly installments ending December 2013

 the Board granted each of the two directors serving on the strategic committee and consulting special counsel each a stock option to purchase up to 1
250 shares of common stock.&amp;#160; Each option has an exercise price of $16.00 per share

&amp;#160; January 1
 2013&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif;&gt;158





000&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=bottom style=width: 30%; vertical-align: bottom; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;&gt;Forfeited
 expired or cancelled&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif;&gt;(27



 December 31
 2013&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif;&gt;169




134&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=bottom style=width: 30%; vertical-align: bottom; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;&gt;Forfeited
 expired or cancelled&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif;&gt;(50


 December 31
 2014&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif;&gt;259


642&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=bottom style=width: 30%; vertical-align: bottom; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=bottom style=width: 30%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;&gt;Exercisable
 December 31
 2014&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif;&gt;129


671&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;&gt;As of December 31
 2014
















 January 1
 2013&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif;&gt;5


820





 expired or cancelled&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif;&gt;(2


 December 31
 2013&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif;&gt;1
815


262



 December 31
 2014&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif;&gt;6
077


 December 31
 2014&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif;&gt;4
895




006

824

055

055





503

322

 2014
 we have two warrant agreements outstanding (with one holder) that contain antidilution clauses.&amp;#160; The related warrants are classified as derivative warrant liabilities in our balance sheets.&amp;#160; Under the antidilution clauses contained in these warrants
 in the event of equity issuances at prices below the exercise prices of these warrants
 we may be required to lower the exercise price on these warrants and increase the number of shares underlying these warrants.&amp;#160; Equity issuances may include issuances of our common stock
 certain awards of options to employees
 and issuances of warrants and/or other convertible instruments.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify;&gt;Certain equity issuances in 2013 triggered the antidilution clauses in certain liability warrants and
 as a result
 we were required to lower the exercise price and increase the number of shares underlying certain liability warrants.&amp;#160; In addition


 Shares Authorized under Stock Option Plans
 Exercise Price Range
 Exercisable Options

  

 Shares Authorized under Stock Option Plans
 Exercise Price Range
 Exercisable Options

  

 Shares Authorized under Stock Option Plans
 Exercise Price Range
 Exercisable Options

  

 Shares Authorized under Stock Option Plans
 Exercise Price Range
 Exercisable Options

  

 Shares Authorized under Stock Option Plans
 Exercise Price Range
 Exercisable Options

  

 Shares Authorized under Stock Option Plans
 Exercise Price Range
 Exercisable Options

  

 Shares Authorized under Stock Option Plans
 Exercise Price Range
 Exercisable Options

  

 Shares Authorized under Stock Option Plans
 Exercise Price Range
 Exercisable Options

  

 Fair Value Assumptions

  

 Fair Value Assumptions

  

 Shares Authorized under Stock Option Plans
 Exercise Price Range
 Exercisable Options

  

 Shares Authorized under Stock Option Plans
 Exercise Price Range
 Exercisable Options

  

 Shares Authorized under Stock Option Plans
 Exercise Price Range
 Exercisable Options

  

 Shares Authorized under Stock Option Plans
 Exercise Price Range
 Exercisable Options

  

 Shares Authorized under Stock Option Plans
 Exercise Price Range
 Exercisable Options

  

 Shares Authorized under Stock Option Plans
 Exercise Price Range
 Exercisable Options

  

 Shares Authorized under Stock Option Plans
 Exercise Price Range
 Exercisable Options

  

 Shares Authorized under Stock Option Plans
 Exercise Price Range
 Exercisable Options

  

 Shares Authorized under Stock Option Plans
 Exercise Price Range
 Outstanding Options

  

 Shares Authorized under Stock Option Plans
 Exercise Price Range
 Outstanding Options

  

 Shares Authorized under Stock Option Plans
 Exercise Price Range
 Outstanding Options

  

 Shares Authorized under Stock Option Plans
 Exercise Price Range
 Outstanding Options

  

 Shares Authorized under Stock Option Plans
 Exercise Price Range
 Outstanding Options

  

 Shares Authorized under Stock Option Plans
 Exercise Price Range
 Outstanding Options

  

 Shares Authorized under Stock Option Plans
 Exercise Price Range
 Outstanding Options

  

 Shares Authorized under Stock Option Plans
 Exercise Price Range
 Outstanding Options

  


  


  


  


  

 Shares Authorized under Stock Option Plans
 Exercise Price Range
 Outstanding Options

  

 Shares Authorized under Stock Option Plans
 Exercise Price Range
 Outstanding Options

  

 Shares Authorized under Stock Option Plans
 Exercise Price Range
 Outstanding Options

  

 Shares Authorized under Stock Option Plans
 Exercise Price Range
 Outstanding Options

  

 Shares Authorized under Stock Option Plans
 Exercise Price Range
 Outstanding Options

  

 Shares Authorized under Stock Option Plans
 Exercise Price Range
 Outstanding Options

  

 Shares Authorized under Stock Option Plans
 Exercise Price Range
 Outstanding Options

  

 Shares Authorized under Stock Option Plans
 Exercise Price Range
 Outstanding Options

  

 Goods

  

 Goods

  

 Goods

  

 Goods

  

 Goods

  

 Goods

  

 Goods

  

 Goods

  


 the consideration transferred to acquire HN
 as well as the amounts of identified assets acquired and liabilities assumed based on the estimated fair value as of the January 2
 2014



785&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=bottom style=width: 68%; vertical-align: bottom; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=bottom style=width: 68%; vertical-align: bottom; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;&gt;Financial assets
 including acquired cash of $1
075&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif;&gt;1


847&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=bottom style=width: 68%; vertical-align: bottom; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;&gt;Deferred&amp;#160; income taxes
 net&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif;&gt;(1




 Stock Options


&amp;#160; January 1
 2013&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif;&gt;158





000&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=bottom style=width: 30%; vertical-align: bottom; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;&gt;Forfeited
 expired or cancelled&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif;&gt;(27



 December 31
 2013&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif;&gt;169




134&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=bottom style=width: 30%; vertical-align: bottom; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;&gt;Forfeited
 expired or cancelled&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif;&gt;(50


 December 31
 2014&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif;&gt;259


642&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=bottom style=width: 30%; vertical-align: bottom; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=bottom style=width: 30%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;&gt;Exercisable
 December 31
 2014&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif;&gt;129




 Stock Options

  




988&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=bottom style=width: 56%; vertical-align: top; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000; text-align: left; margin-left: 16.2pt; text-indent: -7.2pt;&gt;Subordinated notes
 net&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;4
978&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;4

135&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;6

629&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;4

408&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;3

810&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;2

016&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;2

961&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;12

096&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;19

808&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;8




 Employee Stock Purchase Plan


 2014&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; padding-bottom: 2px;&gt;&amp;#160;&lt;/td&gt;&lt;td colspan=2 valign=bottom style=vertical-align: top; border-bottom: #000000 2px solid;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; color: #000000; text-align: center;&gt;December 31



 2014&lt;font style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;

758&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;4

591&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: right; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;1
045&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: right; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;7

873&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;2
873&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=bottom style=width: 44%; vertical-align: top; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;6
705&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;10
961&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;17





































671&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;53





666&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;2





 January 1
 2013&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif;&gt;169



859



 expired or cancelled&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif;&gt;(29


 December 31
 2013&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif;&gt;179

406


262

 expired or cancelled&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif;&gt;(50


 December 31
 2014&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif;&gt;269

503

 December 31
 2014&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif;&gt;138

322






809
364&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif;&gt;1
160

809
364&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif;&gt;1
160

584&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif;&gt;179

651
380&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif;&gt;809
























740&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=bottom style=width: 18%; vertical-align: bottom; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=bottom style=width: 18%; vertical-align: bottom; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-variant: normal; font-weight: normal; font-style: normal; text-align: left; margin-left: 7.2pt; background-color: #cceeff; text-indent: -7.2pt;&gt;&lt;u&gt;December 31














 general and administrative expenses in the statements of operations



 $1.0 million in 2016












124&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;19
515&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;35

972&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;(2

469&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=bottom style=width: 52%; vertical-align: top; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;&gt;Depreciation and amortization (in selling



















251&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;3
020&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;5
423&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=bottom style=width: 52%; vertical-align: top; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;&gt;Property
 net

360&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;15
258&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;24
753&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=bottom style=width: 52%; vertical-align: top; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;&gt;Goodwill

641&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;4
431&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=bottom style=width: 52%; vertical-align: top; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;&gt;Intangible assets
 net


740&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=bottom style=width: 52%; vertical-align: top; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;&gt;Total assets
 end of period&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;4
212&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;17
854&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;24
018&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;46




078&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;22
028&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;31

945&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;1
000&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;3
945&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=bottom style=width: 52%; vertical-align: top; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;&gt;Depreciation and amortization (in selling

















907&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;3
119&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=bottom style=width: 52%; vertical-align: top; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;&gt;Property
 net

231&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;17
672&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;24
958&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=bottom style=width: 52%; vertical-align: top; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;&gt;Goodwill

139&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;4
139&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=bottom style=width: 52%; vertical-align: top; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;&gt;Intangible assets
 net

417&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=bottom style=width: 52%; vertical-align: top; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;&gt;Total assets
 end of period&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;6
039&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;9
796&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;28
743&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;44





257&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;17

470&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;4






686&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=bottom style=width: 56%; vertical-align: bottom; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;&gt;Other current assets (restricted $1
980 and $1
967)&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif;&gt;4
735&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif;&gt;4
546&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=bottom style=width: 56%; vertical-align: bottom; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;&gt;Property
 net (restricted $3
727 and $4
969)&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif;&gt;15
258&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif;&gt;17
672&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=bottom style=width: 56%; vertical-align: bottom; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;&gt;Goodwill and intangibles
 net&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif;&gt;3
722&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif;&gt;4





758&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif;&gt;6
262&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=bottom style=width: 56%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;&gt;Long-term debt
 less current portion (nonrecourse)&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif;&gt;6
203&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif;&gt;6






 January 1
 2013&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif;&gt;5


820





 expired or cancelled&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif;&gt;(2


 December 31
 2013&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif;&gt;1
815


262



 December 31
 2014&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif;&gt;6
077


 December 31
 2014&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif;&gt;4
895





















 which manufactures and distributes SRB in various granulations along with Stage II products and derivatives and (ii) Brazil segment
 which extracts crude RBO and DRB from rice bran
 which are then further processed into fully refined rice bran oil for sale internationally and in Brazil
 compounded animal nutrition products for horses
 cows
 swine
 sheep and poultry and a number of valuable human food and animal nutrition products derivatives and co-products. In addition we incur corporate and other expenses not directly attributable to operating segments
 which include costs related to our corporate staff
 general and administrative expenses including public company expenses
 intellectual property
 professional fees
 and other expenses.&amp;#160; No Corporate allocations
 including interests




124&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;19
515&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;35

972&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;(2

469&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=bottom style=width: 52%; vertical-align: top; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;&gt;Depreciation and amortization (in selling



















251&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;3
020&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;5
423&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=bottom style=width: 52%; vertical-align: top; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;&gt;Property
 net

360&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;15
258&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;24
753&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=bottom style=width: 52%; vertical-align: top; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;&gt;Goodwill

641&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;4
431&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=bottom style=width: 52%; vertical-align: top; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;&gt;Intangible assets
 net


740&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=bottom style=width: 52%; vertical-align: top; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;&gt;Total assets
 end of period&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;4
212&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;17
854&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;24
018&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;46




078&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;22
028&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;31

945&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;1
000&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;3
945&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=bottom style=width: 52%; vertical-align: top; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;&gt;Depreciation and amortization (in selling

















907&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;3
119&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=bottom style=width: 52%; vertical-align: top; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;&gt;Property
 net

231&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;17
672&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;24
958&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=bottom style=width: 52%; vertical-align: top; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;&gt;Goodwill

139&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;4
139&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=bottom style=width: 52%; vertical-align: top; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;&gt;Intangible assets
 net

417&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=bottom style=width: 52%; vertical-align: top; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;&gt;Total assets
 end of period&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;6
039&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;9
796&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;28
743&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;44



257&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;17

470&lt;/div&gt;&lt;/td&gt;&lt;td nowrap=nowrap valign=bottom style=width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;&gt;&amp;#160;&lt;/td&gt;&lt;td valign=bottom style=width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;&gt;4





  


  


  


  


  


  


  


  


  


  


  


  


  


  

 Equity Instruments Other than Options
 Grants in Period

  

 Equity Instruments Other than Options
 Grants in Period

  

 Equity Instruments Other than Options
 Grants in Period

  

  

  

  

  

  

  

 Non-Option Equity Instruments

  

 Non-Option Equity Instruments

  

 Non-Option Equity Instruments

  

 Non-Option Equity Instruments

  

 Non-Option Equity Instruments

  

 Non-Option Equity Instruments

  

 Non-Option Equity Instruments
 Outstanding

  

 Non-Option Equity Instruments
 Outstanding

  

 Non-Option Equity Instruments
 Outstanding

  

 Non-Option Equity Instruments
 Outstanding

  

 Non-Option Equity Instruments
 Outstanding

  

 Non-Option Equity Instruments
 Outstanding

  

 Non-Option Equity Instruments
 Outstanding

  

 Non-Option Equity Instruments
 Outstanding

  

 Non-Option Equity Instruments
 Outstanding

  

 Equity Instruments Other than Options
 Nonvested

  

 Equity Instruments Other than Options
 Nonvested

  

 Equity Instruments Other than Options
 Nonvested

  

 Equity Instruments Other than Options
 Nonvested

  

 Equity Instruments Other than Options
 Nonvested

  

  

  

  

  

 Non-Option Equity Instruments

  

 Non-Option Equity Instruments

  

 Non-Option Equity Instruments

  

 Non-Option Equity Instruments

  

 Non-Option Equity Instruments

  

 Non-Option Equity Instruments

  

  


  


  


  

  

  

  

  


  

  

  

  

  

  

 Non-Option Equity Instruments

  

 Non-Option Equity Instruments

  

 Non-Option Equity Instruments

  

 Non-Option Equity Instruments

  

 Non-Option Equity Instruments

  

 Non-Option Equity Instruments

  

  

  

  


  

  

  

 Options
 Exercisable

  

 Options
 Exercisable

  

 Options
 Exercisable

  

 Options
 Exercisable

  

 Options
 Exercisable

  

 Options
 Exercisable

  

  

  

  

  

  


  


  


  


  


  

 Options

  

 Options

  

 Options

  

 Options

  

 Options

  

 Options

  

 Options
 Outstanding

  

 Options
 Outstanding

  

 Options
 Outstanding

  

 Options
 Outstanding

  

 Options
 Outstanding

  

 Options
 Outstanding

  

 Options
 Outstanding

  

 Options
 Outstanding

  

 Options
 Outstanding

  

 Options
 Outstanding

  

 Options
 Outstanding

  

 Options
 Outstanding

  

 Options
 Outstanding

  

 Options
 Outstanding

  

 Options
 Outstanding

  

 Options
 Outstanding

  

 Options
 Outstanding

  

 Options
 Outstanding

  

 Options
 Outstanding

  


 reduced for estimated forfeitures
 and expensed on a straight-line basis over the service period of the grant.&amp;#160; Forfeitures are estimated at the time of grant based on our historical forfeiture experience and are revised in subsequent periods if actual forfeitures differ from those estimates.&amp;#160; The Black-Scholes-Merton option pricing model requires us to estimate key assumptions such as expected life
 volatility
 risk-free interest rates and dividend yield to determine the fair value of share-based awards

 whichever is more reliably measured.&amp;#160; Generally we value options granted to non-employees and consultants using the Black-Scholes-Merton valuation model.&amp;#160; &lt;/font&gt;If the fair value of the equity instruments issued is used
 it is measured using the stock price and other measurement assumptions as of the earlier of (i) the date at which a commitment for performance by the counterparty to earn the equity instruments is reached or (ii) the date at which the counterparty's performance is complete.&amp;#160; The expense associated with stock awards issued to consultants or other third parties are recognized over the term of service.&amp;#160; In the event services are terminated early or we require no specific future performance


 Shares Authorized under Stock Option Plans
 Exercise Price Range

  

 Shares Authorized under Stock Option Plans
 Exercise Price Range

  

 Shares Authorized under Stock Option Plans
 Exercise Price Range

  

 Shares Authorized under Stock Option Plans
 Exercise Price Range

  

 Shares Authorized under Stock Option Plans
 Exercise Price Range

  

 Shares Authorized under Stock Option Plans
 Exercise Price Range

  

 Shares Authorized under Stock Option Plans
 Exercise Price Range

  

 Shares Authorized under Stock Option Plans
 Exercise Price Range

  

 Shares Authorized under Stock Option Plans
 Exercise Price Range

  

 Shares Authorized under Stock Option Plans
 Exercise Price Range

  

 Shares Authorized under Stock Option Plans
 Exercise Price Range

  

 Shares Authorized under Stock Option Plans
 Exercise Price Range

  

 Shares Authorized under Stock Option Plans
 Exercise Price Range

  

 Shares Authorized under Stock Option Plans
 Exercise Price Range

  

 Shares Authorized under Stock Option Plans
 Exercise Price Range

  

 Shares Authorized under Stock Option Plans
 Exercise Price Range

  


  


  


  


  


  


  


  


  


 U.S. Dollars.&amp;#160; The functional currency for Irgovel is the Brazilian Real.&amp;#160; Assets and liabilities of Irgovel are translated into U.S. Dollars using the exchange rate in effect at the consolidated balance sheet date.&amp;#160; Equity accounts are translated at historical rates
 except for the change in accumulated deficit during the year
 which is the result of the income statement translation process. Irgovel&amp;#8217;s revenues and expenses are translated using the average exchange rates in effect during the period.&amp;#160; Translation differences are recorded in accumulated other comprehensive income (loss) as foreign currency translation.&amp;#160; Gains or losses on transactions denominated in a currency other than Irgovel&amp;#8217;s functional currency which arise as a result of changes in foreign exchange rates are recorded as foreign exchange gain or loss in the statements of operations. As of March 31
 2015
 the Brazilian Real has fallen against the U.S. Dollar since December 31
 2014

 2014
 we maintained our cash
 including restricted cash
 and cash equivalents

 customer concentrations
 customer credit-worthiness
 current economic trends and changes in our customer payment patterns when evaluating the adequacy of the allowance for doubtful accounts.&amp;#160; From period to period

 with cost determined by the first-in
 first-out method.&amp;#160; In the USA segment
 we employ a full absorption procedure using standard cost techniques.&amp;#160; The standards are customarily reviewed and adjusted annually so that they are materially consistent with actual purchase and production costs.&amp;#160; In the Brazil segment we use actual average purchase and production costs.&amp;#160; Provisions for potentially obsolete or slow moving inventory are made based upon our analysis of inventory levels

 Intangible Assets and Goodwill&lt;/font&gt; &amp;#8211; Long-lived assets
 consisting primarily of property
 intangible assets
 and goodwill

 used to identify potential impairment
 compares the fair value of a reporting unit with its carrying amount
 including goodwill.&amp;#160; If the fair value of a reporting unit exceeds its carrying amount
 goodwill of the reporting unit is not considered impaired
 and
 thus
 the second step of the quantitative impairment test is unnecessary.&amp;#160; If the carrying amount of a reporting unit exceeds its fair value
 the second step of the quantitative goodwill impairment test is performed to measure the amount of impairment loss
 if any.&amp;#160; Fair values are derived based on an evaluation of past and expected future performance of our reporting units.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify;&gt;In assessing the recoverability of goodwill
 we make estimates and assumptions about sales
 operating margin
 terminal growth rates and discount rates based on our budgets
 business plans
 economic projections
 anticipated future cash flows and marketplace data.&amp;#160; No impairment was deemed to exist as of December 31
 2014.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify;&gt;We review our long-lived assets
 which include intangible assets subject to amortization
 for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.&amp;#160; An impairment loss is recognized when the undiscounted future cash flows estimated to be generated by the asset to be held and used are not sufficient to recover the unamortized balance of the asset.&amp;#160; An impairment loss is recognized based on the difference between the carrying values and estimated fair value.&amp;#160; The estimated fair value is determined based on either the discounted future cash flows or other appropriate fair value methods with the amount of any such deficiency charged to operations in the current year.&amp;#160; Estimates of future cash flows are based on many factors
 including current operating results
 expected market trends and competitive influences.&amp;#160; We also evaluate the amortization periods assigned to its intangible assets to determine whether events or changes in circumstances warrant revised estimates of useful lives. Assets to be disposed of by sale are reported at the lower of the carrying amount or fair value

 generally upon shipment for USA segment customers and Brazil segment international customers and upon customer receipt for Brazil segment domestic customers.&amp;#160; Each transaction is evaluated to determine if all of the following four criteria are met: (i) persuasive evidence of an arrangement exists; (ii) delivery has occurred; (iii) the selling price is fixed and determinable; and (iv) collectability is reasonably assured.&amp;#160; If any of the above criteria cannot be satisfied then such a transaction is not recorded as revenue
 or is recorded as deferred revenue and recognized only when the sales cycle is complete and payment is either received or becomes reasonably assured.&amp;#160; Changes in judgments and estimates regarding the application of the above mentioned four criteria might result in a change in the timing or amount of revenue recognized by such transactions.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify;&gt;We make provisions for estimated returns
 discounts and price adjustments when they are reasonably estimable.&amp;#160; Revenues on the statements of operations are net of provisions for estimated returns
 routine sales discounts

 we were required to lower the conversion price on the convertible debt based on certain issuances of our common stock
 awards of options to employees
 additional issuance of warrants and/or other convertible instruments below certain conversion prices.&amp;#160; &lt;font style=font-size: 10pt; font-family: 'Times New Roman', Times, serif;&gt;We accounted for the conversion liabilities associated with these antidilution clauses as liability instruments
 separate from the host debt.&amp;#160; The conversion liabilities were classified as debt on our consolidated balance sheets.&amp;#160; These conversion liabilities were valued using the lattice model in each reporting period and the resultant change in fair value was recorded in the consolidated statements of operations in other income (expense).&amp;#160; There were no derivative conversion liabilities at December 31

 we may be required to lower the exercise price on these warrants and issue additional warrants based on future issuances of our common stock and awards of options to employees

 reduced for estimated forfeitures
 and expensed on a straight-line basis over the service period of the grant.&amp;#160; Forfeitures are estimated at the time of grant based on our historical forfeiture experience and are revised in subsequent periods if actual forfeitures differ from those estimates.&amp;#160; The Black-Scholes-Merton option pricing model requires us to estimate key assumptions such as expected life
 volatility
 risk-free interest rates and dividend yield to determine the fair value of share-based awards

 whichever is more reliably measured.&amp;#160; Generally we value options granted to non-employees and consultants using the Black-Scholes-Merton valuation model.&amp;#160; &lt;/font&gt;If the fair value of the equity instruments issued is used
 it is measured using the stock price and other measurement assumptions as of the earlier of (i) the date at which a commitment for performance by the counterparty to earn the equity instruments is reached or (ii) the date at which the counterparty's performance is complete.&amp;#160; The expense associated with stock awards issued to consultants or other third parties are recognized over the term of service.&amp;#160; In the event services are terminated early or we require no specific future performance

 when necessary


 the Financial Accounting Standards Board (FASB) issued guidance on revenue from contracts with customers

 the FASB issued guidance which makes targeted amendments to current consolidation guidance.&amp;#160; Among other things


 Shares

  


  

  

  

  

  

  

  

  

  

 Value

  

 Value

  

 Value

  

 Value

  

 Value
 Share-based Compensation

  

 Value
 Share-based Compensation

  

 Options

  

 Options

  

 Options

  

 Options

  

 Options

  

 Options

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  


  


  


  


  


  


  


  


  


  


  


  


  


  

  

  


  


  


  


  


  


  


  


  


  


  


  


  


  

  

  

  

  

  

  


 customer concentrations
 customer credit-worthiness
 current economic trends and changes in our customer payment patterns when evaluating the adequacy of the allowance for doubtful accounts.&amp;#160; From period to period


  

  




 Deferred Tax Asset
 Increase (Decrease)

  

 Deferred Tax Asset
 Increase (Decrease)

  

  

  

  

  

  

  

 Annual Increase in Number of Reserved Shares

  


  

  

  

  

  


  

 Warrants




006

824

055

055





503

322


  

  

  

  

  

  


  


  

  

  


  

  


  

 Recognized Identifiable Assets Acquired and Liabilities Assumed

  

 Recognized Identifiable Assets Acquired and Liabilities Assumed

  

  

  

  

  

  


  


  

 Fair Value Assumptions

  

 Fair Value Assumptions

  

  

  

  

 Non-Option Equity Instruments

  

 Non-Option Equity Instruments

  

 Non-Option Equity Instruments

  

  

  

  

 Non-Option Equity Instruments
 Exercisable

  

 Non-Option Equity Instruments
 Exercisable

  

 Non-Option Equity Instruments
 Exercisable

  

 Non-Option Equity Instruments
 Outstanding

  

 Non-Option Equity Instruments
 Outstanding

  

 Non-Option Equity Instruments
 Outstanding

  

 Non-Option Equity Instruments
 Outstanding

  

 Non-Option Equity Instruments
 Outstanding

  

 Non-Option Equity Instruments
 Outstanding

  

 Non-Option Equity Instruments
 Outstanding

  

 Non-Option Equity Instruments
 Outstanding

  

 Non-Option Equity Instruments
 Outstanding

  

 Non-Option Equity Instruments
 Grants in Period

  

 Non-Option Equity Instruments
 Grants in Period

  

 Non-Option Equity Instruments
 Grants in Period

  

 Non-Option Equity Instruments
 Grants in Period

  

 Non-Option Equity Instruments
 Grants in Period

  

 Non-Option Equity Instruments
 Forfeitures and Expirations in Period

  

 Non-Option Equity Instruments
 Forfeitures and Expirations in Period

  

 Non-Option Equity Instruments
 Forfeitures and Expirations in Period

  

 Non-Option Equity Instruments
 Forfeitures and Expirations in Period

  

 Non-Option Equity Instruments
 Forfeitures and Expirations in Period

  

 Non-Option Equity Instruments
 Exercisable

  

 Non-Option Equity Instruments
 Exercisable

  

 Non-Option Equity Instruments
 Exercisable

  

 Non-Option Equity Instruments

  

 Non-Option Equity Instruments

  

 Non-Option Equity Instruments

  

 Non-Option Equity Instruments

  

 Non-Option Equity Instruments

  

 Non-Option Equity Instruments

  

 Non-Option Equity Instruments

  

 Non-Option Equity Instruments

  

 Non-Option Equity Instruments

  


  


  


  

 Shares Authorized under Stock Warrant Plans
 Exercise Price Range

  

 Shares Authorized under Stock Warrant Plans
 Exercise Price Range

  

 Shares Authorized under Stock Warrant Plans
 Exercise Price Range

  

 Shares Authorized under Stock Warrant Plans
 Exercise Price Range

  

 Shares Authorized under Stock Warrant Plans
 Exercise Price Range

  

 Shares Authorized under Stock Warrant Plans
 Exercise Price Range

  

 Shares Authorized under Stock Warrant Plans
 Exercise Price Range

  

 Shares Authorized under Stock Warrant Plans
 Exercise Price Range

  

 Shares Authorized under Stock Warrant Plans
 Exercise Price Range

  

 Shares Authorized under Stock Warrant Plans
 Exercise Price Range

  

 Shares Authorized under Stock Warrant Plans
 Exercise Price Range

  

 Shares Authorized under Stock Warrant Plans
 Exercise Price Range

  

 Shares Authorized under Stock Warrant Plans
 Exercise Price Range

  

 Shares Authorized under Stock Warrant Plans
 Exercise Price Range

  

 Shares Authorized under Stock Warrant Plans
 Exercise Price Range
 Outstanding Warrants

  

 Shares Authorized under Stock Warrant Plans
 Exercise Price Range
 Outstanding Warrants

  

 Shares Authorized under Stock Warrant Plans
 Exercise Price Range
 Outstanding Warrants

  

 Shares Authorized under Stock Warrant Plans
 Exercise Price Range
 Outstanding Warrants

  

 Shares Authorized under Stock Warrant Plans
 Exercise Price Range
 Outstanding Warrants

  

 Shares Authorized under Stock Warrant Plans
 Exercise Price Range
 Outstanding Warrants

  

 Shares Authorized under Stock Warrant Plans
 Exercise Price Range

  

 Shares Authorized under Stock Warrant Plans
 Exercise Price Range

  

 Shares Authorized under Stock Warrant Plans
 Exercise Price Range

  

 Shares Authorized under Stock Warrant Plans
 Exercise Price Range

  

 Shares Authorized under Stock Warrant Plans
 Exercise Price Range

  

 Shares Authorized under Stock Warrant Plans
 Exercise Price Range

  

 Shares Authorized under Stock Warrant Plans
 Exercise Price Range
 Exercisable Warrants

  

 Shares Authorized under Stock Warrant Plans
 Exercise Price Range
 Exercisable Warrants

  

 Shares Authorized under Stock Warrant Plans
 Exercise Price Range
 Exercisable Warrants

  

 Shares Authorized under Stock Warrant Plans
 Exercise Price Range
 Exercisable Warrants

  

 Shares Authorized under Stock Warrant Plans
 Exercise Price Range
 Exercisable Warrants

  

 Shares Authorized under Stock Warrant Plans
 Exercise Price Range
 Exercisable Warrants

  

 Shares Authorized under Stock Warrant Plans
 Exercise Price Range
 Exercisable Warrants

  

 Shares Authorized under Stock Warrant Plans
 Exercise Price Range
 Exercisable Warrants

  

 Shares Authorized under Stock Warrant Plans
 Exercise Price Range
 Exercisable Warrants

  

 Shares Authorized under Stock Warrant Plans
 Exercise Price Range
 Exercisable Warrants

  

 Shares Authorized under Stock Warrant Plans
 Exercise Price Range
 Exercisable Warrants

  

 Shares Authorized under Stock Warrant Plans
 Exercise Price Range
 Exercisable Warrants

  

 Shares Authorized under Stock Warrant Plans
 Exercise Price Range
 Outstanding Warrants

  

 Shares Authorized under Stock Warrant Plans
 Exercise Price Range
 Outstanding Warrants

  

 Shares Authorized under Stock Warrant Plans
 Exercise Price Range
 Outstanding Warrants

  

 Shares Authorized under Stock Warrant Plans
 Exercise Price Range
 Outstanding Warrants

  

 Shares Authorized under Stock Warrant Plans
 Exercise Price Range
 Outstanding Warrants

  

 Shares Authorized under Stock Warrant Plans
 Exercise Price Range
 Outstanding Warrants

  

  

  

  

  

  


  


  

 Options
 Outstanding

  

 Options
 Outstanding

  

  

  


  

  

  

  

  

  

  

 Stock option deferred reduction for forfeited

  

 Stock option deferred reduction for forfeited

  


  


  


  


  


  


  

  

  


  


  

 Nondeductible Expense

  

 Nondeductible Expense

  

 United States

  

 United States

  

 Brazil

  

 Brazil

  


  


  


  


  

 Tax Deferred Expense

  

 Tax Deferred Expense

  

 Other

  

 Other

  

 Net

  

 Net

  


  


  

  

  

 Warrant Liability


 we may be required to lower the exercise price on these warrants and issue additional warrants based on future issuances of our common stock and awards of options to employees


 Goodwill and Intangible Assets


 Intangible Assets and Goodwill&lt;/font&gt; &amp;#8211; Long-lived assets
 consisting primarily of property
 intangible assets
 and goodwill

 used to identify potential impairment
 compares the fair value of a reporting unit with its carrying amount
 including goodwill.&amp;#160; If the fair value of a reporting unit exceeds its carrying amount
 goodwill of the reporting unit is not considered impaired
 and
 thus
 the second step of the quantitative impairment test is unnecessary.&amp;#160; If the carrying amount of a reporting unit exceeds its fair value
 the second step of the quantitative goodwill impairment test is performed to measure the amount of impairment loss
 if any.&amp;#160; Fair values are derived based on an evaluation of past and expected future performance of our reporting units.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify;&gt;In assessing the recoverability of goodwill
 we make estimates and assumptions about sales
 operating margin
 terminal growth rates and discount rates based on our budgets
 business plans
 economic projections
 anticipated future cash flows and marketplace data.&amp;#160; No impairment was deemed to exist as of December 31
 2014.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify;&gt;We review our long-lived assets
 which include intangible assets subject to amortization
 for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.&amp;#160; An impairment loss is recognized when the undiscounted future cash flows estimated to be generated by the asset to be held and used are not sufficient to recover the unamortized balance of the asset.&amp;#160; An impairment loss is recognized based on the difference between the carrying values and estimated fair value.&amp;#160; The estimated fair value is determined based on either the discounted future cash flows or other appropriate fair value methods with the amount of any such deficiency charged to operations in the current year.&amp;#160; Estimates of future cash flows are based on many factors
 including current operating results
 expected market trends and competitive influences.&amp;#160; We also evaluate the amortization periods assigned to its intangible assets to determine whether events or changes in circumstances warrant revised estimates of useful lives. Assets to be disposed of by sale are reported at the lower of the carrying amount or fair value



 we were required to lower the conversion price on the convertible debt based on certain issuances of our common stock
 awards of options to employees
 additional issuance of warrants and/or other convertible instruments below certain conversion prices.&amp;#160; &lt;font style=font-size: 10pt; font-family: 'Times New Roman', Times, serif;&gt;We accounted for the conversion liabilities associated with these antidilution clauses as liability instruments
 separate from the host debt.&amp;#160; The conversion liabilities were classified as debt on our consolidated balance sheets.&amp;#160; These conversion liabilities were valued using the lattice model in each reporting period and the resultant change in fair value was recorded in the consolidated statements of operations in other income (expense).&amp;#160; There were no derivative conversion liabilities at December 31


 Plant and Equipment Restricted
 Net-Variable Interest Entity

  

 Plant and Equipment Restricted
 Net-Variable Interest Entity

  

 Measurement with Unobservable Inputs Reconciliation
 Recurring Basis
 Liability
 Change in Unrealized Gain (Loss) on Investments Still Held-Fair Value
 Measurements

  

 Measurement with Unobservable Inputs Reconciliation
 Recurring Basis
 Liability
 Change in Unrealized Gain (Loss) on Investments Still Held-Derivative Financial Instruments
 Liabilities [Member]-Fair Value
 Measurements

  

 Measurement with Unobservable Inputs Reconciliation
 Recurring Basis
 Liability
 Change in Unrealized Gain (Loss) on Investments Still Held-Fair Value
 Measurements

  

 Measurement with Unobservable Inputs Reconciliation
 Recurring Basis
 Liability
 Change in Unrealized Gain (Loss) on Investments Still Held-Fair Value
 Measurements
 Recurring [Member]-Derivative Financial Instruments

  


  


  

 Shares

  

 value

  

 value

  

 value

  

 value

  

  

  

  

  

 Value

  

 Value

  

 Value

  

 Value

  

  

  

  

  

  

  

  

  

  

  

  

  

  

 Amount Over (Under) Carrying Value

  

  

 Maximum Borrowing Capacity

  

 Borrowing Capacity
 Percentage of Collateral

  


  


  


  

 Borrowing Capacity
 Percentage of Collateral

  

  


  

  

  


  


 to the Investors in an amount equal to 2.3 times the Investors&#x2019; capital contributions
 less the aggregate amount of non-Yield distributions paid to the Investors
 (ii) second
 to us in an amount equal to twice the capital contributions made by us
 less the aggregate amount of distributions paid to us; and (iii) third



 2014
 which results
 or will result
 in (i) a person or group of persons exercising the right to appoint members to our board of directors holding one third or more of the votes of all board members
 (ii) the sale
 exchange


  

 Current-Variable Interest Entity

  

 Current-Variable Interest Entity

  


  

  

  

 Ownership Percentage by Noncontrolling Owners-Variable Interest Entity

  

 Ownership Percentage by Noncontrolling Owners-Variable Interest Entity

  


  


  


  


  

  

  


  


  


  


  

  

  

 Options

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

    
















    


    


    


    


    













 based on an internal evaluation of market conditions



    




































        
        
        
        


        
        
        
        



        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        




        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        



        
        
        
        



        
        
        
        



        
        
        
        



        
        
        
        



        
        
        
        



        
        
        
        



        
        
        
        



        
        
        
        



        
        
        
        



        
        
        
        



        
        
        
        



        
        
        
        






        
        
        



        
        
        
        



        
        
        
        



        
        
        
        



        
        
        
        



        
        
        
        



        
        
        
        



        
        
        
        



        
        
        
        




 STOCK

        
        
        





        
        
        





        
        
        





        
        
        





        
        
        




 ASSUMPTIONS

        
        
        





        
        
        





        
        
        



        
        
        
        



        
        
        
        



        
        
        
        



        
        
        
        



        
        
        
        



        
        
        
        



        
        
        
        



        
        
        
        





        
        
        





































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































    


    


    


    


    


    


    


    


    


    


    






    


    


    


    


    


    


    


    

    


    






 Net




 net of allowance for doubtful accounts of $574 and $501 (variable interest entity restricted $1
980 and $1






    


    


    


    


    


    


    


    

    


    





    






 Share-based Compensation
 Stock Options



    


    

    









    


    






    





    

    

    


    


    




    


    


    

    


    









 Recognized Identifiable Assets Acquired and Liabilities Assumed



    


    


 Recognized Identifiable Assets Acquired and Liabilities Assumed



    


 Recognized Identifiable Assets Acquired and Liabilities Assumed



    


    


    


 Recognized Identifiable Assets Acquired and Liabilities Assumed



    






    


    


    


 Recognized Identifiable Assets Acquired and Liabilities Assumed




 including acquired cash of $1



 Recognized Identifiable Assets Acquired and Liabilities Assumed



    


    


    


 Acquired Receivables



    



 Cost of Acquired Entity



    


    





    







    





    


    


    


    





    









    


    

    


    

    


    





    



 no par value
 25
000
000 shares authorized
 9
383
571 and 2
832















    





    

    


    


    


 Net of Tax







 Net of Tax







 Net of Tax



    


    


    


    


    


    

    


    






    


    


    


    

    


    


    





    

    


    

    


    

    


    


    





    


    


    


    


    


    


    


    

    

    


    


    


    





    

    


    


    


 Convertible



    






    





    

    


    


    


    


 Property



    


    


    


    


    


    





    


    


    





    


    


 Operating Loss Carryforwards



    


 Valuation Allowance



    





    


    


 Property



    





    

    


    


 Depletion and Amortization



    


    


    





    

    


    

    

    


    


    


    


    


    

    


    

    


    


    


    

    


    


    






    

    

    


    


    


    


    


    


    


    


    

    


    


    


    









    


 Measurements



    

    






    






    


 Measurements










    






    


 Measurement with Unobservable Inputs Reconciliation
 Recurring Basis
 Liability






    


 Measurement with Unobservable Inputs Reconciliations
 Recurring Basis



    



 Measurements



    

    


    


    


    


    


    



 Liabilities Measured on Recurring Basis



    


 Measurement with Unobservable Inputs Reconciliation
 Recurring Basis
 Liability
 Transfers



    


 Measurement with Unobservable Inputs Reconciliation
 Recurring Basis
 Liability



    



 Liabilities Measured on Recurring Basis



    


    


    


 Amortization Expense



    


    


    


    


    


    





    









    


    


 Amortization Expense



    

    


    

    


    


    


    






    


    


    


    










    

    

    


    


    

    











    


    


    


    


    

    


    

    

    


    


    


    


    


 Income Taxes
 Extraordinary Items



    


 Extraordinary Items



    


    


    


    


    

    

    


    


    


    

    


    


    


    


    


    






    


    

    


    

    


    


    


    


    

    


    

    






 net



    

    









    

    

    


    





    

    


    


    

    





    





    


    


    

    


    


    


 Work in Process



    


    





    










    


    


    





    

    





    


    





    


    

    


    









    


    


    

    


    


    


    


    


    


    


    


 Maturities



    


 Maturities



    


 Maturities




758 and $6


    

    



 less current portion (variable interest entity nonrecourse $6
203 and $6


    





    


 Maturities



    


 Maturities



    


 Maturities



    


    


    





    


 Damages Sought



    


    


    


    


    

    


    


    


    


    

    


    


    





    


    


    


    

    

    


    


    


    


    





    





    





    


    

    


    


    

    


    


    

    


    


    


    


 Future Minimum Payments



    


    


    

    


    


 Future Minimum Payments



    


 Future Minimum Payments



    


    


 Future Minimum Payments



    

    


    


    


 Future Minimum Payments



    

    


    


    


    


 Future Minimum Payments Due



    

    






 Foreign Currency Transaction and Translation Adjustment



    

    


    

    


    


980 and $1






    


    

    


    


    












    





    


    


 Foreign Currency Transaction and Translation Adjustment
 Net of Tax



    


    


    


    









    


    


 Plant



    


    


    


    


    



 20
000











    


    


    









    


    









    


    

    


    

    


    










 Plant
 and Equipment




 net (variable interest entity restricted $3
727 and $4






 net (restricted $3
727 and $4



 net



    


 Plant and Equipment



    


    






 Plant and Equipment




 Plant and Equipment



    









    


    

    






    


    


    








    


    

    


    


    


    


    





    


    

    


    


    





    


    

    


    


    

    


    


    

    


    


    


    


 Shares Authorized under Stock Option Plans
 Exercise Price Range
 Exercisable Options



    


 Fair Value Assumptions



    


 Shares Authorized under Stock Option Plans
 Exercise Price Range
 Exercisable Options



    


 Shares Authorized under Stock Option Plans
 Exercise Price Range
 Outstanding Options











    


 Shares Authorized under Stock Option Plans
 Exercise Price Range
 Outstanding Options



    

    


 Goods



    


    






    


    


    


 Stock Options



    

    


    


 Stock Options



    

    


    


 Employee Stock Purchase Plan



    


    


    





    


    


    


    





    





    

    













    


    










    

    







 Shares Authorized under Stock Option Plans



    

    


    

    


    





    


    


    


    





    





    


    


    

    










    
















    


 Equity Instruments Other than Options
 Grants in Period



    

    






 Non-Option Equity Instruments



    

    


 Non-Option Equity Instruments
 Outstanding



    


 Equity Instruments Other than Options
 Nonvested



    


    


    


    


 Non-Option Equity Instruments



    


    





    

    

    


    

    


    


 Non-Option Equity Instruments



    


    


 Non-Option Equity Instruments



    


    






    


    


 Options
 Exercisable



    


 Options
 Exercisable







    


    


    





    













 Options



    

    


 Options
 Outstanding



    

    

    


 Options
 Outstanding




 Shares Authorized under Stock Option Plans



    


    


    









    

    


    


 Shares Authorized under Stock Option Plans
 Exercise Price Range



    


 Shares Authorized under Stock Option Plans
 Exercise Price Range











    





    

    


    


    


    


    


    


    


    


    


    


    


    


    


 Shares







    


    


 Value







 Value
 Share-based Compensation



    


 Options



    

    





    

    






    


    





    





    

    


    

    


    





    

    





    


    


    


    


    


    


    

    


    


    

    


    

    

    


    


    


    


    


    

    

    


    


    


    


    


 Deferred Tax Asset
 Increase (Decrease)



    


    

    





    


    


 Classification of Carrying Amount
 Assets and Liabilities



    


    

    

    


    

    


    


    

    


    

    


    

    


    

    

    


    

    

    





    


    


 Annual Increase in Number of Reserved Shares


    


    




    


    

    









    

    



 whether oral or written
 express or implied


    


    

    

    


    

    

    


    

    


    

    

    



 including
 but not limited to





    


    

    

    



 by grouped ranges
 including the upper and lower limits of the price range
 the number of warrants



 Warrants


    


    

    


    

    

    


    

    


    

    

    


    




    


    




    


    

    


    

    


    




    



 or to the bearer of the note
 at a fixed time or on demand and which can be exchanged for a specified amount of another security
 typically the entity's common stock


    


    

    


    




    


    

    


    


 Recognized Identifiable Assets Acquired and Liabilities Assumed


    


    


 Recognized Identifiable Assets Acquired and Liabilities Assumed


    


    

    

    


    

    

    


    

    

    


    

    

    



 in connection with the Exchange
 these warrants were cancelled in exchange for 75
377 shares of our common stock (with a fair value of $0.3 million at time of the Exchange)
 however the shares will not be issued until after shareholders vote to approve an increase in our authorized shares of common stock. If shareholders do not approve an increase to the authorized number of shares of common stock by July 1
 2014


    

    


    

    

    


    

    

    


    

    

    


    

    


    








    

    

    


    

    

    



 or to the bearer of the note


    

    


    

    

    


    

    

    


    

    

    


    

    

    


    

    

    


    

    

    


    

    


    

    


    

    

    



 Zanesville Partners Fund
 LLC
 which is beneficially owned by James C. Lintzenich (director)
 and the Edward L. McMillan Revocable Trust


    

    


    

    


    

    

    


    

    

    


    

    


    

    

    


    


 Fair Value Assumptions


    


    

    

    


    

    

    


    

    

    


    

    

    


    

    

    


    

    

    


    

    

    


    

    

    


    

    

    


    

    

    


    

    


    

    

    


    

    

    


    


 Non-Option Equity Instruments


    





    

    



 Non-Option Equity Instruments
 Outstanding






    


 Non-Option Equity Instruments
 Exercisable


    


    


 Non-Option Equity Instruments
 Outstanding


    

    


    


 Non-Option Equity Instruments
 Grants in Period


    


    


 Non-Option Equity Instruments
 Forfeitures and Expirations in Period






    


 Non-Option Equity Instruments
 Exercisable


    



 stock (unit) options
 or other equity instruments


    

    

    



 in 'PnYnMnDTnHnMnS' format
 for example
 'P1Y5M13D' represents the reported fact of one year
 five months



 Non-Option Equity Instruments





    



 in 'PnYnMnDTnHnMnS' format
 for example
 'P1Y5M13D' represents the reported fact of one year
 five months









    


 Shares Authorized under Stock Warrant Plans



    


 Shares Authorized under Stock Warrant Plans



 Shares Authorized under Stock Warrant Plans




 Shares Authorized under Stock Warrant Plans


    


    


 Shares Authorized under Stock Warrant Plans
 Exercise Price Range






    


 Shares Authorized under Stock Warrant Plans
 Exercise Price Range






    


 Shares Authorized under Stock Warrant Plans
 Exercise Price Range


    



 in 'PnYnMnDTnHnMnS' format
 for example
 'P1Y5M13D' represents the reported fact of one year
 five months



 Shares Authorized under Stock Warrant Plans
 Exercise Price Range
 Outstanding Warrants


    


    


 Shares Authorized under Stock Warrant Plans
 Exercise Price Range


    


    


 Shares Authorized under Stock Warrant Plans
 Exercise Price Range
 Exercisable Warrants


    



 in 'PnYnMnDTnHnMnS' format
 for example
 'P1Y5M13D' represents the reported fact of one year
 five months



 Shares Authorized under Stock Warrant Plans
 Exercise Price Range
 Exercisable Warrants


    


    


 Shares Authorized under Stock Warrant Plans
 Exercise Price Range
 Outstanding Warrants


    


    

    


    

    


    

    

    


    

    

    


    

    

    


    

    

    


    

    

    


    

    


    

    

    

    


    

    

    


    




    


    


 Options
 Outstanding


    


    

    

    



 after deducting returns
 allowances and discounts


    

    


    

    


    

    



 after deducting returns
 allowances and discounts


    

    



 after deducting returns
 allowances and discounts


    

    


    

    

    


    

    

    


    








    

    


    

    

    


    

    



 between total income tax expense or benefit as reported in the Income Statement for the year/accounting period and the expected income tax expense or benefit computed by applying the domestic federal statutory income tax rates to pretax income from continuing operations


    

    



 between total income tax expense or benefit as reported in the Income Statement for the year/accounting period and the expected income tax expense or benefit computed by applying the domestic federal statutory income tax rates to pretax income from continuing operations
 that is attributable to adjustments to stock option deferred reduction for forfeited



 Stock option deferred reduction for forfeited







 between total income tax expense or benefit as reported in the Income Statement for the year/accounting period and the expected income tax expense or benefit computed by applying the domestic federal statutory income tax rates to pretax income from continuing operations





    



 between total income tax expense or benefit as reported in the Income Statement for the year/accounting period and the expected income tax expense or benefit computed by applying the domestic federal statutory income tax rates to pretax income from continuing operations





    



 between total income tax expense or benefit as reported in the Income Statement for the year/accounting period and the expected income tax expense or benefit computed by applying the domestic federal statutory income tax rates to pretax income from continuing operations





    





    





    




    



 or differences in the methodologies used to determine expense amounts for financial statements prepared in accordance with generally accepted accounting principles



 Nondeductible Expense


    


    

    


    

    


    


 United States


    


    


 Brazil


    



 between total income tax expense or benefit as reported in the Income Statement for the year/accounting period and the expected income tax expense or benefit computed by applying the domestic federal statutory income tax rates to pretax income from continuing operations





    





    


    




    


    


 Tax Deferred Expense


    





    


    


 Other


    


    


 Net


    


    




    



 between total income tax expense or benefit as reported in the Income Statement for the year/accounting period and the expected income tax expense or benefit computed by applying the domestic federal statutory income tax rates to pretax income from continuing operations


    

    

    



 which may include the accounting treatment for the difference
 if there is any
 between the carrying value and redemption amount. For example



 Warrant Liability


    



 plant and equipment which may include the basis of such assets
 depreciation methods used and estimated useful lives
 the entity's capitalization policy
 including its accounting treatment for costs incurred for repairs and maintenance activities
 whether such asset balances include capitalized interest and the method by which such is calculated
 how disposals of such assets are accounted for and how impairment of such assets is assessed and recognized. Also



 Goodwill and Intangible Assets






    

    

    



 net of accumulated depreciation
 depletion and amortization
 of restricted long-lived physical assets used in the normal conduct of business and not intended for resale. Examples include
 but are not limited to
 land
 buildings
 machinery and equipment
 office equipment
 furniture and fixtures



 Plant and Equipment Restricted






    

    

    






 Measurement with Unobservable Inputs Reconciliation
 Recurring Basis
 Liability


    










 but is not limited to



 Shares


    


    


 value






    

    

    



 but is not limited to



 Value


    


    

    

    


    

    

    


    

    


    

    

    






 Amount Over (Under) Carrying Value


    





    

    



 for example
 but not limited to


    


    

    

    


    

    



 typically the entity's common stock


    

    


    

    

    



 generally on a draw down
 or as needed


    


    

    



 and under which borrowings outstanding may be either short-term or long-term
 depending upon the particulars


    

    


    

    


    

    



 typically the entity's common stock


    

    


    

    

    



 generally on a draw down
 or as needed


    


    

    


    

    



 Halpern Trust fund controlled by Mr. Halpern


    





    

    


    

    


    

    



 and under which borrowings outstanding may be either short-term or long-term
 depending upon the particulars


    

    


    

    

    


    

    

    


    


 Maximum Borrowing Capacity


    


    


 Borrowing Capacity
 Percentage of Collateral



 percentage of collateral



    

    


    




    


    


 Borrowing Capacity
 Percentage of Collateral



 percentage of collateral



    

    


    

    


    

    

    



 for example
 but not limited to


    


    

    


    

    


    








    

    

    


    

    

    


    

    

    


    

    

    


    

    

    


    

    

    


    

    

    


    








    

    

    


    

    

    


    

    

    


    

    

    



 depreciable assets that are used in the creation


    





    


    

    





    



 David Resyng
 who filed an indemnification suit against Irgovel
 Osmar Brito and the remaining Irgovel stockholders (Sellers) on August 28


    


    

    


    

    





    

    


    




    



 pertaining to costs that are statutory in nature
 are incurred on contractual obligations
 or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes
 interest


    


    




    


    

    





    


    

    


    

    


    

    



 sold
 or consumed within one year (or the normal operating cycle





    



 located in Pelotas
 Brazil


    


    

    

    


    

    








    





    


    

    

    


    

    





    


    

    

    


    

    





    

    

    


    

    

    


    


 Options


    


    

    

    


    

    

    





    

    


    

    

    


    

    

    





    


    

    


    

    

    


    

    

    


    

    

    


    

    

    


    





    

    


    

    

    





    



































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































    
    
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else {
							e.nextSibling.style.display='none';
							}
							}
  
      

In Thousands
 except Share data
 unless otherwise specified

        

      










        
        
        


        
$ (23
029)
$ (15
021)


        
        
        


        
5
809
364
1
160
196


        
        
        


        
5
809
364
1
160
196


        
        
        


        
        
        


        
201
584
179
493


        
        
        


        
        
        


        
        
        


        
4
651
380
809
311


        
        
        


        
        
        


        
        
        


        
        
414
683


        
        
        


        
        
        


        
87
167
        




        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

 determined based on the timing of issuance of shares or units in the period.
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

 after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding
 determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    





















    
    
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else {
							e.nextSibling.style.display='none';
							}
							}
  
      

          

        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        

      


 2014

          



 2013

          



 2011

          



 2014



          



 2013



          



 2014



          



 2013



          



 2014





          



 2013





          



 2014





          



 2013





          



 2014





          



 2013





          



 2014





          



 2013





          



 2014





          



 2014





          



 2014





          



 2011





          



 2014





          



 2013





          



 2014





          



 2013





          



 2014





          



 2014





          



 2014





          



 2014





          



 2013





          



 2014





          



 2013





          



 2014



          



 2014

          



 2012





          



        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        


        
$ 16
096
000
$ 19
169
000
        
$ 5
135
000
$ 6
250
000
$ 10
961
000
$ 12
919
000
$ 157
000
        
$ 98
000
$ 174
000
        
$ 1
988
000
$ 2
408
000
$ 3
213
000
        
        
        
        
$ 3
629
000
$ 4
795
000
$ 1
810
000
$ 2
386
000
        
        
        
$ 3
016
000
$ 2
351
000
$ 4
978
000
$ 4
262
000
        
        
        


        
4
808
000
8
250
000
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        


        
11
288
000
10
919
000
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        


        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        


        
4
808
000
        
        
50
000
        
4
758
000
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        


        
7
636
000
        
        
6
591
000
        
1
045
000
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        


        
886
000
        
        
64
000
        
822
000
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        


        
764
000
        
        
        
        
764
000
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        


        
699
000
        
        
        
        
699
000
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        


        
2
873
000
        
        
        
        
2
873
000
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        


        
17
666
000
        
        
6
705
000
        
10
961
000
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        


        
(1
570
000)
        
        
(1
570
000)
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        


        
16
096
000
        
        
5
135
000
        
10
961
000
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        


        
        
        
8
100
000
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
6
500
000
        
2
400
000
        
        


        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        


        
        
        
        
        
        
        
        
        
        
        
        
        
        

  2017
        
        
        
        

  2021
        
        

  2015
        
        
        
        

  2029
        

  2016
        

  2016

  2016

  2019


        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        


        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
1
500
000
        
        
        
        
        
        
        
        
        
        
        
        
        
        


        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
1
700
000


Borrowing capacity
 percentage of collateral
 lower range limit (in hundredths)
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        


Borrowing capacity
 percentage of collateral
 upper range limit (in hundredths)
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        


        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        




        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

 but is not limited to
 notes payable
 bonds payable
 commercial loans
 mortgage loans
 convertible debt
 subordinated debt and other types of debt
 with initial maturities beyond one year or the normal operating cycle
 if longer.
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

 under the debt agreement.
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

 in CCYY-MM-DD format.
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

 which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit
 standby letters of credit
 and revolving credit arrangements
 under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before
 as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis
 or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision
 (2) no violation exists at the BS date
 and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.
              
 -Paragraph 19
 20
 22
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

 net of unamortized discount or premium
 including current and noncurrent amounts. Includes
 but not limited to
 notes payable
 bonds payable
 debentures
 mortgage loans and commercial paper. Excludes capital lease obligations.
              
 -Paragraph 20
 22
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

 after unamortized discount or premium
 scheduled to be repaid within one year or the normal operating cycle
 if longer. Includes
 but not limited to
 notes payable
 bonds payable
 debentures
 mortgage loans and commercial paper. Excludes capital lease obligations.
              
 -Subparagraph (SX 210.5-02.19
20)
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

 sinking fund requirements
 and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach
 from latest balance sheet date.
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

 sinking fund requirements
 and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach
 from latest balance sheet date.
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

 sinking fund requirements
 and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach
 from latest balance sheet date.
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

 sinking fund requirements
 and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach
 from latest balance sheet date.
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

 sinking fund requirements
 and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach
 from latest balance sheet date.
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

 sinking fund requirements
 and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach
 from latest balance sheet date.
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

 net of unamortized discount or premium
 excluding amounts to be repaid within one year or the normal operating cycle
 if longer (current maturities). Includes
 but not limited to
 notes payable
 bonds payable
 debentures
 mortgage loans and commercial paper. Excludes capital lease obligations.
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

 aggregate carrying amount of all types of notes payable
 as of the balance sheet date
 with initial maturities beyond one year or beyond the normal operating cycle
 if longer.
              
 -Paragraph 19
 20
 -Paragraph 13
 16
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

 sales
 use
 payroll
 excise
 real
 property and other taxes.
              
 -Subparagraph 1
 5
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    





















    
    
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else {
							e.nextSibling.style.display='none';
							}
							}
  
      

EQUITY AND SHARE-BASED COMPENSATION
 STOCK OPTION AND WARRANT ACTIVITY (Details) (USD $)

        

      














        
        
        
        


Shares Under Options
 Outstanding [Roll Forward]
        
        
        


        
179
437
169
254
        


        
141
134
40
000
        


        
        
        
        


        
        
        
        


        
        
        
        


Forfeited
 expired or cancelled (in shares)
(50
929)
(29
817)
        


        
269
642
179
437
169
254


        
138
671
        
        


Options
 Weighted Average Exercise Price [Roll Forward]
        
        
        


        
        
        
        


        
        
        
        


Forfeited
 expired or cancelled (in dollars per share)
        
        
        


        
        
        
        


        
        
        
        


Options
 Additional Disclosures [Abstract]
        
        
        


Outstanding
 weighted average remaining contractual life
        
        
        


Exercisable
 weighted average remaining contractual life
        
        
        


        
        
        
        


        
        
        
        


        
2
406
282
806
769
        


        
4
262
436
1
859
111
        


        
        
385
292
        


        
        
(496
061)
        


        
        
        
        


Forfeited
 expired or cancelled (in shares)
(164
759)
(148
829)
        


        
6
503
959
2
406
282
806
769


        
5
322
264
        
        


Equity and Liability Warrants Outstanding
 Weighted Average Exercise Price [Roll Forward]
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


Forfeited
 expired or cancelled (in dollars per share)
        
        
        


        
        
        
        


        
        
        
        


Equity and Liability Warrants
 Additional Disclosures [Abstract]
        
        
        


Outstanding
 weighted average remaining contractual life
        
        
        


Exercisable
 weighted average remaining contractual life
        
        
        




        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

 excluding stock (or unit) options relates to impact of amendment.
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

 in 'PnYnMnDTnHnMnS' format
 for example
 'P1Y5M13D' represents the reported fact of one year
 five months
 and thirteen days.
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

 in 'PnYnMnDTnHnMnS' format
 for example
 'P1Y5M13D' represents the reported fact of one year
 five months
 and thirteen days.
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

 including both vested and non-vested instruments.
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

 in 'PnYnMnDTnHnMnS' format
 for example
 'P1Y5M13D' represents the reported fact of one year
 five months
 and thirteen days.
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

 the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

 including both vested and non-vested options.
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

 in 'PnYnMnDTnHnMnS' format
 for example
 'P1Y5M13D' represents the reported fact of one year
 five months
 and thirteen days.
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
 -Subparagraph (SX 210.5-02.28
 -Paragraph 29
 30
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    


















begin 644 Financial_Report.xlsx
M4$L#!!0`!@`(````(02XK.50`(``0E```3``@6T-O;G1E;G1?5'EP97-=
M+GAM;"B!`(HH``````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M``````````````````````````````````````#

^/C5=D&V[;LE_.;G\YMBM-#


I13.4HJ'(453D*

@J4&25*+)*%%DE

MV/CZ[Q'&




$%``&``@````A`+55

M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````

%'*86C1DQFH9=R4Y3V&OQY0+3S5
MP6H(!WL'JC[Z//FRMS1-;W@OYGUBETZ

M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````O)K-:MM`%(7WA;Z#F'TMW_E+4B)GT5+(
?7KBP^;S:Z-GX?VQR'V^3_OJ'\-XV/J8LQET3!N
M8V[4=O5YR?:+TIF5;\01]AQ!


R@:5LV%UN8)M;MA$L-()E&\%([A9C3!U
M]<N-[@QJ=%=&8:Z^KV$<=AH4QK,AZ$$A:T(P8I@



:6JG-


&4Q3Q4KW2`6<KVTQOJ*R:Z2$@ZFP^,.4K!`;?(&N6@'
^?_+OF4




=2BIL!O
\LSR^-
(91X(
MC_O_()4+Z-O/:`BHW%F!B.MQAE._:/09X7+AN6!:\(B/P5TU)`Q:J8SXV72
MIN^SH*JVF+GN]('/YU@'M]600



Q&8/YL^8\1@PK8'

M6I4[=ZYG5\RA[\Q9J![

);]W=#GNK.54^


:81XWPB+OQ


MF-:H*Z'R1(--91%&

)Z/C2L.B)03C]NP3


+B

1YC9PV\>\\
MR.5+5$KH=`-3#(M6&HVA3Z,P,'&P:.V&Z]OYJYC`432J0LCUV+F[6)D/UFEX
M2



M76^C.!1]7VG_`^(]`=M`XJKI:*:W9%VI=5J/YXI(0EJ!'0:?OO]]K7`5\S




_'/L_F]=?RVI_Z'=






MNS0$D.X]6M3A2:EH@3(:D](W;&PC'GA%8RAY8.[0B^MH4(4@KBA*7E6T6
M,HJ'IPFIU1Q2NS4SN@68X40JW:L&^3%:DQ9&G`]20KL1&


KX8(1@-%HG8

5%TXC9A0@)!NKCU)3

X9AQ2LM1;+4A^/&T59LA
MI_VD4S&IP9BL)(([@
P`W$:@]&8I-YM*MW2*)3480PM&G9/3C`*$%*
'2LW1
M[QLCAZ)
*GYL)5-5B!DJWLJ=22T%A/RCY
NE*O<$8:CQ<.469&0`F

M8ZNQGI`9M4?1!^K%9XF^1CO$QBK!.C
8)


?'MS%V*3-'&5*.H$M?QBQQBCC
FLSJ5A
MFS4




M)/76?R&6[GC-*(#QI1P+@9*;-0S$]`O`EB9

MND_RQ\9.
R0OPT$=NJFCJ

#4@[
)X'4IA
M[6\
'?2#$
:2D%E)IOQFS0`X[IRHK#NR4P.ZR@_]7..'QZ)X:EB7[;[
RN.Q
M\XKF11UY



[.6=)[__';\3#YFI557IPV4V^VF$ZRTZ[8





MAGC

M&7

MW_-39K)MYLG.P&-1?+'4W_86
C?/Q=V?FQGXLYSLLZ?T]5#_5;S]FN7/+[69
M[LA$9`.[VW]76;4S&37#S/S(CK0K#D:`^7=RS&UIF(RDWYJ?;_F^?ME
@^4L

$KI1
MS



%IZ2
ME'6TI
/H(4X_#HG(5!R.R




\


M=CH;F5PG

9!4@6B
4+'6;$;/

MXT


:(T2A?Y/1-6RZ.8O%WMB1H``^


M*&ZR.?NQI]DTHYD0KT^.!%&$BP$K)XS(EU.E'`-'@*R21F#]:'PM@7OA6HHC
MOJ/V6XM#8:Y8DI..U'X_40+1&*&BF3..7*I##LEWV#ZWN$0@2B`:(U0IL\&1
M2L'7B-G(IL+-+_$YH@2B
4*56E\:7PC@8K@0!IH*D*45T.K$1-Z47*!P(N
M9(00_?:[UGC]#9N:92`:BB

M(/J(([V??$H0K5*YZRCW&*'RK9NAVAE7Y8&]B\Y!'(D/C4#J523NMAY1`M$8

MYL]1^C@U1F@
-]EC

M&=QDD0V;5O7`X@2+!(6V


M/R
:(S2&FZPR'+!*T5





T!#.UXYM:9-E\U\$__3J2

MV\@JQ\`!P)

S
GR!8S
M0WXJBKK]Q0KOCH8^_`\``/__`P!02P
$%``&``@````A`*W'KRB9#0``F4T`











M+*1R%7SWR*BIY=X'1DU'T5%;S%A9#XRF^=8A!\*`Q6D

;A\TM%J[CU;H05&


MLB5U8$6.DT`$D`A(#2QQ%0TU47K/\Q.))`
B`YD`)(:1R755MW&W5PA]

M`D@)I'()M5TW4!^PW?1=9(T_9_




^RF1+:HD$3AM27)NB6YE31%
ML@!2`JE<0H=!]T?N,%Q9STU;Y0['8LZ6%X'G]%YV/#@15F.=;;UB07J^KGR

MSEG7$UA1


9`$2`I$`LF`Y$`*(60RB743'7(DN/\NKH[
MTF%L9LYXAV]%C74A$&')^2H`F]T1^7QZITHJ*[F0,@&2`I%`,B`YD`)(:1R
M76:=Y!7.MW62;(&(R
R'6:$V$UIHXN_

B1@94C?T
_XP0
0$V)U;0;.5!$@*

1

M$5&T-=




9`$2`I$`LDL
4/FC=7CDNPXR2&F`%(J5QS=7=V^WE9*S#
MV
SFSY`&5N3.;!/6$`&:$@,)+%D/C[=+U./B+!*ED*([`K)N@0YYR`E$`J

MFHW9QE

4*I:5;Y`^G!F/H%H$((!&0&$AB
MB?'?][TQWW8*

MB8#$0!(@*1`))`.2`RF`E$`JEU`3V[K*[A9];!K&RRVZ%37U(@0B@$1`8B`)






SV_.^C+2;P!A//#NP]/KIQ@7WKUZR0[J


M`%!+`P04``8`````$`F0G:R;


M3\E1'8]%EK


Z6]XH]1S8@0V9


M044AS=Q;B4Q9=8$;@)^SLA!3`RJ2?NU^OQ6']KRS%NOY:N
L7)#/7O*FY85(




M$\
C[+%XQBR_^]3HUYP(@IFE+;%@@Z9^*#7+85WN
6`81!AP#&(
$@T8MF#3

@PH!+L.H6^F(!2PHOJAB')!HP_
%S



M#(
(`R[!8!



M5+01FE&Q`;^_

MVH[&%THT%`



.BA]&&^_'CRY
=CS[
KN/BWEJI=*.X4V)$$Q'8D5


2#P]'9X;#.93Y].'[
M;AM\J]JN;O:+D$73
*CVRV95[U\7X3]_?WJ8AT'7E_M5N6WVU2+\477AA^=?





+!!E+/AI4!Z#TQC'5G
V]K(35Z$#G
M
ZG`#JV
T$*006LT^&B-8Y16?@LM!79HD5HK$)0
Q4B2(\Z
R7&

F30I\W
8O-.)4W]*TV`25#!@$K\PTBH?=[V-HV(.M$0CD6:%IN8TH+;B:&

M:Q+-LMS\(8U-6&B61C&)3&J`A[L2!X/[E86`DD)B(+I4
$1A#'$29:12A`5(

M0%DB(9!Z*!BB

MV36:T;&$642HA9I8FQ2G$
0M=U5_7*[V2*.YEE#[0)-.,SVFCTHX0,I]F
MH+V84UJA*L+ZCL+D_F%5/HTC3NI1!3227C&DY@T+C$\=CREL7F:
W;:*:@)












Q^9A^MJVI[OYO-F\5H=U
ZM/U1&N/-?G

X4[LC<V-WVIZZ:#604IIE%



MQO?S[Z#(QH(*#X@CR@OI-_,JS'0)7$.A'O6D$#*VB_BA9P!&W*760L,P-P]
MVT@0\26'*)=R#(=
(PM*$?9FAPGOUQZ%]9F$&A!2*YRQ3D4B$GZ.RME0)
`
MHP122TI&]NN)-(

MQAE2=CMG

64@21]2H#F@28]L:&19L*<S*#0B6$&$))
M!C0)
$HK3NEZZ1BPDYY

M0R30%47?U!;@X6N:/.%[V2L%%@U:@^`MDE28K2@TB&'-EDY$TPA/I.GD@EBX


J
M`QTB)#2BK-!P
I0ZEA%#1-#]1=*U17B4%EXT4FF?)V5R:QPA:LA?Z40TC?,
MJ



Y7J-)^@5@J%\VF11@.WO8Q6+76W9
M@R[?FVD:X1P])A/NCP8A1(=LRO.R10VI*IV(IA%.3#C)N
UU@EYQO7%;$.4E




MIN=[V-(2YIA/



!KS68?:FTCCY=B*U5:`
TE#NDBR!-?;
97=P_5^:4JJ_V^

M4RYF.:S\

M__A_````__\#`%!+`P04``8`````$`\.?OF&8&```:'0``&0```'AL+W=O








M4!##'M%1(HP?LLX$$L*2`D@BGD8#`!$9):]])E[TBP22V


RE5*L
;U--1@*.&5LZE:B
M4
A8!%YDQ#PE@-#WPCF2=]4%9BL
(J3Q3!0*23+N
2
C4@*@&4$]:52&&SUI





+3_-I_TJTS!F+[#P

#3*


&ZN&

=A;


MYK/_P
``/__`P!02P
$%``&
M``@````A`






;T])


MCAH`-H?I$H`(HHFCA$[:E%Y&:XGZ4C!$OD96!Q!*_5U7(W`W0)S5+2ENH2X8



!`1_Q!+T13@]1%$[$

$T-W$)
]&$/3WQHN''@HN(




M%NKB76P5P-;AC(P(NX!NNH6Z4+@;336AU+0&-M6
%/-/DE?1'SA`5.9&AD

+8.+R`!N
0+Z$8X/5.O

=&.V3

M\)Q
-MV+DXU]O-H:$2Z+NMFMZ1N_BZ^ZES






8ZLF&,ND[#E_T-#[0F_!8??5





M'O2@\K(*?'^S*M/BZL(

M;
ET95I_?;Z]RZKR)J=X*BY%^T-/ZCIE=O_Y=*WJ].DBS_N[6*=9-[?^
)J^
M++*Z:JICZ\GI5E#H^)SC5;R2



O
+EL(1[
MT,#D!=$QIL$#NL^D;8(B0[<%U706JZB^?[H4;RB-5NJ1H2\P1%:!0.O)3N@


*PR6J+B

M89MGPB803;A@:F+'D8VT1$96M9(VUHNSF$+LABZ4O1'A]?P:9
6;**O5-LP:


5X&7MF1
:#P).WPOA'

T+73:M4
&4`L$



M
0Y%:':&X87&`5?G0;@&46\#NK



H%/8U+'`7]*$8$(^X0BM`J&7HM/
MP$Z+3PBPQB<4(=G5^?);+?M3CV*
F5\FV%$O4_(!BAJ)!A6.ZUQ`LQJ['RG
M-F
PQ\'P6!'VDQ$AGW$5J&`B&Y*+=D!G_,^;4$LZ
(S:Z`B+(OVT_R71W.

2YX;6R4EUV3

?



D'_5/3





M-';)!H4F


M
R
V(';HNRM+5#\WVPEQ]F32:XS.=A7)^LA4;NUX&D7A-+SDV`;$1FT`WM=_
MN0`J9YER.WO8

M=RN7G)/D5$LN?


P/N__'F`0R*%]]!P#.*2


O

M+
E(RNGM.Y(2=VD*W;VQ+7OFF_G_&;QX/

UT*U%?[Q
M?7

M:;21U
'1M
0.AM
Z)

'_=M.

2T'0&Q%+]PY0#&2K'QNE39TVX/N4W9/V94=#C=X*9C1


MU%^$XF`VC



?D80:#XV`%4

M?RR)@N-^1?L'VO*OU+16=3S!JAI\@#+8.)VQ8/30[!YJQUL17CLX?`809I
M`L&-UNYZ\/L[_E:6OP$``/__`P!02P


RKEC7L.\W$A;EJ;:\.O?5&7'.-OV#I1S


M&YMOWA\I+T%1*./XD:A4LAH(P&^KJ80U0)'B3?X]5IM^O[2#V(EF7D``;JTI

F+6W8WM@
/S#:

('K]?&P$VM9GJHC:(4;11!K258WWE^[01

QH)!JWZ]?AS%!B`&&;?(]$
MB=''7$.061JFDP-UEB)&#2O=CBBX:NSG-)WT`I!J30Y29PH2M4??4_Y4!+1
M?NQ



-5S9A`T'1[H\*)G
M!WEJ6+







$[F[\D2^2S36Y9P%
[C()Z]HQ:H




!*P!&#5)[SZ?MWN@J0*L:FLD(
JIITJD$%42
!(P!*`

MI#BBP\FUT\



0JQ%.$JG-/U5X&^2%6$
M

7M2;ZQ%HL.

&ZL#_9*+D%;GGGM@%T


M&DC$*



02Q&N



5LE[%\JSM2;1F#
.+EZCKXB55048A[@+;


M0@X7E9

`4$L#!!0`!@`(````(0!]S$+6

VJYX.:]_<PKG:C;_.!N3\VNZ[MVY=AI=RM@2B?<[$NULK3T^.^43/085]T
M]<MF^3E\D$FZ7#\]F@#]V=0?O?/WHG]K/_[1-?M_-:=:15NMDUZ!Y[;]JJ&_
M[[5)#5ZST5_,OR[6^SKE^K]


MW7L_M

P$93543X]=^[%06:.^LS]7


DA^3)
GK
MD]#\1$1I9]YC4S(

LZQ=!%Y%/%)`

MA'
J


5

MU*

=9Q)6EQ)!$=5YT



M9HU9I&M!349$Y&YF($'1%+LKYT3CVCW#E

TVX#`E6$&(`V5`GF2_4`(&RQCB/#VD1B^^2*#.*



M6YKIX=32N!9$
;E+Z

N%NEB




I4F#JXTP8?AO9L[H4]MX.Z

`4$L#!!0`!@`(````
M(0!JSD0K-!



0P#[L\O
MV70]_W3W9Q@D#TE4H&B]$)HR:H+-74.;Y8*WHUI-W=GKK6L)C`2V!7VS&6^T
M:A5MHZX%?0GLB6\U]5P0#.U<#2,$7)T%=X?'?VMB7<5-7[Y7A91PNT1FG)(


/!\F.





R1_1!RM9[B3P!#!?ZAPZPIBF#)P1NU4D%;$&





EL(;

_!G)E
D5211H-!`#

M]KJK?E`I,VF8M8KDJKWH02B@&@@!HA-Y-T1)).S@R8\)=R2.NS1Z?9\NJ\_
M$\-.(I)2D534@BNH-%`#!`+I`+B@'A*^-'+B'I=$*D_5@PN7`@B245=D.%5
M@48#
4`LD`J(`^(IX2[(

M9%Q6S:_*JDE%'8&LAH-Q`QB;2?)BSS3+P;%=0X()X2[LJXK)I?E563BKH
M614T&H@!8CO5EIQ!E%UJGZEE=OW5

L@@XD)HD53$&2`*
MB`9B@-A$XDJ[G(@-5U#@@'A*N7CLNKLJJR:5-02R*J@T4`,$)M(.X2R?6'









BZWP@LF(*22IJB8R



Q0&PB[P\@N64';7A*N?CPNIB,*S`B.C:9GJ^HZC@&@@
M!HCMR/D!)+?ONKIV2'E*N#/C
NMB

+&15+(`J(!F*`6`5$`?$4\*/?BB67I%
M8NZ[E$)D.BP7DB@@&H@!8H%40!P03PES82F3Z'4K;E
F$BFFD*0BPP*(`J*!

MDZC\)E&G:J=


MZO+P;`J4TA244\@K()&`S%`;$?.#RY-=?5M4/*4\*=&9=9EX.95::0I*+.



%T7!+AN+I%2$D

#XBEASJS&1=:F[&((

4!L


ZIASJS'
MY=:F[&)N32KB#!`%1`,Q0&PB<9)93<1*5T&!`^(IX9:,2Z[KJY)K4E%+(+F
M1@




4`L
MDJ1T-F;VXQ/\GQ&[R(HYA('#7A*N$7C\NMZ*+_F,'/(M%JF.FJ1U&C0&`6

$'_U0-KU\)6T3LRF=3/6^TE$38AE
M/5&@T4`

MGT/\.R]R3\9EU$U
EJ&S=ZL
WH$_B:@U




M+MUN8FZE\TYXD^05@J3J'2F!*`:B`%B@51`'!!/7
AW
=UX&K:Y74YUO'[
M!.+W*J(#XC

MKPD7T7`]:E7


@5L6\B84]MY(%+R1*'@C
M4?!&HN-1,&;B/JE2*PP192)&P9EWKK1W?BM?J9.LM6EEO1N@[D'P1!7^D
M*O@C4?!'HN/1









#$M#828EOP+

MQ8^%3@(
BF0WD()(2


M:)$V!A.Z2;JX3[J<XXM!@?JSE*D6AE97!(F2B`1;FG&WN.K#_16!].D7+?59
M[W,]![[^(PRL)0'B7.&



#,K_0MX,PFK5`0D

MA5:0JYN!?I9#F78I!C5N=6XL`T_/MR_V'!Q3(E@7LM
G5


BI;4=(7PE0R($*1DX

+`
3X/$HSQXUT1
1)MRV7OXKI9SGOLVA9
*B11NY8

^Z\5.]+AS2CGE@2&3N_V9%/OIS#
MBT'9







'1?6R?*!\0I(A7=








M/

`Y
2F$HED3INQO



M

^&9#$H

I*WX'
MD_A-*ESZ'CP49VLP(8'!E16]@TGT)A5;9GQCZ57:

M%H


8U?H=6




M_P


MTDE]&]KC@`'#NF&7`;OM

M?WS_W^

MG$COVM;[[UW%FRHD$4&P/I:;N.V%2B6;E8KT81C+RSPA




4W
MEO#USG:WVW3P!F3QS25\_TJK67?Q!A0R&D^7T-JA_7Y*/8=
.-LMA6\`?*.:




F@AT8LOG_SV
M[
F+KS[]_;O')?!M@4=%^)!&1*);Y`@=\`AT




R





^46
MYS3IBI=B!F?'

ML6*/R%A0UT#FWIO]U`(H6ZJ25H&#.YD_+GO:0:-`MWD%//-J63YWFMSX)_N
M?&PR@U)N'38-36;_7,2\/5CLJG:]69[MO45%],2BS:IG60',EM!*TW[UQ3A
MG%NMK5A+&J\U



A9




MBW^]^M.K5_W_?//MOWZP5__^\8_%]W[\1N^E:HA
\




0Y\2+:\5?VLXW+-&4T%1&

M56=%



MX%LN_-E+1Z2_#XR$4TYP=FFF1T_.\A
H8[L



M!T!


M_4:%?N!)FH]C]

M.&+0T?P[H!@ZFH%I-'0T!5
(;`X^8TY03[`9LB


C[A`&;

M584DT3#LJD12#%W5R-P5PZY*)('0586DGNBJ1%(
7=5(XHJN2B2!`(QT4B&I



FZD!][XXY7?))MNOC'2:AGC]@+B00-+BT?YZA5L<



M=H8$QKA







ROF

%Y1@8&





D3V^F([OWEZ




1))NBONVV)RB*[.:
1&E(




^8/^Z=UXOYN5@\3^[TX:=G527

M:MZ=_'C:_25

M?;'/9BZG\][F3Z_+




;I;FA]W=Q
YJ:QK

MQ]5F

52N+=K)J7


;D&5ZST.\HWMWKCD1G'4'<T'BV@3(\C$R?-RMM5
M].#Y?`DY:F1J#GINRDL(*-2?5Y/J`CIT(8IO5)^QSW5?8X9]-3!U)XA@8]67



M8[&S-.#`!A1;&

-)D6

M?/%X=Q-7
8+@R]FSZ7H+C]PMKY=CLX!#)'






M6H[JJT@H[:\[^G`ZKT:7DQ#-#/Y/@\,[#MB-7(=1*M`2KP@D4@72IV0;(-




M]4=M@NS$!E/;7P_UNB5P0WCZ^XC!OY[@@9-QG9
&&/:\TU




HR[2RY[



M\

J:\:'\@QZJ=/BYFHTN()Q:3HAN[RD9XN&K)&(

%]XQ'1!+$'

T_




TO_/\KKV1^/B]=*^JNN;2DGT@;;


8E@!Q-+^$8&
@D7
U68QO
M+?W0;$CD
=*8\J43J;@N_X;O








MC!

PH+`DY4$$)(N;
KJV;;C&

M;`:D*2BH*']QPZ*Q68Z.I-)O

M


M5I/!##?*1IWGEAZS/I^6\O3HS&RL5]O#
!&-2L6L


P`8
$'3JD+!IS
XD5MKB8G1M)M[8-!.-

M4O]1-`_X0W;\`=I&?]&WVM@D8ED4%LX@8X(*OZXXBH6U*3^R+VN80OD0%Y9C
M?AUPG(79^
OA
Y/'OZ*/8-%#LGCA03*&OKIHLJ7T2$\7:1-A7K#D1.CZPXBZ
M!V-BR




MHJX'WF
.%B5JSV&0B
=\1


M74N7F0'/0@)!



M&



K=A/DO;2


MR4_%N\/B].C[XZ/#H_T]2D1[^_OO/AR?'1U_7[Q_]^9H_^B@5QOZ\C?OJPKM



M*/(38BHCT
K&&*$GOBJX%J*-)QE

$)/DW?KJ.C72C8H8@\H]+!P7DX

4MJ(PA'&O-ZCHKJ


-C@*[;3
MM_!F#!P0-VQJ64T)ZRP00U`09%\0'UN9M

MN]=%G.^Q=:@BG2JW7!OK&V-$H:42
\TD%J436=&7IT8V::%K%==&'T67*+B#





Z!R0
MF.-S(H+RIF\SX;!@):JR'DGWHO$[@2?\$@Y3&YC

M&*`0

MMMV9:J)S%.-ON5!9A6H39(AV1(2HQN0




Y$(T;.U%%.21%R@8-$9$I;MU1@]'%'E.QWU
16NZ5%*G








?20DM+&)4NB(QO?3*XA_JO4.:[
ME0X\H
FK&U)W1HWS2LK:?1[IA9`D485
^UKER4KX0FMTI(E-E:6^F8@:M*P=


@#M2P`DF&VP
M/$]!/D(2&]T)A=<0*-F`6;

MG1!W[FG#5*J[^TV0F=_C\Y(CPE-6P])X]%&%&`OLY`L;=;H$L

MMUID=LY]]L`E%\W:DG,:':PH+-VG1)N\YP)0;6CLYXRRPX@L![QADMHJY[

!
FWA%+]G





M\W3:#CSY.5C
@BW
JNH2'J9)NY(L-V
4$&/AO9]R$-[
M2J@Z8XIZDI


A

M;767CI68E.MC(RW9AQ\O

R)_5V5




$X@P.B(#)?(\@+H)&M@


M6-Q:
U49\6J$Q#6REG%.PR`RZB1I@J:Y('TYI;.9-BG;
@=:X#L:\Z`G:1_O



M-[X*B[8YPT\#-DE7ZERV9LP(J!
7=@+2*.ETN059%J#9;B$
HSA*\
R
V7
M0WX]1^OYDK@7.Z-!;P9*.)IQMV[8%Z52LH.

4R)1[?L5ZMKRK@:9HSN%034K9<@<^`_NK83*;TA3X




M*BDKGN@$JR6F++L'

;AI==J3U
'2:VT.9

L\=)

M1Q4I#75?G^7FQ^KF



M%;892JHK!ML92)M8\5FI@
G-<Y3$BH#-$XBUC<RQ4N0@)8U[
(0
M2.+XS?+*
3JR9AG;Z%DX-2@V
GKVIK981[%8-'1H($)NO!H=516;5_*9FJQ0

*X?PGE'E#4RZA



;158&&DRVXZXX7`Z
MCU.;W]6XT6'C:@*277($I

\N*I@TN(KQ94[+!2


M:XQ;5Y7E:F-:1ZDSA\[YA22:'3W)

M=D@P'M-MHDGT`C(3'L2C


ADO4RZ

?:5E0(.Y56B?88M

MZ.:C?TJ[L`C25&[*JL2&MB7O!)!A%PVZMSR#\3NC!!(BX*EZ27V&:QAS.
M/07#2&+WW


MC-]



BJBGMGW/O35U($6-32&HLP6X
M4$E]012W*Y8&I*Q\6A.$R!%R&EU4_H?L[U
5TU9J:7KJ+6VLF8QL5]B!]=2


M*[`&X'7[-X$F1)2V*GE`)%4J3%T*$D5_`XMCZHZ;6=+-)O


8@&'T+IRTR9@:Z:.&72-
M5JA)8-F+JK+87_BJ9.^7QAS26VT-)OYHXHT8!C#K+
$4X.-T&'.^BN563#
3='MQ<;AWNDK;EU2[H*N5F[.]`X8


M3G+\AJ.@8)A7%



MW@?#





M[$K






K*0]`G:99$$X*'(644

6GD][3E
+S].*Y&IUUSWHHK)!0K`_K,O@S2
M:1AFHYAZ`M0C_$5]&/VL^ES6X<Y^I;;4[0(F9&YTX21A./$GX:^T3SS08)L







5<FPFA0\2OU%S;%H,_XK8&/*
M'.!T]&;A]XK'4E/XH*'M.B_BQM%0`\DAV`R%GE@LW3T2LLPM5;J4S[[FJ)5

98AX?2S


2TVZ

L8?Q?&'LY.]XG3OGWO[OG#BZ7;QSX&#ZZC\-$S5+[&Y*^*2@Y7VX\)V#Z/:
M55(_(:RICZ$MDF\6;-_O%1OSG0]%=/BI\)0N
&XEOT;Y7&.:/PV$N^6+4
MZS@YN9E^-@\P&K+
$-AH((B^8N/;V()=?T[6
UWEM
I)%+!2Y5[9;%?U@$'\

0`&
MZ3$3GL]RIAS5A`SC)1$;F24./N@ZC$P#)0A[;+67

MKY3O)KQE
^Y*=;E`=VF2ZIC7OT^*3%HH::X




;3T!2K2TC".ICVAAT0#M(\SU*:1YD/WV?N
MPS1(T-()^:IX6),_9\H<OQ^^7[SQ&&ZF<KP'*ZA#Z)I[S81
-W;$#7A!:XA
M?Y[^F=!4;+#\C3MQ4L.'D:R!DLLU?HV?/]FLF$W-)Q3!3B+;\BR[@N4:Q1

M

M4?




M7^&K?QB]F'7S

6U0#29\'KOPF2?8S.=38=1A#`1)J2$!6KM;F(6C
MSU4]XB7CS&--




#2



M2\?^8\F.0A%?J(&N;#BW&A4M


M56\=65;&HOX

:ZG^?K@J=;7VC_6EA.;@`9%5LGY!5UGP-/U^#FK'/Z

1




M

&Q7[+[\-Y!G
[B%A



UZJC64RDHFFZO-Z+-V\.EXUJ;6






M$RPL'$.H98[:ZF)F@4\.^0+*QS*R[XT/6`5(.+=U#O*PV%;M\&WA6MV1W?M4


=7\`_=Y_H0MJWX/GV



MA@8V$-9_%`4\/O9*_[A[$

OWJL1M?P1ZD'K@5735MJ2CW.&

GX_UGH-)ZL9:T
]*JU$EV:U+TH:!CUEVX^D=@2WM!!


*3'D5?#-_!^UIV(ZA177C=
M6($WY9Y?I6Q'L:/9RY)!KRUD/I]0HV8@GND\&:]M;U
Y
ULF4U8D4&HFEP_(



M;0:$UH]?.(U!
*


RL`/@O)
ME



MU
'@1(0UIRL-KVR5_S$Y':FT??[3!WIF-X
\#NS
#`20PT[Q/D$IGM&9*4;6
MZ2





+%'
._
M\^3TSW$`;

M3AUPN9#!6!K/UK]PIS$)B-3Z61V

Q\Q]:$ZM


'

H/-ZR-R]'DZ#-]$S
MEPFP

:9`5SK:)86XL56&2I1MW*F8_!6=+V\/UV7ASK?8&-3&K
ME;U?_&!LZ3_HNBL^%9;DU7B+:'!C)?\$P#-7F\WD=DH\GMX:8I3YS=#O^$!C

?60W(?8\
M-'2I#Q_J;@!X[`6/G(Q\_Y[O%S=!F1%?K&3O&JI'I?4R!A%Y*/S;:1=2URH
M?
8VQ*V_I_0DY0
K6K(3&_B`)8)2L.TF]BN64+*4R(VX]T3X\!,'%&Y`[UD
MJPJ\K74EX?'C,V#WIB-C)3XD?%1#6IO5L\3'[5'B)5`_FNR5C4#\0LS67Z
M=:MG+%^P61`F%V/-5'MY1@(@R4QE'F=GK**0G7UBT/!=C9KQ..6:MC_`/##

M3S9L&B7NY\^Z!9(2DMHZ])J)783B8&!%_`


?Y;EB-6AP17EED%.5
4&(*0ZC8J
M@H


86^I)/O-E%
4M_Q1TZT$BXP

B=RGB-4%7'/0:6:3)7$P$&H+)8V@49!Y
MUAG)0^R3)6274:8@%TZ
5]]+$Y0R8%<%AD#6H+\P5WJ
9S


MVQV(EMF!E523VF\M:E$C`D&EY`7HUZ3NUVB5U$)#[71]C#@PW5M\C
EV-VWR

@AJGOIA\VC;;V`)2?;O:

M[6DXX






\L\S09D
_YT

.U/IZ;5-2$7!3ZJN+ZF;V]=7Q=CO+RF0#I\-ZT[SU



MJ-
%[#(?ST[)*NE)&VB1?-KB
.^P6+HW0_T&
3PLK\Y=8=M2
*+@=[S0Z:
1W4)%TJ)M/Y_!O<`'IK\`M<RF#7#TA)&6T#3ZT


J9+A_
!S)32ZO/EG:#\N:
MV&A.



RS-0P(QZ;)K9J/SBM5
M:W.\MC7+PM.$MHB4+E?I3@LP(IQY@\J

*;69G#$Z((2&A*/O+]LR1D`85CH

5BD@#!PWZE=KJHT*_11W+`PVK3X*$.;RREY
M#(EZJ63Z^?D^O%
UL+_NX2^_$2.I$T













L5LV9*L1BEY5P3):.^JQ#DG!Y]I$L7X:.






M%0$1YI?'257_BI*X#PJTTZJ8$2NJ3A;FN








Y%


B[AXQ);'VN
M^Y!0B1)=#!MSON.4%B42--581_

MQ

ML[C:)]



ME75T_




(Q?S^)_OFK[K?N;S':-4^=9%RKC])
M


MB=T


M

`ARQ#?]43)`+?\C!=A8#`F$$
1(+`/7L'64
M1UK*Y684!O+:K4N.@()GW@-(*S9MGZ4#'T$/4QPMG00$8ZN=;@/88^&+
M(3U9





Y^;%N'M[?R`%PB?NOD:.&

ME$LJ9@



ML-[$(I/QF=#


^_`N-4P\8()

#4R0N/O0)Q@ZK-%^JP.$6SM`Z-0C2+CFO`?70



@X40!7


MFZ-'H6F%_/!0AN$J.(`
?G-#$:IN&`!MVLT*4SJ'0SKA8622CT55:=G.HH
M&RE9QI:#\\$U(D':M9R`SV=@^
O2M



LR5W=?Z+@T*&
CSTDJB*


U9Z



MZU9]
:6B%X;YTIFL/`I:.X&1X32?7^.-@Y.A]\(Q5?RL8^I(T()ZP#(3I#4.



M&MY'Q\#Q;VY'5^7\;XM+IPH12;-!/^)^[L+H#



.IJ

M?3_
?[G\0!`]I#0S1
*''IF!:\HTZ.Q;-/.CFIG^JM?9R7M/;/H$+4M:H&P
!1YA
M(ZI'EV@33;=KZ`&EH=37$OM#!'!E^D!&W!
$5JQ*=];LIPJ%[)]8)U]+^SV


MU*ZY.H@PM7[S!:


ME8X[FDVCP:F\R(C(U&K56%':;OL/&6JZ?'TCGD\S2P.6+?B#EK6_=IP'S?LB





-6BSHC#Z;POZP]^/
M$B





#.6;K$

-\8Q#



M'

EX830PJ37









HU/*L^AT27'81X5OBD]T&'L1:


T($#X/H.N65LX6G3Q328]L0K':
M&ZE5:X&6/;4#IF:5I?H^NSM!]I+:K2?\D$
$\OU9]



M%5-?`N#VK7?TB


M84V+

M0SBF*.O]Y3DM?%.^!A0#ASR7@X3



MR@/(DG@@/+0P6-N*?YOGB3A:7W'`*-1L
05:7/+L2BKDHQL`4BMB'@%8I8*:








MG9MJ_YNZ
]N-*TG.\*O418^'`DA9W+1@#`


MNK0!W:KT42$FDY=(D`P[VZEE6!J/PV[ZCF(:)/??AF3R40G9)'QJ-J!\-RJN
M

TY8C!WAD5.45G$Y1W!)LA%B)\/

MAO7!9_[W]C-C\G_45KFV+NGDX@[KH[HG`=O]QW?
E_?)@GB4Q^;#/8?`M*XT

IA;UW

M.M[$1`8ZL/*
-X
M]$LV4N.UI1^SK9??)K208-F2(


M




IIQ'&1[O]5%9P02







M

M[CY[/&C_

XAX2FTQS
[U5[XS]0QX;_J07E^?;95AR4I(3!IPN+NG&
M_1J;H#N;S)

?+X.Y$6SZ7S$9B)



U

M0;J^_\A*E8M


2']_8#6FG/1$<NT8*G3

M'A$EQT-ZEG_5;/)R_B=N_LBL)OD?VG=SR[WVYY=Y\[`9R)[YGZ80X
7@-5)!


MO/H-?\_;
=.U)\77S/3I:F'2PFJSN5;^VF8MV7Q6O&-+Z\^*MU3VVM+^L;39

V
T'A*PY'K
8?Y%))'
M]:W

M/LU(GBIWDOFW+$3(X@E8


$:7.*22_P\C7S_RH1VM-L)B;5HYFGO&
M/2_D


M9
5!HWDKBDSNZ
021UMOKT7


M'5D4\0J
MH^^C_.0.7-26+*E,:2LZIE/WA1]U;*L;CE]G=[R%EL@7^W4[!^CQHJ;-QP&
MF^[$4%7.9@MC'(;2*


MX3CDD;\RQ=_9A0LTG)B^KFBPLS^=#@Y&D\'T]7`R&BR-#J:/!DN'.KZ2LK2G
S+;,I^`)\<CR-)00-&R`[_J#Y$=JD(8RHHO\_;(]NX(,/1M1AA!(%
.@4

3734HS=BRZ9$)[L#7-.X(NLR!9[81@_9QW*#Q


[FU

MO33)+6@?UW%#=P7T


M.E





M(


&&[R=\)(

M\CODYZQ




X3KPN^QI2(V<#S+@:='A2

MR@5J';R_GP'^N0-;1T\:Z\/L@G\T0^D@F[R7X?T=&0KG7Y.0K3CEG_1E1L
M5`

M25
8`=(_RVZRGW\QM=P(X5EF-^CS6?GU6.L!S^6RWY`4-^AQ7/`6'ZK!H-
M(J:W94SU<`PR
$$!%=T2-4NFSZ.*612V4=1_FX+H65'.G)XV'*9XM4]J?HM

%\

MBI[C54@;'LR^6&3/4-Z:3A^JA-$;+


78
`HWLDVX

M^)`





)X2T'8?VH*I\]7GDLY)OM0MWD##.;B@9.:7$+'V




M=
\9^*O0Z63^X





DBPEKCK\ML`W(^J6


M8TS$FD/RW#F%.T4X/_J$9X;*
J98KLB%BPOVIR-I@5VI5%#FO/[8HC/FS'L9


XD[XXMPT`_


MU\Q8R^VRGCC%^R`5F
%K(E=IIR/4=WYD/88KNS)GI.G@D''S@\X_B1HBUS1J

MB:3S??ZEYA\O.`276G.E1]6K41GC1+C7CJCJ;G;B=RC5BNA=$90RFIZM^8



M*'_E1YG=#DVVGU

MGL+-[\A/?XSF[H





M(4M]N9?[GRD\


M/
HUQU%VR44QG5J3

MCPC)&O*QBZY#GVWU($*!)P?LAJKI'(X.

CQ]

5RO$FO


)+RT15UG9+'7F%#DM4T&H\/18E&H7JVW

`V

M$

M=
F\CI$N/)J7CB3;N?PPB6U-5JR(AHAJ


MOSZ@@



M('[;GGTZ/^&%N?WUS6N-AGM#`^),SD8JG(*6;H4H(S74$IO:8R2V+*^1Y8







FOW/)`$%$^SB7-.Z4$#B7L/&22!$/P_\_
'6'<9L.Z2Z




DV&[M&\OP

FI[
+\SZ*U(^0ZOQ_RN).%@
GL!5:G*Q^
M(??5WNEG-BOD52H

MN

T@_D$V3;4D8JNMHHNGJ[

`4$L#!!0`!@`(````(0`#I92)_P
``'
.```8


M@*IDM?=6:J6JNK=]#HF!:)
XBLVR^^_OV)
-MD$LRSZP8)\9GSDS'MN++R]-



MD
S!LXPL!'TN1P8A29NOTDB9`II#.IY72;SPGD'!8HL$0(;8(0$)B*[@)B.
M$`_HC1PA\H]SE$86QV1TK\)8(V2J5)9Q9=J`00$T0E
V
V9]
LX:U*!P=4UNHR:-


`T#GYPV




Z'ICMM?;$*?:\^5=VN.3UN_7_^_O(A\[UA+$^[\MB=ZJW_HQ[\C_<__W3W
MW/5?AT-=CQYX.`U;_S.YTT0#-6A;LMAU9WK$UCV7=^6(WSM'X/AW-?E;AK4
M'@
9ADG0ELW)1P^;_A8?W7[?5/7GKGIJZ].(3OKZ6([`?S@TY^'%6UO=XJXM
M^Z]/YP]5UY[!Q4-S;

?=M4?3=T



12RB1$23RF+
M$L'

YL(U

&,E/&!G+/(9I[R6B;7*+5$
M&5A^<H$8PTN%*6N$@@*B.+(`2DV+J%-7MZFU0.DE%%E9YP:#%*5*8QL<K'L&
M6,?6`Z6HY=:A^'8_A1G0HT+NL$@-:4B7FK4+B([GA);I/=B+OC*UC%V@
&8

&
B5P@4'%JF=.`+9)\@8H-A7;9NA4K[MQ@G$.#^X1.ODC:Q5S;
M%5MV;C!81I',F*H5Q*Y4=JV^%PF\FN\X@IO
*:^93@CACZ
W3WQD(C)13H_

:SDG%L
+]P%CEK8*

H2ADQH);2`*``[Y=)*6X


SLYRUAN


MK


M_S\```#__P









WYV!JR7W'G(=*?%0(J``/

MDE$:T*X?M(_
FCOI67NAGE&$$#5G3T?$$C'D+`TC36^I^Z02PD^$R@+ZA[*8



MC@9W



14]A?*5D*)&$*1F+$4.48!JZGL%445IQ


6

;*E964RN^*U^M4!]XY]*_H*!V;PV_.IO72#RXQ(3]V5O`
M0O_6Q(@4P$HPX0-G&E9ON(

`4$L#
M!!0`!@`(````(0`
73<CPJRNUYOSWFY^Q^_
KQK\\_/



Z:OXV@JZ$FQ67K
M[I%@#='JRB/I9BU^MA2P!B[(9Q?E?@RW(U2Y@/[Y]A$B\7=]!LL^LX;;3J
MN$5:6[@5=G&-!P!II!!DP8LVO\A#1?%I5%__J8&VKQ0;FVJ%U


`2@)&&*DK2_95U3K*R2\%I


MJ3IQ(%1O]VR`4D('JQX#W@B7]M
J2?1D]2:4

M#4T[CPYS`(B2-7#0:H0HQ!+$4[1206A.+`E4&!$2\@)%A`9\E0E8I2-I0BG
MZ@2#4.UI9076LTHEF/



Q`:I+
;
M\`.K;#GO#L4;
!`ZY4[NBT

MJ`]G+-1M8!]HE8


D'Z0O'$G121
ML=)S`Z!P\;59R3=O$9$WWT82

M#=HY8[@+?)

02Q%.]5U2&:-4]K2#

ML




R]?4'6E&*$C&Q1Q%.,5W5R
0B6J
MJ/H#K7Q_+/H7._5QVZ2
1WR




M'O4]K+=JB:4*

;DL3J;:I0HQ+$4XU0_I:X+ZVM=!:$4[2+&1VIM+$4X5:=S


@LG6OUYT
'G')







M:&5E='

AO
M3\'D&R]4ZR]Q!/YQG#UMG]??W\[_//S\ZW;W\GKVPYW[B$)@#T]_N.UIXS/J


9^G5MOZVA



M]UOF3Y*E&!


43$3222QH:
M=N`TDNOK9T2+::RWA2$[5`LTU0-!4.D*PEP^!P:P5U38*BD:&X$0#H'QL
M4ZB9#B


.?2#JI5R46YX\Y*DCPV

M*TJQPM0(PH$I

@$MV8O-6(T@')9B68GP


G500T
?84`OG/TELPX64*)7$E&**UHCJ'V^5Q2E+







MO+PGZ6FJ]52?1A&$64[5[&PU
A1/+KRN:]P72(N7

MZL__`AAK!'5T[#*XI2EH19.]?\2SPP4C\?ZBB

M9@/JJ([(*:





M2+X6/767E@



R=2(5RG;O+/;5PZD(_QRE0H754WZDAZ&(

MW7T
Q




3+U)FOG[LE?$M5BDJA&

[;B8?B3D5CB:D3U

4/G$_E

MS0
((CE:MZJ`Y@.@#TH(@@'PJBJVN9;YC;_2X[KFT$_9PV.CA;


DE;*ZVM^KR$


KOW;OAZ?]
MZ]VU=Y.YOMJ]/NP?GUZ_WETOYLT_RM=7A^/]Z^/]\_YU=W?]S^YP_;]/__W/
MQQ_[]S\/WW:[XY7T\'JXN_YV/+Y]N+T]/'S;O=P?;O9ONU?YY




M/LD1^



B0W/]]^O^/I\?CM[OK7/&F
M4
*YUZRY<M[*06]2,*#?<GF;[Q\YI(]J82#XMMA#^C?[(IW'EP9H+?
MBW?&RX5[$PUO3GI.Z8T?!NNP'%6P$__&8AF*4S?9Z%AR_\+D;'@T
BG^/[LC


YXH:%*DM-1


MGTI&WBM5





-1AJ
-9AH
-5@


M\E2MIFCOO)83XE6+*\I)D[1N%='^-S1H:M#2H*U!1X.N!CT-^AH
-!AJ
-)@
MK
%$@ZD&
PWF&BPT6&JPTFMP4:#K0;&@`3N1LZ8P,T8@7L&]AGX9V@B3OH
M9-9_7B3]$J*OUIE5]RVK5F

2^!LY8P([

MVAIT-.AJT-.@K\%`@Z$&(PW&&DPTF&HPTVNP4*#I08K#=8:;#38:F`,+PS
M

_`/0/[#/PS


0
8@$Y`IR`QD#K(`
M68*L0-8@&Y`MB#PAX$?H[CHR5)X(`*H1T7=9X$=#6BT+^%`YWKH!]Y]Q2'_*




M(%L0B;:V0J(-1

M

MR!!D!#(&F8!


M



@09
M@8Q!)B!3D!G('&0!L@19@:Q!-B!;$




.CF7WQ6J_=`[&N;UYUV$

MD/R\41B:GRO$`6*7#%V\\B=+))[9[+XYW=YN8WUFTGC-W._[OS:XE:H:M:J
MXK-&DSHT#9`F2`ND#=(!Z8+T0/H@`Y`AR`AD##(!F8+,0.8@Y`ER`ID#;(!
2!]D`#($&8&
M028@4Y`9R#P@P:V.I%/]!1HM058@:Y`-R!9$0JX=E)`#U8AHM
08#6FUQ!@J

048@

K6;W85@.I@S1`FB`MD#9(!Z0+T@/I
M@PQ`ABC@`195E]18^@G(%.0&<@<9`&R!%F!K$$V(%L02;*V4Y(
1(NE3$-%

95@==%=]=^3JJJQ)G5H&B!-D!:(_Z)B

TE-9'J



M-*!I.NI6




M[1]6VV9?WXQ_U.WXU]M__7+]UAR^ML]U?1Q!A'U[
WX^'E^N9K-V_5SO5NVT



$:X.?6(TCX^;=?VY




MQ#Z3R]5U$XCY&2*80(KZ
_%@Z!-V86
6V3DPLD.0/=-=L@/BTG;(I3WX9@SW





5^D

M/&$-

M4






:6=BR4KF2JU[\D4

3

@EHE3!M&OQN$LG44M.`0B#D:.&3B+(C+Q8*7-)61=?1)0QD

5IX'F)+'@U9#0N5
6C

TIO

E









O_^


`4$L#!!0`!@`(````(0`_





MQCMZZ++`ZS7+V+%XYAZW4Q8G3?+T6)6O#NP#N(OU)=&[RM]`YGZNS)T=9N^M
%VP++!M^/VDNU=:S%Q[:^H:RX*[,%%-Q0K
M6Q)S=S?!ULD;HI()LE%Z^7:3J2X!C[M*K)N&.RO\3=
BV$WXQ40!%/[TT
C

4B.N6]J%^/
M



X
%8GWYT*+D0MR2H4FW+L@2RSJHX
+@0%
MD@*%@.5B?8\++48NR#$:FG#O@F[O/CJXH$!0(E0%@N?.C'QD]&JT8^KJ=X
M6V##+OZ6D2$\.&%$,(949C8;G0A'KVT?%.V\0F\\$D_$':BWA)Q'`WAJR63
M]7H`*:1CA

M&]3%%!G4%0:^3WQ087Q3@HE1
M2P4UWG(F(D9D0P(AE1F-AV=%%=MX_W7Q3
M=L$,KN_TJ.Y4V`8JUUUO2XE@5TE&%:V#5U(Q]LP99?

MIA&
R(&TWPSLKD(-05B=MB-=5

B68.([)?11H6ZG(6(D9D0P(AE1F-@V
M=%4=;\/48+*^R$6^JA2=S8HB9E&

K3%*+(3AX


;$__JYD(;C43
S+XL%.].7DFR;6Z

%O5O!B&1$86)[NZNS$P_0#8A67%AI[H..F(D9D0P(AE1F-@V[NHL]*^K
ML.P^*&=MM@G073$8D(PH3V\9=[41PJYV8T0:I4V$;M
&(F48P(AE1`]'%












!Y8#1T!6L4\'V7@Y7W%0

Z!X$!R
MH*(L\S?.80_^131O(GAP'+@
BL\'GL$U:$5MP*-H_G44.LX$!P(#E0$40K
M)I

DKSX$+EK]91FBB#G-UT1=

#Q`)QE.1VA(AUA1TQD3$[V`WKOY
M+0T
3@1H)!`%1`

M$`O$49*;$J+6)TR)8V9`BLFR7')%$Y$P8D$HA+YJQ63]V@!PO$49(Y4EZ7
M
0]RR)A\Q4PJLF($4`D$)5('!Z=:1O:&`6B*


$1]:Y`'70*\6B*

MU_`I%WM.X3^S`I=XO&Q2.SIEN$:1@'10`P0\11DKMP7;XL8T[L25A)=:JU
M`2*`2`*B`9B@%@@CI*\^A#SZ()QX1B(Z3!?.H6?.8ESY`-$`%$`E&)Q)DR

4`L$$=)


#Q`)QE.2F\&QYH2F=&9

520R);/SP
MST2BGK$PZ4`C02B@&@@!H@%XBC)7;@N;DXNBIM)1:N/[4Y$@$844`T$`/$
M`G&4Y-5_+FY..N


+C

M(J31Z[*)485F?`Q4
`:BBKK`B4@]G302B`*B/TCX]=URPG*_^?CQ\3=7+1!'
M26[)=6FTZDRC?-5
ZKNR9

MGAP;(`*(!*(2B:
]_)8VO]W6T


MX)991Q5U@1

M=(1(']SR)ZKS.JIH]9P(T$@@*I$S6R:T

ELT2_B]3S1-C`T0`D4`4



^+^[E

MF_?#FRF^;?;^%2.'?[[X5\JT_GT0XQLO?MIL]L=OP@$^7E+S]4\```#__P
`

M:&5E=#
V+GAM;*R=65
;2;.&[T_$^0\$]P-HAP[;7QAMW9):^W['8-DF!I`#




MROG17Z[[ZJQ:KC4NLS-1X%FBI+'GT&2/.S_OCKO$)]'\PZF41:6H?CZ#)?J'


M6X..!ET-8@T2#7H:]#48:)!J
-1@I


@*1`AD!&0
9`

ZB6NK5&%
M_AR





M
A-PF@*9^3+!V:*E7^'9.NJR-+AR;*$MD$EJ6KJFLZKZOLA/ZA2ENN5$Y5


@^
L+LH]UHJL,=Q5'#]`&
$P$RVIT437B[D6)D33&M'6$G=O
M+2=D=[W-

MR$BT1HQ$:^P0_6&M5L)FC(2K1FC3L\6V;WR3];OS3S-UL(JF=WJ'B2P7ZO

MSK3#W`?5V6G1&Q
/YQAT

ML7=4C7W6DFYF@#6F;%5XC

MB#`ES08:I.3[9R)V'XZN!NZ^KTL670IJ(FHA:B/J(.HBBA$EB'J(^H@&B%)$
-$]=D$.X;]8X#`=A4&9_2`=5\A+ZJ(T%\V&#5&NH4N].77MK/P









/93O.^3)#]`Q131$K1%JC=%Q
RO<=\J(?H&.*
M:(A:(]0:BZ,?JIK,3L2*0YVB_`SEY^BX0+1$K15JK<71#U6M5C9BQ:%N`_DP
MW\Q6Q#OR#;<ZS/Y(.PV'?+.6
LAE6]J[PM5AQZQZ$@WVR-GGPLCG[+JLQ


M*$A6&X0G'XNC)U]1T^)$K%B^A_)]ASSY@3CZ\NI\I&+%\D.4'Z'\6!P]^9**

M];CM;_

M%4BMT6^#:!M(A9EFMHO]3'MCL':[R_[BUZ)PP[NJAN%FV3G*B6@Y9*:WARX1




M=3\XE;I


MMH%\
*94].V;;*K].T^698HJ[^U-GW#8J:GV;+*C7.DM1C2)/APP#CML%6RP

MK0J#&+&5!#%F5!C$Q%E5[;3UJE95R3YE&;D3/F

M=/QRH&+O3/EW
!QJ-'B!5VR\Y$KHN5\:7`Z=%F)


1&O
CJ(U821:4W84K1DC


N1KO+0KGN7IZ

M(KP`J?
++D`]*3AN_6E4U'5ID9J'J]/5K#A'Z5):#M$FJ'3ZULKL5ATNKX8^






MG36


M(TH0]1#U$0T0I8B&B$:(QH@FB*:(9HCFB!:(EHA6B-:(-HBV`0I3C
YVD&)O
\;4<\HZO[5#XK<R&FA1VQ(H/




M


M9M\NKZ1*)=D44?O4S$]Z9OTNE%!!GE:)M.B+?5C+YU(]^DSSE9R2\D7TF;:Q

AU*CLXUG;\\_6Y2@V9V_CF/.8(T4H\,NML
M#)6V9*SW



O8D7FW76
FCZ


/SR?WN*\U++[*[-D_V]]GM_[RX7[[Z<_]OZM.4U?ZV=[=S9<=_;K
MA?G-FZ_[_0O_#QW8N?E=^.R7?S_]GP````#__P
`4$L#!!0`!@`(````(0!L


W+GAM;)Q676^;
M
!1]G[3_@'@O8`)B4*J=E6W29LT3?MX=L`$JX1[33MO]^UG1^FI*]A&.


6+(O224-2<%EG!^D=-:G-C*9`I=B?G3






M2CCYH&Y1K\5



TB0/;


MYXTB-ZB.)$82^$22Z':P08(-X!




M;(9O'V91\O[Z&PAXC38+:Q-)BXPLG

-

M=CYK]C@@AL#HPZ4CD?/WR#A

M!FD\`A4&

(CT#)(SPR



.
M\L4@9&K:U(O(0TIJ*GEG:!4QK2$$8B.N@BWI[]]@&./7.^26)BT`K$%;$$
MXAHAU&P4W2K7-T33



M







ML66X&XDRT5;8:


MKA%YG$\4^O4$$U/G'.UO4DE+,Y=E+1AFL9S'A)BM(4B-0PZR!%B*;1``O%

U4'-()82LM5XT-^NZQ0=-\&:\EY2$HNU84B
M-0SR!&
9






M/222.4)ALY384(1



$

M=E8V-Y%5&$1%T.`@:K+B@^CQ.GK1DDH28;%?%F4;&E:-8=9SB)56_02CYO
M



[O`#**BAH.#J
E*#&*F;K
T9'5J$')M@


K1B
(2S9Q*RLPU05S+]BX66?7(RQ7</^`OK-.YOSRDY*7.

ML*[.ITB^2#RD0IC*W!E:4'YAB*$(80!)9JFBJ=$'O[UB*6NR(HKJGQ\?U(
MK6!#37JTY
IUKJ4S+G+F*D1Y2&E(K7Z68$.N(0\)#2&$(2I2N:(D%JXA0URA


2@BQ
=**T6
&YSDG



MR^'J:?
`0O+W-_?^Y3]XLQ-_;O]I=X27]D#Y`J]T@9

$%``&``@````A`)D'J++5`@``-@@``!D`












M6QJ8U_:V@O\SAP$7AP`NI#3O#RC0__'7_P```/__`P!02P
$%``&``@````A




I^/4C&M7A4.0DJ/+7DEQ:)E*3

FAY7Y9/NI[9G6


MJ`Q

3!8
D6?(S(G2I!$]6Y;1_4YP8B(2(1(CM$8D021%*9*#[!FJCX]'&*
MT.C.#M&)#2.NE!(!(B$B$2([!)$4D0266B=!1&1^GH?UPPJ8SJ`/@@)PB
M4VWT^R!A7(!(B$B$R`Z1&)$$D50FBBDSS92/1Y]&JWUG1!Y]1`)$0D0B1':(

M4](,E.S(^R#1'9$B.P0B1%)$$D9@:(/E!5#H!;!ADQ'PH]OU15Z^AESJ*!J
M#B.2.3H(.+[PL




MB!J$$X&8
'SYJ
*IN-\)JP;1TNX3!K%*4#&((R73'*UK6UKAT.D[#'[`$62:
MZ%K(D4@KS]


?MOT[?.'#]HEYO/!A

;&\^'KY`Z?^%#
M`[?Z-X*SJ6MV)+]F];&X-
:9'


&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;*R96W.C1A%WU.5
M_Z#2^UKB)EF4[2U+W$FJ4JE-\HP1LBA+0@5XO?[WZ6&FF4LK7GNS+Y;UJ3DP


M10]?V\=9=VZK8CML=#S
[/E\



JFP



(O)

D)H@
M
T&N`

M76:&;`T_8R8,!F8EFY8I
)-G0X@]K0
M?W`A9C*Z)YR`)VJ,%D9QB*T


($183$A2$I(1DG$WBLHY)\
A


MP+0-
KJ!B&&*X=QK:=I(ZMP0(%`MKJ0V8[1*(58Q8X!FM%X7Z$PL.]UC`E
GL6(4;!F)#VQJU0D3V8*/G&H1_B[C%0L$'RB<8)5$*2(A[!E!



[V@QEI'*.Z
+EF[7M;SGZ
MSH:)=_]::`720NL:DVMCC54RM!PIR0I%E5A$W?G,1;C"MDLF(JG65NHJ*



M@%W3]/B%[6!\GWGW+P```/__`P!02P
$%``&``@````A`+[`PW?T#P``QDX`

M#=4V72=S!3[M=M^


)T!_+UZV)C6H1M9_W5WZ%'C[=/QZ=YDK





M0&I`0B!U(`T@32`M(&T@'2!=(#T@?2`#($
@(R!C(!
@4R`S('

FR$1H0Q)]AY%


@8R`3(%
@


@$R!3*+2.(
MYQ&1

C5BZ!=)ML.G$

C5AZ9*6E0L9@
XE)4EJ=]30V
M8NF9E9:SGEL;.>M%1`JT=I;+6-`I&1NQ]HI[:2DV;?/S,FS.KJ3BIN3%B63
M$E&542[N)VJ(0HOR4C-UMI*J:3`2K2:B%FJUV4JT.HR
7'FU#;
4*Y9?.?)N
MSIG]0]Q3EL'UO'[0W#E2':%%^?QIASE/MX35B5;8(LZWJB4Y&:IJB$*+$L-%
L+,'&C38Y*Q@4[:**K&L

/7#=(BRB
MCC5.[%Q!)5.%':-'

.
(P_2(JDCLR*.
M


MTB8?S:[R7E$/S15K01_L5+6(9K^
:HQDO1:RH[2O.B/1:KC:#49B5:+'46K
MS4BT.NPH6EU&HM5C1]'J,Q*M`3N*UI1:(W84;3&C$1KPHZB-64D6C-V%*TY
M(]%:L*-H+1F)UHH=3UINRE!']IZ4


U27





:(C\=HK5U1[R:&U
D_WQE8I*S2(V&!YB=AD


M89AW([!A%-Y[L^0DX[8&1M+6*XBJ%B5GX(QD%ABRH\PHZXQ$OL&.
J-L
A*M

/
MO8E%^]WQ2B=74JN3BG5T\BEVY`930ZL041U1`U$340M1&U$'41=1#U$?T0#1
M$-$(T1C1!-$4T0S1'-$T1+1RD%N/IF[&\E\^DV?8V^&2'_V8.[
4R8E$J*
MJ(JHABA$5$?40-1$U$+41M1!U$740]1'-$`T1#1-$8T031%-$
T1[1`M$2T

;


8IVLTMEM7@.
M^;@LGNLHW&`K$6XR2EYM?(B#K5+FD+0GY513-#^0Y?)Y;=6HJ-5RA%0:JG5\


V&3D1E3+M19K_2JB







0\)XA!X!II-..S(J!Z/4DQZ7`_

M7P[




M\VYWY']




M.:/^S
$;Z;AW_S!G\KE[J@
_LB/_S+!UI^]XD-T_3*_C9^[Q6

MCW7PNW^839\7N+%FH/N'V?)Y@1MK%+I_Z);G`]=%N#\[\@_=Y'P$QCIA=/\P



M


@$\/ZEUK8\YTW0\]G+E3&&0*60&B2%S2`))(1DDAQ20
M$K*`+$K2`6I(6M(`VDA&\@6LH/L(0?(PP.)H_H0N:V\!
E\XB7HE=?S71D_
M6KU(M-SY:A+
5T

H/$D#DD@:20#))#D@)646D!6D@M20-:2!M)`-
M9`O90?:0`^3A@?1(BESRTB:?7;VTG9^ONM9^J'IQYRO(%#*#Q)`Y)(&DD`R2
)%Z)43UK&.
M'RY#P91U$TQ9MM4P9Y%FI)@T)R6DE)21<E)!*DD+TI*T(E6DFK0F-:26M%M

*PMB.F4]=HMC7?CEDX6S_'4;SG5#*]UP:C=4FI%B
MTIR4D%)21LI)!:DD+4A+THI4D6K2FM206M*&M7M2'O2@219Q$!*%FF19WX6








M23O2GG0@2;XPMI(OFC_@?KZZU6





6E.2D@I*2/E
MI()4DA:D)6E%JD@U:4UJ2UI0]J2=J0]Z42+&(@)8NTR#
_B]U*LYO%)^:Z
M?F':BQS6JJ/N#XJ$[Z6@&5O%I#DI(:6DC)23E))6I6I!6I(M6D-:DAM:0-
M:4O:D?:D`TGRA5&3?-'\`??RU3U*Y^7KE==UQSK^9UA#P;V)\'L3MM4PUY%F

M21O2EK0C[4D'DN3KQ+V)$^8/N)^O;D79?2]]Y77=5;\R[;[)&@KFNO![$[:5


DB+?+
SV*WTNQF\8FYKE^8



OS=Q-;2RGV%!
[:*

M#:DE;4A;THZT)QU(DB\
I.2+Y@^XEZ_)J7L3KWB^[EC'OS=AJ'L?'Z[K)I?A
M]R9LJV&N(\U(
6E.2D@I*2/EI()4DA:D)6E%JD@U:4UJ2UI0]J2=J0]Z42
M/_]K[DW8Q8B'QQ
7X?<F;N-YY0T(\6D.2DAI:2
E)
*4DE:D):D%:DBU:0UJ2&UI`UI2]J1

I[*2WRS
]7MWKLYNN5

M(M6D-:DAM:0-:4O:D?:D`TFRB%&3+-(BS_PL=BO-;A;/?X:=]`O37N2P5AV9

M;5?-'_`_7QUJ\=NOEX[U_6KT%[PAH5I]S-L^+V)R=!*)[8I:4:*27-20DI)
M&2DG%:22M`M22M21:I):U)#:DD;TI:T(^U)!Y)D$0
I6:1%GOE9[%::W2P^
M




L2%GP.=LE5AR







MO]-:=N_W2O9



MFYN+\`IC8WO3X]NR](ZE][:T;GCP:GFYO3E]+\CF]GD?ZX]E_$M3)7]*#88_






MY=4-/%I#DI(:6DC)23E))6I6I!6I(M6D-:DAM:0-:4O:D?:D`TGRA;%]





+WNEC<B#`5S77`K)K*M]4R)<U(
M
6E.2D@I*2/EI()4DA:D)6E%JD@U:4UJ2UI0]J2=J0]Z42+.(FDV21Y@^X

%)/FI(24DC)23BI()6E!6I)6I(I4D]:D
Q.O^-6!6]Z;
!3










QIZ\G)BJ)\0KOA
O^[
MFQ
43DQ?3N%42=YKAMD0?QH@TU8GTM)=H;NG*7R_?]XU47^=[YT]0S*RPXY-








MDB]:Y)F?KVYIVLW7J^YGW)L%;C=V/=E[F)%I9&5JQ/]5SNO@KO+
MM+9

M)$!8*)8`#=O:0^//L3K-]-`D4_VFSMF33*$+R=2I+O`;ETXS[4(RA2XD4^A
M,G6JB_!'925F0S/M0F*&+B1FZ$)B-FSKG*CP*1F0S/M0F*&+B1FZ$)B-FSK


YC$K#?G%20Q&]HYAW8=


74C
AFW/'(7$;&BF
M74C


STP
M5EO?LC0A81LV-;I(OQ;EQ*RH9EV(2%#%Q(R=$A&[9UN@A_PE5-C33+B1D
MZ$)ABXD9
.V3A?A44C(AF;:A80
74C(T(6$;-C6Z2(\@G9T$R[D)Y700A






A\0+

]ER2AMB0)M25)



[6TJ^4%[R





8H9[

M&/-FI-Y




MT*




$D5#)$4QB!),8P21&,`D.3((#D^#`)4P
MB05
8@&36

M*Q1^HNU-(FA?MY/KX`:/[-[03%]LDE28)!4F285)4F&25)@D%29)A4E289)4
MF05)DF%25)ADE28)!4F285)4F&25)@D%29)A4E289)4F05)DF%=4DE2E*)

'S+!';P3T?4KIURW;O<+3O-7QZR]DW':XZN#0N1#]QO
MWW^O]V1]<6&/2/A?6I]XZ/[LY%(LS77M?D.N&]?VK0-0Y<K#@]77-)S'5U!


MF;5]_I?NW$X]Y%1I+;I\/[#6M.-6YDCG_K!_^45LRH81_5A%O7EG344-)1


UEHKPKM=:&]





M#:ODT-G]XD(8.&/3L0)I

JUUC


D0H%\N'F


V#=/01M(MI`_&B#T(84^7MJ:(-P\Q2T

-0AM2Y$+1!N'F*6@#24$;B!]M$-J0


%\:$



AY_G
.;')(EYNP/Q79COMS+&I;9MTV;F18/Y
MILW
BQ_
BP;@H@&XQ`-P\0/PT
:BIKO9`!YN7E
`EQ0`+GX`'MJ8(MWH`_!P
M\Q0`+BD`7/P`7#1H%@V:)1XTBQ\TAS8..54%FL/-APS-D@*:Q0^:0QM3I*H8

4FBV6YS*
UW7A!I=TOF^;O?05GNG3)_BP;+39M9[G[+W`_+LBTL


$K')(E2NQURC-)O?
:.
MSP/JV7;3[/&%N*4KSZ`W.[6ORK@Y&Q_,?ZENR%0W5,M%T$/7...O^\V5$=Z
MUZZ:5R%'WZT=;?F'&S^$AHHE_A0WF

M6.\WZ[0\09=(?+I$XM
6UX<B'5AC:0^+2!Q*<-)#[
A]]7:@/F$A[
M8S


\'

M#;&?A[;$?A%:BWUVDMK^I3L



FW
]LW&/)3I4]ZV6

M0[5$AVJ)#M7A=ZAPB@W5S3Y


/#M42

8X#$IS$B_I%RT2O-
MS<MU?I)N+-`L/=2D&:1A#1+)/1J6;-





M2!4-4D6#5-$@531(%0U218-4T2!5-$@5#5)%@U31(%4T2!4-4D6#5-&
5!4A



M&I2*!J5-&SY


M.Y+BT^#F*3Z[U@HUSZ#VTP[%#'KW

M3P')8XI$LMW3T'.!WT%ROSDRGJ+:]QS-7Q``R:)!LFA@*QK8-FW&5OS`-K2Q
M5&E!$&S#S4L%MI(;,4/;$,;4Z0E.K`--T\!MI(;
4/;$6#4=%@5.+!J/C!

@P*BE@5/Q@-+0Q1:H*C(:;IX#1
45BU.Y0?!=&VZV.Z8S5
MOE]*&!4-1D6#4=%@M&DSH^('HZ&-I4H/SL!HN'FI8%12P*CXP6AH8XJT9`&C

H:C$H\&!4_&`UM''*JHR&FP\91B4%C(H?C(8VIDA5








M#LI3]-3F4VAH5I0[6$ANJF^5+-!;_WD*H
TA(??B4^_$I\^.U:*\SI23ZR

M(_AMFTZGS*ZUB^_=9K_9;=
E

M@%=2`*^D`-[NM[S1P-NUY0`%KV.\Q*O=EO@NO+;[&]





0U&J!I_=-\O'^G9V?IX$`#
M]`VGDV9)0`-$@B/O(0W0W/A


M\H:A(H&H:)!J&@0*AI0B@:4H@&E:$`I&M.N:$`H&A*!G&BO2\T&!
_&!
-

M!JFB0:IHDH:I(H&J:)!JFB0*AJDB@:IHD&J:)`J&J2*!JFB0:IHDH:I(H&
MJ:)!JFB0*AJDB@:IHD&J:)`JFI&J(J2J*FCF$BUVR+?A=1^?V6:0)N62$U'
M6H87;@.IHD&J:)`J&J2*!JFB0:IHDH:I(H&J:)!JFB0*AJDB@:IHD&J:)`J
M&J2*!JFB0:IHDH:I(H&J:)!JFB0*IJ1JB*DJIA0F$D]RW?I;GGL[.?3ER[



MT2VA'4E!MX2;IZ!;)`7=(GYO!FU(L4J%XJ`AF](MDH)N$3^Z);0A12X4W1)N


7T0VECZU//T0;CYIO2!
MI*`/Q(\^&U,D=:'Z(-P\Q3T@:2@#\2//@AM3*%'C7#S%/2!I*`/Q(\^&U


A0[BD@'#Q
^'&XW=J;E[;.F<5/(



W6^]_FUWCV9VF\9C6




S2`):`9)0#-(`IJA:U^K#
T@T6D&B6[-(.&M
M&:;XJ39VH!BCSZUP?L?;M@?_M/33M=L.%.XV'2@NTKQPM7:W98)^X!H/;0]=



G?3.#WA


MHM
H7?M:86@-B4YK2'1K#0EOK3'%E])8:XSQ4VO8/3MIC7_H4QWG[3;@=+[5


)3W\PRW+
M1N?M)MM


M0'5$HU%$HU%$HU%$HU%$HU%$HU%$HU%$HU%$HU%$HU%$HU%$HU%$HU%$HU%$
MHU%$HU%$HU%$HU%$HU%$HU%$HU%$HU%$HU%$LT91D491
:&0Z+
;%R-]=AU@

L4+Z.;AI8CHV05K887KCY-`^IHD&J:)`J
M&J2*!JFB0:IHDH:I(H&J:)!JFB0*AJDB@:IHD&J:)`J&J2*!JFB0:IHDH:
MI(H&J:)!JFB0*IJ1JB*DJIA02*3:S8&1U-OFR7XS83F7)F?3YGE2-.@3#?I$
M@S[1H$\TZ!
-^D2#/M&@3S3H$PWZ1(
^T:!/-.@3#?I$@S[1H$\TZ!
-^D2#
M/M&@3S3H$PWZ1(





MK[55?EU6?FV57Y?



#FDI=JYWE\8'/)2V7CU
G*QG
#57G


7FDI?*QB


MU=F:+R#9P@M?OZDVMMO:=I6-[7:VW5?V86WCK$Y-J.?:V*UL;\QFDV1EM._E
ML*
AW\ZA(V6;P[&7+T]0(U^QO^*`P`^CJ8W?1SAC-_B*3;7Q*P%G['YI8[MS


8O5)2_5=ORHQ8K#
M8[D/V-9FJ_8!FQU6RWW`MC5;]3Y@VYFM&@L_[+'B
%#:^(&/U24OU7;\T

MPV.Y#]C69JOV`9L=5LM]P+8U6[4/V'9FJ\;RT






7BK


MG1FOJKW`9F?&JVJDV.S



V7BK;4[


MQ8K.I
MI


LW5.3O`IW3T:OP:


M;!^P?@M'^URK;R2^\A%UZ?RBOHCEUR?RBNNCUQP?2JOMSYRN?6I',%K1OZ
MM+S!\J:TO


'RI+0\Q?*L
M'/531OVL'/531OVL'/531OVL'/531OVL'



$%``&

3(N

X$H7O%]AW

MF;??HL@263QJQT[/7$PZGXI%\:A8+-*.;G_]8_LR^'V]/VQVKW?#\=5H.%B_

M(`^OA[OA\_'X=G-]?5@]K[?+P]7N;?U*5YYV^^WR2+_NOUP?WO;KY6/;:/MR








6Z
-CRJ!P:!6)$0;
%-BAB4
5`QJ&)0

M:SEV2\*G#Z0`4@)10H@-1`-I`F)&*BIL''9O#(%T?%YL_KZL*-PH'6E1X4


M*`@5FTZ/WW9OK1[GBV

^F\=-L

RGJ+TE'LK;E@X).+)^DKL4T]G2126BMN$

SZ(DG4Q&$ME]I,]L9RV(8^,E2FP.R?*IE#.


ID9YJM;$:=3N*ZL6&#GJ`R!7$H
MI



M!)ZU]#Q-IE$B:?@&6\\RYDQ9C%)=ND2XXCI4SB'QD&=1&LK'G957SJ+4'\V5

\M$ZU$F
49A


MM1F.^:/SP%6MH1@61?

ME9^A#!:)F`!4T&X^DJ%$I!!5B&I$&E$CD!RSJ03#
7_H%
3LN*
T^BQ-[Y'
M\B4#SY36

+ENG.B@=:


;-?9Y`KD=6Y^U)F4EZR$O.^4DL8\6F
LHC3
@N5TQFZL`E0@
M*A$I1!6B&I%&U`@DQDQ'U7+

BL24&

M&`[3KT/!:')$!:(2D4)4(:H1:42-0'+
?67Y1V+5;O!`5AF4103T38K]U8^
M)KJ&C$JT4H@J1#4BC:@12.ICZLP+8L*5I:$,%HF8`%28UR7DQ*10E0AJA%I


M2
1$&I\LY%EGY6

MSV4UY@1K3(?F$!4(H1*405HAJ11M0()



J$)6(%*(*48U((VH$DF/^BVK

HQH$U8@*A$I1!6B&I%&9-[(

Z-[:%Y[$

MWQ5J8X_[X_$DI+7]1`FND-;TG;(^;Z2U_205VI#6])VCGC;FIONX8\^3IWW
M]DU=]S[EA#2VGP[!/9'&]$1WE




MP39^;
_8

MOA0;^WO1VI^W/_^T?JV;I_94%)T%%B[MQCYUW77E.&U^*JJLG=37X@)O#G53





MY=(V^V&8K\J\J=OZT$W`G

=-3DOG:4#EK;K?0D

.Q64QPV]H.[2KW0=K9K

O!'8^V+
M0_9\[OZL7W\MRN.I@W0'P`B)K?;?XZ+-(:)@9N(%:FOS^``_&M5)98&13[
MQIZOY;X[;6QO/O$6@1N$(&\]%FV7EFC3MO+GMJNK?[B4*VQQ*YZP`D]AQ0\G

=2'0@



MZA\+OP_2[US
:(9ZSA'P7`EV

M'BE]7U-



M.)(I[(Z:^SYL'V^XBUK:EB$@FHZ0EDR$)QU4'!91+RKK@4'
-P-'9]5RO@
M5.J
I`
;I
+G#1Z\G9*PTA=0;ZQ/?1



F/`1$TZ'50P2%



MH\30?2
+M-XYVD[CF'%`<B(:5`L0DE)I02B+J)'5QQ$U?-!TZM
M,,@8_G-(B[P^+@E%0JE7E,E(3F\P<8O<D5.B=](\\O


M[

M7
4_L).;AN_@BIX-D#KN@:$Q?\'=



`4$L#!!0`!@`(````
&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;*R:

MX:!I\^


AL?\O(XE`K+^C


M

;R1KG/B_%B#$IWM[L2/!!A

MZ4X@&#QFHZ

MA=*VVL

M0@YVU6#XQ


M-(G3Y1(1UETXT(FU))Y1$(P$C(2

M
C0DD`$S.S?6-GOC3!P`2,A(Q$C,2,)(RDCF4E(4&_)$&YG'UA37V7Q
P^
M(P$C(2

A(
MQ$C
2
)(RDAF$A(4:%](4YG7UA3WR4QL\](P$C(2,1(S$C2
I(9A+BJ&B0






A6C\['\Y4Y^.3M2H[2)(0B=SNE*B;]QMQ_-V
M0WE6(Y]YE95&H;)R==U'B/3J$'.M!*VT5HI(:V6(.BT:]'QF;$XLXB9\U
V
MB
1GA6@1V@\U3F^EBU`B5R]VH;*Z)5A`.[4[LNI#$BLY:85LJU
AS8:=$P


M=I_L]%8Z?A*Y-WWMA
K*A6^
7%@M5X1:9H4Q^02UM'R*Z*)\1N1IT8DVU(ZA

Q
M0V0L9CC0*#5$6BO!@7IA3!%IK0P'\L4
EA`:BP]\%N:6SPJ9/C


MB'2Z(D1FZIE\@E9:*T6DM3)$9U(OFEE[&74FL(I^X+QJ@O5%UI##;BK0&K#Z






M_P```/__`P!02P


M[:K4_?/[YF+A.D+BKL`-ZTCJ/A'A7FZ^?ED?&+\7-2'2`89.I&XM9;_R?9'7
MI




LW=;M-9L?[ZE305-WI3!G_#&;HO&@9
MGQI+`V#6*Y(C`
5S=


$%``&``@````A`/=Z1D(^!P``+B(``!@`




MZ

PC$G[
!QC9!_&.V




#X


MK$?V
0&

.&FRWPD#
MD+F9`D;\POA[2:5#3GD]
N:F-=#B=J/%0#$Q)ZK




M:0?&S+2:/LX
-!@S(S*8

M1-CI4TUB0.:X\RA@]


'T-02



H'\&&W+*@=8'9'_.^O2
M,P;0EDHX@$Q=HCB,8G)+0.QW,:#\Y7KXW!J3^D\KQ'Y3M/B@9DN(REXB)
M

SJ*8WG?1I/=CLQ(

NXKX?$H@P$+L@)^6_%
2RX-2)B-_0
MPC[Q[MQ:)R7N&^CY@#-%SLF
3F3RNA]QTA^7V-HQS*E%$WWOC)(&U-M#PCBA


H<G5YX'($A+#<?D8S+D)LYTRF1TPZ,&9&!X`:CGD'`IV..9P\X2QB
M)&UA`/:AZ8P!-@8G_-`8X/6



M6=N.VS80?2_0?S#T;END;M9BO4&D(&V`%BB*7IZUMKP68EN&I
TF?]\AAQ8Y
M(WDM]V43:PZ'AS/#

M\F9M5YRVQ:$^E6OO1]EZ'YY^_NGQK6Z^MONR[&;@X=2NO7W7G1^6RW:S+X]%

\5'O=M6F_%1O
M7H_EJ4

MO)SJIG@^P+J_B[#87'SK'P/WQVK3U&V]ZQ;@;HE$AVM.E^D2/#T];BM8@0K[


J@;F;
^%JD'Q
M`)XO*T

A!K:$Q5!$?D&H

M2/9^=4@SQ(2Z!%2

M]QX(


DI9N'+7+'QIS825:E9

[018;P:#


!B;U;369N*'9;)15:EL4Y:6D

@[BJWJ4%YW2;T8:OV*%5)F
#BO57$3+71@





M9%V]@/*SEE


M3!W#9XQ^:L
PFRX8C0.=Z0O`5W:;E&<W9L[LR`D!U\.$I9\'(
M`,44-O.4&Q/T:9TP&!%V?A;.#`@Y1D$RH(A.<$]$B:T\2E`IL--Q)A)$W2:;
M,N'B'B#(!#&0*3_E$$`2[NK*46F_!

3Z8VT@X1E

M8K]&[ZYV$(RT@\%1S(`P:D*RK.?$'/K7MBYK!Q/#-M(6$EO8)JNNZHO(YW69


8(LA(M.]\1]'V
[@
M?D[_=P_WL25<S/@+`._JNKO\4-=7_0WOTW\```#__P,`4$L#!!0`!@`(````
M(0U;?VO=0
```@





IGWS_A;)MJJ#<4U$PA;Q


M%BIT-JFTI:\`QVRG$WSOXH7`4R:^MD!)6K4(AI4$)N7YJX?.)I.V])5@U#TI

EP
]S:Q($DQ..J/@^D3VQX)7SX4V[_%K;'P-_,ZH.'\U*F]S0AQ,_:OA
M=\;!U8JJ@QT2/2S,3!X_NUJ1WKOT<I-3L:6?:)9)*^([W*E\V$H::[/OK:N.
MZMHGBS4$`?WL-&]@#RO)EGXG8LL*:64T`4QW=`^-(?0FIQ\4+R%TV,:X@@VL
M^IOQDUA
W&QSQ/.5?V`!
T.O_H'``#__P
`4$L#!!0`!@`(````(0#W2^^/

V$(7O


M6/N?HO*_;G[]9?4NR]?J($3M086B6ON'NCXN@Z!*#B*/JXD\B@+^LI-E'M?P
ML=P'U;$4\98&Y5G`I]-YD





02#@][H9UJ!OTMO*W;Q*:O_


M;7U8^^%\

O]/)3&:E*I%4WN*ZWBS*N6[!^L-

M32SNV_IJ!BHGHK9W?44_(XB#8&W`U:5MO=8V23#[3M*BG9;677A4;N\N)I-Z



U27%'01-U/Z%]<9B!B@$_:O^#0+MI
MJ`*043;C`STNYVB;3

-L14R.+'@H'0_8X[


M3*!*!K.9XW#`1S&!L@T_KO

M%QX?-Q8.^J%AND03TAXWYC@BA*.`0-F&F`L(H04(X?#ZT#!#PH(#YC@BA*-P


2&R
M

MN9@069APBQ\%@.XW$ZID/F^.(P)^S[J=91M^'$Q(;(P81C9-,I0L`!.TX(





M8?

3```I80``&0```'AL+W=O




MB9GF@.+



M^?_PD:$Q/L+5O0'`3HN%0R`!E50PDL);20:!7`*%!-82*5026`C@5H


M8%=A-MQ8H3%][(62R204FN^%]CFCD(5E@I9*2132*Z00B%KA90*J12R44BM
MD$8AK4(Z'PG\1@MLX+?A%#+2O7MP46\L0KX`,E=(JI%0I8*62DD4TBND$(A
M:X64JD4LE%(K9!&(:U.A\)+CQM3X(+;Q?\#V8'_?K]_NZ7FQT%-ZU$!QPR




#Z4='
M3^2?80G]:I&I[[5+N9MS6LD^25.+Q%2E]RM:/!9JR=DHA;^W@LUL:EX[[:


<2AH)I`,AFC#G,#\&IATG\MM!
M08(G$U%UYE#T4MQ!
4
+0'Z2)Q
QJR6D_)*B+N%*6\R@R!9S0('%Z2AT6@&I
M08MK;;&$(ENL`(46Q:9G`ZE!B[6VV$1+;:`0HLB[CM(';,8A@]QJ?)O+W%
M28N%.0/+:+)04$B2J5POH

6:TBQQ0;T;+$%%%H4



5
A52P]9B.5MZEA\VAZ''D0&Q<%!Y)RY]P#

6:^X&4H

MKK$E^L(

4P1DPG[ATQXAIW?HQ82%0CL8F8FYOWLAI9*#A+
M.2A

M(#5HL=86&RBRQ190:%$L#AVDCED



MS%7(/![%(N0VH&'F&A`S-YJY#9FGDU@M&.Z:]LRA5ZD^O


1BK)U(VH&'F&A`S-YJY#9DGD[$H
QUH=
J:C?L[4K87

A/;JSD4.2)3!]$'CG


G&GFW$&..9I=

M@6?_T@


F


MV!O68W;]S`E+@;T+V$.OT_9D
$E/ZY]2LU.YVD)!698KSAQZ7(52!YDA[[LE

MBM1!_M



MXH&7FKD*F:/12.RF-Z!AYAH0

'6@.I+EIITB7OWT3)W9=&-_%

MFE`'KF

MN10'TR6DCB69??@`4CR(#-#@(')(7=I;3.H.(;[G$K(&Q+9*0(.V*DB%$Q9K

MT!Q2?B&SBOXVR4G1-@F*2T#


S==`;?0Y(



^(BTBP4
M[FS4HP3F1\A&D3



/9`T=HH<M*F#@KRW4M0=
8^9346T+D'B)[SB
MS31O[B#:E/4_=XCEXQ^%9EX#XA&7FKD*F:-9(G\FN`$/#[H&Q-2-IFY#ZGAR
M)1_&Z

G7SR-!D8

M@3-UNP
L3+P&Q





V!\#+G7'7E_LYM1GJCM[J*%@HB
+D2'?\Y%#DF



M6AGHM=?TOR38TANG1^9EBU]WNU?\@X9TL?^?''S^KP````#__P
`4$L#!!0`

;\_:^O4GG.N'5M)5&-;+DN9
MS/S[;1#=`AHO1[:\N1E-'C2:Y

[/




MQ_//TU6_N#Z__/1A$.C_-NN?.^__SW;?MS^+E\U]NWE:D]ITG\P=^++=_F9
MJWN#J/
E]

S_G'*R4PD`\S^G









ME-'

^5(.N9-G^:56GK5D)LD%R6(7



MKH.=F5H
1J+()*4G2
0YK!]%%@51%)Q!



MLVANT\


+@)E!I-X8
4
I&.7K`QH@^1.!/$







[^VD4W-O.68G[7KE7]X.RGN/WXVTI



+^*@ZR\1L^-N'%GW`IRGKO`



MLX&*=NN&\E*Y%9FS
FX6P:9)SLTJVMF)B\E2G#B_E2`[BJZC8
:KT7'CNLC9

=Z6#J^HCG6A3.+7*P'0SAA`Q7K7%RYN


M*]+;XE!-
Q:YR3VLQFG9



MVX/;L]:#(ZQMPWOPIN*`]C'#XH!1
#@.1.V4H.#V

F\47+


1].WUE2]?NX0

M\SM`@Q]=B3

M!
PJ9!Y$48[@Q6I8V#DKD3]%E'*$16(2D05HAI1@ZA%U'J%=):FX+5U_IX


;

G

J

M*A#JQQ1@:A$5&J$36(6D0=HEXAK;4I@_Q\ZW@.$-NJR2]7&7F!F2!*$66(

M*:(

48ZH0%0BJA#5B!I$+:(.4:^0TF\Q
M5EN]8W]U\*-K*T8DK#^O!E\G2)S5(58198AR1`6B$E&%J$;4(&H1=8AZA;36


96N6(D0EH@I1C:A!U+J$/4*::U/JZT66%LQ\I1)$*6(
D0YH@)1
MB:A5-J$+6(.D2]0EJ_L=KJ/;&*M=6:RN=KX;/6)V5B]5#1T$96N6(D0E
MH@I1C:A!U+J$/4*::U/JZT66%LQ4K%JK3R4HE6&*$=4(H158AJ1`VB%E&'

VH97KV`ECFU#%OI84M




J0]]6VVLA?K0=ZO&6DAK^M;06`MI3=]Q&6LA


M_1@W43[&S=PPQDFG









_



A\9A?SA8F+N/U
2Z!A/X
@]):
MIVXLY+

5))]8893R*!L)TX1L*L7W0QN=&P8+:F9
^P


MNR[


`








4I&NA:DM)6;(TLC

$^1TB^`L
54C#1'*-4<XQ(<^E<L\D)
M6Y'RHA7N'%BCPQJ[Z1I-RM`?JE&IE);=97^ROET\&BB/G7^@/U:B:931?
MQF10$



79EQ
MZL7-Q*;M<_M4=3^5*,[YA)*


4PL8*MG7VE
H8:
MG?C:6V
G5GMK[


M6']EE1P\&AG[2H;33IRZ`24'C4H*[EV@:K%*%Z@\MX=IL:)E
%&;V4]:L4K%


M4`5;6Y&.36B!E&+R'J$/4*Z3[[G-8N%


YEH3C%)-(*H0U8@:1TBAZA#UND^VQ3


M]WDRR3SU].@3$+.-







3

(<3

M(*N[8WBJ5@E$#%
M*%68(+5
7)N
JQ&K5-







MU*ACJ\1Q)XAT-^;-Q:5-M:+[:)5F(EICIR7S!2;SC)2VBDLS=J44C
-=
5+K

M7P5\T2`%HPPJ1HD






M=7^R]S0PD_8T+%.C\G%Q\_&-(:8QF6CJG=?1%*=(376MNKJAEQMBEZOKFWIJ

M7BQSMR`QTK.N4U=H-.@I3[IR
8XYO4?\V_V7U3_O7[^L7[9G3ZO/--$OAPSH




9$K[NZV/]65`3<AGEB
_!
MZ0L+3?8
06



#&?JVGBWF2^L-LBH7



M[!)$4D028=$&3KL$S\C!Y@,+#$P^&:*JWG8UQXW&+LJ1JT[8/ZU$`D11
M9(=(C$B2#HDBDVP)2HV?9XA++IS0PYBPPF,79(M(@$B(2(1(CM$8D021-(A
M408ZU0;*]\L1.X':4Y&_;A


#YE
233M96*LG$C$



8HPVF$48Y1@Q&XPV*OR


KBK-GVL*M


MC^(V%'VOU/\0\;Z$?
&`@-5`R`=II:K:ML^9$`:(C)S.S^^[W^N'9LTRFS

M!./^ZOAY@=STAT%_KHJF;NM]-P0ZFW74'//4GMK`M)SO*A@!D=UJROUB\.C
M







M#61K(%D?488^UH;.%N(AV1F[8U4\KVJ88%B8;DCBP8++EF%HBKD)X@.A`R
MP`
=ZL37R

H(OZW
M]%)LD8&::J2!IIEMP9I)DA[P_%&PAR*=,3&'].AJOB(:1XT3
*3I('&HZ%

M%+/]F_U]&Y)G`

M`K2?:QF%#4

MLR$GAQ2'^MIFLL:&TD(AAQ2'


MT1O1&];U)WKI&/$(5SHLQFY*IR88]6ZV5






2YX;6RLG
ERVT@2AN\3
M





M(E



APL*

[X1HO[^37HI[_5QT_]?A&Y;.1
MN4M1;E&??J31ZL=]*9W^=/.#1IB-M7E`FXQK468+,YP8V8H&50UJ&M0U:&C0
MU*E05N#C@9=#7H:]#48:##48*3!6(.)!E
-9AK
-5AHL-1@%0
WE91KE;



M!AH
-1AI


-9G
MY/)Y]\$_6)M\EQE(!4@52`U('4@#2!-(T@;2`=(%T@/2!](`
@0R`C(&
@
M$R!3(#

W?ZX#AC9&BHHD2


MYD`60)9`5G'BY!&EC)-'R5V
L0[2A1_R0T@H-YB4@52`5('4@-2!-(`T@;2`
MM(%T@'2!](#T@0R`#(&
@(R!3(!

-]A/R12]$'D%]IR2WI,#)BG1&0,9`)DF0


19T2D9&++V*2SLI26OJQ)2\J)\S(FY&

G

M:DLB\MVW4;Z#\MUS\KF6GGT1#ZA0'V,.,(P_

MT]O911'G&'&!$9?G(ZI9[^IW$=WF87:$H7G0BW[*
;
(YSG$Y2MRL[6GFXI%

;7I2NJ

!.LSDF`#1HG!AFP5EDMG\8@O


WTREPOUTBL
]Z(

M';4:;5:34:BU6(D6FW4ZK5:'49B5:/D6CU46O`5J(U91:(T:B-4:M5N)
MUI21:


:.TK[JC$2KP8ZBU60D6BUV%*TV(]'JL*-H
M=1F)5H\=1:O/2+0&[A:0T:B-6)'T1HS$JT).XK6E)%HS=A1M.:,1&O!CJ*U
M91:*W8
M-R4
=OD'T@98ZY2QB)W/@HKM




;*WZH:'K&*Q!ICK`E;)99KZL;*E%3O
M/F
5B37'6`NV2HRUM%9T_
QLSV;R&?7`5BP3!'
;!C4R;!@?7[09&=4:+)*V


M1*?WC&ZK1KB*-.5G*?ZK*98L6/+HIA\VZ)8Y]P1Q[B\ZJ:Z8L7R/93OH_Q`
M'./R:DHV%N6'Z'\&.4GXI@@/Q4KEI^A_!SE%VPE3WO)*+['$'^.3KJ:KV1`


MX]3-%.


M\G*\VNR_FU\UH`.M]Y\B;']R(9OV/Y
2-55UA2:X]&L
P0\JP!7S.PU!@=05
M^@&'ST$7HO@#.9RS?\B2T+G8.9^^=87W]#GO?Z8E`5YXR/OT]9HSO.#3MRV0
MTS+2-XM$O$(K0-^L[_`*+=Y\LS3#*[3N\LVJJ_0DLDWR*\0B.U;P9CO$)#
VI0T<_Q#A7\'!]0L<_Q

M









#F=C%+]XPL;54ZYO'9V^SBO4O&K4
MF[=WY[%3N]*K





C!



QSL
C!



C!


$H!^







MTA;2$=(5TA/2%S(0
A0R$C(6
A$R%3(3

*:MM*:+LL@Z*R$K(5LA&R%[(3LA1R$'(6<`@DU32QDB\M*VT^


N4^EA&03ID4B/)692D@KI:1D$
MZ9E(SR5F49)8.NNDRS((TBN17DO,IB2Q=-8@VS((TCN1WDO,H205TL<R-*G
M6#KQI&V6?0]/%C*I)P.)/2FD4Y*H
M?YW;8




M1RV;W+61L%4ZK./(SOQ0_JZCF_KY_*O6NJ\WLV[5@Q#GY7T@:@^HS4+5;[(1
M8(BHYCF[_
\CZ#*K
1SFD$U9@!=W657:'FD&%PG,@B^@0N&E(V^?N^O6
M;2M;;:P@1.TU$+4WU*YHGRVB0CWJV:7809=9[8&8U0$BK

MA5
;%]O3L8TO;

C?'N=?%@2^'/9.RL9R9J
PH).XZ2

@


0N=;/7B*!DEZUDKMFWG\YR0/:OC*!DE
:X<53=.%M&H7%VS!%HK_('1+%


M?4_N\([2`2N;R+3M&7



MIS8M=N!CFSZR;`\;]HD=':7C:'97;A?/S!=VY!2EXRB9D(8H7[;7&K5:/@KT

0F




_*KV1CGIFA






K2+C6R+BE!'45=13U%?T4#14-%(T5C11-%4T4S17-%T5+1
M2M%:T4;15M%.T5[10=%1T4F1^4LNI/E+67K!4W\51QMRC[?YAZD\8[Y:J&2V
MXA+P;9M


MEQIHNJ&B42*5MDVQU1FWS2/CD^^


-@R[



HA


M:*1HK&BB:*IHIFBN:*%HJ6BE:*UHHVBK:*=HK^B@Z*CHI
@^_2:8PBXW+N1#




MF#2EX\813D1RH_5OD)$T;R^0?K3!D%^9G*SU5^P821?%[Z):



MR*]4?JWR&R:
Y//2;QD%^5TBG_JIV/FINI$]Z8/7B@?4LOT'16U'T?7H.&HF

M\G.57S!A))^7?LDHR*]4?JWR&R:

M!R='R796
]N5;2

':$:U_?Y#LD


MY.].Z$=`[!!QEDX=DV\9/^(8W0]N.$J&HGI^/

H5*[C*!F*@E;Q'`7=)Q^_


M

M!XZ:MM-6:NGG63`*A1BI_%CE)XZBTD\=59=^IO)SE5\XJB[]DE$H_4KEURJ_
-GCM6U&H2TZCI(1+VCQ


`27C7?X\7)M1:)8.$!_?ZCJRTXKSY*IY
M?Y\_!]Q#*G;@/A`[\`#(9B+1D)@=*@P1Y8^A75_=9X?@(T0PMS$0<YL`L293
M1UZ3W

M46L$1*VQ:DT01:TI$+5F0-2:J]84=1:`E%K!42MM6IM$$6M+1U=D!GK?1Z
M/[9;_Z2SGZ9NU@.E8TRV\&HSBF.

MRKXY1)2/
?;YI]GN&`*8V1B(F4V`6)&I(PPQM7S


M:*5HK6BC:*MHIVBOZ*#HJ.BDR/PEU];\I2R]X*F_[(:8^L?_9YVPRU4LA5D
M0%R]M^W)P*(I./$'B


@/`H$4[;
MR&YLE6WTQ#M$(9
M





1V@CI(R)?4NHZXSNPY2=_@
M;&4+L3ZCT*\&BH:*1HK&BB:*IHIFBN:*%HJ6BE:*UHHVBK:*=HKVB@Z*CHI.


M*%1QHVBK:*=HK^B@Z*CHI


3C!D%



*\@N57VK4
MBBB2SQMGS2C(;U1^JU$[HD@^;YP]HR!_4/FC1IV(*N0?'A@&_8?720:IT[_3
MEN-MV%^

MHR`_4?FI1LV(8OELMW'.*
T+H)IM11U'B5V#5F3JGB;L*QJHUA!1G'6.@%BNL:*)
M:DT11:T9D)68T_M:MO\^9Q1:8J'R2T11?@7$HJX5;51KBRAJ[8HM5=T4*TC
MHJAU`JJLMAG1+R2S-



MY



W6/0-0]`5'7C)NX0E[C


N'%CI

MQ))
%0)Z;


\L\12(NC
@ZLZ!

)#).'H
P*B\!@H







S&

MT4315-%



MWFQ[5(0Z1%&=\J=
NXQG7J.HH=P^AHU((KD\Z=,AXR_$CEQQHU(:J0GS(*



6NV@RZSV0,SJ`!%6XP@4=&_RO?035,[J8GS(Z#J+<5[/=\!LK_0


11


M
BMH47X-1/F-H^J6V#(*+;&#%N7W0)0_.(I:X@C$EC@AX5DK'5V+PP4=79^Y
M%+\O5+*%DJ-TP






*P1;WYW)EI.+))G.DH&2[K
MV8VM?5]&H=X=1\G
-$0E



PB*IZ,E8U<?ERVKAY!E6'^`L]5OH0;E1$<
M6L8E8X:3DK%&TY(%=?L^S/A+0*ZOLUO/K(QG7O.2
:]%R9C7$LQ;SZ9)C;ML

U-:!Y`
K0
$%F5H':#
=J&0^TZG&;9[(0-<9<_S/@:8?98
M\

M869=869=869=838XS.KC.KC-?MM=8.9$B3
GC,GCM=8`\/EV!L#GC[
M(;-YMWBHKV;O5C!;7K(CX?B@.+G&99C/W3/W3/W3/W3/W3/W3/W
M3/W3/W3/W3/W3/W3/W3/W3/W3/W3/W3/W3/W3/W3/W3/W


&E#Z9E0KV\@TWY9A2&J^%6:^%6:^%6:^%6:^%6:^
M%6:^%6:^%6:^#2QZ1\I\&Q@W)
RV95(V72/??38GEV%H`7.R
'.R
'.R
'.R
M
'.R
'.RL


SRDH597N+
\B6KR

MW:!



M8?U`XHI^4




*IC^,%RJJ4ES43BGJ=4\`;SR-
M/[1/U1(+5?RG3FBEEMB,:D/=;'24W)TBF=BLF=.13&FS_[0.31X]()FZ634\
M2:Z:UY10S+1%E\R[/7R/-T)%
W$1@T/-.
50#8X&H^.T2HU@8J,F
M`()Q`1

ZU!%MW1.*5T?=

MO*
.YQUU..^HH^


M&*+MI9%!#

X1AG..





9;-ZN-*;




6XA

C%D6I8%
M4X^Y.2PK*@G$%@+T@'?*A4.#;.L`!1E]5H+WT'A(K$PA$T.F0]6KR;`P2(WC




!@*ADP+8/(J1D&
XDL
M
W[33

'

4TJF3BE+D)5$]D-FTJ$:

MYU(B5R!7$EFK2W)=Q6DML2;BO);0FWE8QS2IQ3B9R!G$GD?(A*RK6RDMS9


&)C#
GSEPBY%1)8#
M?H6!TMQL@+;9L*K9`FRDLALP(7D0$UP2Y51&:



+IICTQ5D=`:B5CSWC<H*:@-0^JE'U2
M!`JN(L34GH0J8
:

M965T
S

4@@OLKV*2
D)/%16UMG=Z\)EFTJ
M!KF`Q
F_WQY--S/=38C)R4V('W6_(_7TS/0











MAX[P23=X
XBB;F_0O]QB'QWADQPO/QD


M*0]O*S.?!2.C1L/$=OUIX/QHW

5F0RT21()4@JD$F02Y!(4$,PGF$BPD6'J`!1.&0OF

E$D42159*I(IDBN2*'(3)&Y(@M%
MECYA(80ASD+XB^/=R
4`1WE#7B1@6-K!(N\,^H.![P'XI/1*4\5211)%9DJ
MDBF2*U(H,E-DKLAD:5/6+QA

X'LP
)CER
C
MPN-H27B:0&
+W

M+(10'%\10F/-0VA)!*O-Z3&CMJSJT


M

M2
8IYX2L
FR]Q612



M$

$2*L5OV!AB4M+ZO$
M'<20/BJ++&)99!'U=3L0,BG)^%FDE#.T\I1S1)2?G4@4+053YEEDE(_1+]6

MTVBNT4*C)4





B[KU@16?4$)6

`ISP@YY3DAI[P@9)7[O8YX
M]49GEIS

?5H\Z1HI=I^9R0
M_=XI'/1%!5.@@:<\T\ISDG'M+PC]2'F)!K`]@!OD'?-[=K503\A"!&,%0I*
MC(B-#NL(E3-9)6@%'V8M[_7;8JE,T8`-#)1Q)4I&C3GEGL'^OBPT-(STG'2

MTD]:X._-;&(]GY*52XT



R)S&0?.(*
M'!#`E7HB$5?@-8N'.ET%'\/K%W7M(WD(0F=:&$/3YUI^Z(+^62&XHWH:DPU$

F@]LAZ(_C5G^:3_@A^0Z=YUA_!C^(T
M'\




MLKY]EG7PQ+41JLE(-)F2@#=
Y:(I

M'Y1^-!7G-@&QF2DLK9-P]PBDMJ)JKE#;PIE);4PJ
N0]-J3G.W2-9A/)TN






M'3%W'@/7#O.&$&T4P:UZY41C,J8K9RYPM]F;AK93#&4P]`2V[K)17`2X

M^LK8U&)(BRG&T;LQXJHAOZ^`H9Z3V7DGRZ'DY1P1/%3RE;$3G*:]`^\^PA78
MOLR/JX;\OC)T


`4$L#!!0`

HG&A\WN
M.-0
B]
E'/7#PVY;I?7VY5`=SYKD5.TW9WC^YFGWW!#;87L)W6%S^O+R_-NV




MPW)/849J8HO[[VG5;$%1H!GY4\6TK??P`/#_P6&G0@
4V7R['OHP\.[^_'0]

=&&6+HY;VZN3O7K`/8M
MK'KSO%%9P%LH
@HNK6\7;F]%&X298KE5--=#F#\$4@-;Y.M-/`^OQE\AK+=H

AX;V0@B@GE!;G&B@D_FKD3

%&T4
MP(=E%+E&26?4Q8A`5@+)!+(62Z00BEC3@Z0;)V=.HO4A0BRKJ5@R:QU`C



MD4;0B%:[ZD_9;U!1CQ6:!$4=3RYIX8=1SQ52R)IZ5VQ5+-H+U#W]^)GNX=
MH:#3Q)8$N7'$$E%BK

KEB1S3E8F1@N,$CA%,?

]$-N`!+GAQ79/8JR





MR-&.*^WHQ)6&L(Z&L2RC.)@=90@9YAP'LY@+A)`Y\B.62$IZP)YDIQI@*979

MYD1CF`ND#GB:U(ZS.YN56TN5\[[J3*!C;.M(D(0!EVZG[+9)UYG1%--0(1


4&
EI14CYD1ODD]!
MD#LBZZU*M%(EHG=$5UK5IMO2?E`NL*NW)47(:?AF[!(R43]DL[
'0DZT:BO8

&2=G@6B]K1ODQ!*[A




M*$4($A
)O+(=$`9.=IU7-#GY&BXH(

3(3NV-(_B`7A*)[8_[$5RH@4)F[JI17



3A
+50YR7Y#9R&%D7O-_!RWVU;5?G
X:6_/J:E


`


6-*RQ

MU[HIB_]X4)M11^(@7P2R60PG@Y=&^9\E&2$)/))$!W8]()QL
GQMMBX3?&


M`[X.!#JPTX%0!R(=B7``EDZ;:#6OT(;1L.TH:PV!`BQ'$T(BJ`AG@[X.A#H
MP$X'0AV(="6`$4(5Q/B^D8F+[!HV+*2%QQGK:XP9A1)\K60#P#\0TD
)=
M@80&$AE(+-*ZK#S?X4'&`UL
1!8;)#Y4!.%![GPT04YCK:+MEU0YPT#\0TD
M


)CKF0L:A4XXK2=

=-U)-B*Z(ZRR'DB$/
)TALNH`&SCM1=@1)[J&!@BLB2'#%-+#E
M4F5@79ZY&^\=1S9O#N'FIJPV!

[;E6M9AB6G)5





36
MA#R$E-+S@8[@BA*+KU!'U*4F#$B2'#%!%TI/6OXY)S;'UU#\-@=WV.C*;9
7+R'5(X)A-2[15O)UNZB*4/(<4^/

M
K;=F79+!31


M3PWW)@MXIF/BX60!CV5



'];TRVWP_5%RD

L#@:KGW4%

M'2#Q1_C
F@BHE5ZB+B:[O98.'KW!


TGTT%'YC&N$Q
M(GVRG*[+4/O1F/CO'7QFJ3\:RK\Q#?D0V'JWXMAGRTGYZU6V_!N3W6:?[W7K
MO4)FR5][]\#
1!BA
9[NUUX/@

H$
^:!=J[A^8Z
V5

7;_`0``__\#`%!+`P04``8````
M`$`)&6W



M5]N.FS`0?:_4?T\;PCDMHE5MFNMJW42E75R[

MT-A_I])_6'S\



ONZ*;@@JPQXOX5#DARP]8

G7


MQ&6`T[11\+H)QT#W?$'@*1O?2`EQUP,^MU,IK;)\Y90V;9D)Z3$
+8IA+A

-;O$P



M#+.AFS4XIV)#/]$LDU[=[A]1[#8UM+ZRVIL]*6#V=+\\40U&]@8R_)AGXG
M8L
Y<-U!0``51,``!D```!X;]W


)EDI
MD:)H=_/
X+:-!F@+F-O?IXKNAKYXO1XE+\-P7%74J5/=U;#^_%97U@MINY(V
M&]N=S6V+-`4]E

M$*'I-O:Y[R^QXW3%F=1Y-Z

M-HL0M_?$H
.2L'
M(FW7AQ(88-FMEAPW]H


M.^0-5^[H!C-O&;IAA(G?\(RX)URYIW\S5X=5;!`@S?M\NV[IJP5=#37I+CFN

M%!C#ICJPUX%
`AQ@--*3O@?:&$4I42V@E@XNFI+!-A(5Q2'=CK08!@=H

)#60O8%D
J)D#`M`SAB;*8+-X(/-

\J-KDYFMN
X[G<U6IC(==86T43HN/<$)CE1-'8)N8D@OU-AF-1DX,\=B`P*UH
MSQ%&`(X'6O[\9]_('X\HQOXZPX'2G\OB:4<A+\CN2B_Y4NVNV(
E19'H&H2
MK4#-*1F-1EH
\19C!^X9XB\&7;S%

T'K*[T
M.[GB/%4
MCAQ1I=/R2T:CD2-#_&G3WG-D-7`
3([L=\_4SH6]ZY9X@N45\6!\_6&*HU

MQX'CM&A2#LGK2$#1H(;KNUK79L+@BAPX*4^/^'!QBJ,$5&]'8X4I8O&U_?







MT?$CQL.PBVKX#C]NX.ZJXUX

9SE

V`5PIL[?+XB

$%``&``@````A`$9:UOH-!0``


M4LI2C_O^TLNB)'?)PJ:XQX8\G9)8/
KXEHF\(B.%2*



QG25S(4IZJ






DSZMDP
MPM8%!4XR)HR1&B_[
-AZ$@1JV2#L[).
6*D`\(^B&`^0*U;!!K*Q
D8X((
M6AFC(
CNU@#RQ20(U#)!!-H^58-$3`SS80SK/H9@G)F:ED`MH`T8N+;MPI5N

3
B/9!F

U?N:ZZCW:RD3B*8*$XA%
M1A.I)8(QZMAP#E36M#S`




KV=-J5
D8W
UJ



M?J*?I*R:!V2R]@9P_Q\```#__P
`4$L#!!0`!@`(````(0`$JJGFU!4``.YN

M^Q'1.)(
21

0P22A(VK+??K*Z*I%5^8--8+PWAOPAZ\_J

73^??7U]_7%]<





MOQB93^?4GJK


0D

ML:;Y.
@--?)OG
UT'YPED!60-9`8R`9(`B0%D@')@11`2B`5D!I(`Z0%TODD


M9
*(6**R8ZJR8V^TSPX@:R`QD`V0!$@*)`.2`RF`E$`J(#60!D@+I/-)$3:
M!@=!&LX.8QW&PA(_.XL@*R!Q$`V0!(@*9`




M-&


M8V4^G*




Z5%5-MXL;


FXH6CDCT2JXH:P_2D:B57%#T:H9B5;##46K

0[\J6$2K%QG^!S:\SBJ8


M+8_A&&M4\:(,5=CQ**@CD181UQ#28*5V5635E!''#)'PG]\CF;JTF+7AHE
6<D2@7J%R&RI/16`VYBF5$N68DR@TJMZ'R
M;#K6$P;+]
IA5GVIT35F*NH6A1F_D+U8&E6#KS+:)!R%:.ROJ;A_5B9IC
M8G[?SWD03MA*A%-&\U[X:J)7^QD;B'+ND%=-K82Y9*15::!J#=F%5N(=(W2
M#5N)=
O(2H^GWV:T+%%+QW&U9PR^AO3=RJZ.Y24!?X-99N)6)MDTLU9I?.

$J
M66#KEB
M
)E/53&H6$:4:T:BW*!R&RI/IQ.EW+'
@92EB?^4T!ISE;(6J9152]VEB99.


9_(E#GG+JD%..%I?Z:#-C'9'.&8ET

MB$I$%:(:48.H1=0Y1!]QTF6'X=)G-GVX_LY'3Q
\UG'(#YTU\D-GR3O/SSDE




M?'VELZ(7XVU


MH*




:P8YO#''S[O#!M[5A0


MX/.#I;

M=I

1*MCU&L%


%J;5:Q_.`%UVPEG6A8?K`3



4$4TMWDI2Y4#&5B*?HWS!
M5B)?,K+9-8WTW_I7;#*-2HW;7*+:.WE#LV.)WYASQA+QUAY.R0[DQ?R1)


@=2ETX-3HFL


K/+5`KX3A@U$.4?E

J:L[@34M:8




.Y
TB3949
MAX+E&_VY7#@;+;FA+(-6#KUS^.NL^!&3:`*?/;*TK(TVC

MERAE+(WK);/



D





`4$L#!!0`

VP






@.1`B`ED`K(',@R!+(
ML@:R`;(UB16:M#-T$J-OWE_43)TBZ($;+G!U$8]NHL=C(:7[CWF8'3H2X!X
M0'P@4R`!D!!(!0&D@!)@61`9D!R(`60$D@%9`YD`60)9`5D#60#9&L2*X]H
$!_(%$@`)`02`8F!)$!2(!F0
M&9`<2`&D!%(!F0-9`%D60%9`]D`V9K$2@2:H5J)\#=[#R5C9TA-G-ZC9X]J

9`$2`HD`S(#D@
I@)1`*B!S(`L@2R`K(&L@
M&R!;DUA)0TM=5M*T]Q[*VLZ-FIB]!Y`)$`^(#V0*)``2`HF`Q$`2(F0#,@,
M2`ZD`%(J8#
@2R`+(&L@*R!;(!L36(E@EJXMC+A;\YF]CIVCFCD=!]IP,1
MJT,/@LA#Y.:(@H0A8@B1#&B!%&**$


M:(8H1U0@*A%5B.:(%HB6B%:(UH@VB+86LG-$+;J9.:+ZG#Y-CX[D2KU61RLF

V(S

M1%0AFB-:(%HB6B%:(]H@VEK(OOK4!-C
D;\[/JDGTE;R'.;69D([C_C&ZK&U
MFT^`/+3R$4T1!8A1!&B&%&*$64(9HARA$5B$I$%:(YH@6B):(5HC6B#:*M

?J108WG0!Y:.4CFB(*$(6((D0QH@11

W4KG0Z3=TDG



M:-C?O^O6I]?*W:4Z;4&#=0YTHI&9#;7
X.I@Y&LC`TU1*@I$/TB1#%*)25



^%8Y6PE010LWQI$
MR5:M050L_[

MTS+LN-

=#RM(#)

D:B-6
D6CEJ
M%6PE6B4CT:H8[;7LUE+KF&9KN6/)TR82]6JH=8W5Z


I`[775#/C(N4GY.LM2H7IQQI^UCU?^0


IXT
MRK.*E3KP[*
M\'2LC63&












M6:HE8NC&:HSNRG$BD

Q$*!]K9

A5BQ
STEW
.Y*5N&C7
M!S36R&C7B49.5CK7OB=6'+JOD965=8V&?.QIEQW]8+Q8KE(Y2/-3+D$W$T


;:RFCNB49#&LH9ZQA.+^&)



W4OWI=NQ-I#%VHDFQDOG'B)?(^.5

Y6LK%]&
#@*Z^/FSC?;X$:TR;:W1R,CNIQIFV,FK,L<9



G#TK&N=?4R'P-




M0YXM6_TL/LI!JMCMU=43QI_CE0*LYU62-G'.XTUY@=I4N9:$2?$/&8P&-$


5E)CPO)28\K(K'%X

M%


*.K4&DS4$X-X&
M5J#F&$0.3NV!E%H*_KV1UU7PVX/KBO=JC)D


MH3!$62
S2B;[*)U;Q41+V%%*5VI'J1:]W.?BZJ'+D2CU6IDL@=P
:F1&R60?
MI7
OF1SLS1:729$=)8V!(





MZ6`THN0Q^K.AN[8@5CP/G#R$/F(IH@1&B%&
*$&4(LH0S1#EB`I$):(*
MT1S1`M$2T0K1&M$&T=9=CZIZ8-YCV^_+UW5LPWSC4R-K#ZGMC+0!*T\1#ZB
M*:(`48@H0A0C2AEB#)$


%97L
M;X50,J22_:7HE@QZ=`[VG9!;TJ$CK3\!@A**H/[Z%4HH@GKK1RBA.@G$1N.

M]J96_[4_^I6N-ZSXIC_:[F=&3E/0RL5(K4N@!RUAC=3R!);0])].5E
#TM2=
M3E934V[Z60UE=4F4Y64PE-=RFVIA+Z%FRDOO3V.B-O-&&7J[#DALZGIO&
MXZ%ETY%:*D.?96H%3



[I8W4U@180ANFC=1V:$TEUU32=$'35D4405.^TW8Q
M5-*4![1E!Y4T752T/P*5-


M:-\^*FDZ![3IVDAMJ=;@0^=`;7[55-*EDJ;CH?U@J*0I:MH3?J1V?6]0HQ*U
M:SN6T


M2P


E^+#9=7
%W!S*IN-ES!
M:_-BUZM5D0N_SK]M1*7LF_'XSA:O2E1+L?RP/02T^HCW.W5IT&6=M_KD(GO;







0_00

-(-(W3L.N05ND4D90M4##'+,2(SM/.
MJ%JHV9[]?;]N#ON@G?^9!E_AH-+N\*I34U(LUOU6@;N
5T6][4]',?HGXC:&,./T?&_6+\+#%M[//?I78E+45W&IDR/G,<749
M5_6S%

O8V]R92YX;6P@
MH@0!**```0``````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````

0';B1O6@



M[CE;BF


M]EKA4VN\SR:@'@7^33P!V.#]\\_9%P```/__`P!02P$+0`4``8`````$`
MDN*SE4````D)0``$P``````````````````````6T-O;G1E;G1?5'EP97-=
M+GAM;%!+`0(M`!0`!@`(````(0U53`C]0```$P```+````````````````



M%``&``@````A`$



M970T.YX;6Q02P$+0`4``8`````$`HOS&=VH)``!H+P``&0``````````





M965T


&UL4$L!

KJ
((


M`/MBI6V4!@``IQL``!
`````````````````*9T``'AL+W1H96UE+W1H96UE
M
2YX;6Q02P$+0`4``8`````$`\[10/$
``!(=```#0``````````````

M`!0`!@`(````(0`#I92)_P
``'



M=#8P+GAM;%!+`0(M`!0`!@`(````(0#_+-_!)0T``%)#```9````````````

M`!0`!@`(````(0`T7U4^TPD``#LR```9`````````````````*,`0!X;]W

``#I1@``&0````````````````#'




-W]`\``
9.```9````````````````





YX;6Q0
M2P$+0`4``8`````$`IJYM$/T``!!```&``````````````````P;`(`









CDN

M2


M``@````A`/6)7%

M:&5E='







M-BYX;6Q02P$+0`4``8`````$`$;+HB
$```+$0``&0``````````````
M```L.@



M``8`````$`1EK6^@T%``!&%```&0`````````````````F2`





 'defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestSold'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockholdersEquityReverseStockSplit'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CommonStockSharesAuthorized'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SharesIssuedPricePerShare'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CommonStockParOrStatedValuePerShare'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PaymentsOfStockIssuanceCosts'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ExercisePricePerWarrant'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ProceedsFromIssuanceOfWarrants'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_WarrantsOfferingExpenses'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ProceedsAllocatedToEquity'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DerivativeLiabilitiesNoncurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ContributionToNutraSa'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_TitleOfIndividualAxis=ribt_UnderwriterMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ExercisePricePerWarrant'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ProceedsFromIssuanceOfWarrants'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_WarrantsOfferingExpenses'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DebtInstrumentAxis=ribt_SubordinatedNotes2013AndSubordinatedConvertibleNotesMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DebtInstrumentFaceAmount'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ProposedReducedInterestRateOnDebtInstrument'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DebtInstrumentMaturityDate'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ThresholdAmountToRemoveConversionFeature'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_SharesExchangedToPurchaseSharesOfCommonStock'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_WarrantsIssuedToNoteHoldersForAntidilutionProtection'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DebtInstrumentAxis=us-gaap_ConvertibleDebtMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ExercisePricePerWarrant'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ProceedsFromIssuanceOfWarrants'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_WarrantsOfferingExpenses'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DebtInstrumentFaceAmount'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_PercentageOfCommonStockUnderlyingWarrants'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ProceedsAllocatedToEquity'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DerivativeLiabilitiesNoncurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_WarrantsFinancingExpenses'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ContributionToNutraSa'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DebtDisclosureAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ScheduleOfDebtTableTextBlock'
<div style=font-family: 'Times New Roman'
 Times

 Times
<table align=center border=0 cellpadding=0 cellspacing=0 style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock'
<div style=font-family: 'Times New Roman'
 Times

 Times

 Times
<table align=center border=0 cellpadding=0 cellspacing=0 style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_LeasesOperatingAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_LeasesRemainingTerm'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OperatingLeasesRentExpenseNet'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_GainContingenciesByNatureAxis=us-gaap_PositiveOutcomeOfLitigationMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_GainContingenciesLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_GainContingencyUnrecordedAmount'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_LitigationCaseAxis=ribt_SellersMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_LossContingenciesLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OtherAccruedLiabilitiesCurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_LitigationSettlementAmount'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OtherRestrictedAssetsCurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_AmountOfEscrowLiabilityInAccruedExpenses'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_BusinessPreacquisitionContingencyAmount'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_EscrowBalanceAvailableToSettleRemainingContingencies'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_LitigationCaseAxis=ribt_DiabcoLifeSciencesLlcMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_LossContingenciesLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_LossContingencyEstimateOfPossibleLoss'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_LossContingencyDamagesSoughtValue'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_LossContingenciesLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_LossContingencyEstimateOfPossibleLoss'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AccountingPoliciesAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ConsolidationPolicyTextBlock'
<div style=font-family: 'Times New Roman'
 Times

 Times

 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock'
<div style=font-family: 'Times New Roman'
 Times

 Times

 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock'
<div style=font-family: 'Times New Roman'
 Times

 Times

 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_TradeAndOtherAccountsReceivablePolicy'
<div style=font-family: 'Times New Roman'
 Times

 Times

 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_InventoryPolicyTextBlock'
<div style=font-family: 'Times New Roman'
 Times

 Times

 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_LongLivedAssetsGoodwillAndIntangibleAssetsPolicyPolicyTextBlock'
<div style=font-family: 'Times New Roman'
 Times

 Times

 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_RevenueRecognitionPolicyTextBlock'
<div style=font-family: 'Times New Roman'
 Times

 Times

 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock'
<div style=font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times

 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_DerivativeConversionLiabilitiesPolicyTextBlock'
<div style=font-family: 'Times New Roman'
 Times

 Times

 Times
We had certain convertible debt outstanding that contained antidilution clauses.&#160; Under these clauses, we were required to lower the conversion price on the convertible debt based on certain issuances of our common stock, awards of options to employees, additional issuance of warrants and/or other convertible instruments below certain conversion prices.&#160; <font style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_StockholdersEquityNoteWarrantLiabilityPolicyPolicyTextBlock'
<div style=font-family: 'Times New Roman'
 Times

 Times

 Times
<font style=font-size: 10pt; font-family: 'Times New Roman'
 Times
We have certain warrant agreements in effect that contain antidilution clauses.&#160; Under these clauses, we may be required to lower the exercise price on these warrants and issue additional warrants based on future issuances of our common stock and awards of options to employees, additional issuance of warrants and/or other convertible instruments below certain exercise prices.&#160; <font style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansDirectorPolicy'
<div style=font-family: 'Times New Roman'
 Times

 Times

 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times

 Times
If the fair value of the equity instruments issued is used, it is measured using the stock price and other measurement assumptions as of the earlier of (i) the date at which a commitment for performance by the counterparty to earn the equity instruments is reached or (ii) the date at which the counterparty's performance is complete.&#160; The expense associated with stock awards issued to consultants or other third parties are recognized over the term of service.&#160; In the event services are terminated early or we require no specific future performance, the entire amount is expensed.&#160; <font style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncomeTaxPolicyTextBlock'
<div style=font-family: 'Times New Roman'
 Times

 Times

 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_UseOfEstimates'
<div style=font-family: 'Times New Roman'
 Times

 Times

 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription'
<div style=font-family: 'Times New Roman'
 Times

 Times

 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock'
<div style=font-family: 'Times New Roman'
 Times

 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ConcentrationRiskLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_dei_EntityNumberOfEmployees'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AccountsReceivableNetCurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StatementBusinessSegmentsAxis=country_BR'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ConcentrationRiskLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_dei_EntityNumberOfEmployees'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AccountsReceivableNetCurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_MajorCustomersAxis=ribt_Customer1Member'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ConcentrationRiskLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ConcentrationRiskPercentage1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_MajorCustomersAxis=ribt_Customer1Member'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ConcentrationRiskLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ConcentrationRiskPercentage1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_MajorCustomersAxis=ribt_Customer1Member'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ConcentrationRiskLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ConcentrationRiskPercentage1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_MajorCustomersAxis=ribt_Customer1Member'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ConcentrationRiskLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ConcentrationRiskPercentage1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_MajorCustomersAxis=ribt_Customer2Member'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ConcentrationRiskLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ConcentrationRiskPercentage1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_MajorCustomersAxis=ribt_Customer2Member'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ConcentrationRiskLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ConcentrationRiskPercentage1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_MajorCustomersAxis=ribt_Customer2Member'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ConcentrationRiskLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ConcentrationRiskPercentage1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_MajorCustomersAxis=ribt_Customer2Member'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ConcentrationRiskLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ConcentrationRiskPercentage1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_MajorCustomersAxis=ribt_Customer3Member'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ConcentrationRiskLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ConcentrationRiskPercentage1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_MajorCustomersAxis=ribt_Customer3Member'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ConcentrationRiskLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ConcentrationRiskPercentage1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_MajorCustomersAxis=ribt_Customer3Member'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ConcentrationRiskLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ConcentrationRiskPercentage1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_MajorCustomersAxis=ribt_Customer3Member'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ConcentrationRiskLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ConcentrationRiskPercentage1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_MajorCustomersAxis=ribt_FourthCustomerMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ConcentrationRiskLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ConcentrationRiskPercentage1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_MajorCustomersAxis=ribt_FourthCustomerMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ConcentrationRiskLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ConcentrationRiskPercentage1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_MajorCustomersAxis=ribt_FourthCustomerMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ConcentrationRiskLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ConcentrationRiskPercentage1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_MajorCustomersAxis=ribt_FourthCustomerMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ConcentrationRiskLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ConcentrationRiskPercentage1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_MajorCustomersAxis=ribt_FifthCustomerMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ConcentrationRiskLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ConcentrationRiskPercentage1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_MajorCustomersAxis=ribt_FifthCustomerMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ConcentrationRiskLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ConcentrationRiskPercentage1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ReorganizationsAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_NumberOfReportableSegments'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_NumberOfLocationsInCalifornia'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_NumberOfLocationsInLouisiana'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_NumberOfLocationsInLakeCharlesLouisiana'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueServicesNetMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ConcentrationRiskLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ConcentrationRiskPercentage1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=ribt_DrbProductsMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ConcentrationRiskLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ConcentrationRiskPercentage1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=ribt_RboProductsMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ConcentrationRiskLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ConcentrationRiskPercentage1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsImpactOfAntiDilutionClauses'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsImpactOfAmendment'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOtherThanOptionsExercisableWeightedAverageRemainingContractualTerm'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ClassOfWarrantOrRightAxis=ribt_EquityWarrantMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsImpactOfAntiDilutionClauses'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsImpactOfAmendment'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOtherThanOptionsExercisableWeightedAverageRemainingContractualTerm'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ClassOfWarrantOrRightAxis=ribt_LiabilityWarrantMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsImpactOfAntiDilutionClauses'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsImpactOfAmendment'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOtherThanOptionsExercisableWeightedAverageRemainingContractualTerm'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityChangeInUnrealizedGainLossOnInvestmentsStillHeld'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityChangeInUnrealizedGainLossOnInvestmentsStillHeld'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DebtInstrumentFaceAmount'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_AnnualRateOfInterestAccumulationUntilJanuary2015ConvertiblePromissoryNote'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_AnnualRateOfInterestAccumulationFromFebruary2015ToJanuary2016ConvertiblePromissoryNote'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_AnnualRateOfInterestAccumulationAfterJanuary2016ConvertiblePromissoryNote'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DebtInstrumentFairValue'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_FairValueOfCommonStockIssued'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_NotesPayable'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ConversionFeatureOfNote'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DebtInstrumentMaturityDate'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_MaximumAccumulatedInterestOnOutstandingNotes'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ConversionOfStockSharesConverted1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_InterestExpense'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_IncreaseInValueOfCommonStockUnderlyingNotes'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_TotalIncreaseInNumberOfSharesAuthorized'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ProceedsAllocatedToEquity'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AccountingPoliciesAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SignificantAccountingPoliciesTextBlock'
<div style=font-family: 'Times New Roman'
 Times

 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times

 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times

 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times

 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times

 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times

 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times

 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times

 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times

 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times

 Times
We had certain convertible debt outstanding that contained antidilution clauses.&#160; Under these clauses, we were required to lower the conversion price on the convertible debt based on certain issuances of our common stock, awards of options to employees, additional issuance of warrants and/or other convertible instruments below certain conversion prices.&#160; <font style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times

 Times
<font style=font-size: 10pt; font-family: 'Times New Roman'
 Times
We have certain warrant agreements in effect that contain antidilution clauses.&#160; Under these clauses, we may be required to lower the exercise price on these warrants and issue additional warrants based on future issuances of our common stock and awards of options to employees, additional issuance of warrants and/or other convertible instruments below certain exercise prices.&#160; <font style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times

 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times

 Times
If the fair value of the equity instruments issued is used, it is measured using the stock price and other measurement assumptions as of the earlier of (i) the date at which a commitment for performance by the counterparty to earn the equity instruments is reached or (ii) the date at which the counterparty's performance is complete.&#160; The expense associated with stock awards issued to consultants or other third parties are recognized over the term of service.&#160; In the event services are terminated early or we require no specific future performance, the entire amount is expensed.&#160; <font style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times

 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times

 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times

 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times

M;VL-D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y
M/2(M+2TM/5].97AT4&%R=%]B.60V-&0T,E\V-#9F7S0S83)?8C8U9%\X,S(V
M9#8X-S5A8S0B#0H-E1H:7
@9&]C=6UE;G0@:7
@82!3:6YG;&4@1FEL92!7



E\V-#9F7S0S83)?8C8U9%\X
M







T0B5V]R:W-H965T
&-E;%=O<FMS:&5E=#X-B`@



T0B5V]R:W-H965T
&-E;%=O<FMS:&5E=#X-B`@


T0B5V]R:W-H


T0B5V]R


T0B





24Y'7TE.


M14Y44D%424].7T]&7T-2141)5%]225-+/]X.DYA;64^#0H@(`@/'@Z5V]R




30N
M:'1M;(O/@T*(`@/]X.D5X8V5L5V]R:W-H965T/@T*(`@/'@Z17AC96Q7


O4VAE970Q

#I.86UE/@T*(`@(#QX.E=O<FMS:&5E=%-O=7)C92!(



O4VAE





M3D-/345?5$%815







M+U-H965T
C0N:'1M;(O/@T*(`@/]X.D5X8V5L5V]R:W-H965T/@T*(`@





M/E)%1$5%34%3$5?3D].0T].5%)/3$Q)3D=?24Y413$\+W@Z3F%M93X-B`@

M
C@N:'1M;(O/@T*(`@/]X.D5X8V5L5V]R:W-H965T/@T*(`@/'@Z17AC





M4T5$7T-/35!%3E-!


&-E


M

#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1)7;W)K<VAE971S+U-H965T
S8N
M:'1M;(O/@T*(`@/]X.D5X8V5L5V]R:W-H965T/@T*(`@/'@Z17AC96Q7


M;64^4U5-34%265]/1E]324=.249)0T%.5%]!0T-/54Y4




M968]



O4VAE970T




M3TY#14Y44D%424].7T]&7T-2141)5%]225-+7T0\+W@Z3F%M93X-B`@(`\

T0B5V]R:W-H


O4VAE970T-YH=&UL(B\^#0H@(`\+W@Z17AC96Q7



M($A2968]

O




M(`@/'@Z3F%M93Y%455)5%E?04Y$7U-(05)%0D%3141?0T]-4$5.4T$U/]X

MB`@(#QX.D5X8V5L5V]R:W-H965T/@T*(`@(#QX.DYA;64^15%525197T%.

&-E;%=O<FMS:&5E
#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1)7


#I.86UE/@T*(`@(#QX.E=O<FMS:&5E=%-O=7)C

O4VAE970U-YH=&UL(B\^#0H@(`\+W@Z
#I.86UE
M/@T*(`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E='
O



M

051%1%]005)465]44D%.4T%#

M968]


M968]



M:&5E='


&-E;%=O<FMB;V]K/@T*/]X;6P^



#$N:'1M










3XQ
M
B!-;VYT:'





2P@

#$U/&)R/CPO=&@^#0H@


]




]

]
M
T1P;!V86QI9VX],T1T;W`^16YT:71Y($-E;G1R86P@26YD97@@2V5Y/]T






]
T1T97AT/DYO/'-P





]

]


]


]





#0\








]

M86QI9VX]


]
T1R;SX-


]
T1T97AT/CQS

]
T1P;!V86QI9VX],T1T;W`^
M1&]C=6UE;G0@4&5R:6]D($5N9!$871E/]T9#X-B`@(`@(`@/'1D(&-L
M87-S/3-$=&5X=#Y$96
@




;V-A=&EO;CH@9FEL93HO+R]#.B]B
M.60V-&0T
E\V-#9F7S0S83)?8C8U9%\X
S(V9#8X-S5A8S0O5V]R:W-H965T


M(&AT='`M97%U:78]

]





2P@
M

#$S/&)R/CPO=&@^#0H@(`@(`\+W1R/@T*(`@(`@/'1R(&-L87-S


M

]
T1P;!V86QI9VX],T1T
M;W`^4F5S=')I8W1E9!C87-H/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$






]


]
T1N=6UP/C(L-#





]
T1N=6UP/C4X-3QS

]

\



T1T;W`^5&]T

]
T1N
M=6UP/C$T+#`W






]
M

]
T1N=6UP/C0L
M
3







]
T1N=6UP/C4S








]
T1N=6UP/C(L

BPV


M960@97AP96YS97

]


]




34L
3

3@L.38Q/'-P86X^

;VYG

]



T1T;W`^
M1&5R:79A=&EV92!W87)R86YT(&QI86)I;&ET:65S/]T9#X-B`@(`@(`@



]

SDV/'-P86X^



M=&%L(&QI86)I;&ET:65S/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$;G5M





]

]






]

M(#(P+#`P



T1T;W`^0V]M;6]N('-T
M;V-K+!N;R!P87(@=F%L=64L(#(U+#`P,PP

M960L(#DL
S@S+#4W
2!A;F0@
BPX
S(L


M-C$L

M1&YU;7`^
C(W+#4Q

]
T1P
M;!V86QI9VX],T1T;W`^06-C=6UU;&%T960@9&5F:6-I=#PO=&0^#0H@(`@

C0R+#0W



T1T;W`^06-C=6UU






]
T1N=6UP/C4L
M.#

]


V$R7V(V-61?.#

T#0I#
M;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T
Z+V(Y9#8T9#0R7S8T-F9?-#-A
M
E]B-C5D7S@S




]
M


S$L(#(P
30\8G(^/]T:#X-B`@(`@(`@/'1H
M(&-L87-S/3-$=&@^1&5C+B`S
2P@
C`Q

]
M

]



T1T;W`^06-C;W5N
M='


T1T;W`^




]
M
T1N=6UP/C(P+#`P

#`L




]

]
T1N=6UP/C(U
M+#`P




M.2PS.#


BPX
S(L







]
T1T97AT

]


]


T1T;W`^06-C;W5N='



]

RPW



]






M8FEL:71I97


]



]
T1N=6UP/B0@-BPR
#


E\V-#9F
M7S0S83)?8C8U9%\X



M87-C:6DB#0H-CQH=&UL/@T*(`\:&5A9#X-

T1T

M(%1H:7



T0Q(')O
M=W-P86X]

@;V8@


3(@

S$L(#(P
30\8G(^/]T:#X-
MB`@(`@(`@/'1H(&-L87-S/3-$=&@^1&5C+B`S
2P@
C`Q


]

]



T1T;W`^4F5V96YU
M97












]



]
T1N=6UP/C$T+#
U


M9VX]

]





]

\+W1D/@T*(`@(`@

]



@9G)O;2!O

BPW




]
T1R

3$U

M



]
T1N=6T^*#0L



T1T;W`^0VAA;F=E(&EN


]




]
T1N

M/3-$;G5M/B@R+#@Y



]
T1N=6T^*#0T

]
M

3(\

M

]



]

#DI/'-P

]



]
T1N=6UP/C$L-#
Y/'-P

]

]
T1N=6T^*#(V+#8R






]
T1R;W4^#0H@(`@(`@(#QT


C$I



M0G)A;B!496-H;F]L;V=I97




]


M


]
T1P

M/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$;G5M/B0@*#
N.38I/'-P86X^


]








]
T1N
M=6UP/C$L

#4N:'1M











CXQ
B!-;VYT:'


2P@
C`Q

M
#$S/&)R/CPO=&@^#0H@(`@(`\+W1R/@T*(`@(`@/'1R(&-L87-S/3-$



]


M/'1D(&-L87-S/3-$;G5M/B0@*#$W+#8T


]


]
T1N=6T^*#$L
M



]
T1N=6T^*#$Y+#`P




]
M
T1N=6UP/C0L






C
L.34P



#8N:'1M;`T*


M:G


M9#TS1$E$
$54









2P@
M
C`Q

3`L
SDV



]




]

N(#











]


]













]





]
T1N=6UP/C(P-#QS

]

I


\+W1D


]



]











]

M+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$;G5M/B@V.38I/'-P


]
T1N=6T^*#$U+#`R
M


M;3XH
34L


]



]
T1N=6UP/C`\









]
T1N=6UP/C(R-RPU
3



]
T1N=6UP/C4L.#
V


I(&%T($1E8RX@
S$L(#(P
3
\+W1D/@T*

]


]
T1N=6UP/C(L.#
R+#`Q-#QS

]








]



















]


3`L





]


]

]
M




T1T;W`^


]
T1N



M


M;7`^


M9VX]




]


]


]


]



#QS

]



]



]








]
T1R8SX-B`@(`@


]







E\V-#9F7S0S83)?
M8C8U9%\X

T0G=&5X


T0Q(')O=W-P86X]
M



CXQ
B!-;VYT:'
@16YD960\+W1H/@T*(`@(`@

M+B`S
2P@

#$S/&)R/CPO=&@^#0H@(`@(`\+W1R/@T*(`@(`@/'1R




M-BPV





]
M
T1N=6UP/C


RPP







]



]



]

]




M;VX@;&EA8FEL:71I97


]




M+#`W


M9VX]




T1T;W`^1&5F97)R960@=&%X(&)E;F5F:70\

]
T1N=6T^*#$L
C0X*3QS

]

]



T1T;W`^

@86YD(&QI86)I




3


]

]
M


X

]
M
T1P;!V86QI9VX],T1T;W`^3W1H97(\+W1D/@T*(`@(`@(`\=&0@8VQA

]


]
M


]
T1N
M=6T^*#4L


]






]




]
T1N=6UP/C@R.3QS

]

]
M
T1N=6T^*#$L


]
T1N=6T^*#8L
3(U


M9VX]

M=&EV:71I97


]


]
T1N=6T^*#$X+#DW




]
T1N=6UP/C$U

M86QI9VX]
T1T;W`^4')O8V5E9'


\




]




T1T;W`^4')O8V5E9'
@


M


]
T1N=6T^*#4W






T1T;W`^3F5T

\+W1D/@T*

]


]

M=6EV86QE;G1S/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$;G5M/B@S-C
I


]
T1P;!V86QI9VX]
M,T1T;W`^3F5T(&-H86YG92!I;B!C87-H(&%N9!C87-H(&5Q=6EV86QE;G1S
M/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$;G5M/B@Q+#0X


3QS

]

]
T1N=6UP/C4L





]
T1N=6UP/C4L


]



BPV



]



]
T1N=6UP/B0@

#@N



^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C




S$L(#(P
M


($)5


T1T;W`^3$E154E$2519+!-04Y!1T5-14Y4(%!,04Y3($%.
M1!'14Y%4D%
($)54TE.15-3/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$

@3F5W(%)O
M;6%N)RP@5&EM97





3!P

X
C$W.W
@4&QA;G



@3F5W(%)O;6%N
M)RP@5&EM97




M97-S9G5L+B8C







@

#L@4VEG;FEF:6-A


N($AO=V5V97(L('1H97)E(&%R92!N





M.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97




Q-C`[(%5S:6YG(&]U



M+!A(&-O;7!L971E(')I8V4@8G)A;B!N=71R:71I;VYA;!P86-K86=E(&1E







3!P




@9W)A;G5L871I;VYS(&%L;VYG('=I=&@@4W1A9V4@










M97







M;&4]


M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97


@;V8@;W5R



@:&EG:!Q=6%L:71Y+!V86QU92UA9&1E9!C;VYS=&ET
M=65N=',@86YD(&9I;FES:&5D('!R;V1U8W1S+B8C,38P.R!/=F5R('1H92!P
M87-T(&1E8V%D92P@=V4@:&%V92!D979E;&]P960@86YD(&]P=&EM:7IE9!O



@9F]R('5S92!I


L(&-O871I;F=S






M

M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97



#DN)B





'!T.R!F;VYT



M:6YG(&]F(')I8V4@8G)A;B!I;G1O(&9I;FES:&5D('!R;V1U8W1S+B8C
38P
M.R!);B`R


@

@;V8@86YI;6%L(&YU


@3F5W(%)O;6%N
M)RP@5&EM97




M

@

M(S$V



M

M=71R:71I;VX@86YD(&EN9'5S=')I86P@87!P;&EC871I;VYS+B8C
38P.R!$
M4D(@:7





M(#




30@




#DN:'1M;`T*


M:G


M9#TS1$E$


3(@

S$L(#(P



]


]

M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97

6QE/3-$)V9O;G0M<VEZ93H@
3!P=#L@








M87)Y(&%R92!C;VYS;VQI9&%T960N)B
Q-C`[($%L;!S:6=N:69I8V%N=!I


M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97




M

@87)E('1R86YS;&%T960@870@:&ES=&]R


'!T.R!F;VYT

M






3L@06-C;W5N='


M;G1S+B8C

M92!A;&QO=V%N8V4@9F]R(&1O=6)T9G5L(&%C8V]U;G1S+B8C



N)B



M.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97












L($EN=&%N9VEB;&4@


38P.R!0

@87)E(&-A


@;VX@=&AE('-A;&4@





@3F5W(%)O;6%N)RP@5&EM97
L




N)B
Q-C`[($$@







M('1H=7

#L@268@=&AE(&-A



M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97






M92!D871A+B8C


@;V8@1&5C96UB97(@
S$L(#(P



M+!W:&EC:!I;F-L=61E(&EN=&%N9VEB;&4@87-S971S('-U8FIE8W0@=&\@

@


M97)A8FQE+B8C

@:7



M=6YA;6]R=&EZ960@8F%L86YC92!O9B!T:&4@87-S970N)B
Q-C`[($%N(&EM


M=&5D(&9A:7(@=F%L=64N)B



M('9A;'5E(&UE=&AO9'

M('EE87(N)B





'!T.R!F;VYT+69A;6EL





M='D@:7

38P.R!)9B!A;GD@;V8@=&AE


Q-C`[($-H86YG97







@
M8FEL;&5D('1O(&$@8W5S=&]M97(@:6X@82!S86QE('1R86YS86-T:6]N(')E








'1E<FYA






M97
@3F5W(%)O;6%N)RP@5&EM97



3$[
M(#PO9F]N=#Y792!H860@8V5R=&%I;B!C;VYV97)T:6)L92!D96)T(&]U='-T

M

M=F5R=&EB;&4@:6YS=')U;65N='








38P.R!4:&5S92!C;VYV97)S:6]N(&QI86)I;&ET




M9!S=&%T96UE;G1S(&]F(&]P97)A=&EO;G,@:6X@;W1H97(@:6YC;VUE(AE



@870@1&5C96UB97(@
S$L(#(P

'!T.R!F;VYT+69A


38P.SPO9&EV




M




@8F%S


M(&-L875S97
@87

38P.R!4:&5S







M






X
C$W.W
@:G5D

N)B
Q
M-C`[(%=E('=I;&P@=7-E(&%L=&5R;F%T:79E('9A;'5A=&EO;B!M;V1E;'
@


M;&4]






@:7

M='





@
M3F5W(%)O;6%N)RP@5&EM97


X

M;F-O;64@=&%X97










@3F5W(%)O;6%N)RP@5&EM
M97





M971T;&5D+B8C

M(S$V


@3F5W(%)O;6%N)RP@5&EM97
L('-E

T0G9F]N




@870@
M=&AE(&1A=&4@;V8@=&AE(&9I;F%N8VEA;!S=&%T96UE;G1S(&%N9!T:&4@


M93H@


M;W(@=&AE('!R:6]R('EE87(@=&\@86-H:65V92!C;VYS:7-T96YT('!R97-E







C`Q-P@=&AE($9I;F%N8VEA;!!






N
M)B
Q-C`[(%)E=F5N=64@9G)O;2!A(&-O;G1R86-T('1H870@8V]N=&%I;G
@

@=VEL;!B92!A;&QO
M8V%T960@=&\@96%C:!P97)F;W)M86YC92!O8FQI9V%T:6]N(&=E;F5R86QL


#L@5&AE(&=U:61A;F-E(&ES(&5F9F5C=&EV92!F;W(@;W5R(&%N

M=&AE('-T86YD87)D(&EN(#(P


@3F5W(%)O;6%N)RP@
M5&EM97

M;F-E+B8C


M86YA;'ES97


M:6UI;&%R(&5N=&ET:65S('=I;&P@8F4@82!6244@=6YL97-S('1H92!L:6UI


38P.R!!(')I9VAT('1O(&QI

@86MI;B!T;R!A(&MI8VLM;W5T(')I9VAT
M+B8C

@8F5E;B!E;&EM:6YA=&5D+B8C
38P







;V-A=&EO;CH@9FEL93HO+R]#.B]B.60V-&0T
E\V-#9F7S0S83)?8C8U
M9%\X

T1#;VYT96YT

]
T13:&]W+FIS/B\J


M;'-P86X]
T0Q(')O=W-P86X]




]

3U-3(%!%
3H@)U1I;65S($YE=R!2;VUA;B<L
M(%1I;65S+!S97)I9CL@9F]N=US:7IE.B`Q



RX@3$]34R!015(@4TA!4D4@*$50


@8GD@=&AE('=E:6=H=&5D(&%V97)A9V4@;G5M8F5R(&]F(&-O;6UO
M;B!S:&%R97


M='



M97

M;G0M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97





M;65T:&]D+B8C




@3F5W(%)O;6%N)RP@5&EM97
L('-E


M('1H92!%4%


M


M(&9O;G0M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97




M



@3F5W
M(%)O;6%N)RP@5&EM97



T0G=VED=&@Z(#$E.R!V



38P.SPO=&0^/'1D(&-O;'-P
M86X]
T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=V97)T:6-A;UA;&EG
M;CH@8F]T=&]M.R!B;W)D97(M8F]T=&]M.B`C
#`P




3
\+V1I=CX\+W1D/CQT




@3F5W(%)O;6%N)RP@5&EM
M97

M.R!T97AT+6EN9&5N=#H@+3EP=#LG/DY53452051/4B`H:6X@=&AO=7-A;F1S


T1N;W=R87`@

M86QI9VXZ(&)O='1O;3L@=&5X=UA;&EG;CH@;&5F=#LG/B8C,38P.SPO=&0^
M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=W:61T:#H@

M8V%L+6%L:6=N.B!B;W1T;VT[)SXF(S$V

T1B;W1T







@86YD(&1I;'5T960@+2!N970@;&]S



M

#`P
M

3!P



M(%1I;65S+!S97)I9CLG/B@R,RPP,CD\+V1I=CX\+W1D/CQT9!N;W=R87`]
M












M
34L






M/B8C

#L\+W1D/CQT



T0G=VED=&@Z(#$E.R!V97)T





M;F0M8V]L;W(Z(-F9F9F9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B


M9F9F9CLG/B8C

M8F]T=&]M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C






M(V-C965F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL

M



T0G=VED=&@Z



M


M86QI9VX]

T0G=VED=&@Z(#DE.R!V97)T:6-A;UA
M;&EG;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!R:6=H=#L@8F%C:V=R;W5N9UC






3!P=#L@9F]N=UF86UI;'DZ(=4:6UE


M)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N




T0G

M;&4]

V-#PO9&EV/CPO=&0^



M9CLG/B8C

#L\+W1D


M.B`Q



T0G=VED=&@Z(#$E.R!V97)T






M97

M861D:6YG+6)O='1O;3H@
G!X.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F

'0M86QI9VXZ(&QE9G0[(&)A8VMG

M




3!P=#L@9F]N=UF86UI;'DZ(=4

M:61T:#H@


M(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]

M;&4]

M.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@
M(S`P
#`P


M=&]M.R!B;W)D97(M8F]T=&]M.B`C
#`P



M8V5E9F8[)SXF(S$V






M


M86QI9VX]







M9VX]



M8F]R9&5R+6)O='1O;3H@(S`P
#`P


M=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P



M/C$L

M;CH@8F]T=&]M.R!P861D:6YG+6)O='1O;3H@-'!X.R!T97AT+6%L:6=N.B!L





38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O

M)SXF(S$V



T0G



M:61T:#H@



T0G=VED=&@Z(#DE.R!V97)T












M


M86QI9VX]



38P.SPO=&0^/'1D('9A





38P.SPO



M9VX]






M(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]

M;&4]

M


M)B









T0G



M9CLG/B8C



#L\



M9CL@=&5X=UA;&EG;CH@;&5F=#L@;6%R9VEN+6QE9G0Z(#EP=#L@=&5X=UI

T1B;W1T



M86QI9VXZ(&)O='1O;3L@=&5X=UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9UC

38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O

M.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97

C`Q+#4X-#PO


M)B


38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S

M(S$V




M87`]




M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97

M:6=N.B!L969T.R!M87)G:6XM;&5F=#H@
3AP=#L@=&5X=UI;F1E;G0Z(TY

M



M;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R


2PS.#`\+V1I

M

M(-F9F9F9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]

M;&4]





24[



T0G=VED=&@Z(#8V)3L@=F5R

'!T.R!F;VYT+69A;6EL




#L\+W1D/CQT





M







T0G=VED=&@Z(#$E.R!V








M86QI9VX]






T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T


M



Q




'!T

M=&EA;&QY(&1I;'5T:79E('-E8W5R:71I97

M96UB97(@
S$L(#(P
30@86YD(#(P
3

M('1H92!C86QC=6QA=&EO;B!O9B!D:6QU=&5D($504R!I;B`R

M=F4@=VAI8V@@=V5R92!A;G1I9&EL=71I=F4@:6X@


M;&4Z+R\O0SHO8CED-C1D-#)?-C0V9E\T
V$R7V(V-61?.#

T

O4VAE970Q
2YH=&UL#0I#;VYT96YT+51R86YS9F5R+45N


M87-C:6DB#0H-CQH=&UL/@T*(`\:&5A9#X-

T1T

M(%1H:7


]


M

S$L(#(P







M86QL(&]F('1H92!O=71S=&%N9&EN9R!S:&%R97
@;V8@2$X@9F]R(0R+C`@
M;6EL;&EO;B!I;B!C87-H(@D



N

#L@


M=FEN9RP@5&5X87




M/E1H92!A8W%U:7-I=&EO;B!H87
@8F5E;B!A8V-O=6YT960@9F]R(&%S(&$@

@8V]M8FEN871I;VXN)B
Q-C`[(%1H92!R97-U;'1S(&]F($A.
M)B
X
C$W.W










@:6X@=&AE(&-O;G-O;&ED871E



#L\+V1I=CX\=&%B;&4@86QI9VX]
T1C
M96YT97(@8F]R9&5R/3-$

4[)SX\
M='(^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=W:61T:#H@-C@E.R!V

M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97














T0G=VED=&@Z(#$E





T0G=VED=&@Z(#$E.R!V


38P.SPO


@3F5W(%)O;6%N)RP@5&EM
M97







M



T0G=VED=&@Z(#$E.R!V97)T:6-A


M965F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS

P
#`P
#`@
G!X('-O;&ED.R!T97AT+6%L:6=N.B!R:6=H=#L@



24[('9E



M




M=#L@;6%R9VEN+6QE9G0Z(#$V+C)P=#L@=&5X=UI;F1E;G0Z(TW+C)P=#LG


#L\+W1D

#`P
#`P(#)P


T0G


M)SXF(S$V

38P.SPO=&0^/'1D('9A;&EG

#L\



M(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!N;W=R87`]
T1N;W=R87`@=F%L

M9VXZ(&)O='1O;3L@=&5X=UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9UC;VQO


@3F5W
M(%)O;6%N)RP@5&EM97



2PP-S4\





M




M.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97





M;&EG;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O





Q






M


M86QI9VX]

T0G=VED=&@Z(#DE.R!V97)T:6-A;UA
M;&EG;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!R:6=H=#L@8F%C:V=R;W5N9UC


M9CLG/CDV

M8F]T=&]M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C



M969T.B`W+C)P=#L@=&5X=UI;F1E;G0Z(TW+C)P=#LG/DED96YT:69I960@



M;&EG;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O





Q




Q-C`[(&EN8V]M92!T

M/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R




M






M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=W:61T:#H@-C@E.R!V97)T
M:6-A;UA;&EG;CH@8F]T=&]M.R!P861D:6YG+6)O='1O;3H@
G!X.R!B86-K


T0G=VED


M=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P


M97(M8F]T=&]M.B`C
#`P


2PW

'!T.R!F;VYT+69A;6EL


T0G=VED





M:61T:#H@



T0G=VED=&@Z(#$E.R!V


38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S

P
#`P
#`@
G!X('-O;&ED.R!T97AT+6%L:6=N.B!R



M


T1B;W1T;VT@

T0G=VED=&@Z(#8X)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@

'!T.R!F;VYT+69A;6EL

M;CH@;&5F=#L@;6%R9VEN+6QE9G0Z(#$V+C)P=#L@=&5X=UI;F1E;G0Z(TW
M+C)P=#LG/D=O;V1W:6QL(T@55-!('-E9VUE;G0\+V1I=CX\+W1D/CQT9!V
M86QI9VX]



M;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P

@
M3F5W(%)O;6%N)RP@5&EM97


P
#`P
#`@-'!X(&1O=6)L



T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T



M;B!.;W1E(#$P+B8C





M;V0N)B
Q-C`[($EN(#(P
30L('=E(')E8V]G;FEZ960@)#$N-R!M:6QL:6]N
F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97
@3F5W
M(%)O;6%N)RP@5&EM97


BXQ(&UI;&QI

@9F]R(#(P
30N)B
Q-C`[($%F=&5R(&UA:VEN

C`Q
RP@
M87

M(#$L(#(P
3
N)B
Q-C`[($%F=&5R(&UA:VEN9R!A(')E87-O;F%B;&4@969F




;V-A=&EO;CH@9FEL93HO+R]#.B]B
M.60V-&0T
E\V-#9F7S0S83)?8C8U9%\X
S(V9#8X-S5A8S0O5V]R:W-H965T


M(&AT='`M97%U:78]

]


T0Q(')O=W-P86X]
T0R/CQS

12!.3TY#3TY44D]

]
M


T1T

24Y'($E.5$5215-4


T1T;W`^4D5$145-04)
12!.3TY#3TY44D]
3$E.
M1R!)3E1%4D535!)3B!.551202!303PO=&0^#0H@(`@(`@(#QT9!C;&%S

M97
@3F5W(%)O;6%N)RP@5&EM97





M

X

@


#L@3W5R('9A



M9&%T960@8F%L86YC92!S:&5E='


M;W)D97(]
T0P(&-E;&QP861D:6YG/3-$




T0G=VED=&@Z(#$E.R!V




@3F5W(%)O;6%N)RP@5&EM97
L



M9VXZ(&QE9G0[)SXF(S$V



#L\+W1D


3!P=#L@9F]N




#L\


M)B

P
#`P
#`@


C`Q

M8F]T=&]M.R!P861D:6YG+6)O='1O;3H@
G!X.R!T97AT+6%L:6=N.B!L969T





M










T0G=VED=&@Z(#$E.R!V97)T









3!P=#L@9F]N=UF86UI;'DZ(=4:6UE


T0G





!A;F0@)#$L.38W*3PO9&EV/CPO=&0^/'1D('9A;&EG;CTS
M1&)O='1O;2!S='EL93TS1=W:61T:#H@



T0G=VED=&@Z(#$E.R!V97)T





T1B;W1T






T0G=VED

M


#L\+W1D/CPO='(^




'0M86QI


M:61T:#H@



T0G=VED=&@Z(#$E.R!V97)T


38P.SPO=&0^
F4Z

@3F5W(%)O;6%N)RP@5&EM97
L







Q-C`[




T1N;W=R87`@=F%L:6=N/3-$


M9F9F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS


M=&]M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F



CPO9&EV/CPO=&0^/'1D






M/B8C

P
#`P
#`@
G!X('-O;&ED.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O

'0M





M(V-C965F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL

M(S$V

M
#`P






M8V5E9F8[)SXF(S$V






M(-F9F9F9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]

M;&4]



M='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P




M+6)O='1O;3H@-'!X.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O

#L@8F%C:V=R;W5N9UC;VQO<CH@(V9F9F9F
M9CLG/B8C

P
#`P


M;W)D97(M8F]T=&]M.B`C
#`P

@3F5W
M(%)O;6%N)RP@5&EM97

C@L-S0S/]D:78^/]T9#X\=&0@

M9F9F9F8[)SXF(S$V

38P.SPO=&0^/'1D

M(S$V



M8V]L;W(Z(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!N;W=R87`]
T1N;W=R


38P.SPO=&0^/'1D('9A;&EG;CTS1&)O

#L\+W1D/CQT



T1N;W=R87`@=F%L:6=N/3-$


M965F9CLG/B8C


@3F5W(%)O;6%N
M)RP@5&EM97



M)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N


6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N=UF86UI





T0G=VED=&@Z(#$E.R!V97)T









3!P=#L@9F]N=UF86UI;'DZ(=4:6UE


T0G






38P.SPO=&0^/'1D



'!T.R!F;VYT+69A;6EL





T0G=VED=&@Z



M


@3F5W(%)O;6%N
M)RP@5&EM97


M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=W:61T:#H@-38E.R!V97)T
M:6-A;UA;&EG;CH@8F]T=&]M.R!P861D:6YG+6)O='1O;3H@
G!X.R!B86-K




M=&]M.R!B;W)D97(M8F]T=&]M.B`C
#`P





M9CLG/C8L


#L\+W1D/CQT

G!X.R!B86-K9W)O

'0M


T0G=VED=&@Z(#DE

3!P

M9VX]









T0G=VED=&@Z(#$E



M)W=I9'1H.B`Y)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O
M='1O;3H@(S`P
#`P

T0G9F]N




M)B
#L@8F%C:V=R;W5N9UC;VQO<CH@(V-C965F9CLG/B8C
38P.SPO=&0^

P
#`P
#`@-'!X




M
#`P


@3F5W(%)O;6%N)RP@5&EM97
L

3DL-#


#L\



M=')A(%-!)B
X
C$W.W













M=&AO=7-A;F1S*3H\+V1I=CX\9&EV/B8C
38P.SPO9&EV/CQT86)L92!A;&EG

T0P(&-E;&QP861D:6YG/3-$

'!T.R!F;VYT+69A;6EL


T0G



@3F5W(%)O
M;6%N)RP@5&EM97


T0G=VED=&@Z(#$E.R!V97)T



38P.SPO=&0^/'1D(&-O;'-P86X]
M
T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=V97)T:6-A;UA;&EG;CH@
M8F]T=&]M.R!B;W)D97(M8F]T=&]M.B`C
#`P




3



M.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97




38P
6QE/3-$)V9O;G0M





Q

M(V-C965F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL


3!P=#L@9F]N=UF86UI;'DZ(=4:6UE


M:68[)SXY+#(V

M;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R






T0G=VED=&@Z(#$E.R!V97)T


38P.SPO=&0^
F4Z

@3F5W(%)O;6%N)RP@5&EM97
L



3!P

38P.SPO=&0^/'1D('9A;&EG;CTS1&)O

M9F8[)SXF(S$V





T0G=VED

@3F5W(%)O
M;6%N)RP@5&EM97


M5&EM97
@3F5W(%)O;6%N)RP@5&EM97



G(&EN=&5R97-T(&EN(&%C8W5M=6QA=&5D(&]T:&5R(&-O


M









M(V-C965F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL

M



M(%1I;65S+!S97)I9CLG/B@V-C8\+V1I=CX\+W1D/CQT9!N;W=R87`]
T1N



M

M



'!T

M


M/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R




M



C`P/]D:78^/]T9#X\

#L\+W1D

M


#L\+W1D

#`P
#`P(#)P


T0G





T0G=VED=&@Z(#$E.R!V97)T


M(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P

M(S$V

M
#`P




#L\+W1D/CPO

T0G


#L\

#`P
#`P

3!P=#L@


M:7IE.B`Q






T0G=VED=&@Z(#$E


M86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P

M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97


P
#`P
M

3!P

M9VX]




M(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]

M;&4]



M(V-C965F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL


M(S$V






M:#H@



T0G=VED=&@Z(#8V

'!T.R!F;VYT

G!T.R!T97AT+6EN9&5N





24[('9E


M





'!T.R!F;VYT+69A;6EL


T0G=VED=&@Z(#$E.R!V


38P.SPO


@3F5W(%)O;6%N)RP@5&EM
M97




M;2!S='EL93TS1=W:61T:#H@-C8E.R!V97)T:6-A;UA;&EG;CH@8F]T=&]M







M86QI9VX]


M(&9O;G0M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97



M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F









($Q
0R!A

3$

Q-C`[(%1H

F(S@R

X
C$W.W
@






@


@

#$T+B8C
38P.R!792!W:6QL(&-O;G1I;G5E('1O(&5V86QU871E






3!P=#L@9F]N=UF86UI;'DZ(=4:6UE



M96QD*2XF(S$V

M=7



@9&ES=')I8G5T86)L

M:6YC;'5D97









@;VX@36%R8V@@








M=&AE(&UA;F%G96UE;G0@8V]M;6ET=&5E+B8C
38P.R!4:&4@;6%N86=E;65N


M96UE;G0@8V]M;6ET=&5E(&%N9!T:&4@;6%N86=E;65N=!C;VUM:71T964@

@3F5W
M(%)O;6%N)RP@5&EM97

M07
@;V8@1&5C96UB97(@
S$L(#(P
30L('1H97)E(&AA=F4@8F5E;B!N;R!U
M;G=A:79E9!E=F5N=',@;V8@9&5F875L=XF(S$V
#L@179E;G1S(&]F(&1E
M9F%U;'0L(&%S(&1E9FEN960@:6X@=&AE($U)4$$@86YD('1H92!/8W1O8F5R
M(#(P
3




M979E;G1S+B8C



M:6-E0G)A;B!496-H;F]L;V=I97


M;&]N9R!R:6=H='


@*&$@)#4P(&UI




M:6=N.B!C96YT97([)SXF(S$V




X
C$W.R!R:6=H='
@86YD(&%B





@:6X@;W5R

@;V8@=&AE($Q
0R!A9W)E96UE;G0N

M97AT4&%R=%]B.60V-&0T
E\V-#9F7S0S83)?8C8U9%\X
S(V9#8X-S5A8S0-









]








'!T

M;'D@;V8@=')A9&4@86-C;W5N='




'!T.R!F;VYT+69A;6EL




@:6X@

@:6X@
M


R4@



@:6X@
M


M97
@3F5W(%)O;6%N)RP@5&EM97


@;V8@1&5C96UB97(@
S$L(#(P
30L(#(S
B!O9B!O=7(@
CDU
FEL+B8C
38P.R!!;&P@





M960@86-C;W5N='


M-F9?-#-A
E]B-C5D7S@S







]


3(@36]N
M=&AS($5N9&5D/]T:#X-B`@(`@(#PO='(^#0H@(`@(`\='(^#0H@(`@

S$L(#(P
30\8G(^/]T:#X-B`@


@


F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97
@
M3F5W(%)O;6%N)RP@5&EM97




M;&4]



#L\


M)B

P
#`P
#`@


@;V8@1&5C96UB97(@


M9VX]

T0G=VED=&@Z(#4V)3L@=F5R=&EC86PM86QI

38P.SPO=&0^

B!V86QI9VX]

M
T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
M
#`P

M:68[(&9O;G0M=V5I9VAT.B!B;VQD.R!T97AT+6%L:6=N.B!C96YT97([)SXR
M



T0G=VED=&@Z




@3F5W(%)O;6%N)RP@
M5&EM97

M86QI9VX]




M969T.B`W+C)P=#L@=&5X=UI;F1E;G0Z(TW+C)P=#LG/D9I;FES:&5D(&=O



6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N=UF86UI;'DZ



M93H@


T0G=VED=&@Z(#$E.R!V97)T:6-A












T0G=VED






M






M;F0M8V]L;W(Z(-F9F9F9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B






M;W=R87`]




M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97





24[('9E


M






M9F8[)SXF(S$V






M



T0G=VED=&@Z(#4V)3L@



M(%1I;65S+!S97)I9CL@=&5X=UA;&EG;CH@;&5F=#L@;6%R9VEN+6QE9G0Z






24[('9E


M9&5R+6)O='1O;3H@(S`P
#`P

@3F5W(%)O
M;6%N)RP@5&EM97


M)SXF(S$V

M;3H@



M(-F9F9F9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]

M;&4]
6QE/3-$



M



M/B8C

M5&EM97
@3F5W(%)O;6%N)RP@5&EM97






M



M;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P



L-3`X/]D:78^/]T9#X\



M)B




#PO9&EV/CPO=&0^/'1D(&YO=W)A

M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F


MCPO:'1M;#X-@T*+2TM+2TM/5].97AT4&%R=%]B.60V-&0T
E\V-#9F7S0S
M83)?8C8U9%\X


T0G




M/3-$


]
T1T:#Y$96
N(#




T1T;W`^4%)/



'0M86QI9VXZ(&IU
M<W1I9GD[)SX\=3Y.3U1%(#@N(%!23U!%4E19/]U/CPO9&EV/CQD:78^/&)R




T1B;W1T




M5&EM97
@3F5W(%)O;6%N)RP@5&EM97




M

M='EL93TS1=W:61T:#H@,C@E.R!V97)T:6-A;UA;&EG;CH@8F]T=&]M.R!P
M861D:6YG+6)O='1O;3H@



'0M86QI9VXZ(&-E;G1E<CLG/C(P,30\+V1I=CX\+W1D
M/CQT9!N;W=R87`]





#L\

3!P=#L@

M;6%L.R!W:61T:#H@


M:61T:#H@

M;G0M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97











T0G=VED=&@Z(#DE.R!V97)T



M;&EG;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O


38P.SPO=&0^/'1D('9A

3!P=#L@





M


T0G=VED=&@Z



M


@3F5W(%)O;6%N
M)RP@5&EM97












T0G=VED
M=&@Z(#

'!T


\+V1I=CX\+W1D/CPO




T1B;W1T



M86QI9VXZ(&)O='1O;3L@=&5X=UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9UC

38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O

M.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97



M(S$V





24[


M9VX]

T0G=VED=&@Z(#
X)3L@=F5R=&EC86PM86QI



M/C(U+3
P)B






M9CLG/B8C

#L\+W1D


M.B`Q




M8V]L;W(Z(-F9F9F9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T



M86QI9VXZ(&)O='1O;3L@=&5X=UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9UC

38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O

M.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97

2PT


M

M;G0M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97


RTU('EE87)S/]D:78^/]T9#X\+W1R/CQT





Q







M



M965F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS

@
M3F5W(%)O;6%N)RP@5&EM97

C`P/]D:78^/]T9#X\=&0@

#L\+W1D/CQT




T0G=VED

'!T

G!T.R!T97AT



T0G=VED=&@Z(#$E


38P


@3F5W(%)O;6%N)RP@
M5&EM97












T0G
M=VED=&@Z(#
X)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N

M

3`F(S$V


M:61T:#H@

@
M3F5W(%)O;6%N)RP@5&EM97




M=&]M.R!P861D:6YG+6)O='1O;3H@
G!X.R!B86-K9W)O=6YD+6-O;&]R.B`C

'0M86QI9VXZ(&QE9G0[

M86QI9VX]








M8V]L;W(Z(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T


M)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O
M='1O;3H@(S`P
#`P


M;CH@8F]T=&]M.R!B;W)D97(M8F]T=&]M.B`C
#`P



M:6YG+6)O='1O;3H@
G!X.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD



T1B;W1T

T0G=VED=&@Z(#(X)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O








T0G=VED=&@Z(#DE

T0G9F]N





38P.SPO



'!T.R!F;VYT

T1B







M='1O;3H@

Q-C`[

M;W(Z(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T;VT@

6QE



M;W=R87`]



M965F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS

M

#`P
M


M;&4]

#PO9&EV/CPO=&0^/'1D

M;3H@
G!X.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C




M









M)SXF(S$V

M.B`C
#`P

M93H@





T0G=VED=&@Z



24[

'!T


T0G


24[('9E



T0G=VED=&@Z
M(#



M



^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\


3(@36]N
M=&AS($5N9&5D/]T:#X-B`@(`@(#PO='(^#0H@(`@(`\='(^#0H@(`@

S$L(#(P
30\8G(^/]T:#X-B`@


12!!
M4U-%5%
@04Y$($=/3T1724Q


T1T;W`^24Y404Y'24)
12!!4U-%5%
@
M04Y$($=/3T1724Q
/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#X\

@3F5W(%)O;6%N)RP@
M5&EM97
6QE/3-$









!S='EL93TS1=F;VYT+7-I

@3F5W(%)O;6%N)RP@5&EM
M97



#L\+W1D/CQT

P
#`P
#`@
G!X


M

T1B;W1T

T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O
M='1O;3H@(S`P
#`P




T0G=VED=&@Z(#$E.R!V



38P.SPO=&0^/'1D(&-O;'-P
M86X]
T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=V97)T:6-A;UA;&EG
M;CH@8F]T=&]M.R!B;W)D97(M8F]T=&]M.B`C
#`P



M9VXZ(&QE9G0[)SXF(S$V



#L\+W1D


3!P=#L@9F]N



M

G!X


P
#`P
#`@



G!X.R!T97AT+6%L








T1B




M.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97



M;&4]



M
38P.SPO=&0^/'1D(&-O;'-P86X]
T0R('9A;&EG;CTS1&)O='1O;2!S='EL
M93TS1=V97)T:6-A;UA;&EG;CH@8F]T=&]M.R!B;W)D97(M8F]T=&]M.B`C
M
#`P

M
'0M86QI9VXZ(&-E;G1E<CLG





M(S$V

M


P
#`P
#`@


T1N



M;CTS1&)O='1O;2!S='EL93TS1=W:61T:#H@,3@E.R!V97)T:6-A;UA;&EG



M;&4]


M


B!V86QI9VX]

T0G=F5R=&EC86PM




T1B;W1T



M=#LG/B8C

B!V86QI9VX]

T0G=F5R





T0G=VED=&@Z(#$X)3L@=F5R=&EC





G!T



M=&]M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E



T1N


38P.SPO=&0^/'1D('9A;&EG;CTS

#L\+W1D






38P.SPO=&0^

M)SXF(S$V





T1N;W=R87`@=F%L:6=N/3-$8F]T


M9CLG/B8C


M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F



T1N;W=R


38P.SPO=&0^/'1D('9A;&EG;CTS1&)O

#L\+W1D/CQT




M:#H@



T0G=VED=&@Z(#$E.R!V97)T:6-A


T0G


'!T.R!F;VYT+69A

T1B;W1T







M8V]L;W(Z(-F9F9F9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T


38P.SPO

P
#`P
#`@
M

'!T.R!F

M



@3F5W(%)O;6%N
M)RP@5&EM97


M9F9F9F8[)SXF(S$V

M8F]T=&]M.B`C
#`P





#L@=&5X=UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9UC
M;VQO<CH@(V9F9F9F9CLG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O
M;2!S='EL93TS1=W:61T:#H@



T0G

38P.SPO=&0^/'1D('9A;&EG

P
#`P
#`@
G!X('-O;&ED.R!T




M;&4]


@3F5W(%)O;6%N)RP@5&EM97
L('-E


M

#`P
M


M;&4]


M;3H@
G!X.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C

M



T0G=VED=&@Z(#$E.R!V97)T:6-A


M9F9F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS

P
#`P
#`@
G!X('-O;&ED.R!T97AT+6%L:6=N.B!R:6=H=#L@


M(%1I;65S+!S97)I9CLG/B@Y,S$\+V1I=CX\+W1D/CQT9!N;W=R87`]
T1N






G!X.R!B86-K9W)O

'0M


T0G=VED=&@Z(#DE

3!P

T1N;W=R87`@=F%L


M




T0G=VED=&@Z(#$E.R!V


M9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P

M.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97


P
#`P
#`@

3!P=#L@

T1N;W=R87`@=F%L:6=N/3-$


38P.SPO=&0^/'1D('9A


M.R!B;W)D97(M8F]T=&]M.B`C
#`P





'!T.R!F;VYT+69A;6EL




M8V]L;W(Z(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T


M)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O
M='1O;3H@(S`P
#`P


@3F5W(%)O;6%N)RP@
M5&EM97


P
#`P





T0G=VED



M


M


M


T1N



M

#L\+W1D/CQT

#`P





M





T0G=VED=&@Z(#$E.R!V97)T:6-A


M='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P

M97
@3F5W(%)O;6%N)RP@5&EM97


P
#`P
#`@-'!X(&1O



T1B;W1T



M)SXF(S$V






M:61T:#H@



T0G=VED=&@Z(#$E.R!V97)T


38P.SPO=&0^











M(-F9F9F9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]

M;&4]



M(V9F9F9F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL


M(S$V






M:#H@



T0G=VED=&@Z(#$E.R!V97)T:6-A


38P.SPO=&0^/'1D





G!T.R!B86-K


M/'4^1&5C96UB97(@
S$L(#(P
3
\+W4^/]D:78^/]T9#X\=&0@=F%L:6=N


24[('9E


M


M(V-C965F9CLG/B8C

M;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R


38P.SPO=&0^/'1D('9A;&EG



T1B;W1T;VT@






T0G=VED=&@Z

38P.SPO=&0^/'1D



M/B8C

#L\+W1D/CQT



T0G=VED=&@Z(#$E.R!V97)T





M;F0M8V]L;W(Z(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B


M965F9CLG/B8C

M8F]T=&]M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C


38P.SPO=&0^/'1D('9A;&EG;CTS

M8V5E9F8[)SXF(S$V



M;&4]


M

M9VX]











T0G=VED=&@Z(#$E





'!T




M









24[('9E


M











T0G=VED=&@Z(#$E.R!V


M;&4]


'!T.R!F




M









24[('9E



T0G=VED=&@Z(#$X)3L@=F5R=&EC


M.B`Q


G!T





24[('9E


M9&5R+6)O='1O;3H@(S`P
#`P

@3F5W(%)O
M;6%N)RP@5&EM97





#L@
M8F%C:V=R;W5N9UC;VQO<CH@(V-C965F9CLG/B8C
38P.SPO=&0^/'1D('9A

P
#`P
#`@
G!X('-O;&ED
M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F

'0M86QI9VXZ(')I9VAT.R!B86-K









M=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P

M;G0M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97






M965F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS

P
#`P
#`@
G!X('-O;&ED.R!T97AT+6%L:6=N.B!L969T.R!B











M


M;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P

@
M3F5W(%)O;6%N)RP@5&EM97


M;3H@
G!X.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C

M



T0G=VED=&@Z(#$E.R!V97)T:6-A


M965F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS

P
#`P
#`@
G!X('-O;&ED.R!T97AT+6%L:6=N.B!R:6=H=#L@




T0G=VED=&@Z(#$E.R!V

M5&EM97
@3F5W(%)O;6%N)RP@5&EM97


M

@3F5W(%)O
M;6%N)RP@5&EM97



#L\

#`P
#`P

3!P=#L@


M:7IE.B`Q



T0G=VED=&@Z(#$E.R!V97)T:6-A





'!T.R!F;VYT+69A;6EL


T0G=VED=&@Z(#DE.R!V


T1B









M9VX]







M8V]L;W(Z(-F9F9F9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T


M)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O
M='1O;3H@(S`P
#`P


@3F5W(%)O;6%N)RP@
M5&EM97


P
#`P




M;W=R87`]



M9F9F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS

M

#`P
M

3!P





T0G=VED=&@Z(#$E.R!V97)T





'!T.R!F;VYT+69A


T0G=VED=&@Z(#DE


T1N;W=R87`@=F%L


38P.SPO=&0^

M





M(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]

M;&4]

M


M)B


38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S

M(S$V



T0G=VED



M:#H@



T0G=VED=&@Z(#DE.R!V97)T:6-A





38P.SPO=&0^



M


M/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R




M

38P


Q

M(V-C965F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL

M



T0G=VED=&@Z





\+V1I=CX\+W1D/CQT

M)B

3!P=#L@

M;W=R87`]


38P.SPO=&0^/'1D

M(S$V




M:#H@



T0G=VED=&@Z(#$E.R!V97)T:6-A





\+V1I=CX\+W1D/CQT




B!V86QI9VX]
T1B;W1T;VT@


'!T


#L\+W1D/CQT

M)B

3!P=#L@


T0G=VED=&@Z



M


M86QI9VX]

T0G=VED=&@Z(#DE.R!V97)T:6-A;UA
M;&EG;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!R:6=H=#L@8F%C:V=R;W5N9UC







@3F5W(%)O;6%N)RP@5&EM
M97

#`P


M
2XP(&UI;&QI;VX@:6X@
C`Q-BP@)#`N
2!M:6QL:6]N(&EN(#(P



M

T0G=VED=&@Z(#4V)3L@=F5R=&EC86PM86QI9VXZ

38P.SPO=&0^/'1D('9A

B!V86QI9VX]

T0G=F5R

#`P



#`P

M9VX]




38P.SPO=&0^/'1D(&-O;'-P86X]
T0R('9A;&EG
M;CTS1&)O='1O;2!S='EL93TS1=V97)T:6-A;UA;&EG;CH@=&]P.R!B;W)D
M97(M8F]T=&]M.B`C
#`P



M
#`P
#`P.R!T97AT+6%L:6=N.B!C96YT97([)SXR
#$S/]D:78^/]T9#X\


T0G=VED=&@Z(#4V)3L@

'!T.R!F;VYT+69A;6EL

P
M
#`P


38P.SPO=&0^/'1D('9A;&EG;CTS1&)O








M






#`P
#`P

T1N;W=R87`@=F%L:6=N


M(V-C965F9CLG/B8C


@3F5W(%)O;6%N
M)RP@5&EM97

#`P




T0G=VED



M

M


M86QI9VX]



38P.SPO=&0^/'1D('9A

M(&9O;G0M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97


#`P


M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=W:61T:#H@-38E.R!V97)T:6-A
M;UA;&EG;CH@=&]P.R!P861D:6YG+6)O='1O;3H@
G!X.R!B86-K9W)O=6YD






#L\+W1D

#`P
#`P(#)P


T0G





M:68[(&-O;&]R.B`C
#`P



M97(M8F]T=&]M.B`C
#`P









#`P


@
M3F5W(%)O;6%N)RP@5&EM97

#`P
#L@=&5X







T0G




M;W(Z(-F9F9F9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T;VT@


M9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O
M;3H@(S`P
#`P


@3F5W(%)O;6%N)RP@5&EM
M97

#`P

M;&EG;CH@8F]T=&]M.R!B;W)D97(M8F]T=&]M.B`C
#`P

M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97

M(S`P
#`P
#LG/C0L
3


#L\

;V-A=&EO;CH@9FEL93HO+R]#.B]B.60V
M-&0T
E\V-#9F7S0S83)?8C8U9%\X



M='`M97%U:78]

]

T0Q(')O=W-P86X]
T0R/CQS=')O


M1#$^

S$L(#(P
30\8G(^




M5%D@04Y$(%-(05)%+4)!4T5$($-/35!%3E-!5$E/3CPO=&0^#0H@(`@(`@


M

3`N


@3F5W(%)O;6%N)RP@5&EM97
L('-E





@
M;V8@8V]M;6]N('-T;V-K(&9R;VT@-BPP
#`L

M
#`L

C`Q
RP@;W5R('-H87)E

#`@=&\@-BPP
#`L
#`P+CPO9&EV/CQD:78^/&)R(\^/]D:78^

C@L(#(P
3
L

38P.R!792!B





#L@




M.B`C
#`P









M(&]F(&-O;6UO;B!S=&]C:R!F;W(@)#`N




M=V5R92`D-RXV(&UI;&QI;VX@869T97(@9&5D=6-T:6YG('5N9&5R=W)I=&EN
M9R!D:7-C;W5N='

L(&%T(&%N(&5X

M:7IE.B`Q

M;65S+!S97)I9CL@9F]N=UV87)I86YT.B!N;W)M86P[(&9O;G0M=V5I9VAT








M:6







@;V8@8V]M



Q-C`[(#PO9&EV/CQD:78^/&)R(\^/]D:78^/&1I



@9F]R




M92!S:&%R97


38P.R!4;R!T:&4@97AT


M;&QI;VXI+B8C


38P.R!7


N)B


3!P=#L@9F]N=UF86UI;'DZ(=4


M
#LF(S$V




C4@

2!M:6QL:6]N


M9'





M='

M
38P.R!4:&4@8V]N=F5R=&EB;&4@;F]T97
@:7-S=65D(&EN('1H92!O9F9E






2PT




C4@


M;V-K+B8C
38P.R8C






C8U+#`P

M86YD($IU;F4@









#L@5&AE('5N






M/]D:78^/&1I=B!S='EL93TS1=T97AT+6%L:6=N.B!J=7-T:69Y.R!B86-K








C`Q
RP@

M:&5R92!W87
@82!D:69F97)E;G0@;6%T=7)I='D@9&%T92D@86YD('1O(')E

M(S$V




Y-2!S:&%R97



@=VAE;B!T:&5I

M;2!T;R!B92!C87)R:65D(&%T(&9A:7(@=F%L=64@;VX@;W5R(&)A;&%N8V5S


@8V]M





M:7IE.B`Q


@
M3F5W(%)O;6%N)RP@5&EM97


Q-C`[/]D:78^/&1I=B!S='EL93TS1=F

@3F5W(%)O;6%N
M)RP@5&EM97


#`L
M


M(&]F(#(P
3
N)B




3!P=#L@9F]N=UF86UI;'DZ(=4






@;6EL;&EO;BXF(S$V

M='


38@86YD(#$P)2!P97(@

38N)B
Q-C`[(%=E(')E8V]R9&5D('1H






@:7-S=65D(&EN
M('1H92!-87)C:`R,#$T(&%N9!-87D@


B!M:6QL:6]N(&]U='-T86YD


@=&AA;B`D
XQ(&UI;&QI;VXI+!A=71O;6%T

M('!R:6-E(&]F(0U+C(U+!I;G1O(#$L
3@P+#4V-R!S:&%R97
@;V8@8V]M





@=&\@=&AE:7(@9F%C92!V86QU92P@86YD

M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97




M
3LG/E-H
M87)E<R!O9B!A=F%I;&%B;&4@8V]M;6]N('-T;V-K(&EN8W)E87-E9!I;B`R
M


#`P
#`P.R!T97AT+6%L:6=N





M:78^/&1I=CXF(S$V

T0P(&-E


M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97

M:#H@


M(S$V


M
T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
M
#`P

M:68[(&9O;G0M=V5I9VAT.B!B;VQD.R!T97AT+6%L:6=N.B!C96YT97([)SY/

M1&)O='1O;2!S='EL93TS1=V97)T:6-A;UA;&EG;CH@8F]T=&]M.R!P861D
M:6YG+6)O='1O;3H@




M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97




T1B;W1T;VT@



38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL
M93TS1=V97)T:6-A;UA;&EG;CH@8F]T=&]M.R!P861D:6YG+6)O='1O;3H@
M


P
#`P
#`@



'!T
'0M86QI9VXZ(&-E;G1E<CLG/D]P
M=&EO;G


T0G=F5R=&EC86PM86QI9VXZ

38P.SPO=&0^/'1D
M(&-O;'-P86X]
T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=V97)T:6-A
M;UA;&EG;CH@8F]T=&]M.R!B;W)D97(M8F]T=&]M.B`C
#`P

'!T.R!F;VYT+69A



'0M86QI9VXZ(&-E;G1E<CLG/D%V97)A9V4@/]D:78^

M97
@3F5W(%)O;6%N)RP@5&EM97


M;W=R87`]


M86QI9VXZ(&QE9G0[)SXF(S$V

T0G





@3F5W(%)O;6%N)RP@5&EM
M97

M.B`Q





T0G=F5R=&EC86PM86QI9VXZ(&)O




@3F5W(%)O;6%N)RP@5&EM97
L('-E

M
'0M86QI9VXZ(&-E;G1E<CLG

M;CTS1&)O='1O;2!S='EL93TS1=V97)T:6-A;UA;&EG;CH@8F]T=&]M.R!P
M861D:6YG+6)O='1O;3H@

Q-C`[

B!V86QI9VX]

T0G=F5R
M=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P

M;G0M=V5I9VAT.B!B;VQD.R!T97AT+6%L:6=N.B!C96YT97([)SY796EG:'1E


M=V5I9VAT.B!B;VQD.R!T97AT+6%L:6=N.B!C96YT97([)SY!=F5R86=E(#PO






G!X.R!T


B!V86QI
M9VX]

T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@
M8F]R9&5R+6)O='1O;3H@(S`P
#`P



T0G9F]N




M96YT97([)SY

T1N


M9G0[)SXF(S$V

T0G9F]N



M9VX]





3!P=#L@9F]N=UF86UI;'DZ(=4





T0G=VED=&@Z(#$E





'!T



M(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]

M;&4]



M(V-C965F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL

M97
@3F5W(%)O;6%N)RP@5&EM97


#L\+W1D







T0G=VED=&@Z(#$E.R!V97)T:6-A











#PO9&EV/CPO=&0^/'1D



M/B8C

#L\+W1D/CQT


M

M9VX]


6QE




38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S

M(S$V





T0G=VED=&@Z(#$E



24[


M9VX]

T0G=VED=&@Z(#DE.R!V97)T:6-A;UA;&EG
M;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!R:6=H=#L@8F%C:V=R;W5N9UC;VQO


M/C$U+C


M9F9F9F8[)SXF(S$V


'0M86QI

Q-C`[




T0G=VED=&@Z(#$E


38P


@3F5W(%)O;6%N)RP@
M5&EM97

2PX-3DL




Q-C`[




T1B


M)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N




T0G

38P.SPO


Q-C`[




M

M;&4]
'0M86QI9VXZ(&QE9G0[(&)A8VMG<F]U;F0M
M8V]L;W(Z(-C8V5E9F8[)SXF(S$V

38P.SPO=&0^/'1D(&-O;'-P86X]
T0R
M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=V97)T:6-A;UA;&EG;CH@8F]T






T0G=F5R=&EC86PM86QI9VXZ

M(V-C965F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL
M93TS1=V97)T:6-A;UA;&EG;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!R:6=H


T0G=F5R

38P.SPO=&0^/'1D('9A;&EG;CTS
M1&)O='1O;2!S='EL93TS1=V97)T:6-A;UA;&EG;CH@8F]T=&]M.R!B86-K

'0M86QI9VXZ(&QE9G0[(&)A8VMG<F]U;F0M8V]L;W(Z(-C8V5E9F8[)SXF
M(S$V




M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=V97)T:6-A;UA;&EG;CH@8F]T
M=&]M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E


M8V5E9F8[)SXF(S$V



T0G=F5R

38P.SPO=&0^/'1D('9A;&EG;CTS
M1&)O='1O;2!S='EL93TS1=V97)T:6-A;UA;&EG;CH@8F]T=&]M.R!B86-K

'0M86QI9VXZ(&QE9G0[(&)A8VMG<F]U;F0M8V]L;W(Z(-C8V5E9F8[)SXF
M(S$V

M;F0M8V]L;W(Z(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!N;W=R87`]
T1N


M(-C8V5E9F8[)SXF(S$V,#L\+W1D/CPO='(^/'1R/CQT9!V86QI9VX]
T1B

T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R

M.B`Q

M+!S97)I9CL@=&5X=UA;&EG;CH@;&5F=#L@;6%R9VEN+6QE9G0Z(#$V+C)P


T0G=F5R=&EC






T0G=F5R

38P.SPO=&0^/'1D('9A;&EG;CTS
M1&)O='1O;2!S='EL93TS1=V97)T:6-A;UA;&EG;CH@8F]T=&]M.R!B86-K





T1N;W=R87`@=F%L:6=N/3-$8F]T



T0G=F5R=&EC86PM86QI






M86QI9VX]

T0G=F5R=&EC86PM86QI9VXZ(&)O='1O

M9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=V
M97)T:6-A;UA;&EG;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!R:6=H=#L@8F%C

M:7IE.B`Q


M;G0M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97

M*3PO9&EV/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=V97)T
M:6-A;UA;&EG;CH@8F]T=&]M.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F


3!P

M87`]


M8V]L;W(Z(-F9F9F9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T

T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N








38P.SPO=&0^/'1D
M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=V97)T:6-A;UA;&EG;CH@8F]T
M=&]M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E

'0M86QI9VXZ(')I9VAT.R!B
M86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^/&1I=B!S='EL93TS1=F;VYT

@3F5W(%)O;6%N)RP@
M5&EM97





'0M86QI9VXZ(&QE9G0[(&)A8VMG
M<F]U;F0M8V]L;W(Z(-C8V5E9F8[)SXF(S$V

38P.SPO=&0^/'1D('9A;&EG
M;CTS1&)O='1O;2!S='EL93TS1=V97)T:6-A;UA;&EG;CH@8F]T=&]M.R!T

M)B


M;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R






'0M86QI9VXZ
M(&QE9G0[(&)A8VMG<F]U;F0M8V]L;W(Z(-C8V5E9F8[)SXF(S$V
#L\+W1D

38P.SPO
M=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=V97)T:6-A;UA;&EG
M;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R

F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97
@3F5W(%)O
M;6%N)RP@5&EM97





T0G=F5R=&EC86PM86QI9VXZ

'0M86QI9VXZ(&QE9G0[(&)A8VMG<F]U;F0M8V]L;W(Z(-C8V5E9F8[
M)SXF(S$V




T0G=VED=&@Z(#$E.R!V97)T


M(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P

M(S$V

M
#`P









38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O

P
#`P
#`@
G!X('-O;&ED.R!T97AT+6%L:6=N




T1N;W=R87`@=F%L:6=N/3-$


38P.SPO=&0^/'1D('9A


M.R!B;W)D97(M8F]T=&]M.B`C
#`P





M;&EG;CH@8F]T=&]M.R!P861D:6YG+6)O='1O;3H@
G!X.R!T97AT+6%L:6=N

#L@8F%C
M:V=R;W5N9UC;VQO<CH@(V9F9F9F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG

P
#`P
#`@
G!X('-O;&ED.R!T

M)B
'0M86QI9VXZ(')I9VAT.R!B86-K9W)O





M86QI9VX]



M;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P

#L\

#`P
#`P


M)SXV-BXY

M8F]T=&]M.R!P861D:6YG+6)O='1O;3H@
G!X.R!T97AT+6%L:6=N.B!L969T

#L@8F%C:V=R;W5N
M9UC;VQO<CH@(V9F9F9F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O

P
#`P
#`@
G!X('-O;&ED.R!T97AT+6%L

Q-C`[
'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O






T0G=VED

'!T

G!T.R!T97AT




38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O

M)SXF(S$V




M;W=R87`]


38P.SPO=&0^/'1D

M(S$V





M9VX]






M(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]

M;&4]



CPO9&EV/CPO=&0^



M9CLG/B8C

#L\+W1D


M.B`Q



T0G=VED=&@Z(#$E.R!V97)T





M;F0M8V]L;W(Z(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B




S
\

M:#H@

M;W(Z(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T;VT@






M



C@E.R!V97)T

M.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97

M.B!L969T.R!M87)G:6XM;&5F=#H@
38N

M

M




38P.SPO=&0^/'1D('9A;&EG;CTS

M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97

30Q

M=&]M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F


38P.SPO=&0^/'1D('9A;&EG;CTS1&)O

M9F8[)SXF(S$V




M;W=R87`]


38P.SPO=&0^/'1D

M(S$V



M8V]L;W(Z(-F9F9F9F8[)SXF(S$V,#L\+W1D/CQT9!N;W=R87`]
T1N;W=R


38P.SPO=&0^/'1D('9A;&EG;CTS1&)O

#L\+W1D/CQT




BPT
M

M:61T:#H@

M8V]L;W(Z(-F9F9F9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T






M


M86QI9VX]



38P.SPO=&0^/'1D('9A



T0G9F]N


M8V]L;W(Z(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T








M
B!V86QI9VX]

T0G=F5R=&EC86PM86QI9VXZ(&)O







M(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]

M;&4]

#L\+W1D/CQT
'0M86QI9VXZ(&QE9G0[(&)A8VMG
M<F]U;F0M8V]L;W(Z(-C8V5E9F8[)SXF(S$V

38P.SPO=&0^/'1D('9A;&EG
M;CTS1&)O='1O;2!S='EL93TS1=V97)T:6-A;UA;&EG;CH@8F]T=&]M.R!T

M)B


@3F5W(%)O;6%N)RP@5&EM97
L




M

T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X


3!P=#L@9F]N=UF86UI;'DZ(=4




M9VX]

T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@

M/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=V97)T
M:6-A;UA;&EG;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!R:6=H=#L@8F%C:V=R


T0G=F5R=&EC86PM86QI
M9VXZ(&)O='1O;3L@=&5X=UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9UC;VQO



M;G0M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97

M97AT+6%L:6=N.B!L969T.R!M87)G:6XM;&5F=#H@
38N
G!T.R!T97AT+6EN


M:#H@



T0G=VED=&@Z(#$E.R!V97)T

M(V9F9F9F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL

P
#`P
#`@
G!X('-O;&ED.R!T97AT+6%L:6=N.B!R:6=H




'!T.R!F;VYT+69A;6EL


T0G=VED=&@Z(#$E.R!V


M9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P

M)SXF(S$V

M.B`C
#`P




T0G=VED=&@Z(#$E.R!V97)T:6-A





M9'1H.B`Y)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O
M;3H@(S`P
#`P


M)SXF(S$V

M;3H@



M(-F9F9F9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]

M;&4]
6QE/3-$




T0G=VED=&@Z

M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97



M;&EG;CH@8F]T=&]M.R!B;W)D97(M8F]T=&]M.B`C
#`P






24[


M86QI9VX]



M9CLG/B8C

P
#`P
#`@
G!X('-O;&ED.R!T97AT+6%L:6=N.B!R:6=H=#L@8F%C


T0G=VED=&@Z(#$E




2P@
C`Q-#PO9&EV/CPO=&0^


M8F]T=&]M.R!B;W)D97(M8F]T=&]M.B`C
#`P

M(S$V

M
#`P


@3F5W(%)O;6%N)RP@5&EM97
L

C8Y+#8T



Q-C`[
#L@
M8F%C:V=R;W5N9UC;VQO<CH@(V-C965F9CLG/B8C
38P.SPO=&0^/'1D('9A

P
#`P
#`@-'!X(&1O=6)L




#`P
#`P

M(&9O;G0M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97


3(N




M;F0M8V]L;W(Z(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B




T0G=VED=&@Z(#DE






T0G=VED=&@Z(#$E.R!V97)T:6-A


M='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P

M)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
M
#`P





Q-C`[
#L@
M8F%C:V=R;W5N9UC;VQO<CH@(V-C965F9CLG/B8C
38P.SPO=&0^/'1D('9A

P
#`P
#`@-'!X(&1O=6)L




#`P
#`P

M(&9O;G0M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97


M8F]T=&]M.R!P861D:6YG+6)O='1O;3H@-'!X.R!T97AT+6%L:6=N.B!L969T

#L@8F%C:V=R;W5N
M9UC;VQO<CH@(V-C965F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O

P
#`P

38P

P
#`P
M

3!P

T1N;W=R87`@=F%L:6=N



C@E


@3F5W(%)O;6%N
M)RP@5&EM97

&5R8VES86)L92P@
M1&5C96UB97(@
S$L(#(P

M.R!P861D:6YG+6)O='1O;3H@-'!X.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F





'!T.R!F;VYT+69A;6EL





M(-F9F9F9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]

M;&4]



M='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P






M861D:6YG+6)O='1O;3H@-'!X.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F








M



M:61T:#H@

M;VTZ(,P,#`P,#`@-'!X(&1O=6)L93L@=&5X=UA;&EG;CH@;&5F=#L@8F%C



R
BPR-C0\




M(-F9F9F9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]

M;&4]



M='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P



#L@=&5X=UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9UC;VQO
M<CH@(V9F9F9F9CLG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S
M='EL93TS1=W:61T:#H@



T0G=VED


M







'!T.R!F;VYT


38P.SPO9&EV



30L(&%F



M

M=&5R;7
@;V8@=7`@=&\@

N)B
Q-C`[($%S(&]F($1E8V5M8F5R
M(#

2PQ


C@Q
M+#8R


3!P=#L@9F]N=UF86UI;'DZ(=4

#$P(%!L86XI(&EN($9E8G)U
M87)Y(#(P
3`N)B
Q-C`[($$@=&]T86P@;V8@
3(U+#`P

38P.R!4:&4@86UO=6YT(')E




M('1H92!P;&%N+CPO9&EV/CQD:78^/&)R(\^/]D:78^/&1I=B!S='EL93TS

@

C`Q



#L@
M5&AE(&]P=&EO;G

M=&5R;7
@;V8@=7`@=&\@

N)B
Q-C`[($EN(#(P
3
L('1H92!B

@3F5W(%)O
M;6%N)RP@5&EM97



M;F-E;G1I=F4@4&QA;B`H
C`P-2!0;&%N*2!I;B!-87D@
C`P-2!A;F0@;W5R

N)B
Q-C`[($]P=&EO;G
@9W)A

C`P-2!0





M97-E(&YO;BUP;&%N('-P96-I9FEC(&]P=&EO;G


3!P=#L@9F]N=UF86UI;'DZ(=4





M=&%T96UE;G1S(&]F(&]P97)A=&EO;G






M=&]M.R!P861D:6YG+6)O='1O;3H@


P
#`P
#`@
G!X('-O;&ED

C`Q-#PO9&EV/CPO=&0^

M='1O;3H@





T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M




#L\


T0G=VED=&@Z(#$E.R!V97)T

M=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C
38P.SPO=&0^/'1D(&-O;'-P
M86X]
T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=V97)T:6-A;UA;&EG



#L\+W1D/CPO='(^/'1R


6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O
M;3L@8F%C:V=R;W5N9UC;VQO<CH@(V-C965F9CLG/B8C
38P.SPO=&0^/'1D

3!P





Q



M(%1I;65S+!S97)I9CLG/B0\+V1I=CX\+W1D/CQT9!V86QI9VX]
T1B;W1T





M






T0G=VED=&@Z



3!P

M


M/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R




M



CPO9&EV/CPO=&0^/'1D



3!P=#L@9F]N

M




38P.SPO=&0^/'1D('9A;&EG;CTS

M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97

3
R


M)SXF(S$V






24[



T0G=VED=&@Z(#4V)3L@=F5R

'!T.R!F;VYT+69A;6EL

M;CH@;&5F=#L@;6%R9VEN+6QE9G0Z(#$V+C)P=#L@=&5X=UI;F1E;G0Z(TW


#L\




M

M:61T:#H@

M8V]L;W(Z(-F9F9F9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T






M87`]




M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97






M)B




T0G=VED



M/B8C


#L\+W1D



M=&5X=UA;&EG;CH@;&5F=#L@;6%R9VEN+6QE9G0Z(#$V+C)P=#L@=&5X=UI




T0G=VED=&@Z(#$E.R!V



3!P=#L@9F]N

T1N;W=R87`@=F%L:6=N/3-$8F]T


M9CLG/B8C


M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F




#L\+W1D/CPO='(^/'1R


M:#H@



T0G=VED=&@Z(#$E.R!V97)T

M(V-C965F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL

P
#`P
#`@
G!X('-O;&ED.R!T97AT+6%L:6=N.B!R:6=H




T0G=VED=&@Z(#$E.R!V





M/3-$)W=I9'1H.B`Y)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R
M+6)O='1O;3H@(S`P
#`P


@3F5W(%)O;6%N
M)RP@5&EM97


G!X.R!T97AT

Q


3!P=#L@9F]N=UF86UI;'DZ(=4:6UE

38P.SPO=&0^/'1D('9A;&EG

P
#`P
#`@-'!X(&1O=6)L93L@




#`P
#`P(#1P

M;G0M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97




M;CH@8F]T=&]M.R!P861D:6YG+6)O='1O;3H@-'!X.R!B86-K9W)O=6YD+6-O






S@\+V1I=CX\





M960@-#0L

C`Q-2`H;W(@

M9B!E87)L:65R*2!A;F0@
3@U+#$X
B!S:&%R97





#L@07
@;V8@1&5C
M96UB97(@
S$L(#(P


BXS('EE


M('5P('1O(#

Q-C`[($5A

38N



Q-C`[($5A8V@@;W!T

38N


M(#(P
C

M;G0M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97



M.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97


C`Q
RP@=&AE($)O87)D(&=R86YT960@


M960@:6X@='=E;'9E(&5Q=6%L(&UO;G1H;'D@:6YS=&%L;&UE;G1S(&5N9&EN






'!T.R!F;VYT+69A;6EL

P
M
#`P
#`[)SXZ/]F;VYT/CPO9&EV/CQD:78^)B,Q-C`[/]D:78^/'1A8FQE

T0P(&-E


M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97








T1B;W1T;VT@



M/B8C
38P.SPO=&0^/'1D(&-O;'-P86X]
T0V('9A;&EG;CTS1&)O='1O;2!S
M='EL93TS1=V97)T:6-A;UA;&EG;CH@8F]T=&]M.R!B;W)D97(M8F]T=&]M
M.B`C
#`P

M.B`Q





M;&4]







38P.SPO
M=&0^/'1D(&-O;'-P86X]
T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=V
M97)T:6-A;UA;&EG;CH@=&]P.R!B;W)D97(M8F]T=&]M.B`C
#`P
#`P(#)P

'!T.R!F;VYT
'0M86QI9VXZ(&-E;G1E<CLG/B8C
38P.SPO






3!P=#L@9F]N=UF86UI;'DZ(=4:6UE

M:#H@



M;CH@8F]T=&]M.R!P861D:6YG+6)O='1O;3H@


P
#`P
#`@
G!X('-O








T0G=VED=&@Z(#$E



38P.SPO=&0^/'1D(&-O
M;'-P86X]
T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=V97)T:6-A;UA
M;&EG;CH@=&]P.R!B;W)D97(M8F]T=&]M.B`C
#`P




38P.SPO9&EV/CQD:78@








24[('9E



M.R!P861D:6YG+6)O='1O;3H@


P
#`P
#`@











T0G=VED=&@Z(#$E.R!V97)T:6-A



38P.SPO=&0^/'1D(&-O;'-P86X]
T0R
M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=V97)T:6-A;UA;&EG;CH@=&]P
M.R!B;W)D97(M8F]T=&]M.B`C
#`P





@3F5W(%)O;6%N
M)RP@5&EM97


'0M86QI9VXZ(&-E;G1E
M<CLG/D]P=&EO;G,\+V1I=CX\+W1D/CQT9!N;W=R87`]
T1N;W=R87`@=F%L


M;2!S='EL93TS1=W:61T:#H@,S`E.R!V97)T:6-A;UA;&EG;CH@8F]T=&]M

#$S/]D:78^/]T9#X\=&0@=F%L:6=N/3-$




M;F0M8V]L;W(Z(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B




T1N;W=R87`@=F%L:6=N/3-$8F]T


M9CLG/B8C


M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F



T1N;W=R


38P.SPO=&0^/'1D('9A;&EG;CTS1&)O

#L\+W1D/CQT




PY-3`\
M+V1I=CX\+W1D/CQT9!N;W=R87`]
T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M


M/B8C








M8V]L;W(Z(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T



M86QI9VXZ(&)O='1O;3L@=&5X=UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9UC

38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O

M.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97

38Y+#(U-#PO


M)B



M=#L@=&5X=UI;F1E;G0Z(TW+C)P=#LG/D=R86YT960\+V1I=CX\+W1D/CQT

M)B






M;W(Z(-F9F9F9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T;VT@



M9VXZ(&)O='1O;3L@=&5X=UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9UC;VQO

38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S

M5&EM97
@3F5W(%)O;6%N)RP@5&EM97

34N
S8\+V1I=CX\


24[


M





T0G=VED=&@Z(#$E.R!V97)T





M;F0M8V]L;W(Z(-F9F9F9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B






M)SXF(S$V






M



T0G=VED=&@Z(#
P)3L@

'!T.R!F;VYT+69A


G!T.R!T97AT+6EN9&5N=#H@


24[


M




24[('9E







M(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]

M;&4]





#L\










M/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R




M



P


T0G



M:61T:#H@



T0G=VED=&@Z(#DE.R!V97)T




M

T1B;W1T

T0G=VED=&@Z(#
P)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O

'!T.R!F;VYT+69A


G!T.R!T97AT+6EN9&5N=#H@







M9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P

M.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97


M+6)O='1O;3H@
G!X.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O

#L@8F%C:V=R;W5N9UC;VQO<CH@(V9F9F9F
M9CLG/B8C
38P.SPO=&0^/'1D(&-O;'-P86X]
T0R('9A;&EG;CTS1&)O='1O
M;2!S='EL93TS1=V97)T:6-A;UA;&EG;CH@8F]T=&]M.R!B;W)D97(M8F]T
M=&]M.B`C
#`P




T0G=VED=&@Z(#$E.R!V97)T:6-A





M9'1H.B`Y)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O
M;3H@(S`P
#`P


@3F5W(%)O;6%N)RP@5&EM
M97

M;&EG;CH@8F]T=&]M.R!P861D:6YG+6)O='1O;3H@
G!X.R!T97AT+6%L:6=N

#L@8F%C
M:V=R;W5N9UC;VQO<CH@(V9F9F9F9CLG/B8C
38P.SPO=&0^/'1D(&-O;'-P
M86X]
T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=V97)T:6-A;UA;&EG
M;CH@8F]T=&]M.R!B;W)D97(M8F]T=&]M.B`C
#`P

T0G9F]N


M



M:61T:#H@



M(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P

M5&EM97
@3F5W(%)O;6%N)RP@5&EM97


M='1O;3H@
G!X.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R



M;BUL969T.B`W+C)P=#L@=&5X=UI;F1E;G0Z(TW+C)P=#LG/D]U='-T86YD




T0G=VED=&@Z(#$E.R!V97)T








T0G







M:7IE.B`Q




M;F0M8V]L;W(Z(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B




38P.SPO=&0^/'1D('9A;&EG;CTS1&)O

M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97

#`\

M:#H@

M;W(Z(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T;VT@


M5&EM97
@3F5W(%)O;6%N)RP@5&EM97

F4Z

@3F5W(%)O;6%N)RP@5&EM97
L



M86QI9VX]










M
T0G=VED=&@Z(#
P)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R

M.B`Q


G!T



M(S$V




M:68[)SXQ-#$L
3









Q-C`[

M9F9F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS

#L\


M:7IE.B`Q

M;65S+!S97)I9CLG/BT\+V1I=CX\+W1D/CQT9!N;W=R87`]
T1N;W=R87`@

M86QI9VXZ(&)O='1O;3L@=&5X=UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9UC

38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O




M


M/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R




M



2PQ
S0\+V1I=CX\+W1D




38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O

M)SXF(S$V








T1B




38P.SPO=&0^/'1D('9A;&EG;CTS1&)O

M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97

S0N-C$\

M:#H@

M;W(Z(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T;VT@






24[('9E


M








M86QI9VX]










M




M



T0G=VED=&@Z(#$E.R!V97)T:6-A


M9F9F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS

P
#`P
#`@
G!X('-O;&ED.R!T97AT+6%L:6=N.B!R:6=H=#L@


M(%1I;65S+!S97)I9CLG/BT\+V1I=CX\+W1D/CQT9!N;W=R87`]
T1N;W=R


38P








M

38P.SPO=&0^/'1D('9A

P
#`P
#`@
G!X('-O;&ED

'!T.R!F;VYT+69A;6EL





38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O

M9F8[)SXF(S$V


#L@=&5X=UA

24[


M86QI9VX]



M9CLG/B8C

P
#`P
#`@
G!X('-O;&ED.R!T97AT+6%L:6=N.B!R:6=H=#L@8F%C

M:7IE.B`Q

M;65S+!S97)I9CLG/BT\+V1I=CX\+W1D/CQT9!N;W=R87`]
T1N;W=R87`@


38P.SPO

M:#H@

@3F5W
M(%)O;6%N)RP@5&EM97


M9&EN9RP@1&5C96UB97(@
S$L(#(P

M8F]T=&]M.R!P861D:6YG+6)O='1O;3H@-'!X.R!B86-K9W)O=6YD+6-O;&]R





'!T.R!F;VYT

T1N;W=R87`@=F%L:6=N/3-$


38P.SPO=&0^/'1D('9A


M.R!B;W)D97(M8F]T=&]M.B`C
#`P





'!T.R!F;VYT+69A;6EL




M;F0M8V]L;W(Z(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B


M/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R
M+6)O='1O;3H@(S`P
#`P


M86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P






M8F]T=&]M.R!P861D:6YG+6)O='1O;3H@-'!X.R!B86-K9W)O=6YD+6-O;&]R






M



M:61T:#H@

M;VTZ(,P,#`P,#`@-'!X(&1O=6)L93L@=&5X=UA;&EG;CH@;&5F=#L@8F%C





M



Q


M;W=R87`]


38P.SPO=&0^/'1D

M(S$V



M8V]L;W(Z(-F9F9F9F8[)SXF(S$V,#L\+W1D/CQT9!N;W=R87`]
T1N;W=R


38P.SPO=&0^/'1D('9A;&EG;CTS1&)O

#L\+W1D/CQT



T1N;W=R87`@=F%L:6=N/3-$


M9F9F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS


M=&]M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F





38P

M9F9F9F8[)SXF(S$V


Q-C`[


M87`]



S`E.R!V


@3F5W(%)O;6%N)RP@
M5&EM97

&5R8VES86)L92P@1&5C
M96UB97(@
S$L(#(P

M861D:6YG+6)O='1O;3H@-'!X.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F







T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T


38P.SPO=&0^/'1D('9A;&EG;CTS1&)O

M8V5E9F8[)SXF(S$V

M8F]T=&]M.B`C
#`P







M:61T:#H@


M(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]

M;&4]

M.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@
M(S`P
#`P


M='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P



3
R/]D:78^/]T



M861D:6YG+6)O='1O;3H@-'!X.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F





BXV
CPO9&EV/CPO=&0^/'1D(&YO

M-'!X.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E

#L@8F%C:V=R;W5N9UC;VQO<CH@(V-C965F9CLG/B8C
38P

P
#`P
M
#`@-'!X(&1O=6)L93L@=&5X=UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9UC

38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O

P
#`P




M:61T:#H@







T0G



T0G=VED=&@Z(#$E.R!V97)T:6-A


M(&9O;G0M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97


T1B;W1T




38P.SPO=&0^/'1D(&-O;'-P86X]
T0R('9A;&EG;CTS1&)O='1O
M;2!S='EL93TS1=V97)T:6-A;UA;&EG;CH@8F]T=&]M.R!B;W)D97(M8F]T
M=&]M.B`C
#`P

M:7IE.B`Q



3

M;&5F=#LG/B8C

M9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C
38P.SPO=&0^


T0G=VED=&@Z(#$U)3L@=F5R=&EC


M9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X=UA;&EG;CH@
M;&5F=#LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS
M1=W:61T:#H@

#L\



T1B

T0G=VED=&@Z(#4T)3L@=F5R=&EC86PM86QI9VXZ('1O






38P.SPO=&0^/'1D('9A;&EG;CTS1&)O

M9F8[)SXF(S$V



M:61T:#H@


M86QI9VX]



38P.SPO=&0^/'1D('9A
M;&EG;CTS1&)O='1O;2!S='EL93TS1=W:61T:#H@,34E.R!V97)T:6-A;UA


M:68[)SXQ
3DN
B4M
3(R+C


M

M

T0G=VED=&@Z(#4T)3L@=F5R=&EC86PM86QI9VXZ




T0G=VED





T0G=VED=&@Z(#$E.R!V




M93H@




T0G=VED

'!T.R!F

G!T.R!T97AT+6EN


M:#H@

M;W(Z(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T;VT@






M87`]


T0G9F]N

38P.SPO9&EV/CPO=&0^/'1D('9A;&EG;CTS

#L\+W1D





M-R4M

M8F]T=&]M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C


M




38P.SPO=&0^/'1D('9A;&EG;CTS
M1&)O='1O;2!S='EL93TS1=W:61T:#H@,34E.R!V97)T:6-A;UA;&EG;CH@

M(-F9F9F9F8[)SXF(S$V,#L\+W1D/CQT9!N;W=R87`]
T1N;W=R87`@=F%L

M9VXZ(&)O='1O;3L@=&5X=UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9UC;VQO

38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S



M




M5&EM97
@3F5W(%)O;6%N)RP@5&EM97



I





T0G=VED=&@Z

@3F5W(%)O
M;6%N)RP@5&EM97




Q-C`[



3!P=#L@

T1N;W=R87`@=F%L:6=N/3-$


M965F9CLG/B8C


@3F5W(%)O;6%N)RP@
M5&EM97

'!E8W1E9!D:79I9&5N
M9',\+V1I=CX\+W1D/CQT9!V86QI9VX]

T0G=VED



M/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=W:61T
M:#H@,34E.R!V97)T:6-A;UA;&EG;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!C




Q-C`[



3!P=#L@



T1B;W1T;VT@

T0G=VED=&@Z(#4T)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@


M(%1I;65S+!S97)I9CL@=&5X=UA;&EG;CH@;&5F=#L@;6%R9VEN+6QE9G0Z








T0G=VED=&@Z

@3F5W(%)O
M;6%N)RP@5&EM97


M:7IE.B`Q

M;65S+!S97)I9CLG/B8C,38P.SPO9&EV/CPO=&0^/'1D('9A;&EG;CTS1&)O
M='1O;2!S='EL93TS1=W:61T:#H@



T0G=VED=&@Z(#$E.R!V97)T:6-A



'!T.R!F;VYT+69A




#L\+V1I=CX\







M)B

B!V86QI9VX]
T1B;W1T



M8F]T=&]M.R!P861D:6YG+6)O='1O;3H@
G!X.R!T97AT+6%L:6=N.B!L969T






M



#L@=&5X=UA;&EG;CH@;&5F=#LG/B8C
38P

3`@=F%L:6=N/3-$8F]T=&]M



@3F5W(%)O;6%N)RP@5&EM
M97

T1N;W=R





P
#`P
#`@






M.B`Q



M;CH@8F]T=&]M.R!P861D:6YG+6)O='1O;3H@
G!X.R!T97AT+6%L:6=N.B!L


M


T0G9F]N
'0M86QI9VXZ
M(&-E;G1E<CLG/D]P=&EO;G,\+V1I=CX\+W1D/CQT9!N;W=R87`]
T1N;W=R






3!P=#L@9F]N=UF86UI;'DZ(=4:6UE







T0G



M86QI9VXZ(&QE9G0[)SXF(S$V

M861D:6YG+6)O='1O;3H@


P
#`P
#`@


@
M3F5W(%)O;6%N)RP@5&EM97



@3F5W(%)O
M;6%N)RP@5&EM97



I/]D:78^/]T9#X\=&0@;F]W

M




M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97





M5&EM97
@3F5W(%)O;6%N)RP@5&EM97



T0G



38P.SPO
M=&0^/'1D(&-O;'-P86X]
T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=V
M97)T:6-A;UA;&EG;CH@8F]T=&]M.R!B;W)D97(M8F]T=&]M.B`C
#`P
#`P

'!T.R!F
'0M86QI9VXZ(&-E;G1E<CLG/E=E:6=H



M.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97







#L\

3!P=#L@

3!P=#L@9F]N

'!T.R!F;VYT+69A







38P

M:61T:#H@






M=&]M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E




T0G=VED=&@Z(#$E.R!V





M



M






M









T0G=VED=&@Z(#$E

38P.SPO=&0^/'1D('9A






M;&4]



M;&EG;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O







M8V]L;W(Z(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T






M87`]



24[('9E









M)SXF(S$V




M;F0M8V]L;W(Z(-F9F9F9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B

T0G=VED=&@Z(#$R)3L@=F5R=&EC86PM86QI9VXZ(&)O






T0G

38P.SPO




M=&]M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F




T0G=VED=&@Z(#$E.R!V



3!P=#L@9F]N

T1N;W=R87`@=F%L:6=N/3-$8F]T


M9CLG/B8C



38P.SPO=&0^/'1D('9A;&EG;CTS

M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97

3$Q

M=&]M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F




T0G=VED=&@Z(#$E.R!V



3!P=#L@9F]N

T1B



#L\







3!P=#L@9F]N=UF86UI;'DZ(=4


@3F5W(%)O;6%N)RP@5&EM97
L

C@N






3(E.R!V97)T





M:61T:#H@



T0G=VED=&@Z(#$P)3L@=F5R

M93H@






T0G



M93H@

T1N;W=R87`@

M86QI9VXZ(&)O='1O;3L@=&5X=UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9UC

38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O
6QE/3-$)W=I

38P.SPO=&0^
F4Z

@3F5W(%)O;6%N)RP@5&EM97
L









T1N;W=R87`@

M86QI9VXZ(&)O='1O;3L@=&5X=UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9UC

38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O
6QE/3-$)W=I

38P.SPO=&0^
F4Z

@3F5W(%)O;6%N)RP@5&EM97
L



M8F]T=&]M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C

M

T0G







T0G=VED=&@Z





T0G=VED=&@Z(#$E





M)B



M87`]


38P.SPO=&0^/'1D('9A



M/B8C

@3F5W(%)O
M;6%N)RP@5&EM97







T0G=VED=&@Z

T0G








T0G=VED=&@Z

T0G







T0G=VED=&@Z

T0G





M


M


3!P=#L@9F]N=UF86UI;'DZ(=4:6UE

#PO9&EV/CPO=&0^




M


M/3-$)W=I9'1H.B`Q





38P.SPO



M(V-C965F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL
M93TS1=W:61T:#H@,3`E.R!V97)T:6-A;UA;&EG;CH@8F]T=&]M.R!T97AT






T0G=VED=&@Z(#$E.R!V

38P.SPO=&0^/'1D('9A;&EG






T0G




M8F]T=&]M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C



#PO9&EV/CPO=&0^




M




3!P=#L@9F]N=UF86UI;'DZ(=4:6UE

#PO9&EV/CPO=&0^




M




3!P=#L@9F]N=UF86UI;'DZ(=4:6UE



38P.SPO=&0^

M






T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M


M/B8C



38P.SPO=&0^/'1D('9A;&EG;CTS1&)O
M='1O;2!S='EL93TS1=W:61T:#H@,3(E.R!V97)T:6-A;UA;&EG;CH@8F]T

'!T.R!F;VYT+69A




T0G=VED

38P.SPO=&0^



T1B;W1T



#L\+W1D





M:#H@






T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M


M/B8C



38P.SPO=&0^/'1D('9A;&EG;CTS1&)O

M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97

#`\

M:#H@










M

M(&9O;G0M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97


M='1O;3H@

'!T.R!F

M




#L\

#`P
#`P

6QE



M87`]



M9CLG/B8C


M9&5R+6)O='1O;3H@(S`P
#`P

#L\+W1D/CQT






M9VX]


38P.SPO=&0^

P
#`P
#`@
G!X
M('-O;&ED.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C

'0M86QI9VXZ(')I9VAT

24[('9E



T0G=VED=&@Z

M965F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS

P
#`P
#`@
G!X('-O;&ED.R!T97AT+6%L:6=N.B!L969T.R!B







M8V]L;W(Z(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T


38P.SPO=&0^/'1D('9A;&EG

P
#`P
#`@
G!X('-O;&ED.R!T

M)B
'0M86QI9VXZ(')I9VAT.R!B86-K9W)O





T0G=VED=&@Z(#$E.R!V

M/B8C

P
#`P
#`@
G!X('-O;&ED.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O

'0M


M:61T:#H@


M(-C8V5E9F8[)SXF(S$V,#L\+W1D/CPO='(^/'1R/CQT9!V86QI9VX]
T1B


M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97

M/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=W:61T:#H@,3(E
M.R!V97)T:6-A;UA;&EG;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!R:6=H=#L@




T0G=VED




M.R!B;W)D97(M8F]T=&]M.B`C
#`P

#L\

'!T

T1N;W=R87`@=F%L


38P.SPO=&0^

M)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
M
#`P


@3F5W(%)O;6%N)RP@5&EM97
L('-E

M1=W:61T:#H@,3`E.R!V97)T:6-A;UA;&EG;CH@8F]T=&]M.R!B;W)D97(M
M8F]T=&]M.B`C
#`P


@3F5W(%)O;6%N
M)RP@5&EM97

3(N
#L@
M=&5X=UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9UC;VQO<CH@(V9F9F9F9CLG
M/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=W:61T
M:#H@







'!T.R!F;VYT+69A

T1B;W1T;VT@





M;&EG;CH@8F]T=&]M.R!B;W)D97(M8F]T=&]M.B`C
#`P

M9F8[)SXF(S$V

M=&]M.B`C
#`P


@3F5W(%)O;6%N)RP@
M5&EM97

3
X+#8W



M)B


M



M;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P





M:6YG+6)O='1O;3H@-'!X.R!T97AT+6%L:6=N.B!R:6=H=#L@8F%C:V=R;W5N









Q-C`[/]D:78^/&1I=B!S='EL93TS1=F;VYT

@3F5W(%)O;6%N)RP@
M5&EM97


M;G0@86-T:79I='D@9'5R:6YG(#(P
30@86YD(#(P
3

@3F5W(%)O
M;6%N)RP@5&EM97

#`P
#LG/CH\+V9O;G0^


T0G=F5R

M
38P.SPO=&0^/'1D(&-O;'-P86X]
T0Q

M

T1N;W=R


M)SXF(S$V


M;&4]
T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@
M(S`P
#`P


M)SY


T1B;W1T;VT@



38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL
M93TS1=V97)T:6-A;UA;&EG;CH@8F]T=&]M.R!P861D:6YG+6)O='1O;3H@
M


P
#`P
#`@



T1N;W=R87`@


M(S$V



'!T.R!F
'0M86QI9VXZ(&-E;G1E<CLG/D%V97)A

M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97



M



38P.SPO=&0^/'1D(&-O;'-P86X]
T0R
M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=V97)T:6-A;UA;&EG;CH@8F]T
M=&]M.R!B;W)D97(M8F]T=&]M.B`C
#`P




M;&4]
'0M86QI9VXZ(&-E;G1E<CLG/D%V97)A9V4@/]D:78^/&1I=B!S='EL93TS


T0G





M;CH@;&5F=#LG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL
M93TS1=V97)T:6-A;UA;&EG;CH@8F]T=&]M.R!P861D:6YG+6)O='1O;3H@
M


P
#`P
#`@



T1N;W=R87`@


M(S$V



'!T.R!F
'0M86QI9VXZ(&-E;G1E<CLG/D%V97)A

M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97



M



38P.SPO=&0^/'1D(&-O;'-P86X]
T0R
M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=V97)T:6-A;UA;&EG;CH@8F]T
M=&]M.R!B;W)D97(M8F]T=&]M.B`C
#`P




M;&4]
'0M86QI9VXZ(&-E;G1E<CLG/D%V97)A9V4@/]D:78^/&1I=B!S='EL93TS


T0G





M;CH@;&5F=#LG/B8C


@3F5W(%)O
M;6%N)RP@5&EM97


M86YU87)Y(#$L(#(P
3







38P

M8V5E9F8[)SXF(S$V





T1N;W=R87`@=F%L:6=N


M(V-C965F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL


M8F]T=&]M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C








T0G=VED



M



M8V]L;W(Z(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T



M86QI9VXZ(&)O='1O;3L@=&5X=UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9UC






M:#H@



T0G=VED=&@Z(#$E.R!V97)T:6-A


38P.SPO=&0^/'1D
F4Z(#$P

@3F5W(%)O;6%N)RP@5&EM97
L('-E




M

M

M(-F9F9F9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]

M;&4]










T0G=VED=&@Z(#$E



3!P=#L@




T0G



M9CLG/B8C



#L\








M;F0M8V]L;W(Z(-F9F9F9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B




38P.SPO=&0^/'1D('9A;&EG;CTS1&)O

M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97

38N
#`\

M:#H@

M;W(Z(-F9F9F9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T;VT@



#L\+W1D/CQT




T0G=F5R=&EC86PM86QI9VXZ(&)O




T0G=F5R=&EC86PM86QI9VXZ

M(V-C965F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL
M93TS1=V97)T:6-A;UA;&EG;CH@8F]T=&]M.R!B86-K9W)O=6YD+6-O;&]R







M9VX]

T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@





M8V]L;W(Z(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T


38P.SPO
M=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=V97)T:6-A;UA;&EG

'!T.R!F

T1N;W=R87`@=F%L:6=N



T0G=F5R=&EC

M(&9O;G0M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97



M;&EG;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O






M='EL93TS1=V97)T:6-A;UA;&EG;CH@8F]T=&]M.R!B86-K9W)O=6YD+6-O

#L\

M

3PO9&EV/CPO=&0^/'1D(&YO


M


M


@3F5W(%)O;6%N)RP@5&EM
M97











T0G=F5R=&EC86PM86QI9VXZ

3!P=#L@9F]N

M

T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X




38P.SPO=&0^
M/'1D(&-O;'-P86X]
T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=V97)T
M:6-A;UA;&EG;CH@8F]T=&]M.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F



T0G

38P.SPO=&0^/'1D('9A;&EG
M;CTS1&)O='1O;2!S='EL93TS1=V97)T:6-A;UA;&EG;CH@8F]T=&]M.R!T

T1B;W1T


38P.SPO


M.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97




38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O
M;2!S='EL93TS1=V97)T:6-A;UA;&EG;CH@8F]T=&]M.R!T97AT+6%L:6=N

F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97






M8V5E9F8[)SXF(S$V

M(V-C965F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL
M93TS1=V97)T:6-A;UA;&EG;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!L969T


M1&)O='1O;2!S='EL93TS1=V97)T:6-A;UA;&EG;CH@8F]T=&]M.R!T97AT

Q

M(S$V



'0M86QI9VXZ(&QE9G0[(&)A8VMG<F]U
M;F0M8V]L;W(Z(-C8V5E9F8[)SXF(S$V

38P.SPO=&0^/'1D(&-O;'-P86X]
M
T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=V97)T:6-A;UA;&EG;CH@





T0G=F5R=&EC86PM86QI
M9VXZ(&)O='1O;3L@=&5X=UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9UC;VQO

38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S
M='EL93TS1=V97)T:6-A;UA;&EG;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!R


T0G


C@E.R!V97)T


@3F5W(%)O;6%N)RP@5&EM
M97


M;W(@8V%N8V5L;&5D/]D:78^/]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T


M:#H@



M='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P

M97
@3F5W(%)O;6%N)RP@5&EM97



3!P=#L@

38P.SPO

P
#`P
#`@
M
G!X('-O;&ED.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R

'0M86QI9VXZ(')I


M



T0G

M=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P
M


M;W)D97(M8F]T=&]M.B`C
#`P






38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S

M)SXF(S$V

M.B`C
#`P







3!P

38P

P
#`P
M
#`@
G!X('-O;&ED.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O

'0M86QI9VXZ


M;W=R87`]



M9F9F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS

M

#`P
M


38P.SPO

M+6)O='1O;3H@
G!X.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O








T0G=VED=&@Z(#$E.R!V



3!P=#L@9F]N

T1N;W=R87`@=F%L:6=N


M(V-C965F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL


M8F]T=&]M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C




#L\+W1D








M;W(Z(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T;VT@



M9VXZ(&)O='1O;3L@=&5X=UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9UC;VQO

38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S

M5&EM97
@3F5W(%)O;6%N)RP@5&EM97



Q

M(V-C965F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL

M



M(%1I;65S+!S97)I9CLG/C4N,C0\+V1I=CX\+W1D/CQT9!N;W=R87`]
T1N


38P.SPO=&0^/'1D('9A;&EG;CTS

#L\+W1D





M93TS1=V97)T:6-A;UA;&EG;CH@8F]T=&]M.R!B86-K9W)O=6YD+6-O;&]R




M97)I9CLG/C0L




M86QI9VX]

T0G=F5R=&EC86PM86QI9VXZ(&)O='1O







T0G=F5R=&EC86PM86QI9VXZ

M(V9F9F9F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL
M93TS1=V97)T:6-A;UA;&EG;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!R:6=H


T0G=F5R

38P.SPO=&0^/'1D('9A;&EG;CTS
M1&)O='1O;2!S='EL93TS1=V97)T:6-A;UA;&EG;CH@8F]T=&]M.R!B86-K

'0M86QI9VXZ(&QE9G0[(&)A8VMG<F]U;F0M8V]L;W(Z(-F9F9F9F8[)SXF
M(S$V



M;CTS1&)O='1O;2!S='EL93TS1=V97)T:6-A;UA;&EG;CH@8F]T=&]M.R!T

M)B

M)SXF(S$V





T0G=F5R=&EC86PM
M86QI9VXZ(&)O='1O;3L@=&5X=UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9UC

38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O
M;2!S='EL93TS1=V97)T:6-A;UA;&EG;CH@8F]T=&]M.R!B86-K9W)O=6YD

'0M86QI
M9VXZ(&QE9G0[(&)A8VMG<F]U;F0M8V]L;W(Z(-F9F9F9F8[)SXF(S$V
#L\

M;W(Z(-F9F9F9F8[)SXF(S$V,#L\+W1D/CQT9!N;W=R87`]
T1N;W=R87`@


T1B;W1T;VT@


'!T

G!T.R!T97AT




M86QI9VX]

T0G=F5R=&EC86PM86QI9VXZ(&)O='1O

M9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=V
M97)T:6-A;UA;&EG;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!R:6=H=#L@8F%C

M:7IE.B`Q

M;65S+!S97)I9CLG/BT\+V1I=CX\+W1D/CQT9!N;W=R87`]
T1N;W=R87`@



T0G


@3F5W(%)O;6%N)RP@5&EM97
L











T0G=F5R=&EC86PM86QI9VXZ(&)O






B!V86QI9VX]

T0G=F5R

'!T.R!F;VYT+69A;6EL





M9VX]

T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@

M)SXF(S$V
'0M86QI
M9VXZ(&QE9G0[(&)A8VMG<F]U;F0M8V]L;W(Z(-C8V5E9F8[)SXF(S$V
#L\


M(&]R(&-A;F-E;&QE9#PO9&EV/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S
M='EL93TS1=V97)T:6-A;UA;&EG;CH@8F]T=&]M.R!P861D:6YG+6)O='1O
M;3H@


P
#`P
#`@
G!X('-O;&ED.R!T

M)B

P
#`P
#`@
G!X

'!T.R!F;VYT

T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M


M(-F9F9F9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]

M;&4]









M(V9F9F9F9CLG/B8C






M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=V97)T:6-A;UA;&EG;CH@8F]T
M=&]M.R!P861D:6YG+6)O='1O;3H@
G!X.R!T97AT+6%L:6=N.B!L969T.R!B





M/C4N


38P
M.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=V97)T:6-A;UA
M;&EG;CH@8F]T=&]M.R!B;W)D97(M8F]T=&]M.B`C
#`P



#L\+W1D/CPO='(^/'1R


#$T/]D:78^/]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T


M:#H@

M(,P,#`P,#`@-'!X(&1O=6)L93L@=&5X=UA;&EG;CH@;&5F=#L@8F%C:V=R







M



M;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P



#L@=&5X=UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9UC;VQO<CH@
M(V-C965F9CLG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL
M93TS1=W:61T:#H@



T0G=VED=&@Z

M;F0M8V]L;W(Z(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B







M)B










38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O

M9F8[)SXF(S$V

M=&]M.B`C
#`P






M;W=R87`]



M965F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS

M

#`P
M


M.R!B;W)D97(M8F]T=&]M.B`C
#`P

@
M3F5W(%)O;6%N)RP@5&EM97

BXY/]D:78^/]T9#X\=&0@

M8V5E9F8[)SXF(S$V












M:#H@



T0G=VED=&@Z(#$E.R!V97)T



M.B`Y)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@
M(S`P
#`P



24[('9E


M9VX]




T0G=VED



#L\



M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F



M:7IE.B`Q

M;65S+!S97)I9CLG/C0R-BPT.#D\+V1I=CX\+W1D/CQT9!N;W=R87`]
T1N



M

#L\+W1D/CQT

#`P





M

T1N;W=R87`@=F%L


38P.SPO=&0^


M8F]T=&]M.R!B;W)D97(M8F]T=&]M.B`C
#`P

M(S$V

M
#`P


@3F5W(%)O;6%N)RP@5&EM97
L



#L\+W1D





38P.R8C
38P.R8C
38P.R8C
38P.R8C
38P.R8C
38P
M.R8C
38P.R8C
38P.R8C
38P.R8C
38P.R8C
38P.R8C
38P.R8C
38P.R8C
M
38P.R8C
38P.R8C
38P.R8C
38P.R8C
38P.R8C
38P.R8C
38P.R8C
38P
M.R8C
38P.R8C
38P.R8C
38P.R8C
38P.R8C
38P.R8C
38P.R8C
38P.R8C
M
38P.R8C
38P.R8C
38P.R8C
38P.R8C
38P.R8C
38P.R8C
38P.R8C
38P
M.R8C
38P.R8C
38P.R8C
38P.R8C
38P.R8C
38P.R8C
38P.R8C
38P.R8C
M
38P.R8C
38P.R8C
38P.R8C
38P.R8C




Z
M/]D:78^/&1I=CXF(S$V,#L\+V1I=CX\=&%B;&4@8F]R9&5R/3-$,!C96QL


M93H@

B!V
M86QI9VX]

T0G=F5R=&EC86PM86QI9VXZ(&)O='1O


M=#LG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=V
M97)T:6-A;UA;&EG;CH@8F]T=&]M.R!P861D:6YG+6)O='1O;3H@

M)B
Q-C`[)B

3`@=F%L:6=N/3-$8F]T=&]M



@3F5W(%)O;6%N)RP@5&EM
M97

T1N;W=R


M)SXF(S$V


M;&4]
T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@
M(S`P
#`P



M

P
#`P
#`@



@
M3F5W(%)O;6%N)RP@5&EM97






@3F5W(%)O;6%N)RP@5&EM97
L

M:68[(&9O;G0M=V5I9VAT.B!B;VQD.R!T97AT+6%L:6=N.B!C96YT97([)SY7


M)SXF(S$V

M93H@


M;G0M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97


T1N;W=R87`@=F%L:6=N/3-$8F]T


#L\+W1D/CQT
!S;VQI




F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM
M97
@3F5W(%)O;6%N)RP@5&EM97




M;&4]


38P.SPO=&0^/'1D(&-O;'-P86X]
T0R('9A;&EG;CTS1&)O
M='1O;2!S='EL93TS1=V97)T:6-A;UA;&EG;CH@8F]T=&]M.R!B;W)D97(M
M8F]T=&]M.B`C
#`P








M
'0M86QI9VXZ(&-E;G1E<CLG

M
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=V97)T:6-A
M;UA;&EG;CH@8F]T=&]M.R!P861D:6YG+6)O='1O;3H@

Q-C`[

P
#`P
M
#`@




'!T.R!F;VYT+69A;6EL


M93TS1=V97)T:6-A;UA;&EG;CH@8F]T=&]M.R!P861D:6YG+6)O='1O;3H@
M


M
B!V86QI9VX]

T0G=F5R=&EC86PM86QI9VXZ(&)O
M='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P



M





M8F]T=&]M.R!P861D:6YG+6)O='1O;3H@
G!X.R!T97AT+6%L:6=N.B!L969T


B!V86QI9VX]

M;&4]
T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@
M(S`P
#`P



M:68[(&9O;G0M=V5I9VAT.B!B;VQD.R!T97AT+6%L:6=N.B!C96YT97([)SY!





M;G0M=V5I9VAT.B!B;VQD.R!T97AT+6%L:6=N.B!C96YT97([)SY

T1N;W=R87`@=F%L:6=N/3-$


#L\+W1D




T1B;W1T;VT@





#M





T0G=VED=&@Z(#DE.R!V






T0G=VED=&@Z(#$E.R!V97)T


@3F5W(%)O;6%N)RP@5&EM97
L


M97
@3F5W(%)O;6%N)RP@5&EM97




M9CLG/B8C

#L\+W1D


M.B`Q


M86QI9VX]






M;W(Z(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T;VT@





M

M(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]

M;&4]

M97
@3F5W(%)O;6%N)RP@5&EM97

F4Z(#$P

@3F5W(%)O;6%N)RP@5&EM97
L('-E

M;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R


38P.SPO=&0^/'1D('9A;&EG






T0G



T0G


'!T.R!F;VYT+69A

T1N;W=R87`@=F%L:6=N


M(V9F9F9F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL



M(V9F9F9F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL

M





T0G=VED=&@Z(#$E



24[


M9VX]

T0G=VED=&@Z(#DE.R!V97)T:6-A;UA;&EG
M;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!R:6=H=#L@8F%C:V=R;W5N9UC;VQO


M/C4N


M;F0M8V]L;W(Z(-F9F9F9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B






M;W=R87`]


38P.SPO=&0^/'1D

M(S$V




M:68[)SXR+#@R-PY-S4\+V1I=CX\+W1D/CQT9!N;W=R87`]
T1N;W=R87`@

M86QI9VXZ(&)O='1O;3L@=&5X=UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9UC

38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O


M;&EG;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O




M








M;&EG;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O





M



M86QI9VXZ(&QE9G0[)SXF(S$V


Q-C`[






M(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]

M;&4]



M(V-C965F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL

M97
@3F5W(%)O;6%N)RP@5&EM97




M9CLG/B8C

#L\+W1D


M.B`Q


M86QI9VX]






M;W(Z(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T;VT@







M)B


38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S

M(S$V




M


38P.SPO=&0^/'1D('9A;&EG

#L\







3!P=#L@9F]N=UF86UI;'DZ(=4



!T;R`D,38N.#`\+V1I=CX\+W1D/CQT9!N;W=R87`]
M


38P.SPO=&0^/'1D('9A;&EG



38P.SPO=&0^/'1D('9A;&EG






M





T0G=VED=&@Z(#DE.R!V













T0G=VED=&@Z



M


@3F5W(%)O;6%N
M)RP@5&EM97

3(L




Q-C`[




T1N;W=R87`@=F%L:6=N/3-$


M9F9F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS


M=&]M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F







#PO9&EV/CPO

M+6)O='1O;3H@
G!X.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O




M



M9&5R+6)O='1O;3H@(S`P
#`P

#L\+W1D/CQT

#`P



M.R!P861D:6YG+6)O='1O;3H@
G!X.R!T97AT+6%L:6=N.B!L969T.R!B86-K



38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S

P
#`P
#`@
G!X('-O;&ED.R!T97AT+6%L:6=N.B!L




T1N;W=R87`@=F%L:6=N/3-$8F]T


38P.SPO=&0^/'1D('9A;&EG


M;W)D97(M8F]T=&]M.B`C
#`P






M.R!P861D:6YG+6)O='1O;3H@
G!X.R!T97AT+6%L:6=N.B!L969T.R!B86-K



38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S

P
#`P
#`@
G!X('-O;&ED.R!T97AT+6%L:6=N.B!L




T1N;W=R87`@=F%L:6=N/3-$8F]T


38P.SPO=&0^/'1D('9A;&EG


M;W)D97(M8F]T=&]M.B`C
#`P








M;CH@8F]T=&]M.R!P861D:6YG+6)O='1O;3H@
G!X.R!B86-K9W)O=6YD+6-O

'0M86QI9VXZ


T0G=VED=&@Z(#DE.R!V97)T

3!P=#L@9F]N

T1N;W=R87`@=F%L:6=N/3-$8F]T







T0G=VED=&@Z(#DE

M9CLG/B8C

M=&]M.R!P861D:6YG+6)O='1O;3H@-'!X.R!T97AT+6%L:6=N.B!L969T.R!B



M.R!P861D:6YG+6)O='1O;3H@-'!X.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F





'!T.R!F;VYT+69A;6EL

T1B;W1T









M





M



M:61T:#H@

M;VTZ(,P,#`P,#`@-'!X(&1O=6)L93L@=&5X=UA;&EG;CH@;&5F=#L@8F%C



\+V1I=CX\
#L@=&5X=UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9UC
M;VQO<CH@(V9F9F9F9CLG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O
M;2!S='EL93TS1=W:61T:#H@



T0G


M9VX]







M



M9&5R+6)O='1O;3H@(S`P
#`P

@3F5W(%)O
M;6%N)RP@5&EM97


P
#`P
#`@-'!X(&1O=6)L93L@=&5X


3!P=#L@9F]N=UF86UI;'DZ(=4



M;W(Z(-F9F9F9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T;VT@


M9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O
M;3H@(S`P
#`P


M(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P



3PO9&EV/CPO

M+6)O='1O;3H@-'!X.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O


M1$134$9


M=&@Z(#$P




#`P
#`P.R!A;&EG;CH@


M(&9O;G0M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97



\9F]N=!S='EL93TS1=F;VYT+7-I

@3F5W(%)O;6%N)RP@5&EM
M97

#`P





#L@5&AE(')E;&%T960@

@87)E(&-L87-S:69I960@87
@9&5R:79A=&EV92!W87)R86YT

#L@56YD


@86YD(&EN8W)E87-E('1H

N
M)B

@;6%Y(&EN8VQU9&4@:7-S=6%N8V5S

M;G




@


@:6X@
C`Q


E]B
M-C5D7S@S






]

T1)1#!%344^#0H@(`@(`\='(^#0H@

3XQ
B!-;VYT:'
@16YD960\+W1H/@T*

M=&@^1&5C+B`S
2P@

]

]


]


M.B`Q

M








M.R!P861D:6YG+6)O='1O;3H@


P
#`P
#`@


P
#`P

30\

38P

B!V86QI9VX]
T1B;W1T;VT@


M(S`P
#`P


#`P
#L@=&5X


T0G=VED=&@Z(#$E.R!V



3!P=#L@9F]N


T0G=VED



38P.SPO=&0^/'1D

B!V
M86QI9VX]














P
#`P





T0G=VED



M:#H@


#`P



@3F5W(%)O;6%N)RP@5&EM
M97

#`P
#LG/C$L.3@X/]D:78^/]T9#X\

#L\+W1D





M;F0M8V]L;W(Z(-F9F9F9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B







M:61T:#H@

M8V]L;W(Z(-F9F9F9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T







M93TS1=W:61T:#H@-38E.R!V97)T:6-A;UA;&EG;CH@=&]P.R!P861D:6YG
M+6)O='1O;3H@







M86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P

M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97

M(S`P
#`P

M;&EG;CH@8F]T=&]M.R!P861D:6YG+6)O='1O;3H@
G!X.R!T97AT+6%L:6=N

#L@8F%C
M:V=R;W5N9UC;VQO<CH@(V-C965F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG

P
#`P
#`@
G!X('-O;&ED.R!T

M)B
'0M86QI9VXZ(')I9VAT.R!B86-K9W)O

M87`]



M9CLG/B8C





M/3-$)W=I9'1H.B`Y)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R
M+6)O='1O;3H@(S`P
#`P


@3F5W(%)O;6%N
M)RP@5&EM97

#`P
#LG/C4L
3



M.R!P861D:6YG+6)O='1O;3H@
G!X.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F

'0M86QI9VXZ(&QE9G0[(&)A

M9VX]





T1N;W=R87`@=F%L


38P.SPO=&0^


M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97


#`P


M(V-C965F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL

M



T0G=VED=&@Z



M


M86QI9VX]

T0G=VED=&@Z(#DE.R!V97)T:6-A;UA
M;&EG;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!R:6=H=#L@8F%C:V=R;W5N9UC








\+V1I=CX\+W1D






M:#H@



T0G=VED=&@Z(#$E.R!V97)T:6-A


38P.SPO=&0^/'1D
F4Z(#$P

@3F5W(%)O;6%N)RP@5&EM97
L('-E

#`P
#LG/C0L-SDU/]D:78^/]T9#X\=&0@;F]W

#L\+W1D/CPO='(^



38P.SPO=&0^/'1D('9A;&EG;CTS

M8V5E9F8[)SXF(S$V




P
#`P
#`[)SXR

M=&]M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E


38P.SPO=&0^/'1D('9A;&EG;CTS1&)O

M9F8[)SXF(S$V




P
#`P
#`[)SXS+#(Q
M

M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F


M93H@




T0G=VED=&@Z



3!P

M87`]


38P.SPO=&0^/'1D('9A

M




M(&-O;&]R.B`C
#`P










T0G=VED=&@Z(#DE.R!V



T0G



M:61T:#H@



T0G=VED=&@Z(#DE.R!V97)T



T0G=VED




#`P
#`P.R!T97AT+6%L:6=N.B!L
M969T.R!M87)G:6XM;&5F=#H@
38N

G!T

M+6)O='1O;3H@

Q

M8V]L;W(Z(-F9F9F9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T





T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M


38P.SPO=&0^/'1D('9A;&EG;CTS


M97(M8F]T=&]M.B`C
#`P





M(,P,#`P,#`[)SXQ-S0\+V1I=CX\+W1D/CQT9!N;W=R87`]
T1N;W=R87`@


38P.SPO







M)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
M
#`P


@3F5W(%)O;6%N)RP@5&EM97
L('-E

#`P
#LG/C$P+#DV
3PO9&EV/CPO=&0^/'1D(&YO

M
G!X.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E

#L@8F%C:V=R;W5N9UC;VQO<CH@(V-C965F9CLG/B8C
38P

P
#`P
M
#`@
G!X('-O;&ED.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O

'0M86QI9VXZ


T1B;W1T




#`P
#`P


38P



'!T.R!F

P
#`P





T0G=VED=&@Z(#$E.R!V



3!P=#L@9F]N

24[('9E



T0G=VED=&@Z(#4V)3L@=F5R=&EC


M

P
#`P




M

#`P
M


M;&4]

T1B;W1T







M86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P

M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97


#`P
#LG/C@L


M

M;&4]
'0M
M86QI9VXZ(&QE9G0[(&UA<F=I;BUL969T.B`W+C)P=#L@=&5X=UI;F1E;G0Z
#L@8F%C:V=R;W5N9UC

38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O

P
#`P

M;&4]



M

P
#`P
#`[)SXQ
#L@=&5X=UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9UC;VQO<CH@(V9F
M9F9F9CLG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS
M1=W:61T:#H@



T0G=VED=&@Z(#$E


M:68[(&-O;&]R.B`C
#`P


P
#`P
#`@-'!X(&1O=6)L93L@=&5X


3!P=#L@9F]N=UF86UI;'DZ(=4





T0G9F]N
'0M86QI9VXZ(&-E
M;G1E<CLG/B8C,38P.SPO9&EV/CQD:78@<W1Y;&4],T0G9F]N=US:7IE.B`Q
M


Q

'!T.R!F;VYT+69A

P
#`P





M;&EG;CTS1&)O='1O;2!S='EL93TS1=W:61T:#H@-#0E.R!V97)T:6-A;UA
M;&EG;CH@=&]P.R!P861D:6YG+6)O='1O;3H@




P
#`P
M


38P.SPO=&0^/'1D('9A

B!V86QI9VX]

T0G=F5R

#`P



#`P

M

#`P
#`P.R!T97AT


T1B




M5&EM97
@3F5W(%)O;6%N)RP@5&EM97


'!T.R!F;VYT

#`P
#`P.R!T97AT+6%L:6=N.B!C

M;&EG;CH@8F]T=&]M.R!P861D:6YG+6)O='1O;3H@
G!X.R!T97AT+6%L:6=N



#`P
#`P.R!T97AT+6%L:6=N.B!L

M)SXR


#L\




M;&]R.B`C
#`P









M:61T:#H@



T0G=VED=&@Z(#$E.R!V97)T

38P.SPO=&0^/'1D('9A;&EG;CTS

M8V5E9F8[)SXF(S$V




P
#`P
#`[)SXT

M=&]M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E




#`P
#`P.R!T97AT+6%L:6=N.B!L969T

M


#L\+W1D




M.B`C
#`P









M:61T:#H@



T0G=VED=&@Z(#$E.R!V97)T

38P.SPO=&0^/'1D('9A;&EG;CTS

M9F9F9F8[)SXF(S$V




P
#`P
#`[)SXW

M=&]M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F




#`P
#`P.R!T97AT+6%L:6=N.B!L969T

M


#L\+W1D




M.B`C
#`P









T0G=VED=&@Z




M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F



#`P


M(S$V




T0G=VED=&@Z(#$E

38P.SPO=&0^/'1D('9A





P
#`P
M


M9F9F9F8[)SXF(S$V


24[


M9VX]

T0G=VED=&@Z(#DE.R!V97)T:6-A;UA;&EG
M;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!R:6=H=#L@8F%C:V=R;W5N9UC;VQO


M8V]L;W(Z(,P,#`P,#`[)SXW-C0\+V1I=CX\+W1D/CQT9!N;W=R87`]
T1N


38P.SPO=&0^/'1D('9A;&EG;CTS
6QE

38P


@3F5W(%)O;6%N)RP@
M5&EM97

#`P





M;&]R.B`C
#`P
#`P.R!T97AT+6%L:6=N.B!L969T.R!M87)G:6XM;&5F=#H@

#$Y/]D:78^/]T9#X\



M=&]M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E



#`P



M)B



T0G=VED=&@Z(#$E.R!V97)T:6-A







M;W(Z(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T;VT@


M/B8C

#L\+W1D/CQT


M

P
#`P


M='(^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=W:61T:#H@-#0E.R!V
M97)T:6-A;UA;&EG;CH@=&]P.R!P861D:6YG+6)O='1O;3H@
G!X.R!B86-K







M8F]R9&5R+6)O='1O;3H@(S`P
#`P

#L\+W1D

#`P
#`P(#)P


M;&]R.B`C
#`P


#`P



38P.SPO=&0^/'1D('9A

P
#`P
#`@
G!X('-O;&ED
M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F

'0M86QI9VXZ(')I9VAT.R!B86-K

M:61T:#H@



M(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P

M.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@
M(S`P
#`P


M=&]M.R!B;W)D97(M8F]T=&]M.B`C
#`P


#`P

M
BPX-S


M='(^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=W:61T:#H@-#0E.R!V
M97)T:6-A;UA;&EG;CH@=&]P.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F




T0G=VED=&@Z(#$E.R!V97)T





T1N;W=R


38P.SPO=&0^/'1D('9A;&EG;CTS1&)O
6QE/3-$

38P.SPO


@3F5W(%)O;6%N)RP@5&EM
M97

#`P
#LG/C$P+#DV
3PO9&EV/CPO=&0^




M




3!P=#L@9F]N=UF86UI;'DZ(=4:6UE



T1B;W1T



'!T.R!F;VYT+69A;6EL

P
M
#`P




#L\

#`P
#`P


M

T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M





T0G=VED=&@Z(#$E.R!V97)T

M(V9F9F9F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL

P
#`P
#`@
G!X('-O;&ED.R!T97AT+6%L:6=N.B!R:6=H



P
#`P
#`[)SXM/]D:78^/]T


P
#`P
#`@
G!X('-O;&ED.R!T97AT+6%L:6=N.B!L969T.R!B




'0M86QI9VXZ(&QE9G0[(&)A8VMG

M




3!P=#L@9F]N=UF86UI;'DZ(=4




#`P



@3F5W(%)O
M;6%N)RP@5&EM97

#`P








T0G




M;W(Z(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T;VT@


38P.SPO=&0^/'1D('9A;&EG;CTS

P
#`P
#`@-'!X(&1O=6)L93L@=&5X


6QE/3-$)W=I
M9'1H.B`Y)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O
M;3H@(S`P,#`P,`T<'@@9&]U8FQE.R!T97AT+6%L:6=N.B!R:6=H=#L@8F%C

M:7IE.B`Q

M;65S+!S97)I9CL@8V]L;W(Z(
P
#`P
#`[)SXQ
PY-C$\+V1I=CX\+W1D
M/CQT9!N;W=R87`]

M)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O
M='1O;3H@(S`P
#`P


M9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P

M9CLG/B8C

P
#`P

6QE/3-$)W=I9'1H.B`Y)3L@=F5R=&EC86PM
M86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P,#`P,`T<'@@9&]U

'!T.R!F;VYT+69A

P
#`P




Q+`R,#$T+!N;VYE





M3F]T92`Q


#L@07
@9&ES8W5S




M8W1O8F5R(#(P





2P@





38P.R`\9F]N=!S='EL93TS1=F;VYT

@3F5W(%)O;6%N)RP@
M5&EM97



@

@82!D
M:69F97)E;G0@;6%T=7)I='D@9&%T92D@86YD('1O(')E;6]V92!T:&4@8V]N





T0G9F]N





#$T+!T:&4@;F]T97,@:&5L9!A
M('!R:6YC:7!A;!B86QA;F-E(&]F(%(D.XQ(&UI;&QI;VXN(%1H92!A;FYU

@:7


C`R
M
2XF(S$V

N)B
Q-C`[($ER9V]V





Q-C`[


N)B
Q-C`[


@;V8@0W)E9&ET/]U
M/CPO9&EV/CQD:78^/&)R(\^/]D:78^/&1I=B!S='EL93TS1=F;VYT+7-I

@3F5W(%)O;6%N)RP@5&EM
M97

M8V]U;G1S(')E8V5I=F%B;&4N)B

S`E+3$P

M(#$R+C4E('1O(#$R-2XT)2P@86YD(&%V97)A9V4@

Q-C`[(%!R


M(%1I;65S+!S97)I9CL@9F]N=UV87)I86YT.B!N;W)M86P[(&9O;G0M=V5I








@861V86YC97

@9G)O;2!V87)I;W5S(&)A
M;FMS+B8C
38P.R!4:&4@86YN=6%L(&EN=&5R97-T(')A=&5S(&]N('1H97-E
M(&%D=F%N8V5S(')A;F=E(&9R;VT@-2XY)2!T;R`Q
XP)2P@86YD(&%V97)A
M9V4@.XP)2XF(S$V

@;V8@86UO=6YT

#$U+CPO9&EV

M9W)A;7



38P

C`Q-P@27)G;W9E;8C


M;65N='

#(Y+B8C
M

24
@=&%R9V5T(')A=&4L('=H:6-H('=A


M;CX\+W-P86X^/]T9#X-B`@(`@(#PO='(^#0H@(`@/]T86)L93X-B`@

M7S8T-F9?-#-A
E]B-C5D7S@S







]

T1)1#!%344^#0H@


]
T1T:#Y$96
N(#

M;VYG/D5154E462!-151(3T0@24Y615-4345.5!;06)S=')A8W1=/]S=')O





3LG/CQU/DY/5$4@
3(N($5154E462!-151(3T0@

M;&4]

M86=R965M96YT('=I=&@@82!P87)T;F5R('=I=&@@=&AE(&=O86P@;V8@9&5V

M('!R;W1E:6X@9G)O;2!R:6-E(&)R86XN)B

3
L

M=&5R;7



2XR(&UI;&QI;VX@87
@

M.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97



M8V]L;W(Z(,P,#`P,#`[)SY20E0@4%)/+!
3$

'!T.R!F;VYT+69A

P
#`P

3

M=&\@82!S97)I97

@869F:6QI

M:79E;'D@5VEL;6%R*2XF(S$V
#L@26X@8V]N;F5C=&EO;B!T:&5R97=I=&@L


M=6)L:6-E;G-E(&]F('1H92!

M:79E('5S92!T:')O=6=H;W5T($-H:6YA+CPO9&EV/CQD:78^/&)R(\^/]D

M96UE;G1S+!W92!O8G1A:6YE9!R:6=H='


M;6%R(&5S=&%B;&ES:&5S('1O(&1E=F5L;W`@;F5W('!R;V1U8W1S(')E;&%T

@9&5R:79A=&EV92P@87
@9&5F:6YE








#$T(&%N9`R,#$S
M+!A;F0@4D)4(%!23R!H87


M;#X-@T*+2TM+2TM/5].97AT4&%R=%]B.60V-&0T,E\V-#9F7S0S83)?8C8U
M9%\X,S(V9#8X-S5A8S0-D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO
M8CED-C1D-#)?-C0V9E\T
V$R7V(V-61?.#


M='
O4VAE970R




CX\


3XQ
B!-;VYT:'
@16YD960\

M87-S/3-$=&@^1&5C+B`S
2P@

]
T1P


M3D-/344@5$%815



T0G
'0M86QI
M9VXZ(&IU<W1I9GD[)SX\=3Y.3U1%(#$S+B!)3D-/344@5$%815,\+W4^/]D

M




T0P(&-E


M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97








@;V8@1&5C96UB97(@
M



M


38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S

M
B!V86QI9VX]

T0G=F5R=&EC86PM86QI9VXZ('1O

#`P


#`P


M;&4]



M
38P.SPO=&0^/'1D(&-O;'-P86X]
T0R('9A;&EG;CTS1&)O='1O;2!S='EL
M93TS1=V97)T:6-A;UA;&EG;CH@=&]P.R!B;W)D97(M8F]T=&]M.B`C
#`P
M

'!T

#`P
#`P.R!T97AT+6%L
M:6=N.B!C96YT97([)SXR


M

T0G=VED=&@Z(#4V)3L@=F5R=&EC86PM86QI9VXZ


\+W4^/]D:78^/]T9#X\=&0@=F%L:6=N/3-$8F]T

M;3LG/B8C
38P.SPO=&0^/'1D(&-O;'-P86X]
T0R('9A;&EG;CTS1&)O='1O

M

M)SXF(S$V


T1N;W=R87`@=F%L

M9VXZ(&)O='1O;3L@=&5X=UA;&EG;CH@;&5F=#LG/B8C,38P.SPO=&0^/]T



38P.SPO=&0^/'1D('9A;&EG

3!P=#L@9F]N





M;W(Z(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T;VT@



M9VXZ(&)O='1O;3L@=&5X=UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9UC;VQO




M
#`P

L



M;&4]

M='





M


M/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R




M



T1N;W=R87`@=F%L:6=N/3-$8F]T


M9CLG/B8C


@3F5W(%)O;6%N)RP@5&EM
M97

#`P

38P.SPO



'!T.R!F;VYT

P
#`P
#`[)SXV





T0G=VED=&@Z(#$E.R!V97)T:6-A





T1N;W=R87`@

M86QI9VXZ(&)O='1O;3L@=&5X=UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9UC


@3F5W
M(%)O;6%N)RP@5&EM97

#`P
#L@=&5X=UA
M;&EG;CH@;&5F=#L@;6%R9VEN+6QE9G0Z(#$V+C)P=#L@=&5X=UI;F1E;G0Z

38P



'!T.R!F

P
#`P


M93H@




T0G=VED=&@Z(#$E



3!P=#L@

M




M5&EM97
@3F5W(%)O;6%N)RP@5&EM97

#`P
M

38P



'!T.R!F

P
#`P


M.B`Q

M+!S97)I9CL@8V]L;W(Z(
P
#`P
#`[)SXI/]D:78^/]T9#X\=&0@=F%L


24[


M9VX]

T0G=VED=&@Z(#DE.R!V97)T:6-A;UA;&EG
M;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!R:6=H=#L@8F%C:V=R;W5N9UC;VQO




T0G=VED=&@Z(#$E.R!V



#`P
#`P
M.R!T97AT+6%L:6=N.B!L969T.R!M87)G:6XM;&5F=#H@
38N
G!T.R!T97AT


\+V1I=CX\







T0G=VED



M:#H@



T0G=VED=&@Z(#DE.R!V97)T:6-A


M97)I9CL@8V]L;W(Z(,P,#`P,#`[)SXV-3(\+V1I=CX\+W1D/CQT9!N;W=R
M87`]




M.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97

M
#`P

M:61T:#H@

M8V]L;W(Z(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T






T1B;W1T;VT@


M5&EM97
@3F5W(%)O;6%N)RP@5&EM97

#`P
M






T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M






M9VX]



M8F]R9&5R+6)O='1O;3H@(S`P
#`P

#L\+W1D

#`P
#`P(#)P


M;&]R.B`C
#`P


M

G!X




T0G
6QE/3-$)V9O;G0M


M:61T:#H@


M(-F9F9F9F8[)SXF(S$V,#L\+W1D/CPO='(^/'1R/CQT9!V86QI9VX]
T1B

T0G=VED=&@Z(#4V)3L@=F5R=&EC86PM86QI9VXZ('1O



P
#`P




M




M(&-O;&]R.B`C
#`P






T0G=VED=&@Z(#$E.R!V



3!P=#L@9F]N

24[('9E



T0G=VED=&@Z(#4V)3L@=F5R=&EC


M

P
#`P


97-S.B!6
M86QU871I;VX@86QL;W=A;F-E/]D:78^/]T9#X\=&0@=F%L:6=N/3-$8F]T





M9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P

M.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97

M
#`P

M;&EG;CH@8F]T=&]M.R!P861D:6YG+6)O='1O;3H@
G!X.R!T97AT+6%L:6=N



T0G=VED=&@Z(#$E


M86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P

M9F8[)SXF(S$V

M=&]M.B`C
#`P



#`P


M+6)O='1O;3H@
G!X.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O

M86QI9VX]

T0G=VED=&@Z(#4V)3L@=F5R=&EC86PM

'!T

P
#`P


T1B


M/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R
M+6)O='1O;3H@(S`P
#`P


M;&EG;CH@8F]T=&]M.R!B;W)D97(M8F]T=&]M.B`C
#`P


M
#`P

M;&EG;CH@8F]T=&]M.R!P861D:6YG+6)O='1O;3H@
G!X.R!T97AT+6%L:6=N



T0G=VED=&@Z(#$E


M86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P

M9F8[)SXF(S$V

M=&]M.B`C
#`P



#`P


M;3H@
G!X.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C











M;W(Z(-F9F9F9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T;VT@


M/B8C

M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F



38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O

M)SXF(S$V



T0G




M;&]R.B`C
#`P
#`P.R!T97AT+6%L:6=N.B!L969T.R!M87)G:6XM;&5F=#H@
M
38N


M='







M;&4]

M97
@3F5W(%)O;6%N)RP@5&EM97

#`P
#LG






T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T




M93H@


T0G



M9CLG/B8C

@3F5W
M(%)O;6%N)RP@5&EM97

#`P
#LG/B@Q+#$T
M

M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F


M



M9F9F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS

@
M3F5W(%)O;6%N)RP@5&EM97

#`P
#LG/B@Q

M=&]M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F

T1B

T0G=VED=&@Z(#4V)3L@=F5R=&EC86PM86QI9VXZ('1O



P
#`P





M9F8[)SXF(S$V





#`P



38P.SPO=&0^

M)SXF(S$V





#`P




G!X.R!B

M=#L@;6%R9VEN+6QE9G0Z(#$V+C)P=#L@=&5X=UI;F1E;G0Z(TW+C)P=#LG



24[


M8F]R9&5R+6)O='1O;3H@(S`P
#`P

@3F5W
M(%)O;6%N)RP@5&EM97

#`P
#LG/C
W
#PO

M861D:6YG+6)O='1O;3H@
G!X.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O

#L@8F%C:V=R;W5N9UC;VQO<CH@
M(V9F9F9F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL

P
#`P
#`@
G!X('-O;&ED.R!T97AT+6%L:6=N.B!L969T




M86QI9VX]





M;&]R.B`C
#`P
#`P.R!T97AT+6%L:6=N.B!L969T.R!M87)G:6XM;&5F=#H@
M
C4N




M



M965F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS

@
M3F5W(%)O;6%N)RP@5&EM97

#`P
#LG/C
L


M9F8[)SXF(S$V






T1B;W1T;VT@




#`P
#`P.R!T
M97AT+6%L:6=N.B!L969T.R!M87)G:6XM;&5F=#H@
38N
G!T.R!T97AT+6EN




M;&EG;CH@8F]T=&]M.R!B;W)D97(M8F]T=&]M.B`C
#`P









#L@8F%C:V=R;W5N9UC;VQO<CH@(V9F
M9F9F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS

P
#`P
#`@
G!X('-O;&ED.R!T97AT+6%L:6=N.B!L969T.R!B




T1N;W=R87`@=F%L


M









'!T.R!F;VYT+69A;6EL

P
M
#`P

M/3-$)W=I9'1H.B`Y)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R
M+6)O='1O;3H@(S`P
#`P

T0G



M;W(Z(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T;VT@


M9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O
M;3H@(S`P
#`P


@3F5W(%)O;6%N)RP@5&EM
M97

#`P

M;&EG;CH@8F]T=&]M.R!B;W)D97(M8F]T=&]M.B`C
#`P

M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97

M(S`P
#`P




38P.SPO=&0^/'1D('9A;&EG;CTS

M9F9F9F8[)SXF(S$V



M;&4]





T0G=VED=&@Z(#DE

38P.SPO=&0^/'1D(&YO






M)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N


6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N=UF86UI

M
#`P


M97
@3F5W(%)O;6%N)RP@5&EM97

#`P
#LG
M/C$W

M=&]M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E


38P.SPO=&0^/'1D('9A;&EG;CTS1&)O





T1N;W=R87`@=F%L:6=N/3-$8F]T


M9CLG/B8C

M5&EM97
@3F5W(%)O;6%N)RP@5&EM97

#`P
M




T0G=VED=&@Z(#$E


38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O

P
#`P
#`@
G!X('-O;&ED.R!T97AT+6%L:6=N



P
#`P
#`[)SXH
SDV


M93H@



M8V]L;W(Z(-F9F9F9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T


38P.SPO

P
#`P
#`@
M

'!T.R!F

P
#`P


M

38P.SPO


M;CH@8F]T=&]M.R!B;W)D97(M8F]T=&]M.B`C
#`P





#`P


M+6)O='1O;3H@-'!X.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O

T1B


M/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R
M+6)O='1O;3H@(S`P
#`P


@3F5W(%)O;6%N
M)RP@5&EM97

#`P
#LG/B0\+V1I=CX\+W1D

#`P
#`P(#1P

M;G0M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97


#`P







M)B


C`Q-!W87,@
M9'5E('1O(AI*2`D
BXU(&UI;&QI;VX@:6X@;F5T(&]P97)A=&EN9R!L;W-S
M(&%N9`H:6DI(0S+C`@;6EL;&EO;B!F;W(@=&AE(&-H86YG92!I;B!T:&4@






2XQ(&UI;&QI
M;VX@;V8@861J=7-T;65N='
@=&\@:6YT86YG:6)L97
@86YD('-T;V-K(&-O


M(&UI;&QI;VX@:6X@
C`Q
R!W87

M*2`D



'!T.R!F

P
#`P


2P@


M







3
N-R!M:6QL:6]N(&%N9!D;R!N;W0@97AP:7)E(&)U=!M87D@

@

4@;V8@=&%X86)L92!I;F-O;64@:6X@86YY('EE87(I
M+CPO9&EV/CQD:78^/&)R(\^/]D:78^/&1I=B!S='EL93TS1=F;VYT+7-I

@3F5W(%)O;6%N)RP@5&EM
M97

#`P

2!A8V-U;75L

#MC:&%N9V4@:6X@;W=N97)S:&EP)B
X


N)B
Q-C`[(%1H
M97)E9F]R92!I;B`R






M:6=N.B!C96YT97([)SXF(S$V






N('-T871E('1A



#L\+V1I=CX\=&%B;&4@86QI9VX]
T1C96YT
M97(@8F]R9&5R/3-$

4[)SX\='(^
M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=W:61T:#H@
S8E.R!V97)T


M/B8C
38P.SPO=&0^/'1D(&-O;'-P86X]
T0R('9A;&EG;CTS1&)O='1O;2!S
M='EL93TS1=V97)T:6-A;UA;&EG;CH@=&]P.R!B;W)D97(M8F]T=&]M.B`C
M
#`P

M

#`P
#`P.R!T97AT
M+6%L:6=N.B!C96YT97([)SXR


T1B;W1T




M97
@3F5W(%)O;6%N)RP@5&EM97


T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M







M8V5E9F8[)SXF(S$V




T0G=VED=&@Z

T0G




#`P
#`P


M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F


M



T1N;W=R87`@=F%L:6=N/3-$










M



M

P
M
#`P
#`@
G!X('-O;&ED.R!T97AT+6%L:6=N.B!R:6=H=#L@8F%C:V=R;W5N

M

P
#`P
#`[)SXH







T0G=VED

38P.SPO=&0^/'1D('9A;&EG;CTS

P
#`P
#`@
G!X('-O;&ED.R!T97AT



P
#`P
#`[
M)SXH
3(L









M









P
#`P
#`[)SXD

M.B`Y)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@
M(S`P
#`P


M:61T:#H@



M;&]R.B`C
#`P


M9F8[)SXF(S$V

M=&]M.B`C
#`P





M.B`C
#`P











2XS(&UI
M;&QI;VX@:6X@

N(&9E9&5R86P@





M=CX\=&%B;&4@86QI9VX]
T1C96YT97(@8F]R9&5R/3-$

M:68[('=I9'1H.B`X



38P.SPO=&0^/'1D(&-O;'-P86X]
M
T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=V97)T:6-A;UA;&EG;CH@
M=&]P.R!B;W)D97(M8F]T=&]M.B`C
#`P



M(&-O;&]R.B`C
#`P
#`P.R!T97AT+6%L:6=N.B!C96YT97([)SXR



T0G=VED=&@Z(#$E.R!V



@3F5W(%)O;6%N)RP@5&EM97
L('-E

T1N



M;CTS1&)O='1O;2!S='EL93TS1=W:61T:#H@-38E.R!V97)T:6-A;UA;&EG



G!T.R!T97AT+6EN9&5N=#H@



M






#`P
#`P


3!P=#L@9F]N



M86QI9VX]


M(&9O;G0M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97


#`P


'!T.R!F;VYT+69A

P
#`P


M

P
#`P



#`P
#`P





M=&]M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F





38P

M9F9F9F8[)SXF(S$V


Q-C`[


M87`]




M.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97

M
#`P





M;F0M8V]L;W(Z(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B








M:68[(&-O;&]R.B`C
#`P


#L\+W1D




M.B`C
#`P





T0G=VED=&@Z(#4V)3L@=F5R=&EC



P
#`P
#`[
'0M




M)B


#`P

3PO




T0G



M9CLG/B8C

@3F5W
M(%)O;6%N)RP@5&EM97

#`P
#LG/C0L.3(W


M)SXF(S$V



T0G=VED=&@Z(#$E.R!V


38P.SPO


@3F5W(%)O;6%N)RP@5&EM
M97

#`P
#LG/C0X-#PO9&EV/CPO=&0^/'1D



M/B8C

#L\+W1D/CQT


M

P
#`P


#L\+W1D/CPO='(^/'1R



T1B;W1T



M86QI9VXZ(&)O='1O;3L@=&5X=UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9UC

38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O

M.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97

M
#`P







T1N;W=R87`@=F%L:6=N/3-$


M9F9F9CLG/B8C


@3F5W(%)O;6%N)RP@
M5&EM97

#`P




M


M86QI9VX]

T0G=VED=&@Z(#DE.R!V97)T:6-A;UA
M;&EG;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!R:6=H=#L@8F%C:V=R;W5N9UC



M


38P.SPO=&0^/'1D('9A;&EG

#L\




M;&]R.B`C
#`P







M



M9F9F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS

@
M3F5W(%)O;6%N)RP@5&EM97

#`P
#LG/C0Q

M=&]M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F


38P.SPO=&0^/'1D('9A;&EG;CTS1&)O

M9F8[)SXF(S$V




P
#`P
#`[)SXT
34\

M93TS1=W:61T:#H@-38E.R!V97)T:6-A;UA;&EG;CH@=&]P.R!B86-K9W)O

M9VEN+6QE9G0Z(#$V+C)P=#L@=&5X=UI;F1E;G0Z(TW+C)P=#LG/DYO;G1A



24[


M9VX]

T0G=VED=&@Z(#DE.R!V97)T:6-A;UA;&EG
M;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!R:6=H=#L@8F%C:V=R;W5N9UC;VQO


M8V]L;W(Z(,P,#`P,#`[)SXT,3$\+V1I=CX\+W1D/CQT9!N;W=R87`]
T1N


38P.SPO=&0^/'1D('9A;&EG;CTS

#L\+W1D




M.B`C
#`P




M;&4]

T1B;W1T;VT@



M9VXZ(&)O='1O;3L@=&5X=UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9UC;VQO

38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S

M5&EM97
@3F5W(%)O;6%N)RP@5&EM97

#`P
M
#LG/C
L




'0M


T1B





#`P
#`P.R!T97AT+6%L:6=N.B!L969T
M.R!M87)G:6XM;&5F=#H@
38N




M




M(&-O;&]R.B`C
#`P








T1N;W=R





3!P=#L@9F]N=UF86UI;'DZ(=4

24[


M






38P.SPO=&0^

M)SXF(S$V





#`P






38P.SPO=&0^/'1D('9A





P
#`P
M

M8F]T=&]M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C


38P.SPO=&0^/'1D('9A;&EG;CTS

M8V5E9F8[)SXF(S$V




P
#`P
#`[)SXM


M)SXF(S$V



M

P
M
#`P
#`@
G!X('-O;&ED.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD

'0M86QI





M



M9&5R+6)O='1O;3H@(S`P
#`P

#L\+W1D/CQT

#`P


M.B`C
#`P





M1=W:61T:#H@-38E.R!V97)T:6-A;UA;&EG;CH@=&]P.R!P861D:6YG+6)O


G!T.R!T97AT+6EN9&5N

#L@8F%C:V=R;W5N
M9UC;VQO<CH@(V-C965F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O

P
#`P


6QE/3-$)W=I9'1H
M.B`Y)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@
M(S`P,#`P,`T<'@@9&]U8FQE.R!T97AT+6%L:6=N.B!R:6=H=#L@8F%C:V=R

M.B`Q

M+!S97)I9CL@8V]L;W(Z(
P
#`P
#`[)SXH
2PS
#0\+V1I=CX\+W1D/CQT

'!T.R!F;VYT

P
#`P
#`[)SXI/]D:78^/]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M


M:61T:#H@

M;VTZ(,P,#`P,#`@-'!X(&1O=6)L93L@=&5X=UA;&EG;CH@;&5F=#L@8F%C

M:7IE.B`Q

M;65S+!S97)I9CL@8V]L;W(Z(
P
#`P
#`[)SXD/]D:78^/]T9#X\=&0@

M86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P



M(,P,#`P,#`[)SXH,2PT,SD\+V1I=CX\+W1D/CQT9!N;W=R87`]
T1N;W=R




#`P
#`P.R!T



M;W-I=&EO;G

M
2P@

V$R7V(V
M-61?.#

T#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T
Z
M+V(Y9#8T9#0R7S8T-F9?-#-A
E]B-C5D7S@S







M
3XQ
B!-;VYT:'

2P@



]







3!P=#L@9F]N=UF86UI;'DZ(=4

F4Z(#$P<'0[(&9O;G0M9F%M:6QY
M.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97

M
#`P




@3F5W(%)O;6%N)RP@5&EM97
L('-E

#`P


@=VAI8V@@:6YC

N)B
Q-C`[(%=H
M:6QE('1H92!M87AI;75M(&%M;W5N=!T;R!W:&EC:!W92!M87D@8F4@97AP




#`P

M:7IE.B`Q

M;65S+!S97)I9CL@8V]L;W(Z(
P
#`P


@=6YD97(@=F%R:6]U





34[(0P+C4@;6EL;&EO;B!I;B`R
M,#$V.R`D,XS(&UI;&QI;VX@:6X@
C`Q-SL@)#`N
B!M:6QL:6]N(&EN(#(P
M
3@[(0P+C(@;6EL;&EO;B!I;B`R,#$Y(&%N9`D


M93H@

M:68[(&-O;&]R.B`C
#`P



@9F]R(&-O
M;G1I;F=E;F-I97






M8V]S='




T0G9F]N
3LG/D]N($%U9W5S
M=`R.P@,C`P.P@9F]R;65R($ER9V]V96P@<W1O8VMH;VQD97(@1&%V:60@


M(S$V


M=&AE('!R97-E;G1A=&EO;B!O9B!A;&P@9&]C=6UE;G1A=&EO;B!R96QA=&5D



X
C$W.W

M(&-O;G1R;VP@=&\@=7

@
M87

M;G0M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97





@86YD('5S

S$L(#(P

@:6X@8V]N;F5C=&EO;B!W:71H('1H92!A8F]V




P
#`P
#`[)SY/


M:70@;F]T960@86)O=F4N)B

@







F(S@R
















C`Q
M




@86YD('1H92!N970@8F%L86YC92!D=64@


M92!!9W)E96UE;G0N)B
Q-C`[($%S(&]F($1E8V5M8F5R(#
Q+`R,#$T+`D
M




M960@8GD@=&AE(&5S8W)O=R!A8V-O=6YT+B8C
38P.R!)9B!A;F0@=VAE;B!R

M;&]R.B`C
#`P





'!T.R!F;VYT
3LG/DEN($IA;G5A<GD@
C`Q
BP@=V4@9FEL960@



#L@070@
M=')I86P@:6X@075G=7-T(#(P
3
L($1I86)C;R!S=&EP=6QA=&5D('1H870@

C`Q
RP@:6YC;'5D:6YG(&EN
M=&5R97-T(&%N9!L871E(&9E97,L(&%M;W5N=&5D('1O(0P+CD@;6EL;&EO
M;BXF(S$V
#L@26X@4V5P=&5M8F5R(#(P
3

M:6X@=&AE(&%M;W5N=!O9B`D,XY(&UI;&QI;VX@87

#$S

M;V8@)#$N


E\V-#9F7S0S83)?8C8U9%\X
M









]
T1T:#Y$96
N(#



T1T;W`^4D5

]

M;&4]

M:7IE.B`Q




T0G9F]N

M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97


@8F5N969I8VEA;&QY(&]W;F5D

BXV

#$S+B8C
38P.R!)
M;B`R


@8F5N969I8VEA;&QY(&]W;F5D
M(&)Y($UR+B!(86QP97)N+B8C
38P.R!4:&4@=&5R;7
@;V8@=&AE(&YO=&5S




3!P=#L@9F]N





2P@


BXY
M(&UI;&QI;VX@870@=&EM92!O9B!T:&4@17AC:&%N9V4I+B8C
38P.R!4:&4@







M(&-O;&]R.B`C
#`P



30N


@8F5T=V5E;B!*86YU
M87)Y(#(P




M9B!T:&4@17AC:&%N9V4I+B8C




M

T0G


3!P=#L@9F]N


C`Q
B!A;F0@86X@861D
M:71I;VYA;`D,C4@=&AO=7-A;F0@:6X@07!R:6P@,C`Q,RXF(S$V,#L@26X@
M,C`Q-!A;F0@
C`Q

M93H@


Q-C`[($EN($IU;F4@
C`Q
RP@37(N(%-H


3
@=&AR;W5G:!*=6YE(#(P,30N
M)B,Q-C`[($EN(&-O;FYE8W1I;VX@=VET:!T:&4@96QE8W1I;VXL(&EN(#(P
M
3

X
C$W
M.W
@8V]N=F5R=&EB;&4@;F]T97
@8GD@
C


M;G0M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97





3!P=#L@9F]N=UF86UI;'DZ(=4


@3F5W(%)O;6%N)RP@
M5&EM97


@;V8@;W5R(&-O;6UO;B!S=&]C:RXF(S$V
#L@5&AE





M9VAT/]U/CPO9&EV/CQD:78^/&)R(\^/]D:78^/&1I=B!S='EL93TS1=F

@3F5W(%)O;6%N
M)RP@5&EM97



@;6EL;&EO;BXF(S$V
#L@36%R:R!-8TMN


M





#L@5V4@:&%D('1H



Q-C`[

P@,C`Q-P@=V4@:7-S=65D(#(R-2PY



@3F5W(%)O;6%N)RP@5&EM
M97


38P.SPO





#$T+CPO9&EV/CQD:78^/&)R(\^/]D:78^/&1I=B!S='EL93TS

M+W1A8FQE/@T*(`\+V)O9'D^#0H\+VAT;6P^#0H-BTM+2TM+3U?3F5X=%!A

V$R7V(V-61?.#

T#0I#;VYT
M96YT+4QO8V%T:6]N.B!F:6QE.B\O+T
Z+V(Y9#8T9#0R7S8T-F9?-#-A
E]B
M-C5D7S@S





]
T1T:#Y$96
N
M(#













N($EN(&%D9&ET:6]N('=E(&EN



L('=H:6-H(&EN
M8VQU9&4@8V]S='






@3F5W(%)O;6%N)RP@5&EM97
L('-E

T0G9F]N


I+CPO9&EV/CQD:78^/&)R
M(\^/]D:78^/'1A8FQE(&-E;&QP861D:6YG/3-$



M='(^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=V97)T:6-A;UA;&EG
M;CH@=&]P.R!P861D:6YG+6)O='1O;3H@





M5&EM97
@3F5W(%)O;6%N)RP@5&EM97


T1N;W=R87`@=F%L:6=N/3-$8F]T


#L\+W1D/CPO



M.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97


M9VX]

T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@



M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97


M9VX]

T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@



M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97


M86QI9VX]

T0G=F5R=&EC86PM86QI9VXZ(&)O='1O



M;G0M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97



T0G=F5R=&EC86PM86QI

M;2!S='EL93TS1=W:61T:#H@-3(E.R!V97)T:6-A;UA;&EG;CH@=&]P.R!B




M4F5V96YU97



'!T.R!F;VYT+69A

P
#`P
#`[)SXD/]D:78^/]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T



3!P=#L@9F]N=UF86UI;'DZ(=4

T1B


M)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N


6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N=UF86UI

M
#`P


M97
@3F5W(%)O;6%N)RP@5&EM97

#`P
#LG

M8F]T=&]M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C


38P.SPO=&0^/'1D('9A;&EG;CTS





M9VX]







M;&]R.B`C
#`P


M.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97

M
#`P

M;&EG;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O


3!P=#L@9F]N


T0G=VED


M=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P


M97(M8F]T=&]M.B`C
#`P


#`P


M+6)O='1O;3H@
G!X.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O

#L@8F%C:V=R;W5N9UC;VQO<CH@(V9F9F9F
M9CLG/B8C

P
#`P
#`@
G!X('-O;&ED.R!T97AT+6%L:6=N.B!L969T.R!B86-K




M9VX]







M)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
M
#`P


@3F5W(%)O;6%N)RP@5&EM97
L('-E

#`P
#LG/C$Y+#4Q-3PO9&EV/CPO=&0^/'1D(&YO

M
G!X.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F

#L@8F%C:V=R;W5N9UC;VQO<CH@(V9F9F9F9CLG/B8C
38P

P
#`P
M
#`@
G!X('-O;&ED.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O

'0M86QI9VXZ


T1B;W1T





#`P
#`P



Q




T1N


38P.SPO=&0^/'1D('9A;&EG;CTS

#L\+W1D




M.B`C
#`P





T0G=VED=&@Z(#$E.R!V97)T:6-A








M:68[(&-O;&]R.B`C
#`P


#L\+W1D




M.B`C
#`P

T1N;W=R



@
M3F5W(%)O;6%N)RP@5&EM97

#`P
#L@=&5X



M9F8[)SXF(S$V





#`P





24[('9E


T0G



M93H@

M:61T:#H@


#`P


M9F9F9F8[)SXF(S$V


Q-C`[



#`P

#PO9&EV/CPO=&0^




T0G=VED=&@Z(#$E


38P


@3F5W(%)O;6%N)RP@
M5&EM97

#`P
#LG/B@R+#@W.3PO9&EV/CPO




M




P
#`P
#`[('1E
'!E;G-E<SPO9&EV/CPO


M;CH@8F]T=&]M.R!B;W)D97(M8F]T=&]M.B`C
#`P









#L@8F%C:V=R;W5N9UC;VQO<CH@(V-C965F
M9CLG/B8C

P
#`P
#`@
G!X('-O;&ED.R!T97AT+6%L:6=N.B!L969T.R!B86-K




M9VX]


@3F5W(%)O
M;6%N)RP@5&EM97

#`P
#LG/BD\+V1I=CX\

G!X.R!B




T0G=VED

M93H@

M:61T:#H@



M;&]R.B`C
#`P


M9F8[)SXF(S$V

M=&]M.B`C
#`P








#`P



@3F5W
M(%)O;6%N)RP@5&EM97

#`P

\+V1I=CX\



M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F


M



M;&4]


@3F5W(%)O;6%N)RP@5&EM97
L('-E

#`P

M8F]T=&]M.R!P861D:6YG+6)O='1O;3H@-'!X.R!B86-K9W)O=6YD+6-O;&]R





T0G=VED=&@Z(#DE.R!V



T0G=VED=&@Z(#$E.R!V





'!T.R!F;VYT

P
#`P
#`[)SXD/]D:78^/]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M

M8F]R9&5R+6)O='1O;3H@(S`P
#`P

M;&4]

T1N;W=R87`@=F%L:6=N/3-$8F]T


#L@8F%C:V=R;W5N
M9UC;VQO<CH@(V9F9F9F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O

P
#`P


6QE/3-$)W=I9'1H
M.B`Y)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@
M(S`P,#`P,`T<'@@9&]U8FQE.R!T97AT+6%L:6=N.B!R:6=H=#L@8F%C:V=R

M.B`Q

M+!S97)I9CL@8V]L;W(Z(
P
#`P
#`[)SXH
3(L-S8T/]D:78^/]T9#X\

3!P=#L@9F]N

M;CTS1&)O='1O;2!S='EL93TS1=W:61T:#H@-3(E.R!V97)T:6-A;UA;&EG


M9CLG/B8C

#L\+W1D



T0G=VED=&@Z(#$E.R!V



24[('9E


M


M(V-C965F9CLG/B8C

M;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R


38P.SPO=&0^/'1D('9A;&EG



T1B;W1T;VT@






T0G=VED=&@Z

38P.SPO=&0^/'1D





M='1R:6)U=&%B;&4@=&\@4FEC94)R86X@5&5C:&YO;&]G:65S('-H87)E:&]L


M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F


M




6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N=UF

M.B`C
#`P



M;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R

T1B;W1T




T1N;W=R87`@=F%L

M9VXZ(&)O='1O;3L@=&5X=UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9UC;VQO

38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S


M;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R

T1B;W1T




T1N;W=R87`@

M86QI9VXZ(&)O='1O;3L@=&5X=UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9UC



38P.SPO=&0^

M



M









T0G=VED=&@Z(#DE.R!V




M;&4]


M(V-C965F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL

M



M(%1I;65S+!S97)I9CL@8V]L;W(Z(
P
#`P
#`[)SXM/]D:78^/]T9#X\

#L\+W1D







T0G=VED

@3F5W(%)O
M;6%N)RP@5&EM97

#`P
#LG/BD\+V1I=CX\






S0\+V1I=CX\+W1D




P
#`P

M)W=I9'1H.B`U


M:68[(&-O;&]R.B`C
#`P
#`P.R!T97AT+6%L:6=N.B!L969T.R!M87)G:6XM



M9VX]



38P.SPO=&0^/'1D('9A;&EG

M;G0M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97


#`P





T0G=VED=&@Z(#$E.R!V97)T:6-A








M:68[(&-O;&]R.B`C
#`P


#L\+W1D




M.B`C
#`P


M




T0G=VED=&@Z(#$E.R!V



3!P=#L@9F]N

24[('9E



#`P


M.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97

M
#`P


M(V-C965F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL

M



M(%1I;65S+!S97)I9CL@8V]L;W(Z(
P
#`P
#`[)SXQ-3(\+V1I=CX\+W1D


24[('9E


T0G



M93H@



38P.SPO=&0^

M)SXF(S$V





#`P

RPP





T0G=VED=&@Z



3!P

M87`]




M.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97

M
#`P



M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F



#`P

3


M(S$V









T0G=VED=&@Z(#$E


38P


@3F5W(%)O;6%N)RP@
M5&EM97

#`P
#LG/C$U+#(U.#PO9&EV/CPO


Q-C`[

M9F9F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS

#L\


M:7IE.B`Q

M;65S+!S97)I9CL@8V]L;W(Z(
P
#`P
#`[)SXR-PW-3,\+V1I=CX\+W1D
M/CQT9!N;W=R87`]


38P.SPO


M;G0M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97


#`P



'0M86QI


T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M


M/B8C



M)B


#`P


M









T0G=VED=&@Z(#$E.R!V


38P.SPO


@3F5W(%)O;6%N)RP@5&EM
M97

#`P
#LG/C0L-#
Q/]D:78^/]T9#X\

#L\+W1D




T1B




38P.SPO=&0^/'1D('9A;&EG;CTS1&)O

M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97

M(S`P
#`P



M9VX]





3!P=#L@9F]N=UF86UI;'DZ(=4

T1N;W=R87`@=F%L:6=N


M(V9F9F9F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL


M8F]T=&]M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C



#`P


M:61T:#H@

M8V]L;W(Z(-F9F9F9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T






T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M


M/B8C


@3F5W(%)O;6%N)RP@5&EM97
L

#`P





M;F0M8V]L;W(Z(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B






T0G=VED=&@Z(#$E.R!V97)T:6-A





M8V]L;W(Z(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T




T1N;W=R87`@

M86QI9VXZ(&)O='1O;3L@=&5X=UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9UC

38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O


M;&EG;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O



#`P
M

C0L







M9VX]


M


M93H@;F]R;6%L.R!T97AT+6%L:6=N.B!C96YT97([)SXF(S$V
#L\+V1I=CX\
M9&EV/B8C





T0G=F5R=&EC

38P.SPO
M=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=V97)T:6-A;UA;&EG
M;CH@8F]T=&]M.R!P861D:6YG+6)O='1O;3H@






M



M=UW96EG:'0Z(&)O;&0[(&-O;&]R.B`C,#`P,#`P.R!T97AT+6%L:6=N.B!C
M96YT97([)SY#;W)P;W)A=&4\+V1I=CX\+W1D/CQT9!N;W=R87`]
T1N;W=R


M)SXF(S$V


M9CL@9F]N=UW96EG:'0Z(&)O;&0[(&-O;&]R.B`C,#`P,#`P.R!T97AT+6%L
M:6=N.B!C96YT97([)SY54T$\+V1I=CX\+W1D/CQT9!N;W=R87`]
T1N;W=R


M)SXF(S$V




T0G

M/B8C
38P.SPO=&0^/'1D(&-O;'-P86X]
T0R('9A;&EG;CTS1&)O='1O;2!S
M='EL93TS1=V97)T:6-A;UA;&EG;CH@=&]P.R!B;W)D97(M8F]T=&]M.B`C
M
#`P

M

#`P
#`P.R!T97AT

M

T0G=VED=&@Z(#4R)3L@=F5R=&EC86PM86QI9VXZ



P
#`P


M+C)P=#LG/E)E=F5N=65S/]D:78^/]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M





M(&-O;&]R.B`C
#`P


M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97

M(S`P
#`P



M9VX]


M;G0M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97


#`P


'!T.R!F;VYT+69A;6EL

P
M
#`P
#`[)SXQ
BPP
C



M86QI9VX]


M(&9O;G0M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97


#`P


'!T.R!F;VYT+69A

P
#`P
#`[)SXR
RPP





T0G=VED=&@Z(#$E.R!V97)T:6-A


@3F5W(%)O;6%N)RP@5&EM97
L('-E

#`P


'!T.R!F;VYT

P
#`P


M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=W:61T:#H@-3(E.R!V97)T:6-A
M;UA;&EG;CH@=&]P.R!P861D:6YG+6)O='1O;3H@
G!X.R!B86-K9W)O=6YD




M

P
M
#`P
#`@
G!X('-O;&ED.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD

'0M86QI


T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M


38P.SPO=&0^/'1D('9A;&EG;CTS


M97(M8F]T=&]M.B`C
#`P







T0G=VED=&@Z(#$E.R!V97)T:6-A





M9'1H.B`Y)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O
M;3H@(S`P
#`P


@3F5W(%)O;6%N)RP@5&EM
M97

#`P
#LG/C(R+#`R.#PO9&EV/CPO=&0^

M='1O;3H@
G!X.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R

#L@8F%C:V=R;W5N9UC;VQO<CH@(V9F9F9F9CLG
M/B8C

P
#`P
#`@
G!X('-O;&ED.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O

'0M


M



B4[


M
#`P








M87`]


38P.SPO=&0^/'1D('9A

M




M(&-O;&]R.B`C
#`P






T0G=VED=&@Z(#$E.R!V



3!P=#L@9F]N

T1N


38P.SPO=&0^/'1D('9A;&EG;CTS

#L\+W1D




M.B`C
#`P



M;&EG;CTS1&)O='1O;2!S='EL93TS1=W:61T:#H@-3(E.R!V97)T:6-A;UA


G!T.R!T97AT+6EN9&5N


24[('9E


T0G



M93H@

M:#H@


#`P


M9F8[)SXF(S$V





#`P





T0G=VED=&@Z(#$E.R!V


38P.SPO


@3F5W(%)O;6%N)RP@5&EM
M97

#`P
#LG/B@W-38\+V1I=CX\+W1D/CQT




P
#`P





T0G=VED=&@Z(#DE.R!V




M;&4]


3!P

38P.SPO=&0^/'1D('9A;&EG





P
#`P
#`[


M9F8[)SXF(S$V






T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M



6QE/3-$
M)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N
M9UC;VQO<CH@(V-C965F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O

M9F8[)SXF(S$V




P
#`P


M(S$V










3!P=#L@9F]N=UF86UI;'DZ(=4:6UE


T0G=VED=&@Z(#$E.R!V


M9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P

M)SXF(S$V

M.B`C
#`P



#`P


3!P=#L@9F]N




T0G

38P.SPO=&0^/'1D('9A;&EG

P
#`P
#`@
G!X('-O;&ED.R!T



P
#`P
M
#`[)SXH
BPP




P
#`P





M9'1H.B`Y)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O
M;3H@(S`P
#`P


@3F5W(%)O;6%N)RP@5&EM
M97

#`P
#LG/B@T+#0T
CPO9&EV/CPO=&0^

M='1O;3H@
G!X.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R

T1B;W1T


M)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O
M='1O;3H@(S`P
#`P


M;CH@8F]T=&]M.R!B;W)D97(M8F]T=&]M.B`C
#`P


#`P
M


M;&EG;CH@8F]T=&]M.R!P861D:6YG+6)O='1O;3H@
G!X.R!T97AT+6%L:6=N



T0G




P
#`P






'!T.R!F;VYT+69A;6EL

P
M
#`P

M/3-$)W=I9'1H.B`Y)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R
M+6)O='1O;3H@(S`P
#`P

T0G

T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T





38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S

P
#`P

M


'!T

P
#`P
#L@
M=&5X=UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9UC;VQO<CH@(V-C965F9CLG
M/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=W:61T
M:#H@



T0G=VED=&@Z(#$E.R!V97)T


M;&]R.B`C
#`P


P
#`P








#`P



M=&]M.R!B;W)D97(M8F]T=&]M.B`C
#`P


3!P=#L@9F]N=UF86UI;'DZ(=4:6UE





#`P


3!P=#L@9F]N

M;CTS1&)O='1O;2!S='EL93TS1=W:61T:#H@-3(E.R!V97)T:6-A;UA;&EG


M9CLG/B8C

#L\+W1D



T0G=VED=&@Z(#$E.R!V



24[('9E


M


M(V9F9F9F9CLG/B8C

M;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R


38P.SPO=&0^/'1D('9A;&EG



T1B;W1T;VT@






T0G=VED=&@Z

38P.SPO=&0^/'1D





M='1R:6)U=&%B;&4@=&\@4FEC94)R86X@5&5C:&YO;&]G:65S('-H87)E:&]L


M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F


M




6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N=UF

M.B`C
#`P



M;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R

T1B;W1T




T1N;W=R87`@=F%L

M9VXZ(&)O='1O;3L@=&5X=UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9UC;VQO

38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S


M;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R

T1B;W1T




T1N;W=R87`@

M86QI9VXZ(&)O='1O;3L@=&5X=UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9UC



38P.SPO=&0^

M



M









T0G=VED=&@Z(#DE.R!V




M;&4]


M(V9F9F9F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL

M



M(%1I;65S+!S97)I9CL@8V]L;W(Z(
P
#`P
#`[)SXM/]D:78^/]T9#X\

#L\+W1D







T0G=VED

@3F5W(%)O
M;6%N)RP@5&EM97

#`P
#LG/BD\+V1I=CX\







T0G

@3F5W
M(%)O;6%N)RP@5&EM97

#`P
#LG/BD\+V1I





#L\




M;&]R.B`C
#`P




38P.SPO=&0^/'1D



'!T.R!F;VYT+69A;6EL

P
M
#`P


3!P=#L@




T0G=VED=&@Z(#$E.R!V97)T:6-A








M:68[(&-O;&]R.B`C
#`P


#L\+W1D




M.B`C
#`P


M



G!T.R!T97AT






T0G=VED=&@Z(#DE.R!V



T0G=VED



M:#H@



T0G=VED=&@Z(#DE.R!V97)T:6-A


M97)I9CL@8V]L;W(Z(,P,#`P,#`[)SXQ.3$\+V1I=CX\+W1D/CQT9!N;W=R
M87`]


38P.SPO=&0^/'1D('9A

M




M(&-O;&]R.B`C
#`P

BPY





T0G=VED=&@Z(#$E.R!V



3!P=#L@9F]N

T1N




M97
@3F5W(%)O;6%N)RP@5&EM97

#`P
#L@




Q


#`P



24[('9E


T0G



M93H@



38P.SPO=&0^

M)SXF(S$V





#`P



#L\+W1D/CQT

M)B





T0G=VED=&@Z


B4[


M
#`P


M:#H@

M;W(Z(-F9F9F9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T;VT@







M





T0G=VED=&@Z(#DE.R!V


M:#H@



T0G=VED=&@Z(#$E.R!V97)T:6-A


38P.SPO=&0^/'1D
F4Z(#$P

@3F5W(%)O;6%N)RP@5&EM97
L('-E

#`P
#LG/C0L
3
Y/]D:78^/]T9#X\=&0@;F]W



Q




24[



T0G=VED=&@Z(#4R)3L@=F5R



P
#`P
M



'0M


T1N;W=R87`@=F%L:6=N/3-$8F]T


M9CLG/B8C


M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F



#`P


M(S$V






M





T0G=VED=&@Z(#DE.R!V



T0G


M.B`U


M;&]R.B`C
#`P
#`P.R!T97AT+6%L:6=N.B!L969T.R!M87)G:6XM;&5F=#H@


'0M





M



M9F9F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS

@
M3F5W(%)O;6%N)RP@5&EM97

#`P
#LG/CDL


M9F8[)SXF(S$V






T1B;W1T






T0G=VED

M



M='








M+6)O='1O;3H@


P
#`P
#`@


P
#`P

30\+V1I=CX\+W1D

38P.SPO=&0^/'1D

B!V86QI9VX]

T0G

#`P


#`P

M86QI9VX]




#`P
#`P.R!T97AT+6%L:6=N.B!L

M)SY5;FET960@4W1A=&5S/]D:78^/]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M





M(&-O;&]R.B`C
#`P


M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97

M(S`P
#`P
#LG/C(Q+#
X




38P.SPO=&0^/'1D

3!P




T0G=VED=&@Z(#$E.R!V97)T



#`P
#`P.R!T


T1B




38P.SPO=&0^/'1D('9A;&EG;CTS1&)O

M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97

M(S`P
#`P




38P.SPO=&0^/'1D



'!T.R!F;VYT+69A;6EL

P
M
#`P

M;CTS1&)O='1O;2!S='EL93TS1=W:61T:#H@,S8E.R!V97)T:6-A;UA;&EG
M;CH@=&]P.R!P861D:6YG+6)O='1O;3H@
G!X.R!B86-K9W)O=6YD+6-O;&]R





#L\

#`P
#`P


M

T1B;W1T;VT@







M86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P

M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97

M(S`P
#`P
#LG/C0L


#L\

M
#L@8F%C:V=R;W5N9UC;VQO<CH@
M(V9F9F9F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL

P
#`P

T0G


'!T.R!F

P
#`P
#`[)SXT
PQ,#@\+V1I=CX\+W1D/CQT9!N;W=R87`]
M



M/B8C

#L\+W1D

#`P
#`P(#1P

3!P=#L@9F]N



#`P

S4L
M



V$R7V(V
M-61?.#

T#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T
Z
M+V(Y9#8T9#0R7S8T-F9?-#-A
E]B-C5D7S@S








]
T1T:#Y$96
N(#

544@





M/'4^3D]412`Q-RX@1D%)4B!604Q512!-14%355)%345.5#PO=3X\+V1I=CX\






#L@5&AE(&9A:7(@=F%L=64@;V8@;W5R($)R87II


M5&EM97
@3F5W(%)O;6%N)RP@5&EM97

#`P
M


38P.R!#97)T86EN(&%S




M;G0M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97


#`P



]
T1$







#`P
M

2`F(S@R
3$[(&EN



]

3!P



M(&9O;G0M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97






#`P





'!T.R!F;VYT+69A;6EL






M(&-O;&]R.B`C
#`P

M
R`F(S@R






M.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97


Q-C`[)B

M5&EM97
@3F5W(%)O;6%N)RP@5&EM97




I.CPO
M9&EV/CQD:78^)B

T1N


M=UA;&EG;CH@;&5F=#LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O
M;2!S='EL93TS1=W:61T:#H@


B!V86QI9VX]

T0G=F5R=&EC86PM86QI

#`P


#`P

T1B

T0G=VED=&@Z(#$N



38P.SPO=&0^/'1D(&-O;'-P86X]
T0R('9A;&EG
M;CTS1&)O='1O;2!S='EL93TS1=V97)T:6-A;UA;&EG;CH@=&]P.R!B;W)D
M97(M8F]T=&]M.B`C
#`P



M
#`P
#`P.R!T97AT+6%L:6=N.B!C96YT97([)SY



T0G=VED=&@Z(#$N
30E.R!V



@3F5W(%)O;6%N)RP@5&EM97
L('-E

M




B!V86QI9VX]

T0G=F5R=&EC

#`P



#`P

T1N;W=R87`@=F%L:6=N




#`P
#`P.R!F

M969T.B`W+C)P=#L@=&5X=UI;F1E;G0Z(TW+C)P=#LG/CQU/D1E8V5M8F5R
M(#









M)W=I9'1H.B`Q+C$T)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X=UA
M;&EG;CH@;&5F=#LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S
M='EL93TS1=W:61T:#H@

B!V86QI9VX]
T1B;W1T;VT@








#L\

M


M+6)O='1O;3H@
G!X.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O





M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97


#`P

M.R!B;W)D97(M8F]T=&]M.B`C
#`P


#`P


M.R!P861D:6YG+6)O='1O;3H@
G!X.R!T97AT+6%L:6=N.B!L969T.R!B86-K



38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O

P
#`P
#`@
G!X('-O;&ED.R!T97AT+6%L:6=N



T0G=VED=&@Z(#DN
M

M


T0G=VED=&@Z(#$N
M



M


@3F5W(%)O;6%N)RP@5&EM97
L('-E

#`P

M;CH@8F]T=&]M.R!B;W)D97(M8F]T=&]M.B`C
#`P


#`P
M

M;&EG;CH@8F]T=&]M.R!P861D:6YG+6)O='1O;3H@
G!X.R!T97AT+6%L:6=N



T0G=VED=&@Z(#$N
M


M86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P




M;&4]









M5&]T86P@;&EA8FEL:71I97


M;3H@-'!X.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C

#L@8F%C:V=R;W5N9UC;VQO<CH@(V9F9F9F9CLG
M/B8C

P
#`P

6QE/3-$)W=I9'1H.B`Y+C$V)3L@=F5R=&EC86PM
M86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P,#`P,`T<'@@9&]U

'!T.R!F;VYT+69A

P
#`P





T0G=VED=&@Z(#$N
30E


M86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P

M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97

M(S`P
#`P

M;W)D97(M8F]T=&]M.B`C
#`P

@3F5W
M(%)O;6%N)RP@5&EM97

#`P
#LG/BT\+V1I




M;W)D97(M8F]T=&]M.B`C
#`P







#`P


M;3H@-'!X.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C

T1B;W1T;VT@

T0G=VED=&@Z(#$N

M)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O
M='1O;3H@(S`P
#`P


@3F5W(%)O;6%N)RP@
M5&EM97

#`P
#LG/B0\+V1I=CX\+W1D/CQT

#`P
#`P(#1P

M;G0M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97


#`P



P
#`P
M




M87`]


38P.SPO=&0^/'1D('9A



T0G=VED=&@Z






M



M8V]L;W(Z(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!N;W=R87`]
T1N;W=R


38P.SPO=&0^/'1D('9A;&EG;CTS



T0G=VED=&@Z(#$E.R!V






#L\+W1D



M(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!N;W=R87`]
T1N;W=R87`@=F%L

M86QI9VXZ(&)O='1O;3L@=&5X=UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9UC


@3F5W
M(%)O;6%N)RP@5&EM97

'0M86QI9VXZ(&QE9G0[(&UA<F=I;BUL969T.B`W+C)P
M=#L@8F%C:V=R;W5N9UC;VQO<CH@(V9F9F9F9CL@=&5X=UI;F1E;G0Z(TW
M+C)P=#LG/CQU/D1E8V5M8F5R(#
Q+`R,#$S/]U/CPO9&EV/CPO=&0^/'1D



M9CLG/B8C

#L\+W1D



T0G=VED=&@Z(#$N
M



M:#H@



T0G=VED=&@Z(#DN
38E.R!V97)T





M




T0G=VED=&@Z(#$N
30E.R!V



24[


M9VX]

T0G=VED=&@Z(#DN
38E.R!V97)T:6-A;UA
M;&EG;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!R:6=H=#L@8F%C:V=R;W5N9UC





3!P

T1N




'0M86QI9VXZ(&-E;G1E<CLG/B@Q*3PO9&EV/CPO=&0^/'1D('9A;&EG
M;CTS1&)O='1O;2!S='EL93TS1=W:61T:#H@


M.R!B;W)D97(M8F]T=&]M.B`C
#`P




P
#`P

M+C$V)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@
M(S`P
#`P


@3F5W(%)O;6%N)RP@5&EM97
L

#`P
#L@=&5X=UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9UC;VQO<CH@(V-C
M965F9CLG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS
M1=W:61T:#H@

M(S$V

M
#`P


M

P
#`P
#`[)SXD/]D:78^/]T9#X\=&0@=F%L:6=N

M9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P

M.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97

M
#`P




M;CH@8F]T=&]M.R!B;W)D97(M8F]T=&]M.B`C
#`P



P
#`P
M

M)W=I9'1H.B`Y+C$V)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R
M+6)O='1O;3H@(S`P
#`P


@3F5W(%)O;6%N
M)RP@5&EM97

#`P
#LG/B@Q+#8X-3PO9&EV

M861D:6YG+6)O='1O;3H@
G!X.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O

M9VX]

T0G=VED=&@Z(#$N


M;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P













3!P=#L@






T0G=VED=&@Z(#$N
M


M86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P

M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97


#`P

M.R!B;W)D97(M8F]T=&]M.B`C
#`P

@
M3F5W(%)O;6%N)RP@5&EM97

#`P
#LG/BT\




M.R!B;W)D97(M8F]T=&]M.B`C
#`P








#`P


M;3H@-'!X.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C

#L@8F%C:V=R;W5N9UC;VQO<CH@(V9F9F9F9CLG
M/B8C

P
#`P

6QE/3-$)W=I9'1H.B`Y+C$V)3L@=F5R=&EC86PM
M86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P,#`P,`T<'@@9&]U

'!T.R!F;VYT+69A

P
#`P
#`[)SXH



P
#`P
#`[



24[

'!T

P
#`P
#`[)SXD/]D:78^/]T9#X\=&0@=F%L:6=N/3-$

M(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P



T1N;W=R87`@=F%L


M;&4]


:7-T5&%B;&4@




P
#`P



@=&AE('!R;V)A8FEL

@









M='1O;2!S='EL93TS1=W:61T:#H@-#0E.R!V97)T:6-A;UA;&EG;CH@=&]P
M.R!P861D:6YG+6)O='1O;3H@






T0G=VED=&@Z(#$E.R!V97)T



38P.SPO=&0^/'1D(&-O;'-P86X]
M
T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=V97)T:6-A;UA;&EG;CH@
M=&]P.R!B;W)D97(M8F]T=&]M.B`C
#`P



M(&-O;&]R.B`C
#`P
#`P.R!T97AT+6%L:6=N.B!C96YT97([)SY$96-E;6)E

2P@
C`Q

M;CH@8F]T=&]M.R!P861D:6YG+6)O='1O;3H@
G!X.R!T97AT+6%L:6=N.B!L




#`P
#`P.R!T97AT+6%L:6=N.B!L969T



#L\+W1D





M;W(Z(,P,#`P,#`[)SXP+C$E(T@
2XP)3PO9&EV/CPO=&0^/'1D(&YO=W)A


38P.SPO=&0^



24[



#`P

Q-C`[/]D:78^/]T









M





T1N




M97
@3F5W(%)O;6%N)RP@5&EM97

#`P
#L@




T0G=VED




M.B`Q

M+!S97)I9CL@8V]L;W(Z(
P
#`P




P
#`P
#`[)SXF(S$V
#L\+V1I




34E





M

@
M3F5W(%)O;6%N)RP@5&EM97

#`P
#LG/B8C
M

M5&EM97
@3F5W(%)O;6%N)RP@5&EM97



M9V5S(&EN(&QE=F5L(#
@:71E;7



3!P=#L@9F]N=UF86UI;'DZ(=4:6UE


T0P(&-E


M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97

M:#H@


M

P
#`P
M
#`@

P
#`P





#`P



#`P

P
#`P






M1=V97)T:6-A;UA;&EG;CH@8F]T=&]M.R!P861D:6YG+6)O='1O;3H@
G!X


B!S


#`P



M(&-O;&]R.B`C
#`P
#`P.R!T97AT+6%L:6=N.B!C96YT97([)SY4;W1A;#PO

6QE/3-$)V9O;G0M<VEZ93H@
3!P




P
#`P
F4Z(#$P<'0[(&9O;G0M9F%M:6QY
M.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97



#L\+W1D




#`P
#L@


P
#`P

38P.SPO9&EV/CQD



#`P

M.B`Q

M+!S97)I9CL@9F]N=UW96EG:'0Z(&)O;&0[(&-O;&]R.B`C
#`P
#`P.R!T


38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O
M;2!S='EL93TS1=V97)T:6-A;UA;&EG;CH@8F]T=&]M.R!P861D:6YG+6)O
M='1O;3H@






M5&EM97
@3F5W(%)O;6%N)RP@5&EM97


'!T.R!F;VYT

#`P
#`P.R!T97AT+6%L:6=N.B!C

3!P



@3F5W(%)O;6%N
M)RP@5&EM97



#`P

M






#`P


#`P

P
#`P
#`[('1E


T0G


#`P

P
#`P



#`P
M





M


P
#`P



@3F5W(%)O;6%N)RP@5&EM97
L('-E


M(%1I;65S+!S97)I9CL@9F]N=UW96EG:'0Z(&)O;&0[(&-O;&]R.B`C
#`P
M


3!P=#L@9F]N=UF86UI;'DZ(=4

M=')U;65N='

M(&9O;G0M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97


M


M(&QE9G0[)SXF(S$V



M;G0M=V5I9VAT.B!N;W)M86P[(&-O;&]R.B`C
#`P


M=#L@=&5X=UI;F1E;G0Z(TW+C)P=#LG/CQU/C(P
30\+W4^/]D:78^/]T

M.B!B;W1T;VT[)SXF(S$V


T0G
M=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X=UA;&EG;CH@;&5F=#LG/B8C
M,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=V97)T:6-A


M9VXZ(&QE9G0[)SXF(S$V




@
M3F5W(%)O;6%N)RP@5&EM97


B!V86QI9VX]

T0G


38P.SPO=&0^/'1D('9A;&EG

M)B

M


#L\+W1D/CQT


Q-C`[

B!V86QI
M9VX]



M/B8C



@3F5W(%)O;6%N)RP@5&EM97
L

#`P




T0G=VED=&@Z(#$E.R!V97)T


@3F5W(%)O;6%N)RP@5&EM97
L

#`P


'!T.R!F

P
#`P
#`[)SXH


M:7IE.B`Q

M;65S+!S97)I9CL@8V]L;W(Z(
P
#`P
#`[)SXI/]D:78^/]T9#X\=&0@


M


#`P

F4Z

@3F5W(%)O;6%N)RP@5&EM97
L

#`P
#LG/B@Q+#$U
3PO9&EV/CPO=&0^/'1D




T0G=VED=&@Z(#$E.R!V


M;&4]



#`P




3!P=#L@9F]N=UF86UI;'DZ(=4:6UE

M:#H@

M;W(Z(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T;VT@


M5&EM97
@3F5W(%)O;6%N)RP@5&EM97

#`P
M




P
#`P
#`[)SXX+#DP
M

M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F

P
#`P
#`[)SXH


Q



M(%1I;65S+!S97)I9CL@8V]L;W(Z(
P
#`P
#`[)SXD/]D:78^/]T9#X\


M


T0G=VED=&@Z


@3F5W(%)O;6%N
M)RP@5&EM97

#`P
#LG/BD\+V1I=CX\+W1D






P
#`P




M:61T:#H@



T0G=F5R=&EC


M

P
#`P



M/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=V97)T
M:6-A;UA;&EG;CH@8F]T=&]M.R!B;W)D97(M8F]T=&]M.B`C
#`P
#`P(#)P

M


T0G=F5R=&EC86PM

38P.SPO
M=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=V97)T:6-A;UA;&EG
M;CH@8F]T=&]M.R!P861D:6YG+6)O='1O;3H@
G!X.R!B86-K9W)O=6YD+6-O


P
#`P
#`@
G!X('-O;&ED.R!T97AT+6%L:6=N.B!L969T.R!B86-K


P
#`P
#`@
G!X('-O;&ED.R!T97AT+6%L:6=N.B!R



P
#`P
#`[)SXH-3@\+V1I










@3F5W(%)O;6%N
M)RP@5&EM97

#`P
#LG/BD\+V1I=CX\+W1D


38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S
M='EL93TS1=V97)T:6-A;UA;&EG;CH@8F]T=&]M.R!B;W)D97(M8F]T=&]M
M.B`C
#`P






M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97

M:6=H=#H@8F]L9#L@8V]L;W(Z(,P,#`P,#`[)SXH,RD\+V1I=CX\+W1D/CQT
M9!V86QI9VX]

T0G=F5R=&EC86PM86QI9VXZ(&)O

38P.SPO=&0^/'1D('9A;&EG;CTS1&)O
M='1O;2!S='EL93TS1=V97)T:6-A;UA;&EG;CH@8F]T=&]M.R!B;W)D97(M
M8F]T=&]M.B`C
#`P


#`P






@3F5W(%)O;6%N)RP@5&EM
M97

#`P

T1B






M;G0M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97


#`P

M

P
M
#`P






P
#`P
M
#`[)SXH




P
#`P





'!T.R!F;VYT+69A;6EL

P
M
#`P

M/3-$)W=I9'1H.B`Y)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R
M+6)O='1O;3H@(S`P
#`P

T0G

T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T





38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S

P
#`P

M


'!T

P
#`P
#`[)SXH-RPV

'!T.R!F;VYT+69A;6EL

P
M
#`P



M


M

P
#`P
#`[)SXD/]D:78^/]T9#X\=&0@=F%L:6=N

M(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P



M9VX]









P
#`P
#`[

M9'1H.B`Y)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O
M;3H@(S`P
#`P


M:61T:#H@



M;&]R.B`C
#`P


M9F8[)SXF(S$V

M=&]M.B`C
#`P





M.B`C
#`P


#L\


38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S


M;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R


T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M


M/B8C



M)B




38P.SPO=&0^

M)SXF(S$V



M;F0M8V]L;W(Z(-F9F9F9F8[)SXF(S$V,#L\+W1D/CQT9!N;W=R87`]
T1N


38P.SPO=&0^/'1D('9A;&EG;CTS

#L\+W1D



T1N;W=R87`@=F%L:6=N


M(V9F9F9F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL


M8F]T=&]M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C



T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T


M



Q


M;W=R87`]



C@E

M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97


P
M
#`P


T0G=VED=&@Z(#$E.R!V97)T


38P.SPO=&0^








P
#`P
#`[)SXH
3PO9&EV/CPO=&0^



P
#`P
#`[)SXI/]D:78^/]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M




M;W(Z(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T;VT@


M/B8C

M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F



38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O

M)SXF(S$V



T0G



M:61T:#H@



T0G=VED=&@Z(#DE.R!V97)T





38P.SPO



M9VX]


6QE/3-$



M/B8C
6QE/3-$






T0G

@3F5W
M(%)O;6%N)RP@5&EM97

#`P
#LG/BD\+V1I






P
#`P
#`[)SXD






M;&4]

M97
@3F5W(%)O;6%N)RP@5&EM97

#`P
#LG





P
#`P
M





T1B;W1T


M.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97

M
#`P



'!T.R!F;VYT+69A

P
#`P
#`[)SXD/]D:78^/]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T



3!P=#L@9F]N=UF86UI;'DZ(=4

'!T.R!F;VYT

#`P



M:61T:#H@


#`P



@3F5W(%)O;6%N)RP@
M5&EM97

#`P
#LG/B@Q+#8X-3PO9&EV/CPO




T0G=VED=&@Z






#`P

W
CPO



T1B;W1T;VT@





P
#`P





38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O
M;2!S='EL93TS1=V97)T:6-A;UA;&EG;CH@8F]T=&]M.R!B;W)D97(M8F]T
M=&]M.B`C
#`P





M;G0M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97


#`P

38P
M.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=V97)T:6-A;UA
M;&EG;CH@8F]T=&]M.R!B;W)D97(M8F]T=&]M.B`C
#`P


3!P=#L@

@3F5W(%)O
M;6%N)RP@5&EM97

#`P
#LG/BD\+V1I=CX\


38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O
M;2!S='EL93TS1=V97)T:6-A;UA;&EG;CH@8F]T=&]M.R!B;W)D97(M8F]T
M=&]M.B`C
#`P





T1B;W1T;VT@






#L\



T0G=F5R
M=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P

M;G0M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97


#`P


M;CH@8F]T=&]M.R!P861D:6YG+6)O='1O;3H@
G!X.R!T97AT+6%L:6=N.B!L


P
#`P

38P.SPO
M=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=V97)T:6-A;UA;&EG
M;CH@8F]T=&]M.R!B;W)D97(M8F]T=&]M.B`C
#`P


3!P=#L@9F]N


T0G=F5R=&EC86PM86QI9VXZ(&)O

38P.SPO=&0^/'1D('9A
M;&EG;CTS1&)O='1O;2!S='EL93TS1=V97)T:6-A;UA;&EG;CH@8F]T=&]M
M.R!P861D:6YG+6)O='1O;3H@
G!X.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E


P
#`P
#`@
G!X('-O;&ED.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E


M1=W:61T:#H@,C@E.R!V97)T:6-A;UA;&EG;CH@=&]P.R!P861D:6YG+6)O


G!T.R!T97AT+6EN9&5N


R!F86ER('9A;'5E/]D:78^/]T







P
#`P
M

M)W=I9'1H.B`Y)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O
M='1O;3H@(S`P
#`P

T0G9F]N






#L@8F%C:V=R;W5N9UC;VQO<CH@
M(V9F9F9F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL

P
#`P

T0G


'!T.R!F

P
#`P
#`[)SXH
2PP



P
#`P
M



24[

'!T

P
#`P
#`[)SXD/]D:78^/]T9#X\=&0@=F%L:6=N/3-$

M='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P



T1N;W=R87`@=F%L:6=N


T0G
#L@8F%C
M:V=R;W5N9UC;VQO<CH@(V9F9F9F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG

P
#`P
#`@-'!X(&1O=6)L93L@


6QE/3-$
M)W=I9'1H.B`Y)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O
M='1O;3H@(S`P,#`P,`T<'@@9&]U8FQE.R!T97AT+6%L:6=N.B!R:6=H=#L@


M(%1I;65S+!S97)I9CL@8V]L;W(Z(
P
#`P
#`[)SXW+#(S-SPO9&EV/CPO

M+6)O='1O;3H@-'!X.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O

#L@8F%C:V=R;W5N9UC;VQO<CH@(V9F9F9F
M9CLG/B8C

P
#`P

6QE/3-$)W=I9'1H.B`Y)3L@=F5R=&EC86PM
M86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P,#`P,`T<'@@9&]U

'!T.R!F;VYT+69A

P
#`P
#`[)SXH




P
#`P
#`[)SXI





'!T.R!F;VYT

P
#`P
#`[)SXD/]D:78^/]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M

M8F]R9&5R+6)O='1O;3H@(S`P
#`P

M;&4]





#`P

'!T.R!F


T0G


@3F5W(%)O;6%N
M)RP@5&EM97


M


@3F5W(%)O;6%N)RP@5&EM97
L







M

M


'!T.R!F;VYT

P
#`P






N/]T9#X\+W1R/CPO=&%B;&4^/]D:78^/&1I=B!S='EL93TS


]






M;&4]

M+6%L:6=N.B!T;W`[(&-O;&]R.B`C
#`P
#`P.R!T97AT+6%L:6=N.B!L969T

M='D@87




'!T.R!F
6QE/3-$)W=I9'1H.B`Q.'!T.R<^

'!T.R!F;VYT+69A;6EL


@3F5W(%)O;6%N)RP@5&EM97
L('-E



]
T1$4U!&3&ES=%1A8FQE('-T






#`P
#`P.R!T97AT+6%L:6=N






#`P
#`P.R!T97AT+6%L:6=N.B!J=7-T



M+SX\+V1I=CX\=&%B;&4@8F]R9&5R/3-$


M.B`Q

M




38P.SPO=&0^/'1D(&-O;'-P86X]





M97
@3F5W(%)O;6%N)RP@5&EM97




T1B;W1T

T0G=VED=&@Z(#$N






P
M
#`P

3
\+V1I=CY);7!A:7)M



M;&4]
T0G=VED=&@Z(#




G!X.R!T97AT+6%L







T0G=VED=&@Z
M(#$N




@3F5W(%)O;6%N)RP@
M5&EM97






M

3!P=#L@




G!X.R!T




T1B

T0G=VED=&@Z(#$N



38P.SPO=&0^/'1D(&-O;'-P86X]
T0R('9A;&EG
M;CTS1&)O='1O;2!S='EL93TS1=V97)T:6-A;UA;&EG;CH@=&]P.R!B;W)D
M97(M8F]T=&]M.B`C
#`P



M
#`P
#`P.R!T97AT+6%L:6=N.B!C96YT97([)SY
;W-S97
\+V1I=CX\+W1D

38P.SPO=&0^

M



T0G=VED
M=&@Z(#$N



38P.SPO


B!V86QI9VX]

T0G=F5R=&EC86PM86QI




T1B;W1T

T0G=VED=&@Z(#$N


M;&5F=#LG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS


T0G=VED=&@Z(#$E



M.B`C
#`P

M;&4]





24[

6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N=UF86UI;'DZ

#`P
M
#`P.R!T97AT+6%L:6=N.B!C96YT97([)SXH

G!X.R!B86-K9W)O

'0M

#`P


P
#`P
#`@
G!X('-O;&ED.R!T97AT+6%L:6=N.B!R:6=H=#L@8F%C

M:7IE.B`Q

M;65S+!S97)I9CL@8V]L;W(Z(
P
#`P
#`[)SXM/]D:78^/]T9#X\=&0@


M861D:6YG+6)O='1O;3H@
G!X.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F

'0M86QI9VXZ(&QE9G0[(&)A8VMG


#`P


P
#`P
#`@
G!X('-O

'!T.R!F;VYT+69A

P
#`P


#L\

G!X


6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N=UF86UI

M
#`P


P
#`P
#`@
G!X('-O;&ED.R!T97AT+6%L:6=N.B!R



P
#`P
#`[)SXS.30\+V1I




M;W(Z(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T;VT@


M

'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD


T0G=VED=&@Z(#$N
M



M


@3F5W(%)O;6%N)RP@5&EM97
L('-E

#`P

M;CH@8F]T=&]M.R!B;W)D97(M8F]T=&]M.B`C
#`P


#`P
M



#L\+W1D

T0G
#L@=&5X=UA

2XP



T0G=VED=&@Z(#$E.R!V97)T:6-A

6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N=UF

M.B`C
#`P


P
#`P




T1B;W1T;VT@

T0G=VED=&@Z(#$N








P
#`P

M+C`Y)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@
M(S`P
#`P


M



M
T0G=VED=&@Z(#$N

M.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@
M(S`P
#`P


@3F5W(%)O;6%N)RP@5&EM97
L

#`P

M;&EG;CH@8F]T=&]M.R!B;W)D97(M8F]T=&]M.B`C
#`P

M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97

M(S`P
#`P
#LG/C


Q-C`[
#L@8F%C:V=R;W5N9UC;VQO<CH@(V9F9F9F9CLG/B8C
38P.SPO=&0^/'1D

P
#`P
#`@-'!X(&1O







P
#`P
#`[)SXS.30\




M8V]L;W(Z(-F9F9F9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T



#`P


P
#`P

M93H@

M:#H@





M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97

M



#`P
#`P

2D\+W1D/CQT9!S='EL93TS1=F;VYT+7-I

@3F5W(%)O;6%N)RP@5&EM
M97



#`P




C`Q
RXF(S$V

@


M;VX@86X@:6YT97)N86P@979A;'5A=&EO;B!O9B!M87)K970@8V]N9&ET:6]N




E]B-C5D7S@S
C9D-C@W



]
T1R


]
M


T1T

M4$]
24-)15



]

T0G

M




3$[(%1H92!C;VYS;VQI
M9&%T960@9FEN86YC:6%L('-T871E;65N='
@:6YC;'5D92!T:&4@86-C;W5N
M='

M(S$V


#L@06QL('-I9VYI9FEC86YT(&EN=&5R+6-O;7!A;GD@
M86-C;W5N='



I(&%T=')I8G5T86)L92!T;R!N;VYC;VYT



M;F-I97













M=VAI8V@@:7


X
C$W.W

@


M(S$V
#L@5')A;G-L871I;VX@9&EF9F5R96YC97
@87)E(')E8V]R9&5D(&EN


@87)E(')E8V]R9&5D(&%S(&9O

M(&]F(&]P97)A=&EO;G

Q+`R,#$U+!T:&4@0G)A

N($1O;&QA

2P@


M;G0M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97

6QE/3-$)V9O;G0M<VEZ93H@
3!P





@870@



T1T;W`^06-C;W5N='
@4F5C96EV86)L

M;G0M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97




M92XF(S$V

M;W5N='

@86YD(&-H
M86YG97

@=VAE;B!E


@;W(@97-T:6UA=&5S('5T:6QI

@:6X@=&AE



]

6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N=UF



@3F5W(%)O;6%N)RP@5&EM97
L('-E




N)B
Q-C`[(%1H92!S=&%N9&%R
M9'


M



]

3H@)U1I;65S($YE=R!2;VUA;B<L(%1I;65S+!S97)I9CL@


@3F5W(%)O;6%N)RP@5&EM97
L('-E

T0G9F]N

M/B`F(S@R



#L@17AP96YD


Q-C`[($=A:6YS(&]R

M(&%R92!R969L96-T960@:6X@=&AE(&-O;G-O;&ED871E9!S=&%T96UE;G1S
M(&]F(&]P97)A=&EO;G,N)B,Q-C`[($EN=&%N9VEB;&4@87-S971S(&%R92!S
M=&%T960@870@8V]S=!L97-S(&%C8W5M=6QA=&5D(&%M;W)T:7IA=&EO;B!A
M;F0@87)E(&%M;W)T:7IE9!O=F5R('1H96ER('5S969U;!L:69E(&]N(&$@

M.R!T97AT+6%L:6=N.B!C96YT97([)SXF(S$V





@8V%R







@;&5S


M97-T+B8C




Q-C`[($EF('1H92!F86ER('9A;'5E(&]F



@;F]T(&-O;G-I



M86ER;65N=!L;W-S+!I9B!A;GDN)B
Q-C`[($9A:7(@=F%L=65S(&%R92!D





L(&]P97)A=&EN


M9FQO=W



2P@
C`Q

M:7IE.B`Q




M97



#L@5&AE

L


@=&\@9&5T97)M
M:6YE('=H971H97(@979E;G1S(&]R(&-H86YG97




M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97










M92P@;W(@:7




@


M;G0M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97



M861J=7-T;65N='
N)B
Q-C`[(%)E=F5N=65S(&]N('1H92!S=&%T96UE;G1S
M(&]F(&]P97)A=&EO;G


@3F5W
M(%)O;6%N)RP@5&EM97





]









#L@26YT97)N86P@8V]S='
@:6YC





]










Q-C`[(%1H92!C;VYV97)S:6]N(&QI






M3&EA8FEL:71I97



T0G


'!T.R!F;VYT+69A;6EL



@86YD

@8F%S960@;VX@9G5T=7)E(&ES



@87
@;&EA






]



@3F5W(%)O;6%N)RP@5&EM97
L('-E

T0G9F]N


M
#L@1F]R9F5I='5R97
@87)E(&5S=&EM871E9!A=!T:&4@=&EM92!O9B!G



M;F%G96UE;G0F(S@R


@:&%V92!C:&%R86-T97)I


M;G0M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97



M=&EO;B!A=V%R9'
@9W)A;G1E9!T;R!N;VXM96UP;&]Y965S(&%N9!C;VYS





#L@1V5N97)A;&QY('=E('9A
M;'5E(&]P=&EO;G
@9W)A;G1E9!T;R!N;VXM96UP;&]Y965S(&%N9!C;VYS

M:6]N(&UO9&5L+B8C
38P.R`\+V9O;G0^268@=&AE(&9A:7(@=F%L=64@;V8@




M



M









M+!S97)I9CL@9F]N=US:7IE.B`Q



M;F-O;64@5&%X97
\+V9O;G0^(8C.#(Q,3L@5V4@86-C;W5N=!F;W(@:6YC
!A<W-E=!O


@86YD(&]P97)A=&EN9R!L;W-S
'!E;G-E(&]R(&)E;F5F:70@:7



M.B`Q








N)B
Q

!B96YE9FET<R!W:6QL(&YO=!B92!R96%L:7IE9X\+V1I=CX\



3!P=#LG/CQD




X
C$Q

@:6X@








'!T

'!T.R!F

M)B
X

M861E('1O(&%M;W5N='





M;F]U;F-E;65N='



T0G






@:6X@







38P.R!4:&4@9W5I9&%N8V4@
M:7




M9VAT.B!B;VQD.R!T97AT+6%L:6=N.B!C96YT97([)SXF(S$V
#L\+V1I=CX\

3!P=#L@9F]N=UF86UI;'DZ(=4

M9&%N8V4@=VAI8V@@;6%K97

M96YT(&-O;G-O;&ED871I;VX@9W5I9&%N8V4N)B
Q-C`[($%M;VYG(&]T:&5R






#L@3&EM



@:&]L9!S=6)S
M=&%N=&EV92!K:6-K+6]U=!R:6=H='

M='
N)B








M97)S:&EP(&]R('-I;6EL87(@96YT:71Y+B!4:&4@9W5I9&%N8V4@:7
@969F





M-&0T
E\V-#9F7S0S83)?8C8U9%\X


M(&-O;G1E;G0]


M/3-$


@4$52(%-(05)%(A%4%,I
M(A486)L97


]
T1T:#Y$
M96
N(#



]


]

M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97



@8V]M



M:6YG/3-$

M.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97



T0G=VED=&@Z(#$E




@3F5W(%)O;6%N)RP@5&EM
M97

M9VX]




38P.SPO=&0^/'1D(&-O;'-P86X]
T0R('9A;&EG
M;CTS1&)O='1O;2!S='EL93TS1=V97)T:6-A;UA;&EG;CH@8F]T=&]M.R!B
M;W)D97(M8F]T=&]M.B`C
#`P




3


M;G0M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97

M97AT+6%L:6=N.B!L969T.R!M87)G:6XM;&5F=#H@.7!T.R!T97AT+6EN9&5N
M=#H@+3EP=#LG/DY53452051/4B`H:6X@=&AO=7-A;F1S*3H\+V1I=CX\+W1D


T1N;W=R87`@=F%L:6=N/3-$8F]T

M;3L@=&5X=UA;&EG;CH@;&5F=#LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS
M1&)O='1O;2!S='EL93TS1=W:61T:#H@

M;W1T;VT[)SXF(S$V


T0G










M;&EG;CH@8F]T=&]M.R!B;W)D97(M8F]T=&]M.B`C
#`P




'!T

T1N;W=R87`@=F%L


M

M8F]T=&]M.R!P861D:6YG+6)O='1O;3H@-'!X.R!B86-K9W)O=6YD+6-O;&]R





34L


3!P



38P.SPO=&0^



M


M/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R




M

38P


Q

M

M




T0G=VED=&@Z(#$E.R!V97)T:6-A





M8V]L;W(Z(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T


M9CLG/B8C

M=&]M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E










T0G=VED=&@Z(#DE.R!V






38P.SPO



'!T.R!F;VYT

M









M;3H@



M(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]

M;&4]
6QE/3-$



24[('9E



T0G=VED=&@Z


M86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P

M8V5E9F8[)SXF(S$V

M8F]T=&]M.B`C
#`P



M






T0G=VED=&@Z(#$E

M8V]L;W(Z(-F9F9F9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T






M;W(Z(-F9F9F9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T;VT@


M9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O
M;3H@(S`P
#`P


M(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P



38P+#$Y-CPO

M861D:6YG+6)O='1O;3H@-'!X.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O



M9CLG/B8C

#L\+W1D



T0G=VED=&@Z(#$E.R!V



24[('9E


M


M(V-C965F9CLG/B8C

M;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R



Q







M8V]L;W(Z(-F9F9F9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T



M86QI9VXZ(&)O='1O;3L@=&5X=UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9UC

38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O


M9F8[)SXF(S$V

T0G9F]N

38P.SPO=&0^/'1D('9A;&EG



T1B;W1T;VT@






T0G=VED=&@Z

38P.SPO=&0^/'1D











T0G=VED=&@Z(#$E.R!V


38P.SPO


#L\+W1D/CPO='(^/'1R




M+CDP(D\+V1I=CX\+W1D/CQT9!V86QI9VX]

T0G



M9CLG/B8C

@3F5W
M(%)O;6%N)RP@5&EM97

C`Q+#4X-#PO9&EV/CPO=&0^/'1D



M/B8C

#L\+W1D/CQT


M

T1N;W=R87`@

M86QI9VXZ(&)O='1O;3L@=&5X=UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9UC


@
M3F5W(%)O;6%N)RP@5&EM97

M87)G:6XM;&5F=#H@






M)B







T0G=VED=&@Z



3!P



M;W(Z(-F9F9F9F8[)SXF(S$V,#L\+W1D/CPO='(^/'1R/CQT9!V86QI9VX]
M

T0G=VED=&@Z(#8V)3L@=F5R=&EC86PM86QI9VXZ




M;&4@9&5B=#PO9&EV/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS


M=&]M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E






Q




M9VX]





M:61T:#H@

M8V]L;W(Z(-F9F9F9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T






M;W=R87`]


38P.SPO=&0^/'1D

M(S$V






M9F9F9F8[)SXF(S$V


;V-A=&EO;CH@
M9FEL93HO+R]#.B]B.60V-&0T
E\V-#9F7S0S83)?8C8U9%\X
S(V9#8X-S5A



]


T0Q(')O
M=W-P86X]

]



T1T;W`^/'-T


T1T;W`^4V-H961U;&4@;V8@


M93H@


M(&-O;G-I9&5R871I;VX@=')A;G-F97)R960@=&\@86-Q=6ER92!(3BP@87
@

@87-S=6UE9!B87-E9!O;B!T:&4@97-T
M:6UA=&5D(&9A:7(@=F%L=64@87

BP@


6QE/3-$




T0G=VED=&@Z(#$E.R!V


M;&4]


'!T.R!F



T1B;W1T

T0G=VED=&@Z(#8X)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O









T0G=VED=&@Z(#$E.R!V97)T:6-A





T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T


M

M97
@3F5W(%)O;6%N)RP@5&EM97








M86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P

M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97

BPW


M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=W:61T:#H@-C@E.R!V97)T
M:6-A;UA;&EG;CH@8F]T=&]M.R!P861D:6YG+6)O='1O;3H@
G!X.R!B86-K


38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O

P
#`P
#`@
G!X('-O;&ED.R!T97AT+6%L:6=N





M='(^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=W:61T:#H@-C@E.R!V
M97)T:6-A;UA;&EG;CH@8F]T=&]M.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E


38P.SPO=&0^/'1D('9A;&EG;CTS1&)O

M9F8[)SXF(S$V



M


3!P

L(&EN8VQU9&EN
M9R!A8W%U:7)E9!C87-H(&]F(0Q+#`W-3PO9&EV/CPO=&0^/'1D('9A;&EG

#L\




M+#

M=&]M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F








T0G=VED=&@Z(#DE

T0G9F]N



#L\+W1D/CPO='(^/'1R/CQT




M;&4]



M(V9F9F9F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL

M97
@3F5W(%)O;6%N)RP@5&EM97


#L\+W1D








T0G=VED=&@Z(#DE

T0G9F]N



#L\+W1D/CPO='(^/'1R/CQT


















M.R!B;W)D97(M8F]T=&]M.B`C
#`P






M8F]T=&]M.R!P861D:6YG+6)O='1O;3H@
G!X.R!T97AT+6%L:6=N.B!L969T

M;&EG;CTS1&)O='1O;2!S='EL93TS1=W:61T:#H@-C@E.R!V97)T:6-A;UA
M;&EG;CH@8F]T=&]M.R!P861D:6YG+6)O='1O;3H@
G!X.R!B86-K9W)O=6YD

38P.SPO=&0^/'1D('9A;&EG;CTS1&)O

P
#`P
#`@
G!X('-O;&ED.R!T97AT+6%L

Q-C`[
'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O

T1N;W=R87`@=F%L:6=N





@3F5W(%)O;6%N
M)RP@5&EM97

M=#H@
38N




M(S$V

M
#`P

M





T0G=VED=&@Z(#$E.R!V


M:'1M;#X-@T*+2TM+2TM/5].97AT4&%R=%]B.60V-&0T,E\V-#9F7S0S83)?
M8C8U9%\X,S(V9#8X-S5A8S0-D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O
M0SHO8CED-C1D-#)?-C0V9E\T
V$R7V(V-61?.#


M:&5E='

T0G=&5X




M

3(@36]N=&AS($5N9&5D
M/]T:#X-B`@(`@(#PO='(^#0H@(`@(`\='(^#0H@(`@(`@(#QT:!C

S$L(#(P


12!.3TY#3TY44D]








@3F5W(%)O;6%N
M)RP@5&EM97



M+V1I=CX\=&%B;&4@86QI9VX]
T1C96YT97(@8F]R9&5R/3-$





38P.SPO=&0^/'1D(&-O
M;'-P86X]
T0V('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=V97)T:6-A;UA
M;&EG;CH@8F]T=&]M.R!B;W)D97(M8F]T=&]M.B`C
#`P

'!T.R!F;VYT+69A;6EL


Q+#PO

M861D:6YG+6)O='1O;3H@

Q-C`[


M;&4]



@
M3F5W(%)O;6%N)RP@5&EM97



T0G=VED=&@Z(#$E



38P.SPO=&0^/'1D(&-O
M;'-P86X]
T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=V97)T:6-A;UA
M;&EG;CH@8F]T=&]M.R!B;W)D97(M8F]T=&]M.B`C
#`P

'!T.R!F;VYT+69A;6EL


3
\+V1I=CX\+W1D



M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97



M9CLG/B8C
6QE





M:61T:#H@

M8V]L;W(Z(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T


M.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97



@3F5W(%)O;6%N)RP@5&EM
M97



M;&EG;CTS1&)O='1O;2!S='EL93TS1=W:61T:#H@-38E.R!V97)T:6-A;UA


2PY.#`@86YD(0Q
M+#DV-RD\+V1I=CX\+W1D/CQT9!V86QI9VX]

T0G



M9CLG/B8C

@3F5W
M(%)O;6%N)RP@5&EM97

M;W=R87`]


38P.SPO=&0^/'1D

M(S$V





M;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R





L-S(W(&%N9`D-PY-CDI/]D:78^/]T


M:61T:#H@



T0G=VED=&@Z(#DE.R!V97)T





38P.SPO=&0^/'1D



'!T.R!F;VYT+69A;6EL

T1B;W1T;VT@






38P.SPO=&0^/'1D('9A;&EG;CTS

M9F9F9F8[)SXF(S$V




M:61T:#H@



T0G=VED=&@Z(#$E.R!V97)T


38P.SPO=&0^
F4Z

@3F5W(%)O;6%N)RP@5&EM97
L

T1N;W=R87`@

M86QI9VXZ(&)O='1O;3L@=&5X=UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9UC


M(&9O;G0M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97





M;&EG;CH@8F]T=&]M.R!B;W)D97(M8F]T=&]M.B`C
#`P






#L\

G!X.R!B




T0G=VED

M93H@

M86QI9VX]







T0G

M=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P
M

M(&9O;G0M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97


P
#`P



#L@=&5X
M=UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9UC;VQO<CH@(V9F9F9F9CLG/B8C
M,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=W:61T:#H@
M



T0G=VED=&@Z(#$E.R!V97)T:6-A

6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N=UF

M)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
M
#`P




M;&EG;CH@8F]T=&]M.R!P861D:6YG+6)O='1O;3H@-'!X.R!T97AT+6%L:6=N






M)B




T0G=VED



M/B8C


#L\+W1D





M)SXF(S$V





T1N;W=R87`@=F%L:6=N/3-$8F]T


M9CLG/B8C


M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F



T1N;W=R



M97
@3F5W(%)O;6%N)RP@5&EM97






M)B





38P



'!T.R!F



T1B;W1T

T0G=VED=&@Z(#4V)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O

'!T.R!F;VYT+69A


G!T.R!T97AT+6EN9&5N=#H@



M861D:6YG+6)O='1O;3H@
G!X.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F

'0M86QI9VXZ(&QE9G0[(&)A8VMG

M




3!P=#L@9F]N=UF86UI;'DZ(=4


M



M:61T:#H@



M(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P

M5&EM97
@3F5W(%)O;6%N)RP@5&EM97


M;CTS1&)O='1O;2!S='EL93TS1=W:61T:#H@-38E.R!V97)T:6-A;UA;&EG
M;CH@8F]T=&]M.R!P861D:6YG+6)O='1O;3H@-'!X.R!B86-K9W)O=6YD+6-O


T0G=VED=&@Z(#$E.R!V97)T


M(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P

M5&EM97
@3F5W(%)O;6%N)RP@5&EM97


P
#`P
#`@-'!X

3!P=#L@9F]N

T1N;W=R87`@=F%L:6=N/3-$


38P.SPO=&0^/'1D('9A


M.R!B;W)D97(M8F]T=&]M.B`C
#`P





'!T.R!F;VYT+69A;6EL

T1B;W1T;VT@




F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97
@
M3F5W(%)O;6%N)RP@5&EM97





I.CPO9&EV/CQD:78^)B


T0G=VED=&@Z(#8V)3L@

M/B8C

B!V86QI9VX]
T1B

T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R
M+6)O='1O;3H@(S`P
#`P

M.B!C96YT97([)SXR



M;&4]



@
M3F5W(%)O;6%N)RP@5&EM97



T0G=VED=&@Z(#$E









M.B`Q

M+!S97)I9CLG/B0\+V1I=CX\+W1D/CQT9!V86QI9VX]

M;&4]






#L\






M9VX]

T0G=VED=&@Z(#DE.R!V97)T:6-A;UA;&EG
M;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!R:6=H=#L@8F%C:V=R;W5N9UC;VQO


M/CDL


M8V5E9F8[)SXF(S$V

T0G


M(S$V




M:68[)SXH

'!T.R!F


T0G=VED



M/B8C

@3F5W(%)O
M;6%N)RP@5&EM97






3!P=#L@9F]N=UF86UI;'DZ(=4:6UE

38P.SPO



'!T.R!F;VYT

T1N;W=R87`@=F%L:6=N/3-$8F]T











T0G=VED=&@Z(#$E.R!V97)T:6-A


@3F5W(%)O;6%N)RP@5&EM97
L('-E


@3F5W(%)O;6%N
M)RP@5&EM97


G('!U



Q-C`[







T0G



M9CLG/B8C

@3F5W
M(%)O;6%N)RP@5&EM97

2PR



G!X


#L@8F%C:V=R;W5N9UC;VQO<CH@(V-C965F9CLG/B8C
38P.SPO=&0^/'1D

P
#`P
#`@
G!X('-O
M;&ED.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E

'0M86QI9VXZ(')I9VAT.R!B


T0G=VED=&@Z(#$E.R!V97)T

M97
@3F5W(%)O;6%N)RP@5&EM97



M=&]M.R!B;W)D97(M8F]T=&]M.B`C
#`P







M='(^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=W:61T:#H@-C8E.R!V
M97)T:6-A;UA;&EG;CH@8F]T=&]M.R!P861D:6YG+6)O='1O;3H@-'!X.R!B






'!T.R!F;VYT


T0G=VED=&@Z


T1N;W=R87`@


38P.SPO


M;CH@8F]T=&]M.R!B;W)D97(M8F]T=&]M.B`C
#`P




'!T.R!F





T0G=VED=&@Z(#8V)3L@


M;F0M8V]L;W(Z(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B



#L\


24[


M




M='(^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=W:61T:#H@-C8E.R!V
M97)T:6-A;UA;&EG;CH@8F]T=&]M.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F

T1B




38P.SPO=&0^/'1D('9A;&EG;CTS1&)O

M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97

#PO






T0G=VED



M












M(S$V













T0G=VED=&@Z

T0G


M:7IE.B`Q

M;65S+!S97)I9CLG/B4\+V1I=CX\+W1D/CPO='(^/]T86)L93X\+V1I=CX\

M9#0R7S8T-F9?-#-A
E]B-C5D7S@S






]

T1)1#!%344^



S$L(#(P
M




M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97






M

M='EL93TS1=W:61T:#H@-38E.R!V97)T:6-A;UA;&EG;CH@8F]T=&]M.R!P
M861D:6YG+6)O='1O;3H@




T1B





M.R!P861D:6YG+6)O='1O;3H@


P
#`P
#`@


C`Q-#PO9&EV/CPO=&0^/'1D

M;3H@





T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T




M(S$V




T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M


M/B8C






T1N;W=R87`@

M86QI9VXZ(&)O='1O;3L@=&5X=UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9UC


@
M3F5W(%)O;6%N)RP@5&EM97





'0M


M:61T:#H@



T0G=VED=&@Z(#$E.R!V97)T


38P.SPO=&0^
F4Z

@3F5W(%)O;6%N)RP@5&EM97
L



M;&4]


M;F0M8V]L;W(Z(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B







T0G=VED



M:#H@



T0G=VED=&@Z(#DE.R!V97)T:6-A


M97)I9CLG/C0T

M;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R


3!P=#L@9F]N




M;F0M8V]L;W(Z(-F9F9F9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B


38P

P
#`P
M
#`@

'!T

M







M=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P
M

M(&9O;G0M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97




#L\+W1D/CPO='(^

T0G9F]N


T0G=VED


M=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P

M;G0M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97


P
#`P

M93H@


T0G=VED=&@Z(#$E.R!V97)T:6-A





'!T.R!F;VYT+69A;6EL


T0G=VED=&@Z(#DE.R!V


T1N;W=R87`@=F%L:6=N




M+R\O0SHO8CED-C1D-#)?-C0V9E\T
V$R7V(V-61?.#

T+U=O

O4VAE970S


T0G




M/3-$

T0Q/C$R($UO

#$T/&)R/CPO=&@^#0H@


]
T1T

]

]
T1T97AT







T0P

3!P=#L@9F]N=UF86UI;'DZ(=4:6UE

M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=W:61T:#H@,C@E.R!V97)T
M:6-A;UA;&EG;CH@8F]T=&]M.R!P861D:6YG+6)O='1O;3H@

Q



T0G=VED=&@Z(#$E



T0G=VED=&@Z(#(X)3L@

M/B8C

B!V86QI9VX]
T1B

T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R
M+6)O='1O;3H@(S`P
#`P

M.B!C96YT97([)SXR



M;&4]



@
M3F5W(%)O;6%N)RP@5&EM97




G!X.R!F;VYT
#LG/CQD:78@<W1Y
M;&4],T0G9F]N=US:7IE.B`Q




M1=W:61T:#H@,C@E.R!V97)T:6-A;UA;&EG;CH@8F]T=&]M.R!B86-K9W)O

38P
6QE/3-$)V9O;G0M





24[


M

@
M3F5W(%)O;6%N)RP@5&EM97


M(&9O;G0M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97




M8V5E9F8[)SXF(S$V


C@E.R!V97)T:6-A

M5&EM97
@3F5W(%)O;6%N)RP@5&EM97





24[('9E


M





M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F



38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O

M)SXF(S$V





T0G=VED=&@Z(#$E



3!P=#L@9F]N=UF86UI;'DZ(=4:6UE







T0G=VED=&@Z(#DE

T0G9F]N





38P.SPO



'!T.R!F;VYT

T1B



M




M=&5R(&%N9!S;V9T=V%R93PO9&EV/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O
M;2!S='EL93TS1=W:61T:#H@


M86QI9VX]







M;&4]





T0G=VED=&@Z(#DE

T0G9F]N




M;&4]

M;2!S='EL93TS1=W:61T:#H@,C@E.R!V97)T:6-A;UA;&EG;CH@8F]T=&]M

38P.SPO=&0^/'1D('9A;&EG;CTS

M8V5E9F8[)SXF(S$V





T0G=VED



M:#H@



T0G=VED=&@Z(#DE.R!V97)T:6-A


M97)I9CLG/C(P

M;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R




#MY96%R



3!P=#L@9F]N=UF86UI;'DZ(=4:6UE

38P.SPO=&0^



'!T.R!F;VYT+69A

T1B;W1T






T0G=VED

M





M9G0[)SXU+3$P)B




38P.SPO=&0^

P
#`P
#`@
G!X
M('-O;&ED.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C

'0M86QI9VXZ(')I9VAT


T0G=VED=&@Z(#$E.R!V97)T





M)W=I9'1H.B`Y)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O
M='1O;3H@(S`P
#`P


@3F5W(%)O;6%N)RP@
M5&EM97


M



3!P=#L@9F]N




T0G=VED=&@Z(#$E.R!V97)T





M
S

M:61T:#H@

M8V]L;W(Z(-F9F9F9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T






M;W=R87`]


38P.SPO=&0^/'1D

M)B










M=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P
M

M(&9O;G0M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97




#L\+W1D/CQT

G!X.R!B86-K9W)O

'0M


T0G=VED=&@Z(#DE

3!P


S@E.R!V97)T


M93H@




M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F



M)SXR-PW-3,\+V1I=CX\+W1D/CQT9!N;W=R87`]
T1N;W=R87`@=F%L:6=N


38P.SPO=&0^/'1D


M=&]M.R!B;W)D97(M8F]T=&]M.B`C
#`P


3!P=#L@9F]N=UF86UI;'DZ(=4:6UE


'!T.R!F;VYT+69A

T1B;W1T





;V-A
M=&EO;CH@9FEL93HO+R]#.B]B.60V-&0T
E\V-#9F7S0S83)?8C8U9%\X
S(V




]
T13:&]W+FIS/B\J($1O($YO

M
T0Q(')O=W-P86X]

12!!4U-%5%
@04Y$
M($=/3T1724Q



#$T/&)R/CPO=&@^#0H@(`@(`\+W1R/@T*


]

6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N=UF

M.B`C
#`P



I
M.CPO9&EV/CQD:78^)B



T0G=VED=&@Z(#$X)3L@=F5R=&EC

38P

3`@=F%L:6=N/3-$8F]T=&]M



@3F5W(%)O;6%N)RP@5&EM
M97

T1N;W=R






3!P=#L@9F]N=UF86UI;'DZ(=4:6UE


M+6)O='1O;3H@




T0G=VED=&@Z(#$X)3L@=F5R

M

B!V86QI9VX]
T1B;W1T

T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O
M='1O;3H@(S`P
#`P





M;&4]



@
M3F5W(%)O;6%N)RP@5&EM97



T0G=VED



38P.SPO=&0^
M/'1D(&-O;'-P86X]
T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=V97)T
M:6-A;UA;&EG;CH@8F]T=&]M.R!B;W)D97(M8F]T=&]M.B`C
#`P
#`P(#)P

'!T.R!F;VYT






#L\+W1D


Q

P
M
#`P
#`@


M;CH@8F]T=&]M.R!P861D:6YG+6)O='1O;3H@
G!X.R!T97AT+6%L:6=N.B!L


M





T1B;W1T;VT@




M97
@3F5W(%)O;6%N)RP@5&EM97



\+V1I=CX\+W1D


3@E


@3F5W(%)O;6%N)RP@
M5&EM97



2P@




M/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X=UA
M;&EG;CH@;&5F=#LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S
M='EL93TS1=W:61T:#H@

M(S$V


T0G=VED=&@Z(#$E

M.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C
38P.SPO=&0^/'1D
M(&-O;'-P86X]



#L\+W1D/CQT


T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M

M=&5X=UA;&EG;CH@;&5F=#LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O
M='1O;2!S='EL93TS1=W:61T:#H@

M;VT[)SXF(S$V


T0G=VED

M)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C
38P.SPO
M=&0^/'1D(&-O;'-P86X]



#L\







T0G=VED=&@Z(#$E.R!V97)T


@3F5W(%)O;6%N)RP@5&EM97
L


M97
@3F5W(%)O;6%N)RP@5&EM97




24[('9E


T0G

@3F5W
M(%)O;6%N)RP@5&EM97


M;G0M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97


M:61T:#H@

M8V]L;W(Z(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T


M.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97



@3F5W(%)O;6%N)RP@5&EM
M97






T0G=VED=&@Z(#$E.R!V97)T:6-A


@3F5W(%)O;6%N)RP@5&EM97
L('-E


@
M3F5W(%)O;6%N)RP@5&EM97

BPV






T0G=VED

@3F5W(%)O
M;6%N)RP@5&EM97


M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97



M)SXF(S$V






T0G=VED=&@Z(#DE.R!V97)T








M=UI;F1E;G0Z(TW+C)P=#LG/D%C8W5M=6QA=&5D(&%M;W)T:7IA=&EO;CPO

#L\+W1D/CQT

#`P


T0G9F]N


G!X.R!T





M



M

P
M
#`P
#`@
G!X('-O;&ED.R!T97AT+6%L:6=N.B!R:6=H=#L@8F%C:V=R;W5N

M

T1N;W=R87`@=F%L:6=N


38P.SPO=&0^/'1D


M=&]M.R!B;W)D97(M8F]T=&]M.B`C
#`P





M9CLG/B@T+#
T

M;CH@8F]T=&]M.R!P861D:6YG+6)O='1O;3H@
G!X.R!T97AT+6%L:6=N.B!L




M(-F9F9F9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]

M;&4]

38P.SPO=&0^/'1D

P
#`P
#`@
G!X('-O

'!T.R!F;VYT+69A

T1B;W1T



@3F5W(%)O;6%N)RP@5&EM
M97


M)SXF(S$V

M.B`C
#`P





S$\+V1I=CX\+W1D

'!T.R!F


T0G=VED


M=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P


M97(M8F]T=&]M.B`C
#`P



'!T.R!F;VYT+69A;6EL


T0G=VED









Q




#L@=&5X
M=UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9UC;VQO<CH@(V-C965F9CLG/B8C
M,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=W:61T:#H@
M



T0G=VED=&@Z(#$E.R!V97)T:6-A

6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N=UF

M)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
M
#`P




#L\+W1D/CQT







M

M.R!P861D:6YG+6)O='1O;3H@-'!X.R!T97AT+6%L:6=N.B!L969T.R!B86-K



38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S

P
#`P

M

M8F]T=&]M.R!B;W)D97(M8F]T=&]M.B`C
#`P

M5&EM97
@3F5W(%)O;6%N)RP@5&EM97

#L@=&5X=UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9UC;VQO
M<CH@(V-C965F9CLG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S
M='EL93TS1=W:61T:#H@



T0G=VED




M9&5R+6)O='1O;3H@(S`P
#`P

M


M)SXF(S$V












Q-C`[

M8V]L;W(Z(-F9F9F9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T



M86QI9VXZ(&)O='1O;3L@=&5X=UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9UC

38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O


M9F8[)SXF(S$V









T0G=VED=&@Z(#$E.R!V


38P.SPO




Q-C`[







M;W(Z(-F9F9F9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T;VT@



M9VXZ(&)O='1O;3L@=&5X=UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9UC;VQO

38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S


M)SXF(S$V






M:61T:#H@



T0G=VED=&@Z

'!T.R!F



M965F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS

#L\



T0G=VED=&@Z(#$E



24[


M9VX]

T0G=VED=&@Z(#DE.R!V97)T:6-A;UA;&EG
M;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!R:6=H=#L@8F%C:V=R;W5N9UC;VQO


M;&EG;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O


38P.SPO=&0^/'1D('9A



T1B;W1T






T0G=VED

38P.SPO=&0^



M9CLG/B8C

#L\+W1D



T0G=VED=&@Z(#$E.R!V



24[('9E


M


M(V-C965F9CLG/B8C

M;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R










M86QI9VX]

T0G=VED=&@Z(#DE.R!V97)T:6-A;UA
M;&EG;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!R:6=H=#L@8F%C:V=R;W5N9UC







'!T.R!F;VYT


T0G=VED=&@Z

T0G






M.B`Q

M+!S97)I9CLG/B0\+V1I=CX\+W1D/CQT9!V86QI9VX]

M;&4]





#L\






M9VX]

T0G=VED=&@Z(#DE.R!V97)T:6-A;UA;&EG
M;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!R:6=H=#L@8F%C:V=R;W5N9UC;VQO




M9F9F9F8[)SXF(S$V



'!T.R!F;VYT+69A


T0G=VED=&@Z(#DE

T0G9F]N







M.B`Q

M+!S97)I9CLG/B0\+V1I=CX\+W1D/CQT9!V86QI9VX]

M;&4]





#L\

M;&4]

M965F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS

P
#`P
#`@
G!X('-O;&ED.R!T97AT+6%L:6=N.B!L969T.R!B











M


M;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P

@
M3F5W(%)O;6%N)RP@5&EM97




#L@8F%C:V=R;W5N9UC;VQO<CH@(V-C965F9CLG/B8C
38P.SPO=&0^/'1D

P
#`P
#`@
G!X('-O
M;&ED.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E

'0M86QI9VXZ(')I9VAT.R!B

24[('9E







M)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
M
#`P


@3F5W(%)O;6%N)RP@5&EM97
L('-E






38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S

P
#`P
#`@
G!X('-O;&ED.R!T97AT+6%L:6=N.B!L




T1B;W1T



@3F5W(%)O;6%N)RP@5&EM
M97


M)SXF(S$V

M.B`C
#`P





SPO9&EV/CPO

M+6)O='1O;3H@
G!X.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O

M='EL93TS1=W:61T:#H@,3@E.R!V97)T:6-A;UA;&EG;CH@8F]T=&]M.R!P
M861D:6YG+6)O='1O;3H@-'!X.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F




M



M;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P




M;3H@-'!X.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C

#L@8F%C:V=R;W5N9UC;VQO<CH@(V9F9F9F9CLG/B8C
M

P
M
#`P



M8F]T=&]M.B`C
#`P


@3F5W(%)O;6%N
M)RP@5&EM97



Q
#L@8F%C:V=R;W5N9UC;VQO<CH@(V9F9F9F9CLG/B8C
38P.SPO=&0^/'1D

P
#`P
#`@-'!X(&1O




#`P
M


@3F5W(%)O;6%N)RP@5&EM97
L('-E



#L\+W1D/CQT











M(-F9F9F9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]

M;&4]



M='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P



#PO9&EV/CPO=&0^

M='1O;3H@-'!X.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R

#L@8F%C:V=R;W5N9UC;VQO<CH@(V9F9F9F9CLG
M/B8C

P
#`P


M97(M8F]T=&]M.B`C
#`P

@3F5W(%)O
M;6%N)RP@5&EM97

2PT

M='EL93TS1=W:61T:#H@,3@E.R!V97)T:6-A;UA;&EG;CH@8F]T=&]M.R!B


38P



M86QI9VX]






M;W(Z(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T;VT@


M/B8C

M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F



38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O

M)SXF(S$V



T0G



M:61T:#H@



T0G=VED=&@Z(#DE.R!V97)T





38P.SPO



M9VX]






M(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]

M;&4]

M


M)B





T0G=VED




\

M:#H@


B!V86QI
M9VX]

T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@





M)SXF(S$V






T1N;W=R87`@=F%L:6=N/3-$8F]T


M9CLG/B8C


T0G




T0G=VED





M)B


38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S

M(S$V



T0G=VED




@3F5W(%)O
M;6%N)RP@5&EM97

#`P
#LG/D%M;W)T:7IA

2XP(&UI;&QI;VX@:6X@
C`Q-BP@)#`N
2!M:6QL:6]N(&EN
M(#(P




T0G=VED=&@Z(#4V)3L@=F5R=&EC

38P.SPO

B!V86QI9VX]

M;&4]

M
#`P


#`P


T0G=VED=&@Z(#$E.R!V97)T



38P.SPO=&0^/'1D(&-O;'-P86X]
M
T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=V97)T:6-A;UA;&EG;CH@
M=&]P.R!B;W)D97(M8F]T=&]M.B`C
#`P



M(&-O;&]R.B`C
#`P
#`P.R!T97AT+6%L:6=N.B!C96YT97([)SXR



T0G=VED

'!T.R!F

P
#`P


38P.SPO=&0^/'1D('9A

3!P=#L@





M8V]L;W(Z(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T



M86QI9VXZ(&)O='1O;3L@=&5X=UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9UC




M.B`C
#`P

T1N;W=R



@
M3F5W(%)O;6%N)RP@5&EM97

#`P
#L@=&5X

M

M(-F9F9F9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]

M;&4]








T0G=VED=&@Z(#$E.R!V


38P.SPO


@3F5W(%)O;6%N)RP@5&EM
M97

#`P



G!X.R!B







M(S$V

M
#`P









#`P



M=&]M.R!B;W)D97(M8F]T=&]M.B`C
#`P






24[

6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N=UF86UI;'DZ

#`P
M

M.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97

M
#`P




M9&]U8FQE.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C

T1B;W1T;VT@







M



M9&5R+6)O='1O;3H@(S`P
#`P

@3F5W(%)O
M;6%N)RP@5&EM97

#`P
#LG/B0\+V1I=CX\

#`P
#`P

M(&9O;G0M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97


#`P
#LG/C0L
3


M)SXF(S$V


;V-A=&EO;CH@9FEL93HO
M+R]#.B]B.60V-&0T
E\V-#9F7S0S83)?8C8U9%\X
S(V9#8X-S5A8S0O5V]R



M(#Q-151!(&AT='`M97%U:78]

]



3XQ
B!-;VYT:'
@16YD960\+W1H/@T*

M=&@^1&5C+B`S
2P@

]





M/&1I=CXF(S$V

T0P(&-E;&QS


M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97

M


M


T0G
M=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P
M



M='1O;2!S='EL93TS1=V97)T:6-A;UA;&EG;CH@8F]T=&]M.R!P861D:6YG
M+6)O='1O;3H@





M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97





M;&4]


38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS
M1=V97)T:6-A;UA;&EG;CH@8F]T=&]M.R!P861D:6YG+6)O='1O;3H@
G!X


P
#`P
#`@




'!T.R!F
'0M86QI9VXZ(&-E;G1E<CLG/D]P=&EO
M;G


T0G=F5R=&EC86PM86QI9VXZ(&)O

38P.SPO=&0^/'1D(&-O
M;'-P86X]
T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=V97)T:6-A;UA
M;&EG;CH@8F]T=&]M.R!B;W)D97(M8F]T=&]M.B`C
#`P

'!T.R!F;VYT+69A;6EL



'0M86QI9VXZ(&-E;G1E<CLG/D%V97)A9V4@/]D:78^/&1I

@
M3F5W(%)O;6%N)RP@5&EM97


M87`]


M9VXZ(&QE9G0[)SXF(S$V

T0G9F]N

M:7IE.B`Q




@3F5W(%)O;6%N)RP@5&EM97
L

M
'0M86QI9VXZ(&-E;G1E<CLG



M86QI9VX]

T0G=F5R=&EC86PM86QI9VXZ(&)O='1O



M(&9O;G0M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97


'!T
'0M86QI9VXZ(&-E;G1E<CLG/E=A

M1&)O='1O;2!S='EL93TS1=V97)T:6-A;UA;&EG;CH@8F]T=&]M.R!P861D
M:6YG+6)O='1O;3H@


B!V86QI9VX]

T0G=F5R=&EC
M86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P




M9VAT.B!B;VQD.R!T97AT+6%L:6=N.B!C96YT97([)SY!=F5R86=E(#PO9&EV






G!X.R!T97AT


B!V86QI9VX]
M

T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R
M9&5R+6)O='1O;3H@(S`P
#`P







M97([)SY

T1N;W=R


M)SXF(S$V




M




3!P=#L@9F]N=UF86UI;'DZ(=4:6UE




T0G=VED=&@Z(#$E.R!V


M;&4]


'!T.R!F




M



M965F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS

@
M3F5W(%)O;6%N)RP@5&EM97


#L\+W1D/CQT

M)B




M86QI9VX]












#PO9&EV/CPO=&0^/'1D(&YO



M



'!T

M


6QE/3-$




M(V9F9F9F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL

M





T0G=VED=&@Z(#$E.R!V



24[('9E


M




M+C


M9F8[)SXF(S$V









T0G=VED=&@Z(#$E.R!V


38P.SPO


@3F5W(%)O;6%N)RP@5&EM
M97

2PX-3DL








T1B;W1T






T0G=VED

38P.SPO=&0^





#L\

M
'0M86QI9VXZ(&QE9G0[(&)A8VMG<F]U;F0M8V]L
M;W(Z(-C8V5E9F8[)SXF(S$V


38P.SPO=&0^/'1D(&-O;'-P86X]
T0R('9A
M;&EG;CTS1&)O='1O;2!S='EL93TS1=V97)T:6-A;UA;&EG;CH@8F]T=&]M





T0G=F5R=&EC86PM86QI9VXZ(&)O

M965F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS
M1=V97)T:6-A;UA;&EG;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!R:6=H=#L@


T0G=F5R=&EC

38P.SPO=&0^/'1D('9A;&EG;CTS1&)O
M='1O;2!S='EL93TS1=V97)T:6-A;UA;&EG;CH@8F]T=&]M.R!B86-K9W)O

'0M
M86QI9VXZ(&QE9G0[(&)A8VMG<F]U;F0M8V]L;W(Z(-C8V5E9F8[)SXF(S$V
M


M:68[)SXS.#4L

M;&EG;CTS1&)O='1O;2!S='EL93TS1=V97)T:6-A;UA;&EG;CH@8F]T=&]M
M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F


M9F8[)SXF(S$V




T0G=F5R=&EC

38P.SPO=&0^/'1D('9A;&EG;CTS1&)O
M='1O;2!S='EL93TS1=V97)T:6-A;UA;&EG;CH@8F]T=&]M.R!B86-K9W)O

'0M
M86QI9VXZ(&QE9G0[(&)A8VMG<F]U;F0M8V]L;W(Z(-C8V5E9F8[)SXF(S$V
M

M8V]L;W(Z(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!N;W=R87`]
T1N;W=R


T1B;W1T

T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N

M



T0G=F5R=&EC86PM






T0G=F5R=&EC

38P.SPO=&0^/'1D('9A;&EG;CTS1&)O
M='1O;2!S='EL93TS1=V97)T:6-A;UA;&EG;CH@8F]T=&]M.R!B86-K9W)O





T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M



T0G=F5R=&EC86PM86QI9VXZ







M9VX]

T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@

M/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=V97)T
M:6-A;UA;&EG;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!R:6=H=#L@8F%C:V=R

M.B`Q


M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97


M)B

3!P=#L@

M


M;W(Z(-F9F9F9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T;VT@








'0M

38P.SPO=&0^/'1D('9A
M;&EG;CTS1&)O='1O;2!S='EL93TS1=V97)T:6-A;UA;&EG;CH@8F]T=&]M
M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F

'0M86QI9VXZ(')I9VAT.R!B86-K
M9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^/&1I=B!S='EL93TS1=F;VYT+7-I

@3F5W(%)O;6%N)RP@5&EM
M97






38P.SPO=&0^/'1D('9A;&EG;CTS
M1&)O='1O;2!S='EL93TS1=V97)T:6-A;UA;&EG;CH@8F]T=&]M.R!T97AT

Q


M8F]T=&]M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C






'0M86QI9VXZ(&QE
M9G0[(&)A8VMG<F]U;F0M8V]L;W(Z(-C8V5E9F8[)SXF(S$V
#L\+W1D/CQT

38P.SPO=&0^
M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=V97)T:6-A;UA;&EG;CH@
M8F]T=&]M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C

'0M86QI9VXZ(')I9VAT
M.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^/&1I=B!S='EL93TS1=F

@3F5W(%)O;6%N
M)RP@5&EM97





T0G=F5R=&EC86PM86QI9VXZ(&)O

M8V5E9F8[)SXF(S$V
'0M86QI9VXZ(&QE9G0[(&)A8VMG<F]U;F0M8V]L;W(Z(-C8V5E9F8[)SXF
M(S$V




T0G=VED=&@Z(#$E.R!V97)T:6-A


M='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P

M

#`P
M


M:68[)SXH






38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S

P
#`P
#`@
G!X('-O;&ED.R!T97AT+6%L:6=N.B!L




T1N;W=R87`@=F%L:6=N/3-$8F]T


38P.SPO=&0^/'1D('9A;&EG


M;W)D97(M8F]T=&]M.B`C
#`P



M(V9F9F9F9CLG/B8C

M;CH@8F]T=&]M.R!P861D:6YG+6)O='1O;3H@
G!X.R!T97AT+6%L:6=N.B!L

#L@8F%C:V=R
M;W5N9UC;VQO<CH@(V9F9F9F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS

P
#`P
#`@
G!X('-O;&ED.R!T97AT

Q
'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD





M9VX]



M8F]R9&5R+6)O='1O;3H@(S`P
#`P

#L\+W1D

#`P
#`P(#)P


M-BXY

M=&]M.R!P861D:6YG+6)O='1O;3H@
G!X.R!T97AT+6%L:6=N.B!L969T.R!B



38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O

P
#`P
#`@
G!X('-O;&ED.R!T97AT+6%L:6=N









T0G=VED=&@Z

'!T.R!F

G!T.R!T97AT+6EN




38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S

M(S$V




M87`]


38P.SPO=&0^/'1D('9A

M





M


M/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R




M



CPO9&EV/CPO=&0^/'1D



M/B8C

#L\+W1D/CQT


M


T0G=VED=&@Z(#$E.R!V97)T:6-A





M8V]L;W(Z(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T




S
\+V1I

M

M(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]

M;&4]





T1N



C@E.R!V97)T:6-A

M5&EM97
@3F5W(%)O;6%N)RP@5&EM97

M969T.R!M87)G:6XM;&5F=#H@
38N

G!T

T1B




38P.SPO=&0^/'1D('9A;&EG;CTS1&)O

M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97

30Q+#$S

M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F



38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O

M)SXF(S$V




M87`]


38P.SPO=&0^/'1D('9A

M



M;W(Z(-F9F9F9F8[)SXF(S$V,#L\+W1D/CQT9!N;W=R87`]
T1N;W=R87`@

M86QI9VXZ(&)O='1O;3L@=&5X=UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9UC

38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O


M;&EG;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O



BPT
S8\

M:#H@

M;W(Z(-F9F9F9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T;VT@






24[


M9VX]



38P.SPO=&0^/'1D('9A;&EG





M;W(Z(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T;VT@







B!V
M86QI9VX]

T0G=F5R=&EC86PM86QI9VXZ(&)O='1O








M

'0M86QI9VXZ(&QE9G0[(&)A8VMG<F]U
M;F0M8V]L;W(Z(-C8V5E9F8[)SXF(S$V

38P.SPO=&0^/'1D('9A;&EG;CTS
M1&)O='1O;2!S='EL93TS1=V97)T:6-A;UA;&EG;CH@8F]T=&]M.R!T97AT

Q


@3F5W(%)O;6%N)RP@5&EM97
L('-E



M;F0M8V]L;W(Z(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B



3!P=#L@9F]N=UF86UI;'DZ(=4:6UE




M

T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X

M
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=V97)T:6-A
M;UA;&EG;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!R:6=H=#L@8F%C:V=R;W5N


T0G=F5R=&EC86PM86QI9VXZ

M(V-C965F9CLG/B8C


M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97

M+6%L:6=N.B!L969T.R!M87)G:6XM;&5F=#H@
38N
G!T.R!T97AT+6EN9&5N


M



T0G=VED=&@Z(#$E.R!V97)T:6-A


M9F9F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS

P
#`P
#`@
G!X('-O;&ED.R!T97AT+6%L:6=N.B!R:6=H=#L@


M(%1I;65S+!S97)I9CLG/B@U,PY




T0G=VED=&@Z(#$E.R!V97)T


M(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P

M(S$V

M
#`P



M86QI9VX]







M.B`Y)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@
M(S`P
#`P


M(S$V

M




M
6QE/3-$)V9O




T0G=VED=&@Z(#$E

M.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97



M;CH@8F]T=&]M.R!B;W)D97(M8F]T=&]M.B`C
#`P






24[('9E


M9VX]



M/B8C

P
#`P
#`@
G!X('-O;&ED.R!T97AT+6%L:6=N.B!R:6=H=#L@8F%C:V=R


T0G=VED=&@Z(#$E.R!V



3!P=#L@9F]N=UF86UI;'DZ(=4

2P@
C`Q-#PO9&EV/CPO=&0^/'1D


M=&]M.R!B;W)D97(M8F]T=&]M.B`C
#`P

M

#`P
M


@3F5W(%)O;6%N)RP@5&EM97
L('-E

C8Y+#8T

M;&EG;CH@8F]T=&]M.R!P861D:6YG+6)O='1O;3H@-'!X.R!T97AT+6%L:6=N

#L@8F%C
M:V=R;W5N9UC;VQO<CH@(V-C965F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG

P
#`P
#`@-'!X(&1O=6)L93L@




#`P
#`P(#1P

M;G0M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97

M
3(N




M8V]L;W(Z(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T




T0G=VED=&@Z(#DE.R!V





M86QI9VX]



M;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P

M=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P
M




M;&EG;CH@8F]T=&]M.R!P861D:6YG+6)O='1O;3H@-'!X.R!T97AT+6%L:6=N

#L@8F%C
M:V=R;W5N9UC;VQO<CH@(V-C965F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG

P
#`P
#`@-'!X(&1O=6)L93L@




#`P
#`P(#1P

M;G0M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97


M=&]M.R!P861D:6YG+6)O='1O;3H@-'!X.R!T97AT+6%L:6=N.B!L969T.R!B



38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O

P
#`P

38P.SPO

P
#`P
#`@

3!P=#L@

T1N;W=R87`@=F%L:6=N/3-$



C@E.R!V


@3F5W(%)O;6%N)RP@
M5&EM97

&5R8VES86)L92P@1&5C
M96UB97(@
S$L(#(P

M861D:6YG+6)O='1O;3H@-'!X.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F












M



M;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P






M)B







T0G



M:#H@

M(,P,#`P,#`@-'!X(&1O=6)L93L@=&5X=UA;&EG;CH@;&5F=#L@8F%C:V=R


R
BPR-C0\+V1I





M



M;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P



#L@=&5X=UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9UC;VQO<CH@
M(V9F9F9F9CLG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL
M93TS1=W:61T:#H@



T0G=VED=&@Z

M;F0M8V]L;W(Z(-F9F9F9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B






]
M










T0P('-T



M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=W:61T:#H@-38E.R!V97)T:6-A
M;UA;&EG;CH@8F]T=&]M.R!P861D:6YG+6)O='1O;3H@

Q-C`[

'0M86QI9VXZ(&-E;G1E
M<CLG/C(P,30\+V1I=CX\+W1D/CQT9!N;W=R87`]
T1N;W=R87`@=F%L:6=N


M:61T:#H@








M86QI9VXZ(&QE9G0[)SXF(S$V

'!T.R!F;VYT

G!T.R!T97AT+6EN9&5N





M/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X=UA
M;&EG;CH@;&5F=#LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S
M='EL93TS1=W:61T:#H@

M(S$V


T0G=VED=&@Z(#$E






M9F8[)SXF(S$V





T1B;W1T




6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N=UF86UI;'DZ



M93H@

M86QI9VX]












M87`]


38P.SPO=&0^/'1D('9A

M





M;2!S='EL93TS1=W:61T:#H@-38E.R!V97)T:6-A;UA;&EG;CH@8F]T=&]M


M(V-C965F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL

M





T0G=VED=&@Z(#$E.R!V97)T





M;F0M8V]L;W(Z(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B






M)B

M93H@


T0G=VED=&@Z



M


@3F5W(%)O;6%N
M)RP@5&EM97

3











M;&4]
T0G=VED=&@Z(#4V)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C

M:7IE.B`Q


M




M:#H@



T0G=VED=&@Z(#DE.R!V97)T:6-A





38P.SPO=&0^



M





\





24[('9E


M




38P.SPO=&0^/'1D('9A;&EG;CTS

M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97



M)B


3!P=#L@9F]N=UF86UI;'DZ(=4

T1B


M/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R
M+6)O='1O;3H@(S`P
#`P


M;&EG;CH@8F]T=&]M.R!B;W)D97(M8F]T=&]M.B`C
#`P


30\+V1I





M

38P.SPO=&0^/'1D('9A

P
#`P
#`@
G!X('-O;&ED

'!T.R!F;VYT+69A;6EL






M(&9O;G0M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97



M;VX@97AP96YS93PO9&EV/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL

M(S$V

M
#`P

M





T0G=VED=&@Z(#$E.R!V





'!T.R!F;VYT


T0G=VED=&@Z







M/3-$)V9O;G0M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97
L('-E

M93H@



M(,P,#`P,#`[)SXZ/]F;VYT/CPO9&EV/CQD:78^)B


T0G
M=VED=&@Z(#


38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S

M-B!V86QI9VX]

T0G=F5R=&EC86PM86QI9VXZ(&)O
M='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P

M.R!T97AT+6%L:6=N.B!C96YT97([)SY%;7!L;WEE97


M.R!P861D:6YG+6)O='1O;3H@

Q




M86QI9VXZ(&QE9G0[)SXF(S$V

M861D:6YG+6)O='1O;3H@


M



M;&EG;CTS1&)O='1O;2!S='EL93TS1=W:61T:#H@,S`E.R!V97)T:6-A;UA
M;&EG;CH@=&]P.R!P861D:6YG+6)O='1O;3H@




'!T.R!F;VYT+69A






M86QI9VX]




M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97




M5&EM97
@3F5W(%)O;6%N)RP@5&EM97




M








M;&4]



T1B




M5&EM97
@3F5W(%)O;6%N)RP@5&EM97



@3F5W
M(%)O;6%N)RP@5&EM97




G!X.R!T97AT



'0M86QI9VXZ(&-E;G1E<CLG/E1O=&%L/]D:78^/&1I=B!S='EL93TS



@3F5W(%)O;6%N)RP@
M5&EM97

M:7IE.B`Q




M;CH@;&5F=#LG/B8C


@3F5W(%)O
M;6%N)RP@5&EM97


M9RPF(S$V

38P.SPO



'!T.R!F;VYT



M;F0M8V]L;W(Z(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B


M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97



@3F5W(%)O;6%N)RP@
M5&EM97

C8N





T0G=VED=&@Z(#$E.R!V97)T






M:61T:#H@

M8V]L;W(Z(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T


M.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97



@3F5W(%)O;6%N)RP@5&EM
M97









T1B;W1T







T0G=VED=&@Z(#$E.R!V97)T


38P.SPO=&0^
F4Z

@3F5W(%)O;6%N)RP@5&EM97
L








T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T


M



Q






38P.SPO



'!T.R!F;VYT




T0G



M9CLG/B8C

@3F5W
M(%)O;6%N)RP@5&EM97

#`P/]D:78^/]T9#X\=&0@

#L\+W1D/CPO







Q







38P.SPO=&0^/'1D('9A









T0G=VED=&@Z(#$E


38P


@3F5W(%)O;6%N)RP@
M5&EM97


M93H@

38P.SPO=&0^/'1D('9A;&EG





#PO9&EV/CPO


Q-C`[

M965F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS

#L\


M:7IE.B`Q


T1N






M(V9F9F9F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL

P
#`P
#`@
G!X('-O;&ED.R!T97AT+6%L:6=N.B!L969T





M;&4]



'!T.R!F;VYT


G!X.R!T97AT

Q
#L@8F%C:V=R;W5N9UC;VQO<CH@(V9F9F9F9CLG/B8C
38P.SPO=&0^/'1D

P
#`P
#`@
G!X('-O
M;&ED.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F

'0M86QI9VXZ(')I9VAT.R!B


T0G=VED=&@Z(#$E.R!V97)T:6-A







M:6YG+6)O='1O;3H@
G!X.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD

#L@8F%C:V=R;W5N9UC;VQO<CH@(V9F
M9F9F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS

P
#`P
#`@
G!X('-O;&ED.R!T97AT+6%L:6=N.B!L969T.R!B





M






2P@
C`Q
SPO9&EV/CPO=&0^/'1D('9A;&EG

#L\




M-CDL-S


M8V5E9F8[)SXF(S$V



'!T.R!F;VYT+69A


T0G=VED=&@Z(#DE

T0G9F]N








T1N;W=R87`@=F%L:6=N/3-$8F]T


M9CLG/B8C


M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F



T1N;W=R


38P.SPO=&0^/'1D('9A;&EG;CTS1&)O

#L\+W1D/CQT




W


M)SXF(S$V





T0G=VED



M



M8V]L;W(Z(-F9F9F9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T



M86QI9VXZ(&)O='1O;3L@=&5X=UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9UC

38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O

M.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97


M;&4]





T0G=VED=&@Z(#DE

T0G9F]N




B!V86QI9VX]

T0G=F5R=&EC




M;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R


38P.SPO=&0^/'1D('9A;&EG







38P

M:61T:#H@


@3F5W(%)O;6%N)RP@5&EM97
L('-E



M)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N




T0G

M;&4]

PY,CD\+V1I=CX\+W1D/CQT
M9!N;W=R87`]


M






T1N;W=R87`@=F%L:6=N/3-$8F]T


M9CLG/B8C


M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F






Q-C`[



T1N;W=R


38P.SPO=&0^/'1D('9A;&EG;CTS1&)O

#L\+W1D/CQT









M;BUL969T.B`W+C)P=#L@=&5X=UI;F1E;G0Z(TW+C)P=#LG/D5X97)C:7-E

#L\+W1D

#`P
#`P(#)P


T0G
#L@=&5X
M=UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9UC;VQO<CH@(V9F9F9F9CLG/B8C
M,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=W:61T:#H@
M


B!V86QI9VX]

T0G=F5R=&EC
M86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P




T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M


38P.SPO=&0^/'1D('9A;&EG;CTS


M97(M8F]T=&]M.B`C
#`P









B!V86QI9VX]
T1B

T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R
M+6)O='1O;3H@(S`P
#`P

3!P=#L@9F]N

T1N



M

#L\+W1D/CQT

#`P


T0G9F]N




M9VX]



M8F]R9&5R+6)O='1O;3H@(S`P
#`P


M=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P







M;F0M8V]L;W(Z(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B




M86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P






M8F]T=&]M.R!P861D:6YG+6)O='1O;3H@-'!X.R!B86-K9W)O=6YD+6-O;&]R





'!T.R!F;VYT




M9VX]



M8F]R9&5R+6)O='1O;3H@(S`P
#`P

@3F5W
M(%)O;6%N)RP@5&EM97


P
#`P
#`@-'!X(&1O=6)L93L@




M:6YG+6)O='1O;3H@-'!X.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD

#L@8F%C:V=R;W5N9UC;VQO<CH@(V-C
M965F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS

P
#`P

38P.SPO=&0^/'1D('9A

P
#`P
#`@-'!X(&1O=6)L







T0G=VED=&@Z(#
P)3L@=F5R=&EC

M:#H@

M;W(Z(-F9F9F9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T;VT@



#L\+W1D/CQT





T0G=VED








T0G=VED=&@Z(#$E.R!V97)T



M9F9F9F8[)SXF(S$V



M



M

M

M(-F9F9F9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]

M;&4]






T1B;W1T


M)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O
M='1O;3H@(S`P
#`P


M9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P



SD\




M(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]

M;&4]



M='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P






M861D:6YG+6)O='1O;3H@-'!X.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F










M8V]L;W(Z(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T


M)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O
M='1O;3H@(S`P
#`P


@3F5W(%)O;6%N)RP@
M5&EM97


P
#`P





T0G=VED



M









]

M('-T;V-K(&]P=&EO;G

3!P=#LG/CQD:78^5&AE(&9O




T0G=VED=&@Z


38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS

B!V86QI
M9VX]

T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@
M8F]R9&5R+6)O='1O;3H@(S`P
#`P

M+6%L:6=N.B!C96YT97([)SXR


T1B;W1T




M5&EM97
@3F5W(%)O;6%N)RP@5&EM97



T0G=VED


M


M/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X=UA
M;&EG;CH@;&5F=#LG/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS
M1=W:61T:#H@

M



M9VXZ(&)O='1O;3LG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S


M;&4]
T0G=VED=&@Z(#$U)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X

T1N;W=R87`@=F%L

M9VXZ(&)O='1O;3L@=&5X=UA;&EG;CH@;&5F=#LG/B8C,38P.SPO=&0^/]T


M9VX]



38P.SPO=&0^/'1D('9A;&EG
M;CTS1&)O='1O;2!S='EL93TS1=W:61T:#H@,34E.R!V97)T:6-A;UA;&EG


M)SXQ

M:61T:#H@

M8V]L;W(Z(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T










38P.SPO9&EV/CPO=&0^


M/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R




M


M(S$V





C$N
24@=V5I9VAT

M1&)O='1O;2!S='EL93TS1=W:61T:#H@-30E.R!V97)T:6-A;UA;&EG;CH@






M;F0M8V]L;W(Z(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B

T0G=VED=&@Z(#$U)3L@=F5R=&EC86PM86QI9VXZ(&)O

M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97

2XW

M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F


M(V-C965F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL

M







T0G=VED=&@Z(#4T)3L@=F5R=&EC

M

M(-F9F9F9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]

M;&4]




T0G=VED






T1B;W1T;VT@



M







T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M


M/B8C



M)B

M

CPO9&EV/CPO=&0^/'1D(&YO=W)A








#L\+W1D






M:#H@

M;W(Z(-F9F9F9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T;VT@






M




M.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97









T1B;W1T;VT@


M5&EM97
@3F5W(%)O;6%N)RP@5&EM97






T0G=VED=&@Z(#$U)3L@


@3F5W(%)O;6%N)RP@
M5&EM97


M


]
&5R8VES86)L92!O<'1I;VYS/]T9#X-B`@(`@(`@/'1D(&-L

@
M3F5W(%)O;6%N)RP@5&EM97


3!P=#L@9F]N=UF86UI;'DZ(=4


38P.SPO9&EV/CQT86)L92!B;W)D97(]
M
T0P(&-E;&QP861D:6YG/3-$



M87`]






P
#`P
#`@
G!X('-O

@;V8@1&5C96UB
M97(@
S$L(#(P

M;&5F=#LG/B8C


T1B;W1T;VT@


M1#$P('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=V97)T:6-A;UA;&EG;CH@
M8F]T=&]M.R!B;W)D97(M8F]T=&]M.B`C
#`P







T0G=VED=&@Z(#$E.R!V97)T:6-A

M1=V97)T:6-A;UA;&EG;CH@8F]T=&]M.R!B;W)D97(M8F]T=&]M.B`C
#`P
M

'!T
'0M86QI9VXZ(&-E;G1E<CLG/D5X


B!V86QI
M9VX]

T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@
M8F]R9&5R+6)O='1O;3H@(S`P
#`P



3!P=#L@9F]N=UF86UI;'DZ(=4:6UE

M;W=R87`]





#L\+W1D/CQT








#L\+W1D/CQT


Q-C`[

P
#`P
M
#`@


M;G0M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97







M



38P
M.SPO=&0^/'1D(&-O;'-P86X]
T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS
M1=V97)T:6-A;UA;&EG;CH@8F]T=&]M.R!B;W)D97(M8F]T=&]M.B`C
#`P
M

'!T
'0M86QI9VXZ(&-E;G1E<CLG/E=E





'!T.R!F;VYT+69A



M.R!P861D:6YG+6)O='1O;3H@

Q






T1N;W=R87`@=F%L:6=N


M:61T:#H@









M:7IE.B`Q






M9G0[)SXF(S$V

M='1O;3H@


P
#`P
#`@




@3F5W(%)O;6%N
M)RP@5&EM97




@3F5W(%)O;6%N)RP@5&EM
M97




M


M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97

M9&EV/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=W:61T:#H@
M,3(E.R!V97)T:6-A;UA;&EG;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!R:6=H



M


38P.SPO=&0^/'1D('9A;&EG



M
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=W:61T:#H@
M,3(E.R!V97)T:6-A;UA;&EG;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!R:6=H



M87`]


38P.SPO=&0^/'1D('9A











M:61T:#H@



T0G=VED=&@Z(#DE.R!V97)T


M;&EG;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O



T0G=VED



M

T1N;W=R87`@

M86QI9VXZ(&)O='1O;3L@=&5X=UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9UC

38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O
6QE/3-$)W=I

M


'!T.R!F;VYT

T1N;W=R87`@=F%L:6=N/3-$8F]T


M9CLG/B8C



38P.SPO=&0^/'1D('9A;&EG;CTS

M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97



M)SXF(S$V



3(E.R!V97)T:6-A


M97)I9CLG/C8N
#`@+20Q-BXP





M

B4[



T0G=VED=&@Z(#$E.R!V





Q


M


38P.SPO=&0^/'1D('9A;&EG



M


@3F5W(%)O;6%N
M)RP@5&EM97







T0G=VED=&@Z(#DE

T0G9F]N









M


38P.SPO=&0^/'1D('9A;&EG



M


@3F5W(%)O;6%N
M)RP@5&EM97


#L\+W1D/CPO='(^/'1R/CQT






#L\+W1D





M


3!P=#L@9F]N=UF86UI;'DZ(=4:6UE


T0G




M8F]T=&]M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C






38P.SPO



M(V-C965F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL

M97
@3F5W(%)O;6%N)RP@5&EM97


#L\+W1D





M




#L\+W1D





M




#L\+W1D





M



CPO9&EV/CPO=&0^/'1D





M(%1I;65S+!S97)I9CLG/B0\+V1I=CX\+W1D/CQT9!V86QI9VX]
T1B;W1T

T0G=VED=&@Z(#$R)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O



#PO


M)B



T0G=VED=&@Z(#$E.R!V97)T:6-A





T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M


M/B8C



38P.SPO=&0^/'1D('9A;&EG;CTS1&)O
M='1O;2!S='EL93TS1=W:61T:#H@,3`E.R!V97)T:6-A;UA;&EG;CH@8F]T

'!T.R!F;VYT+69A




T0G=VED

38P.SPO=&0^



'!T.R!F;VYT+69A

T1B;W1T;VT@



#L\+W1D/CQT






M)B



T0G=VED=&@Z(#$E.R!V97)T:6-A





#PO


M)B



T0G=VED=&@Z(#$E.R!V97)T:6-A





T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T


M







T1N;W=R87`@=F%L:6=N


M(V-C965F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL
6QE/3-$)W=I9'1H.B`Q

38P.SPO=&0^/'1D('9A
M;&EG;CTS1&)O='1O;2!S='EL93TS1=W:61T:#H@,3(E.R!V97)T:6-A;UA

'!T



M(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]

M;&4]

M



M:68[)SXV

M9VX]




M(S$V







Q




T1N;W=R87`@=F%L:6=N


M(V-C965F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL
6QE/3-$)W=I9'1H.B`Q

38P.SPO=&0^/'1D('9A

M(&9O;G0M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97





Q





M8V5E9F8[)SXF(S$V

M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F

3(E.R!V








T0G=VED=&@Z(#$R)3L@




T0G=VED=&@Z(#$E.R!V97)T



M9F9F9F8[)SXF(S$V


Q-C`[



T1N


38P.SPO=&0^/'1D('9A;&EG;CTS
6QE

38P


@3F5W(%)O;6%N)RP@
M5&EM97







T0G=VED=&@Z(#DE.R!V









T0G=VED=&@Z(#DE.R!V








T0G=VED=&@Z(#DE.R!V





#L@=&5X=UA;&EG;CH@



M

T0G=VED=&@Z(#$R)3L@=F5R=&EC86PM86QI9VXZ




M87`]



M9CLG/B8C


M9&5R+6)O='1O;3H@(S`P
#`P

#L\+W1D/CQT






M


38P.SPO=&0^/'1D

P
#`P
#`@
G!X('-O
M;&ED.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E



T0G9F]N

BXP


G!X.R!T

M)B


M

38P.SPO=&0^/'1D('9A

P
#`P
#`@
G!X('-O;&ED

'!T.R!F;VYT+69A;6EL


M;&4]




M;CH@8F]T=&]M.R!B;W)D97(M8F]T=&]M.B`C
#`P





M;&EG;CH@8F]T=&]M.R!P861D:6YG+6)O='1O;3H@
G!X.R!T97AT+6%L:6=N



T0G=VED=&@Z

38P.SPO=&0^/'1D('9A;&EG;CTS1&)O

P
#`P
#`@
G!X('-O;&ED.R!T97AT+6%L




T0G




M=&]M.R!B;W)D97(M8F]T=&]M.B`C
#`P





M9CLG/C$N

M8F]T=&]M.R!P861D:6YG+6)O='1O;3H@
G!X.R!T97AT+6%L:6=N.B!L969T



M:7IE.B`Q

M;65S+!S97)I9CLG/B0\+V1I=CX\+W1D/CQT9!V86QI9VX]
T1B;W1T;VT@

T0G=VED=&@Z(#$R)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@



M-#(N









P
#`P




M:#H@



M
T0G=VED=&@Z(#$E.R!V97)T:6-A;UA;&EG;CH@8F]T=&]M.R!P861D:6YG
M+6)O='1O;3H@-'!X.R!T97AT+6%L:6=N.B!R:6=H=#L@8F%C:V=R;W5N9UC

38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O

P
#`P

M;&4]


'!T.R!F;VYT+69A;6EL




M;F0M8V]L;W(Z(-F9F9F9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B


38P.SPO=&0^/'1D('9A

P
#`P
#`@-'!X(&1O=6)L

M9CLG/B8C

P
#`P



T1N;W=R


38P

M9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O
M;3H@(S`P
#`P


M(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P



T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T


38P.SPO=&0^/'1D('9A;&EG;CTS1&)O


M9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P

M.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97


P
#`P
#`@

3!P=#L@


M8F]T=&]M.R!P861D:6YG+6)O='1O;3H@-'!X.R!T97AT+6%L:6=N.B!L969T




T0G=VED=&@Z(#$E.R!V

M;W(Z(-F9F9F9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T;VT@




M




F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97
@
M3F5W(%)O;6%N)RP@5&EM97



30@86YD(#(P
3
\

M5&EM97
@3F5W(%)O;6%N)RP@5&EM97

#`P
M

T1B;W1T;VT@



38P.SPO=&0^/'1D(&-O;'-P86X]
T0Q




M;W=R87`]


M86QI9VXZ(&QE9G0[)SXF(S$V

M

T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R
M9&5R+6)O='1O;3H@(S`P
#`P

M:6=N.B!C96YT97([)SY

\+V1I=CX\+W1D/CQT

M9VX]

T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@

38P.SPO=&0^/'1D('9A;&EG;CTS
M1&)O='1O;2!S='EL93TS1=V97)T:6-A;UA;&EG;CH@8F]T=&]M.R!P861D
M:6YG+6)O='1O;3H@


P
#`P
#`@


M

M87`]


M9VXZ(&QE9G0[)SXF(S$V

T0G9F]N

M:7IE.B`Q




@3F5W(%)O;6%N)RP@5&EM97
L



T0G=F5R=&EC86PM86QI9VXZ

38P.SPO=&0^/'1D
M(&-O;'-P86X]
T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=V97)T:6-A
M;UA;&EG;CH@8F]T=&]M.R!B;W)D97(M8F]T=&]M.B`C
#`P

'!T.R!F;VYT+69A



'0M86QI9VXZ(&-E;G1E<CLG/D%V97)A9V4@/]D:78^







38P.SPO=&0^/'1D('9A;&EG;CTS
M1&)O='1O;2!S='EL93TS1=V97)T:6-A;UA;&EG;CH@8F]T=&]M.R!P861D
M:6YG+6)O='1O;3H@


P
#`P
#`@


M

M87`]


M9VXZ(&QE9G0[)SXF(S$V

T0G9F]N

M:7IE.B`Q




@3F5W(%)O;6%N)RP@5&EM97
L



T0G=F5R=&EC86PM86QI9VXZ

38P.SPO=&0^/'1D
M(&-O;'-P86X]
T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=V97)T:6-A
M;UA;&EG;CH@8F]T=&]M.R!B;W)D97(M8F]T=&]M.B`C
#`P

'!T.R!F;VYT+69A



'0M86QI9VXZ(&-E;G1E<CLG/D%V97)A9V4@/]D:78^








C@E.R!V97)T:6-A

M5&EM97
@3F5W(%)O;6%N)RP@5&EM97


M)SY86QA;F-E+!*86YU87)Y(#$L(#(P
3


Q-C`[




T1N;W=R87`@=F%L:6=N/3-$


M965F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS


M=&]M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E



T1N


38P.SPO=&0^/'1D('9A;&EG;CTS

#L\+W1D





M:#H@

M;W(Z(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T;VT@






M


M86QI9VX]



T0G9F]N


'!T.R!F;VYT+69A;6EL





T0G=VED=&@Z



M


@3F5W(%)O;6%N
M)RP@5&EM97



#L\+W1D/CPO='(^/'1R/CQT





M




3!P=#L@9F]N=UF86UI;'DZ(=4:6UE

3$\+V1I=CX\


24[


M






M8V]L;W(Z(-F9F9F9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T



M86QI9VXZ(&)O='1O;3L@=&5X=UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9UC

38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O


M9F8[)SXF(S$V






M:#H@



T0G=VED=&@Z(#$E.R!V97)T:6-A


38P.SPO=&0^/'1D
F4Z(#$P

@3F5W(%)O;6%N)RP@5&EM97
L('-E

38N



M9VX]




M(S$V

M93TS1=V97)T:6-A;UA;&EG;CH@8F]T=&]M.R!B86-K9W)O=6YD+6-O;&]R


T0G=F5R=&EC






T0G=F5R

38P.SPO=&0^/'1D('9A;&EG;CTS
M1&)O='1O;2!S='EL93TS1=V97)T:6-A;UA;&EG;CH@8F]T=&]M.R!B86-K





T1N;W=R87`@=F%L:6=N/3-$8F]T



T0G=F5R=&EC86PM86QI






M86QI9VX]

T0G=F5R=&EC86PM86QI9VXZ(&)O='1O

M9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=V
M97)T:6-A;UA;&EG;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!R:6=H=#L@8F%C

M:7IE.B`Q

M;65S+!S97)I9CLG/C,X-2PR.3(\+V1I=CX\+W1D/CQT9!N;W=R87`]
T1N


M(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]

M;&4]


@3F5W(%)O;6%N)RP@
M5&EM97


M1=V97)T:6-A;UA;&EG;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!L969T.R!B




38P.SPO=&0^/'1D(&YO=W)A

M;CTS1&)O='1O;2!S='EL93TS1=V97)T:6-A;UA;&EG;CH@8F]T=&]M.R!B

M9F8[)SXF(S$V




3PO9&EV




T1B

T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R

@3F5W
M(%)O;6%N)RP@5&EM97


M;2!S='EL93TS1=V97)T:6-A;UA;&EG;CH@8F]T=&]M.R!T97AT+6%L:6=N


#L\

38P.SPO=&0^





T0G=F5R

M93H@


T0G=F5R=&EC86PM86QI9VXZ




M/B8C
38P.SPO=&0^/'1D(&-O;'-P86X]
T0R('9A;&EG;CTS1&)O='1O;2!S
M='EL93TS1=V97)T:6-A;UA;&EG;CH@8F]T=&]M.R!B86-K9W)O=6YD+6-O


M8V]L;W(Z(-F9F9F9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T


38P.SPO
M=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=V97)T:6-A;UA;&EG

M86QI9VX]

T0G=F5R=&EC86PM86QI9VXZ(&)O='1O

M9CLG/B8C

M(&9O;G0M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97



38P.SPO=&0^/'1D('9A
M;&EG;CTS1&)O='1O;2!S='EL93TS1=V97)T:6-A;UA;&EG;CH@8F]T=&]M
M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F

'0M86QI9VXZ(')I9VAT.R!B86-K
M9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^/&1I=B!S='EL93TS1=F;VYT+7-I

@3F5W(%)O;6%N)RP@5&EM
M97






38P.SPO=&0^/'1D('9A;&EG;CTS
M1&)O='1O;2!S='EL93TS1=V97)T:6-A;UA;&EG;CH@8F]T=&]M.R!T97AT

Q


M8F]T=&]M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C






'0M86QI9VXZ(&QE
M9G0[(&)A8VMG<F]U;F0M8V]L;W(Z(-C8V5E9F8[)SXF(S$V
#L\+W1D/CQT

38P.SPO=&0^
M/'1D(&-O;'-P86X]
T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=V97)T
M:6-A;UA;&EG;CH@8F]T=&]M.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F



T0G

38P.SPO=&0^/'1D('9A;&EG
M;CTS1&)O='1O;2!S='EL93TS1=V97)T:6-A;UA;&EG;CH@8F]T=&]M.R!T

T1B;W1T


38P.SPO

M:#H@

@3F5W
M(%)O;6%N)RP@5&EM97








M86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P

M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97





M9CLG/B8C

P
#`P
#`@
G!X('-O;&ED.R!T97AT+6%L:6=N.B!L969T.R!B86-K







M8V]L;W(Z(-F9F9F9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T


M)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O
M='1O;3H@(S`P
#`P


M;CH@8F]T=&]M.R!B;W)D97(M8F]T=&]M.B`C
#`P

T1N;W=R87`@=F%L:6=N/3-$8F]T


38P.SPO=&0^/'1D('9A;&EG


M;W)D97(M8F]T=&]M.B`C
#`P





M-#8L





M9F9F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS

P
#`P
#`@
G!X('-O;&ED.R!T97AT+6%L:6=N.B!L969T.R!B




T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T


38P.SPO=&0^/'1D('9A;&EG;CTS1&)O

M9F9F9F8[)SXF(S$V

M8F]T=&]M.B`C
#`P



M9CLG/B8C

M=&]M.R!P861D:6YG+6)O='1O;3H@
G!X.R!T97AT+6%L:6=N.B!L969T.R!B






24[('9E


T0G



M93H@

T1N


38P.SPO=&0^/'1D('9A;&EG;CTS

#L\+W1D






M)SXF(S$V






24[


M9VX]



38P.SPO=&0^/'1D('9A;&EG

M;G0M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97


M8F]T=&]M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C


38P.SPO=&0^/'1D('9A;&EG;CTS

M8V5E9F8[)SXF(S$V






38P.SPO=&0^

M)SXF(S$V





M1&)O='1O;2!S='EL93TS1=V97)T:6-A;UA;&EG;CH@8F]T=&]M.R!B86-K

#L\+W1D

T0G

C8R+#0S-CPO9&EV/CPO=&0^/'1D(&YO





T0G=F5R=&EC86PM

3!P



T0G=F5R

38P.SPO=&0^/'1D('9A;&EG;CTS
M1&)O='1O;2!S='EL93TS1=V97)T:6-A;UA;&EG;CH@8F]T=&]M.R!T97AT

T1B;W1T;VT@


38P.SPO=&0^
M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=V97)T:6-A;UA;&EG;CH@

'0M86QI9VXZ(&QE9G0[(&)A8VMG<F]U;F0M8V]L;W(Z
M(-F9F9F9F8[)SXF(S$V



M;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R



T0G9F]N


M

38P.SPO=&0^/'1D('9A
M;&EG;CTS1&)O='1O;2!S='EL93TS1=V97)T:6-A;UA;&EG;CH@8F]T=&]M

'0M86QI9VXZ(&QE9G0[(&)A8VMG<F]U;F0M8V]L;W(Z(-F9F9F
M9F8[)SXF(S$V


M87`]


M8V]L;W(Z(-F9F9F9F8[)SXF(S$V,#L\+W1D/CPO='(^/'1R/CQT9!V86QI
M9VX]

T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@


M(%1I;65S+!S97)I9CL@=&5X=UA;&EG;CH@;&5F=#L@;6%R9VEN+6QE9G0Z





T0G=F5R=&EC86PM
M86QI9VXZ(&)O='1O;3L@=&5X=UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9UC

38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O
M;2!S='EL93TS1=V97)T:6-A;UA;&EG;CH@8F]T=&]M.R!T97AT+6%L:6=N



M87`]


M8V]L;W(Z(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T

T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N

@3F5W(%)O
M;6%N)RP@5&EM97

M='EL93TS1=V97)T:6-A;UA;&EG;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!L


#L\+W1D

38P.SPO=&0^/'1D





T0G=F5R=&EC

M


B!V86QI9VX]
T1B;W1T;VT@


'!T





T0G=F5R=&EC86PM86QI

'0M86QI9VXZ(&QE9G0[(&)A8VMG<F]U;F0M8V]L;W(Z(-C8V5E
M9F8[)SXF(S$V

M;&4]

M;CTS1&)O='1O;2!S='EL93TS1=V97)T:6-A;UA;&EG;CH@8F]T=&]M.R!P
M861D:6YG+6)O='1O;3H@
G!X.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F


P
#`P
#`@
M
G!X('-O;&ED.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R


P
#`P
#`@
G!X('-O;&ED.R!T97AT+6%L:6=N.B!R:6=H=#L@8F%C:V=R

M.B`Q

M+!S97)I9CLG/BT\+V1I=CX\+W1D/CQT9!N;W=R87`]
T1N;W=R87`@=F%L



M



'!T.R!F;VYT+69A;6EL













T0G


G!X.R!T97AT+6%L








M9F9F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS
M1=V97)T:6-A;UA;&EG;CH@8F]T=&]M.R!B;W)D97(M8F]T=&]M.B`C
#`P
M


#L\

M;&4]

#$T/]D:78^/]T9#X\=&0@=F%L:6=N











M;F0M8V]L;W(Z(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B




M86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P







M(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]

M;&4]



T0G=VED=&@Z(#DE.R!V97)T:6-A






M8F]T=&]M.R!P861D:6YG+6)O='1O;3H@-'!X.R!B86-K9W)O=6YD+6-O;&]R





'!T.R!F;VYT

T1N;W=R87`@=F%L:6=N/3-$


38P.SPO=&0^/'1D('9A


M.R!B;W)D97(M8F]T=&]M.B`C
#`P





'!T.R!F;VYT+69A;6EL

T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T


38P.SPO=&0^/'1D('9A;&EG;CTS1&)O

M8V5E9F8[)SXF(S$V

M8F]T=&]M.B`C
#`P


M;&EG;CH@8F]T=&]M.R!B;W)D97(M8F]T=&]M.B`C
#`P

M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97









24[



#L@=&5X=UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9UC;VQO
M<CH@(V9F9F9F9CLG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S
M='EL93TS1=W:61T:#H@



T0G=VED




M9&5R+6)O='1O;3H@(S`P
#`P

M
#L@=&5X=UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9UC;VQO<CH@(V9F9F9F
M9CLG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=W
M:61T:#H@



T0G=VED=&@Z(#$E.R!V

M;W(Z(-F9F9F9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T;VT@





M9F8[)SXF(S$V


Q-C`[









M(V9F9F9F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL

M(S$V

M
#`P

M




M



M/B8C

#L\+W1D

#`P
#`P(#1P


M97(M8F]T=&]M.B`C
#`P

@3F5W(%)O
M;6%N)RP@5&EM97



M)SXF(S$V

]




M

M+V1I=CX\9&EV/B8C
38P.SPO9&EV/CQT86)L92!B;W)D97(]
T0P(&-E;&QP
M861D:6YG/3-$

M.B`Q

M+!S97)I9CL@=VED=&@Z(#$P,4[)SX\='(^/'1D(&-O;'-P86X]
T0R('9A
M;&EG;CTS1&)O='1O;2!S='EL93TS1=V97)T:6-A;UA;&EG;CH@8F]T=&]M
M.R!P861D:6YG+6)O='1O;3H@


M(S$V
#LF(S$V

T1B;W1T;VT@

T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O
M;3H@(S`P
#`P




M/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=V97)T
M:6-A;UA;&EG;CH@8F]T=&]M.R!P861D:6YG+6)O='1O;3H@

Q



T0G=F5R

M9&5R+6)O='1O;3H@(S`P
#`P





M87`]


M9VXZ(&QE9G0[)SXF(S$V

M

'!T
'0M86QI9VXZ(&-E;G1E<CLG/E=A


M:68[(&9O;G0M=V5I9VAT.B!B;VQD.R!T97AT+6%L:6=N.B!C96YT97([)SY5

3!P=#L@9F]N

T1B;W1T





M.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97




3!P=#L@9F]N=UF86UI;'DZ(=4:6UE



M;CH@;&5F=#LG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL
M93TS1=V97)T:6-A;UA;&EG;CH@8F]T=&]M.R!P861D:6YG+6)O='1O;3H@
M


P
#`P
#`@



@3F5W(%)O;6%N)RP@5&EM
M97




@3F5W(%)O;6%N)RP@5&EM97
L('-E



M;&EG;CTS1&)O='1O;2!S='EL93TS1=V97)T:6-A;UA;&EG;CH@8F]T=&]M
M.R!P861D:6YG+6)O='1O;3H@

Q

B!V86QI9VX]

T0G
M=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P
M

M(&9O;G0M=V5I9VAT.B!B;VQD.R!T97AT+6%L:6=N.B!C96YT97([)SY3:&%R
M97

M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97



\+V1I=CX\

M



38P.SPO=&0^/'1D(&-O;'-P86X]
T0R
M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=V97)T:6-A;UA;&EG;CH@8F]T
M=&]M.R!B;W)D97(M8F]T=&]M.B`C
#`P




M;&4]
'0M86QI9VXZ(&-E;G1E<CLG/D%V97)A9V4@/]D:78^/&1I=B!S='EL93TS



@3F5W(%)O;6%N
M)RP@5&EM97

T1N;W=R


M)SXF(S$V



'!T
'0M86QI9VXZ(&-E;G1E<CLG/D%V

M;G0M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97


'!T.R!F;VYT
'0M86QI9VXZ(&-E;G1E<CLG/D-O;G1R86-T



T1B


6QE/3-$)V9O





M(S$V





T0G=VED=&@Z(#$E.R!V


38P.SPO


@3F5W(%)O;6%N)RP@5&EM
M97




38P.SPO=&0^

M



#L\+W1D








M;W(Z(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T;VT@



M9VXZ(&)O='1O;3L@=&5X=UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9UC;VQO

38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S

M5&EM97
@3F5W(%)O;6%N)RP@5&EM97



Q

M(V-C965F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL


3!P=#L@9F]N=UF86UI;'DZ(=4:6UE






'0M


M:61T:#H@



T0G=VED=&@Z


@3F5W(%)O;6%N
M)RP@5&EM97


M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97


M8F]T=&]M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C


M93H@


T0G=VED=&@Z(#$E


38P


@3F5W(%)O;6%N)RP@
M5&EM97

24[


M9VX]



38P.SPO=&0^/'1D('9A;&EG

M;G0M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97


M=&]M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F


38P.SPO=&0^/'1D('9A;&EG;CTS1&)O

M9F8[)SXF(S$V





T0G=VED=&@Z



M


M86QI9VX]

T0G=VED=&@Z(#DE.R!V97)T:6-A;UA
M;&EG;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!R:6=H=#L@8F%C:V=R;W5N9UC



M;&EG;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O


38P.SPO=&0^/'1D('9A







38P

M9F9F9F8[)SXF(S$V


Q-C`[






3!P=#L@





T0G=VED=&@Z(#$W)3L@

'!T.R!F;VYT+69A

M;&EG;CH@;&5F=#LG/B8C


#L\







M




3!P=#L@9F]N=UF86UI;'DZ(=4:6UE

M:61T:#H@



T0G=VED=&@Z(#$E.R!V97)T


38P.SPO=&0^
F4Z

@3F5W(%)O;6%N)RP@5&EM97
L



M;W(Z(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T;VT@



M9VXZ(&)O='1O;3L@=&5X=UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9UC;VQO

38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S

M5&EM97
@3F5W(%)O;6%N)RP@5&EM97



M(S$V






T0G=VED=&@Z(#$E.R!V



24[('9E


M




M

M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F





T0G=VED=&@Z(#DE.R!V97)T:6-A




T0G=VED=&@Z(#$E.R!V



M(S$V


'0M





T0G=VED=&@Z(#$E.R!V


38P.SPO


@3F5W(%)O;6%N)RP@5&EM
M97






T0G=VED=&@Z(#$E.R!V97)T:6-A





T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T


M



Q


BPP





T0G=VED=&@Z(#$E.R!V



3!P=#L@9F]N

T1B


M)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N




T0G

M;&4]

N-3PO9&EV/CPO=&0^/'1D(&YO






T0G=VED=&@Z(#DE.R!V97)T










M(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]

M;&4]

38P.SPO=&0^/'1D

P
#`P
#`@
G!X('-O

'!T.R!F;VYT+69A




M



M9&5R+6)O='1O;3H@(S`P
#`P

#L\+W1D/CQT

#`P


M

M.R!P861D:6YG+6)O='1O;3H@
G!X.R!T97AT+6%L:6=N.B!L969T.R!B86-K



38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S

P
#`P
#`@
G!X('-O;&ED.R!T97AT+6%L:6=N.B!L







M



M9&5R+6)O='1O;3H@(S`P
#`P

#L\+W1D/CQT

#`P



M.R!P861D:6YG+6)O='1O;3H@
G!X.R!T97AT+6%L:6=N.B!L969T.R!B86-K



38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S

P
#`P
#`@
G!X('-O;&ED.R!T97AT+6%L:6=N.B!L




T1N;W=R87`@=F%L:6=N/3-$8F]T


38P.SPO=&0^/'1D('9A;&EG


M;W)D97(M8F]T=&]M.B`C
#`P






M.R!P861D:6YG+6)O='1O;3H@
G!X.R!T97AT+6%L:6=N.B!L969T.R!B86-K

#L@=&5X=UA








M9VX]

T0G=VED=&@Z(#$W)3L@=F5R=&EC86PM86QI




T0G


M9VX]







M



M9&5R+6)O='1O;3H@(S`P
#`P

@3F5W(%)O
M;6%N)RP@5&EM97


P
#`P
#`@-'!X(&1O=6)L93L@=&5X


3!P=#L@9F]N=UF86UI;'DZ(=4



M;W(Z(-F9F9F9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T;VT@


M9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O
M;3H@(S`P
#`P


M(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P



SPO9&EV/CPO

M+6)O='1O;3H@-'!X.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O

#L@8F%C:V=R;W5N9UC;VQO<CH@(V9F9F9F
M9CLG/B8C

P
#`P

38P.SPO=&0^/'1D('9A;&EG

P
#`P
#`@-'!X(&1O=6)L93L@



T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M


38P.SPO=&0^/'1D('9A;&EG;CTS


M97(M8F]T=&]M.B`C
#`P











38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S

M)SXF(S$V

M.B`C
#`P


M8F]T=&]M.R!B;W)D97(M8F]T=&]M.B`C
#`P

M5&EM97
@3F5W(%)O;6%N)RP@5&EM97



M;W(Z(-F9F9F9F8[)SXF(S$V,#L\+W1D/CPO='(^/]T86)L93X\9&EV/CQB


M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97

M:#H@



M5&EM97
@3F5W(%)O;6%N)RP@5&EM97

3AP=#L@



M93H@


E]B-C5D7S@S
C9D


]
M

T1)1#!%
D8^#0H@(`@(`\='(^#0H@(`@(`@(#QT


]


M9VX]




]
T1T97AT/CQD





2P@


M


M(&9O;G0M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97








C`Q-#PO9&EV

M:6YG+6)O='1O;3H@






M86QI9VXZ(&QE9G0[)SXF(S$V

'!T.R!F;VYT+69A

P
#`P




B!V86QI9VX]

T0G=F5R=&EC86PM





T1B

T0G=VED=&@Z(#4V)3L@=F5R=&EC86PM86QI9VXZ('1O



P
#`P




M(S$V



T0G=VED=&@Z(#DE.R!V97)T


M


M86QI9VX]



T0G9F]N



#`P







38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O

M)SXF(S$V




P
#`P
#`[)SXT+#DW.#PO


M)B


38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S

M(S$V




P
#`P
#`[)SXT+#(V
CPO9&EV


Q




T1B;W1T


M)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O
M='1O;3H@(S`P
#`P


M;CH@8F]T=&]M.R!B;W)D97(M8F]T=&]M.B`C
#`P


#`P
M



#L\+W1D/CQT

G!X.R!B86-K9W)O

'0M


T0G=VED=&@Z(#DE

3!P


T0G=VED=&@Z(#$E.R!V




T0G=VED=&@Z(#$E


M86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P

M9F8[)SXF(S$V

M=&]M.B`C
#`P



#`P

S4\+V1I=CX\+W1D
#L@=&5X=UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9UC;VQO
M<CH@(V9F9F9F9CLG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S
M='EL93TS1=W:61T:#H@



T0G=VED

38P.SPO=&0^/'1D('9A;&EG;CTS

P
#`P
#`@
G!X('-O;&ED.R!T97AT



P
#`P
#`[
M)SXV+#(U

M8F]T=&]M.R!P861D:6YG+6)O='1O;3H@
G!X.R!T97AT+6%L:6=N.B!L969T











24[


M9VX]



38P.SPO=&0^/'1D('9A;&EG



M




T0G=VED=&@Z



3!P

M87`]


38P.SPO=&0^/'1D('9A

M




M(&-O;&]R.B`C
#`P

M




M5&EM97
@3F5W(%)O;6%N)RP@5&EM97

#`P
M










T0G=VED



M/B8C

@3F5W(%)O
M;6%N)RP@5&EM97

#`P
#LG/C
L


M(S$V



38P



'!T.R!F

P
#`P
#`[)SXQ+#@Q




38P.SPO



'!T.R!F;VYT

P
#`P
#`[)SXR+#





3!P=#L@9F]N=UF86UI;'DZ(=4:6UE

\+V1I=CX\+W1D






M:#H@



T0G=VED=&@Z(#$E.R!V97)T:6-A


38P.SPO=&0^/'1D
F4Z(#$P

@3F5W(%)O;6%N)RP@5&EM97
L('-E

#`P
#LG/C(L
S4Q/]D:78^/]T9#X\=&0@;F]W

#L\+W1D/CPO='(^


M:61T:#H@



T0G=VED=&@Z(#$E.R!V


38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S

P
#`P
#`@
G!X('-O;&ED.R!T97AT+6%L:6=N.B!R



P
#`P
#`[)SXY.#PO9&EV

M:6YG+6)O='1O;3H@
G!X.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD

#L@8F%C:V=R;W5N9UC;VQO<CH@(V9F
M9F9F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS

P
#`P
#`@
G!X('-O;&ED.R!T97AT+6%L:6=N.B!L969T.R!B




M9VX]





M86QI9VX]



M;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P

#L\

#`P
#`P


M(&-O;&]R.B`C
#`P



M)SXF(S$V

M;3H@



M(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]

M;&4]
6QE/3-$






M;F0M8V]L;W(Z(-C8V5E9F8[)SXF(S$V,#L\+W1D/CPO='(^/'1R/CQT9!V
M86QI9VX]

T0G=VED=&@Z(#4V)3L@=F5R=&EC86PM



P
#`P
#`[('1E







T0G=VED=&@Z(#$E.R!V97)T





M;F0M8V]L;W(Z(-F9F9F9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B




M(,P,#`P,#`[)SXQ.2PQ-CD\+V1I=CX\+W1D/CQT9!N;W=R87`]
T1N;W=R



M(&9O;G0M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97


#`P




24[('9E


M9&5R+6)O='1O;3H@(S`P
#`P

@3F5W(%)O
M;6%N)RP@5&EM97

#`P



M=&]M.R!P861D:6YG+6)O='1O;3H@
G!X.R!B86-K9W)O=6YD+6-O;&]R.B`C

'0M86QI9VXZ(&QE9G0[

M86QI9VX]










M

M8F]T=&]M.R!P861D:6YG+6)O='1O;3H@-'!X.R!B86-K9W)O=6YD+6-O;&]R





T0G=VED=&@Z(#DE.R!V



T0G=VED=&@Z(#$E



24[('9E

'!T.R!F

P
#`P
#`[)SXD/]D:78^/]T9#X\=&0@=F%L:6=N/3-$8F]T

M;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P






]
T1P



@3F5W(%)O;6%N
M)RP@5&EM97


@;VX@;W5R(&1E8G0@87
@;V8@
M1&5C96UB97(@
S$L(#(P


@3F5W(%)O;6%N)RP@5&EM97
L('-E

#`P





T0G=VED=&@Z




@3F5W(%)O;6%N)RP@5&EM
M97


#`P

T1B;W1T;VT@



M/B8C
38P.SPO=&0^/'1D(&-O;'-P86X]
T0R('9A;&EG;CTS1&)O='1O;2!S
M='EL93TS1=V97)T:6-A;UA;&EG;CH@=&]P.R!B;W)D97(M8F]T=&]M.B`C
M
#`P

M

#`P
#`P.R!T97AT

P
M
#`P


38P.SPO=&0^/'1D

B!V86QI9VX]

T0G

#`P


#`P

P
#`P
#`[('1E


M86QI9VX]

T0G=VED=&@Z(#0T)3L@=F5R=&EC86PM



P
#`P
#`[('1E



M:61T:#H@



T0G=VED=&@Z(#DE.R!V97)T



T0G=VED=&@Z




M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F



#`P

T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M


M/B8C



38P.SPO=&0^/'1D('9A;&EG;CTS1&)O

M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97

M(S`P
#`P



M;&4]
'0M
M86QI9VXZ(&QE9G0[(&UA<F=I;BUL969T.B`W+C)P=#L@=&5X=UI;F1E;G0Z
M(TW+C)P=#LG/C(P,38\+V1I=CX\+W1D/CQT9!V86QI9VX]
T1B;W1T;VT@


M/B8C

#L\+W1D/CQT


M

P
#`P
#`[)SXV+#4Y
3PO9&EV/CPO=&0^/'1D(&YO



M8V]L;W(Z(-F9F9F9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T






T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M


M/B8C



38P.SPO=&0^/'1D('9A;&EG;CTS1&)O

M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97

M(S`P
#`P




M;&4]
'0M
M86QI9VXZ(&QE9G0[(&UA<F=I;BUL969T.B`W+C)P=#L@=&5X=UI;F1E;G0Z

T1B;W1T;VT@


M/B8C

#L\+W1D/CQT


M

P
#`P
#`[)SXV-#PO9&EV/CPO=&0^/'1D(&YO=W)A



M;W(Z(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T;VT@










T0G=VED=&@Z(#$E

38P.SPO=&0^/'1D('9A





P
#`P
M

M='1O;2!S='EL93TS1=W:61T:#H@-#0E.R!V97)T:6-A;UA;&EG;CH@=&]P



G!T

C`Q.#PO9&EV/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS
6QE/3-$)W=I9'1H.B`Q)3L@

38P.SPO=&0^/'1D('9A;&EG

M;G0M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97


#`P










T0G=VED




M=&]M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F



#`P



M)SXF(S$V

'0M86QI9VXZ(&QE9G0[(&UA
M<F=I;BUL969T.B`W+C)P=#L@=&5X=UI;F1E;G0Z(TW+C)P=#LG/C(P,3D\
M+V1I=CX\+W1D/CQT9!V86QI9VX]

T0G=VED=&@Z

38P.SPO=&0^/'1D



'!T.R!F;VYT+69A;6EL

P
M
#`P




M


M86QI9VX]

T0G=VED=&@Z(#DE.R!V97)T:6-A;UA
M;&EG;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!R:6=H=#L@8F%C:V=R;W5N9UC


M9CL@8V]L;W(Z(,P,#`P,#`[)SXV.3D\+V1I=CX\+W1D/CQT9!N;W=R87`]
M


38P.SPO=&0^/'1D('9A;&EG



M


@3F5W(%)O;6%N
M)RP@5&EM97

#`P
#LG/C8Y.3PO9&EV/CPO


Q-C`[


#`P
#`P.R!T97AT+6%L





M;CH@8F]T=&]M.R!B;W)D97(M8F]T=&]M.B`C
#`P




M


M;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P

M=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P
M


M;W)D97(M8F]T=&]M.B`C
#`P


#`P

BPX-S
\
'0M86QI9VXZ


T0G=VED=&@Z(#$E.R!V97)T


M97(M8F]T=&]M.B`C
#`P







T0G=VED=&@Z(#$E.R!V97)T:6-A




M:#H@



T0G=VED=&@Z(#DE.R!V97)T:6-A




T0G=VED=&@Z




M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F



#`P

3`L.38Q


M)SXF(S$V




M;F0M8V]L;W(Z(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B




M(,P,#`P,#`[)SXQ-RPV-C8\+V1I=CX\+W1D/CQT9!N;W=R87`]
T1N;W=R



M(&9O;G0M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97


#`P


T0G=VED=&@Z(#$E

M9CLG/B8C

P
#`P
#`@
G!X('-O;&ED.R!T97AT+6%L:6=N.B!L969T.R!B86-K




M9VX]


@3F5W(%)O
M;6%N)RP@5&EM97

#`P
#LG/BD\+V1I=CX\

G!X.R!T

M:#H@



M='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P

M97
@3F5W(%)O;6%N)RP@5&EM97

#`P
#LG
'0M86QI


T0G=VED=&@Z(#$E.R!V


M;W)D97(M8F]T=&]M.B`C
#`P





M;W(Z(,P,#`P,#`[)SXH,2PU-S`\+V1I=CX\+W1D/CQT9!N;W=R87`]
T1N






#`P
#`P

#L@=&5X=UA;&EG;CH@


T0G=VED=&@Z(#$E.R!V97)T


M;&]R.B`C
#`P


P
#`P




T1N;W=R87`@=F%L:6=N/3-$8F]T


38P.SPO=&0^/'1D('9A;&EG


M86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P

M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97


#`P

M;W)D97(M8F]T=&]M.B`C
#`P

@3F5W
M(%)O;6%N)RP@5&EM97

#`P
#LG/C$P+#DV
M

M.R!B;W)D97(M8F]T=&]M.B`C
#`P

#L\

#`P
#`P


M8F]R9&5R+6)O='1O;3H@(S`P
#`P

@3F5W
M(%)O;6%N)RP@5&EM97

#`P
#LG/B0\+V1I

#`P
M


@3F5W(%)O;6%N)RP@5&EM97
L('-E

#`P
#LG/C$V+#`Y-CPO9&EV/CPO=&0^/'1D(&YO

M-'!X.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E



E\V-#9F
M7S0S83)?8C8U9%\X



M87-C:6DB#0H-CQH=&UL/@T*(`\:&5A9#X-

T1T

M(%1H:7


]

]



M344@5$%815





@3F5W(%)O;6%N)RP@
M5&EM97



M;&QO=VEN9R`H:6X@=&AO=7-A;F1S*3H\+V1I=CX\9&EV/B8C
38P.SPO9&EV

T0P(&-E;&QP861D:6YG
M/3-$

'!T

T1B;W1T;VT@




@
M3F5W(%)O;6%N)RP@5&EM97


M9VX]





M=&]M.R!P861D:6YG+6)O='1O;3H@


P
#`P
#`@


P
#`P

M

M

B!V86QI9VX]
T1B;W1T


M;3H@(S`P
#`P


#`P
#L@


T0G=VED=&@Z(#$E



3!P=#L@




M.B!B;W1T;VT[)SXF(S$V


T0G

M/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C
38P
M.SPO=&0^/'1D(&-O;'-P86X]
T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS



#L\







T0G=VED=&@Z(#$E.R!V97)T:6-A


@3F5W(%)O;6%N)RP@5&EM97
L('-E

#`P


'!T.R!F;VYT

P
#`P
#`[)SXR+#4P




38P.SPO=&0^

M




T0G=VED=&@Z(#$E.R!V



#`P
#`P
M.R!T97AT+6%L:6=N.B!L969T.R!M87)G:6XM;&5F=#H@
38N
G!T.R!T97AT







M;F0M8V]L;W(Z(-F9F9F9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B




M(,P,#`P,#`[)SXS-CD\+V1I=CX\+W1D/CQT9!N;W=R87`]
T1N;W=R87`@

M86QI9VXZ(&)O='1O;3L@=&5X=UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9UC

38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O


M;&EG;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O



#`P
M



T0G


M(S$V




M:68[(&-O;&]R.B`C
#`P




Q-C`[




24[('9E



T0G=VED=&@Z(#4V)3L@=F5R=&EC



P
#`P
#`[
'0M


M)SXF(S$V





#`P




T0G=VED=&@Z(#$E.R!V97)T


38P.SPO=&0^
F4Z

@3F5W(%)O;6%N)RP@5&EM97
L

#`P
#LG/C$L
3DT/]D:78^/]T9#X\=&0@

#L\+W1D/CPO







T0G=VED



M

M


#`P


M)SXF(S$V





#`P











T0G=VED=&@Z

T0G



38P

M9F9F9F8[)SXF(S$V


Q-C`[



#`P


#L\+W1D






M;&4]



M(V-C965F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL

M97
@3F5W(%)O;6%N)RP@5&EM97

#`P
#LG
M/B@Q

'!T.R!F;VYT+69A

P
#`P
#`[)SXI/]D:78^/]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T




M(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]

M;&4]




6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N=UF

M.B`C
#`P

M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97


#`P
#L@8F%C:V=R
M;W5N9UC;VQO<CH@(V9F9F9F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS

P
#`P
#`@
G!X('-O;&ED.R!T97AT

Q
'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD


T0G=VED=&@Z(#$E



24[('9E


M9&5R+6)O='1O;3H@(S`P
#`P

@3F5W(%)O
M;6%N)RP@5&EM97

#`P
#LG/C0U
3PO9&EV

M:6YG+6)O='1O;3H@
G!X.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD





\+V1I=CX\+W1D






M:#H@



T0G=VED=&@Z(#$E.R!V97)T:6-A


38P.SPO=&0^/'1D
F4Z(#$P

@3F5W(%)O;6%N)RP@5&EM97
L('-E

#`P
#LG/C4S+#DT-SPO9&EV/CPO=&0^/'1D(&YO







M;W(Z(-F9F9F9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T;VT@


38P.SPO=&0^

P
#`P
#`@
G!X

'!T.R!F;VYT

P
#`P
#`[)SXH



P
#`P
#`[



24[('9E


M9&5R+6)O='1O;3H@(S`P
#`P

@3F5W(%)O
M;6%N)RP@5&EM97

#`P
#LG/B@U



M.B`Q

M+!S97)I9CL@8V]L;W(Z(
P
#`P
#`[)SXI/]D:78^/]T9#X\+W1R/CQT




#`P
#`P.R!T97AT+6%L:6=N.B!L969T.R!M
M87)G:6XM;&5F=#H@
C4N


#L@8F%C:V=R;W5N9UC

38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O

P
#`P
#`@
G!X('-O;&ED.R!T97AT+6%L:6=N




T1N




#L@8F%C:V=R;W5N9UC;VQO<CH@(V-C965F9CLG/B8C
38P.SPO

P
#`P
#`@
M
G!X('-O;&ED.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R

'0M86QI9VXZ(')I







@3F5W
M(%)O;6%N)RP@5&EM97


P
#`P



#L\+W1D



T1N;W=R87`@=F%L:6=N


M(V9F9F9F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL


M8F]T=&]M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C



T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T


M


@3F5W(%)O;6%N)RP@5&EM97
L('-E

#`P

38P.SPO=&0^/'1D('9A;&EG;CTS

M8V5E9F8[)SXF(S$V




P
#`P
#`[)SXH
M

'!T.R!F;VYT+69A;6EL

P
M
#`P

M/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R




M




6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N=UF86UI

M
#`P


@3F5W(%)O;6%N
M)RP@5&EM97

#`P

38P.SPO=&0^/'1D('9A;&EG





P
#`P
#`[
M)SXH

'!T.R!F;VYT

P
#`P
#`[)SXI/]D:78^/]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M




M;W(Z(-F9F9F9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T;VT@




T1N;W=R87`@=F%L

M9VXZ(&)O='1O;3L@=&5X=UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9UC;VQO







T0G=VED=&@Z



M


@3F5W(%)O;6%N
M)RP@5&EM97

#`P


M









T0G=VED




P
#`P




M)SXF(S$V

M.B`C
#`P





T1N;W=R87`@=F%L:6=N/3-$


38P.SPO=&0^/'1D('9A


M.R!B;W)D97(M8F]T=&]M.B`C
#`P





M8V]L;W(Z(,P,#`P,#`[)SXR.#4\+V1I=CX\+W1D/CQT9!N;W=R87`]
T1N



M


@3F5W(%)O;6%N)RP@5&EM97
L('-E

#`P
#L@=&5X=UA;&EG;CH@;&5F=#L@;6%R9VEN
M+6QE9G0Z(#(U+C)P=#L@=&5X=UI;F1E;G0Z(TW+C)P=#LG/DYE=!D969E

38P.SPO=&0^/'1D('9A





P
#`P
M

M;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R


38P.SPO=&0^/'1D('9A;&EG





P
#`P
#`[
M)SXX.#

M;2!S='EL93TS1=W:61T:#H@-38E.R!V97)T:6-A;UA;&EG;CH@=&]P.R!P
M861D:6YG+6)O='1O;3H@
G!X.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F


Z(%9A;'5A=&EO;B!A;&QO=V%N

M;3H@



M(-F9F9F9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]

M;&4]
6QE/3-$








#`P



M;W)D97(M8F]T=&]M.B`C
#`P









#`P


M97
@3F5W(%)O;6%N)RP@5&EM97

#`P
#L@
M=&5X=UA;&EG;CH@;&5F=#L@;6%R9VEN+6QE9G0Z(#(U+C)P=#L@=&5X=UI

M:#H@



T0G=VED=&@Z(#$E.R!V97)T


M;&]R.B`C
#`P


P
#`P




T1B;W1T;VT@









P
#`P
#`[)SXD/]D:78^/]T

M=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P








T0G



M86QI9VX]




M)SXF(S$V

M:61T:#H@

M8V]L;W(Z(-F9F9F9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T



#L\+W1D









M9VX]


M;G0M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97


#`P


'!T.R!F;VYT+69A;6EL

P
M
#`P



M9VX]


M;G0M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97


#`P


'!T.R!F;VYT+69A;6EL

P
M
#`P





!L:6%B:6QI

M861D:6YG+6)O='1O;3H@
G!X.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F

'0M86QI9VXZ(&QE9G0[(&)A8VMG

M




3!P=#L@9F]N=UF86UI;'DZ(=4

M



@3F5W(%)O;6%N
M)RP@5&EM97

#`P
#LG/BD\+V1I=CX\+W1D

G!X.R!B86-K




T0G=VED=&@Z

M


T0G=VED=&@Z(#$E




T0G=VED=&@Z


M86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P

M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97


#`P

M;W)D97(M8F]T=&]M.B`C
#`P

@3F5W
M(%)O;6%N)RP@5&EM97

#`P
#LG/B@R
C4\


M.B`Q

M+!S97)I9CL@8V]L;W(Z(
P
#`P
#`[)SXI/]D:78^/]T9#X\=&0@=F%L







P
#`P

M)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
M
#`P



24[





@8F5F;W)E(&EN8V]M92!T




M=&AE(&9O;&QO=VEN9R`H:6X@=&AO=7-A;F1S*3H\+V1I=CX\9&EV/B8C
38P

T0P(&-E;&QP
M861D:6YG/3-$

M.B`Q


T1B




M5&EM97
@3F5W(%)O;6%N)RP@5&EM97


T1N;W=R87`@=F%L:6=N/3-$8F]T


M



M93H@

C`Q
SPO9&EV/CPO=&0^/'1D(&YO=W)A

G!X



3!P=#L@9F]N=UF86UI;'DZ(=4:6UE

38P.SPO=&0^

M





M:7IE.B`Q

M;65S+!S97)I9CL@8V]L;W(Z(
P
#`P
#`[)SXI/]D:78^/]T9#X\=&0@


M


#`P

F4Z

@3F5W(%)O;6%N)RP@5&EM97
L

#`P
#LG/B@V+#@S
CPO9&EV/CPO=&0^/'1D




T0G=VED
M=&@Z(#




P
#`P


M+C)P=#LG/D1O;65S=&EC/]D:78^/]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M


M:61T:#H@



M(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P

M5&EM97
@3F5W(%)O;6%N)RP@5&EM97

#`P
M
#LG/B@Q-RPT
#L@=&5X=UA;&EG;CH@



P
#`P





M9'1H.B`Y)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O
M;3H@(S`P
#`P


@3F5W(%)O;6%N)RP@5&EM
M97

#`P
#LG/B@Q


'!T.R!F

P
#`P




M(&-O;&]R.B`C
#`P
#`P.R!T97AT+6%L:6=N.B!L969T.R!M87)G:6XM;&5F

;W-S(&)E9F]R92!I
M;F-O;64@=&%X97


M)B


M9VX]




T1N;W=R87`@


M;&4]

#L@8F%C:V=R;W5N9UC;VQO<CH@(V-C965F9CLG/B8C
38P.SPO=&0^/'1D

P
#`P
#`@-'!X(&1O







P
#`P
#`[)SXH
3DL



M93H@


]
T1P



@3F5W(%)O;6%N
M)RP@5&EM97

#`P




@*&EN('1H;W5S86YD

T0P

3!P=#L@9F]N=UF86UI;'DZ(=4:6UE

M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=W:61T:#H@-38E.R!V97)T
M:6-A;UA;&EG;CH@=&]P.R!P861D:6YG+6)O='1O;3H@

Q-C`[



24[('9E



M.R!P861D:6YG+6)O='1O;3H@


P
#`P
#`@


P
#`P

3
\

38P


M(&9O;G0M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97


#`P



M)B




P
#`P
#`[)SXD/]D:78^/]T


M93H@

M:61T:#H@


#`P


M8V5E9F8[)SXF(S$V




T0G=VED=&@Z

T0G

T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T




M93H@




T0G=VED=&@Z








T0G=VED=&@Z(#$E.R!V97)T:6-A



M9F8[)SXF(S$V

M;2!S='EL93TS1=W:61T:#H@-38E.R!V97)T:6-A;UA;&EG;CH@=&]P.R!B

M=#L@;6%R9VEN+6QE9G0Z(#$V+C)P=#L@=&5X=UI;F1E;G0Z(TW+C)P=#LG


38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S

M(S$V




P
#`P
#`[)SXH



3!P=#L@9F]N=UF86UI;'DZ(=4:6UE

M:#H@

M;W(Z(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T;VT@







M;&4]

M97
@3F5W(%)O;6%N)RP@5&EM97

#`P
#LG





T0G=VED=&@Z(#$E.R!V



3!P=#L@9F]N


T0G=VED=&@Z(#$E.R!V


@3F5W(%)O;6%N)RP@5&EM
M97

#`P


Q




24[



T0G=VED=&@Z(#4V)3L@=F5R



P
#`P
M


M9&5F97)R960@8F%L86YC97





M9VX]






M(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]

M;&4]





T1B;W1T;VT@



M:7IE.B`Q

M;65S+!S97)I9CL@8V]L;W(Z(
P
#`P












T0G=VED=&@Z(#$E.R!V


38P.SPO


@3F5W(%)O;6%N)RP@5&EM
M97

#`P







38P.SPO=&0^/'1D('9A;&EG;CTS

M8V5E9F8[)SXF(S$V




P
#`P
#`[)SXU

M:61T:#H@

M8V]L;W(Z(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T










M


M

P
#`P


M:6]N(&]F(%4N4RX@;F5T(&]P97)A=&EN9R!L;W-S97
\+V1I=CX\+W1D/CQT

M)B





T0G=VED=&@Z



M


M86QI9VX]

T0G=VED=&@Z(#DE.R!V97)T:6-A;UA
M;&EG;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!R:6=H=#L@8F%C:V=R;W5N9UC


M9CL@8V]L;W(Z(,P,#`P,#`[)SXT,34\+V1I=CX\+W1D/CQT9!N;W=R87`]
M




M5&EM97
@3F5W(%)O;6%N)RP@5&EM97

#`P
M

38P.SPO=&0^/'1D('9A;&EG;CTS1&)O

M9F8[)SXF(S$V




P
#`P
#`[)SXT
3$\

M:#H@

M;W(Z(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T;VT@










T0G

'!T

P
#`P



\+V1I=CX\






M:61T:#H@



T0G=VED=&@Z(#$E.R!V97)T


38P.SPO=&0^
F4Z

@3F5W(%)O;6%N)RP@5&EM97
L

#`P
#LG/C4R
3PO9&EV/CPO=&0^/'1D(&YO






M;F0M8V]L;W(Z(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B









T0G=VED



M/B8C

@3F5W(%)O
M;6%N)RP@5&EM97

#`P




P
#`P
#`[




#`P
#`P.R!T97AT+6%L:6=N.B!L969T.R!M
M87)G:6XM;&5F=#H@
38N




#L\+W1D/CQT




M
#`P




M9VX]





3!P=#L@9F]N=UF86UI;'DZ(=4

T1B





#`P
#`P.R!T97AT+6%L:6=N.B!L969T
M.R!M87)G:6XM;&5F=#H@
38N


M061J=7-T;65N='





T0G=VED=&@Z(#DE.R!V



T0G=VED



M:#H@



T0G=VED=&@Z(#DE.R!V97)T:6-A



24[



T0G=VED=&@Z(#4V)3L@=F5R


M.B`Q

M+!S97)I9CL@8V]L;W(Z(
P
#`P









M)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
M
#`P


@3F5W(%)O;6%N)RP@5&EM97
L('-E

#`P


M)SXF(S$V

M;3H@



M(-F9F9F9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]

M;&4]
6QE/3-$







M:68[(&-O;&]R.B`C
#`P



@3F5W(%)O;6%N)RP@5&EM97
L('-E

#`P



M


M

P
#`P
#`[)SXD/]D:78^/]T9#X\=&0@=F%L:6=N

M(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P



T1N;W=R87`@=F%L


M

#L@
M8F%C:V=R;W5N9UC;VQO<CH@(V-C965F9CLG/B8C
38P.SPO=&0^/'1D('9A

P
#`P
#`@-'!X(&1O=6)L


6QE
M/3-$)W=I9'1H.B`Y)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R
M+6)O='1O;3H@(S`P,#`P,`T<'@@9&]U8FQE.R!T97AT+6%L:6=N.B!R:6=H



P
#`P
#`[)SXH
2PT
SD\+V1I


M

P
#`P
#`[)SXI/]D:78^/]T9#X\+W1R/CPO=&%B

M;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO8CED-C1D-#)?-C0V9E\T
V$R
M7V(V-61?.#


O4VAE970S-2YH=&UL#0I#


M87-C:6DB#0H-
MCQH=&UL/@T*(`\:&5A9#X-B`@(`\345402!H='1P+65Q=6EV/3-$0V]N





]
T1T


3(@36]N=&AS($5N9&5D/]T
M:#X-B`@(`@(#PO='(^#0H@(`@(`\='(^#0H@(`@(`@(#QT:!C;&%S

S$L(#(P





M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97

M(S`P
#`P








@3F5W(%)O;6%N)RP@5&EM97
L





T1B;W1T


M;3H@(S`P
#`P


#`P
#L@


T0G=F5R=&EC86PM

M='1O;2!S='EL93TS1=V97)T:6-A;UA;&EG;CH@=&]P.R!P861D:6YG+6)O
M='1O;3H@


B!V86QI9VX]
T1B


M='1O;3H@(S`P
#`P


#`P
M









G!X.R!T


B!V86QI
M9VX]


M9&5R+6)O='1O;3H@(S`P
#`P

M(S`P
#`P








M;2!S='EL93TS1=V97)T:6-A;UA;&EG;CH@8F]T=&]M.R!P861D:6YG+6)O
M='1O;3H@







T0G=VED=&@Z


@3F5W(%)O;6%N
M)RP@5&EM97

#`P
#LG/B0\+V1I=CX\+W1D


M.B`Q

M+!S97)I9CL@8V]L;W(Z(
P
#`P
#`[)SXM/]D:78^/]T9#X\=&0@;F]W



Q



M(%1I;65S+!S97)I9CL@8V]L;W(Z(
P
#`P
#`[)SXD/]D:78^/]T9#X\


M

M:#H@



T0G=VED=&@Z(#$E.R!V97)T:6-A


T0G
6QE/3-$)W=I9'1H.B`Y)3L@=F5R
M=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X=UA;&EG;CH@<FEG:'0[(&)A8VMG


#`P


#$R/]D:78^/]T9#X\

#L\+W1D






P
#`P







T0G=VED




P
#`P






M;W)D97(M8F]T=&]M.B`C
#`P










T0G=VED=&@Z(#$E.R!V


M9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P

M)SXF(S$V

M.B`C
#`P



#`P

38L
3(T/]D:78^/]T9#X\


M:6YG+6)O='1O;3H@

M)B

M;F0M8V]L;W(Z(-F9F9F9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B



3!P=#L@9F]N=UF86UI;'DZ(=4:6UE




M86QI9VX]



M;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P

#L\

#`P
#`P


M(&-O;&]R.B`C
#`P

S4L-C


M)SXF(S$V

'0M86QI9VXZ(&QE9G0[(&UA
M<F=I;BUL969T.B`W+C)P=#L@=&5X=UI;F1E;G0Z(TW+C)P=#LG/D=R;W-S
M('!R;V9I=#PO9&EV/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS
M1=W:61T:#H@

M;F0M8V]L;W(Z(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B






T1B;W1T;VT@






T0G=VED=&@Z

T0G


M;&4]





T0G=VED=&@Z(#DE

T0G9F]N






38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S

M(S$V




P
#`P
#`[)SXT+#0V.3PO9&EV


Q

3!P






M;W(Z(-F9F9F9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T;VT@




T1N;W=R87`@=F%L:6=N





38P.SPO=&0^/'1D('9A





P
#`P
M
#`[)SXH
BPQ

'!T.R!F

P
#`P
#`[)SXI/]D:78^/]T9#X\=&0@=F%L:6=N/3-$8F]T




M8V]L;W(Z(-F9F9F9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T







M(&-O;&]R.B`C
#`P


#L\+W1D/CQT




M
#`P


3!P

M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=W:61T:#H@-3(E.R!V97)T:6-A
M;UA;&EG;CH@=&]P.R!P861D:6YG+6)O='1O;3H@
G!X.R!B86-K9W)O=6YD







M:61T:#H@



M(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P

M5&EM97
@3F5W(%)O;6%N)RP@5&EM97

#`P
M
#LG/B@U+#DT

M;CH@8F]T=&]M.R!P861D:6YG+6)O='1O;3H@
G!X.R!T97AT+6%L:6=N.B!L



T0G=VED=&@Z(#$E.R!V


M9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P

M)SXF(S$V

M.B`C
#`P



#`P

3
S/]D:78^/]T9#X\

3!P=#L@9F]N




T0G

38P.SPO=&0^/'1D('9A;&EG

P
#`P
#`@
G!X('-O;&ED.R!T



P
#`P
M
#`[)SXH-PR.#`\+V1I=CX\+W1D/CQT9!N;W=R87`]
T1N;W=R87`@=F%L


M

#L@
M8F%C:V=R;W5N9UC;VQO<CH@(V-C965F9CLG/B8C
38P.SPO=&0^/'1D('9A

P
#`P
#`@
G!X('-O;&ED
M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F

'0M86QI9VXZ(')I9VAT.R!B86-K


'!T.R!F

P
#`P





M(&-O;&]R.B`C
#`P
#`P.R!T97AT+6%L:6=N.B!L969T.R!M87)G:6XM;&5F

I


M9F8[)SXF(S$V

M=&]M.B`C
#`P





M.B`C
#`P



3!P=#L@9F]N=UF86UI;'DZ(=4:6UE

M:#H@



T0G=VED=&@Z(#$E.R!V97)T


M;&]R.B`C
#`P


P
#`P







M



M9&5R+6)O='1O;3H@(S`P
#`P

@3F5W(%)O
M;6%N)RP@5&EM97

#`P
#LG/B0\+V1I=CX\

#`P
#`P

M(&9O;G0M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97


#`P
#LG/B@W+#0W
SPO9&EV/CPO=&0^/'1D(&YO=W)A

M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F


M

M)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
M
#`P


@3F5W(%)O;6%N)RP@5&EM97
L('-E

#`P

M8F]T=&]M.R!B;W)D97(M8F]T=&]M.B`C
#`P

M5&EM97
@3F5W(%)O;6%N)RP@5&EM97

#`P
M
#LG/B@Q




P
#`P

M9'1H.B`U

M;W(Z(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T;VT@



M9VXZ(&)O='1O;3L@=&5X=UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9UC;VQO

38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S


M)SXF(S$V






M:61T:#H@



T0G=VED=&@Z(#$E.R!V97)T


38P.SPO=&0^











M(-C8V5E9F8[)SXF(S$V,#L\+W1D/CPO='(^/'1R/CQT9!V86QI9VX]
T1B

T0G=VED=&@Z(#4R)3L@=F5R=&EC86PM86QI9VXZ('1O



P
#`P



38P
6QE/3-$)V9O;G0M




M;W=R87`]


T0G
6QE/3-$)W=I9'1H.B`Q)3L@=F5R
M=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N9UC;VQO<CH@(V9F9F9F
M9CLG/B8C
6QE






T0G



M:61T:#H@


#`P



@3F5W(%)O;6%N)RP@
M5&EM97

#`P
#LG/B@V+#DP-CPO9&EV/CPO




T0G=VED=&@Z






#`P


M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F

T1B;W1T




M(%1I;65S+!S97)I9CL@8V]L;W(Z(
P
#`P







M86QI9VX]


M(&9O;G0M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97


#`P






T1N;W=R87`@=F%L

M9VXZ(&)O='1O;3L@=&5X=UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9UC;VQO

38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S


M;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R


#`P
#`P



3!P=#L@9F]N



M86QI9VX]






M86QI9VX]


M(&9O;G0M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97


#`P


'0M86QI9VXZ(&QE9G0[(&UA<F=I;BUL969T.B`W+C)P=#L@=&5X=UI;F1E



M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F



#`P



Q

M(V9F9F9F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL

M



M(%1I;65S+!S97)I9CL@8V]L;W(Z(
P
#`P
#`[)SXH
2PP
C(\+V1I=CX\




P
#`P
#`[)SXI





T0G=VED=&@Z

T0G

T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T





38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O

M)SXF(S$V




P
#`P
#`[)SXH
RPV-S`\



P
#`P
M





#`P
#`P.R!T97AT+6%L:6=N.B!L969T

M=7)C:&%S97






M86QI9VX]






M;W(Z(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T;VT@




M9VX]






M(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]

M;&4]



M


M/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R




M



T1B






#`P
#`P.R!T97AT+6%L:6=N.B!L969T


38P



'!T.R!F

P
#`P
#`[)SXQ





T0G=VED=&@Z(#$E.R!V97)T





T1N;W=R


38P.SPO=&0^/'1D('9A;&EG;CTS1&)O

#L\+W1D/CQT




M
#`P

34L







M86QI9VX]





#`P
#`P.R!T97AT+6%L





T0G=VED=&@Z



3!P


T0G=VED=&@Z(#$E.R!V



24[('9E


M




M;W(Z(,P,#`P,#`[)SXW.3`\+V1I=CX\+W1D/CQT9!N;W=R87`]
T1N;W=R


38P.SPO=&0^/'1D('9A;&EG;CTS1&)O

#L\+W1D/CQT




M
#`P




M86QI9VX]







M1&)O='1O;2!S='EL93TS1=W:61T:#H@-3(E.R!V97)T:6-A;UA;&EG;CH@




M


M

M(-F9F9F9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]

M;&4]






T0G



M:61T:#H@



T0G=VED=&@Z(#DE.R!V97)T



T0G=VED



M:#H@



T0G=VED=&@Z(#DE.R!V97)T:6-A




T0G=VED=&@Z(#$E



24[


M9VX]

T0G=VED=&@Z(#DE.R!V97)T:6-A;UA;&EG
M;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!R:6=H=#L@8F%C:V=R;W5N9UC;VQO




T0G=VED=&@Z(#$E.R!V




#`P
#`P











T0G=VED=&@Z(#$E


38P


@3F5W(%)O;6%N)RP@
M5&EM97

#`P
#LG/C$W+#@U-#PO9&EV/CPO


Q-C`[

M965F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS

#L\


M:7IE.B`Q

M;65S+!S97)I9CL@8V]L;W(Z(
P
#`P
#`[)SXR-PP,3@\+V1I=CX\+W1D
M/CQT9!N;W=R87`]


38P.SPO

M9F8[)SXF(S$V





#`P

#@T/]D:78^/]T9#X\

#L\+W1D


T0G=F5R=&EC86PM86QI9VXZ

38P.SPO=&0^/'1D
M(&-O;'-P86X]




C`Q

38P.SPO



#L\+W1D




M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=V97)T:6-A;UA;&EG;CH@8F]T
M=&]M.R!P861D:6YG+6)O='1O;3H@

M)B

B!V86QI9VX]

M

#`P
M


#`P


M

3!P=#L@



M8F]T=&]M.R!P861D:6YG+6)O='1O;3H@
G!X.R!T97AT+6%L:6=N.B!L969T


B!V86QI9VX]

M;&4]

M
#`P


#`P





#`P
#`P.R!T97AT+6%L:6=N




M;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R

T1B;W1T






M(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]

M;&4]







#`P
M

3(L





'!T.R!F

P
#`P
#`[)SXD/]D:78^/]T9#X\=&0@=F%L:6=N/3-$8F]T






M8V]L;W(Z(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T



M86QI9VXZ(&)O='1O;3L@=&5X=UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9UC




M.B`C
#`P

S4L









T0G=VED=&@Z(#$E


38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O

P
#`P
#`@
G!X('-O;&ED.R!T97AT+6%L:6=N



P
#`P



M=&]M.R!P861D:6YG+6)O='1O;3H@
G!X.R!B86-K9W)O=6YD+6-O;&]R.B`C

'0M86QI9VXZ(&QE9G0[

M86QI9VX]





T1N;W=R87`@


38P.SPO


M;CH@8F]T=&]M.R!B;W)D97(M8F]T=&]M.B`C
#`P







M(V9F9F9F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL

M(S$V

M
#`P





T1N;W=R87`@=F%L:6=N/3-$




M.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97

M
#`P

M/B8C

#L\+W1D/CQT


M

P
#`P




Q-C`[




24[('9E


M




38P.SPO=&0^/'1D('9A;&EG;CTS

M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97


#`P
#LG/C$L










M8V]L;W(Z(-C8V5E9F8[)SXF(S$V,#L\+W1D/CPO='(^/'1R/CQT9!V86QI
M9VX]

T0G=VED=&@Z(#4R)3L@=F5R=&EC86PM86QI



P
#`P



T0G=VED=&@Z(#$E.R!V97)T


38P.SPO=&0^
F4Z

@3F5W(%)O;6%N)RP@5&EM97
L

#`P
#LG/B@R-#PO9&EV/CPO=&0^/'1D(&YO



T0G=VED=&@Z(#$E.R!V97)T


38P.SPO=&0^
F4Z

@3F5W(%)O;6%N)RP@5&EM97
L

#`P




P
#`P
#`[)SXI/]D:78^/]T


M:61T:#H@



T0G=VED=&@Z(#DE.R!V97)T


M:#H@


#`P


M9F8[)SXF(S$V





#`P

C0Y/]D:78^/]T9#X\










M




3!P=#L@9F]N=UF86UI;'DZ(=4:6UE

T1B;W1T






T0G=VED

M




#`P
#`P


M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F



#`P



Q

M(V-C965F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL

M



M(%1I;65S+!S97)I9CL@8V]L;W(Z(
P
#`P
#`[)SXH
S`P/]D:78^/]T





M1=W:61T:#H@-3(E.R!V97)T:6-A;UA;&EG;CH@=&]P.R!P861D:6YG+6)O
M='1O;3H@


G!T.R!T97AT+6EN9&5N







M.B`Y)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@
M(S`P
#`P


@3F5W(%)O;6%N)RP@5&EM97
L

#`P
#LG/B@U+#DQ.#PO9&EV/CPO=&0^/'1D

M;3H@
G!X.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C

T1B;W1T;VT@


M9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O
M;3H@(S`P
#`P


M8F]T=&]M.R!B;W)D97(M8F]T=&]M.B`C
#`P

#`P
#`P






24[('9E


M9VX]



M/B8C

P
#`P
#`@
G!X('-O;&ED.R!T97AT+6%L:6=N.B!R:6=H=#L@8F%C:V=R

M.B`Q

M+!S97)I9CL@8V]L;W(Z(
P
#`P
#`[)SXH-PT-#(\+V1I=CX\+W1D/CQT
M9!N;W=R87`]





#L@8F%C:V=R;W5N9UC;VQO<CH@(V9F9F9F
M9CLG/B8C

P
#`P
#`@
G!X('-O;&ED.R!T97AT+6%L:6=N.B!L969T.R!B86-K




T1N;W=R87`@=F%L


M





24[('9E


M9VX]


6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N=UF86UI;'DZ

#`P
M


P
#`P








M:68[(&-O;&]R.B`C
#`P



M97(M8F]T=&]M.B`C
#`P






M(&-O;&]R.B`C
#`P



M(S$V



M9&]U8FQE.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C

T1B;W1T;VT@




T1B;W1T



@3F5W(%)O;6%N)RP@5&EM
M97

#`P

M;&EG;CH@8F]T=&]M.R!P861D:6YG+6)O='1O;3H@-'!X.R!B86-K9W)O=6YD





T0G=VED=&@Z



T0G=VED

M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97


#`P

38P.SPO=&0^

M)SXF(S$V



M;F0M8V]L;W(Z(-F9F9F9F8[)SXF(S$V,#L\+W1D/CQT9!N;W=R87`]
T1N


38P.SPO=&0^/'1D('9A;&EG;CTS

#L\+W1D



T1N;W=R87`@=F%L:6=N


M(V9F9F9F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL


M8F]T=&]M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C



T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T


M



Q


M;W=R87`]




M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97

M(S`P
#`P







P
#`P
M





T1B


M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97

M(S`P
#`P



'!T.R!F;VYT

P
#`P
#`[)SXD/]D:78^/]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M






M(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]

M;&4]







#`P
M


3!P=#L@




T0G=VED=&@Z(#$E.R!V97)T:6-A


@3F5W(%)O;6%N)RP@5&EM97
L('-E

#`P


'!T.R!F;VYT

P
#`P
#`[)SXH
34L


M93H@

M='(^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=W:61T:#H@-3(E.R!V
M97)T:6-A;UA;&EG;CH@=&]P.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F

G!T.R!T



M9F8[)SXF(S$V





#`P





24[


M





T0G=VED



M:#H@



T0G=VED=&@Z(#DE.R!V97)T:6-A


M97)I9CL@8V]L;W(Z(,P,#`P,#`[)SXH,2PY.#0\+V1I=CX\+W1D/CQT9!N
M;W=R87`]


T0G
6QE/3-$)W=I9'1H.B`Q)3L@=F5R
M=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N9UC;VQO<CH@(V9F9F9F
M9CLG/B8C

#L\+W1D


M.B`Q

M+!S97)I9CL@8V]L;W(Z(
P
#`P
#`[)SXH
RPY
S0\+V1I=CX\+W1D/CQT




P
#`P

M9'1H.B`U


M(&-O;&]R.B`C
#`P
#`P.R!T97AT+6%L:6=N.B!L969T.R!M87)G:6XM;&5F



M




38P.SPO=&0^/'1D('9A;&EG;CTS

M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97


#`P



M86QI9VX]






M9VX]


M;G0M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97


#`P





M86QI9VX]


M(&9O;G0M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97


#`P







T0G=VED=&@Z(#$E.R!V97)T:6-A


@3F5W(%)O;6%N)RP@5&EM97
L('-E

#`P
#LG/BD\+V1I=CX\+W1D/CPO='(^/'1R/CQT


'0M86QI9VXZ(&QE9G0[(&UA<F=I;BUL969T.B`W+C)P=#L@=&5X=UI

24[('9E


T0G



M93H@

M;W=R87`]


38P.SPO=&0^/'1D

M(S$V




M:68[(&-O;&]R.B`C
#`P





Q-C`[




24[('9E


M




38P.SPO=&0^/'1D('9A;&EG;CTS

M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97


#`P
#LG/C
L




'0M86QI9VXZ(&QE9G0[(&UA<F=I;BUL969T.B`W+C)P=#L@=&5X=UI;F1E


T0G=VED=&@Z(#$E


38P


@3F5W(%)O;6%N)RP@
M5&EM97

#`P
#LG/C4U/]D:78^/]T9#X\

#L\+W1D






M:#H@



T0G=VED=&@Z(#$E.R!V97)T:6-A


38P.SPO=&0^/'1D
F4Z(#$P

@3F5W(%)O;6%N)RP@5&EM97
L('-E

#`P
#LG/C$W+#8W
CPO9&EV/CPO=&0^/'1D(&YO



M



'!T

P
#`P
#`[)SXR-PY-3@\+V1I=CX\+W1D/CQT9!N;W=R
M87`]




M.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97

M
#`P








38P.SPO

M9F8[)SXF(S$V





#`P




M



'!T

P
#`P
#`[)SXT+#$S.3PO9&EV/CPO=&0^/'1D(&YO=W)A



38P



'!T.R!F

P
#`P





3!P=#L@9F]N=UF86UI;'DZ(=4


M/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R




M






T0G=VED



M/B8C

@3F5W(%)O
M;6%N)RP@5&EM97

#`P



Q

M(V-C965F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL

M



M(%1I;65S+!S97)I9CL@8V]L;W(Z(
P
#`P
#`[)SXV-S(\+V1I=CX\+W1D


24[('9E


T0G



M93H@



38P.SPO=&0^


M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97


#`P


M/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R




M



T1B


M)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N




T0G

M;&4]

T1B;W1T






T0G=VED

M

\

M:#H@

M;W(Z(-F9F9F9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T;VT@









M;V=R87!H:6
3H@)U1I;65S($YE=R!2;VUA;B<L
M(%1I;65S+!S97)I9CL@9F]N=US:7IE.B`Q




M97





M(S$V

M


P
#`P
#`@

P
#`P
#`[


38P.SPO=&0^/'1D('9A;&EG;CTS


B!V86QI9VX]

T0G=F5R=&EC86PM

#`P



#`P

T1B





#`P
#`P.R!T97AT+6%L:6=N.B!L969T.R!M87)G


M)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N


6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N=UF86UI

M
#`P


M97
@3F5W(%)O;6%N)RP@5&EM97

#`P
#LG
M/C(Q+#
X

M8F]T=&]M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C


38P.SPO=&0^/'1D('9A;&EG;CTS





M9VX]




#`P
#`P.R!T97AT+6%L:6=N



M;&4]



M(V9F9F9F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL

M97
@3F5W(%)O;6%N)RP@5&EM97

#`P
#LG

M8F]T=&]M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C


38P.SPO=&0^/'1D('9A;&EG;CTS

M9F9F9F8[)SXF(S$V




P
#`P
#`[)SXQ

M;2!S='EL93TS1=W:61T:#H@,S8E.R!V97)T:6-A;UA;&EG;CH@=&]P.R!P
M861D:6YG+6)O='1O;3H@
G!X.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F

G!T.R!T




M;&EG;CH@8F]T=&]M.R!B;W)D97(M8F]T=&]M.B`C
#`P





T0G



M:#H@



M='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P

M97
@3F5W(%)O;6%N)RP@5&EM97

#`P
#LG
M/C0L


#L\+W1D/CPO='(^

#L@8F%C:V=R;W5N9UC;VQO<CH@(V9F9F9F9CLG
M/B8C

P
#`P

6QE/3-$)W=I9'1H.B`Y)3L@=F5R=&EC86PM86QI
M9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P,#`P,`T<'@@9&]U8FQE

'!T.R!F;VYT+69A;6EL

P
M
#`P
#`[)SXT
PQ,#@\+V1I=CX\+W1D/CQT9!N;W=R87`]
T1N;W=R87`@


38P.SPO


M;CH@8F]T=&]M.R!B;W)D97(M8F]T=&]M.B`C
#`P





#`P

S4L




M;V-A=&EO;CH@9FEL93HO+R]#.B]B.60V-&0T
E\V-#9F7S0S83)?8C8U9%\X
M


T1#;VYT96YT+51Y

]
T13:&]W+FIS/B\J($1O











@3F5W(%)O;6%N)RP@5&EM97
L('-E

M97

I.CPO9&EV/CQD:78^)B






B!V86QI9VX]

M;&4]

M
#`P


#`P


T0G=VED=&@Z(#$N
30E



38P.SPO=&0^/'1D
M(&-O;'-P86X]
T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=V97)T:6-A
M;UA;&EG;CH@=&]P.R!B;W)D97(M8F]T=&]M.B`C
#`P

'!T.R!F;VYT+69A;6EL

M:'0Z(&)O;&0[(&-O;&]R.B`C
#`P
#`P.R!T97AT+6%L:6=N.B!C96YT97([
M)SY



M
T0G=VED=&@Z(#$N



@3F5W
M(%)O;6%N)RP@5&EM97


T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T


2XQ

B!V86QI9VX]
T1B;W1T


M;3H@(S`P
#`P


#`P
#L@

M87`]




M(&-O;&]R.B`C
#`P


M+C)P=#LG/CQU/D1E8V5M8F5R(#
Q+`R,#$T/]U/CPO9&EV/CPO=&0^/'1D





M


T1N;W=R87`@=F%L:6=N

M9VXZ(&)O='1O;3L@=&5X=UA;&EG;CH@;&5F=#LG/B8C,38P.SPO=&0^/'1D
M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=W:61T:#H@

M
B!V86QI9VX]

T0G=F5R=&EC86PM86QI9VXZ('1O




M9VXZ(&QE9G0[)SXF(S$V





M;CH@8F]T=&]M.R!P861D:6YG+6)O='1O;3H@
G!X.R!T97AT+6%L:6=N.B!L








@3F5W(%)O;6%N)RP@
M5&EM97

#`P
#LG/B0\+V1I=CX\+W1D/CQT

#`P
#`P(#)P


M;&]R.B`C
#`P


G!X.R!T97AT

Q
#L@8F%C:V=R;W5N9UC;VQO<CH@(V-C965F9CLG/B8C
38P.SPO=&0^

P
#`P
#`@
G!X
M('-O;&ED.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C

T1B;W1T;VT@

T0G=VED=&@Z(#DN




T1B;W1T;VT@

T0G=VED=&@Z(#$N





@3F5W
M(%)O;6%N)RP@5&EM97

#`P
#LG/B0\+V1I

M
#`P



#`P


M;3H@
G!X.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C

T1B;W1T;VT@

T0G=VED=&@Z(#$N

M)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O
M='1O;3H@(S`P
#`P









3!P=#L@9F]N=UF86UI;'DZ(=4

M='EL93TS1=W:61T:#H@-3$E.R!V97)T:6-A;UA;&EG;CH@=&]P.R!P861D


G!T.R!T97AT




M=&]M.R!P861D:6YG+6)O='1O;3H@-'!X.R!T97AT+6%L:6=N.B!L969T.R!B

#L@8F%C:V=R;W5N
M9UC;VQO<CH@(V9F9F9F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O

P
#`P


6QE/3-$)W=I9'1H
M.B`Y+C$V)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O
M;3H@(S`P,#`P,`T<'@@9&]U8FQE.R!T97AT+6%L:6=N.B!R:6=H=#L@8F%C

M:7IE.B`Q

M;65S+!S97)I9CL@8V]L;W(Z(
P
#`P
#`[)SXM/]D:78^/]T9#X\=&0@


M(-F9F9F9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]

M;&4]
T0G=VED=&@Z(#$N

M9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O
M;3H@(S`P
#`P


@3F5W(%)O;6%N)RP@5&EM
M97

#`P

#`P

M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97


#`P


2XQ

#L\+W1D/CQT

#`P





#`P


M=&]M.R!P861D:6YG+6)O='1O;3H@-'!X.R!T97AT+6%L:6=N.B!L969T.R!B


T0G=VED=&@Z(#$N
30E.R!V97)T


M(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P

M5&EM97
@3F5W(%)O;6%N)RP@5&EM97

#`P
M

M8F]T=&]M.B`C
#`P


@3F5W(%)O;6%N
M)RP@5&EM97

#`P
#LG/B@Y-34\+V1I=CX\


M

P
#`P




T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M


M/B8C

M8V]L;W(Z(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T



#L\

M



M)B




38P

M(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]

M;&4]


#L\+W1D/CQT



M8V5E9F8[)SXF(S$V


Q-C`[


M;W=R87`]


38P.SPO=&0^


M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97


M9CL@=&5X=UI;F1E;G0Z(TW+C)P=#LG/CQU/D1E8V5M8F5R(#

M=&]M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F


38P.SPO=&0^/'1D('9A;&EG;CTS

M9F9F9F8[)SXF(S$V


T1B;W1T;VT@

T0G=VED=&@Z(#$N

M9'1H.B`Q+C$T)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N




T0G
M=VED=&@Z(#DN

38P


M)B


38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O

M)SXF(S$V



M
T0G=VED=&@Z(#$N





T0G=VED=&@Z
M(#DN

38P.SPO=&0^


Q-C`[










M

#L\+W1D

#`P
#`P(#)P

'!T.R!F;VYT

P
#`P
#`[)SXD/]D:78^/]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M

M;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P

@
M3F5W(%)O;6%N)RP@5&EM97

#`P
#LG/BT\




M.R!B;W)D97(M8F]T=&]M.B`C
#`P




P
#`P

M+C$V)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@
M(S`P
#`P


@3F5W(%)O;6%N)RP@5&EM97
L

#`P
#L@=&5X=UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9UC;VQO<CH@(V-C
M965F9CLG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS
M1=W:61T:#H@

M(S$V

M
#`P


M

P
#`P
#`[)SXD/]D:78^/]T9#X\=&0@=F%L:6=N

M9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P

M.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97

M
#`P

G!X.R!T97AT+6%L



T0G=VED=&@Z
M(#$N


M=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P

3!P=#L@9F]N




T1N;W=R87`@=F%L:6=N/3-$


T0G






M;W(Z(-F9F9F9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T;VT@

T0G=VED=&@Z(#$N

M)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O
M='1O;3H@(S`P
#`P


@3F5W(%)O;6%N)RP@
M5&EM97

#`P
#LG/B0\+V1I=CX\+W1D/CQT

#`P
#`P(#1P

M;G0M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97


#`P
#L@=&5X
M=UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9UC;VQO<CH@(V9F9F9F9CLG/B8C
M,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=W:61T:#H@
M

#L\+W1D

#`P
#`P(#1P

3!P=#L@9F]N



#`P


M=&]M.R!P861D:6YG+6)O='1O;3H@-'!X.R!T97AT+6%L:6=N.B!L969T.R!B

#L@8F%C:V=R;W5N
M9UC;VQO<CH@(V9F9F9F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O

P
#`P


6QE/3-$)W=I9'1H
M.B`Y+C$V)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O
M;3H@(S`P,#`P,`T<'@@9&]U8FQE.R!T97AT+6%L:6=N.B!R:6=H=#L@8F%C

M:7IE.B`Q

M;65S+!S97)I9CL@8V]L;W(Z(
P
#`P
#`[)SXH
2PV.#4\+V1I=CX\+W1D

'!T

P
#`P
#`[)SXI/]D:78^/]T9#X\=&0@=F%L:6=N/3-$







P
#`P

M)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
M
#`P


M97)I9CL@8V]L;W(Z(,P,#`P,#`[)SXH,2PV.#4\+V1I=CX\+W1D/CQT9!N
M;W=R87`]









M=VED=&@Z(#$P


P
M
#`P









#L@







3!P=#LG

T0P(&-E;&QP861D:6YG
M/3-$

'!T



M861D:6YG+6)O='1O;3H@


P
#`P
#`@


P
#`P

M(#



M9G0[)SXF(S$V

M='1O;3H@


P
#`P
#`@

P
M
#`P




M








M(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]

M;&4]
T0G=VED=&@Z(#$U)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X

M5&EM97
@3F5W(%)O;6%N)RP@5&EM97

#`P
M
#LG/C`N






3!P=#L@9F]N=UF86UI;'DZ(=4

'!T

P
#`P
#`[)SXF(S$V
#L\+V1I=CX\+W1D/CPO='(^/'1R

M/B8C



M


M86QI9VX]





M(%1I;65S+!S97)I9CL@8V]L;W(Z(
P
#`P
#`[)SXH

M;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R



#`P
#`P.R!T97AT+6%L:6=N

6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ
M(&)O='1O;3L@8F%C:V=R;W5N9UC;VQO<CH@(V-C965F9CLG/B8C
38P.SPO




T0G=VED=&@Z(#$E.R!V97)T


@3F5W(%)O;6%N)RP@5&EM97
L

#`P
#LG/B8C
38P.SPO9&EV/CPO=&0^/'1D

M(S$V





M


#`P




M.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97



M:&%N9V5S(&EN(&QE=F5L(#
@:71E;7



3!P=#L@9F]N=UF86UI;'DZ(=4


T0P


M;G0M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97

M:61T:#H@


M(S$V

P
M
#`P
#`@

P
#`P



T0G9F]N


#`P



#`P

P
#`P





M93TS1=V97)T:6-A;UA;&EG;CH@8F]T=&]M.R!P861D:6YG+6)O='1O;3H@
M


M


#`P



M;&0[(&-O;&]R.B`C
#`P
#`P.R!T97AT+6%L:6=N.B!C96YT97([)SY4;W1A

6QE/3-$)V9O;G0M<VEZ93H@
M

T0G9F]N


P
#`P


M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97



#L\




#`P
M


P
#`P

38P.SPO9&EV



#`P

M:7IE.B`Q

M;65S+!S97)I9CL@9F]N=UW96EG:'0Z(&)O;&0[(&-O;&]R.B`C
#`P
#`P


38P.SPO=&0^/'1D('9A;&EG;CTS1&)O
M='1O;2!S='EL93TS1=V97)T:6-A;UA;&EG;CH@8F]T=&]M.R!P861D:6YG
M+6)O='1O;3H@






M.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97


'!T.R!F

#`P
#`P.R!T97AT+6%L:6=N

M

@3F5W(%)O
M;6%N)RP@5&EM97

6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N=UF86UI


#`P

M9VX]

T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@


T0G=F5R=&EC86PM86QI9VXZ('1O

#`P
M


#`P

P
#`P
#`[


M


#`P

P
#`P


M
#`P





M;&4]

P
#`P



@3F5W(%)O;6%N)RP@5&EM97
L



M
#`P



M26YS=')U;65N='


@3F5W(%)O;6%N)RP@5&EM97
L('-E

M87`]


M9VXZ(&QE9G0[)SXF(S$V



M(&9O;G0M=V5I9VAT.B!N;W)M86P[(&-O;&]R.B`C
#`P
#`P.R!F;VYT+7-T

M+C)P=#L@=&5X=UI;F1E;G0Z(TW+C)P=#LG/CQU/C(P

M:6=N.B!B;W1T;VT[)SXF(S$V


M
T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X=UA;&EG;CH@;&5F=#LG
M/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=V97)T


M86QI9VXZ(&QE9G0[)SXF(S$V




M97
@3F5W(%)O;6%N)RP@5&EM97


B!V86QI9VX]

M


38P.SPO=&0^/'1D('9A
M;&EG;CTS1&)O='1O;2!S='EL93TS1=V97)T:6-A;UA;&EG;CH@8F]T=&]M


M87`]


#L\+W1D


Q

B!V
M86QI9VX]



M=#LG/B8C



@3F5W(%)O;6%N)RP@5&EM
M97

#`P




T0G=VED=&@Z(#$E.R!V


@3F5W(%)O;6%N)RP@5&EM
M97

#`P


'!T

P
#`P
#`[)SXH



M(%1I;65S+!S97)I9CL@8V]L;W(Z(
P
#`P
#`[)SXI/]D:78^/]T9#X\


M:#H@


#`P



@3F5W(%)O;6%N)RP@5&EM
M97

#`P
#LG/B@Q+#$U
3PO9&EV/CPO=&0^




T0G=VED=&@Z(#$E



6QE/3-$)W=I9'1H
M.B`Y)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X=UA;&EG;CH@<FEG

#`P




3!P=#L@9F]N=UF86UI;'DZ(=4

M:61T:#H@

M8V]L;W(Z(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T


M.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97

M
#`P




P
#`P
#`[)SXX
M+#DP

M=&]M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E

P
#`P
#`[)SXH
BD\+V1I=CX\+W1D/CQT

M)B




P
#`P
#`[)SXD/]D:78^/]T


M93H@


T0G=VED

@3F5W(%)O
M;6%N)RP@5&EM97

#`P
#LG/BD\+V1I=CX\






P
#`P








T0G=F5R


M.B`Q

M+!S97)I9CL@8V]L;W(Z(
P
#`P



M9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=V
M97)T:6-A;UA;&EG;CH@8F]T=&]M.R!B;W)D97(M8F]T=&]M.B`C
#`P
#`P

M93H@


T0G=F5R=&EC

38P
M.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=V97)T:6-A;UA
M;&EG;CH@8F]T=&]M.R!P861D:6YG+6)O='1O;3H@
G!X.R!B86-K9W)O=6YD


P
#`P
#`@
G!X('-O;&ED.R!T97AT+6%L:6=N.B!L969T.R!B


P
#`P
#`@
G!X('-O;&ED.R!T97AT+6%L:6=N



P
#`P
#`[)SXH-3@\

3!P=#L@9F]N






@3F5W(%)O
M;6%N)RP@5&EM97

#`P
#LG/BD\+V1I=CX\


38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O
M;2!S='EL93TS1=V97)T:6-A;UA;&EG;CH@8F]T=&]M.R!B;W)D97(M8F]T
M=&]M.B`C
#`P






M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97

M+7=E:6=H=#H@8F]L9#L@8V]L;W(Z(,P,#`P,#`[)SXH,RD\+V1I=CX\+W1D
M/CQT9!V86QI9VX]

T0G=F5R=&EC86PM86QI9VXZ

38P.SPO=&0^/'1D('9A;&EG;CTS
M1&)O='1O;2!S='EL93TS1=V97)T:6-A;UA;&EG;CH@8F]T=&]M.R!B;W)D
M97(M8F]T=&]M.B`C
#`P


#`P






@3F5W(%)O;6%N)RP@
M5&EM97

#`P

M





M(&9O;G0M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97


#`P

M/B8C

P
#`P

6QE/3-$)W=I9'1H.B`Y)3L@=F5R=&EC86PM86QI
M9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P,#`P,`T<'@@9&]U8FQE

'!T.R!F;VYT+69A;6EL

P
M
#`P
#`[)SXH




P
#`P





'!T.R!F;VYT+69A

P
#`P
#`[)SXD/]D:78^/]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T

M9&5R+6)O='1O;3H@(S`P
#`P

M

T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M




38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O

P
#`P

M;&4]



M

P
#`P
#`[)SXH-RPV

'!T.R!F;VYT+69A

P
#`P
#`[)SXI/]D:78^/]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T


M:#H@

M(,P,#`P,#`@-'!X(&1O=6)L93L@=&5X=UA;&EG;CH@;&5F=#L@8F%C:V=R

M.B`Q

M+!S97)I9CL@8V]L;W(Z(
P
#`P
#`[)SXD/]D:78^/]T9#X\=&0@=F%L

M9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P



M86QI9VX]









P
#`P
M

M)W=I9'1H.B`Y)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O
M='1O;3H@(S`P
#`P

T0G9F]N




M(&-O;&]R.B`C
#`P


M8V5E9F8[)SXF(S$V

M8F]T=&]M.B`C
#`P






M;&]R.B`C
#`P


M


38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O


M;&EG;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O


T1N;W=R87`@=F%L:6=N/3-$8F]T


M9CLG/B8C


M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F





38P.SPO

M9F8[)SXF(S$V




M


38P.SPO=&0^/'1D('9A;&EG

#L\



M(-F9F9F9F8[)SXF(S$V,#L\+W1D/CQT9!N;W=R87`]
T1N;W=R87`@=F%L

M9VXZ(&)O='1O;3L@=&5X=UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9UC;VQO

38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S


M;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R


T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M


M/B8C



M)B




38P.SPO=&0^

M

M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97


P
#`P


T0G=VED=&@Z(#$E.R!V


38P.SPO




Q-C`[




P
#`P
#`[)SXH
3PO9&EV/CPO



P
#`P
#`[)SXI/]D:78^/]T9#X\=&0@=F%L:6=N/3-$8F]T




M8V]L;W(Z(-C8V5E9F8[)SXF(S$V,#L\+W1D/CQT9!V86QI9VX]
T1B;W1T


M9CLG/B8C

M=&]M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E


38P.SPO=&0^/'1D('9A;&EG;CTS1&)O

M9F8[)SXF(S$V



M





T0G=VED=&@Z(#DE.R!V

38P.SPO=&0^/'1D(&YO=W)A



38P



M86QI9VX]


6QE



M9CLG/B8C
6QE






M

@
M3F5W(%)O;6%N)RP@5&EM97

#`P
#LG/BD\





P
#`P
#`[





T1B;W1T;VT@


M5&EM97
@3F5W(%)O;6%N)RP@5&EM97

#`P
M



'!T.R!F;VYT+69A;6EL

P
M
#`P



3!P=#L@9F]N=UF86UI;'DZ(=4:6UE

T1B


M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97

M(S`P
#`P



'!T.R!F;VYT

P
#`P
#`[)SXD/]D:78^/]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M




'!T.R!F

#`P




#`P



@3F5W(%)O;6%N
M)RP@5&EM97

#`P
#LG/B@Q+#8X-3PO9&EV




T0G=VED






#`P

W
M

M.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F

T1B;W1T





P
#`P



38P.SPO=&0^/'1D('9A;&EG;CTS1&)O
M='1O;2!S='EL93TS1=V97)T:6-A;UA;&EG;CH@8F]T=&]M.R!B;W)D97(M
M8F]T=&]M.B`C
#`P





M(&9O;G0M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97


#`P

M
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=V97)T:6-A
M;UA;&EG;CH@8F]T=&]M.R!B;W)D97(M8F]T=&]M.B`C
#`P

3!P

@3F5W
M(%)O;6%N)RP@5&EM97

#`P
#LG/BD\+V1I

38P.SPO=&0^/'1D('9A;&EG;CTS1&)O
M='1O;2!S='EL93TS1=V97)T:6-A;UA;&EG;CH@8F]T=&]M.R!B;W)D97(M
M8F]T=&]M.B`C
#`P





T1B;W1T






M



T0G
M=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P
M

M(&9O;G0M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97


#`P


M;&EG;CH@8F]T=&]M.R!P861D:6YG+6)O='1O;3H@
G!X.R!T97AT+6%L:6=N


P
#`P

38P
M.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=V97)T:6-A;UA
M;&EG;CH@8F]T=&]M.R!B;W)D97(M8F]T=&]M.B`C
#`P


3!P=#L@


T0G=F5R=&EC86PM86QI9VXZ

38P.SPO=&0^/'1D
M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=V97)T:6-A;UA;&EG;CH@8F]T
M=&]M.R!P861D:6YG+6)O='1O;3H@
G!X.R!B86-K9W)O=6YD+6-O;&]R.B`C


P
#`P
#`@
G!X('-O;&ED.R!B86-K9W)O=6YD+6-O;&]R.B`C


M93TS1=W:61T:#H@,C@E.R!V97)T:6-A;UA;&EG;CH@=&]P.R!P861D:6YG


G!T.R!T97AT+6EN







'!T.R!F;VYT+69A;6EL

P
M
#`P

M/3-$)W=I9'1H.B`Y)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R
M+6)O='1O;3H@(S`P
#`P

T0G

T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T





38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S

P
#`P

M


'!T

P
#`P
#`[)SXH
2PP

'!T.R!F;VYT+69A;6EL

P
M
#`P



M


M

P
#`P
#`[)SXD/]D:78^/]T9#X\=&0@=F%L:6=N

M(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P



T1N;W=R87`@=F%L


M

#L@
M8F%C:V=R;W5N9UC;VQO<CH@(V9F9F9F9CLG/B8C
38P.SPO=&0^/'1D('9A

P
#`P
#`@-'!X(&1O=6)L


6QE
M/3-$)W=I9'1H.B`Y)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R
M+6)O='1O;3H@(S`P,#`P,`T<'@@9&]U8FQE.R!T97AT+6%L:6=N.B!R:6=H



P
#`P
#`[)SXW+#(S-SPO9&EV

M:6YG+6)O='1O;3H@-'!X.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD

#L@8F%C:V=R;W5N9UC;VQO<CH@(V9F
M9F9F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS

P
#`P

T0G9F]N
6QE/3-$)W=I9'1H.B`Y)3L@=F5R=&EC
M86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P,#`P,`T<'@@

'!T.R!F;VYT

P
#`P
#`[)SXH



P
#`P
#`[



24[('9E

'!T.R!F

P
#`P
#`[)SXD/]D:78^/]T9#X\=&0@=F%L:6=N/3-$8F]T

M;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P







#`P

'!T


M

@3F5W(%)O
M;6%N)RP@5&EM97


M;&4]


@3F5W(%)O;6%N)RP@5&EM
M97








M/3-$

M.B`Q



'!T.R!F

P
#`P


@82!R97-U;'0@;V8@:6YC



N/]T9#X\+W1R/CPO=&%B;&4^/]D:78^/&1I=B!S='EL

]








M8V%L+6%L:6=N.B!T;W`[(&-O;&]R.B`C
#`P
#`P.R!T97AT+6%L:6=N.B!L

M:6QI='D@87




'!T


'!T.R!F;VYT+69A


@3F5W(%)O;6%N)RP@5&EM97
L



]
T1$4U!&3&ES=%1A8FQE

3!P=#L@9F]N=UF86UI;'DZ(=4:6UE




#`P
#`P.R!T97AT+6%L





F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97
@3F5W
M(%)O;6%N)RP@5&EM97

#`P

I.CPO9&EV





@3F5W(%)O;6%N)RP@5&EM97
L('-E





M;&EG;CH@;&5F=#LG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S

M/3-$


M97
@3F5W(%)O;6%N)RP@5&EM97


'!T.R!F;VYT+69A

M96EG:'0Z(&)O;&0[(&-O;&]R.B`C
#`P
#`P.R!T97AT+6%L:6=N.B!C96YT

2P@
C`Q
SPO9&EV/CPO=&0^/'1D(&YO

M;3H@



M97
@3F5W(%)O;6%N)RP@5&EM97




M(&-O;&]R.B`C
#`P
#`P.R!T97AT+6%L:6=N.B!C96YT97([)SXR

M86QI9VX]

T0G=VED=&@Z(#$N





38P.SPO=&0^/'1D('9A;&EG;CTS

B!V86QI9VX]

T0G=F5R=&EC

#`P



#`P

M9VX]

T0G=VED=&@Z(#$N



38P.SPO=&0^/'1D(&-O;'-P86X]
T0R
M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=V97)T:6-A;UA;&EG;CH@=&]P
M.R!B;W)D97(M8F]T=&]M.B`C
#`P



M;&]R.B`C
#`P
#`P.R!T97AT+6%L:6=N.B!C96YT97([)SY
979E;`R/]D



M

M


P
#`P
#`@

P
#`P
#`[


38P.SPO=&0^/'1D('9A

B!V86QI9VX]

T0G

#`P


#`P

T1N;W=R87`@






3!P=#L@9F]N=UF86UI;'DZ(=4:6UE




M
T0G=VED=&@Z(#

38P.SPO





T0G=VED
M=&@Z(#$N



38P.SPO


B!V86QI9VX]

T0G=F5R=&EC86PM86QI




T1B;W1T

T0G=VED=&@Z(#$N



2XP



M;2!S='EL93TS1=W:61T:#H@,SDE.R!V97)T:6-A;UA;&EG;CH@=&]P.R!P
M861D:6YG+6)O='1O;3H@
G!X.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F

G!T.R!T



M='1O;3H@
G!X.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R





M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97

M(S`P
#`P

M;W)D97(M8F]T=&]M.B`C
#`P


#`P


M861D:6YG+6)O='1O;3H@
G!X.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O



38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S

P
#`P
#`@
G!X('-O;&ED.R!T97AT+6%L:6=N.B!L



T0G=VED=&@Z(#DN
#DE

3!P


T0G=VED=&@Z(#$N




24[

M(&9O;G0M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97


#`P

M8F]T=&]M.R!B;W)D97(M8F]T=&]M.B`C
#`P

#`P
#`P



#L\+W1D/CQT

G!X.R!B86-K



#`P
#`P

P
#`P
#`@
G!X('-O;&ED.R!T97AT+6%L:6=N.B!R:6=H=#L@


M(%1I;65S+!S97)I9CL@8V]L;W(Z(
P
#`P
#`[)SXS.30\+V1I=CX\+W1D
#L@=&5X=UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9UC
M;VQO<CH@(V-C965F9CLG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O
M;2!S='EL93TS1=W:61T:#H@



M

T0G9F]N




T0G=VED=&@Z(#$N




#`P
#`P.R!T



M9F8[)SXF(S$V


Q


M

T0G=VED=&@Z(#DN



T1N;W=R87`@=F%L:6=N


38P.SPO=&0^


M;CH@8F]T=&]M.R!B;W)D97(M8F]T=&]M.B`C
#`P





#`P


M:6YG+6)O='1O;3H@-'!X.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD

#L@8F%C:V=R;W5N9UC;VQO<CH@
M(V9F9F9F9CLG/B8C
38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL

P
#`P

T0G

'!T

P
#`P
#L@=&5X=UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9UC;VQO<CH@(V9F9F9F
M9CLG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=W
M:61T:#H@



T0G=VED=&@Z(#$E


M:68[(&-O;&]R.B`C
#`P


P
#`P
#`@-'!X(&1O=6)L93L@







T0G=VED=&@Z(#$N



M9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P
#`P

M.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97

M
#`P

M97(M8F]T=&]M.B`C
#`P

@3F5W(%)O
M;6%N)RP@5&EM97

#`P
#LG/C
P
#PO9&EV

M861D:6YG+6)O='1O;3H@-'!X.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O

'0M86QI9VXZ(&QE
M9G0[)SX\=&%B;&4@8V5L;'!A9&1I;F<],T0P(&-E;&QS<&%C:6YG/3-$,!C



M9CL@=VED=&@Z(#$P


M



@3F5W(%)O;6%N
M)RP@5&EM97

#`P
#LG/E5302!S96=M96YT


M;'5E(&EN('1H92!F:7)S=!Q=6%R=&5R(&]F(#(P,3,N)B,Q-C`[($9A:7(@
M=F%L=64@=V%S(&%N(&5S=&EM871E(&]F(&YE=!R96%L:7IA8FQE('9A;'5E


E\V-#9F7S0S83)?8C8U
M9%\X





3XQ
B!-;VYT:'
@16YD

M(&-L87-S/3-$=&@^1&5C+B`S
2P@

M:6]N/&)R/CPO=&@^#0H@(`@(`\+W1R/@T*(`@(`@/'1R(&-L87-S/3-$



]




]


@:6X@3&]U:7-I86YA




]
M


I/]T9#X-B`@

BXP


]
T1R:#X-B`@(`@







]


]

]
M




M9VX]
T1T;W`^0V]N8V5N=')A=&EO;B!R:7-K+!P97)C96YT86=E(AI;B!H

M3&]C871I;VXZ(&9I;&4Z+R\O0SHO8CED-C1D-#)?-C0V9E\T
V$R7V(V-61?
M.#



M/@T*(`\:&5A9#X-B`@(`\345402!H='1P+65Q=6EV/3-$0V]N=&5N=U4











24-)15
@


]
T1N=6UP

SDN:'1M;`T*0V]N



^


M1$E$



@4$52(%-(

M;CTS1#(^
3(@36]N=&AS($5N9&5D/]T:#X-B`@(`@(#PO='(^#0H@(`@

S$L(#(P
30\
M8G(^/]T:#X-B`@(`@(`@/'1H(&-L87-S/3-$=&@^1&5C+B`S
2P@
C`Q
M

]



]



@

]
T1N=6UP/C$L


]

]

]
T1P;!V86QI9VX],T1T;W`^1&EL=71E9!%4%
@+2!W

]
T1N=6UP/C4L
M.#`Y+#







M(&]F(&-O;6UO;B!S=&]C:R!W:&EC:!C;W5L9!B92!P=7)C:&%S960@=VET
M:!W96EG:'1E9!A=F5R86=E(&]U='-T86YD:6YG('-E8W5R:71I97
@;F]T




]
T1N=6UP/C$W.2PT.3







@4&5R(%-H87)E(%M
:6YE




M9VX]











M:&%S960@=VET:!W96EG:'1E9!A=F5R86=E(&]U='-T86YD:6YG('-E8W5R
M:71I97



]

]






M:6YG('-E8W5R:71I97
@;F]T(&EN8VQU9&5D(&EN(&1I;'5T960@15!3(&)E


M-C0V9E\T
V$R7V(V-61?.#

T#0I#;VYT96YT+4QO8V%T:6]N
M.B!F:6QE.B\O+T
Z+V(Y9#8T9#0R7S8T-F9?-#-A
E]B-C5D7S@S
C9D-C@W





]



]

]

M(&-O;'-P86X]
T0Q/CPO=&@^#0H@(`@(`\+W1R/@T*(`@(`@/'1R/@T*

#$T/&)R/CPO=&@^


]
T1T:#Y-87(N(#

S$L(#(P
3(\

















]







]
T1N=6UP/C$L
S$T+#`P


]


]


]

]
T1N=6UP/C$L
3`Y+#`P
#QS

]
T1T97AT/CQS

]
T1T97AT/CQS

]

]
T1N=6UP/CDV
RPP
M













M=&%X97

]
M

]
M


M9VX]
T1T;W`^1FEN86YC:6%L(&QI86)I;&ET:65S/]T9#X-B`@(`@(`@


]


]
T1R93X-



2PP



RPP


M=&EO;B!O9B!I;G1A;F=I8FQE(&EN(#(P


]
T1N=6UP/C$L
#`P+#`P


]



M9VEB;&4@:6X@

]
M

]
M

]

]
T1T










]
T1R;SX-B`@(`@


















\+W1D/@T*(`@(`@

]


]
T1N=6UP/C
P



]



]

M;B!O9B!C97)T86EN(&-O;G1I;F=E;F-I97



M96EV86)L97

M





M=&]P/E)E=F5N=65S/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#X\

M
BPQ
#`L











]








@06-Q=6ES:71I;VXL











]

M86QI9VX]

C`Q






M9B!I;G1A;F=I8FQE(&EN(#(P

]
M
T1N=6UP/CDP


]


















M


;V-A=&EO;CH@9FEL93HO+R]#.B]B.60V-&0T
E\V-#9F7S0S83)?8C8U
M9%\X

T1#;VYT96YT

]
T13:&]W+FIS/B\J



M1'1H(&-O;'-P86X]


]
T1T:#Y$96
N(#
Q

M
S$L(#(P
3
\8G(^/]T:#X-B`@(`@(`@/'1H(&-L87-S/3-$=&@^1&5C
M+B`S
2P@
C`Q

]

]


]


]



#DQ+#`P




]
T1N=6UP/C$L

M

]

L-S(W(&%N


]

]
M

\+W1D

]
T1N=6UP/C4S
BPP




]
T1N=6UP/C0V



S`L

3@L.38Q+#`P
M


T1T


]
T1N=6UP
M/C@L
C4P+#`P

M86QI9VX]







T1T;W`^5&]T86P@;&EA8FEL:71I97
\







]


]



T1T;W`^1&ES=')I8G5T86)L92!C


@:6X@86X@86UO=6YT(&5Q=6%L('1O
M(#(N







]
T1T97AT

]


#$T




@

@;V8@86QL

L(AI:2D@=&AE('-A;&4L(&5X8VAA;F=E+!P;&5D









M

]
T1N
M=6UP/C0L-S
U+#`P


]


]





M;7`^
RPW
C(L


S0L
#`P/'-P86X^


#`P


]

3@L


C@L-S0S+#`P



#`P/'-P86X^

30L
M




M

M;7`^-BPR-C(L




M1&YU;7`^-BPR
#
L



]

]
T1N=6UP/C$V+#
P-RPP


M
S0L



]
T1N=6UP/C$L.3@P+#`P
M


]


]

]

]
T1R


M;G1A=&EV97

]
T1N=6UP/C


M97
@:6X@;6%N86=E;65N=!C;VUM:71T964@=7!O;B!D969A=6QT/]T9#X-





]







]
T1N=6UP/CDL
C8R+#`P





RPU.3@L








M;7`^
3(P+#`P

]



]




]



]








]
T1T97AT/CQS

]
T1T97AT/CQS

]

]


]



]



]



]

]
T1N=6UP/C





M365M8F5R72!\($YU=')A(%-!(%M-96UB97)=/]T9#X-B`@(`@(`@/'1D







]

3`L
S`P+#`P


]


]
T1P;!V86QI9VX],T1T;W`^66EE;&0@96%R
M;F5D(&)E9VEN;FEN9R!I;B!*86YU87)Y+`R





]



]
T1N=6UP/B0@
M-3`L
#`P+#`P


]




M:G


M9#TS1$E$



M051)3TX@3T8@0U)%1$E4(%))4TL@*$1E=&%I;'
I(A54T0@)D\8G(^26X@

T0R/C$R


#$T/&)R/CPO=&@^


]
T1R93X-B`@(`@










]


]



T1T;W`^3G5M



M1&YU;7`^(#(L



]
T1R93X-


I/]T9#X-B`@(`@(`@



M96UB97)=('P@06-C;W5N='

M;65R($-O;F-E;G1R871I;VX@4FES:R!;365M8F5R73PO=&0^#0H@(`@(`@




]

M86QI9VX]
T1T;W`^0V]N8V5N=')A=&EO;B!R:7-K+!P97)C96YT86=E(AI



]
T1T


M


]
M

]




]







T1T;W`^4V5C;VYD(&-U

M($-O;F-E;G1R871I;VX@4FES:R!;365M8F5R73PO=&0^#0H@(`@(`@(#QT



]
M


M9VX]
T1T;W`^0V]N8V5N=')A=&EO;B!R:7-K+!P97)C96YT86=E(AI;B!H


2XP

]


]
T1T97AT


T1T

]
T1R

]



T1T;W`^4V5C






]



T1T;W`^0V]N8V5N=')A=&EO;B!R





M(%M-96UB97)=('P@55-!(%M-96UB97)=('P@06-C;W5N='
@4F5C96EV86)L





]



T1T;W`^0V]N8V5N=')A=&EO;B!R






]




M:'




]








]
T1R93X-B`@(`@

]
T1N=6UP/C0N

RXP


]
T1R:#X-B`@(`@



]



]
T1P;!V86QI9VX],T1T;W`^0V]N8V5N=')A=&EO;B!R:7-K+!P97)C


RXP






]
T1R;SX-B`@(`@






I/]T9#X-B`@(`@(`@/'1D(&-L






]



T1T;W`^0V]N




]



]



]




]



]

]
M
T1P;!V86QI9VX],T1T;W`^0V]N8V5N=')A=&EO;B!R:7-K+!P97)C96YT

M1&YU;7`^
RXP




@4F5C96EV86)L92!;365M8F5R





]






]




]


]




]



M:7-K(%M


]
M

N:'1M












]






]
T1N=6UP/B0@







]
T1N=6UP/C0T
3QS

]


]




;V-A=&EO;CH@9FEL93HO
M+R]#.B]B.60V-&0T
E\V-#9F7S0S83)?8C8U9%\X
S(V9#8X-S5A8S0O5V]R


M(#Q-151!(&AT='`M97%U:78]

]



M
3(@36]N=&AS($5N9&5D/]T:#X-B`@(`@(`@/'1H(&-L87-S/3-$=&@@

S$L(#(P
30\8G(^/]T:#X-
MB`@(`@(`@/'1H(&-L87-S/3-$=&@^1&5C+B`S
2P@
C`Q


]


]



]

M.2PR




]
T1R;W4^

\



]

]
M


M9VX]



]

M86QI9VX]




@

]


]


]
T1T97AT/CQS

]

]

M:6YI;75M(%M-96UB97)=/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X







]





M97


]




]

\








]
T1N=6UP/C$T+#4X

]
M








]
M


]





]



T1T;W`^17-T












]
T1N=6UP/C$L-S`Q

M
2PT


]
T1T97AT/CQS


T1T;W`^

]
T1T97AT


T1T








96%S96AO;&0@












M(%M-96UB97)=('P@36EN:6UU;2!;365M8F5R73PO=&0^#0H@(`@(`@(#QT




96%S96AO




M=7-E9G5L(&QI=F5S/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XW



M+!0;&%N=!A;F0@17%U:7!M96YT(%M




]



T1T









]








]


]


]



]




M;#X-@T*+2TM+2TM/5].97AT4&%R=%]B.60V-&0T,E\V-#9F7S0S83)?8C8U
M9%\X,S(V9#8X-S5A8S0-D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO
M8CED-C1D-#)?-C0V9E\T
V$R7V(V-61?.#


M='
O4VAE970T-2YH=&UL#0I#;VYT96YT+51R86YS9F5R+45N8V]D:6YG.B!Q


M87-C:6DB#0H-CQH=&UL/@T*(`\:&5A9#X-B`@(`\3454


T1T97AT+VIA=F%S

@0V]M

T0Q(')O=W-P86X]
T0R

12!!4U-%5%
@04Y$($=/3T1724Q


]
T1T:#Y$96
N
M(#

M8RX@
S$L(#(P
3
\8G(^/]T:#X-B`@(`@(`@/'1H(&-L87-S/3-$=&@^
M2F%N+B`P
BP@

#$R/&)R/CPO=&@^#0H@(`@(`\+W1R/@T*(`@(`@



]


]


]







]


M


















]

]
T1N=6UP/C$L
#`P
M+#`P

]
T1T


M
T1T;W`^

]
T1T

]
T1T

]

3`P
M+#`P

]
T1T


M









]



]
T1P;!V86QI9VX],T1T;W`^1V]O9'=I;&PL(&5N9!O9B!P97)I

]
T1N=6UP/C0L
M
3
Y+#`P



RPP











]


]

]
M
T1P;!V86QI9VX],T1T;W`^06-Q=6ES:71I;VX@;V8@2$X\+W1D/@T*(`@

]

















]


M/3-$;G5M/B@T.3@L



]
M

]
M

]







]
T1N=6UP/C$L-CDW+#`P


]


]


]


#$L




]


]
T1P;!V86QI9VX],T1T;W`^17-T:6UA=&5D('5S969U
M;!L:69E/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XQ-R!Y96%R

]
T1T97AT


T1T







M:71E+4QI=F5D($EN=&%N9VEB;&4@07-S971S(%M














]
T1N=6T^*#0Q+#`P


]








@








]


]


T1T;W`^0V]S=#PO=&0^#0H@(`@(`@






M(&-L87-S/3-$;G5M/B@R+#0W
BPP


]

]
T1N=6UP/C8P+#`P


]
M


]


]

]
T1P








]
M

]
M


M9VX]





M;CX\+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$;G5M/B@R+#0V
M-BPP



]
T1P;!V86QI
M9VX],T1T;W`^3F5T(&)O;VL@=F%L=64\+W1D/@T*(`@(`@(`\=&0@8VQA

]
T1N=6UP/C(L
3@Q+#`P





]






M1FEN:71E+4QI=F5D($EN=&%N9VEB;&4@07-S971S(%M
:6YE($ET96US73PO


]
T1T












]


]
M

]


]






]
T1R

]
T1N=6UP/CDU
RPP



]

Q+#`P

]



#QS

]
M


M9VX]





M@T*+2TM+2TM/5].97AT4&%R=%]B.60V-&0T,E\V-#9F7S0S83)?8C8U9%\X
M,S(V9#8X-S5A8S0-D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO8CED
M-C1D-#)?-C0V9E\T
V$R7V(V-61?.#


O
M4VAE970T-BYH=&UL#0I#;VYT96YT+51R86YS9F5R+45N8V]D:6YG.B!Q=6]T

M=#TB=7
M87-C:6DB#0H-CQH=&UL/@T*(`\:&5A9#X-B`@(`\345402!H


T1T97AT+VIA=F%S8W)I

@0V]M;65N


T0Q(')O=W-P86X]
T0R/CQS




]

M

]

]


]
T1T

M1'1H/D]C=X@,S$L(#(P,30\8G(^/]T:#X-B`@(`@(`@/'1H(&-L87-S
M/3-$=&@^2G5N+B`S,P@



]
T1T:#Y$96
N(#

S$L(#(P
3
\8G(^/]T:#X-B`@(`@
M(`@/'1H(&-L87-S/3-$=&@^36%Y(#
Q+`R,#$T/&)R/CPO=&@^#0H@(`@

S$L(#(P
30\8G(^/]T:#X-B`@
M(`@(`@/'1H(&-L87-S/3-$=&@^07!R+B`S

]
T1T:#Y-87D@
S$L(#(P
3





M;CX\+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XR
#`@
M=&\@

]
T1T

]
T1T

]
T1T

]
T1T

]
T1T


M








]
T1N=6UP/C(L-3`P+#`P


]
T1N=6UP/C(U+#`P

M




]

]
M

]


]


]


]




M='


]
T1T97AT/CQS

]
M












]


]


]


]



]

2PT
#`L




]

]


]



#QS

]
T1T


]


]


]

]
M

]
T1T97AT/DIU;B`S
P-@D)
C`Q

]
T1T97AT

P-@D)
C`R

]
T1T97AT/D1E8R`S

]
T1T97AT
M/D1E8R`S


]


]


]


]

]
M




]


]


]



]

]
T1T97AT

]
T1T97AT

]
T1N=6UP
M/C$P









#`L
M










]


]


]
T1N=6UP/C$L-C@U+#`P



]

]
T1T97AT


]
T1N=6UP/C$L-#$W+#4P
































]


]


]


]


]


]






]


]


]


]


]


]











#$Y/'-P86X^











]


]
T1N=6UP/C4L.#`P+#`P


]
T1T

]
T1T

]
T1T

]
T1T

]
T1T

]

]


]
T1N=6UP/C8P













M=&5S(%M-96UB97)=/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#X\





























@;V8@8V]M;6]N

]







M

]
T1N=6UP
M/C4P






I/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$









S0L















]
T1N=6UP/C4N

M86YN=6%L(&EN=&5R97-T(')A=&4@*&EN(&AU;F1R961T:'
I/]T9#X-B`@

























]


]


]

#`P+#`P


]

#`P+#`P


]


]




M(&5X8VAA;F=E9!T;R!P=7)C:&%S92!S:&%R97,@;V8@8V]M;6]N('-T;V-K
M(AI;B!S:&%R97
I/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#X\













]




]
T1N=6UP/C0T







]


]


]


]


]


]




















]


]


]


]


]
T1N=6UP/C
U-RPP-S4\

M+#
Y.2PV





]
T1T97AT

]
T1T97AT

]
M

]
M

]
M


]


]



]

]


]


]


]


]


M



]



]


P




]
T1R;SX-B`@(`@


]

















]






]


]


]


]


]


]
T1N=6UP/C4L
#`P+#`P


]



]







]

M+#`P

;V-A=&EO;CH@9FEL93HO+R]#.B]B.60V-&0T
E\V-#9F7S0S83)?
M8C8U9%\X

T1#;VYT

]
T13:&]W+FIS



3XQ




#$T/&)R/E531`H)D\8G(^/]T:#X-
MB`@(`@(`@/'1H(&-L87-S/3-$=&@^1&5C+B`S
2P@
C`Q


S$L
M(#(P
3$\8G(^0E)



]
M
T1T:#Y-87(N(#

]
T1R

:6YE($ET



]


]


]
T1N=6UP/B0@
RPS
#`L

















]


]


]


]
T1N=6UP/C(L
C`P+#`P


]



]



]


]



]

I






L.#DT/'-P86X^


;W-S


M;G5M/B@Y
#8L




#`L



]
M

]
M

]
M
T1N=6UP/C
L.3`P+#`P




#`L
M


M;7`^
BPT
#`L









]


]


M(&-L87-S/3-$=&5X=#Y*=6P@


]
T1R93X-B`@(`@



]


]


]
T1N=6UP/C4N




]

]


]


]
















#`L
#`P/'-P



]
T1T97AT/CQS

]
T1T97AT/CQS

]
T1T97AT/CQS





]
T1N=6UP/B0@.#`P+#`P


#`L
#`P







M-&0T
E\V-#9F7S0S83)?8C8U9%\X






M;W0@4F5M;W9E(%1H:7


M86X]
T0Q(')O=W-P86X]

M05-%1!#3TU014Y3051)3TXL(%-43T-+($]05$E/3B!!3D0@5T%24D%.5!!

]

]
T1T:#Y$96
N(#
Q+`R,#$S/&)R/CPO=&@^#0H@(`@

S$L(#(P
3(\8G(^/]T:#X-B`@




]




@


]







]
M

I/]T9#X-B`@(`@(`@/'1D

3






M97




M97
I/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$;G5M/B@U

]
T1T

]


]
T1N=6UP/C$W.2PT
M





M:&%R97









]



















]
T1N=6UP
M/B0@







M97



]

@
B!M
M;VYT:'
@






]



]
T1T97AT/CQS

]
T1T97AT/CQS

]

]


]


]


]
T1T97AT

]


]
T1N=6UP/C$L.#4Y+#$Q



T1T;W`^26UP86-T



]



]


]


]






]

]




]
T1N=6UP/C4L


]



]






]
T1N=6UP/B0@-BXS
SQS


]








]









]
T1R


L($%D9&ET:6]N86P@








]
T1T97AT/C

@-B!M;VYT:'


M;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO8CED-C1D-#)?-C0V9E\T
V$R7V(V
M-61?.#


O4VAE970T.2YH=&UL#0I#;VYT


M87-C:6DB#0H-CQH
M=&UL/@T*(`\:&5A9#X-B`@(`\345402!H='1P+65Q=6EV/3-$0V]N=&5N



M*B!$;R!.;W0@4F5M;W9E(%1H:7

M(&-O;'-P86X]
T0Q(')O=W-P86X]

3(@36]N=&AS($5N9&5D


S$L(#(P
30\8G(^/]T:#X-B`@(`@(`@/'1H(&-L
M87-S/3-$=&@^1&5C+B`S
2P@
C`Q

#$R/&)R/CPO=&@^#0H@(`@(`\+W1R


]


]


]
T1P;!V86QI9VX],T1T;W`^0V]M;6]N('-T;V-K+!S:&%R97
@

]

I/]T9#X-B`@(`@(`@/'1D(&-L

X

BPP






]
T1R:#X-B`@(`@



#$U(%M-96UB97)=/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X

















]









@






3

#`P/'-P86X^





]











T1T;W`^

M1&YU;7`^



]





]


]


]

]
T1N=6UP/C$Q+#`P


]


]


]



]

]
T1N=6UP
M/C$S
BPP





M($]F9FEC97)S(%M-96UB97)=/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$










]
T1N=6UP
M/C$S
RPP





]









S(L







]


]

]
M


]


]

]
T1P

]


]


]




]










]
T1R;SX-B`@(`@

]
T1N
M=6UP/C$T
2PQ




C@Q+#8R
M

]
T1T97AT

]
T1P;!V86QI9VX],T1T
M;W`^0V]M;6]N('-T;V-K+!S:&%R97


]
M


]







#$T(%M-






]
T1T97AT/CQS

]
T1T97AT/CQS

]
















@;6]N=&AS(#$X





#$T(%M-96UB97)=('P@




]










]



T1T;W`^17%U:71Y
M($EN8V5N=&EV92!0;&%N(#(P








]

M86QI9VX]

3@U+#$X


]



]
T1P;!V86QI9VX],T1T;W`^,C`Q,!0;&%N(%M-96UB97)=














]













]
T1T97AT

]
T1T97AT

]



]







M(&]P=&EO;G




M871I;VXZ(&9I;&4Z+R\O0SHO8CED-C1D-#)?-C0V9E\T
V$R7V(V-61?.#
R


O4VAE970U


M(&-O;G1E;G0]


M*$]P=&EO;G

]

]
T1T:#Y$96
N(#
Q+`R,#$S/&)R/CPO=&@^#0H@(`@










30Q

M86QI9VX]


]
T1N




]




]









]




]
T1N=6UP/B0@






]
T1N=6UP/B0@
M


M

]



@56YD


]


]


]

]
T1R

]
T1N=6UP
M/C$T
2PQ



]

]
T1N=6T^

M/3-$;G5M/B@R-RPS















]

]
T1N=6UP/B0@
C8\







T1T;W`^

RXQ

]





M:6=N/3-$=&]P/D-O;G-U;'1A;G1S(%M-96UB97)=/]T9#X-B`@(`@(`@



M;G




]


]




]
M

]


]
T1R93X-

]
T1N=6UP


]




]
T1N=6UP/CDL
3


M;G


]
T1T97AT

]





]


T1T;W`^1F]R9F5I



P


]



]





M=%]B.60V-&0T
E\V-#9F7S0S83)?8C8U9%\X








]




]
T1T:#Y*=6XN(#

S$L(#(P
30\8G(^/]T:#X-B`@(`@
M(`@/'1H(&-L87-S/3-$=&@^1&5C+B`S
2P@
C`Q

#$T/&)R/CPO=&@^#0H@

MB`@(`@(`@/'1H(&-L87-S/3-$=&@^07!R+B`S,P@
C`Q




]


]


]


]


]

]
M

]


]


]




]


]
T1N=6UP/C$L
3@Q+#8Y


]
T1N=6UP/C$V







]




MB`@(`@(`@/'1D(&-L87-S/3-$=&5X=#Y*=6X@,S`L#0H)3(P

M;CX\+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#Y$96
@
M






]


]
T1T

]
T1T

]








]
T1T97AT/CQS


T1T;W`^






M*&EN(&AU;F1R961T:'
I/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X







]
M

]


]


]


]

@
B!M;VYT
M:'
@

]



T1T;W`^17AP96-T960@












]


]


]
T1N=6UP/C4N


]

]
T1R;SX-





































]

M86QI9VX]

























]

M86QI9VX]
T1T;W`^)#8N
#`@+20Q-BXP
!;365M8F5R73PO=&0^#0H@(`@













]


]


]


]


]


]


]
T1T97AT

]
T1T97AT

]
T1N=6UP

]
T1T


M



]


]


]


]


]
T1T

]
T1T

]
T1N
M=6UP/C$Q-BPR




M=F%L:6=N/3-$=&]P/E=E:6=H=&5D($%V97)A9V4@4F5M86EN:6YG($-O;G1R









]


]
M

]
M

]
M
T1N=6UP/C$Q





M;G1R86-T=6%L($QI9F4@*%EE87)S*2`M($5X97)C:7-A8FQE/]T9#X-B`@











]




]
T1T97AT/CQS

]
T1T97AT/CQS

]
T1T97AT/CQS

]
T1T97AT/CQS

]
T1T97AT/CQS

]






M=&5D($%V97)A9V4@4F5M86EN:6YG($-O;G1R86-T=6%L($QI9F4@*%EE87)S
M*2`M($]U='-T86YD:6YG/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X







]


]


]


]


]


]

@56YD97(@3W!T


]


]


]


]


]


]
T1T97AT/C(X('EE87)S/'-P86X^










M=F%L:6=N/3-$=&]P/B0T
XP,!;365M8F5R73PO=&0^#0H@(`@(`@(#QT











]


]


]


]




M9&5R($]P=&EO;G











]
T1R;SX-B`@(`@


]
T1T97AT


T1T



]


]


]





I/]T9#X-B`@(`@(`@/'1D(&-L87-S







]






]


]


]












]













]


]


]


]


]



]





]


]


]


]
T1T

]
T1T

]
T1N
M=6UP/B0@

I/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#X\





M+#`P

]
T1T


M




]


]


]


]
T1R

M













]


]


]


]


]

]
M






M1&YU;7`^
BPU




M=F%L:6=N/3-$=&]P/E=E:6=H=&5D($%V97)A9V4@4F5M86EN:6YG($-O;G1R

]


]


]


]


]


]
T1N=6UP/B0@-BXR






]


]


]

]
T1T

]
T1T

]
T1T












#`@6TUE;6)E

]


]


]


]
















]
T1T97AT/CQS

]
T1T97AT/CQS

]
T1T97AT/CQS

]
T1T97AT

]
T1T97AT

]


]


]


]
T1T97AT/C(T


]




]


]


]


]


]


]


C0R('EE87)S


















]
T1R;SX-B`@(`@




















]


]


]

]


]

]


]


]

3
X+#8W


]





]


]


]



]

]


]


]


]


]


]



]


]


]


]




M=6T@*&EN(&AU;F1R961T:'
I/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$








]


]


M=6UP=&EO;G












]


]


]







]


]


]




]






















]


]


]


]


]
T1N=6UP/C
L-S4P/'-P

2PR


]


]


]


]






]
T1R93X-B`@(`@


M(&-L87-S/3-$=&5X=#Y*86X@
C


]
T1R:#X-B`@(`@
















]


]


]


]



T1T;W`^0V]M;6]N('-T;V-K(&ES









]


]
T1T

]
T1T

]
T1T

]
T1N
M=6UP/B0@












]
T1R





@


]




M:G


M9#TS1$E$





]


]
T1T:#Y$96
N(#

S$L(#(P
3(\


]


]
T1N=6UP/C(L-#`V+#(X


]
T1R

I/]T9#X-B`@(`@(`@/'1D(&-L

BPT



]

]


]
T1N=6T^*#0Y





I/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$





I/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$







I/]T9#X-B`@(`@(`@/'1D

R





]


]


]

S






]


]



]






]


]
T1N=6UP/B0@
M





]








]












I/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$;G5M





]
T1N=6UP/C0L
C8R+#0S-CQS

]
M

]





T1T;W`^26UP

]




]





2PX
34L
#



]


]


]



]
T1N=6UP/B0@-BXV


]



]


]
T1R





]









M;CX\+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XU('EE













]


]


M



]


]
M


]





I/]T9#X-B`@




]
T1N=6UP/C@P
2PP
3
\


]





]


]


]


M




]




]
T1R93X-B`@(`@







]
T1N=6UP/B0@-2XR


]







]


]



]



]
T1T97AT/C(@

@


M(`@(`@/'1D(&-L87-S/3-$=&5X=#XS('EE87)S(#8@;6]N=&AS/'-P86X^



@


]


M-3



^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\




M/D5154E462!!3D0@4TA!4D4M0D%3140@0T]-4$5.4T%424].+!705)204Y4
M4R!/55135$%.1$E.1R!!3D0@15A%4D-)4T%3$4@*$1E=&%I;'






#
L





M(`@/'1D(&-L87-S/3-$9FX^/]T9#X-B`@(`@(#PO='(^#0H@(`@(`\

]


]

]


]
M

]





M(`@/'1D(&-L87-S/3-$9FX^/]T9#X-B`@(`@(#PO='(^#0H@(`@(`\

]

]



M('P@)#4N


]

]

]




]





]




]
T1N=6UP/C0L
#`V+#8W



M




]


]


]





BPX


MB`@(`@(`@/'1D(&-L87-S/3-$9FX^/]T9#X-B`@(`@(#PO='(^#0H@

]






]



]

]



]

I/]T9#X-B`@(`@(`@/'1D(&-L

M/3-$=&]P/E=E:6=H=&5D($%V97)A9V4@4F5M86EN:6YG($-O;G1R86-T=6%L
M($QI9F4@*%EE87)S*2`M($]U='-T86YD:6YG/]T9#X-B`@(`@(`@/'1D


M+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$9FX^/]T9#X-B`@




M+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$9FX^/]T9#X-B`@



]


]






]


T1T;W`^



]
T1F;CX\+W1D/@T*


]



]




]

I/]T9#X-B`@(`@(`@/'1D(&-L87-S

BPP


M/E=E:6=H=&5D($%V97)A9V4@4F5M86EN:6YG($-O;G1R86-T=6%L($QI9F4@
M*%EE87)S*2`M($]U='-T86YD:6YG/]T9#X-B`@(`@(`@/'1D(&-L87-S









]

]

]









@+2!/=71S=&%N9&EN

]
T1R93X-


MB`@(`@(`@/'1D(&-L87-S/3-$9FX^/]T9#X-B`@(`@(#PO='(^#0H@

]

I/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$;G5M


T1T;W`^5V5I9VAT

]
T1N
M=6UP/B0@




M(`@/'1D(&-L87-S/3-$9FX^/]T9#X-B`@(`@(#PO='(^#0H@(`@(`\

]

]







]

]


]







M=7`^6S%=/]S=7`^/]T9#X-B`@(`@(#PO='(^#0H@(`@(`\='(@8VQA

]


]








]




N/]T9#X-B`@
M(`@(#PO='(^#0H@(`@/]T86)L93X-B`@/]B;V1Y/@T*/]H=&UL/@T*

E]B-C5D7S@S
M






]

T1)1#!%



#$T/&)R/E531`H)D\8G(^
M/]T:#X-B`@(`@(`@/'1H(&-L87-S/3-$=&@^1&5C+B`S
2P@
C`Q
SQB

M8RX@
S$L(#(P
3$\8G(^0E)


M97)=/&)R/E531`H)D\8G(^/]T:#X-B`@(`@(`@/'1H(&-L87-S/3-$
M=&@^1&5C+B`S
2P@


M8RX@
S$L(#(P
3


]
T1T:#Y$96
N(#
Q

S$L(#(P
30\8G(^3W1H


]
T1T:#Y$96
N(#
Q
M+`R,#$S/&)R/D]T:&5R(%M-96UB97)=/&)R/D)R87II;!396=M96YT(%M-
M96UB97)=/&)R/E531`H)D\8G(^/]T:#X-B`@(`@(`@/'1H(&-L87-S
M/3-$=&@^1&5C+B`S
2P@



]
T1T:#Y$96
N(#
Q

S$L(#(P
30\8G(^5V]R


S$L(#(P
30\8G(^5V]R:VEN9R!#87!I=&%L

S$L(#(P
30\8G(^5V]R:VEN9R!#87!I



S$L(#(P
30\8G(^5V]R:VEN9R!#


S$L(#(P
3$\8G(^0V%P:71A

M1'1H/D1E8RX@
S$L(#(P
FEL(%-E9VUE;G0@6TUE;6)E<ET\8G(^55-$(@D

M


2P@
C`Q



M(`@(`@/'1H(&-L87-S/3-$=&@^1&5C+B`S
2P@




M8G(^/]T:#X-B`@(`@(`@/'1H(&-L87-S/3-$=&@^1&5C+B`S
2P@
C`Q



M4')O9W)A;7


]
T1T:#Y$
M96
N(#






]
T1T:#Y-87(N(#






]


]
T1N=6UP/B0@
38L
#DV+#`P

]




]
T1N=6UP/B0@




]
T1N=6UP/B0@
2PY.#@L

#`\

M(#
L
C$S+#`P


]


]



#QS


S4Q+#`P


#`P/'-P

]






]
T1N=6UP
M/C$P+#DQ.2PP







































































]


]
T1N=6UP/C4P+#`P


]
T1N=6UP/C0L-S4X+#`P


]


]


]


]


]


]


]


]


]


]


]


]


]



T1T;W`^
C`Q
































]


]


]


]


]


]


]


]


]


]


]


]


]


]


]
T1P;!V86QI9VX],T1T;W`^,C`Q.#PO=&0^#0H@(`@



]





































]



]

]
T1N=6UP/C(L


]
M


]





]
T1T

]
T1T

]
T1T

]
T1T

]
T1T

]
T1T

]
T1T

]
T1T

]
T1T

]
T1T

]
T1T

]
T1T

]
T1T

]
T1T

]

]
T1N=6T^







]


]


]


]


]


]


]


]


]


]


]


]


]



]
T1N=6UP/C$V+#`Y-BPP









#`L



























#`L

BPT
#`L

M=&5R97-T(')A=&4@*&EN(&AU;F1R961T:'
I/]T9#X-B`@(`@(`@/'1D
















BXU










]
T1N
M=6UP/C@N







]
T1N=6UP/C4N


]
M

















Q+`T*




Q+`T*0DR,#$V/'-P86X^/]S







M('5P('1O(&9A8V4@=F%L=64@*&EN(&AU;F1R961T:'

BXW






]

















M:6=N/3-$=&]P/D%M;W5N=!B;W)R;W=E9#PO=&0^#0H@(`@(`@(#QT9!C

































2PW
#`L



M(&AU;F1R961T:'
I/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#X\













M























]


]


]


]


]


]


]
T1N=6UP/C$P






















]


]


]


]


]


]


]


]


]


]


]


]


]










M
E\V-#9F7S0S83)?8C8U9%\X

M;G1E;G0]


M




3XQ
B!-;VYT:'
@16YD960\+W1H/@T*

M=&@^1&5C+B`S
2P@
C`Q

]



]


]


V$R7V(V-61?
M.#

T#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T
Z+V(Y
M9#8T9#0R7S8T-F9?-#-A
E]B-C5D7S@S

'0O:'1M



]


M
CXQ
B!-;VYT:'

2P@


#$S/&)R










]
T1N=6UP/C0P
RPP



@86YD('=A

C4L
#`P

M
2PQ.3DL





]

M9#X-B`@(`@(`@/'1D(&-L87-S/3-$;G5M/B@X,PP

S(L
#`P




]

3$V+#`P
M

M86QI9VX]






T1T


]
T1N=6T^*#4S+#DT-RPP



]
T1N=6T^*#(R-2PP




]



M;3XH
C@L




]
T1N=6T^*#$L-34U+#`P

]
T1R;SX-




X
2PP



C@U+#`P


]
T1N=6UP/C@X
RPP



@+79A;'5A

M87-S/3-$;G5M/B@X.#
L



]










M


]




T1T;W`^0VAA;F=E(&EN





]

]
T1N=6UP/C(L-3`P+#`P



T1T;W`^




]
T1R93X-






]




]


]


T1T;W`^

;W-S(&)E9F]R92!I;F-O;64@=&%X97



#0L
#`P

M=F%L:6=N/3-$=&]P/D1O;65S=&EC/]T9#X-B`@(`@(`@/'1D(&-L87-S
M/3-$;G5M/B@Q-RPT






M-RPY
S$L





]


]


]
T1N=6UP/C





]



]


M(`@(`@/'1D(&-L87-S/3-$;G5M/B@V+#0X-RPP





C`V+#`P


T1T;W`^




M96YT('1O(&EN=&%N9VEB;&4@9&5F97)R960@8F%L86YC97




]





T1T;W`^17AP:7)A=&EO;B!O9B!5+E


T1T;W`^3F]N=&%X86)L92!F86ER('9A;'5E(&%D:G5S=&UE


]
T1N=6UP/C
L

M+#`P


]

\+W1D


T1T;W`^



]


M;7`^
34L




]




2PS
#0L




]


]





2PS
#`L
#`P*3QS


T1T;W`^

:6YE($ET




]


]
T1P;!V86QI9VX],T1T;W`^1F5D97)A;!;365M8F5R73PO=&0^







L







]



]

]
M
T1N=6UP/C8L
#`P+#`P





]


]


M9VX]







]

]
T1P

]



]

M1&YU;7`^
RPP
#`L



]

]
T1T


M




]
T1N=6UP/C0Q+#@P










M;#X-@T*+2TM+2TM/5].97AT4&%R=%]B.60V-&0T,E\V-#9F7S0S83)?8C8U
M9%\X,S(V9#8X-S5A8S0-D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO
M8CED-C1D-#)?-C0V9E\T
V$R7V(V-61?.#


M='
O4VAE970U-RYH=&UL#0I#;VYT96YT+51R86YS9F5R+45N8V]D:6YG.B!Q


M87-C:6DB#0H-CQH=&UL/@T*(`\:&5A9#X-B`@(`\3454


T1T97AT+VIA=F%S

@0V]M

T0Q(')O=W-P86X]
T0R

@04Y$($-/3E1)3D=%3D-)15
@*$1E=&%I
M;'
I(A54T0@)D\8G(^26X@36EL;&EO;G


@16YD960\+W1H

3XQ($UO;G1H

T0Q

#$T/&)R/CPO=&@^#0H@(`@(`@(#QT

]
T1T:#Y*86XN(#
Q+`R,#$R/&)R/CPO=&@^#0H@(`@

S$L(#(P
30\8G(^/]T:#X-B`@
M(`@(`@/'1H(&-L87-S/3-$=&@^2G5L+B`S
2P@
C`Q



]









]

]
M

]
M

]
M


M9VX]
T1T;W`^






M/3-$=&]P/C(P

]
T1T97AT

]
T1T97AT

]
T1T97AT

]



]
T1R

]
T1N=6UP/C`N


]


]





96%S92!E
















]


]


]


T1T;W`^2G5D9VUE;G0@06UO=6YT/]T9#X-B`@





M;VYT:6YG96YC:65S(%M




]


]



]
T1P;!V86QI9VX],T1T;W`^4V5T=&5L;65N=!R


]


]


]

]
M














]
T1R;SX-B`@(`@


]

]
M


]


]

M86QI9VX]
T1T;W`^1&EA8F-O($QI9F4@4V-I96YC97
L($Q
0R!;365M8F5R








]


]


]



















]


]


]


]











M-&0T
E\V-#9F7S0S83)?8C8U9%\X






M;W0@4F5M;W9E(%1H:7


M86X]
T0Q(')O=W-P86X]


2!-;VYT:'
@

M
CXQ
B!-;VYT:'





#$T

]
T1T:#Y$96
N(#
Q

M
S$L(#(P
30\8G(^/]T:#X-B`@(`@(`@/'1H(&-L87-S/3-$=&@^1&5C
M+B`S
2P@
C`Q

C`Q

#$R/&)R/CPO=&@^#0H@(`@(`\+W1R/@T*(`@(`@











]
M

]
M




]
T1N=6UP/C$L-#$W+#4P









]


]


]


]

M86QI9VX]

M(%M

BPP
#`L
#`P


















]


]


]


]


]



]



]


]

























]
M

I














]
M

]
M

]


]


]









]


]


]


]


]



]














]


]


M


#`L
















]



]


]


]


]





]


]





]


]


]


]


]



]









]
M

]
M

]
M

]
M


M9VX]















]


]


]
T1N=6UP/C$P+#`P
#QS

]
T1T97AT/CQS


T1T;W`^

M('P@17AP:7)A=&EO;G



]


]


]


]


]



]


]


]


]
T1N=6UP/C



]


]







]
T1R93X-B`@(`@


]


]


]


]


]


]

C`Q-R!;365M8F5R73PO=&0^#0H@
























]

]


]


]


]


]


]








M;7`^


]


]
T1P;!V
M86QI9VX],T1T;W`^36%R:R!-8TMN:6=H=!;365M8F5R72!\($@@86YD($X@

]


]


]


]



T1T;W`^/'-T

:6YE($ET96US73PO







#`L













]
M

]
M

]
M

]
M

]
M

]













]


]


]


]


]


]
T1R;SX-












]






















#`\






]


]


]
T1N=6UP/C4N





]





M871I;VXZ(&9I;&4Z+R\O0SHO8CED-C1D-#)?-C0V9E\T
V$R7V(V-61?.#
R


O4VAE970U.2YH=&UL#0I#;VYT96YT+51R





M;W0@4F5M;W9E(%1H:7


M86X]
T0Q(')O=W-P86X]






]
T1T:#Y$96
N(#

#(L(#(P
30\8G(^/]T:#X-B`@(`@(`@
M/'1H(&-L87-S/3-$=&@^1&5C+B`S
2P@
C`Q



]


]


]

M86QI9VX]

\+W1D





]
T1R93X-B`@(`@



]


]
T1N=6UP/B0@
S4L



]
T1N=6UP/C
Q

]
T1T




]

]
M






]




M/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$;G5M/B@Q
BPS-C8I/'-P86X^



]

]
T1N






]





]
T1N=6T^
M*#
L.3

]
M

]




]

RPQ




]

]



]


T1T;W`^1V]O9'=I;&PL(&5N

]
T1N=6UP/C0L
M-#





BPW


]
M

]


]
T1R;SX-




]






















]



]
T1R;W4^

]











]



2D\



]





]


]

]
T1N


]



#QS


]









]
M


]





]










]
T1N=6UP/C0L


























M4F5V96YU97







]











R


]


]






]




]

]

38L





]


]






]
T1N=6T^*#
P
M


]





]
T1R974^#0H@(`@(`@













]

]
T1P


]
T1T


M





]




]
T1T

]
T1T


M




]



]

]
T1N=6UP



M=&]P/DEN=&%N9VEB;&4@87-S971S+!N970L(&5N9!O9B!P97)I;V0\+W1D








]
M




]
M

]
M


M9VX]

M960@86YD(')E8V]N8VEL:6%T:6]N(&]F('-E9VUE;G0@:6YF;W)M871I;VX@


]


]


]

]
T1N=6UP/C$W+#`Q
CQS

]
T1T


M

]
T1R974^#0H@(`@(`@(#QT

]










]

]
T1P



]




]
T1N=6T^*#0L

]
T1T



M(&-L87-S/3-$;G5M/B@W+#0W




]

M86)L92!T;R!2:6-E0G)A;B!496-H;F]L;V=I97







]
M


]

]
T1P




]
T1N=6UP/C
L


BPY



]

]


]



T1T;W`^1V]O9'=I

]
T1N
M=6UP/C



]

]
T1N=6UP/C@R/'-P







;V-A=&EO;CH@9FEL93HO
M+R]#.B]B.60V-&0T
E\V-#9F7S0S83)?8C8U9%\X
S(V9#8X-S5A8S0O5V]R


M(#Q-151!(&AT='`M97%U:78]

]






CY$96
N(#

T0R/D1E8RX@
S$L(#(P
3



]



]


M9VX]

@97AC

]


]

]

@



]

]
T1N=6UP/C4L
3`P
M+#`P

]





M/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$9FX^/]T9#X-B`@(`@(`@





]
T1F;CX\


]




]

]
M

]

@;65A



]

]
T1N=6T^*#DU-2PP
#`I


]
T1F;CX\+W1D/@T*


]


M(`@/'1D(&-L87-S/3-$9FX^/]T9#X-B`@(`@(#PO='(^#0H@(`@(`\

]






]
















T1T;W`^3&5V96P@
2!;365M8F5R72!\($YO

]


]



M




T1T;W`^3&5V96P@
B!;365M8F5R72!\(%)E


]



]


T1T;W`^
M5&]T86P@;&EA8FEL:71I97


]

]
T1R:#X-


]

]
T1F

]





]


]

]
T1R:#X-


]

]
T1F;CX\


]





MB`@(`@(`@/'1D(&-L87-S/3-$9FX^/]T9#X-B`@(`@(#PO='(^#0H@

]

]
T1N=6T^*#DU-2PP
#`I/'-P86X^


]
T1F;CX\+W1D/@T*(`@(`@


]








]


]

]



]
T1F;CX\+W1D/@T*


]




]
M

]


]

]
T1F


]








3`W+C`P)3QS


T1T;W`^1&5R:79A=&EV92!W87)R


]
T1F

]
T1F;CX\+W1D/@T*(`@(`@


]


]

]
T1T97AT/CQS



M97-T(')A=&4@*&EN(&AU;F1R961T:'
I/]T9#X-B`@(`@(`@/'1D(&-L

]
T1N=6UP
M/C`N





M=64@87-S=6UP=&EO;G




]
T1N=6UP/C$N



]




]


M+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$9FX^/]T9#X-B`@

M(`@(`@/'1D(&-L87-S/3-$9FX^/]T9#X-B`@(`@(#PO='(^#0H@(`@





]

]
M


]


]

]

M:'D@;V8@:71E;7


]

]
M

]
M





]
M

]


]



]
M

M(%M-96UB97)=('P@4F5C=7)R:6YG(%M-96UB97)=/]T9#X-B`@(`@(`@

M/'1D(&-L87-S/3-$9FX^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X









]


M

2PV
M.#4L

T1T;W`^55-!('-E9VUE;G0@;6%C:&EN97)Y(&%N

M
T1T;W`^6S)=/]T9#X-B`@(`@(`@/'1D(&-O;'-P86X]
T0T('9A;&EG








;V-A=&EO;CH@9FEL93HO+R]#
M.B]B.60V-&0T
E\V-#9F7S0S83)?8C8U9%\X
S(V9#8X-S5A8S0O5V]R:W-H


M151!(&AT='`M97%U:78]

]




3(@36]N=&AS($5N9&5D/]T:#X-B`@

M(&-O;'-P86X]
T0R/D1E8RX@
S$L(#(P
30\8G(^/]T:#X-B`@(`@(`@

2P@
C`Q



]




]


MB`@(`@(`@/'1D(&-L87-S/3-$9FX^/]T9#X-B`@(`@(#PO='(^#0H@

]


]
T1N
M=6T^*#$L
#



\+W1D/@T*

]


]

]

]

MB`@(`@(`@/'1D(&-L87-S/3-$9FX^/]T9#X-B`@(`@(#PO='(^#0H@

]


]

;W-S97
I


]

]
T1R:#X-


]

]
T1F;CX\


]




]



]


M9VX]

@

]
T1F;CX\

]
T1F


]




]




]






]


]
T1N=6T^*#$L-C@U*3QS



M;&EZ960@1V%I;G

@4W1I;&P@2&5L





M86QI9VX]




M+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$9FX^/]T9#X-B`@


@;V8@0F5G

]
T1F

]
T1F;CX\+W1D/@T*


]


]


]



]

MB`@(`@(`@/'1D(&-L87-S/3-$9FX^/]T9#X-B`@(`@(#PO='(^#0H@

]




M:7(@5F%L=64L(&%T($5N9!O9B!097)I;V0\+W1D/@T*(`@(`@(`\=&0@

]
T1N=6UP/B0@

]
T1N=6UP
M/B0@






T1T;W`^6S)=/]T9#X-B`@(`@
M(`@/'1D(&-O;'-P86X]





M='





]
T1I;FYE

M=&AE($UO9&EF:6-A=&EO;B!A;F0@)#`N



E]B-C5D7S@S
C9D-C@W-6%C-`T*




M8F]O:RYH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T
#$N:'1M;(O
M/@T*(#QO.D9I;&4@2%)E9CTS1)3:&5E=#`R+FAT;6PB+SX-B`\;SI&:6QE
M($A2968],T0B4VAE970P,RYH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H
M965T,#0N:'1M;(O/@T*(#QO.D9I;&4@2%)E9CTS1)3:&5E=#`U+FAT;6PB
M+SX-B`\;SI&:6QE($A2968]
T0B4VAE970P-BYH=&UL(B\^#0H@/&\Z1FEL
M92!(4F5F/3-$(E-H965T

M:&5E=#`X+FAT;6PB+SX-B`\;SI&:6QE($A2968],T0B4VAE970P.2YH=&UL
M(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,3`N:'1M;(O/@T*(#QO.D9I
M;&4@2%)E9CTS1)3:&5E=#$Q+FAT;6PB+SX-B`\;SI&:6QE($A2968]
T0B
M4VAE970Q
BYH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T
3
N:'1M
M;(O/@T*(#QO.D9I;&4@2%)E9CTS1)3:&5E=#$T+FAT;6PB+SX-B`\;SI&
M:6QE($A2968],T0B4VAE970Q-2YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$
M(E-H965T,38N:'1M;(O/@T*(#QO.D9I;&4@2%)E9CTS1)3:&5E=#$W+FAT
M;6PB+SX-B`\;SI&:6QE($A2968]
T0B4VAE970Q.YH=&UL(B\^#0H@/&\Z
M1FEL92!(4F5F/3-$(E-H965T,3DN:'1M;(O/@T*(#QO.D9I;&4@2%)E9CTS
M1)3:&5E=#(P+FAT;6PB+SX-B`\;SI&:6QE($A2968]
T0B4VAE970R
2YH
M=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T
C(N:'1M;(O/@T*(#QO
M.D9I;&4@2%)E9CTS1)3:&5E=#(S+FAT;6PB+SX-B`\;SI&:6QE($A2968]
M,T0B4VAE970R-YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T
C4N
M:'1M;(O/@T*(#QO.D9I;&4@2%)E9CTS1)3:&5E=#(V+FAT;6PB+SX-B`\
M;SI&:6QE($A2968],T0B4VAE970R-RYH=&UL(B\^#0H@/&\Z1FEL92!(4F5F
M/3-$(E-H965T,C@N:'1M;(O/@T*(#QO.D9I;&4@2%)E9CTS1)3:&5E=#(Y
M+FAT;6PB+SX-B`\;SI&:6QE($A2968]
T0B4VAE970S
YH=&UL(B\^#0H@
M/&\Z1FEL92!(4F5F/3-$(E-H965T,S$N:'1M;(O/@T*(#QO.D9I;&4@2%)E
M9CTS1)3:&5E=#,R+FAT;6PB+SX-B`\;SI&:6QE($A2968]
T0B4VAE970S
M
RYH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T
S0N:'1M;(O/@T*
M(#QO.D9I;&4@2%)E9CTS1)3:&5E=#

T0B4VAE970S.2YH=&UL(B\^#0H@/&\Z1FEL92!(
M4F5F/3-$(E-H965T-#`N:'1M;(O/@T*(#QO.D9I;&4@2%)E9CTS1)3:&5E
M=#0Q+FAT;6PB+SX-B`\;SI&:6QE($A2968],T0B4VAE970T,BYH=&UL(B\^
M#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T-#,N:'1M;(O/@T*(#QO.D9I;&4@
M2%)E9CTS1)3:&5E=#0T+FAT;6PB+SX-B`\;SI&:6QE($A2968]
T0B4VAE
M970T-2YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T-#8N:'1M;(O
M/@T*(#QO.D9I;&4@2%)E9CTS1)3:&5E=#0W+FAT;6PB+SX-B`\;SI&:6QE
M($A2968],T0B4VAE970T.YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H
M965T-#DN:'1M;(O/@T*(#QO.D9I;&4@2%)E9CTS1)3:&5E=#4P+FAT;6PB
M+SX-B`\;SI&:6QE($A2968],T0B4VAE970U,2YH=&UL(B\^#0H@/&\Z1FEL
M92!(4F5F/3-$(E-H965T-3(N:'1M;(O/@T*(#QO.D9I;&4@2%)E9CTS1)3
M:&5E=#4S+FAT;6PB+SX-B`\;SI&:6QE($A2968]
T0B4VAE970U-YH=&UL
M(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T-34N:'1M;(O/@T*(#QO.D9I
M;&4@2%)E9CTS1)3:&5E=#4V+FAT;6PB+SX-B`\;SI&:6QE($A2968]
T0B
M4VAE970U-RYH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T-3@N:'1M
M;(O/@T*(#QO.D9I;&4@2%)E9CTS1)3:&5E=#4Y+FAT;6PB+SX-B`\;SI&
M:6QE($A2968],T0B4VAE970V,YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$

F9#8T9#0R7S8T-F9?-#-A
E]B-C5D7S@S

 'defref_us-gaap_InventoryDisclosureAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_InventoryWorkInProcessNetOfReserves'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_InventoryRawMaterialsNetOfReserves'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_InventorySuppliesNetOfReserves'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_InventoryNet'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_InventoryDisclosureAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock'
<div style=font-family: 'Times New Roman'
 Times

 Times
<table align=center border=0 cellpadding=0 cellspacing=0 style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_NoncontrollingInterestAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock'
<div style=font-family: 'Times New Roman'
 Times
<table align=center border=0 cellpadding=0 cellspacing=0 style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_RedeemableNoncontrollingInterestTableTextBlock'
<div style=font-family: 'Times New Roman'
 Times

 Times
<table align=center border=0 cellpadding=0 cellspacing=0 style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ComponentsOfDeferredTaxAssetsAndLiabilitiesDomesticAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_DeferredTaxAssetsTaxDeferredExpenseGainOnSaleOfMembershipInterest'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_DeferredTaxAssetsCapitalizedExpenses'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_DeferredTaxAssetsConvertibleDebt'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DeferredTaxAssetsOther'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DeferredTaxAssetsGross'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DeferredTaxAssetsValuationAllowance'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_DeferredTaxLiabilitiesUnitedStatesNet'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ComponentsOfDeferredTaxAssetsAndLiabilitiesForeignAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_DeferredTaxAssetsOtherForeign'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_DeferredTaxLiabilitiesNetForeign'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DeferredTaxAssetsValuationAllowanceCurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_DeferredTaxLiabilitiesBrazilNet'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DeferredTaxLiabilities'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNetCurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNetNoncurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ChangeInNetOperatingLossAndOtherDeferredChanges'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ImpactOfAdjustmentsToCapitalizedExpensesAndStockOptionCompensation'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_IncomeTaxReconciliationAdjustmentToFixedAssetDeferredBalances'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OperatingLossCarryforwardsLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DeferredTaxLiabilities'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_IncreaseDecreaseResultingFromAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_IncomeTaxReconciliationAdjustmentToIntangibleDeferredBalances'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_IncomeTaxReconciliationAdjustmentToFixedAssetDeferredBalances'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_IncomeTaxReconciliationStockOptionDeferredReductionForForfeitedExpiredOrCancelledOptions'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_IncomeTaxReconciliationExpirationOfUSNetOperatingLosses'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_IncomeTaxReconciliationNontaxableFairValueAdjustment'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_IncomeTaxReconciliationNondeductibleExpenseConvertibleDebtIssuanceExpenses'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpense'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_IncomeTaxReconciliationAdjustmentsToBrazilDeferredBalances'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_IncomeTaxReconciliationAdjustmentsToUnitedStatesDeferredBalances'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncomeTaxExpenseBenefit'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_BusinessAcquisitionAxis=ribt_HAndNMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ComponentsOfDeferredTaxAssetsAndLiabilitiesForeignAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DeferredTaxLiabilities'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OperatingLossCarryforwardsLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DeferredTaxLiabilities'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_InternalRevenueServiceIRSMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OperatingLossCarryforwardsLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OperatingLossCarryforwards'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_OperatingLossCarryforwardsExpirationPeriod'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OperatingLossCarryforwardsLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OperatingLossCarryforwards'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_OperatingLossCarryforwardsExpirationPeriod'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_TaxCreditCarryforwardDeferredTaxAsset'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OperatingLossCarryforwardsLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OperatingLossCarryforwards'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_EstablishmentOfValuationAllowanceAmountAgainstBrazilTaxAssets'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncomeTaxAuthorityAxis=ribt_ExpiringNetOperatingLossesMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OperatingLossCarryforwardsLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_TaxCreditCarryforwardDeferredTaxAsset'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncomeTaxAuthorityAxis=ribt_OtherDeferredItemsMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OperatingLossCarryforwardsLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_TaxCreditCarryforwardDeferredTaxAsset'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentGross'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentNet'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentGross'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentGross'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ManufacturingFacilityMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentGross'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ManufacturingFacilityMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ManufacturingFacilityMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=ribt_ComputerAndSoftwareMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentGross'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=ribt_ComputerAndSoftwareMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=ribt_ComputerAndSoftwareMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentGross'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentGross'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentGross'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock'
<div style=font-family: 'Times New Roman'
 Times

 Times
<table align=center border=0 cellpadding=0 cellspacing=0 style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock'
<div style=font-family: 'Times New Roman'
 Times

 Times
<table align=center border=0 cellpadding=0 cellspacing=0 style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ScheduleOfGoodwillTextBlock'
<div style=font-family: 'Times New Roman'
 Times

 Times

 Times
<table align=center border=0 cellpadding=0 cellspacing=0 style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ReorganizationsAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ReorganizationUnderChapter11OfUSBankruptcyCodeDisclosureTextBlock'
<div style=font-family: 'Times New Roman'
 Times

 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times

 Times
W<font style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times

 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times

 Times
RiBalance, a complete rice bran nutritional package derived from further processing of SRB; RiSolubles, a highly nutritious, carbohydrate and lipid rich fraction of RiBalance; RiFiber, a fiber rich insoluable derivative of RiBalance, and ProRyza, rice bran protein-based products, and a variety of other valuable derivatives extracted from these core products.&#160; <font style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times

 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times

 Times
RiBalance, a complete rice bran nutritional package derived from further processing of SRB; RiSolubles, a highly nutritious, carbohydrate and lipid rich fraction of RiBalance; RiFiber, a fiber rich insoluable derivative of RiBalance, and ProRyza, rice bran protein-based products, and a variety of other valuable derivatives extracted from these core products.<font style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock'
<div style=font-family: 'Times New Roman'
 Times

 Times

 Times
<table cellpadding=0 cellspacing=0 style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock'
<div style=font-family: 'Times New Roman'
 Times

 Times
<table align=center border=0 cellpadding=0 cellspacing=0 style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock'
<div style=font-family: 'Times New Roman'
 Times

 Times

 Times
<table align=center border=0 cellpadding=0 cellspacing=0 style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock'
<div style=font-family: 'Times New Roman'
 Times
<table align=center border=0 cellpadding=0 cellspacing=0 style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock'
<div style=font-family: 'Times New Roman'
 Times

 Times
<table border=0 cellpadding=0 cellspacing=0 style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock'
<div style=font-family: 'Times New Roman'
 Times

 Times

 Times
<table cellpadding=0 cellspacing=0 style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ScheduleOfShareBasedCompensationWarrantsByExercisePriceRangeTableTextBlock'
<div style=font-family: 'Times New Roman'
 Times

 Times
<table border=0 cellpadding=0 cellspacing=0 style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<table cellpadding=0 cellspacing=0 class=DSPFListTable style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<td style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<td style=font-size: 10pt; font-family: 'Times New Roman'
 Times

 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashHoldbackForContingencies'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedConvertibleNotesPayable'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_BusinessCombinationConsiderationTransferred1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssetsNoncurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_Goodwill'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_Revenues'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_BusinessAcquisitionAxis=ribt_HAndNMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_BusinessAcquisitionLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_BusinessAcquisitionOutstandingSharesPurchased'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_AmountPayableThroughPromissoryNote'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_BusinessCombinationContingentConsiderationAsset'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_BusinessCombinationAcquiredReceivablesFairValue'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_Revenues'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CashAcquiredFromAcquisition'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_BusinessAcquisitionAxis=ribt_HAndNMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_BusinessAcquisitionAxis=ribt_HAndNMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ShareBasedCompensationSharesAuthorizedUnderStockWarrantPlansExercisePriceRangeAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ShareBasedCompensationSharesAuthorizedUnderStockWarrantPlansExercisePriceRangeNumberOfOutstandingWarrants'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ShareBasedCompensationSharesAuthorizedUnderStockWarrantPlansExercisePriceRangeOutstandingWarrantsWeightedAverageRemainingContractualTerm'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ShareBasedCompensationSharesAuthorizedUnderStockWarrantPlansExercisePriceRangeOutstandingWarrantsWeightedAverageExercisePrice'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ShareBasedCompensationSharesAuthorizedUnderStockWarrantPlansExercisePriceRangeNumberOfExercisableWarrants'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ShareBasedCompensationSharesAuthorizedUnderStockWarrantPlansExercisePriceRangeExercisableWarrantsWeightedAverageExercisePrice'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ShareBasedCompensationSharesAuthorizedUnderStockWarrantPlansExercisePriceRangeExercisableWarrantsWeightedAverageRemainingContractualTerm'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_NumberOfWarrantAgreementsOutstanding'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ClassOfWarrantOrRightAxis=ribt_EquityWarrantMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ShareBasedCompensationSharesAuthorizedUnderStockWarrantPlansExercisePriceRangeAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ShareBasedCompensationSharesAuthorizedUnderStockWarrantPlansExercisePriceRangeLowerRangeLimit'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ShareBasedCompensationSharesAuthorizedUnderStockWarrantPlansExercisePriceRangeUpperRangeLimit'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ShareBasedCompensationSharesAuthorizedUnderStockWarrantPlansExercisePriceRangeNumberOfOutstandingWarrants'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ShareBasedCompensationSharesAuthorizedUnderStockWarrantPlansExercisePriceRangeOutstandingWarrantsWeightedAverageRemainingContractualTerm'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ShareBasedCompensationSharesAuthorizedUnderStockWarrantPlansExercisePriceRangeOutstandingWarrantsWeightedAverageExercisePrice'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ShareBasedCompensationSharesAuthorizedUnderStockWarrantPlansExercisePriceRangeNumberOfExercisableWarrants'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ShareBasedCompensationSharesAuthorizedUnderStockWarrantPlansExercisePriceRangeExercisableWarrantsWeightedAverageExercisePrice'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ShareBasedCompensationSharesAuthorizedUnderStockWarrantPlansExercisePriceRangeExercisableWarrantsWeightedAverageRemainingContractualTerm'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ClassOfWarrantOrRightAxis=ribt_EquityWarrantMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ShareBasedCompensationSharesAuthorizedUnderStockWarrantPlansExercisePriceRangeAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ShareBasedCompensationSharesAuthorizedUnderStockWarrantPlansExercisePriceRangeLowerRangeLimit'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ShareBasedCompensationSharesAuthorizedUnderStockWarrantPlansExercisePriceRangeUpperRangeLimit'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ShareBasedCompensationSharesAuthorizedUnderStockWarrantPlansExercisePriceRangeNumberOfOutstandingWarrants'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ShareBasedCompensationSharesAuthorizedUnderStockWarrantPlansExercisePriceRangeOutstandingWarrantsWeightedAverageRemainingContractualTerm'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ShareBasedCompensationSharesAuthorizedUnderStockWarrantPlansExercisePriceRangeOutstandingWarrantsWeightedAverageExercisePrice'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ShareBasedCompensationSharesAuthorizedUnderStockWarrantPlansExercisePriceRangeNumberOfExercisableWarrants'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ShareBasedCompensationSharesAuthorizedUnderStockWarrantPlansExercisePriceRangeExercisableWarrantsWeightedAverageExercisePrice'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ShareBasedCompensationSharesAuthorizedUnderStockWarrantPlansExercisePriceRangeExercisableWarrantsWeightedAverageRemainingContractualTerm'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ClassOfWarrantOrRightAxis=ribt_EquityWarrantMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ShareBasedCompensationSharesAuthorizedUnderStockWarrantPlansExercisePriceRangeAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ShareBasedCompensationSharesAuthorizedUnderStockWarrantPlansExercisePriceRangeLowerRangeLimit'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ShareBasedCompensationSharesAuthorizedUnderStockWarrantPlansExercisePriceRangeUpperRangeLimit'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ShareBasedCompensationSharesAuthorizedUnderStockWarrantPlansExercisePriceRangeNumberOfOutstandingWarrants'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ShareBasedCompensationSharesAuthorizedUnderStockWarrantPlansExercisePriceRangeOutstandingWarrantsWeightedAverageRemainingContractualTerm'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ShareBasedCompensationSharesAuthorizedUnderStockWarrantPlansExercisePriceRangeOutstandingWarrantsWeightedAverageExercisePrice'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ShareBasedCompensationSharesAuthorizedUnderStockWarrantPlansExercisePriceRangeNumberOfExercisableWarrants'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ShareBasedCompensationSharesAuthorizedUnderStockWarrantPlansExercisePriceRangeExercisableWarrantsWeightedAverageExercisePrice'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ShareBasedCompensationSharesAuthorizedUnderStockWarrantPlansExercisePriceRangeExercisableWarrantsWeightedAverageRemainingContractualTerm'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ClassOfWarrantOrRightAxis=ribt_EquityWarrantMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ShareBasedCompensationSharesAuthorizedUnderStockWarrantPlansExercisePriceRangeAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ShareBasedCompensationSharesAuthorizedUnderStockWarrantPlansExercisePriceRangeUpperRangeLimit'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ShareBasedCompensationSharesAuthorizedUnderStockWarrantPlansExercisePriceRangeNumberOfOutstandingWarrants'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ShareBasedCompensationSharesAuthorizedUnderStockWarrantPlansExercisePriceRangeOutstandingWarrantsWeightedAverageRemainingContractualTerm'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ShareBasedCompensationSharesAuthorizedUnderStockWarrantPlansExercisePriceRangeOutstandingWarrantsWeightedAverageExercisePrice'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ShareBasedCompensationSharesAuthorizedUnderStockWarrantPlansExercisePriceRangeNumberOfExercisableWarrants'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ShareBasedCompensationSharesAuthorizedUnderStockWarrantPlansExercisePriceRangeExercisableWarrantsWeightedAverageExercisePrice'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ShareBasedCompensationSharesAuthorizedUnderStockWarrantPlansExercisePriceRangeExercisableWarrantsWeightedAverageRemainingContractualTerm'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ClassOfWarrantOrRightAxis=ribt_LiabilityWarrantMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ShareBasedCompensationSharesAuthorizedUnderStockWarrantPlansExercisePriceRangeAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ShareBasedCompensationSharesAuthorizedUnderStockWarrantPlansExercisePriceRangeUpperRangeLimit'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ShareBasedCompensationSharesAuthorizedUnderStockWarrantPlansExercisePriceRangeNumberOfOutstandingWarrants'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ShareBasedCompensationSharesAuthorizedUnderStockWarrantPlansExercisePriceRangeOutstandingWarrantsWeightedAverageRemainingContractualTerm'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ShareBasedCompensationSharesAuthorizedUnderStockWarrantPlansExercisePriceRangeOutstandingWarrantsWeightedAverageExercisePrice'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ShareBasedCompensationSharesAuthorizedUnderStockWarrantPlansExercisePriceRangeNumberOfExercisableWarrants'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ShareBasedCompensationSharesAuthorizedUnderStockWarrantPlansExercisePriceRangeExercisableWarrantsWeightedAverageExercisePrice'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ShareBasedCompensationSharesAuthorizedUnderStockWarrantPlansExercisePriceRangeExercisableWarrantsWeightedAverageRemainingContractualTerm'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AssetsCurrentAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AccountsReceivableNetCurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_InventoryNet'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncomeTaxesReceivable'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DeferredTaxAssetsNetCurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OtherAssetsCurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AssetsCurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentNet'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_Goodwill'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OtherAssetsNoncurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_Assets'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_LiabilitiesCurrentAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AccountsPayableCurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AccruedLiabilitiesCurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OtherLiabilitiesCurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_LongTermDebtCurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_LiabilitiesCurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_LongTermDebtNoncurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DerivativeLiabilitiesNoncurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DeferredTaxLiabilitiesNoncurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_Liabilities'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CommitmentsAndContingencies'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_TemporaryEquityAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockholdersEquityAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PreferredStockValue'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CommonStockValue'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_RetainedEarningsAccumulatedDeficit'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockholdersEquity'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_LiabilitiesAndStockholdersEquity'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FiniteLivedIntangibleAssetsGross'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FiniteLivedIntangibleAssetsNet'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_GoodwillRollForward'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_Goodwill'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_Goodwill'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StatementBusinessSegmentsAxis=country_US'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_GoodwillRollForward'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_GoodwillAcquiredDuringPeriod'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StatementBusinessSegmentsAxis=country_BR'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_GoodwillRollForward'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_GoodwillTranslationAdjustments'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FiniteLivedIntangibleAssetsGross'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FiniteLivedIntangibleAssetsNet'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FiniteLivedIntangibleAssetsGross'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FiniteLivedIntangibleAssetsNet'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FiniteLivedIntangibleAssetsGross'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FiniteLivedIntangibleAssetsNet'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerListsMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FiniteLivedIntangibleAssetsGross'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FiniteLivedIntangibleAssetsNet'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerListsMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerListsMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerListsMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FiniteLivedIntangibleAssetsGross'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FiniteLivedIntangibleAssetsNet'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CommonStockSharesOutstanding'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_WarrantsIssuedDuringPeriodValueIssuedForFeesAndServices'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_WarrantsIssuedDuringPeriodSharesIssuedForFeesAndServices'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_SharesIssuableInExchange'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_StockIssuedDuringPeriodValueReverseStockSplits'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_NetIncomeLoss'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CommonStockSharesOutstanding'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_NetIncomeLoss'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_WarrantsIssuedDuringPeriodValueIssuedThroughPrivatePlacement'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_IssuanceOfSharesToFormerWarrantsHoldersAndNoteHolderInShares'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_IssuanceOfSharesToFormerWarrantsHoldersAndNoteHolder'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_WarrantFairValuesTransferredUponIncreaseInAvailableShares'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockholdersEquityOther'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockholdersEquityOtherShares'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CommonStockSharesOutstanding'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SegmentReportingAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_NumberOfReportableSegments'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SegmentReportingInformationProfitLossAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_Revenues'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CostOfGoodsSold'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_GrossProfit'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OtherDepreciationAndAmortization'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AssetImpairmentCharges'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OperatingCostsAndExpenses'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OperatingIncomeLoss'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_NetIncomeLoss'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_InterestExpense'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CostOfGoodsSoldDepreciation'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentAdditions'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SegmentReportingInformationAdditionalInformationAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentNet'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_Goodwill'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_Assets'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SalesRevenueGoodsNet'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SegmentReportingInformationProfitLossAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_Revenues'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CostOfGoodsSold'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_GrossProfit'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OtherDepreciationAndAmortization'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AssetImpairmentCharges'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OperatingCostsAndExpenses'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OperatingIncomeLoss'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_NetIncomeLoss'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_InterestExpense'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CostOfGoodsSoldDepreciation'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentAdditions'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SegmentReportingInformationAdditionalInformationAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentNet'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_Goodwill'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_Assets'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ConsolidationItemsAxis=us-gaap_ReportableGeographicalComponentsMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SalesRevenueGoodsNet'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ConsolidationItemsAxis=us-gaap_ReportableGeographicalComponentsMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SalesRevenueGoodsNet'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ConsolidationItemsAxis=us-gaap_ReportableGeographicalComponentsMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SalesRevenueGoodsNet'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SegmentReportingInformationProfitLossAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_Revenues'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CostOfGoodsSold'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_GrossProfit'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OtherDepreciationAndAmortization'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AssetImpairmentCharges'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OperatingCostsAndExpenses'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OperatingIncomeLoss'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_NetIncomeLoss'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_InterestExpense'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CostOfGoodsSoldDepreciation'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentAdditions'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SegmentReportingInformationAdditionalInformationAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentNet'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_Goodwill'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_Assets'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SegmentReportingInformationProfitLossAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_Revenues'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CostOfGoodsSold'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_GrossProfit'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OtherDepreciationAndAmortization'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AssetImpairmentCharges'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OperatingCostsAndExpenses'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OperatingIncomeLoss'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_NetIncomeLoss'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_InterestExpense'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CostOfGoodsSoldDepreciation'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentAdditions'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SegmentReportingInformationAdditionalInformationAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentNet'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_Goodwill'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_Assets'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SegmentReportingAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock'
<div style=font-family: 'Times New Roman'
 Times

 Times

 Times
<table cellpadding=0 cellspacing=0 style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<table cellpadding=0 cellspacing=0 style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock'
<div style=font-family: 'Times New Roman'
 Times

 Times
<table align=center border=0 cellpadding=0 cellspacing=0 style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_RelatedPartyTransactionsAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock'
<div style=font-family: 'Times New Roman'
 Times

 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times

 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times

 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times

 Times
. John Short, our chief executive officer and director, invested $25 thousand in our subordinated convertible notes and related warrants in January 2012 and an additional $25 thousand in April 2013.&#160; In 2014 and 2013, we paid<font style=font-size: 10pt; font-family: 'Times New Roman'
 Times
 of interest on subordinated notes beneficially owned by Mr. Short.&#160; In June 2013, Mr. Short made an election to be paid in stock, rather than cash, for interest accruing under the notes from February 2013 through June 2014.&#160; In connection with the election, in 2013 we issued to Mr. Short a PIK warrant with 234 underlying shares of common stock, and increased the shares underlying Mr. Short&#8217;s convertible notes by 234 shares as payment for interest accruing under the convertible notes from February 2013 through October 2013.&#160; The terms of the notes beneficially owned by Mr.<font style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times

 Times
connection with the Exchange, warrants beneficially owned <font style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FairValueDisclosuresAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock'
<div style=font-family: 'Times New Roman'
 Times

 Times
<table border=0 cellpadding=0 cellspacing=0 style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<table cellpadding=0 cellspacing=0 class=DSPFListTable style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<td style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<td style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock'
<div style=font-family: 'Times New Roman'
 Times

 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock'
<div style=font-family: 'Times New Roman'
 Times

 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times

 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<table cellpadding=0 cellspacing=0 class=DSPFListTable style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<td style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<td style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<table cellpadding=0 cellspacing=0 class=DSPFListTable style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<td style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<td style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<table cellpadding=0 cellspacing=0 class=DSPFListTable style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<td style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<td style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<table cellpadding=0 cellspacing=0 class=DSPFListTable style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<td style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<td style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<table cellpadding=0 cellspacing=0 class=DSPFListTable style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<td style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<td style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock'
<div style=font-family: 'Times New Roman'
 Times

 Times
<table border=0 cellpadding=0 cellspacing=0 style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times

 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<table cellpadding=0 cellspacing=0 class=DSPFListTable style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<td style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<td style=font-size: 10pt; font-family: 'Times New Roman'
 Times

 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FairValueDisclosuresAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FairValueDisclosuresTextBlock'
<div style=font-family: 'Times New Roman'
 Times

 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<table cellpadding=0 cellspacing=0 class=DSPFListTable style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<td style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<td style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<table cellpadding=0 cellspacing=0 class=DSPFListTable style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<td style=font-size: 10pt; font-family: 'Times New Roman'
 Times

 Times
<td style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<table cellpadding=0 cellspacing=0 class=DSPFListTable style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<td style=font-size: 10pt; font-family: 'Times New Roman'
 Times

 Times
<td style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<table border=0 cellpadding=0 cellspacing=0 style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<table cellpadding=0 cellspacing=0 class=DSPFListTable style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<td style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<td style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<table align=center border=0 cellpadding=0 cellspacing=0 style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times

 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<table cellpadding=0 cellspacing=0 class=DSPFListTable style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<td style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<td style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<table cellpadding=0 cellspacing=0 class=DSPFListTable style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<td style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<td style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<table cellpadding=0 cellspacing=0 class=DSPFListTable style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<td style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<td style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<table cellpadding=0 cellspacing=0 class=DSPFListTable style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<td style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<td style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<table cellpadding=0 cellspacing=0 class=DSPFListTable style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<td style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<td style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<table border=0 cellpadding=0 cellspacing=0 style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times

 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<table cellpadding=0 cellspacing=0 class=DSPFListTable style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<td style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<td style=font-size: 10pt; font-family: 'Times New Roman'
 Times

 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ProfitLoss'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_Depreciation'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AdjustmentForAmortization'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ProvisionForDoubtfulAccounts'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AccretionExpense'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_UnrealizedGainLossOnDerivatives'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_FinancingExpense'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AssetImpairmentCharges'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OtherNoncashIncomeExpense'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncreaseDecreaseInInventories'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncreaseDecreaseInOtherCurrentAssets'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ProceedsFromSaleOfProductiveAssets'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_LicenseCosts'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_RepaymentsOfDebt'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ProceedsFromIssuanceOfDebt'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ProceedsFromIssuanceOfWarrants'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ProceedsFromIssuanceOfCommonStockAndWarrantsNetOfCosts'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ProceedsFromSaleOfInterestInPartnershipUnit'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ProceedsFromSaleOfInterestInCorporateUnit'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SupplementalCashFlowInformationAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_InterestPaid'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncomeTaxesPaid'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AssetsCurrentAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockholdersEquityAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PreferredStockSharesAuthorized'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PreferredStockSharesIssued'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CommonStockNoParValue'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CommonStockSharesAuthorized'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CommonStockSharesIssued'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CommonStockSharesOutstanding'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AssetsCurrentAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AccountsAndOtherReceivablesNetCurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_PropertyPlantAndEquipmentRestrictedNet'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_LiabilitiesCurrentAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OtherLongTermDebtCurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_LiabilitiesNoncurrentAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OtherLongTermDebtNoncurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock'
<div style=font-family: 'Times New Roman'
 Times

 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times

 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times

 Times
 limited liability company agreement for Nutra SA<font style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times

 Times
the holders of our subordinated convertible notes agreed to amend their notes to reduce the interest rate to 5% from 10%, change the maturity of the notes to July 2016 (if there was a different maturity date) and to remove the conversion feature and antidilution protections upon the closing of an equity raise in excess of $7.0 million (Modification).&#160; Concurrently, certain warrant holders agreed to exchange warrants to purchase 496,060 shares of common stock for the future issuance of 1,554,734 shares of our common stock (Exchange).&#160; Most of the warrants impacted (warrants to purchase 441,395 shares) were warrants issued to the note holders when their notes were originally issued and had contained antidilution protections which caused them to be carried at fair value on our balances sheets.&#160; The former warrant holders committed to exchange their warrants, which were cancelled upon our<font style=font-size: 10pt; font-family: 'Times New Roman'
 Times
.&#160; The fair market value of the shares was recorded in common stock in the fourth quarter of 2013.&#160; We issued the shares, as required, after shareholders approved an increase in our authorized shares of common stock<font style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times

 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times

 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times

 Times
<table cellpadding=0 cellspacing=0 style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<table align=center border=0 cellpadding=0 cellspacing=0 style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times

 Times
<table align=center border=0 cellpadding=0 cellspacing=0 style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<table align=center border=0 cellpadding=0 cellspacing=0 style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<table border=0 cellpadding=0 cellspacing=0 style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times

 Times
<table cellpadding=0 cellspacing=0 style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<table border=0 cellpadding=0 cellspacing=0 style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<table cellpadding=0 cellspacing=0 class=DSPFListTable style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<td style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<td style=font-size: 10pt; font-family: 'Times New Roman'
 Times

 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_DocumentAndEntityInformationAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_dei_EntityRegistrantName'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_dei_EntityCentralIndexKey'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_dei_CurrentFiscalYearEndDate'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_dei_EntityWellKnownSeasonedIssuer'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_dei_EntityVoluntaryFilers'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_dei_EntityCurrentReportingStatus'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_dei_EntityFilerCategory'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_dei_EntityPublicFloat'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_dei_EntityCommonStockSharesOutstanding'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_dei_DocumentFiscalYearFocus'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_dei_DocumentFiscalPeriodFocus'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_dei_DocumentType'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_dei_AmendmentFlag'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_dei_DocumentPeriodEndDate'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DebtDisclosureAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DebtDisclosureTextBlock'
<div style=font-family: 'Times New Roman'
 Times

 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<table align=center border=0 cellpadding=0 cellspacing=0 style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times

 Times
<table align=center border=0 cellpadding=0 cellspacing=0 style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times

 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncomeStatementAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SalesRevenueGoodsNet'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CostOfGoodsSold'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_GrossProfit'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OperatingExpensesAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SellingGeneralAndAdministrativeExpense'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DepreciationAndAmortization'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OperatingExpenses'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OperatingIncomeLoss'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_NonoperatingIncomeExpenseAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_InvestmentIncomeInterest'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_InterestExpenseAccretedOnDebtConvertedToEquity'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_InterestExpenseOther'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_UnrealizedGainLossOnDerivatives'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_FinancingExpense'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OtherNonoperatingIncome'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OtherNonoperatingExpense'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_NonoperatingIncomeExpense'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncomeTaxExpenseBenefit'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ProfitLoss'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_NetIncomeLoss'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_EarningsPerShareAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_EarningsPerShareBasic'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_EarningsPerShareDiluted'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_NoncontrollingInterestAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_MinorityInterestDisclosureTextBlock'
<div style=font-family: 'Times New Roman'
 Times

 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<table align=center border=0 cellpadding=0 cellspacing=0 style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<table align=center border=0 cellpadding=0 cellspacing=0 style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times

 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_BusinessCombinationsAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_BusinessCombinationDisclosureTextBlock'
<div style=font-family: 'Times New Roman'
 Times

 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times

 Times
.&#160; <font style=font-size: 10pt; font-family: 'Times New Roman'
 Times
technologies. <font style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<table align=center border=0 cellpadding=0 cellspacing=0 style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SegmentReportingAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SegmentReportingDisclosureTextBlock'
<div style=font-family: 'Times New Roman'
 Times

 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times

 Times
<table cellpadding=0 cellspacing=0 style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<table cellpadding=0 cellspacing=0 style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<table align=center border=0 cellpadding=0 cellspacing=0 style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_EquityMethodInvestmentsDisclosureTextBlock'
<div style=font-family: 'Times New Roman'
 Times

 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times

 Times
 was a wholly owned subsidiary whose only asset was the License acquired in March 2013.&#160; I<font style=font-size: 10pt; font-family: 'Times New Roman'
 Times
we entered into a series of agreements with various affiliates of Wilmar International Limited (collectively Wilmar).&#160; In connection therewith, <font style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock'
<div style=font-family: 'Times New Roman'
 Times

 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<table align=center border=0 cellpadding=0 cellspacing=0 style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ConvertibleDebtAmountOverUnderCarryingValueFairValueDisclosures'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_LiabilitiesFairValueDisclosure'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AssetsFairValueDisclosureAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DebtConversionOriginalDebtAmount1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_LiabilitiesFairValueDisclosure'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AssetsFairValueDisclosureAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentFairValueDisclosure'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_LiabilitiesFairValueDisclosure'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AssetsFairValueDisclosureAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentFairValueDisclosure'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_LiabilitiesFairValueDisclosure'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AssetsFairValueDisclosureAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentFairValueDisclosure'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_LiabilitiesFairValueDisclosure'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AssetsFairValueDisclosureAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentFairValueDisclosure'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DerivativeLiabilities'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FairValueAssumptionsAndMethodologyForAssetsAndLiabilitiesAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FairValueAssumptionsExpectedVolatilityRate'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FairValueAssumptionsAndMethodologyForAssetsAndLiabilitiesAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FairValueAssumptionsRiskFreeInterestRate'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FairValueAssumptionsAndMethodologyForAssetsAndLiabilitiesAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FairValueAssumptionsRiskFreeInterestRate'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FairValueAssumptionsAndMethodologyForAssetsAndLiabilitiesAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FairValueAssumptionsRiskFreeInterestRate'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DerivativeLiabilities'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DerivativeLiabilities'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DerivativeLiabilities'

#$T
3(S
2YX


G4K1%&1Q-T4J(&FW\NGO6@!?DDB)
ME/@`)4S-3LL22PL_-8#P,):__A_OLU,Y950Q[MGT_4L_:)0BS='AO6R\\G


STY/L?=OS]14@%C+^1$_&C^?3%UW_N
//[R]

M8+^&CSI&TH/0K/K#__?I]E&?DIEVNDH/=C^.7HQ3
_B!_Q@\:CAVKZ
.-PV6
M/Q&^8+T2QUUNVR'ZV8O]^@/_#5Y3NZ=M];2K!B_!/+]HVCQ\:Z(YSZP'_P=\

#2#-U)?HO]A*^HRZ\XAI[\

M6004!%M1_H$2]:/#9.6!3!0F83_BO/U\XABSN8FP[Z;4C+Y^02I.`TZ._OF
MC$^4'WA#3#'`S`)-WUS%&/]\HN-S;;6MNG9('GLV?)I8KN$N_._;XTQ?C\Q


M



6[H1/9'/NV


W%Z\

M4'4K

)6MM*E3A)0)XEV6I`'




071WODC/1?;[@JW2X'H=+=Q+/*Q())9=HD
M2%'(+PH?Z+.T!YGMP1JWI#T04`A6M]TO8%!C`Z^0OH+JTCW*@I*OO^FF-R;C
_UK
M6KM


Y!##VV\7UOBNV0A+&9IO
MD6

^K:&/5:=J];

M#B^I:^JR)J6*2=S'S3##?WXT+

T;H`S&9I^=,C7D0(?'H/3OD+P\#$%_A/V%TQ,KWS<95#F;%CA72
MN59DI$3*!,2E9)FHD@*A)

M2:_!)):9

MDB$E0X@5086;9*MPOV'AM39U).*/`O%L9VAETJ4MV+JFD&(BQ40N*Z0-*72+


M4AADFV#L1=


M+R#$4B

MJ


MU

3
L[QL%?YQZ)`1'


M0R7(\2^/VC\0T_
M'1,DTH=_6%HB.R`^:?H4U==Q'\_(D1L&/]A02*[X;@EFD.FMCF^F<VI_<J

MULM'33=
&



MCV/15/[ZY5#T9\
-?7-5:(

56S.*J[&O0:!



%XGCWT?


U''6

6=$A
*KERHDI-=RV0+?+UJ]1JF1$C]









MZLPFS4L-FT

6I9

TN6M-ZY.6OB&*
=Z?=;Z
IY*2$JGLT:3W0E71/*42H)SMQ51



M_M!

M.



M6HF)M'8[N
@%NMUQ:$J_2HTK;Y@<IAP<@AVHU?
O3=TW[RBW




9&TPS'S8`M@S[P`PXDA+*`@(!8$=VXSXD;:D
M3ELB,'ZZFU#C7Z=$`KKUAN7-'T?/PTN\=O:X.MP=Z4?LM?6AD!K4R5-QY3
M`'#];6Y0PWJY(^X]-*^Y\/G6=AQRR(*_;='Y7!N5`!R_L68_[H
@-Q=.JBI

M+;R7&_:$V0:@SPB]H3`GQ&1EW::V.09?5WLUQ@_$65@O?GAE]#*Z1)[#7O\
MRPW4B.%OAP*4:(R14D@9;*&'SVE(S3Q/!^60M$?M3GN0A-M'8IJ$-MSS2)WM





9553=_EH_D
V#VZ$%W!(?HJ[#`
M#/.V:8S9N0!+L\BC
H+


MMLK[^+7^A!F01QE9M\^D$%0$.?$$\0CV`ZL2@N8ZRXW2^?)\I`8OYP`\\'0D







M%Z^$:B^DV3*=(#:)XVNR^`BMXXY`MANT?CXHV6Z:O3XXQ2/7T[7+=F-E5]I(
M:2.E'!VV#93VJ'A[5'O\WIUMT8
[XC^L$+[U*3JLX(
T'KP0%+63<Y!8;AQH!-[KZ%2]PW%E6Z^$XMP&

@)`Y:?2ET6^8
M0I8B(D5$`!$I)[6















M_2X75Z;F.`;TS18)




S5T%QS5[]060(2_!!\'P_=I$Q)1O@WW6WC4




B#6HV
8V9&_J[2-O\LIO\2EJ\&+\+\]Q$4V[SS0X'X-UWZ-HNF)8``&@`(2/


K:!ZHP'4=
M[]&9&G
G6IW]QIR\NPW+-4X%)^(6:8A(X!2LY!OCO6/GVXSNGX$'R#IQ#
80
M=`)_`_&_BT(-TCJ^7'S2_F53MO9C[P6#71IK$';PN?O/^
3M/JS8$4VDO=;X


/8GV4C^##\#0TU(N9MC3Z1VF*W%0

M%+_\CL_Y4!T
FS*16T_S&B^#J:O



S[.:99
M9&FR_OO$=I3KM?OQ'46.V;QIA!X
8E


HS4]R;V'^-&C)7D3V05G!W=

ZK*O3RC2N9S*V;5X7D_@U%./YIC/^]S]`:N_C!)JZT=KNU#2*9K

0!NWG_B6
MGDXHWG!BHP+302P=&MZ:5B:!_*N@`1?-DS%FMLBV^'(XD6=9\L=DRB:XD:V;
MZ(K2&@4U9_!N7)BA1\-GRD37:LX:=BOX::I9O]KV^
TPS=W$_+PW+`UL6TDN


&\

?E+8TPX






M]EDG]E3
;\1N

=!)6?9+E!G\`8FF@Y^%?=*

M\9[_1707
Q:\V?0K*\/!K\@K6G2/_NQ_:[/Y3_]+';1_4G!:D/7%S`N;`NA
M@0GUE1OZA3`(^2;YOC![
!=EL`%F(RCU.W3N:9_Y=4:8

FW*`&)[5
'B
RYY62`N



MF:ZO%?AOYQUU^!-\








C4]UT+7T


M5)O_?
+_/:ET
M
P]4-
N


]5&7HU&/A6S&.KM&+SLK'7+E

Y&G2%DDEI+#
8R_1(?6D\
M#]-X=EOGO:%0@BJ-YW9!#2[AQ0*%#%[+S]6^83=6I1(K#6N%AO6=VNIWQ/)W



T'%46V9H(S5(V4GY@=V-B#$MXL=J[
M7'CYR25T%MX/TM



-;85-COK0K:XWQ-AN.&[H#GOS-+HA-@?#8


MY)58'KL%R*X/PH`[

MO+#)FVJOA-]K]?AOP.0Q00$R+

2/Y(%7IA3
D=0
]AJ:QQ[%A_E\K*I\__/&
MQ!4)62/'!3!&6B93J/CZ;FN7ZF:SFLUUSRXT&RXD9*Z%T2[Z4

.&M'9^FC?\)_;49]#@^N*`LKUL3.U2
M7Z&A&0!T3W`I.E@VC3(UJ$&154YBT%UP=8BI8IM`EJVS3@95396+V%7Z&/





MCJ4X6

MH]?N+Y?PS-.W0*/.5PWD5.V=ESMLP/51BGS8[F)SS3:S=X*]F.9RO*.LHR
MMI6N:AQ4EAGK#M1VHP;5R9)/NMVK;%#%%&W88X)%J.DP&!T#NT6I)Z(.S@=[




(-NV%$C\S.#O^XI!D&^@G3QN!-[F+=`




^V;
?-F02@A



-.7%IPXLZ
M=OS%
Z/&*?;#\-9_1C1_D_+7_OANS\MU]W@WPY_6JZ-Q+\]3_QVM!X9C
:



C^@3

MV


S1UL%GQS9
5I,SL1_),&2(&#!CUA)P?%N*+YL^

-LR4XPS^@E-;5


(0!'/UX&EWVY2NS)45ML\*-+1!K
Q(2[4T
M0'ZKP*VP[97[R8$1::6P/[C!ZN_

?!
M8]Q6Y=Y


M







D6;9



V6
MH;641TVG;#OQM_964'@4X4;0!04)?JF'GL[G6OQG85W_+'WOK?,Y(CO$8'

5&D4G\=$5[C1W:Q+D7






KNX&P:

M^5!7!2Q#-B.CLK6`BG\F%,R)9:#X[OQ4X'?8BKPEH*EB.R)\J1]:RD7*WG!
M/[.@EX3A1\WQUJ1^PDTL6].S$YWU%_SF=(Z$V%\^3*=GJH@U
/JQG=G6WY@
M(3N1#C+JY1APO



NS#[Z(*1';.V]W








M\EBWS[JC#9R/#6QGCOO

M:==!Q\)Z*





M-4)-KXKASE.9ZH0=IIXN8Z7;*?D`18Q=X09HZ(R[PJH(N_CI^Q
%6=0&.
3=
MC*N9JG8:8H==2T94[B6EGYB);28S3=327&?;43JR8]%])KG+1+@CPFYAJJ]S
M?


5[6\3


N]IU[%-J!G7$F+S^)H9:U'%4*

MLV.
#8T:/$V/7PG++WE!17:S7B5LGBZG]^Q1A]*;UC#)

QQO%)#1AJYC9
MQZ^[-L-:7\_$(A

!?

K;\.#^'
MB'7

M1^B1=HL;:6]4RD@_4WMF.(Y-%PSL10Q:S;!C&'6+O69B0+=;&`/N#-V&L7_2





]?TX.]BF/AFC-WIC\IY^_MHQET:
M?AJC26







M41RUTD6YT^JUQ3JBEXN%8\-@M]6I[F:!7)648DXNQJ^:I:
%L:(J!K!$L:FK



E`=$Q[$YKPY:[9%8NWORA.CH0#AJJ8
&QE$*



M2E32HV3UM!MY?OUEL1:+$JJU8



MPC^Y$Z)
MHKU00GA!A(E-644$VW
=5[.0D[PZ@@[T:8:E3`Q+LW0#7''=?B7PV77.$L99

`/MOA+'M2G@(!0:!7`W
-O8Z]G`T;$::?(1N5/0-B]3Y5YW

-5]


SQ3/E@
MFZ9&:Y[R[?-[I<T-W)2^_C;7+(;O6QL^B#[1H.M`PFR#2;RAKZ`L)H*J^\1

RY_$9
'B7@2UW_R1#<.1)9&F@QE#!RI&(K?[*?:^#].Y3'?@KS@)
/VD`5W@+JF!*X@E$9PMN\8)H!JFL:`9#T=E0XE
%#BY'&P5E`NMA


L5-S@2GA6H)W9'ES@
M):`W$BU4)F2


BB/E








Q&]



MN;Q1?'F\R(C?O2;JRV-Y`WUTF4U.W





-DG#.@*R
KH!ZGGE?$P
UC7//$L



=G1B$G
*0O*YHK]ZQA`8!=


M@`;X^\';[%WP4\(W=XI'.#U?=?*R=B?&&+L9QC@X[W;V'22L#V#!Q]P7?NUS





K]
]WX;E;?V*.?@L$.P-!EN\ZST'C^=[/#G3A6G:
M;[ACVE*N






*_IRWY[
M35^*/OI^<:/O%##ZX,%%_,N/8:&&B$IPNN(6,&0(QMGL=(MY1/1
&2__@#
M)LABF:WAV\)9IWJYF-GRL7)

T@%'.G+5A'/.@K^.W&FGNNPW[H

MN&1VJF;56)MGG

'9.BXQ9J
M0


M2\4__;HT;T$RE*!0@N4AH.

S`&`R7BHO



4W=GL_JF\(


M8LSF8!)8&XX#/M

M-F`
]R$
57$E%]X
M8C(=0X.!17OY\3X)N_(1$A7&2.&AD$)X24S[C?$('`X;/'B3'\\Z845/P75
MF&.$`(IQ+JR#RS1FQ+Z=JB]RD?9KM_.2B=^V?J?3]HGBDY
TR_0'O[M@/0$
M?Q?#)K]*_*C]?63PH[+M[GA+=?G!($=Y^0Z6EY]I]
6P3K'6.'2+!+.9PFI]
BQ6X45K*G!

;U4C(8J




MZY`RIYC0!HC_3CT_ZP_89=_O.H.S45LI[7Z@]&5R^3*%GRQTVFJK?RY6`*3T



M7#



M8:G0R87K=_



M'*2!AEM@/;`7OZC2
['(Q$@0C]G

MR78U

ER3W$]N
M+%;OS-/
*RWR%U5YB2VQ8IH/@:R^4L.K3/92




'#K^_*D_#'.F49!5
M:
72_)*KM\;










MU







M.9@N](T:!M#=[FQ)JR.*S#;




MOV3$??9CN%H8S%
H6

S18E+GQ-
MW$2.%)NWHHA%7(EPEK(E94O*EI0M*5N-EZWNJ-A\\E*ZI'1)Z9+2):5+2E?I

DUY0UM!\F




+2\G%AA\DZ9MI^M2P


N+TR_F@WR8_0*RSQI

J:T3
G9XCE5'

MK
&3-IK!B/V
:C.-?B4L+?F8I=



M4&`KC6@R%RWE!HC`'(].


I)`+T.MF'_\
!6Y_[6H6JS(L`V;'?4PT/;`5G+&I79SM9R='YX
MD!(?*65IHFT:9+4BK-#3[6R:;]ZNV-K#26'3[_ZIW#(F.DW1&1UU5(R+O9$_



MGVUW2BB6;B?&*Z^0RBX]!(_

4

+.
='5&



MTQ8A+7


=?GHT*



V[7[9IVF\




MBHNY9T
B0C1$=0B)*6$-&5B)(\!'Q9+N:V3`\[%83)-6Q*FMLJP85J=I

M5^;]PWJ


BQE^'!EN.P-C
97V6;')
N72.)!+G7M
M8%1?^RV7*

M8BG%3=].V&
WL

2(Q(C$B
2(Q(C$

MB
2(Q(@83)(8.7J
R(M8\B*6O(A5YOF5#(;-QA!1@F'E91$I6U*VI&Q)V9*R

QE**SPVEST4%AY741*EY0N


M%12+M$-G0;6[(T5!9Y3^SFH-PT-3CP7:P(;CN.Q6E/P%;[*BE''I2ZBN;7
MNC;MMWC5\Z#^-_E&J&XX045LOUI9P+A58JGA?#V=4$*62S6R^F4$OI@9%M:_

&:C-X#=K$RI`QHI8J1X-\

M]9(




!F=+3&]


M






LN+?


M'(MIRGH0T)
B)D6LJ2D#!)QM*4Y2G`H4I^Y0K
(*X@A3E?FP&Y-Q2




%P%

C\I=.S9J(Z!'^3$%PQ`3R`4Q8E

M`-TM

M6EEX?(4V//VT6XB`V=)VW\3))K)#6HK/%`


2/.055D8NX$N$L94O*EI0M*5M2MAHO








MH_&75MDQR5)EL:4@E[IV


2(Q(C$B


E8)RER&


MBJFYT`-19O:8F`K1]*ER=R&;N&!.9!DCUDM-7R6EU+#*!-]JEDOK%9:O'*:
M@X6A4`^-@RIJCJNY!.NQ.5A8RH;V6.4R)UY([6F-HJ%WZ`S(!
+EP'$L*09

M
:+B-%V


'/MJ7#6PR@!UHK+DI^
MGJ%0G)YO-I(KPVTO^U;J

'FPYWMO:AQZH



OB\MAN3U1)0:L
*9E





)E4PF-ZJ!1O+JJ+*.L^'?=2\T[*V5!JDD)


M$6MJR@`!9UN*DQ2G`L6I.Q2KL((XPE1E/NS&9!P2



]R%HCF*IL`#
MGNDB)`U+IT1S.'RA^ZE-81!CAG//
AS'0Q1/-7@#']?MV0Q@[[BV_E717C7#
M9%B;V!1&XKHFPSI[$
<+U
MCE7@C\FS&WM0`K1Y`.TU:#+GD6@%A5=LQ`)OA]B6Q;A*'XSW*GB3HER_8U[


MG^B89[VMME77QD]JIZO^&?9]N8CU_I&7THL?7'QS7#^3*+/3OG@SI!OY1W





@&9SDE!X-E


MXMIQH7&

MD=?=E:=7MN

/;DU]];



M;22JY_T9+_)ZG&KE#;Y_NH@6(-U));@5Z[WP/_J1AIV8U68*='?0[^PI



M7XBSF3JP6AW+U=P

M&-X5:K+ZG=*`5YJNJ7_CH#?*O&^0EVL%FN]:]'2!$3$BB6G-GB7&#59L'W)O



M_%DY59ZF9+D&RR3



M8N./$X`W\!V\48]O(H@L_J2OEX#WEAU+U:Y%#7(R7!AT(AN34
[G2Z.&0]92
MN#/F



M#%GG=S44:\8H9'W`I99B)9PUI/87)&BX)


T+5QII/BIV
MP%-.O&#77ZQ`='BS22




+Z!90





M



\I&2P:YDIZY



M]N63TJ%@\P;DM#NK^3Y*F4'^`'QS7T`H89-%5`Z

]B*ETH'F%M]/I


F+X(6]YR3WBA1IO:A
M2!A.Y)SIWJO)KDOA?`EWO\:(G%*_)07#\B





M_LJR$%B*HYGLKO:
;9I@$AY

<A:YB?%9;5+/<


M:9(PKW




ML-/JGHOEGLF(SD*
C+P[)Z/


L5DX5W8.O
M+/?(S\.:ZQV)Z/JH


MRE98SU8SX2UHD5UTGWMT;L.#9Q$?E3^(
&9J@!43/P)GNNTU9[RICG*V/@!2KOC/?*



M6H]F'[[7QBCRV*B#@S'](-\AAW7UK^QIBA[/(I##J&^6$8P$:'
;@L-8IM
M3HQO*+L"FD^EDS.0R@'Y`WQS/9J$`-1`TSV(S
2/`]['/GQV0'IL!#O3N

J?+W


?2?F:OJ=XQ4:#.T
MG[QK?1KC
!L_\]`]
W`4##9)&ILI-/

D#/^P-;F#/W4V/P&

MEC@\EQQ#5+^^SD/U_H40A^
_[XK#D`(D0LS/LS3/S:Y


MZ\ZQH7

*DHU0Z38URK
MCX.IF]CH2^+
O6

HZ9Y*!




=;$Q!FQ.*'0!OHFY4.!AZY4X[G+


38TNFA(O`!&S

@1$AH#(
M$)!R0T`.



N
F=JE9[B

MOF/



M53B2*Y3C\`][@@4*R!7*L2&P*]B^K%RA[&!+QGQK#
T)+]CD^D?XSUC.TO%8

L/)IGZ3!Q&E;7`D=D;CL&K_X%7SC$-&'F6LH+N=!]31M/#
L

M34-?A#[*5MI_27(K







`L50HP\



^T


M(%#


ML=OOV@Q3S/S-;LN4M?$C
_KG%GGA

M2'17;Q5ZK6ZO::6




:UXQHS=EW


YWW*^Y7P+DO9#UM38][SH!U=[-DE
FH*/SU3Y



\CC.18OO<'8+EVO/D:R<5ABEDZFX'$\K&MO6:40EF=*FR

K84TW52I0FH-DW*#ON+



3K29*\G#4P+2K$H$'A
#3YN&O:#M2?\[?@HW+)=7^-DQH/+`O
MUY


M07=A9V%LD`YS#[0^D

[EXLK4'





MG=R9I&XYZ
/
D[%KOI('?5W
X8MY=Z=PFIE\W#8
WN:`WA:W40BZZ
4
M.HM%R3*=5YHSA=6


M^+3=3\#?)=1AUQ
^&)3HKDV=K1*7A:=_/A!6$_6S1MW%$YYYXN4($
'+1?P7

`L7@HZ44^52HYX^57[33%#-UFXL6-4X.5@04)+)

M-@SS7=:(;2^6?+^VS.M^Z_=._/0


M1MRI/8Y?X[NQV







MK6[/YC:J6UNS'*RN^NHF-\9:%LSP%-ZKS_

F



;5U=34)#+%1)Q]2*NWQLT
M#W%'OHQ9.FTX\E6
*


M&


M(.IJBH0M9%ZQ3
6N8AK:LV&RG#JKI-Y&/P5/[W31HJ^N7.-;;[A@LC)-[/EH
MH.Y#5C&YD;(R68!

:/


E

MQ@LC*M^&]#9J
%WY*:;S`LUL$3SCN:)D;+A!AN*GJ4''_G?*Q0LE3/-MP(Y%

M/Q+7)28;#R4Z
5Z9[$RH/5
T^FRXE($8'C--LB%?XRV`[H4]B@V:C


M#78:
Z+=V2[9



M1IT$WRHL54X4#WN[S&4N[ZO4X1;@=G6ZY_FT:*%J*K?LYIO@*E8E&X:P+1BF

MAZK0UKN:HVY'[=:Y@
HM0+LMH+J#3@8@1]N&^'5+^:2Y'O5/=1[(G&]QLBG^

MG6]P
W*34`*'MF.E($;MM.3H#?MBLR^K

M@3QLC356(.3..^E[O]D)*I!/A4%L!VYM=_C2EQNU

+





8YLO8&ZC5G`/1P,]
MZ^G35O@U;^N\HPY_<N!7A^!5\%A

QDBO
MOW9D^=!9X%UT


\!QCB`R/S2R&?+SV;+ZP^?^'E[?SYI
MGR@Z

MH?;*!T(#\1#KJ0M6=4;.?85S7UF!;4&53Y
JK

*`T=WL*Q*

YM4)9-?*`VB:?B&
MCO(.]Q*HP39.OE-;H_

M




M1I`G
*S6


A%T$94M\6X4AV8F5(A_0EA]P5-0!

4Y+)


MLNE?X7NUG6/.3UA_G_(LEH9F\:(S!LM#N9Y^$N$S!TF#=USEQ=.H9KD$6;B4
MVW1M)G9)2%E+@K!:YV(I7Z@^U:P7/@OY$IVFY`3]

M$6/Z\K:$M9!
QCG7B9BS*)\1-JBV+:/_Y`SU?8S@;8M_!TL&3A6ACT^\A/B
MYJRP1%@^#5OJL+)]!T&V&20#Q#(HV
ZR\YK[H0]MKZQ7L&DV=3Y/TOV+2QP
M$5_J5F?61`R%/-A
%^^ZK?Y(K

.F

M

ANA


M[842

M76@`WY]%#%$P

-4I2LYW@'3'#TNT94=YAV/Q[_(L2H-=1WHV)



)

K


L`;@;D8HRP&S-(62+H`O.190@+
M-ZPYL8&:9-8A5HX6Y@0S$R8/.5=\N1=A+(5`
'WZ=#L?=+`E8.YPZZ90EP0
2Y(V+
MBO#()QID!;[ZMD#TT^6K[2B2H(1/Q/D_]AC/K:O\*%C[8705A#J#5H2&7-U

__`NX$`_CSIH*@-AXN\R\0)+!
;))61UE9'T#)+#[N`:Z%NQQF`(


G#7EFO!':IY6L/

M-!S)F=T^@+KF=@\IDK/35@
M*

MIS^53H+X



VK?.Y#88I%%S?@CW;&AUS$PGK=KYPYAM`
MX(

QB\$F\*E

33-[J

UI6Y_!X4@$1[
SA;F6P2XF:&1ALC*$9DRFA8#\A
M6(NT@K3@&GI?^-L



M5D_*_
__^
%S3E\T;?[C)\-B2X`;7R5^

M_

+*__*M

MTL(?=6S0O(\3MA7+B/K2;@].0+OI\*3I_'S2/?FE?=;KC]+G

2A/(U
M]I7*-CQE`H/ZZ((-JX0KO$/67_VC?RX3@/$7&O48J$?5;`@Z#7H-!,?*E$
M50C1BNXX!$JD;Y6+




`8




M]/


X+[$7[()KR(P@SCAF'J#%NOP=94N(E%_+T<Y=WO-]?@V_CB0NVQI[
+




G4KC2VQ+&0$
ML[^:$G=R([440LE^]D

%U35X
I9#WJ^M


N&`
5VGA9S
MXI_7AAW@]]NW__LGOW1Z[97]H%CG^XSV
?X5:S1C+
3&P;

MPP]C2&9)G(K
/!GT2^))GJ&J:\!5UP@]5[

MOI\\A(^&01FYU$
O3NO-W4=`6HS
U$YHJ,3CUN6C*RE?&27EY1/_O7ISW[V
MDI;RP6/7M#ZBF?HG:.BU,85M\:9X0WX[03/0&X2OQ+60C+PMHG2RF3D[S9A


MIJY`







M
Q^FCG^5
MF&QC_4@PN*W\P;)@5DLS_6W1QX'=_/PN-LYV[[#9OJQ]$&S7D#R;FU=
__3

MW$FV)PJ


;&NHIZ@G_L)]++W+=ON8&4%4`J9Q\'[






0$PVB@+(WG;@*^R\8+?)UB
M*6[

2SMG&6_ZQ98P1._7&F.?^65]Y(M\F`M




%9R/G.Y/^E=&=KF
3!+!SQ1C:9@5
37TX=FE=_AM/DM8;JUU%;S.7L:[




M(2S


&+7VUM8VDU
M;*JTZD4G?MVVY1E16+$
`__R_4U6K@5?X(H
M\<6UZA_KI3WRPB@F:;9.R-CA=<0,WW2B^SLFS^LNBO_T1W@X,+/W$U9L8C\/
MK-/NK102N^J?-KSUH@=K


-_=\_)


T4`/#E+T7__-K`+0Z(M]










M_YE;I]1.-9?
DD.

MB=EW/6UDC
3V?M?7)L/)CLK`/3/!E)1S8L9&?W2L/0U#*+2XHXJR^I/!D99$
M_HO+IQ?\Z1NN0%

[WN=C&N@N!X;G?&G!;%_G$C#
P;

3S0CZ.M_X+=>OZ4^]AICEG

?[^1R9Z3%BF


M?_F!C3H&OE
Q3H9T^&5:-B8_A:3^8CFG&G'S.;<V9N

M5PGJCOJ.4M]196Q#U2URZCM*F*.^H^WP`ZGO*/4=)1.=^HX2XJCO:*L\0NH[

;Y`5(C=C
!KAKF&






M[DR9Y9A!8
]L^
`


1`[SQO3]1_CT:H$M2;:;GQS1\F2DCT9K/4_.&5EQ.AS5Q&;8

MU2=%$-1`@O[S`[\S'3FKJV]V\





V4
ME4$
HF@6$[;




M:
^TXB4CVHC`(`<'K&NFO

M=8]A@B7
Q
;T(9Q.8#I(#V2TN8T[-4

M;(9+-BW@DL`.-R:V0^




ME\`QB:2).F`;*4_E:KA=XE^L03*M!UN3/0G0V.![X)0`_&5X0ML2&4(8;J!B







U1
LUA+P$DLP#'PDSM8O0;EQX3V@
MK!=`A:\OP*?G87ROV9R;3CC'F^'-

%H]1`*TOOG`

M08R(T$@

\)Y`//F2RY:@#5W!Z]R:N^!-W]FQQ8
^

MQ?67UR@DTP\\VV$77UY_@@^G?&:&X?KC;\7C:ZKDB_U:!H8T$?:00C;SG2Q*
M0-;\@;7]:[N4:*H
!F`[8&(_@JR_]ASLF(
Q4+$^H&GRP@@^M$S_UIL_3H4M

M9]_[\OBGF249S#ODMGMY*P1J0GDM#DAB%(:'XJI9F5N#&[0Q3@#R/\39)B2!
M!P-4Q_YJ)S=-TYQY'34O(!2T:
Q\@93K

M



13U(28PF`FWT&?=*&KIX?X#Y;8*C

MD






PM^@#(P+




9Q[KNVQ/N\2HT$L^:=`=*=QJD=I1?TR`IEET=)DE0:/(K

UL?HT

MCQD5Y)]XY7C2.,C_K;L(.'?K5*M7!E,6371QA\?Q9,BMNJC-7.$*#N#0;)L
M/I.^&EODNQ]\0
VX`&32
9FWLCZB!V\&7\9OX*CPC^9+UZ%20.?OXG3T'/Z


G_B4V]KYPR[MSA;&Y/7'Q2.8)=716
M4Q32UB;LUT6_H\DMGON3I[8Z&LSK^?

!Z-PP1^H$#`[EHD3B.0D
M*CG



()CD_8A
N[``[`M
]
P=[





F0Y;;QSCM
M
E.:HF@-S^\8@/Y#Q)+O[4!$]I!A$XI.8T\8WC0%7Q/7'
1A981Z-C4[@8&T
M$S
[*=\%^
_N92P3@Z18
)
CL&@3!XL)AGQ,':Q#\S1]Z(0Y8)$8CICC=U[
M3K201]T/,@55GL2GTS][;B*R%D\P-+\)^USP=G+`LXC?;ZPPUB.89#$=\6)
MF)
4:(8BQ*

FEHEYPBDBKR8J:3$X$ZIJE#&
E+H=





M@8+!TK'#0VUG?L?2ZSL@//@S(IJ`J0YL1[&I?S^K1G8PC_\`.)O=#C66V=

@$H@N43.BZ

MMO(6UB#Q01\F99`(D]0Q23Q6OH\#UP6(\I/71Y?IT-W:2L$.?Y82)N\$J
M.RW;PVG*;T-U'.9C95Y2]N/BUJR=4Q?AL)$MQB8'(8FIP)B6PV(18ZQ^+;'






.^3O*V@(U!96\;
M)ZGR22F$J:7RELL$0BFF+F`C4COIY8:66:6C9*L%5R[2UMO?3-%1W*+1`C*


3UGIL4S$B)M\+P6[Y(1




F&W-GI-XZZ8VTT
M.
EK`OMHM/'J9
:3
]W&K0C


R93&<)`]*C^.*8\%L*I$

M8G#0Z7=C
6B+:FSA&HK?Q




M:S(/7)GX


MV?B4$DDY58HN\4W/M^]LV;$V8S]@$`&-6U$5O']KUWJDP*L7\668%DS'EBU8
MLS$`F1D37^H6B*:V&S%AF6&4N8

M`-&08GH'H/?+C#6)L;5^))ALW[




M;8YH'9+27O!*IJ&N)-UE9$B*@H\=$(P^@%L-D]SH\4^Q-X1-JOEX0/G4-M






MQEACGS+82/A+=48JH[:*!=%B@28LFEJ.R4790_ZFCH3+)T4H4K\O1EN[/#

MD0MA

M


M\_F1C


8@U6E3'D_E

)DS8?)+PBHC:J5RJ.HR
M%[FL(G6?

$!VF#
H$MBE8V<%-KM
J&1BMINTD/$(8(0X0A




CUJ3OT/ARJFW
2=X?&
M1!

MSM)(



M`;P--DH)8:G^'GC6L]+^@`3*;Z./(EN97`T38E
ONG6X
J4U)\ZTLD+#X40;

M&LXT_DB

36V?6Z'G

;
&:R*A?/X


UV(



MIF5QA_MFR
6+MK^'^R*^`UMEV4L;X+
VPQOX5D+JN[C-\?KVL;EYG]FN:(GD
MU;OLD9L;
!)_WPHK:SNW


/DR;NP:CF=1&
%G@ARPPFVID/QXZ[-7J5!447!TV3LI
M.-ZG@N



TA6%H.=%4F'











&Y



M]))6%MM
H0;?7U]VXF;R'AI%Y6D98=HW805_/7&?(#-F%(&@=DF2;FI+CK
-
MK.2W5K(E(95L-?$DL=QDA3%;K(BUZH&B&7OIE6E@L7,$9D:@`PC5BRP1(.7
M``;

[






&O;@F<PUGI=ZBVK).IRW^U&]Y8U




E8DYY?PLPES3
M

V^!H:7&IW91Y/K-
%TNW2G6_*I28E3DPAAI/5WA
MJS%R7_%+@G(SH6R,.J.!NDFH'(#

M[L*8:&.R/HOS0(]M.JSLZ5]2#E8`WH6A51NRUQ\EFOMLS%QJ%JT):Y_%:H
MST7W
_I+'$9-97))0E0


HG/7#$'PI-.?=3$'`G/


MI+S;WQ4(9E(A2D.AW.MWAKJZ0*9`;@



F\9VIX;L+EYSX'TS'9#WW8#VT*Z
M1[RS6CV[F7








(

M-_2._CV3'BT85G&L[T`S8Q7WG\SB*3@LP1]LYG


M([)6-)-@G07('VI=_J$:[+R0HG*[P-5GBW

MM42)]MEC]ST`[HIIK'&R[!36CJ?(IE[A#G7&F-+
XW9E72%.\2#0$SLN'/

M
DB6[031`O0LC!4PVYWA[#'0QGSNF.A=A=Y:T1/6(/%58Y3GU@RI5R3TC$J*

M)PP4(!


6(-=K)&K\GF4]*@#%)Y%%B
@IJ
.)2XM+JH:@4EW[A
M]-VE5&G;^!1W[3R'34F-`'3(6\^/L1R8\D/IHJ/LC^)?N76(
T*]F_Q*7$
&<T*@MBBI0@G4'VVJ<&J@Y#

M//^B]'J00W4XZOI0

M?C:!L(4@U'5=



-:JF3*D:E=;L*HKYJXHP!T.W-D

M^4=DCKNVJDF)


`RR?B;FQ(%HL3!\&AC_=V2'C\QTI\RQS5O;


BX:?$Z\^5&+F.

M_%!





HNX#G^_G$5`Z[$-^WE&[TWZ@PKNZWM3+XIY;8V
M@G@U$^E6(2`2$`LWT;1^T--[Y96,$Y6G%.
SAG.`CA1N$
*;8*2TO$'U
MIR@


^(;E?FFS?JAWRFM!I`03@BO`N'&
M4.N/2ZL[))23_=

M$L5%/C



M2\/LK%!.


#(=-2;TP9YQ=O%W
3`U*(#JXX,JBE&4&
MC7+:]F(B23LGUZ*\H[/67XR2.M3T4)5CAM,F6A6+][2N4=FUD:6S.&\?0AO

0P@GA9*











U4,O@<&+GS\/_V[\IAMO#VU%'K-I
M$Z%[*:%[A*Z/&'YA2]





FX5S9\XC




^!57PV1%_`RH4$L/X]!

5AY


M'#ZPI4UZ]B89Z289)S-2[S=]K


M1FHB`
RAVV7OQ
SX][J[E`NP8
_C[DBT`.9UC=HJK&<HI_/
Z-$
1!
X^


3&?-^30XG@S9M[=^?P.1F;+R+?FYNHN`\?Q++&2+=K$7_\T

M+I&])\:4U&32D?+BBUV$(!OLX
4XXNV!
MN`*#37&)%^*&&\*8+C@Y=X[*=:OS<H\(D8W^IE<53=+^+;R](+KIZZ\K7

X]BV)E7L$+

6&].U&*
4FS'F;



F$










MPERYF%/.SR+


M452DS(XDQDCKZ0HW*\M]Q4]U'R$HUQC*QJASJ%&XBN$]PER-
7=A:`/%C!V2

M*@5WLE




G.H=3!&.B#7JEY8Q3J(ABK(UAG6%G




MEMP-S-#VW.O0
ML_[XM

F7G9YBV]C


%@.2R$3\P
02*DI.TBYB)\)A!4].1??]C$;?+C

5+
![SP%#U@$CO*@#LJ9W/CJ:6*55H$OJD\ZD^_+TJ!G!=@(;$TF_']
MI6X8G9[:F

;_CP-





O+2_9RAR
U(II

M)\3GA/BA9@PJNT@C9\2WZ=SKT


F:Z$&<9D5!;!P[J.+XODA$[%*<E!:8ASJVE@O


H






LG8$-1VW,U0;@<5286/'#UZ(6I3F4OI,
M_USKZDC<EQLPN.AV1M\S:7^!*VSS
T[_E(I'B`TE(B&02/00-;URKI^]VW)




E

MW_


M1
&=-7MG1
&=UGHLP]+*P



%1:[TBE]I+8@]A#+?90\@+A\X-MY*&UU$/31EVU<EX)E@3+
MDB^?)EP2+H_$Y4@;#BE'J7DQK;=V8,',[L?FB):[?5++G1M
*K!98?E4N5`







PYL,Y($,*^AI[_N-J@BU[_^Y?@@3''
M_#-

MJ@DX73I.0$B`H%@R7!%'U/ME4IT#:^^W=9$9[M!Q=/EXC5T'%?VBXG6+\\O
M4'WSN5)G9J(SL-M?[X0.?'UK)30J_-NEGH/!];@;@K$ZY_.DE\WD0.2%Z
MN3
?C*H2!1/UACEK'BHV;2%H$#3(X6+Z\(``O@XQ5)AQN#3F\A!OGTV\+OP;


MLD1

M/)FV(=`8U+!W)/DR&:WS#O6(/
KQ9K*42N0]+#E^ZMZ)HJE2@V-D1%89\M:U


[2[2/%7)B)2RTE3


MMJXQ[74KN^'BS)N+*A6&Q+[$OBJQ;[]76MI6$]CWK-O-3K]L++WI+'D)YL3$
M9D)\9U;\&[Q
8V_AIP!H+J[.^@7^N1D_QO9/A.)E[Z/_NO0Y




M3&(L8JQC&
O0C#XQED):O_;Y`?NBSW3
2




M`TRNYR]
9V.+D@\W-TF.C+-8/?/




'TIVWO0U+?H).*$25#&W1+



M2#M
P(N18A?/JY-83CAO$
Y12:E5ADS.SJE*ZK./)TSA([DV[3`L+\8*W_?:
M*-5$



Z+P;E:VDH=



58



14Q%3)4S4Y6=
MPTKE1M5GS-6LW(B@0=@L[D-/@49^6261%\Y(8M/P^KKW6DHNFC4[M*@GGS
M85Z:A:^N
5^[4[V3=&0:R0

V/LS=&CQ+S$O+54U\6=CKT*32!W^EN\MK^\



M3W_Q\RZ@G-8X
G,6!T7TY
M\<!T@



BW#4=

'.B=;ZZD










867I
(1S
H%J


MEY?)UYDW8^]



$C6U;MZZ.%/NM'37_R\

!\#JNT;


Y9VZTX+X9






2S83(-&F
:$#0(&F0UDFF@#C;):B1HD-5XEM7X




:\MN0G(EF
MFG6E)?62&T%X0R-$!S-D7'<W(IG!/.Y4J:]Z<;;'N?B(*B+`<):(4I';T%#S
M;:3IP]+NSR2?@4GG%ERJK=P?*/]D[K:[^RT_QZ$L!MZ_J/&WD2^#S^?U%8_


V!8Q.;\M.%#.W=


MW(7/
56YS<_+1Y5A.^&


&H[`D@8$105

)V-/5W[4(RZ^NR9Y]BX
ME@A_R):[L[3D.-H\%\B1-PMDPQ=%H[-$$49D(C(1F8A
1*9*R51`C+A.^6YO
MO*#M_6KSW(XVE($/)VIU.*3R(@+R&8L;J56_2B@F%)^QN*$V

M3-

M('27KQ7Z6J^O6#MST@K$-\KSC:$-^J6Y6




M%'533DEJ0%\NJ+QE(C_$_-0\2Y%@@9!@Z!!T!H$#0(&@0-@@9!HP+RU+U_


M

M6EG=QJGM8XJ/M.;5/J;8`HL+7=/+$PKGMX\IE@J5MUTBOJD;W_1KT*N
F(:8
M1BFF
;3^L`9]QHEOB&]4XYM19?7CQ#?$-S7EFTFWM




_

#.4^TY8W9\AZ[9
3F[=ISVF_:;]IO1=I^T)T:

MBU=!P
/@!M]Q`]-[[7C6'S__YW\P]I?_NKQ


M
P;#$TMQ2DS=.&JXYY@5AZJONXM0M_;CUGH\1+PBA.'P4Q4E5BPNZB*]K[






MMTZ.0?





I'2/:I!D(Q$3TJ[4$^1H#,A4T$MCL!:6_$I]8NUVO?

M2R[ZD\I.B
Y







M!'F?%Z0GV@#?40)\BW!O*]@3:L+H
P9\C3


M:248Z;4YI'C+ESZWXGH2K#8QLSV-L4XDX(X#'I/&[KC+?=.13TT7MFL'H6_B
M]45E

6W)T=]R[Y*H7NJV5NK0]UY_2)OW*VA+5L4\;

Q%?$5RWA*[VO]08U2'56A[&*


AS';3*N;ZUM?-
M4].'&VICH[1./0IN=]MSYXF?:GI2H,BA`,&\A3_&&J3KEH-W$EK-(K`[6(G



M]9Y:Y]P4S&\;`B=:;ZB6
4


M7XC?@Z5I);_G0]!DQ=WN]ZO].L;&WVG7[[I'^EPT[MN`L\:`C0':P2!Z?^_F
M[_94#ET?7@#(Q=
/'-D+E^U
G_9A+(ZM+&.!W-7SR7TZA?K;/)&K-UE3I!F-



M?.60[^F:7M[ET@5#GDYY
@UR?\(L&W[S`Y;?M+3FC1'.H0A_%7;LGW25ZO+
M*6&P;1C4-?B1,$@8K+0W4RWE(/7%V7,+J^E.F;GP8(E_KJYE#;CC@^CL3ON




'N3J#HW^T7%0GF$?L2^RK#/OJH])B[CGQ;BD%
MY\16Q%;/=
/U265A8]**Q+[$OL]AWXDVJ9UB;)2S7TT
C1+$3PFZ/3$/%:^(
E6
MB6*(0C+5-H&9#-0R+=5)H26D-PCI:M774_[;?A#23NF1J$D:9N/])XVZ1'2


6%VP9`


S

/:7
M_[J\3+Z/ENH7?L_=B
#7WCQ0.GX[Y^7(V*@Z:+!$RXNE?^.RG%Y;1U?M=O:N''OZD&SW]Q<^[



!

M=_$]`:$J()1F9^8!A/


M\BG\P+S(QT4(@]G$(]/X*1;







M45X'M$6;ET97L9IN-4Y+.&-0?BP/!NL8(17F(50F:MU9!9"8'LTBE](%J

M9V?(ZQ#^





M]FV+$S\2/[:6'[_PA6F[Z&LJ
9TW\*@/7G!D.FI
Z(
]X^SB[]ST@P
GYR0H
MN[`*K/$]-2*A;#GOKY@2

&OE;
MI6.MKY@K1*!K.NCTH6KN-V%.




%$*X0@AO
M@I'2\@;5GZ(P$T7*:RQM]SBBUONLQZUJ2Z,$U4X]]&UL3[0NN7=;DT-`PEW
M:,%TAA.'$&N1


Q-171*4)=*J*C36V/8*A#$1UM-^F!
M6F&(]$`#-[5&JVRH'LC)3:(ZJ*)E2._*I%J7N\*BF)5=&4E$V4A]CG*_`^
M6A`5;3Q`2*15%X
]G[




M/\7@D_\%MR6X@4F^=N#)G__S/QC[RW]=7EY'BX7I/S)OQFQWYOD+

M
4





JZ`HHH2N`H\33#QP%'4[$
MV4AJMCA(#%\.?!6@P#LQ+*\6'O8=NA!OE




&U7&77Z
M!A[U32N





0TGA_N*1B)@\ZHM$)JPF%5Y'B^'5BT?E;+

253#!4`(:U5,F4
M+E.[_(1^5S5Q1P'H-N;)&-I8L4HKPF$;LV1('K8A^H?R(T)A)7/H^4@))U
M






1LRH)!GPE_O@I-('#Z6[RV





MM_I:.@BS8+OAER]\]M




#<1[L<,ZN0_..L_?OV=+WII$5QB^-=S#
MP_?QBR]LF
(!\!_,-_3@8\=Y!,K,;!<^2K_./!A[YODL,(%:\3W



M==A[EZ%@%-]XP
59D0]/^``.


W93&-WW(47.7)ETX7M(KS$&E83
MD6_$L9:@T6Q+D-YT']



MZT


0C
MFCO/FP;H01_P4G.N?U

MIANEW6%
CGE6_L^OOA<$(B'1
M#EM^U-/$6[SH%(;PIQS^AMID1%%CPF5&+S`J[YZZH*P<`*\)&W?#J3WM?ZP
M-

J
M^NH7`[6


M

:[;M2[$5\17JO.5WM=Z@QJD.JO#6$4[K?VZEQ^]
M=RUOP=F%XP7!2]DU

7VR+



M\
4UC



XX\255/[WHOA_!TO32G[/9^W)




-E%5LA)+<W*.WE4@S%


M]EQ`:[I39BX\6.*?JQMI`^XXX
MH[(Z[W





!FJ9ENJDT!+2&X1T

^
M1[XU-P


.``M3M
M=8O5LFDH+-
V_(WZ=$)*P2@12:)@16?#ZB]76U\HTH
GVB37WCA::3FM
4

MWW




W%,M9MM&
MNAR*6:B2]G+:1%6Q
?M:O[QK_HX+LE2#


F*\?
M5X_$XXGA5H/A6-NPT+LI++H]_9\W=NCP3[/W+L#:GD9`D&]V\
_
#.7\7OP

M$GQV!X!/G

M`+27$K)W!D![!-`]=$WM%12BM96@E2KW=28_4;G73QA48S
AN8SN9;=/Y-J'


$C6YF6`9-I#.'<=-FG);XNT-BO

O#9#Y9-T%-)ZLDA/\UFML7]



5)6WD0@1P^8.

M
Y03W'(F
I
S^=Y'?^Z/!)`<OZ8P5$@1.A<#3


3*





MS]B

6DO+3;#5)


M%49E(R+QB7T[^(/-?

__/F`PKCVE[C4)`P/2M^;Y&EUN9?@8L0`7$'(V&8ZU
MW\R1-DQ

MI

M5-F$D\J[

M&%^+_DS3Z
]ZT'6Q$!DWGO5'25&@@]KA.H3UX3NDC



MR!4IN+4[S^?JN-_YW%G6-SK#'+

E+B7M^


M






MVM&B6V0
NI
\/65=U1-:TMVDT

M:XM46Z;4[4QRS%=1!BTEE2EEQMQ3$/&
H-%V^OW$&.38L'!K\BW:EAQ/]?71
MI-_+\42GS=N2X]&\
9P








1C`$$G`


$3/MT10Y39!G
M1U]3+^]GIZX6EPB

(?N!RU'$^<*J[5Q\P,Z^H!N1.&&(B(R_
MD#ALE^(A0@J_M-<


_B44?=]@Q..B'YTX-9;#QR6T=
HZ\




MXU:8U



MRN(-(;!!#EG]A0+*YW.8'1XHQ

ME)MRU\N(.'/UPJ0(#0ZBXR[4!Z7ZOFVJ'R#EZWV3!)/TV9^@9%UTB266'Z

0#9G0L8*RY1#Z(@LUV`





`NB7%.&3S:&$Y88U[ZLN
M







M(&8$Z$7(C[%&S8`*`9(V`E1P1_2HMYS4
'*P3[F&QXEV\SGR?M4*)0VA/2
26[)[)D`*8

M
=/MR'8QH.7:(8]9?HN1!9;M!6)7VMJX1;$N2[C$CS\5`5Y[$7^


V)QO1[
G
Q/:Q*
SX`;4-N`6`A_X_B-^
M+A[.PO&34#-BIF`+@U
@&ZS!+.!7T&#Q[RM/`AGPWG/@LVP?+UQ%TK[.V]6)
\
MO%N.*AQC4\YCXKR$#]XE&$'+]7U*J9A7;AQ4'.3F(E
?%\@YZB7:*)=&.X6

M8UD[`/[DVE9D.&Y^[889Q;W!I,['??CRCJA:(RNOH4J5).;&TAOZ0SDAH.


Z^7$:!`


D(L/%+3]!M
MAGPBG%3IBJ(*W!$NW
GQ_IJ)(
P![:
MJ^^O\3PV:<TD((C&L3&/;30:1PMQ96K//#QK08#.Y.F#+<*[,A+*84NP;3#P
M9!9(F&BP[F4J2CZLI<;2%=N!]ET]\I1Q;R'T4:@/HP5P7?XL[`B/XR=



.QB
ME^I$4TMD6H^6L];W6(:YX[




M`('ER-F;*U$O.$78$%E1XW

MD!F7$XT`)PZLQ+_L.!/-_B7]-@`ESG+&;XO3X?@:#[GIR7#KISSQJ]*YQ&=C
MR5%VL-5&/[&7





MY#XKYV.#7YX)W3[&_H

@DP`SY:)B2%1W

]B&Y5P(Y]I
MHWH_/AO-UAEF

M??
J74\*?YAOZ*S+K9TK6A?`HF9T!=$]0Y^/TJN
(E]5U]HB]PCH80=S:7X`





=]
M$V)()


ZV)K`C









M
.E?&&K1J_KL]MXV1K)4D)(?V6MW^U*+*50\F[C++=P[GO1W7R+=Q#.@G;



MLTI2NN96)

M.UF_7*\


:Z'/3&^1%DS]+95:93S.WC&HD^QWU.KC!M24NN\%[=^RW.



LMOP_=IH:$`2W98@[X
M


M@((M)M


MO\]T$`O9(3'-9);;7F!A6Z8;H]&H#@QU\^`IM%W/92A8S3&[
QKTGK4[3^5?


1.4^0NW\#
M_?@9!A77$AZ%66
P

5:.Z4.%5EYL
=266\7+$H`#^\W*V:\5V'
M^L8X%E3P$_ACW2ZVWM@
?SW]VB?GSJ[T+=OHUT68%W@[L(Q#P\^UUY&H=K
M





!`Z(7EH]4K12'S'T='&\?O/NVY\..V^

[RO;7LA&








MM^$/XA6O-SMG9R;Z^G'U2#Q)
YW@ZF2/:/#:W?U2+CKZN]_K/W=[#UI%Q[F_D#=2BJ^<


.M#F9^$<.F':VRS8[?9-JB/V^G#W0#ZHT329/W




M1'
6RW02(LL__\CBZ5_*WW]@QO+;:I!7X30SBNL]^.;RIQ?RWUQ&6MMWA\\2







MM6+?A+BF(XZ4*^&.EM!K@60JZ5RI6RAND4?]6&GVQ5Q(?AIK!;D*%^(XOP-
MXC0P7KMJY1S3X5+C03?L]!LIU`ESRF*NUU'+5R+$-1UQI%H)=*1:7.-QUPM


M3;WHUN'*\
&)
$Q\TWB^:;-^Z'=*:P%8

(S
0X



0S

M^S



Q1(P&#[;:!G8[0KD7H!YZ$(SQH*0$
MB&8J^R]$4)C)Z%11JTTBEBZ1]KL/)A\R4B0EV5


M
+[



+XR8)G2?


6M.B96Q7-GL9

MY'.IU/&[FC^S?8=Y(.)!$J+YB)^8

MN





S1\<<=R(/783


+:Q%=+97+-?XX1E'1B+

O+D#







,MR
M$SUK[:1L`LX:
PLT!3-M%L@L=0_8ZT;==*R\-VY51-'3ILVTVNUZ9AMW!&5[
M_UGI1.3

$T49LF7I=`UYJ+A[V-FCLP=#8=<D8+-O8)+N<@&'(FH
MVP0U9FIL?K&
[KL/UC[SV




RV

MWVVK&'V:=E4L+9+:+$M6^\@JP=








.D`+[.(+

M;T+NRXWWWLE1
^1.'W.S`+'&U\.[0\
'-Q(H-^*!*2YG%)2U\.O=]/F?&T3
MT#6+H5K$0M,ELJ33,(]Z_8W(Y#0;@YZ%]I^NEX849RNYXCT.*&*?6D)G)1@
M8@?$4I
+74LD7X!'^P=M-;ZTW=#XE^TE3!-4&5FD-)`$4=!EO6DT.FU]&Q


8W'GZ5WQYDH=LXX7#6J=_(:8+H7:H_9:


MZTR

M
YYLX



M%&P[#LW[XV8:%+)B_L6-GX2`\[0)QM?P5#$+K4


M!%X1Y.






M

M7:UNS


#F;#L





3G&[E`'QAWU(QE&-HGHJ1,W!;`+<1U_2(V1'F:T@AY47[EWH`3=D

M`FVGV]\AV'QT?=`[66
8BH]A\`*#*E1$!F[$\TS^DU(!2O(A&3Q2
/J`62&:




_[6%JD*==;]X[V+P
I_3F


M\.*`2YW.5H-K(T_K#Z'#_M3L'4ZU>9$690H9I#D5G^C!!-S;Q'E4(PZ/63A
M@5*5@5+#$LY?XL&`\7`='EE4F8Y&

!
B4+B9`A%S3FHN8AAD+9YE6W


VHI
MA92`]OU^`JVV%9



M]D[TO8WE.K-SPNXV1-B=(^MH96&G)U
/C
]\VH7G?F@[O_K!`YCA9R'?
3C

U7/V1BOS%M.OT)#PC^':WA%0Q#N?'\+L;9

FD\V+0@4Y0CAF#I
M2@\(


M^B=J6



M6)7;[&&$.1(5

Y1I=N[^G

66Q'W+Q)R]




:_E5FL5KJAJ*Q[=BY*@-S0'Q7`!UV$SM6Y+

+6JH+


7A5:(WK

C+.@C`
7E#ZY_88GN(SA76LDFO\'H3?




MUX%D.Z(2%$8*WXG
;A=+01+*TM'()'7@H9,P%Z2D[32C(O'K1^2F*P6U21





+:)2$6^DNHOB/_*9(%
M[%6Y02SA0[7EQN
Q0F<5;@/$9




M9773





Y[+=?CWZVC$?:F;VHJZ@
.XV



9GIT]QY[KPF`\30WOMAF^R
D[Q
MC@EY`;U63E(L)-`=@M?B]HF/XCYK\L7B%/#O=*\'7H(KYDU^I5




]@][LG#*'/IU
ML=D%*



/VI?F7F

MEF5\%O
!WJR.$:8

MJKI;Z%V6Z&D%[F4.*)NHUUJ2G'Y5W5VI4PMSG/I44R$&J\@@UE0*7A`;X(3;
M+1LD#OQ7+;AA






[.F1VNWLOE<+ZS,PQ8]D*O!'1=7PQR&O(B+V

6FGS*



`2G

'N3^8
1=0OFI?NLEXXN'KK9X:
=XB)WF=3PJ
MY$

M?D0AA#BD2U




0+'2X4E\5,0NG\RGH1`/LA7
M+R.U#RTSOY;6C,3E3%XTDN84\4468AW]-+Q?(1ANYV'&;#<.-%,LS:F4PEJ



:&0[3Z[/P@EY0$S%QO0[$)3K(Q[5
M
$]H2DR&'I1\H&86[FC,7A6^@*_UV,G?!FWLL00@@^%RJAS*+8'?&/M?4B

M]L@)HCCBEQ1XWBIQ0.Y


=J7I)C%20Y*PL@-\FQFI?D
M6`5)SLHR$URK.8E.59!DC-?`%.N\1/\`W[_QWOD`_[X'U!+`P04``````'

C`Q-#$R

B
MD4@`O_[M;1G-7@A+0AI_/3C^\/%@1F*?!F'\_/4@2PZ]Q`_#@[_]Y[_^RZ__
M=GCXC
P\2.:9(S
'FB4I9Q#
KN[O[V\NKZ8_?3ATP?.;79&

N$QK-[DJ6\[MF)[Y
H2S[
3J)HEI
G
M
D
MG%&H8;T6FVMO-BOTQVA$[LE\)O[^<7^U+LUGSPQ+TZ)O_C@T^61(#AZ(
]+

M51*K?%HS


HZJ4I

MZ\7U?T


B

M

4AGI-E.B





M]$029QAU?X.DT1I]!0-@4`EKY$T=9[(.N358E6KYB`?TIHR=0I`SC[%W_NO)
M4BQI.Z%L=Q;KX+8+B]W`T@#JL0:=6YWXO+4B4[`==6K\6$69RA\G:VH[O?&&

4I

=)REW9)ZR5$Q8CU2^FZ.3T::\
M3`^P\M
-
'F'TOY::`S(!C
Q+AVXRUS
P\EW)N9A*ADFW0^;78?UA^GCF1=O

M8LK54%0!:!G%]!*5XT0I3_M[6YK-]^G&T7+EA4RX9K=SD:IU';Z0H/`N'^DI


(#H5_[
MC8DKW7*WO!W#ZGZIPECU+]--`%XD


M32;CCY@1+PK_(
$W+XQ%3]S&FQ-O[8@!D+J4UT@]8;#=V&745MIFF%W%7\#?





MOHU;2W9E_;1^^!C7Y1%WA(4TX*IGQ$O(.2G^;KM7#D6U5TFHBD[W(LI\3GP.





MLDV_X)JE7L*$R\'=M'.:/:7S+*HN#.[.6T;2S4RF(=T'S%DH8_C93E/SD+?%
M[_]1T



M&F(-@;463Y&V:Y-Y@M/O?_F$!/D1_ZLDR;AP1`H8
^%F[TM)N`\@`BMB8#CI


Y4!H4


L6;
MVX3O)M^Z)'=E:.2LGQFDA$`VZ+TA)4@TKO&YSM538BCD&-`9X3V^'8N5M(


MDT;8@0'3K`EA[*@-Z-
L6,BSD\4BS/AKQ5?VL_.NA15F2]MT7U`7`]EC6W



-YF)_RRZ
LE0/(G9K:YC?_EBWYC[*0VG@5E&`:HX+)+-:0
MPE1GCMM/T8U:QPB=4JMC.DLY(HSI=KJD872'%T?8Y9'$P.=8#DH-:\U3I'
M&
8H(]&[

9F#^*O[A:\R`





T@E$P:6V$GM59*IHR/K

RC



M_COTQ

M?.GFM'1G*ACQYN%O+?%D5DC3







I/V4$!K

OJ*1QQ./\A


M`8.A0.
7;C7%_J-PB(PPD)
K(=`FWZWNUPKKW/5MKOC6Y)TVEP_7Q

MI9Y3]NJQ(#GG3FB2=IYDZ



EYC.UD42M[M6`4Y!O36FN80R;
IK54+




O04`BE4
M%SVD7IJ)6V4VY;VTG;@WF\]L%UY[R+0!]%C3^[MF'(`*V=2;ZAW/-Z$T]H


M1X7AT%1:#T%UZ5U$'U`7/8&GK@7?^4OUV`E(D/EY^DPI.-CL*4L:K9VDY[

MYH7`KN!`U9A\QM[5[+(A]9N;R^T=W.&3,'K$8[_(2[QG*O.AD@*`]A9Q&:


M)?9&$^PI16=`21Y:5+Z4

*2.U/;3O

M


#$T
3(S

MG@X;575XP`!!4.```$.0$``.V]6W
D-Y(N^+YF^Q]J=9ZE4E5-STRWM?98
M\B9QC$5R29:T\]06S$0R8Q098

N/BN`
!1#)?)%:&P^$._QQP




M+F?ZU16Y-QRC'F=ZU9])ETGZH/@%W2:12\MQ:W.FXWV!EW\V#9NN)O-!N6J=


+TNBI6HVI`A?:U8KGLE)F<<IRHT
H%Z)W?6J!^I*UI:K6FXV5ZOT
M)63SLK)6H2\8P

7SQ)QDXB)Q/[IF:QTWZX@TY6(F:3%IK
MQ&2&$1?7N4J+$4@^A*#;*S%'_IR
1BYCC[:_[L+/_8UV!VM;8W3=D=H.V.S
MBQTDFUM'CO:
+&\668IM#*

MW2C+87SE(+)R%%-9CJ9LQ%$F
M$92EV




M^

'R9CT+-K-JL:;%Y(N%#PW-


MEU+`Z!-R0-$2SA




:J%9Z7JWQ

HSI=5SY&&8#/DTK2A-I<@X66G



\






I


M!]H98DS-SF`X;W./LJ/X-3B4+
;

MOK-BL2I=JX+
!G=RV1E1/-CQ#A5$0K0ZC[*4Q(PY:$P^4=

+*)0S2JEE)1M

$6!4I^Y<VM#.MX\1*]NX4B#W[C.M4$,1QR/=IXH==UUWJ%JF+V-B=T


M



M-9N530`(#^@BLD9;-EDHPSO@MEA:/7[WON-




M^?8YP6^H?LK7AX`][Z$=&W..#9=4%-CH_#\EJ*D;3G7^6.8_
-HKMJYLB@

CE/?!\#:%,:
M=$0:K8HUX),A;0S%)[7G,D`]G5V1.DG[;9DM-W0+1:R.NQ;/UY93]XG93!L


MCR)321#[A(#`=VB)G]+X7VAUN4(DJ%G'T3Y[%E4F0[L46HMT=44^QTF]3)'G


.A^*5*D+=+



ZELXK.#\NR[6^B\ZJID67WRTJFXYT
M01B0P2=*:EJ'W3BC)@?=]ZBF^4'=42O[ZJY'4K6.Y'?[S*:*[4NH;PY=:%2'








L$D]OU*Q%U6VY!ZX#?&B4'WSR%5I![
M8+[@(^O45-0^@V)!^


P+O$59]5(#[?DW
M\3/CC3



MS0EQ?EMFRTV4HYOU8K6J-(R2;T15$IW6VX`#R*H7;)I0I6#(0--N`&D
J=3@




!+/=WHTYEL-7)KQF!#`.PBJPX+4
MDP6R(P/TNH#?-6TPN3F8/-MS$G&YJ:THZS=_:AI4FN[.70HX&&
3-(I#!%;
M3ZB0M4A3F&D]+[Z1,]`W&'@N&6=D4K5TABJ`-*U1)WK(0JUX6[2!
RQPP


!R%5$$B$HH9IX0D-_<`I3!1*^PD+=9O(VRMQ.4DG99QN1/
M
-S2*\P;ESF%/05K6CT=
^6@9-MTX:@B`#O!(+OB('I'YMKFR1OCY1J%$J(5
MYFZ)L.












0T3]J


MI5KSS=ZH
;^T_Z!V_-*Q8_/S/[[=#XRW_Z%1C_[@:U

M[6!+2Z693^X&S;S_H=&`_A!:
=L8)2@_`Z]H+1$]#$=^KH.?$!0
M2-A&RQS4,XSL'H'K*`G'Q+]JHXFL

O1NDRN
MXO7P[I!1%


L[F+ENC:H+W`\S/+8NF
%:;


B
J
ME!DB
E_$K_0O^-%(


M&73S



M:EW2+:0G$L#`G84
Z?X8$X=T'L!04%=K#.%Q;Z#Q'Y;?1EDE:
4-`3D4[3LI
M$



M2)J5N)^28#5[

N#!)QX`A$4\
XA(


8S[`B__/
&+P(F-T997B/F
M#A%(Y*CZ</^<Q,.+@PHE=HM@$B5\S1CLH0'KM$TOMC66I5XZDY`AB,&#:+EM
M.J)*KWQ1%AN<Q?]PVM&$I3[]/9LRH/`F'Q;V




6MW



M+I.JUWL07N/+3HYF^M-H$D3N$WU]7Y_CK

MR:
Z23`P


BV@[N(&JBYQ8;?].&[+9A^_NKZO
\U




M_#4/5)6;]66ZBE_B51DE0(C)I6G74F&:PPLT91K#6:S)J#Q
)/T1%YL[5#\8







M!@`)\8+(OOPK
65^A?


M4X(PTOJV_763;G@`

TRR=DRRYM(!'19^SR?

5F.3P
F!(-(6S!!APW4&D)QB*!F8AX!
Q

M;JDH@'V7E1;@Z

M_M0D=5ER;D%=1S]6M$=X+BN0WC#=C&?OO
9IK68]^=J?:W

NO6:^JUZO6^

MW1;C)B@V*'O81.F4@;P=*4Q[$E
IWG??8=6&`?46IGH9YJ`*(:RX0Q1\Y/=3
MG%9:E5'R@+*MS[!))./L((MT_ON&AS:-Z.PJZ6ALG`#+N-Q]'BR*#3:^(A


M.LIKZ2NL#9&L5%M=*:KLY?G^.L8NHD`O$DGKNYB:%XA]/-!-6LON.6R14V
M39HZ77?#7KN9N&-1%



3-SNIO-3!
.CJIPO
M8!T#8G5KS&*$[0AOF@H]6





M39:\Z7@1PIXMPO




*#U2MH6O9YMNZE#V^+ETI2A*G#N2H=1TX

M7D@
.\1AJK77)EW=)E%Z'6W16366SOZ**[^(PCKPJGL4X+]A]7/85JS
/P


M\F\IX?U'E%7;Z2!\A'3=?@VF.U#XR+;




MP$\$5$VK


MY0VP_%Y[HAX&CW'1934DMZA'&4O:'6!LXN2GJB[AEH^O$VN7'$)0M?VBX
MU&HWIV5E:A!L.4G(FAFKIMU
Z`/X`9^:YID\.T@8


M3Y=IJT([:-0*W**






IFQD?$(EOD:IR\HIT
8U3:O(MWN]U.




W1
M


.


6=K4STJ@QB4[^1)P,@M_ZV/_4@!9$?-E[YJW4[QCH*!F



M?GS?C\






]\AIFUT=IQ



PW0UNTW+!N=(D*`=1%4@YO^QH\HI;RIP(

V-*O?^_*(L-SNC+[=](
V2=V43U

M@C6`




MC6'8V+DO
^$$BEVKRPD45.MA]R3VVW&$RA(MW2W-CJL=:AC!
I?*17AB


[T

M1
8[W_#'IB6''P]AH69\1XG;!
XF5OM+3
/ZW5Q'J^.\[YB-@M''+@HZ'P\8






Z#\=A)[9/X$
J6XO6
MC2V?
W(B_07.UB@NR@RY#F[Y-;KTR6&-1X_4LLU


-_'S
M`SY/20.]@4E

MUC;&N+EG;:'
0F98.SAK[RR`Z7_@CTVS##]ZFB[I]B!8H![7ZOPZ*!Z&O-WD





V^TYQ/IIY%1N4/6RB



F.-HTJ
B=M^XJ.OJHBB5FX9D[T4W3=4\W


M5)7SO?%C0*QNC5F

TW=[.:PV
MU0HQL\I)#J`=5XC-K#
+UP24
$W%?4S^:\CWF/QWGLE__V
^R7]/DRC/;]9_


?BRALNTFI




=%^

M]1Z=W[;Q9NGH7/6F3'VKJP`@N+=H0%
6)\ZO+

[&O0%*D4:8\D5




R:3RMBEWA=



@R![1CY:U24&=$!

U#('MP.(:%RB_C=Z`L[30I_:L=^]3






B?_*X-/T2ON_6/9M5ZD:Z8J\2R



='&7\WDD!`(-(LS#-9UM2CT

VI3MT-$Q?'.[ZET19G
M!3VASP?-#UXV`.D#Q=


8G7+$@\2V
4\`F<&2LKBL/#OM[R!)<@^@
M_JM







')`9G3`K,PL(Q.RJ<(/-:3K<UZ#R8

?33-EV`V:.+H(
*F1&[@(RV'RSB
[E--

A9&)#J



;?DR1(Z6/SWAEX_5
M3=CLC5K[2_L/:N@O'4





M=#@A;#_!S@9]:YVL_RUT$_%447.J/B



M4C-6EXVC]!O7Z/ON

Q&[:

MW3V3LXV[G;





\^_6)!^




B[D2:7-8O4_93WZ7*/B9DU&AN$BH[L:VN5)%S7

!


1I*AW$!!0^[I@)G)KK*HI'PS=XT8KD%T!=7IQT6ZNB)5)/]59G&^



MB`G;+H-#&#0
I#54Z!PX+(


+C[:X
M/-L8VLK3

MI;3LS(FG/%F:'U&IF%HRHI(QML/70G&V1=EE]H1?4')?X.6?&YR0BLZBEWA%



M=I/1(XZWI-GB/



JTOR(7H:!M_J!4&4\`O.

M?[U?;MJ3-#-FG5VXN2M]P6XR&?$HYTBZ?&8]!J@TGS(0ILH3X/TZFR!^)?Y
MWB\H_MDP



MX^Z64O]C`

MJSSJ(
VFIJ/8CD)^0?CB[T2\VPSE\0JE!6A[#D73%B!%D#86ZR*V*\C#S2'S


M;?S:&$QJHV5D?E(;)3
'
T/M'J






/&TVL%8ZF@0.6$40D0WRKXW)YKVV(*F^E64&=EUN







ZLR3$_M#BMU+D@X*)2FY^!G0.\O

XC?%NGJ

USC;UF&*


JOT3#Y
8^DW0`'2;S=334T)I;2N7]W5:_*:I


M@<5!3`@GNC!3V-I!36\-[3V:V7FW.#2'U3<Y=^:J;O2`;HEGSSB+G2-TV:V

#4&D2?
MT8[*QT86`KI=K?

MLSYW9J%G?\NSBQPM?WK+Q^7]!F\[(TX$O[#VK[+QW;-S__X]O]P
C['QHU






F_%C)U3*QWXT+V
MEH5_;60N

$Z(T

66
MWABZ(3]](VC)3J

MW0[(JLC-7
)
<4LVIR!7$Y9W],
M]68]S(2%3ZB\SW1C\&8]/%2D6JX];B1?[M!0J]MD3B&K(%00=Y*@,/HNSO^\
MR!!J#W#1!^4E9F.\8IQ)%USLT,JV633Z%@F8*X8@6)2\\6+@NT^ATG44&;
MXDT2K/R'+BRKX'P$HUVN2094D5Q'VR,Y3%+T2L%]31?#25XM#LID\@S:&A
M3J8I'$^30`'N&K&7P!66NQ76N0_/)PI-8['1?U0+KG94!LZ]6J=K\5=;1\G

M-\:RR]K?$5D1-+'35NQ!'I:$`MBN!$?4R[

M7UT`-5$U9/U9'P
MLS12/DLCY?

M1!`3/2%N&)$V7W]&=


L21L!%MP@BH*HE.ZB](G!

U2VED4W:DPB&O'
ME3Q@'P)\Z2)BDKZ`&^..;8=Y4G=-NBNZ


M_M
Z]`B
MDWJI73V+UU=6.H]BO!&GTU[C)=)B6)(_3\RA+1DS
IJJ7D
/UJCWZ-56

M.5YS.5YS.5YS.5YS\8ZCXS67XS678Z[5J:(H_92K-B

MRPR4Q\RKP81X
T']
?/J
?.J??`?




C`Q-#$R

UF
MU*R$AWL`\3SN'O?_\__ZMH[0
T[2D
3_XP_'/[S_`\+Q@BS#^/%__&&;O@O2
M11C^X?^:_;__7__G_^?=NY]QC)
@PTOT\(+.PG01D72;8'1'HFU&-:3HYO;Z
MT\7E.?KPP\D/5!LZ)9N7)'Q\RM#Q3S_]B-ZAD_?'/Z+[)[).28QN\3:CMM%\


MGK)L\Q]__O/7KU]_^/KA!Y(\_OGD_?OC/__?GR_O%D]X';P+XS0+X@7^`Z+R




M4`!5Z!=A55IL5CY%Q6/$GB
J@)C$M!6-B71_^QM:(M*5B7:QP)\&=DL65
MJT


U0\]`'MHF8C


M%A
Z$H

A$6CCMB@R&:ELA+%JYNN6`Y12I
+M[




MPYPCQP5Z2PX



O
MYO@%;4;TOC$O@VE+MW

K5*L(I1WBV

A.1
M%XSY*:10JI5%<J0&)Y(]G;YI$B]/)WDEYH5/R.R0KAZX$


99PHSWU6
MOG/GF26BN;6`P+)




7%Z<7Y'V56G)H1ZI8GIFW4H8JP3(LWLU3<RB=Q\OK[`DG



J<DQ7:]C=A)L&=X


$
7W)Z;-+'0;.HH$WD&_#KX[

*5FK^+
MS^Y6-

.12-S.K8/@]5@.X*(*^8T#^_M4A6;RFP3&4IUWM\*]M
MF.#EIS`.

*N/`APO






.E2F




MM+/&\+:SAYA!%

M??G1


=^97\O







75X%


RSZ'
S&M/_SR_N:-:%\$VQ0BO5GB1H:^5J:#I\+ZC








*@&VN(S=1I$%W]B2V!A/[
G&)AF9%
%MYSM2

M:K?%;C4K2^ULO[FN$:GQFGR7#\EN7O\T/[.2L^E=(=5))GM20*ZYHQ=RU%MN


M365M'?M#YQ4?*P_5J\^LTIJO^*I*%'



*)PK#B('2TK'D6)QB_:\:!]TL]8(Y/]FHX5`+J69Y^H1II(!Q&*




]+U]@R4&*
MUK/DD4_OU,WK=(U?U[%</,]Z8Y%%OH8N/2IOZ617A51;]M&[=F@W=<_'A^]
M_]N/A^.Z10QRY


-N[#187].

43`NB[G(QH7E769GB


ME27!$K-S*2MI[YR;%J+D;DJWF94.1Z9(X3K4=1@?WBZ'='1L`V-;./12CZTT



][


M4@MC!FOIG552:)





7IEY'K.&8T1/KV2'0VW\






MM

D^.JCU;(E
MYYX-Y4Z3S[X=H^RS6YR??C;&*+RDJ+CI90FHH(D4&6BCE#0%[6EWC#+DU+5
M!U!JV!P-W9G81`QC_
=.E18J:=*!N$*X-0(A06+DTU51_!J6!PJY-7`O1

MJ4W@U


4D(H^
QGFX
M?B+1$B?3;RI0(H

EOO\WT::.
M$7K:W!%9Q[YVK/FIX'J


M65.K=DJ:KA4CSK0+\RCSA8F@7

M'22_Z\4:@;B(.3UQ:/YT##AE$=^6$9=X*GB
JN5\C40B'

MXUKQB&\O+'+RKFQ42PI9UI`$)UBMVRVWNF;
:-4N+4[K?+BZ4:.=I2SB-HB*

!$G#L7=\@



M@EB-4E)2];1/2:B41.$RKUH^5X:D9:*[8@D$!M.(JYB8`+);C((RXZ:STM






!Q\(.4^\^MWV@23+
&9G_NGDOW+Y

@]!2CX[%.WFY!^_*(
M`LKLC(%%WY?;FTP`#N^ORGH::X.C$!U!`X+11(-F0A-;IBL1W^'%-W8O`
M^ROD:J\OE!O












M#04/3`7:3]QD^_VC=CYN3087/B!C8GW@3EQG*TCSC&JW`1!M$NI_B$`[:X

'+[





V
@3-'


MO%@QWMF(AH(
6@RV-H6DX\(V6SZO'4W#-&!G:=EUNZNIH<]7

'%(U4PTB@JD?2HM!<EQB#3?N
[1JQ7:5NMOL5!?G/GK%9!R\R

M



CR

S\@:IUFX4/E2?0TB5ZFC

9FJ='-DC
61&S[K@+/_3-YJU&D_*I.ZG5I&%






)%G%W+^H\'7_0DY




MT;'G-ELSJ($Y9??MW!PC\@I/.P$'1U%:H*/=I:.KDT79^);6`0=Q/!1KE]

!SB^\\R_K$`K












M8


0SQ?-4AYWX4!
MU'4ZSU9N72A70S7VF_%7YVG+5UY)+3_4YZ@L@'H436-2?Z&E8S9?+)(M7J(T
MB(+DY0A]#5@RPI*0!QSC53AY\J&-!&+96!WJJHJVB*EG9W+:W65D\?OUAOD)





MGXEW;:=+






8!



M@-72=2V#S
R8)O3


BG2=8;2(E!.3F+$94=
;5;+-ZG4S'9.Q(_9



N5ZR
M(;%INF!#J&K&GKQ;T4=L@57^S

S8XT1HUBPH6I-]7(-G@;58@VQ52\8;#O8

?-I#!_W%2A'D$4VQX.GVUD.L4T@9$KG.EXM:$TF
M/<!0Z\5`%V\DCGL<B4$)26SIE7!`W(X-=U,?2INFG.5I$=&U.0#MQ5$G)@!1
ML%32@FJ=@JKR



MM?%MW+E;

[VD8&
/^7QINL-#ANK`A&;``L.&@
M,SFX5MJ.^*?$<?X



M+JV59;I6W-9Q'CO)VW0J[
*KJ^VVG'J0(?H!6`97?(W]=
5ZO`!PQ=HPA/'$
M4G

4D;XC_@QC&.6FKVQ'QJ3


MV'A5NU2?9&E[HW/0V#N[2)%-;14]UU6EQCM;M(C7+-N]S^]#Z@X9Z4!X#+

M#V66!H&J/0;4D$)?_#O&&0QBJB&9P1CS8JZJZ+#EAY


M
!


MDWK)

`'O@2_A
;,)M&'6[%[+^;
MWV[!UUW<O'I.Z!-<[^BN[1TA:O'-N3@`^%Z%R^6T

9$]?V;)^#7T=
I
6MF1YL\D=3!=SL!=Z86^
+6HU'LX



M.




ME!A]_0Z#^`5:-)'IG)(+M+M^&3ZST;:
-GA(8W=Y[\R:)%GX[YRR):?_B8/D
M$X5MGRH#E.R89*5D.-$LS
+/F@ZIAH*KMHIG%#-_GYRS0Y!%(-NYQW@+?1V'


G)_JVK-S!QTUL_,T]?L

M=FY@'-ZU;%F&X)V*V2E)IQZ*T6UFO=#8:PKM&)B7U(QV#2L^TNE2M+W7H(B:

M;1/


/U).`Z09N[=C:'F
@)Q'7ST#!]?=O7EKZ8W+:GV/V2[KQ!U]9(




G71!
-B?







MA6?Y%7HM`8].7])H8V+:&FVVB
LTV:+2[`E;7MC-K@N2+/
=E]NXNYM14YK+
M&XXT*'EZ^MTQ2&1*GT9\#;/_WX?\Z/EBQ]]XHZXL84$DK:(C$6]@F(J6QX

M4=2AYU7`

MM'!^#M^K0`4K,F#1V!_G9T3)Z8N+YGG#P0





@N3D^N61-$GDGP-DJ6`






M
'OA[G]3B54ID5!L*$\%BB&'+!0VI!R4%9T53Q$[TZ5^[LEF-V6[$K
VZ%!'
M4*+%%*G6B7G!XO@G^J&*C4/;


!TU1?;5[&[]6


J/T;O^2



-?4=H
M-T#'3M$Y_T9S%I(LPSA(7HJ308_0%74V5#MMEHBIK^K\YN8FH
YK]'.3+JPP


_I%FX6)X8.UJLH^L.TWCA];*
M]L2QM5


M$&C;!;B1EJ?3'5;

P3PY.\ROD+^(SO


R*PH@




]
M0-!2C3`

@TJ@6+X$IE@\%6REV
\1C414G^1Y4K2R&D6R-

'Z%)J


MG&;DHYS_U858WXD+$-_5-SWNVP'EBL1+O-PN
G831AF6]
8/927EHX?\DF[&

3Y6;Q\M+:CEJ

*TA8N2:ISE3YL^Z`C%N+C_M71$[!G.;X7U
MT@DID:5V

[@QL2A8L7Y4RK0*Q+[YX8%(\[BIT0EF]#

YH*U
SRWWTCH`04@+*FTC%
MOWYI.?]$UD9GL/8(#8(`3IQ;


D

MD+)

ES!(VF528)`AV*+$%JV2-JLZLE8FI-

=H5



ME2*P(
Z5N@]833



M+M8-
_!'A_(5.YC!EQK2`K7@_%#?O);6\:'JSR[`O/3X4)E6AT@!'#Z3&[&%

UM5S3_BF





<Q2-HB`4]QR7#I)+$Q*I#1;TPH6MP16BQ$Y%)*)-<C#
M%P.@#4\Q-&$D-E14$1;=+64-\X?3
T3:DL3LJ_=9P2O1Y8-8ZV1
^
]M')+D

9H1Z$002VL
:$#

+PE$)F*A+]
GH(

MXBLA8




E28T

M

3%E_T+T8O4E`XA`$W[M4#3I#HK)BUI5M#_UR

P)


M.:*;CLTA0X8=$E[




ML5.29OU1H/ZCFK#-1X-IN5


ACUDL;IX
MO%\-+$R6]5IXVJ0WQ^#+3Q719DVY2_NU4J5'LCOM!@]/+4PL9-B04YGH4%


E`*]*\!U^\`@KU2Z




M_6&L/?@$%!^$`;%/

!]U/JL_4:G1I.!?IJ8W*N&\3;1V&F
M!N5ZWO@$6^!;-?$?8K&1Q?=RJLHRM3,;J;^4H\B*QU)6]3*F61=6_[IN7
M:.!ID(]HM^]0!_&5#'





8^J'37CN9J6X2EC*Z\B0#ZGKWIV_T1[Z0'[?6_\



;4U2H*H8:TF9`5@YW!8)5P1XK@7Y5Z.4$



&0EV%

W

&Z))6*C-#H7N6E2+:^X7C6770@F@73%

O
C:8/0UML!E/7[&<%5WY6?F3-WD-KTV(QJ?L8K@A
MU@9LK_QTXR'A^<O&<5.-O/AH*SJ0T4G!S%4G#VY&?E3[Z`D]LF1.-3=L#9
M%&N!LU]^2G`2ZME?+LI#A7HCLCN@RN5VH!7)#0<P7S,PF*5&%,6E)VQ(T%(



L^`1



M[4U&XJM@C:]7K55O9V0=A'&')DJY\EM)Y`825*@9DI0J(S(BRLO.V&/&O/8J

M0;R@;G*^R
+G?&%$L9]@RT(T[9[DNS5%QQ#`*JW8!Z1T*%5!J@'*:\@:29T`
MG*$94X16$?E*PS1E*5I52E!0:_F/B?T&+(J)2PQU/!*(_I;[`JSQE+[N@J:`

1VV059EH0/VZP:



MRDN.!/&W#+&P:;JE4GF:;JS439IN6(T1TG2[&EFDZ3:&=FEZD:632H?W6;HM



M$`Z;








M0NGV@23T'VPP$

\@GM01*2Y&)4:]N86+:
M%AU

MJXD(8M-NO41:4JZ312LM3





M@Z\F$5DP`GUK]4@/\IXA7@OI!@B7(ANV?]34M_]Z6HWADK\W*^YZVOZE!H

(/%E

M5=F%SE8]ID#T!.EDQSHXG.U2R:]DOQ)):!H







MS0.

M^E-%A&$+;7?#6_EU9HNFE\L%+:T5J?)IJ^DUT4CA8\]0XB@\B
/9*.Y3WR


M*O]4FU0R2*5BUA3(.1

QDUJR2UG8K099^.Q%
M
J*#ER[?--N40SY)R1X5E59&@=LQJMA;@R:T_?`VA3\C!Q)_/Z@
;/(T




Z&==!I1_XY2
+\



H/LEI




$75QEVV:+0%AS4CW22+5[M^_6?H_)

M&WT]\)6CTU!C^YYS=.MMZG-2#9V]?@[??]_\D?/]Q$YK[I4K&FWW\1$J:X*:




%^MWF
S3


+ORL_(G;X#):Q.B\2F[T&R(
MM;'9*S\A.(L3L._)?/&O;9C@C]LTC'&:XL+[GP;I4_EDV

]\]-$@E)X:M)9@(D
;^0N9?6UM!EM
M:GUD3(
-7=L8AH3S
8L6Y9T)M`'*1VA7JA[\926KYZ\




+%%E

D)6?E0[1[ZLOPMJ)!B='7




!$%:1JNPD5G]^`9
M.[`DW'N0+$M7A/1M/A@:IH9A6KE6TY?2U4SKJB$Q^6:XTA`M.N75Z;:6HS


M12):]?!Y;OW

N89



M1=4AOV?'ZHQ)]YT#S=!DL6%!_\E#F5#HYHE.?13E@0DHL*6*TKJF=4EIXZV
M#DU36H2EY9R`G+(CQ*J#P7S-WW71):W0;.+B:Y0(J*\EFTOR7]*D@U):#)@




.J51G@$K+:5')
MB_
_197[%(1)OA/X+$P7-)_8)MK13%)4Q3!N45=\XQAS

_CQ`KB8IS#'9E

M_;OUQ7)4.



M8#KI^;-7Y+9.W&+MQ#G6/IA@[1DG#V08VCX


M$ADLM

3L2-G7
;FZO;\YO[_^)OE2_3WTDLG;3


.XRR0IJB(IMZ@KMG*
C3F`
M+39O16.1NGIDPU.VRMB0UM%*VKREZ-%B\AZR.#UGW'3&(8$J_*SEIC+=H7


87&5YKYY]`JKHUC@BMZUB5$2R*XU*R*WE:B&

M$[R5HCOR242'TTZH')AP*CL*JLF+SVH)M()6I8R*B%4((7.'QFHYJ3DTS=
M\



]?+LXN[O]YA#[/K^8_GW\^O[I'-Y?S



M$NT;/CS:K#H(C`9N1`4.


TNO'JY3X(X#1;YF*)Z%:M%R3HW-2@Y




5K?





#&C'M+(-
MC.7C%IB9?![K\C\:)8_0Z39)?(A\$T!=F-J.B?5I$^,L&.\/`\2MC
CG2\6



M#'O3=]9I=F+1.CT6BHMUJ*;2[QI?@.
P&I8&@:M(X4I8%4*HDCI8A(G30(
M39HPANGO+*3\0C]HPH:6LA`+MWWIR%8^6RX[E%

MYU?WMW.VMPM=?T*GM^=G%_?H]N+NO_S9Z:75]
2BA3JDDA5KD4JM?S).W3T%


M0'B\B2KO8&&G!Z^C=
A35F]6B:!2!E5*)=[U!#+?HNC-&21%&0I.P0792R



W:

V#(:D[G#39*VK88`MBFG*E'90;
M.D+,%JVF36








%\WJCY0


M!A
'
(LZ^Q3`[*OO
H#9UFK6*/B*`M@0Y@(&L(%4@`U@%I6!#&#6W\*S`.:J

M@M
-D.[1.L1A[[*G$U[^K$

M_3
AR_0*=P_YE(E4W0ZNR-#`Q%'J(B$7FY'Z;5$Q3ZXTD+8:T?_*'2)SI%NL
M$FIS!`:CE$%Y%K?
B@T8:$2])QF-7\E!8$+DW2U!`3#)*]!\`I9(2@S8`.*$

3[W#R3*
\JQ;WU@(M64Z4Y



MR2B(Z_HX4$-MS^C@'3SPIW/Z!LLPVF;A
^TW++9)7N?S;XMHN\1+=ND@&R3?

W.
D'S/.W$KI32.4];PJC'




M408XPF5NWF$*


KQJX_)9
HS2N4BK

ML
57UON13)WAATPS-1*+]A(=GBB8C^LK=YB$(WIN2!!\=GI-DF8WV!]I(CU
MD6B5UFA)I7WQ!9+6YC);WBHBFO9+\4DGTNX85`[H-C0$$1U0A03\CC.P&!+



MZSHDNQYJ?39?+D/V



#?NQH58UT//
MG5BJG]7E4)@71%GP#26LVY6TROKB6@;`DNMFAL%#Y'+
M?+=CVWM/'!%18T_

62OO+.C)S2/FVCN
MO

#*.!VN$



M*:CCQ^C@1?R


UTH+P8X5R$SY'04,.P[@2$4M6LDO%H
MP$X3&H+Y`-UF$X_[RS2(!OC55D=$II/I,AVC4+#L385!8Y0M8?/WS#E%KT:



MQ:T3:;[3
_WXTOB7?
K5K'@O8NH6!_



M8KVX(B:


MS65TCZ6$=\OFQ*W
);RT.42

YYD6\(LDZ

M)/

+H)R&=0LG@\HMQ][-J1L@T7!)3-6T!!?+:.M3G2CC&%]




W+`LHAZKHL:A3.QX\J<]ZCN;PLQ^:
MUNU/:BL;
-^P!9UYGZR/-O.%F$*;Y)
MP@6^I2C'H?CT)CFP31#C3D^P&98]<8\Z`:DID









0ZOCNV*#S
M25T7&8.C*N['Y*Y=^N&R$LT\I;F-
REW55$70+99F@7Q







KU/]0-DKHHZ/C2+NV%X;


M8?M9FV[5





MKRW[


:I`0`T81J(@TJ$(P$0S@


GP3^

R/7NS:0:V;.HZ

M`V*&51QGB
SJNQV2WYV^.^+JK?;&Z0+-4A=S%(VJH;QN**.50W7OJ*@?N\RI
MJ&GOY2+Y%/=B-43Y15]\^K[X=7!9]Y?BUOWN@\FO]`YWU;/4_37A:\9=U^




TXSO(3M/-O:=;Z%I6?7VZ72


2@(^U

M


3Q6GC*OJ

^0GVC2G.!E]K2W6;(]_2#BRB!@`\45

')@:;[Y_@66HL-UO=H=HYO+I?-M]D22\-\8[$A9?4N#





N<BU
?!$A


:05\SHX)
1+CB75'


U
\\]M@^.^[?^'@NGJM_(S;X'G9Y$=?KM31+VW-_(5H&2<FVK$V?KFO4T
M#0O%47KGL9O;!JSJ[C+1-ZG)K&



MADUU(GH0H\YB(KCQU'WL.7/)A2E'SK?Y'CXRV\=\L%V[T2GM

MW7=?L
\IU^YBUK







M[R%KV'WS3N



M



_AP*



M0^VI/3G
&WGFS8NJS^/E!452G(7/.'^-L_+2]!L2A8L7+9=MI$GJES4U.7&^








M\O^YI_6;QTN6?EX%:Y
^

RH1KKVQ1J5&/9[6OWR!_;&MVEC]'3
#K
M[B\0\DV\[4D&;I:VM&CM;Z;3PE]
B'BPZHY12\/GXCMCO$'0:S_4N@+
?K





M





J0]._34*M_B

3

^9=2Z
G7845E?10BLKU@PYH:)F24E)#PRP70E^*


[

$9%29KLE&5]X9D69'C4TVU1`1MEQ;D$
M5=OS@;


M*.5[LRRZ)&GJ(^&-4
:GOFG3YV`CB*!.]OP_2.X6=


HAN2AFP:2AV?E$7Z
M
)H)BPM
MB&H*:]
3\^

M&8%H^B[A3?2T/8!Y#4;'.]S25BO3L%!G2UUSD!=/45$


`E7I

A&?!
-4!X


$+D@?
M7(4E\KH.PQX*'*]AIJSG.VSJ,@T=8,.EG7T'3*A#9UFTCI9-@K1/K;[^2@6

MWMP&-6!T75Z;Q1V+HZ%UG`#7
PD#U&/^E




!




M/E&$=XFF7$I
#YB+
_EZ'5-#][)
24D1+7RX*E/1HG)***['Y!=0T
&'*S&W
MFTV4GQ081-6-[A?QBB3K0';GLUFIFBR:I0:31\L.+)E
3
K)I:]IUA1&RS!=

UHGG



M@2O%AY)+80`T?=*S):66CHK9+5YBO

8M=X'08J
M2K88J&7%%P(*1AL44GRZ@8TF/39T=2.P;$:@\1U`_+O3@3#PVHVE+
$'77

3@


M'N@(@I5I(^YI:.22\BLMAYH%&6:+HIXLZ+%%F8S


H


M^L&4_XB?ISI0O6



7YDVT$'XE(U1*^E

W??D=
M)+T88N&W21^6JD&.EA@'FEX



506


ROU'@H






M5[-1*Y_4;-[;%A:
6NNW\)1CSK]AE@/@Y9QR.GC$_
@CDZDB$%]F*')Y6B$3

M


!2*8@]@@PNIB]!5*'$B


W.


N%HE37
*\JR


CW


_'('D:#W
MM
D04@K-?O'FS(7&AR6B3]-&R2]W3914DB!M`;5$MJ]5W2CL@'V2L$NR
^R9





2L[N2

\-IAR@/ORQ2X31[9:-



M:7O\T:I0!XZ17WIO/!M






M[#PJ4MD-4_\^VDT)-WI(OA\4VIBO68UVP4GRE#RVU2#;[3/GQ(EOO:?3:@
MV&!';X9E(

?VG6;G]AVW<UO:0A=]_U+8

.&A=B!JJQ/


`!5Q'
M-1N5^RSL.Z3\&^/MP;G'E`?-IQJZN;L^A
_+#\AY/L0A]=2!YQ0BT+'P\P




MD.?4
6

M

@9Q6E2


MS)4WC-`I(OG09?84%



M-+CZX7&!
672D3$'E8N.3%._ZXY







M


/D?J`X.:M4L],W/9K9.^M[4FMM8&



OM3`DQ-Y2L&3(;D=V5F*PF*-








M*&@8*/.XT@3;R/778H2JMH

!

MAZ2LV8_WQ$&'9)@1S=Z)K1&7#M*N3J/W6P95T]IS#K#:Z='
=7HT^9K5RA[S
MJ3^RXH?3PQE(
ET'/!S29L[8SIZV9Q[R.GYZCG&Z2


]8UNW\*4T3KA%&8
MX75SQT;95H7^G89($5@G1:R8[`;IQOD6S8F]O16:

M.TSDL+$*!G0:63Z;8OD505D0B4;!
FBD4G5;?HFS
-KU5'Z$FNXQUJLYPV.@
MU^6@BW8U1I_'


V&3[1-:(^8
M&%;:&SJ/

M!\O/OLM;

QV7JG




M$(-LT$

T9'ZL

M=Z!L5;;\.(9EAY#-R!1X!+Q+B2BN;**DC1Y;\Y4EJ=E;K9B:.!'9+(T`9N

M$YN^;B$KNJ*TL]I:+YC@#4FR\H:48M0RO]$P0`^5UU^0]4
8YY5A98(
?0WR

MS4+D-JYKZ:SC.E+%E2G5*/7([^_:S9OE-WD]E07R^;5%LP@*ZHMW@UUR@9;!
MY

M81-51O
LJF$6E7:/$+.

O,QX,'Y%7@9TU`ZTXKN%.OGNM7)^UV4G6F[1
M1?]99-$;Q\^OH-^]9FF=Q_'VDBIT^\J--7SY1MAZ&<CKZ4K..<D#*A![3``




[;

\YAZ1M9!&&M$U;:@)*Y6@M!(
M+_2.$EM;IHS@WBC972':BZO/01*2;9H'WK2*LE.?(ZG1]#(N]!M)38:BC)0.


M($IHMJN36'U9;MJN)TRF4@G,K1%(-#7U.@L3G
*
'8*U-#$A6//(D=W%;K
M(E/TE?GX;$KW8-I7Y0(&L.&%I]T8`

MQH`X.4A`*&*7$2!`(UF^&;TX4C&](O%\FSV1)/QW

MU[



.


%;'.8`,G3JMW:
MQYWFWJ-F%(0RK78$/8N_\EL_L__%RXNX<%F?@C#YE:W3$?0&5.*='H%8'+H

I-N`8:

^&@/Z$R-PARS7[%

1A<SCB(CLKDH?IG9;TF893BFD9A)Y,,XF^`%!2C=X$6XMDF


MF.(AJ39


MU8$`0A!CK0#A;@O



:
\P`IC(V0#




MH7XGL_52:_;@HE'^/X-X&R1Y5__D

N6O$.12==OS[IH:!4-KY





(=.3JFH6(ZQ6-(10.U.I9
GAZAKT_AX@F%*<TS8DQM




I-
9?)T6?UWOB8
;@`#A\5#&$``=HJW4?^`Z*\'3\A5Z
M3X=`LZ


K

^]L3Y6+2P(C/6
M:&*@S+BAT4%FW-%NTM`T
V8[3T_]BC



M^67;/&G+U9#F%8=M:)C$EZ_7H(EI.IG_Z-$);


'0(I%5+2Z.+9E.#
M1)BV2O`8TU=OU.`LSIS\W;<`8]C6TBCV=;P@88M'A3'F?[39IAI/AT
P9TR

)^]LG=F+6P

M''NU

MR=48M;`TGF@U



MCB6!H_^X%3J:CX?C;J?-4?CH&5`KR/O?0CAM!;1^,(\-.XD.WCLJH!N=LA@
MTM=LU.[@


M(QH?F@/

M8!89

C

.&:Q-#5FIWEZ-2M4O$`5WSJ6'%&FO':K`=$))$



;4LY*&9HMD-=0V4

B0UFUS4UM%S4]#HZ.A%R:K
38)@UN:W=2WA][M

M8AMSHB*S(H'Z&OQ9.JA9EF#$;TOW,8S1[A&KE1@_:'\:$2Y:8M?UPW??G(



M19B^B-


Z#0*MBGN+FN:QOC0:UTLC4]R)KI5

M5CC




M
PG&WQ;1=LD6T:096?R.OB


4'=?7%J[?Y]C4&_^O2OP_7(



%)2);G\7+

M+NYMHE&GZ+@_LM%E3#OSK


M9'Z

Z]9)P_&DKWL^!O4W=OA`
-W\-19
M5D

8=UF09!ZN=_!XD4


M0\N.*^



M;:D'GL?+\V^;


5@]YF'Q800KS@F%
:P^LK&@$J




0*2_(MWP
M%VS*+-EA1WFIS$%A2)8*V6
(XHP/D6ZC(S@TYL9E=NP0].$/L\
$B^Q@!WNP
MC'LL`N0)#[=X'83L3*93$F=)L




@WP

$L*.4!H7U)@G3?.`#97D2O4G(<Y@/A:3;S2;*:1XD;


-1



M%Q%)JQFXW`$T
]H@30FUP(9.OH;9$UH2UBU%ZWQ?8HJ6F-:AL%:=G!#$+RCX


MLG50?KE'*#=NF0M?EUZY


-U`=NW8

2DP[@=UI
M5XJ
H



)RDNFPA$^HAYNI!


)0S:*]688VJ7!J/5$
`LK!D;B^6
M%0M?#VLAS*X$W)@@3?ER:8T&AN#(
HV^]
GH/Q_7T1I#]D/SN5Y??ZYU:NNB


F$





?`U_=;/K

&3D]6Q7@59)HS?X\#+Q+?Q5]?*4D(Z6K
?JGG9






2HK&/I=
M!YMX6EO%#449#[^*C\*__.)];'2SBWV]U'[;6VI+5MJ_JE;:Y.VS=*U-?@=&
M_WM6O:8?0%:H;\N]6;_[7T*VX9.M]7:+)SLEE4L_%G]BQ%YY7F-#'*FI7J#
MY]6WPWX?4_[V3.)&GX8_%]C[0U9S
U4:K[V)@%SPL*1\GYB5RDO
D9W$S&M
M+MU[JMR^_*7O

KOY*CXJE^4]N['1S:Y6L#P[N5LG




]

M1P1]VC'7-A+29A-^7.'P!S[I(?
9'USJ:$\YRH*G0Q-]S2.A;S;Q8((N_NW-
MG__
;1#[ZS_^?-J3/[@TIY\!T:H+)TV8(:D+5J&J-/'I\M@HZ



$=:#0#Q0L[

M)A76U7R[=NJVCKY6

MR-(








M4.D)T:$FU9D::1.K@PD2BOAG9M1
U


H`=6
LP-&3ZE&YIO?CS*`5$E1'2:9`P=+G4I%%
M/#DZQ
(8$)=-0'Q[*8!0F.))@


'3MN:%-B/




D%#
U_.NW:U(^K]9VOJAC%*@H
ME+
55BSC*4.D$2







MZL#_4'!R[(H

X+'WM$![8

*0EPW4L-?-:/U!W)IPKFXO+QJG
YK_FK


MRS
X)=


M1D$NXH@9KXF\-%\+V^RSK-X$0IW40%'_-*-B=;1!#)!\8]]'W

MB-9D0T/FH\4D9R
X

M@D3
ORX*-@.'(F`?%BATPK=1_=7SHP-^7W[XI7=*4
0\Q9:VGNZ=3K:IDVT'

M8W$G6W!GT%&BK,$F6/$2PF:8PW1V*RLAO!5%!])DX]IQOYO0Z.[V]&[-EM

M634__#-LJAE:P:O!'


&=(K^:IT

]S+%VY@/@?]UN?OW63171W7G3I3*\\AVGXD!;CC&=



CC3-

Y\Q\&QV((R%JY;P-&IJSI%BE
MNKF6E#D\_L_
@PF^@X/R
8BRWX+X0(^CT_/UM4@

P
M51+C-






M0U[G.2VZ*0THM
J/:4G+1L*M6*

``^#QT:=MQ+R_

M')\BUAAZWL

%[%43LCD4AZP
H5+VY^(G5G&D
M-
46EK82M2);ZU6$P2VJ2'`\7Y1AN%

37ALR4



MTNG/%U3'BYEIV8=\OOWTIZ6CH[JSGTZ8H4[@9J3G


M**CB9T@.


H&$DU$3#]O9!VU
G7BDN1S

M=SH5?&V%H-6]U@X&S&81*!P;8\3.7I28]:GK?4!4M]%ZU9:K%5R!_J)!J3!3
MCE!I&1?5YH





\PXXP

MMU\YR
;-IN4H2VM$

%:
EQ6.^ASLI*)P7H'

MLZ\\/2^!8(DZHR(($U'G..&Y73M^--E9WER9Z-QMCIN$UZ8^0X*SE*%!]IVD
M_V)Y-P-7
/GCC`RC3IWTIT;&6+Y?N^=`KI^
A6MXNTIVEG.R`K8RR;ES6]`+
MA)IV8K
%UM`3FOLLG8SR]E9(8[78&*?$99=M8(L[[!+'EX@SK1SFUP-F\1

MT
]X:UF4L;B3H)_/$F2+$2\EZ&?






MBI:.&WDD)XKUK@=R@KIE]BE-'CXQ+(B%0?Z7-`V?HCB^3L(;YD8F#[!7)Q[I

I/;DW-1IU8
D?WW''&H]0K&.2U//A]!CM(8*SW



R2&G8N

=KQV/`&)_;0YQ&S)
M\$CYGA4EC!
3L#_EQ^J
@H@8YJKD#0./X(RS:BFQ3D6%A?5!I`*PGS*Z#Z)

&TM`%+IV/
OZ&G3ZP/&)_Y=7W



R9\YM8XT_O(:;UKD^
MH6'6V2['V(27@]

F0G=UJ=&3!FBGB&9

-_Q013V_TKS((LCP;]R57LJ%
M6:?R

TZ[$24M16!YO'HF(K$$+86




M1


$5O5O
(U*P_R:RA]BUO['1H(EQ`-ID40HH
+OZ*$+5X.HKQ*#J3(EM%:$;::S&'[




3U+N+*WI.W\5GY7O[3E5(_YD)!TDI%'GW@LXKT5D4J

M\JT=D6
*5'6V<GKM=^UG7Y)!X;8*9H


:
M


PM8:%I
JD-IUV






':Z8XCVU8=8'
'
H.)F



M6U?94*UUE?W0EA1&'
\98Q3.Q)!YSA6)1LH'F[X-)S
J1Z3.FS\+5!\W'DJ4
MI?-LRQXQ*0%C*


[*QVB?H_:)H$EQOUTIQ+./=+NO5.O%F
;S85RP.B+ZJ

QK^ND^3FV2=T2G-\GU8Q#%D%(I#4M9TVGOX$ZA
M@Q#M-F?K:N]V\DC&PMP33?





\<//*N$E-QH67@E
MI_L@@_22=;`7C#/Q@/W

M-R^?+:\?K`YDE@?H4)AA68K/X80O8R]:L+11BJ\2V@;%DG!M5E`&N+#2



M@__


YX\P`;7OD'$K0SPI/MF!(^?I
@@K`;_

BVLUU32EX]^VC<M.PQJ.4@+(



MD'V:\RP=$MRGCV5T?QL\\H@^B=
GUCB#VC(I#UW`W1UT'SSS.#\O+/SW0Q0&




RS]#&7

DQ5YH`G-

_(AL+A)_NL0
M/[


Y_K:NLS`'7_3/9I)*2RB'9TQ96Z@FAZ*/*/8=%
M1%G)@$9BZW3+7N4GL`JP((C3Y('_8\4,PIZ*#KS6$Z\D$61%M#[$09:O.$FV
MEN$/,LJ+3+V]8[K-N4%]AHLZ7ON#(2@W0B3#N*0Z/W48=HLYI#[I#,D0$W
M:XD#(U4VA54NY8V):`V^C6COB\5RB4:5'7,!1\LXJ2X;U+N:3)A:P_*R#<MW
MA[Q(H92MZ$5N,U[']A6@4A%T=8)*U&L.

M7KK4T'TD!0.E&$C;7]TD4+!9I'G=/Y
$ZA95E:?*#@N[`\I92S6^=!O!W98U
4_77&AD0C368XF


%@18\?@MCH'*Q@'3Q9\#D'YY2#%3;HQT&^I1`FDMOR2A9J.DT

]*I5SC0ZUB\


6^C$3!PA@0ER\2$$-7





MR(*=XJSO2+/J)*^RF=5Q(@55_%.XPXS4)X&&^IU+S/E58FX4RJD![#KGC10]


1]3/6-'H
[F/F;3.;&L7





M
P@J=_\KF9/8Q[/
Z4'G1&3.^1*@-YXOE

J0A[0$ZKB2G\1A4
ME#;#]D?&W:TC[
8TDW0/K2=DZX@O+8D]DEX13IQPZH23/\NP&0!/3(@=K#*F
;36<C`0;K%6\DF#<P^W;*`O%R(93



M49U







MJ]&;4M0=N8]1$B10
NPZ?(SR-)-7\1IL5-7P4C2R*J0CI8E?OVN(C;J*CKH7


J+JQ-PK_QFKR%HN[QE+Y5
62S
MOE8%/4U8H6O0*=S5M3^-B3468\4V*
B61SS%FFN?16D&\5!^65A.$_;/AB^8





ZN!
Q.J6X=U66]QN^9][F^W071$D'!^H&

M%J:E?1%T(%^:OO5($RIA(9.


O$03%)






MW[772+;CVFB$MD=1TW2[R]IEH[

VQQC8P'Z:-;E.UVEQK]&[
M:V,UDI7N`ZCNF;0/LJ.5KF(=I2WS.@^#M;4@TQS3=BDQI/;%JCA?K5@Z9!W



)?

M[?:R[*-LWF7(5TR2&OJ-#E+P]P@Z@A.^I90PF`*DGK7DSSU4C1
J,SOC&K+SET'E8]W:
M-N%Y3L-.V*R5=





M\
+$R
)(4

&LX0




M\/N4\B2

I?]
MV9;F?\@F9R#YHVHN3_UH$W



):O6-0M
MJO6*K(657]$GB+]64?)0.Q6*+MI*=WW(,C8FMCR/@-32BY.!B4WU9J+C:/0;
M']T,%2$'.$%:DJB)FR($EB/PA%2//%%S%@A0K4/,(8JSCX%?]!WVR+:3ZH
MU$;;E:\UT,X&N$JRZ&INC),2RL,=K[YDZ9YF#,E\=ACSA979^(2F)M^^C6IE
MEQK;(T2=805'U8VRF(82IO;@.2D;^*;]D"CT(26F,'5BE$1/7`I_<J`%C,_
M1:X41YI5.E'9S`KFJKX&G&8D1KJ0_VNCD])5CXFP4
`]T$W[KQ?$1JQ?V7D

MUD4+6=5S7Q0H!E)4ZM
&*JC*\V.:[6AVDSVDCS3^5J3K/\2M[^^#QRADO)^3

M4[*)8
D6)1*0KI+HDT9SR3Y(2IJY5X26Y';?!=DY&T6,812`NT?D8AHAHE





B1PC[!H2*?$QYE,A2B<!^<M#0A51ORZ=
[3S0N

MG%T_!E$


V)
J/
XV$C4Q-X8CN6U@

UB+@+O53X.<
MYC6S.YKMNKO\ZA;5!K^LA=7F:Y\@_K:^DH=ZXU71A=FB#41URFC=47H*U@)L

M`*I==W

D\V;QZM



U&

M!O95@X(O#9[7;*D0
866
N\T^W%A[\98E%
+
6LK/UT*M48T8SF7#L%QHTPY

MRB-07\?E\+
860?VAKW*CZ/=RT88-9F@VW

M


M#!85[;6_@K_X/CT_Q`8;XDT(!=__O/_]:#XK'2Z4HU/W\;VFS9JA;:)X$]

:T$']


?2)7WPZ[*L*YKO)+`[Z#




/R.3M6L@-/#@[X0!AJL1*/(C9%NH;YXX8M/D9@.TRQ)HP5$%O@:@
MJ6KWX0$-=1GV^0`.SNVF+N#&F#%[=)/\$B3!`\\H?9?N=E%14/KK/DW*[(D.
M@BVIE)]J

@;\@DZ8PU(7;
'C

MQE'((]5B0WSI^D6X




MO:T-+;.3]3[`#^P?6[92SFA8;/


)5N5-Z
\P\AFG1!0[@;3HN_0M_24(N\@8;%.?

M)

%\2T`HSS1-0H3ETDE)%_5F
MOD$NYLA@*Y7K
(Q$7F=;;9PT




@M%L*W891FGT

:$8V^CPBVYG
5-PB/4Y8VY_?W2D8;'C5%E

D:VN?!:V!\INBK-`HO7R.Y!CDYT:34MO


=93830

9?





MZM


!`9)8)2$#_.L



1CP.6Q-Q;63J)
M[P4IA:%5ZFDK!5]S
#J#9S^&\




5G0`NW4=A_(A:[;FQ


DB!9
_M;'BKM9IJ-MBL_

MB$DFS;D




M^QC$4GT\M*5-T:&6M4&CI+8]%'&$S![
7QH!=S`]EC?L*K=!-/'B`*0VZ!
I'/







/::UI*F(((.5!R?2DG:#*+


M:A6
1E?

M$










J_)CEVVA?[=!]2^.P']3!
MHWD




5:]F?
M+U8$\.=1WIPV:F4Y&R9H4F=MC%&1)F[HL9Y3;/#3Z'2YH@E
+YFN*2)*\7A%


#$T
3(S



M1=R^N83[0Q9OML4WW__XXU^_^?



1;X.Q^`*+*#$C9\5O+.NH&GVA[TV9EB7RO4DKHWX*)K!R


%.7\`DD


M


MD?V&H]1C3:_Z
W*9R`?%;^`QB6RV'+

MZ4.S\Y2?1

O?P\+T!'F8;U&[-T8Q'U
MTA+HS*#0R+;!E2`G:HIY$\0KK[&2:(UH^)S59?Y




MV:(TVE2[




M3!X=63HS
GQ89&ANHSFK



%N![+_^]!=\[0CQ
M78
L:X*Z&5I7*B?=R.^)L'%9+1J26]1CW_\W.!#!0:'IH6-$$Q@\V#KJX&/$
MN0'(][X#Y++
L(UOXAP-I?\$47:=KJ[0#;`(^L
5ZC.A8.+0]!T.E#08^,CKK.!QJ#0V0
M?@@#2+_`I$06R`XW<0*RG`@@DT/..:P`##UE$'*/.#4#^9Q@`:3SF$]C#

6C^5K$B]O$A@-=P2HWWN0Z'T/#!!TW73@T./:
M@.$_P@`#/O)OKA141R_=ZVSDT4:@0'_

MEGTWZ)?A)(9#-=AY'%$%`R`Q/=500^7=0.7'L*!2Y[;@@X5`1X1+CRY0P-!U




M9=HC4[$RSIPRN^V@FM)]KTRLHCHN%6.M'HSQ!K)7.$C;Z`!K3P#I'^1;U9!
MG6+IIBFD2_N+1#U#&)2NA+U2!!/T-D$=N/\

M7$\\(7G4[@R:(P(-#XC@:^4,2(K%R';*B#XJH1%JE4*TT=.@0HVVT+%J6_
M





!'B'
MNU1'G24K!2#%I3LY(1J=YQ`2U5#2%=%XAKLO4*U'N(#A4'57<@&14P[&:A0

M%:#/



U']O.44E'NMG.H#C&JQ





B+@

M/Q(C#8[1F7





MU@][D%65Y


-Q





DB8&0(WJR`-QOP'3\\
MA21P0FE\2RQ#_GL!&;7HM-$X;DV@V&XA^M'I4[ID&D=:TPQ[%I=BB@055)






`X;JQE#Q=S*5J;^)

:I)
M8HW`3F$[M<DJHZE)H1!C#^<\I\?/_@



M55N0YO%;O8YW]WC`









M/BUX3*)E=7:OLL_&826SV49E%2(
#1IOFFTWJBPMR!4.&VV!O%HDITO0YNQ\









M.M=KJNIJ!HYE1%:IU2./]%RZ;N89



MIWJ



O:QQJ
!031F*S[



D9@U[/<%Y=2KU'NN@:]G-*
[\$9WWF?5
M2XS:U5:GT152(Q7
#










M+/Z$7ZX0W0!^3=V%&A


XN+0BL1W!!(E&N6%
M2KB+AQ-K1ZBB^28C5D3]@%-80^XE\B
R!^=;S6P_H221\73W'^N[NM/U0Y


DZ
!GD

PKIXH<18D0Q0'KYC^
M&\9I\0OZ![(_;?J@6+H-J)$M[2Z4BPIO[O+%V3;QB^GH-K\4

P@R@E.0FJ


M5-%YD!&!4D=U-#._0N?1/%696!Z#.(L&I.]R2/PIQ

M)+%H75N(EJ&N#]U9J
6@G*[]SLRJ`7=H#N?0N[)8?H%SGH&I-@?2'$FSJIJW

/-
M7X]ZT0H@#:L721I;Y$]@9NKPFH-1W`3:I
8W3!
I[#345S&;@)\@\W
?WQ


7_%*TQ_/*/BTGN.35F-
M9=`GP#O







&G

M)0_'?N#\GH?HE.$F3N

[&)9Q&]Q


M^C?ICJ7/G-')=)C/M



7%



\YVQW^;6X7'T#QR/
)YRUO#


M5[7(BTD.U3%9)(7*W5

^_`:QXH









[FBD.1^A=.!-5E%Z(H3ROD+O@;





M]*U

FSEKJ/=N1(/%%R




@Y7BUASTA$HND/;\BD@2!0'MY(%`9FHC

MFF:YHX1AFV9K9A%]YT&(MZ8*BQV.-#-K[3Y/






MSU4FE/QSG


MZ5O;L/UOWC4L0W1VP_8+ACOM&OM!R'(S!*.T1U^]0G

M.!HW]%
@@KJ$D9E#-9B7C:B\T@[_F0%RE*(P/4/C`;VY?:Z?\:MJ1&]/^-((
MV/OBK/^*FQ6RE.EW62Y3W$=[S
)U@+S^!^6ARS=F
X8(
`[7L#HCBYA3U!]G
5!Y^RC2=@4;I[LURQ
M1:&





MPSTLAM$

A*Z^


LOLSGL$:K7@@IBUGIW/

JU










_



M_;:]ZX%FJ.O=

M7Y



M\%I#J*]F$C.G$[-G.\]0;AEH`BG#+2%KD
-;)9&C#RF\.PJ2UT!T@O9.*8%@
MKG#C&F

MA/3


MHWZ6[
DAWF?X!C`\;].A\9Y@DMS`[&N4K08N2ZI



&4X2]E@#A9KFHE@OX

H8E*F


MEF_C_2/(EMA
&W!QZ)/6)$
?;)1IZY@-
0T'X5;




`^[*'Z1581V4R.FC7XZ(`NQZ7^20;AQ+8.Q5J+XV-(Y+I&\*W?7


-T\









&AF*QK)XOZK.:\V`K
U*(
*=X*1GD<7(R<JOB0W-TD



ERO/
`I3T.9('SS2/VY?V4+
`)?78
MWX?'FMO=M)%TS-


]2\[]CO+R




_/C&K:G+U<]JXGM`9@]BO
?K]-
M'S.X!+D8S/@EAC!CE0@&9L)JJ\&
Q=Y.H(L+M#U%7S]':
X51XD8V+@%AEAC

JD2454
4A7.X^Z)'






M=7`^[)#L]FB#T(N3PPZCS&$OZ?[.7JG-RSIVW'E\NYUPS)$9S=LOVXE]K'






MZFNQ7):[
HD*L+K3T0NX]HI@WTJG9.5XL=S(KXC^IWJB$&*#3-]G09V!#;

D

G_;X86SJK`3J#M?C3`4H7[X
M4K+J.9QUD^EV6W#F6C2-A!XM7.:95QKN
/S^;W(CG[G]R(U^K8?[T5JON2M

M5RS5E.R-*WYLL4AEG'VJX..+&;IU`DJ[@:/BV.
PX*.1RF`.^!2SCG'$4JM5
MF)+\6&
X!1O

8$HDPLQ'QR`.*LZT2=J:PJZ$*R)O:B4BFA?G




MC4#@B3K4M#$\


[7H
^H

MO
::B%[B





M1S\3U
I:Q@9F!60P'/XXZ7


M=:Y:RMK.RC2Z-)[A[X&N
HV3ZO3\'J;+


.\A*F

M=;6M@RA/6P3

P-!7\W-4X-#V`^%H
Z%U09(9DGBZ2Q!)G$

MX#5KE7N!)TW_9JI?Z54BV


Z,U6`TA+4P_6GY1Z6<85G+V%V246702%/KQ4L9[1#3
M)-X=P)/RM3'YZ.M
H

K=/X`&`C@,G9G+BTC7F
M8=#YNZK00044MXWD.D-!*CQ;84BC/ONPLZ2M5]W5YE;<I
(/BY=+W
ZD6ZV
MX!.US33@8TAC)YG%AU)'F-%%K#ZHTZ_]7J2"U+E20XIU#K[5.PYE@6MQP&
MU9Z3IIV3IIDU;SU'R#MA0T\P26Y@AC^:,KE0);K-P*ED#DU3'UC8:Y4^?_,-
MTO+W=SZFAV=_6S!UC!T7



B(+%.==9Q=EH4IDTD$!.'$[-I#/5@I=+?F]3K.YN'
V2VY6\E-



M1S3




M%5W79)::55NSR?,+/659WYB\@19GOB.CYI&J]B[&4;I=/GTQ*MV7QB+7[-


CC*K/;F6B9IV7FV%H_7$3GOE]/&/NYLWY@

MN!;?LJY-MPMK+;.:0I76US1AYU_SS$=
E*7-$P]QSN5F
2!


M;JU--\Y(W`IR$1PF*=


M

S+L
*)3AVG



M8[P2P6)*9BW


P30_K4:-[_Y%SX*X@GVQ3Q^Q\'K0?S:W]
M;X*$WT&A$OO0K2-Q!Q:9P

%?


MI0G7]_64X@.4#\V/!4I?X*B_^G
]+R(/M%J9&X2'GGZ#]231RXO`DL!&P$[H
M\UC6;
OB1'90K;
M%#
N_07;ZV%]FZ[BMWA51@EA6LND:0Q.H?%'KU_C8EL=

10_YX/#GM?PP1*TP%M8$RY*X^7%@[

J'W+K



I_PI3%R[XMK
MR8D+=N*WOO3.#WDHD*PPAV)H/N0DF?AB79YV3DDLZ\![GUZ-NY`HKW_4*O
M`L8N+9FQBY6]W$7)CMPWL1/SE6*J.H6S1$&%%5U\91EW/@5TU(`P1D^UZB

X

ZFMP\;?P7*+VCM
I(YWMG5!^3:;V

@/HTVW:ZMV.;;76CR##

M/+XL

MF[[VXPPGQ]0HE
9J

NKF[UG(R#)O4ICT`=9&^T8\3







MN%%/!BWREV#K;6V?:PD*8#Y29^P`'-O;C=M[*9A0_3J^GW'[@P?1(O90L8
M'D:$$G[-_-#LG!CPHR4&G
;_^)Y(T*X/LI%X\'S(1SONF'`V9$26J0X'SY[+





X1#^]'AQ#D/G_7T4(
3N.KC%5IKW41Q]DN4
ME*9C(Q1KMY)62J#V\SFT@5;S\1!:6B
7TT#*-E=]9?AA?0_3-N'U
=GUH+N*

2.:JV_F&7#]ZOV-:V:LN-Y14/9^5]FUNSK+YN.(BQ150
MUL]908+:4Z9F4!;Q4(VE]8<.1I8_NVC#0+'G:Q.V/$B77T&Q1:N8`(W!TH<




@-L4

MU)\



(96I\USF'&=

)AFHV

98*IBG4K


VT(.480F5MK27+
3M:1P+?TS[7W_@KI&!I][&*H\W'6&*(983H
M=21PEO.&B2%$PO!$A
\]''4_SQM)5$-
B*6N#


M:WS9[Z?J^92J;/3\457GGF^BC8+L^2.5YI;J2-$N;4[2A[+(BRA=X;=LZU!3


MSR.'U626[!6QNN!3%

43CZ(**!R/J93A




2]F8!)VQMK3*;S
MO7FFE
I3=-TF*&3(4*XUPAJ%5$MA(D*\5MCY\$WS\[1=KUI$&ZP@O!^V@G
N)#25GT^M`=9




IV.!XU1FZB=
#RODB
M75V_[^.L8CK!

;[2%P.(X[LGZ0$2/WS&$M#M^RB8KNJ@'`VAOK4TWSG249Z52<!4<


9:#YA
M[24M30$]?%]+ZOA)77W9

5&'`RO0JS%FY8GL?
MIX`XU%.^-KJ-OGJVIVRH(2'/#B+[O7JR8-\XDL&WR6/MRD%*1]+H8Q=(G8_S


8.*88LIW51/O4+(S9!M8VS`C`'/2)%#U@#BIE#BV6/*<$U
MD$,]CM^+_1BK*T;J*;?1M9*YQJ<I1#\UU7DO.\DL.\TP:[&Y%M6=G1R\7;L



_=1W


SMLU
M_K3]7%T4=[M&X:576]ZJG=
UJBPV&0##I$D#3R)3I&EIL2(S[H$*-INJ=XB)


MH]2(PIE&=S#=(-^VPU*]H
H(F3=8)&UN(R*)-TH14UVPB2B*::2;
)0W#:9H

T(Z/_43
M8/5\%\:V*/#NUK+:TX11FM
V)EA4I^T(

MY0JU$PG!0A[#1$EOX6F&(/

YV0/J86DQ8$&Z:J)$R$/1=(%V\%)HJ#'2%+67W@`


M;]\M89D6V0'K]T/[#ZS:#QW5FI]_^_(\4.+T0R



4(C

M+JTY!7Z.DCW(TNL451Q3EH-
FD9@HVSKB5F;BF7+^?
5GC'D=AZ6(RS+K9



U3.^@[#N%!4JWZO&7/$G8;*R;?'

M

CHN0W-(&*

M
WX#UV^T6#D!2E*;#RE#:'BF=M*M/^3F+

M8L3M
U



M**A3OXN
&5:)92F

M7TY+$2!P.1H.%'=DRN'HS'5@=-NU(S.)Q6Q'9LY@)#0JCWFHG_^XOASXC'2M

M;



1
!&ER@4

MT0&W/A+X



*G-D%$[Y//T&`H(0R#/H]P;VWU5;Q-
MT?P$Y
433EV$X\)7CR!;8H-LADB0+TATW.R/J-(V0#&).IP=DRR@8
&Q][

!U8

!$I3!+D
MO#.T^








#!Y!1&N/HKU(*H-R[U34'C)&^2
M

_=1P@-[_`3AZFN<)$ASY(B=!._
M)J#^Q.MS`D5I?8E9='9]1-Q0=K'/E$/]LH-WF'[
()IS%H?')*K.W?`VS'XW
M/NJ4+TC#









R1KT
]`\`)F
$TRLA5!O[4$5D_(?@)


&
MU






J




M'E*H;


M)8GA49$)7NTYDAZO4+!GTF1*$-44P
8S!%ZTUFB?1'XM+[UG(E2%X7F!?V&V


@=U.?LWN8
?

^/:
MA52A098F7B'?^X.2\E(0%JU!_1EUZB[`4CR**%H1NJT`P2J
VAOARDP\!V9




($/F]&_CR#FA








MU3\_1P46F':LI


M^:03@2?JO*#J.+
'


MHWC;




MI_9!:

A7IXI'$X790YTB'/'S
0+?]=



L-]NBRH?+
MWEF@TY-W%4CTG@-05F.-W002;_5\J[YL#O/W-T7WYX3W.1D
PPV'U8ZH))F:
M%';(



M\X=R0V+K-PD?-%Z_A1AT;V#])K2R




M

MD*/#P%6.&-47U?H

@:.Q(I/$4(7QL15!YN+A@0/$-]_$2\?V\
M_#V--UMRL[)(&DN023QM6`%]1%J6S



6HZGK)U&I5





A;
WQPA<[`Q60]I(X*UPC:T`S&HPK=AKMDO
MS5LQKY`&A*T('EE_!YI`9E=BXC8%GY`AM?DMU(M#REY`!&B94C?H776.07




M



M4;:Z1F



\IB3K$U]

MJ15.J_.EB?E'_'[)=\/=]AER[4;[N+E@LOJAT4MN/%:VI0^6.PJ&QVBO(7
MV!R;MA
:@!;R

M
J);ZY(%`25!+76=5I=QYU0SXCZFK7[2?@ZZW-1F05D2VRKS7M(E^0B#%V


MF#9PHB2_Y]`=5:32N4P7SFX=**[?*&
XD7.=WIK*

)W_J[#(8FSCE8?KN!
M;]\M\8E/=L#B_]#^`TO^0T?RYN??OCP/Q#W]T


M#M
[B.BSN8CXZ?^-:@E^6;

1LS#'5:J$






+2SE-G`Q8AWM-N[VRT?C+`3PH7P?);HY?PX
(6T%-D(R8

ZHZ&X.#PF



M/

@VH
?/`T6A90??6FDKE
[_`
MUKV+S+J\1J


M/JJ;A^)^DG+!;\BZ
Y
GL0S8Z1B;[(B.OJ;G.XQZPYW62QICM((=W`!393.X
M

A!\1
M0@3W




MW90L?D-#XQL@B=?K*H0M

72QQ=4)$L[FXM9P1'4M5]_PF92QOJ-%DG9`E]$


&)EW=OG-MV7:(S!


X%&I8TM;`/PA_5!?=3Q9%1/

ZU+6U@;P8L3.JN.^0CZ42X[R!5J&E*TD`<1
MS1U1J7'+!)I1='*/QEE'EVPM**9EOU^*U=&/#N[Q5NA&'C[-PS:#5^2ZCU!

P_F1N_-+
ME]SD+UA3%;7Q)$18+I$MJFJ/:?V=*$L&YT5'#GMQDPR:9C]T*C&V+MOB/-=
MZ/-=Z/-=Z/-=Z//-T\ENGOJU'V=ZJ#1Y]60;+*744/=^3_GD3[GD3[GD3[G
MD68ZUUGFD=:YMW12X+3MW8I]X

FF'BW:JF$.C7$;)LDRJ/Y]@DMS`

M`W7
Y
MS?-RE&K:AUVO$5;Q]DSF&J@\+U`JY;O32!A`OA]OGC/E7GT7H[/9]4DYW^
MWZ_I[`7,-E;XOJOG/IME:#G`

MG6I

NP.2-+6I&N[GZ:H$C(PA9%:@#21__Z38DQ`


_





IZE8D
4*'*FE


M.]-A`XR^1


M?![U`KI2X*ZKFNBV4
5;*-MB.\CJ0M;S5B#^$KD4OZ11RN0RY.7`OBQ&8I
MTA56?`=D;27ION,J.8._AV`1U$!8X:X%,0?&H(8EJU@5PE+[SLC:%)ET/'
MLBX#A?E`N+#EW`44

?=Y@W$
M@@EF&5-V@H8K_

M;=`!F&^/X!I

MY3^

V0BMS

[HU.KN`D\(G_IV1K?YL$62Y*6GTNK

,!-_7A`!V.M@$`*1&'*_D(


\<EP.)B!$]<-#.V-D`6G0GMA
MU^;2A*W
D.68E/)[99N88+
2#V^`UZT





+$NL!M%5\#PMSBIK@DA;&@7'=(-KCQ)K.AH9*N?$M#R4TWE3`W
*YJX#?X8L#P98!^<;
M\`[Y#V(2.2]


OYMJ@/;]2.WW(L9:?L`=92
M=K)YV(^=&1`\3EN'AT2VZ/?YMHAVG/!S.^2]
2O)?/$?NS


MD'T


M1Q@0M`*V
6JR6(G3^@C6LT1;UT]C#WO^H0
PW=GH$1`7J?;6]E8E?ST8IY
MC!5,*
M`K



MDNVXT&_
.

MMB\D9=][T;*AGF`NUPT+TF3K=6




!^-7;QGHS;]S
M



M1*-NYE#Z+ZI-%M57M-AXR8)Y82Q#'X9=]0TGS;68)#7[\=EM3I42VOYG&T/]
+
M!W#O#=:!P@[$%/@Q=7-()N@QA(3.\8DOODZ)UTIE6PB#3&A?J5(I52RB13W


M&7^H]LUB`F8E)II*YP*71VC&#3


MC;&2\C1$
UZ]FJ(E*&45+3DM+

MHG6


0F/=DY3G'#VR,\!^%

'T6MN7K^V&J-@U-)IRIR<0^FXM(Z3V)1JJWD`HGWY;-]Y8D=.`.8JA)

M1+/RS)&[PQ3?;LY_A




-<YZ
3N+74_HH_'^&V*M_(![OL/.[4VK2
M2[;9!+CV5L@PW]@%TC`Q=G#HLF^LWO!@_@C8L0NB8S#O0AUFWA;:I1QIK*)R
M$BX4

MX






MU6F0\52L8PM@V*4












M$6I@:DJ8!V@/2YNP3TPDOIY9C?^Q
XMOXZ;B7@XLJ`9N[TKWU_2FH)K'
M9`#-^01:J4

M*A$4H09&SY6O@3GTE6JS39.68U7P%5(&L!`G/C]!V:-[KNL5HPQJ^PI[DEX\

MS`*M$V@K-[PL4SO7'?P!-(+;W'G75)^

4!:P7Q!01
@!1X/U6S5LF/K,/X-4:=9(T?98!`6I`
MGD%O'*K#??*F&USL=]S;-2


<%QA-

DU1


MH%J_WE7'#B]%VC@6KC,U.QST_7V9'IFC%$1KOAI*B[;E)435RYA`^95SJ2
M%/%O7UE6I_1IDJ+;-5,-IVDJ7^B2U%YX1H2B2YY$IEF66.30+7CV:R;=/'




\


_OL7
M4$L!`AX#%`````@`!XI_1C^ELDR^Z0$`16TE`!$`&````````0```*2!````
M`')I8G0M
C`Q-#$R


M:6)T+3(P
30Q
C

M2P$'@,4``````'BG]&]?8C0Z90`0`+K10`%0`8```````!````I(%Y=@(`
*?T;XC3<$7A\``(IR`0`1`!@```````$```D@55E
M!`!R:6)T+3(P
30Q
C
Q+GAS9%54!0`#G@X;575XP`!!4.```$.0$``%!+

 'defref_us-gaap_RisksAndUncertaintiesAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ConcentrationRiskDisclosureTextBlock'
<div style=font-family: 'Times New Roman'
 Times

 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_InventoryDisclosureAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_InventoryDisclosureTextBlock'
<div style=font-family: 'Times New Roman'
 Times

 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<table align=center border=0 cellpadding=0 cellspacing=0 style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock'
<div style=font-family: 'Times New Roman'
 Times

 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<table align=center border=0 cellpadding=0 cellspacing=0 style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times

 Times
<table align=center border=0 cellpadding=0 cellspacing=0 style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncomeTaxDisclosureAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock'
<div style=font-family: 'Times New Roman'
 Times

 Times
<table align=center border=0 cellpadding=0 cellspacing=0 style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock'
<div style=font-family: 'Times New Roman'
 Times

 Times
<table align=center border=0 cellpadding=0 cellspacing=0 style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock'
<div style=font-family: 'Times New Roman'
 Times

 Times
<table align=center border=0 cellpadding=0 cellspacing=0 style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=ribt_RangeOneMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=ribt_RangeTwoMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=ribt_RangeThreeMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=ribt_RangeFourMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=ribt_RangeFiveMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=ribt_RangeSixMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=ribt_RangeSevenMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=ribt_RangeEightMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_RangeAxis=us-gaap_MaximumMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_RangeAxis=us-gaap_MinimumMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_TitleOfIndividualAxis=us-gaap_DirectorMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_NumberOfNonEmployeeDirectors'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_TitleOfIndividualAxis=ribt_DirectorServingOnStrategicCommitteeMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_NumberOfDirectorsOnStrategicCommittee'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock'
<div style=font-family: 'Times New Roman'
 Times

 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times

 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times

 Times
that there is no additional material exposure as any amounts determined to be owed as a result of the above noted litigation and contingencies will be covered by the escrow account.&#160; If and when received, w<font style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_EarningsPerShareAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock'
<div style=font-family: 'Times New Roman'
 Times

 Times
<table align=center border=0 cellpadding=0 cellspacing=0 style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CommonStockSharesIssued'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CommonStockSharesOutstanding'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AllocatedShareBasedCompensationExpense'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_TitleOfIndividualAxis=ribt_DirectorAndExecutiveOfficersMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AllocatedShareBasedCompensationExpense'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AllocatedShareBasedCompensationExpense'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AllocatedShareBasedCompensationExpense'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AllocatedShareBasedCompensationExpense'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AllocatedShareBasedCompensationExpense'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AllocatedShareBasedCompensationExpense'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PlanNameAxis=ribt_EquityIncentivePlan2014Member'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIssuedToPurchaseCommonStock'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CommonStockSharesIssued'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CommonStockSharesOutstanding'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_TermOfOptions'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PlanNameAxis=ribt_EquityIncentivePlan2014Member'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PlanNameAxis=ribt_EquityIncentivePlan2014Member'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PlanNameAxis=ribt_EquityIncentivePlan2014Member'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PlanNameAxis=ribt_EquityIncentivePlan2010Member'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_TermOfOptions'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualIncreaseInNumberOfReservedSharesPercentage'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PlanNameAxis=ribt_EquityIncentivePlan2005Member'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_TermOfOptions'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PlanNameAxis=ribt_OtherPlansMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_TermOfOptions'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_TotalOutstandingOptionsAwardedToCurrentAndFormerDirectorsEmployeesAndConsultants'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_VariableInterestEntityClassificationOfCarryingAmountAssetsAndLiabilitiesNetAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OtherAssetsCurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentNet'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OtherAssetsNoncurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_Assets'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_LiabilitiesCurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_LongTermDebtCurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_LongTermDebtNoncurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_Liabilities'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_MovementInMinorityInterestRollForward'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_DistributableCashTerms'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_MinimumEbitdaTriggeringDefaultStatus'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_TermsOfQualifyingEvent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_VariableInterestEntityClassificationOfCarryingAmountAssetsAndLiabilitiesNetAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OtherAssetsCurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentNet'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IntangibleAssetsNetIncludingGoodwill'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OtherAssetsNoncurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_Assets'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_LiabilitiesCurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_LongTermDebtCurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_LongTermDebtNoncurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_Liabilities'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_RestrictedPortionOfOtherAssetsCurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_PropertyPlantAndEquipmentRestrictedNet'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_dei_LegalEntityAxis=us-gaap_ParentMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_MovementInMinorityInterestRollForward'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_NumberOfRepresentativesInManagementCommittee'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_NumberOfRepresentativesInManagementCommitteeUponDefault'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_dei_LegalEntityAxis=us-gaap_ParentMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_MovementInMinorityInterestRollForward'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_InvestorsPurchaseOfAdditionalUnitsOfEntity'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_AccumulatedYieldClassifiedAsOtherCurrentLiability'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_AverageNoncontrollingInterestOwnershipPercentageByNoncontrollingOwners'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_dei_LegalEntityAxis=ribt_InvestorsMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_MovementInMinorityInterestRollForward'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_NumberOfRepresentativesInManagementCommittee'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_NumberOfRepresentativesInManagementCommitteeUponDefault'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_dei_LegalEntityAxis=ribt_InvestorsMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_MovementInMinorityInterestRollForward'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ContributionsToBeMade'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_YieldEarned'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_AccruedYieldInOtherExpense'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_DragAlongRightTerminationAmount'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ProfitLoss'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ComprehensiveIncomeNetOfTax'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_EarningsPerShareAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_EarningsPerShareTextBlock'
<div style=font-family: 'Times New Roman'
 Times

 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<table align=center border=0 cellpadding=0 cellspacing=0 style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_RelatedPartyTransactionLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_InterestPaid'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_BusinessAcquisitionAxis=ribt_HAndNMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_RelatedPartyTransactionLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_BusinessAcquisitionOutstandingSharesPurchased'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_AmountPayableThroughPromissoryNote'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_ProductSales'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_WarrantsExpirationDateAxis=ribt_WarrantsExpirationDateOneMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_RelatedPartyTransactionLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_WarrantsCanceledDuringPeriod'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_WarrantsGrantedInPeriodFairValue'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_WarrantsExpirationDateAxis=ribt_WarrantsExpirationDateTwoMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_RelatedPartyTransactionLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_WarrantsCanceledDuringPeriod'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_WarrantsGrantedInPeriodFairValue'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_DirectorMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_RelatedPartyTransactionLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DueToRelatedPartiesCurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_InterestPaid'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_DirectorMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_RelatedPartyTransactionLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_DirectorMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_RelatedPartyTransactionLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ribt_OtherOfficersAndDirectorsMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_RelatedPartyTransactionLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DueToRelatedPartiesCurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_InterestPaid'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ribt_OtherOfficersAndDirectorsMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_RelatedPartyTransactionLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_WarrantsCanceledDuringPeriod'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ribt_OtherOfficersAndDirectorsMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_RelatedPartyTransactionLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_WarrantsCanceledDuringPeriod'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_VicePresidentMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_RelatedPartyTransactionLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_VicePresidentMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_RelatedPartyTransactionLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PaymentsToAcquireBusinessesGross'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DebtInstrumentFaceAmount'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ribt_NicoleMcknightMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_RelatedPartyTransactionLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ribt_NicoleMcknightMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_RelatedPartyTransactionLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PaymentsToAcquireBusinessesGross'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DebtInstrumentFaceAmount'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ribt_NicoleMcknightMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_RelatedPartyTransactionLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DebtInstrumentFaceAmount'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_RangeAxis=us-gaap_MinimumMember'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_RelatedPartyTransactionLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_BusinessCombinationsAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock'
<div style=font-family: 'Times New Roman'
 Times
<table align=center border=0 cellpadding=0 cellspacing=0 style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AccountingPoliciesAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ribt_PercentageOfDecreaseInValueOfForeignCurrency'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncomeTaxDisclosureAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncomeTaxDisclosureTextBlock'
<div style=font-family: 'Times New Roman'
 Times

 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<table align=center border=0 cellpadding=0 cellspacing=0 style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<table align=center border=0 cellpadding=0 cellspacing=0 style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<table align=center border=0 cellpadding=0 cellspacing=0 style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times
<div style=font-size: 10pt; font-family: 'Times New Roman'
 Times

